Citrus Sinensis ID: 025440

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250--
Protein Sequence
MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR
Secondary Structure (PSIPRED)
cccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccccHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEccccccccHcHcccccccccccccEEEEEEEccccHccHHHHHHccccHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcHHHHHHHHcHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mpkgslenhlfrrgpqplSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAklsdfglakagptgdrthvstqvmgthgyaapeyvatgrlttksdvYSFGVVLLELLSgrcavdktkvGIEQSLVdwakpylsdkrKLFRIMdtklggqypqkAAHTAATLALQClnnepklrprMSEVLAILERLeapknsaklsqsephrqtgpvtvrkspmrqqrsplnmtptasplpshrqsprvr
Flexible Loop (DISEMBL)
mpkgslenhlfrrgpqplSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSgrcavdktkvgieqslvdwakpylsdkrKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEApknsaklsqsephrqtgpvtvrkspmrqqrsplnmtptasplpshrqsprvr
Low Complexity Region (SEG)
MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR
Disordered region (IsUnstruct)
***************QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN**********VLAI**********************************************************
Disordered Region (DISOPRED)
*PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE********************************************************
Disordered Region (DISEMBL)
MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK*****************************PLNMTP***************
Disordered Region (DISPRO)
****SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA****************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRVR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	252	2.2.26 [Sep-21-2011]
O49840	426	Protein kinase 2B, chloro	yes	no	1.0	0.591	0.767	1e-110
O49839	426	Protein kinase 2A, chloro	no	no	1.0	0.591	0.752	1e-105
P46573	412	Protein kinase APK1B, chl	no	no	0.968	0.592	0.595	6e-80
Q06548	410	Protein kinase APK1A, chl	no	no	0.793	0.487	0.698	7e-80
P43293	389	Probable serine/threonine	no	no	0.884	0.573	0.599	1e-73
Q8GXZ3	410	Serine/threonine-protein	no	no	0.793	0.487	0.66	6e-73
Q9FM85	408	Probable receptor-like pr	no	no	0.821	0.507	0.608	2e-70
Q9SRH7	490	Receptor-like serine/thre	no	no	0.821	0.422	0.607	6e-69
Q9LFP7	493	Probable receptor-like pr	no	no	0.821	0.419	0.607	8e-69
Q8H186	389	Probable receptor-like pr	no	no	0.912	0.591	0.547	9e-67

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  397 bits (1021), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 198/258 (76%), Positives = 222/258 (86%), Gaps = 6/258 (2%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEF
Sbjct: 169 MPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEF 228

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 229 NSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 288

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDK+KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN 
Sbjct: 289 GRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNP 348

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLN 234
           + KLRP+MSEVLA L++LE+ K    +    +Q +  R +    V+KSP R    R  L+
Sbjct: 349 DAKLRPKMSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSIVQKSPRRYSYDRPLLH 408

Query: 235 MTPTASPLPSHRQSPRVR 252
           +TP ASPLP+H  SPRVR
Sbjct: 409 ITPGASPLPTHNHSPRVR 426

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  382 bits (980), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 192/255 (75%), Positives = 214/255 (83%), Gaps = 3/255 (1%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRG QPL+WA+RMKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+F
Sbjct: 172 MPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADF 231

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           NAKLSDFGLAKAGPTGD THVST+V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+S
Sbjct: 232 NAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELIS 291

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR A+D +  G E SLVDWA PYL DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN 
Sbjct: 292 GRRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNP 351

Query: 181 EPKLRPRMSEVLAILERLEA-PKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTP 237
           + KLRP+MSEVL  LE+LE+  K   K +Q E  R      ++KSP+R    R  L+MTP
Sbjct: 352 DAKLRPKMSEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTP 411

Query: 238 TASPLPSHRQSPRVR 252
            ASPLPS+ QSPRVR
Sbjct: 412 GASPLPSYTQSPRVR 426

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  297 bits (760), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 150/252 (59%), Positives = 191/252 (75%), Gaps = 8/252 (3%)

Query: 1   MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           MP+GSLENHLFRRG   QPLSW +R+KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+
Sbjct: 155 MPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDS 214

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           E+NAKLSDFGLAK GPTGD++HVST++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+
Sbjct: 215 EYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEV 274

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           LSGR AVDK +   EQ LV+WA+P L++KRKLFR++D +L  QY  + A   ATLAL+CL
Sbjct: 275 LSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCL 334

Query: 179 NNEPKLRPRMSEVLAILERL----EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSP 232
             E KLRP M+EV++ LE +    EA   +  + Q    R++  V + + P     +++ 
Sbjct: 335 TFEIKLRPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTA 394

Query: 233 LNMTPTASPLPS 244
           + +  TA P PS
Sbjct: 395 VGVIATAYPRPS 406

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  296 bits (759), Expect = 7e-80,   Method: Compositional matrix adjust.
 Identities = 141/202 (69%), Positives = 171/202 (84%), Gaps = 2/202 (0%)

Query: 1   MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           MP+GSLENHLFRRG   QPLSW +R+KVA+GAAKGL FLH +E++VIYRDFK SNILLD+
Sbjct: 154 MPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDS 213

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           E+NAKLSDFGLAK GP GD++HVST+VMGTHGYAAPEY+ATG LTTKSDVYSFGVVLLEL
Sbjct: 214 EYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLEL 273

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           LSGR AVDK +   E++LV+WAKPYL +KRK+FR++D +L  QY  + A   ATL+L+CL
Sbjct: 274 LSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCL 333

Query: 179 NNEPKLRPRMSEVLAILERLEA 200
             E KLRP MSEV++ LE +++
Sbjct: 334 TTEIKLRPNMSEVVSHLEHIQS 355

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  276 bits (705), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 136/227 (59%), Positives = 171/227 (75%), Gaps = 4/227 (1%)

Query: 1   MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M +GSLENHLFRRG   QPLSW  R+++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+
Sbjct: 154 MTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDS 213

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
            +NAKLSDFGLA+ GP GD +HVST+VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLEL
Sbjct: 214 NYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLEL 273

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           LSGR A+DK +   E +LVDWA+PYL++KR+L R+MD +L GQY    A   A LAL C+
Sbjct: 274 LSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCI 333

Query: 179 NNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 225
           + + K RP M+E++  +E L   K ++K  Q  P      + + KSP
Sbjct: 334 SIDAKSRPTMNEIVKTMEELHIQKEASK-EQQNPQISIDNI-INKSP 378

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  273 bits (699), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 132/200 (66%), Positives = 160/200 (80%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M +GSLENHLFR+   PLSW+ RM +A+GAAKGL FLH+AE  VIYRDFK SNILLD+++
Sbjct: 152 MLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY 211

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
            AKLSDFGLAKAGP GD THVST+VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+
Sbjct: 212 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLT 271

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR +VDKT+   EQ+LVDWA+P L+DKRKL +I+D +L  QY  +AA  A +LA  CL+ 
Sbjct: 272 GRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQ 331

Query: 181 EPKLRPRMSEVLAILERLEA 200
            PK RP MS+V+  LE L+ 
Sbjct: 332 NPKARPLMSDVVETLEPLQC 351

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  265 bits (677), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 126/207 (60%), Positives = 159/207 (76%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M +GS+EN+LF R   PLSWA+RMK+A GAAKGL FLH+A+  VIYRDFK SNILLD ++
Sbjct: 162 MARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDY 221

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           NAKLSDFGLAK GP GD++HVST++MGT+GYAAPEY+ TG LT  SDVYSFGVVLLELL+
Sbjct: 222 NAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLT 281

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR ++DK++   EQ+L+DWA P L +K+K+  I+D K+  +YP KA   AA LA  CLN 
Sbjct: 282 GRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNR 341

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKL 207
            PK RP M +++  LE L+A +  A L
Sbjct: 342 NPKARPLMRDIVDSLEPLQATEEEALL 368

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  260 bits (665), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 127/209 (60%), Positives = 162/209 (77%), Gaps = 2/209 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAE 59
           MP+GSLENHLFRR   PL W++RMK+A+GAAKGL+FLH+ A   VIYRDFK SNILLD E
Sbjct: 222 MPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGE 280

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           +NAKLSDFGLAK  P   +THVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L
Sbjct: 281 YNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +GR ++DK +   E +LV+WA+P+L DKR+ +R++D +L G +  K A     LA QCL+
Sbjct: 341 TGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLS 400

Query: 180 NEPKLRPRMSEVLAILERLEAPKNSAKLS 208
            + K+RP+MSEV+ +L+ L   K+ A  S
Sbjct: 401 RDSKIRPKMSEVVEVLKPLPHLKDMASAS 429

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  260 bits (664), Expect = 8e-69,   Method: Compositional matrix adjust.
 Identities = 127/209 (60%), Positives = 163/209 (77%), Gaps = 2/209 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAE 59
           MP+GSLENHLFRR   PL W++RMK+A+GAAKGL+FLH+ A   VIYRDFK SNILLDA+
Sbjct: 228 MPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDAD 286

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           +NAKLSDFGLAK  P   +THVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L
Sbjct: 287 YNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 346

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +GR ++DK +   E +LV+WA+P+L DKR+ +R++D +L G +  K A     LA QCL+
Sbjct: 347 TGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLS 406

Query: 180 NEPKLRPRMSEVLAILERLEAPKNSAKLS 208
            +PK+RP+MS+V+  L+ L   K+ A  S
Sbjct: 407 RDPKIRPKMSDVVEALKPLPHLKDMASSS 435

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  253 bits (646), Expect = 9e-67,   Method: Compositional matrix adjust.
 Identities = 132/241 (54%), Positives = 170/241 (70%), Gaps = 11/241 (4%)

Query: 1   MPKGSLENHLFRRGPQ---PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           M KGSLENHLF  G +   PLSW +R+KVA+ AAKGL FLH    +VIYRD KASNILLD
Sbjct: 147 MHKGSLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLD 206

Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
           ++FNAKLSDFGLA+ GP G++++VST+VMGT GYAAPEYV+TG L  +SDVYSFGVVLLE
Sbjct: 207 SDFNAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLE 266

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           LL GR A+D  +   EQ+LVDWA+PYL+ +RK+  I+DT+L  QY  + A   A++A+QC
Sbjct: 267 LLCGRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQC 326

Query: 178 LNNEPKLRPRMSEVLAILERLE----APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPL 233
           L+ EPK RP M +V+  L +L+     P N   L   +  +  G     K+  + QR+ L
Sbjct: 327 LSFEPKSRPTMDQVVRALVQLQDSVVKPANVDPLKVKDTKKLVG----LKTEDKYQRNGL 382

Query: 234 N 234
           N
Sbjct: 383 N 383

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	252
225425762	420	PREDICTED: protein kinase 2B, chloroplas	0.992	0.595	0.845	1e-121
255558180	419	Protein kinase APK1A, chloroplast precur	0.988	0.594	0.853	1e-121
224099729	418	predicted protein [Populus trichocarpa]	0.992	0.598	0.821	1e-115
224111270	417	predicted protein [Populus trichocarpa]	0.992	0.599	0.809	1e-114
48209875	420	putative protein kinase [Solanum demissu	0.992	0.595	0.797	1e-113
113205211	401	Protein kinase APK1B, chloroplast precur	0.992	0.623	0.797	1e-112
356500447	414	PREDICTED: LOW QUALITY PROTEIN: protein	0.956	0.582	0.827	1e-112
356498210	422	PREDICTED: LOW QUALITY PROTEIN: protein	0.956	0.571	0.827	1e-111
357486685	410	Protein kinase 2B [Medicago truncatula]	0.980	0.602	0.788	1e-109
297817892	426	hypothetical protein ARALYDRAFT_484186 [	1.0	0.591	0.771	1e-109

>gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera]

 Score =  441 bits (1133), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 213/252 (84%), Positives = 232/252 (92%), Gaps = 2/252 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSWAVR++VAIGAA+GL+FLHDAESQVIYRDFKASNILLDAEF
Sbjct: 171 MPKGSLENHLFRRGPQPLSWAVRIRVAIGAARGLSFLHDAESQVIYRDFKASNILLDAEF 230

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 231 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 290

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDKTK+G+EQ+LVDWAKPYL DKR+LFRIMDTKL GQYPQK A  AATLALQCLN 
Sbjct: 291 GRRAVDKTKIGVEQNLVDWAKPYLGDKRRLFRIMDTKLEGQYPQKGAFMAATLALQCLNT 350

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           E K+RPRMSEVLA LE++++PKN+AK  QSE H  T  + V+KSP+RQQ SPLN+TP AS
Sbjct: 351 EAKVRPRMSEVLATLEQIQSPKNAAKHIQSEQH--TVSIPVQKSPLRQQHSPLNLTPRAS 408

Query: 241 PLPSHRQSPRVR 252
           PLPS+RQSPRVR
Sbjct: 409 PLPSYRQSPRVR 420

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis]

 Score =  440 bits (1132), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 216/253 (85%), Positives = 232/253 (91%), Gaps = 4/253 (1%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSWAVR+KVA+GAA+GL+FLHDA+SQVIYRDFKASNILLDAEF
Sbjct: 170 MPKGSLENHLFRRGPQPLSWAVRIKVAVGAARGLSFLHDAKSQVIYRDFKASNILLDAEF 229

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           NAKLSDFGLAK GPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 230 NAKLSDFGLAKEGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 289

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDKTKVGIEQ+LVDWAKPYLSDKRKLFRIMDTKLGGQYPQK+AH AA LALQCL+ 
Sbjct: 290 GRRAVDKTKVGIEQNLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKSAHMAANLALQCLST 349

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSE-PHRQTGPVTVRKSPMRQQRSPLNMTPTA 239
           E K RPRMSEVLA LE++E+PK + +LS SE P  Q   + VRKSPMRQ  SPLN+TP+A
Sbjct: 350 EAKARPRMSEVLATLEQIESPKTAGRLSHSEHPSIQ---IPVRKSPMRQHHSPLNLTPSA 406

Query: 240 SPLPSHRQSPRVR 252
           SPLPSHRQSPRVR
Sbjct: 407 SPLPSHRQSPRVR 419

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa]

 Score =  421 bits (1081), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 207/252 (82%), Positives = 224/252 (88%), Gaps = 2/252 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSWAVR+KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEF
Sbjct: 169 MPKGSLENHLFRRGPQPLSWAVRVKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEF 228

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 229 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 288

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDKTKVG+EQ+L DWAKPYL DKRKLFRIMDTKLGGQYPQK A  AA LALQCL+N
Sbjct: 289 GRRAVDKTKVGVEQNLADWAKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSN 348

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           E K+RPRMSEVLA LE +E+PK +AK S+SE  +QT    VR+SPMR   +P     +AS
Sbjct: 349 EAKVRPRMSEVLATLENIESPKGAAKNSRSE--QQTVQTPVRQSPMRHHHAPGTPPASAS 406

Query: 241 PLPSHRQSPRVR 252
           PLPSH QSPR+R
Sbjct: 407 PLPSHHQSPRLR 418

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa]

 Score =  418 bits (1074), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 204/252 (80%), Positives = 222/252 (88%), Gaps = 2/252 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSWA+R+KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEF
Sbjct: 168 MPKGSLENHLFRRGPQPLSWAIRIKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEF 227

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLE LS
Sbjct: 228 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEFLS 287

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDK+KVG+EQ+LVDW KPYL DKRKLFRIMDTKLGGQYPQK A  AA LALQCL+ 
Sbjct: 288 GRRAVDKSKVGVEQNLVDWVKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLST 347

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           E K+RPRMSEVLA LE++E+PK + K  Q E   QT    VR+SPMR  RSP+  T +AS
Sbjct: 348 EAKVRPRMSEVLATLEQIESPKGAVKNIQLE--HQTVQTPVRQSPMRHHRSPVIPTASAS 405

Query: 241 PLPSHRQSPRVR 252
           PLPSH QSPR+R
Sbjct: 406 PLPSHHQSPRLR 417

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|48209875|gb|AAT40481.1| putative protein kinase [Solanum demissum]

 Score =  412 bits (1058), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 201/252 (79%), Positives = 220/252 (87%), Gaps = 2/252 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPL+WA R+KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEF
Sbjct: 171 MPKGSLENHLFRRGPQPLNWATRIKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEF 230

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 231 NSKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 290

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVD TKVGIEQ+LVDWAKPYL DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+N
Sbjct: 291 GRRAVDNTKVGIEQNLVDWAKPYLGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSN 350

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           EPKLRP+MSEVL  LE L++PK  +KLS +E      PV V  SPMR  RSPL+MTP+AS
Sbjct: 351 EPKLRPKMSEVLTALEELQSPKGVSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSAS 408

Query: 241 PLPSHRQSPRVR 252
           P  ++++SPR R
Sbjct: 409 PFQAYQKSPRGR 420

Source: Solanum demissum

Species: Solanum demissum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|113205211|gb|AAT39953.2| Protein kinase APK1B, chloroplast precursor, putative [Solanum demissum]

 Score =  410 bits (1053), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 201/252 (79%), Positives = 220/252 (87%), Gaps = 2/252 (0%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPL+WA R+KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEF
Sbjct: 152 MPKGSLENHLFRRGPQPLNWATRIKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEF 211

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 212 NSKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 271

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVD  KVGIEQ+LVDWAKPYL DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+N
Sbjct: 272 GRRAVDNAKVGIEQNLVDWAKPYLGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSN 331

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           EPKLRP+MSEVL  LE L++PK  +KLS +E      PV V  SPMR  RSPL+MTP+AS
Sbjct: 332 EPKLRPKMSEVLTALEELQSPKGVSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSAS 389

Query: 241 PLPSHRQSPRVR 252
           PL ++++SPR R
Sbjct: 390 PLQAYQKSPRGR 401

Source: Solanum demissum

Species: Solanum demissum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  408 bits (1049), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 202/244 (82%), Positives = 219/244 (89%), Gaps = 3/244 (1%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSW+VRMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEF
Sbjct: 163 MPKGSLENHLFRRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEF 222

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 223 NSKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 282

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDKT  G+EQ+LVDWAKPYLSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+
Sbjct: 283 GRRAVDKTITGMEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNS 342

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           E K RP M+EVLA LE++EAPK + + S SE HR   P  VRKSP R  RSPLN+TPTAS
Sbjct: 343 EAKARPPMTEVLATLEQIEAPKTAGRNSHSEHHRLQTP--VRKSPAR-NRSPLNLTPTAS 399

Query: 241 PLPS 244
           PLP+
Sbjct: 400 PLPA 403

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max]

 Score =  408 bits (1049), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 202/244 (82%), Positives = 219/244 (89%), Gaps = 3/244 (1%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSW+VRMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEF
Sbjct: 163 MPKGSLENHLFRRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEF 222

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 223 NSKLSDFGLAKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 282

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDKT  G+EQ+LVDWAKPYLSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+
Sbjct: 283 GRRAVDKTITGMEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNS 342

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           E K RP M+EVLA LE++EAPK + + S SE HR   P  VRKSP R  RSPLN+TPTAS
Sbjct: 343 EAKARPPMTEVLATLEQIEAPKTAGRNSHSEHHRVQTP--VRKSPAR-NRSPLNLTPTAS 399

Query: 241 PLPS 244
           PLP+
Sbjct: 400 PLPA 403

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula]

 Score =  400 bits (1028), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 197/250 (78%), Positives = 221/250 (88%), Gaps = 3/250 (1%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRGPQPLSW++RMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEF
Sbjct: 162 MPKGSLENHLFRRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEF 221

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGDRTHVSTQV+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLS
Sbjct: 222 NSKLSDFGLAKAGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLS 281

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDKT  G++Q+LVDWAKPYL DKR+LFRIMD+KL GQYPQK A  AATLALQCLN 
Sbjct: 282 GRRAVDKTIAGVDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNR 341

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
           E K RP M+EVLA LE++EAPK++++ S SE HR   P  VR+SP R  R+P  +TPTAS
Sbjct: 342 EAKARPSMTEVLATLEQIEAPKHASRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTAS 398

Query: 241 PLPSHRQSPR 250
           PLPS RQSPR
Sbjct: 399 PLPSVRQSPR 408

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297817892|ref|XP_002876829.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata] gi|297322667|gb|EFH53088.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata]

 Score =  399 bits (1025), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 199/258 (77%), Positives = 222/258 (86%), Gaps = 6/258 (2%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MPKGSLENHLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEF
Sbjct: 169 MPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEF 228

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N+KLSDFGLAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct: 229 NSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 288

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           GR AVDK+KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN 
Sbjct: 289 GRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNP 348

Query: 181 EPKLRPRMSEVLAILERLEAPKNSAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLN 234
           + KLRP+MSEVLA L++LE+ K    +    +Q +  R +    V+KSP R    R  L+
Sbjct: 349 DAKLRPKMSEVLAKLDQLESTKPGTGIGNRQAQIDSPRGSNGSVVQKSPRRYSYDRPLLH 408

Query: 235 MTPTASPLPSHRQSPRVR 252
           +TP ASPLPSH  SPRVR
Sbjct: 409 ITPGASPLPSHNHSPRVR 426

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	252
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.996	0.589	0.764	1.5e-99
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	1.0	0.591	0.752	5.9e-96
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.964	0.589	0.698	2.4e-85
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.821	0.534	0.729	6e-80
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.968	0.576	0.595	3.6e-73
TAIR|locus:2019180	399	AT1G74490 [Arabidopsis thalian	0.825	0.521	0.669	2.9e-71
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.789	0.430	0.673	2e-69
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.984	0.547	0.567	1.3e-68
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.880	0.570	0.605	1.5e-67
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.789	0.485	0.663	4e-67

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 198/259 (76%), Positives = 221/259 (85%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             MPKGSLENHLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEF
Sbjct:   169 MPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEF 228

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             N+KLSDFGLAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLS
Sbjct:   229 NSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLS 288

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR AVDK+KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN 
Sbjct:   289 GRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNP 348

Query:   181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSE-----PHRQTGPVTVRKSPMRQQ--RSPL 233
             + KLRP+MSEVLA L++LE+ K    +   +     P    G + V+KSP R    R  L
Sbjct:   349 DAKLRPKMSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSI-VQKSPRRYSYDRPLL 407

Query:   234 NMTPTASPLPSHRQSPRVR 252
             ++TP ASPLP+H  SPRVR
Sbjct:   408 HITPGASPLPTHNHSPRVR 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 954 (340.9 bits), Expect = 5.9e-96, P = 5.9e-96
 Identities = 192/255 (75%), Positives = 214/255 (83%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             MPKGSLENHLFRRG QPL+WA+RMKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+F
Sbjct:   172 MPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADF 231

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             NAKLSDFGLAKAGPTGD THVST+V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+S
Sbjct:   232 NAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELIS 291

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR A+D +  G E SLVDWA PYL DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN 
Sbjct:   292 GRRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNP 351

Query:   181 EPKLRPRMSEVLAILERLEA-PKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTP 237
             + KLRP+MSEVL  LE+LE+  K   K +Q E  R      ++KSP+R    R  L+MTP
Sbjct:   352 DAKLRPKMSEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTP 411

Query:   238 TASPLPSHRQSPRVR 252
              ASPLPS+ QSPRVR
Sbjct:   412 GASPLPSYTQSPRVR 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
 Identities = 176/252 (69%), Positives = 195/252 (77%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             MPKGSLENHLFRRG +P+ W  R+KVAIGAA+GL FLH+A  QVIYRDFKASNILLD+EF
Sbjct:   170 MPKGSLENHLFRRGAEPIPWRTRIKVAIGAARGLAFLHEA--QVIYRDFKASNILLDSEF 227

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             NAKLSDFGLAK GPTGDRTHVSTQVMGT GYAAPEYVATGR+T KSDVYSFGVVLLELLS
Sbjct:   228 NAKLSDFGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLS 287

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR  VDKTKVG+E++LVDWA PYL DKRK+FRIMDTKLGGQYP K A   A  ALQCLN 
Sbjct:   288 GRLTVDKTKVGVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQ 347

Query:   181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTAS 240
             EPKLRP+MS+VL+ LE LE    S  +S S     +       S   +QR     TP A 
Sbjct:   348 EPKLRPKMSDVLSTLEELEMTLKSGSISNSVMKLTSSS----SSFTAKQRV---RTPVAD 400

Query:   241 PLPSHRQSPRVR 252
             P+ S R+  RVR
Sbjct:   401 PVLSSRRCRRVR 412

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
 Identities = 154/211 (72%), Positives = 183/211 (86%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             MPKGSLENHLFRRG +P+ W  RMKVA  AA+GL+FLH+A+  VIYRDFKASNILLD +F
Sbjct:   170 MPKGSLENHLFRRGAEPIPWKTRMKVAFSAARGLSFLHEAK--VIYRDFKASNILLDVDF 227

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             NAKLSDFGLAKAGPTGDRTHV+TQV+GT GYAAPEY+ATGRLT+KSDVYSFGVVLLELLS
Sbjct:   228 NAKLSDFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLS 287

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR  +DK+KVG+E++LVDWA PYL D+RK+FRIMDTKLGGQYP K A  AA +AL+CLN 
Sbjct:   288 GRPTLDKSKVGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNT 347

Query:   181 EPKLRPRMSEVLAILERLEAPKNSAKLSQSE 211
             EPKLRP M++VL+ L++LE   +S K+  ++
Sbjct:   348 EPKLRPDMADVLSTLQQLET--SSKKMGSTQ 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 739 (265.2 bits), Expect = 3.6e-73, P = 3.6e-73
 Identities = 150/252 (59%), Positives = 191/252 (75%)

Query:     1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
             MP+GSLENHLFRRG   QPLSW +R+KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+
Sbjct:   166 MPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDS 225

Query:    59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             E+NAKLSDFGLAK GPTGD++HVST++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+
Sbjct:   226 EYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEV 285

Query:   119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
             LSGR AVDK +   EQ LV+WA+P L++KRKLFR++D +L  QY  + A   ATLAL+CL
Sbjct:   286 LSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCL 345

Query:   179 NNEPKLRPRMSEVLAILERL----EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSP 232
               E KLRP M+EV++ LE +    EA   +  + Q    R++  V + + P     +++ 
Sbjct:   346 TFEIKLRPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTA 405

Query:   233 LNMTPTASPLPS 244
             + +  TA P PS
Sbjct:   406 VGVIATAYPRPS 417

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
 Identities = 140/209 (66%), Positives = 170/209 (81%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             +P GSLENHLF R    LSW++RMKVAIGAA+GL FLH+A  QVIYRDFKA+NILLD+ F
Sbjct:   171 LPNGSLENHLFERSSSVLSWSLRMKVAIGAARGLCFLHEANDQVIYRDFKAANILLDSGF 230

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             NAKLSDFGLAK GP  +R+HV+T+VMGT GYAAPEY+ATG LTTK DVYSFGVVLLE+LS
Sbjct:   231 NAKLSDFGLAKEGPKDNRSHVTTEVMGTEGYAAPEYLATGHLTTKCDVYSFGVVLLEILS 290

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR  +DK+K   E++LVDWA PYL DKRK+FRIMDTKL GQYPQKAA   + LALQC+  
Sbjct:   291 GRRVIDKSKSREEENLVDWATPYLRDKRKVFRIMDTKLVGQYPQKAAFMMSFLALQCIG- 349

Query:   181 EPKLRPRMSEVLAILERLEAPKNSAKLSQ 209
             + K+RP M EV+++LE++  P++    S+
Sbjct:   350 DVKVRPSMLEVVSLLEKVPIPRHRKSRSK 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 2.0e-69, Sum P(2) = 2.0e-69
 Identities = 134/199 (67%), Positives = 158/199 (79%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             MP+GSLEN LFRR    L W+ RMK+A GAA GL FLH+AE+ VIYRDFKASNILLD+++
Sbjct:   170 MPRGSLENQLFRRYSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDY 229

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              AKLSDFGLAK GP GD THVST+VMGT GYAAPEY+ TG LT +SDVYSFGVVLLELL+
Sbjct:   230 TAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLT 289

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR +VDK +   EQ+LVDWA+P L+D RKL RIMD +L GQY +  A  AATLA QCL++
Sbjct:   290 GRRSVDKKRSSREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSH 349

Query:   181 EPKLRPRMSEVLAILERLE 199
              PK RP MS V++IL  L+
Sbjct:   350 RPKNRPCMSAVVSILNDLK 368

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 696 (250.1 bits), Expect = 1.3e-68, P = 1.3e-68
 Identities = 148/261 (56%), Positives = 183/261 (70%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAE 59
             MP+GSLENHLFRR   PL W+VRMK+A+GAAKGL FLH+ AE  VIYRDFK SNILLD E
Sbjct:   189 MPRGSLENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGE 247

Query:    60 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             +NAKLSDFGLAK  P   ++HVST+VMGT+GYAAPEYV TG LTTKSDVYSFGVVLLE+L
Sbjct:   248 YNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEIL 307

Query:   120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
             +GR +VDK++   EQ+LV+W +P+L DK++ +R++D +L G Y  K A  A  +A QCLN
Sbjct:   308 TGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLN 367

Query:   180 NEPKLRPRMSEVLAILERLEAPKNSAKLSQS----EP------HRQTGPVTVRKSPMRQQ 229
              + K RP+MSEV+  L+ L   K+ A  S S    +P        Q G    R  P  + 
Sbjct:   368 RDSKARPKMSEVVEALKPLPNLKDFASSSSSFQTMQPVAKNGVRTQGGGFVSRNGPPMRS 427

Query:   230 RSPLNMTPTASPLPSHRQSPR 250
              S LN+ P ASP    RQSP+
Sbjct:   428 LSSLNL-PQASPYRYARQSPK 447

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 686 (246.5 bits), Expect = 1.5e-67, P = 1.5e-67
 Identities = 138/228 (60%), Positives = 173/228 (75%)

Query:     1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
             M +GSLENHLFRRG   QPLSW  R+++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+
Sbjct:   154 MTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDS 213

Query:    59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
              +NAKLSDFGLA+ GP GD +HVST+VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLEL
Sbjct:   214 NYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLEL 273

Query:   119 LSGRCAVDKTK-VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
             LSGR A+DK + VG E +LVDWA+PYL++KR+L R+MD +L GQY    A   A LAL C
Sbjct:   274 LSGRRAIDKNQPVG-EHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDC 332

Query:   178 LNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 225
             ++ + K RP M+E++  +E L   K ++K  Q  P      + + KSP
Sbjct:   333 ISIDAKSRPTMNEIVKTMEELHIQKEASK-EQQNPQISIDNI-INKSP 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 682 (245.1 bits), Expect = 4.0e-67, P = 4.0e-67
 Identities = 132/199 (66%), Positives = 160/199 (80%)

Query:     1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             M +GSLENHLFR+   PLSW+ RM +A+GAAKGL FLH+AE  VIYRDFK SNILLD+++
Sbjct:   152 MLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY 211

Query:    61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              AKLSDFGLAKAGP GD THVST+VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+
Sbjct:   212 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLT 271

Query:   121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
             GR +VDKT+   EQ+LVDWA+P L+DKRKL +I+D +L  QY  +AA  A +LA  CL+ 
Sbjct:   272 GRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQ 331

Query:   181 EPKLRPRMSEVLAILERLE 199
              PK RP MS+V+  LE L+
Sbjct:   332 NPKARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O49840	APK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7674	1.0	0.5915	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	252
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-30
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-29
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-20
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-09
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-07
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  112 bits (282), Expect = 2e-30
 Identities = 42/120 (35%), Positives = 64/120 (53%), Gaps = 7/120 (5%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-E 59
              GSL++ L       LS    +++ +   +GL +LH   + +I+RD K  NILLD+  
Sbjct: 73  CEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDN 129

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLEL 118
              KL+DFGL+K   +         ++GT  Y APE  +  G  + KSD++S GV+L EL
Sbjct: 130 GKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  112 bits (282), Expect = 5e-30
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 37/204 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G L + L R+  + L+    +++A+  AKG+ +L       ++RD  A N L+    
Sbjct: 83  MPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES--KNFVHRDLAARNCLVTENL 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA-----APEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGL++     D            G       APE +  G+ T+KSDV+SFGV+L
Sbjct: 140 VVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAA 171
            E+ +          G         +PY  +S++  L  + D   G +   P+       
Sbjct: 195 WEIFTL---------G--------EQPYPGMSNEEVLELLED---GYRLPRPENCPDELY 234

Query: 172 TLALQCLNNEPKLRPRMSEVLAIL 195
            L LQC   +P+ RP  SE++  L
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  112 bits (282), Expect = 6e-30
 Identities = 65/196 (33%), Positives = 94/196 (47%), Gaps = 24/196 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAE 59
              G L ++L R GP  LS     K+A+   +GL +LH   S  +I+RD K  NILLD  
Sbjct: 80  CEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDEN 134

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLEL 118
              K++DFGLAK       + ++T V GT  Y APE +  G     K DV+S GV+L EL
Sbjct: 135 GVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--Q 176
           L+G+                  +  L   + + RI+   L    P+ ++ +     L  +
Sbjct: 193 LTGK-------------PPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 177 CLNNEPKLRPRMSEVL 192
           CLN +P  RP   E+L
Sbjct: 240 CLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (277), Expect = 3e-29
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 39/205 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G L ++L +  P+ LS +  +  A+  A+G+ +L       I+RD  A N L+    
Sbjct: 83  MPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENL 140

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGL++     D   V        G     + APE +  G+ T+KSDV+SFGV+L
Sbjct: 141 VVKISDFGLSRDLYDDDYYKVK------GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA-- 171
            E+ +          G         +PY  +S+   L  +      G    K  +     
Sbjct: 195 WEIFTL---------G--------EEPYPGMSNAEVLEYLKK----GYRLPKPPNCPPEL 233

Query: 172 -TLALQCLNNEPKLRPRMSEVLAIL 195
             L LQC   +P+ RP  SE++ IL
Sbjct: 234 YKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  109 bits (276), Expect = 4e-29
 Identities = 53/198 (26%), Positives = 77/198 (38%), Gaps = 31/198 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L + L +RG      A      I     L +LH     +++RD K  NILLD + 
Sbjct: 79  CEGGDLFDLLKKRGRLSEDEARFYLRQI--LSALEYLHSK--GIVHRDLKPENILLDEDG 134

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + KL+DFGLA+    G++    T V GT  Y APE +         D++S GV+L ELL+
Sbjct: 135 HVKLADFGLARQLDPGEKLT--TFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT 191

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH-----TAATLAL 175
           G+                   P      +L  +       + P           A  L  
Sbjct: 192 GK-------------------PPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIR 232

Query: 176 QCLNNEPKLRPRMSEVLA 193
           + L  +P+ R    E L 
Sbjct: 233 KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-28
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 45/213 (21%)

Query: 1   MPKGSLENHL-------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 53
           M  G L ++L              LS    +  AI  AKG+ +L     + ++RD  A N
Sbjct: 78  MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARN 135

Query: 54  ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDV 108
            L+  +   K+SDFGL++     D          T G     + APE +  G  T+KSDV
Sbjct: 136 CLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLPIRWMAPESLKDGIFTSKSDV 190

Query: 109 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKA 166
           +SFGV+L E+ +          G        A PY  LS++  L  +      G    K 
Sbjct: 191 WSFGVLLWEIFTL---------G--------ATPYPGLSNEEVLEYLRK----GYRLPKP 229

Query: 167 AHTAATLA---LQCLNNEPKLRPRMSEVLAILE 196
            +    L    L C   +P+ RP  SE++  LE
Sbjct: 230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  105 bits (265), Expect = 2e-27
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 40/205 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L +  P+ LS +  +  A+  A+G+ +L       I+RD  A N L+    
Sbjct: 83  MEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENL 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGL++     D            G     + APE +  G+ T+KSDV+SFGV+L
Sbjct: 140 VVKISDFGLSRDLYDDDYYRK------RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 193

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAA-- 171
            E+ +          G         +PY  +S++  L  + +    G    +  +     
Sbjct: 194 WEIFTL---------G--------EQPYPGMSNEEVLEYLKN----GYRLPQPPNCPPEL 232

Query: 172 -TLALQCLNNEPKLRPRMSEVLAIL 195
             L LQC   +P+ RP  SE++ IL
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 94.9 bits (237), Expect = 2e-23
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 25/165 (15%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH     +++RD K +NIL+D++   KL+DFG AK     +    +  V GT  +
Sbjct: 112 EGLAYLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK-- 149
            APE +        +D++S G  ++E+ +G                   KP  S+     
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATG-------------------KPPWSELGNPM 210

Query: 150 --LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
             L++I  +    + P+  +  A     +CL  +PK RP   E+L
Sbjct: 211 AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 88.6 bits (220), Expect = 6e-21
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 20/206 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L R   Q ++    +  +    KG+ +L     + I+RD  A NIL+++E 
Sbjct: 90  LPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESED 146

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQ-----VMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGLAK  P     +   +     +     + APE + T + ++ SDV+SFGV L
Sbjct: 147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYAPECLRTSKFSSASDVWSFGVTL 202

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLA 174
            EL +     D ++    + L          +  + R+++  K G + P+  +       
Sbjct: 203 YELFT-YG--DPSQSPPAEFLRMIGIA--QGQMIVTRLLELLKEGERLPRPPSCPDEVYD 257

Query: 175 L--QCLNNEPKLRPRMSEVLAILERL 198
           L   C   EP+ RP  ++++ I++RL
Sbjct: 258 LMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 1e-20
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 38/192 (19%)

Query: 1   MPKGSLENHLFRRG--PQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
            P G L +HL + G   +  +  +A  + +A+       +LH     +IYRD K  NILL
Sbjct: 75  APGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLH--SLGIIYRDLKPENILL 126

Query: 57  DAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           DA+ + KL+DFGLAK     G RT+      GT  Y APE +         D +S GV+L
Sbjct: 127 DADGHIKLTDFGLAKELSSEGSRTN---TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLL 183

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF--RIMDTKLGGQYPQKAAHTAATL 173
            E+L+G+                   P+ ++ RK    +I+   L  ++P+  +  A  L
Sbjct: 184 YEMLTGK------------------PPFYAEDRKEIYEKILKDPL--RFPEFLSPEARDL 223

Query: 174 ALQCLNNEPKLR 185
               L  +P  R
Sbjct: 224 ISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 62/190 (32%), Positives = 89/190 (46%), Gaps = 12/190 (6%)

Query: 18  LSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 76
           LSW  R K+AIG AK L FLH      V+  +     I++D +    L    L     T 
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835

Query: 77  DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 136
            +  +S+       Y APE   T  +T KSD+Y FG++L+ELL+G+   D  + G+  S+
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSI 888

Query: 137 VDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 194
           V+WA+   SD   L   +D  + G     Q        LAL C   +P  RP  ++VL  
Sbjct: 889 VEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947

Query: 195 LERLEAPKNS 204
           LE      +S
Sbjct: 948 LESASRSSSS 957

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 5e-20
 Identities = 59/197 (29%), Positives = 87/197 (44%), Gaps = 33/197 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              GSL   + + GP P S        +   +GL +LH  E  VI+RD KA+NIL   + 
Sbjct: 81  AENGSLRQIIKKFGPFPESLVAVYVYQV--LQGLAYLH--EQGVIHRDIKAANILTTKDG 136

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG+  A    D +     V+GT  + APE +     +T SD++S G  ++ELL+
Sbjct: 137 VVKLADFGV--ATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT 194

Query: 121 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---L 175
           G                    PY  L+    LFRI+       +P      +  L    +
Sbjct: 195 GN------------------PPYYDLNPMAALFRIVQD----DHPPLPEGISPELKDFLM 232

Query: 176 QCLNNEPKLRPRMSEVL 192
           QC   +P LRP   ++L
Sbjct: 233 QCFQKDPNLRPTAKQLL 249

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 1e-19
 Identities = 45/126 (35%), Positives = 70/126 (55%), Gaps = 14/126 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   ++ A ++  A+   +G+ +L   E   ++RD  A N+L+  + 
Sbjct: 82  MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDL 139

Query: 61  NAKLSDFGLAKA---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            AK+SDFGLAK    G    +  V         + APE +   + +TKSDV+SFG++L E
Sbjct: 140 VAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWE 191

Query: 118 LLS-GR 122
           + S GR
Sbjct: 192 IYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 84.6 bits (210), Expect = 1e-19
 Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 8/123 (6%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              GSL++ L +   Q L+ +    V     KGL +LH   + +I+RD KA+NILL ++ 
Sbjct: 79  CSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDG 135

Query: 61  NAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             KL DFGL+     T  R      ++GT  + APE +       K+D++S G+  +EL 
Sbjct: 136 EVKLIDFGLSAQLSDTKARNT----MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191

Query: 120 SGR 122
            G+
Sbjct: 192 EGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.2 bits (203), Expect = 9e-19
 Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 21/191 (10%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
             G L   L  +  +PL      +  I    GL  LH    ++++RD K+ N+ LDA  N
Sbjct: 82  ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDN 139

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            K+ D G+AK     D T+ +  ++GT  Y +PE         KSDV++ GVVL E  +G
Sbjct: 140 VKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197

Query: 122 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 181
           +   D    G   +L+           K+ R +   +   Y Q+ A     L  QCL  +
Sbjct: 198 KHPFDANNQG---ALI----------LKIIRGVFPPVSQMYSQQLAQ----LIDQCLTKD 240

Query: 182 PKLRPRMSEVL 192
            + RP   ++L
Sbjct: 241 YRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 81.4 bits (202), Expect = 2e-18
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 29/166 (17%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGY 91
            L +LH    ++++RD K  NI L +    KL DFG++K    T D     T V GT  Y
Sbjct: 115 ALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVV-GTPYY 169

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            +PE         KSD++S G VL EL + +   +   +     L               
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELA-------------L 213

Query: 152 RIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAI 194
           +I+     GQYP   +  ++ L       L  +P+ RP ++++L  
Sbjct: 214 KILK----GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 80.3 bits (199), Expect = 5e-18
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 32/199 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL + L + G   +   V   +A    KGL +LH  +  +I+RD K SN+L++++ 
Sbjct: 81  MDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKG 137

Query: 61  NAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K++DFG++K    T D+ +  T V GT  Y +PE +     +  +D++S G+ LLE  
Sbjct: 138 EVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKR-KLFRIMDTKLGGQYP-----QKAAHTAATL 173
            G+                   P+L   +   F +M     G  P     + +      +
Sbjct: 195 LGKF------------------PFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 174 ALQCLNNEPKLRPRMSEVL 192
           +  CL  +PK RP  +E+L
Sbjct: 237 SA-CLQKDPKKRPSAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.5 bits (199), Expect = 5e-18
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVST 83
           K+A    KGL++LH    ++I+RD K SNILL  +   KL DFG++ +   +   T    
Sbjct: 109 KIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-- 164

Query: 84  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
              GT  Y APE +     +  SDV+S G+ LLE+   R
Sbjct: 165 ---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.6 bits (196), Expect = 8e-18
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 27/199 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KG+L N L  RG   +S    ++ ++  A+G+ +L     ++++RD  A NIL+  + 
Sbjct: 80  MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDG 137

Query: 61  NAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGLA+ G  G D + +  +      + APE +   + ++KSDV+S+GV+L E+ 
Sbjct: 138 VAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDVWSYGVLLWEVF 191

Query: 120 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           S GR    K  +   +  V+          K +R M+       P+        L   C 
Sbjct: 192 SYGRAPYPKMSLKEVKECVE----------KGYR-MEP------PEGCPADVYVLMTSCW 234

Query: 179 NNEPKLRPRMSEVLAILER 197
             EPK RP   ++   LE+
Sbjct: 235 ETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 8e-18
 Identities = 42/123 (34%), Positives = 74/123 (60%), Gaps = 9/123 (7%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+    + GP P+   +  K+A+   +GLT+L++   ++++RD K SNIL+++  
Sbjct: 85  MDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRG 141

Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             KL DFG+     +G+  + ++   +GT  Y +PE +  G+ T KSDV+S G+ ++EL 
Sbjct: 142 QIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196

Query: 120 SGR 122
            G+
Sbjct: 197 LGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 80.9 bits (198), Expect = 1e-17
 Identities = 64/254 (25%), Positives = 92/254 (36%), Gaps = 18/254 (7%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAK 63
            L   + R+GP   S A+ +   I     L +LH     +I+RD K  NILLD +    K
Sbjct: 87  DLLKKIGRKGPLSESEALFILAQI--LSALEYLH--SKGIIHRDIKPENILLDRDGRVVK 142

Query: 64  LSDFGLAK----AGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLL 116
           L DFGLAK     G T     + +  +GT GY APE +        ++ SD++S G+ L 
Sbjct: 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202

Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           ELL+G    +  K     S              L   +         + A+     L  +
Sbjct: 203 ELLTGLPPFEGEKNSSATSQT-LKIILELPTPSLASPLSPSNPELISKAASD----LLKK 257

Query: 177 CLNNEPKLRPRMSEVLAI-LERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNM 235
            L  +PK R   S  L+  L      K S      +P             +    S LN 
Sbjct: 258 LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNS 317

Query: 236 TPTASPLPSHRQSP 249
              +        S 
Sbjct: 318 LAISGSDLKLDDSN 331

Length = 384

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 79.3 bits (196), Expect = 1e-17
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 41/205 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  + +     +   +  K+A+   KGLT+LH+ + ++I+RD K SNIL+++  
Sbjct: 81  MDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRG 138

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVM--------GTHGYAAPEYVATGRLTTKSDVYSFG 112
             KL DFG            VS Q++        GT  Y APE +     + KSD++S G
Sbjct: 139 QIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLG 186

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT---KL-GGQYPQKAAH 168
           + L+EL +GR                   P       L  I++    +L  G++      
Sbjct: 187 LSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235

Query: 169 TAATLALQCLNNEPKLRPRMSEVLA 193
                   CL  +P+ RP   E+L 
Sbjct: 236 ----FVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.4 bits (193), Expect = 3e-17
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 37/200 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  ++R+ P+     V  ++A+   KGLT+L     ++++RD K SN+L++   
Sbjct: 81  MDGGSLD--VYRKIPEH----VLGRIAVAVVKGLTYLWSL--KILHRDVKPSNMLVNTRG 132

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++    T     ++   +GT+ Y APE ++  +    SDV+S G+  +EL  
Sbjct: 133 QVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188

Query: 121 GRCAVDKTK--------VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           GR    + +        + + Q +VD   P L               GQ+ +K  H    
Sbjct: 189 GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV-------------GQFSEKFVHFIT- 234

Query: 173 LALQCLNNEPKLRPRMSEVL 192
              QC+  +PK RP    ++
Sbjct: 235 ---QCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 39/208 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L R      +    + +  G A G+ +L  +E   ++RD  A NIL+++  
Sbjct: 87  MENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYL--SEMNYVHRDLAARNILVNSNL 143

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K+SDFGL++      R   S     T G      + APE +A  + T+ SDV+SFG+V
Sbjct: 144 VCKVSDFGLSR------RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIV 197

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT-KLGGQYPQKAAHTA 170
           + E++S G                   +PY  +S++  +  + D  +L    P       
Sbjct: 198 MWEVMSYGE------------------RPYWDMSNQDVIKAVEDGYRL--PPPMDCPSAL 237

Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERL 198
             L L C   +   RP  S++++ L+++
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 78.6 bits (194), Expect = 5e-17
 Identities = 44/119 (36%), Positives = 62/119 (52%), Gaps = 6/119 (5%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R G      A      I    GL FLH  E  +IYRD K  N+LLD+E + K
Sbjct: 81  GDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIK 136

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           ++DFG+ K G  G  T  ++   GT  Y APE ++        D ++ GV+L E+L+G+
Sbjct: 137 IADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.5 bits (189), Expect = 1e-16
 Identities = 47/156 (30%), Positives = 63/156 (40%), Gaps = 27/156 (17%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
             +LH     +IYRD K  N+LLD+    KL DFG AK   +G +T       GT  Y A
Sbjct: 106 FEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +S G++L ELL+GR                   P+  D      I
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR------------------PPFGEDDEDPMEI 202

Query: 154 MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLR 185
            +  L G    ++P      A  L  Q L   P+ R
Sbjct: 203 YNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 39/122 (31%), Positives = 57/122 (46%), Gaps = 5/122 (4%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G      A  +  A     GL  LH  + +++YRD K  N+LLD   
Sbjct: 75  MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHG 132

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N ++SD GLA     G +        GT GY APE +         D ++ G  L E+++
Sbjct: 133 NVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189

Query: 121 GR 122
           GR
Sbjct: 190 GR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 9e-16
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH     +++RD K SNIL++ +   KL+DFGLA+   T   +   T  + T  Y
Sbjct: 111 EGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167

Query: 92  AAPEYV--ATGRLTTKSDVYSFGVVLLELLSGR 122
             PE +  AT R   + D++S G +L EL  G+
Sbjct: 168 RPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 4e-15
 Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TK+ D++S G +L E+LS R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 71.7 bits (176), Expect = 6e-15
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 40/201 (19%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P GSL   L + G  P    +R+        GL +LHD     ++RD K +NIL+D    
Sbjct: 85  PGGSLAKLLKKYGSFPEP-VIRLYTR-QILLGLEYLHD--RNTVHRDIKGANILVDTNGV 140

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVM-----GTHGYAAPEYVA-TGRLTTKSDVYSFGVVL 115
            KL+DFG+AK         V          G+  + APE +A  G     +D++S G  +
Sbjct: 141 VKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV 192

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAAT 172
           LE+ +G                   KP  S       +F+I  +K     P   +  A  
Sbjct: 193 LEMATG-------------------KPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 173 LALQCLNNEPKLRPRMSEVLA 193
             L+CL  +P LRP  +E+L 
Sbjct: 234 FILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 7e-15
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 34/209 (16%)

Query: 1   MPKGSLENHL--------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M KG L+++L           G  P +    +++A   A G+ +L  A  + ++RD  A 
Sbjct: 91  MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL--AAKKFVHRDLAAR 148

Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +   K+ DFG+ +     D      + +    + APE +  G  TTKSDV+SFG
Sbjct: 149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG 208

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAH 168
           VVL E+                +L    +PY  LS++  L  ++D   GG    P+    
Sbjct: 209 VVLWEMA---------------TLA--EQPYQGLSNEEVLKFVID---GGHLDLPENCPD 248

Query: 169 TAATLALQCLNNEPKLRPRMSEVLAILER 197
               L   C    PK+RP   E+++ L+ 
Sbjct: 249 KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 7e-15
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 25/199 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAE 59
           +P GSL   L R+    L+    +++++ AA G+ +L   ES+  I+RD  A N L+   
Sbjct: 74  VPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGEN 129

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
              K+SDFG+++    G  T           + APE +  GR T++SDV+S+G++L E  
Sbjct: 130 NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF 189

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           S                     PY  +S+++   RI ++      PQ        L LQC
Sbjct: 190 SLG-----------------DTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQC 231

Query: 178 LNNEPKLRPRMSEVLAILE 196
              +P+ RP  SE+   L+
Sbjct: 232 WAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 71.9 bits (177), Expect = 7e-15
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 29/166 (17%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH     VI+RD K+ NILL  + + KL+DFG A A  T +++  ++ V GT  +
Sbjct: 127 QGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVV-GTPYW 182

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK--RK 149
            APE +       K D++S G++ +E+  G                    PYL +   R 
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE------------------PPYLREPPLRA 224

Query: 150 LFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           LF I  T  G    + P+K +        +CL  +P+ RP   E+L
Sbjct: 225 LFLI--TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 71.9 bits (176), Expect = 8e-15
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 8/197 (4%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L +     L+ A  +  A    +G+ +LH      I+RD  A N+LLD + 
Sbjct: 90  VPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDR 144

Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGLAKA P G   + V         + A E +   + +  SDV+SFGV L ELL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +  C   ++     + ++   +  ++  R L  +++  +    P+        L   C  
Sbjct: 205 T-HCDSKQSPPKKFEEMIGPKQGQMTVVR-LIELLERGMRLPCPKNCPQEVYILMKNCWE 262

Query: 180 NEPKLRPRMSEVLAILE 196
            E K RP    ++ IL+
Sbjct: 263 TEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.1 bits (175), Expect = 9e-15
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH   ++ I+RD KA NILL+ E  AKL+DFG+  +G   D       V+GT  +
Sbjct: 110 KGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFW 165

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +       K+D++S G+  +E+  G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.4 bits (175), Expect = 1e-14
 Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL FLH  +  +IYRD K  N+LLD + + K++DFG+ K    G+    ++   GT  Y 
Sbjct: 108 GLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYI 163

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +   +     D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.6 bits (173), Expect = 2e-14
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 16/134 (11%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
           +  G L   L R  P                L  +  + +AI  A G+ +L  +    ++
Sbjct: 90  LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL--SSHHFVH 147

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 106
           RD  A N L+      K+SDFGL++   + D   V ++ +    +  PE +  G+ TT+S
Sbjct: 148 RDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207

Query: 107 DVYSFGVVLLELLS 120
           D++SFGVVL E+ S
Sbjct: 208 DIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 70.2 bits (172), Expect = 2e-14
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 36/179 (20%)

Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ +L  A  + ++RD  A N +LD  F  K++DFGLA+     D+ + S     T 
Sbjct: 107 VAKGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVH-NHTG 161

Query: 90  G-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-----VDKTKVGIEQSLVDW 139
                 + A E + T + TTKSDV+SFGV+L EL++ R A     VD   + +       
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITV------- 213

Query: 140 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
              YL   R+L +          P+        + L C + +P++RP  SE+++ +E++
Sbjct: 214 ---YLLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.0 bits (174), Expect = 3e-14
 Identities = 39/96 (40%), Positives = 55/96 (57%), Gaps = 4/96 (4%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A GL FLH     +IYRD K  N++LDAE + K++DFG+ K    G +T  +    GT  
Sbjct: 111 AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPD 166

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           Y APE +A        D ++FGV+L E+L+G+   D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 3e-14
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 6/92 (6%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGY 91
           GL +LH  E++++YRD K  N+LLD E   K++DFGL K G   GDRT  ST   GT  +
Sbjct: 113 GLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEF 167

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 123
            APE +     T   D +  GV++ E+L G  
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 2/84 (2%)

Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 98
           D  + V++RD K +NI LDA  N KL DFGLAK    G  +  +   +GT  Y +PE + 
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 99  TGRLTTKSDVYSFGVVLLELLSGR 122
                 KSD++S G ++ EL +  
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.8 bits (171), Expect = 5e-14
 Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 23/130 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P +  +  K++I   +GLT+L + + ++++RD K SNIL+++  
Sbjct: 81  MDGGSLDQVLKKAGRIPEN--ILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRG 137

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVM--------GTHGYAAPEYVATGRLTTKSDVYSFG 112
             KL DFG            VS Q++        GT  Y +PE +     T +SD++S G
Sbjct: 138 EIKLCDFG------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Query: 113 VVLLELLSGR 122
           + L+E+  GR
Sbjct: 186 LSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 7e-14
 Identities = 40/124 (32%), Positives = 61/124 (49%), Gaps = 10/124 (8%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R     L     + +     + + +L    +  I+RD  A N L+  + 
Sbjct: 81  MANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDN 137

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGLA+     D  + S+Q  GT     +A PE     R ++KSDV+SFGV++ E
Sbjct: 138 VVKVSDFGLARY--VLDDQYTSSQ--GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193

Query: 118 LLSG 121
           + S 
Sbjct: 194 VFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.5 bits (167), Expect = 9e-14
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 27/200 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 82  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDN 139

Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL K A  T D   +  +      + APE +   + +TKSDV+SFG++L E+ 
Sbjct: 140 VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIY 193

Query: 120 S-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           S GR  V   ++ ++  +    K Y  D                P         +  QC 
Sbjct: 194 SFGR--VPYPRIPLKDVVPRVEKGYKMDA---------------PDGCPPVVYDVMKQCW 236

Query: 179 NNEPKLRPRMSEVLAILERL 198
           + +   RP   ++   LE +
Sbjct: 237 HLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 9e-14
 Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 5/122 (4%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G + L     +  +     G+  LH     ++YRD K  N+LLD + 
Sbjct: 75  MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQG 132

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           N +LSD GLA     G      TQ  GT+GY APE +     +   D ++ G  + E+++
Sbjct: 133 NCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA 189

Query: 121 GR 122
           GR
Sbjct: 190 GR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 68.4 bits (167), Expect = 1e-13
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 20/195 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE- 59
           M  GS+ + L + G      AV +       +GL++LH+  +Q+I+RD K +N+L+D+  
Sbjct: 85  MAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTG 140

Query: 60  FNAKLSDFGLA-KAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
              +++DFG A +    G        Q++GT  + APE +   +     DV+S G V++E
Sbjct: 141 QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           + + +   +  K     +L             +F+I         P+  +     + L+C
Sbjct: 201 MATAKPPWNAEKHSNHLAL-------------IFKIASATTAPSIPEHLSPGLRDVTLRC 247

Query: 178 LNNEPKLRPRMSEVL 192
           L  +P+ RP   E+L
Sbjct: 248 LELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 3/120 (2%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P GSL + L +        +     A+  A G+ +L     + I+RD  A NILL ++  
Sbjct: 78  PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDK 135

Query: 62  AKLSDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
            K+ DFGL +A P  +  +V    +     + APE + T   +  SDV+ FGV L E+ +
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 1e-13
 Identities = 37/89 (41%), Positives = 50/89 (56%), Gaps = 4/89 (4%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L FLH     VIYRD K  NILLDAE + KL+DFG+ K G     T  +T   GT  Y A
Sbjct: 109 LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIA 164

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           PE +         D ++ GV++ E+++G+
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD    +    GT  Y 
Sbjct: 108 GLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYI 163

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +   +  T  D +SFGV+L E+L G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 40/125 (32%), Positives = 66/125 (52%), Gaps = 13/125 (10%)

Query: 1   MPKGSL----ENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L     NH    G Q  L+W V++      AKG+++L   E ++++RD  A N+L
Sbjct: 90  MPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE--EKRLVHRDLAARNVL 141

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T KSDV+S+GV +
Sbjct: 142 VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201

Query: 116 LELLS 120
            EL++
Sbjct: 202 WELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 10/96 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS------TQVM 86
            L +LH   + +I+RD K  NIL+D+  + KL+DFGL+K G    + +++       +++
Sbjct: 105 ALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 87  GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 121
           GT  Y APE V  G+  +K+ D +S G +L E L G
Sbjct: 163 GTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.1 bits (166), Expect = 2e-13
 Identities = 39/125 (31%), Positives = 70/125 (56%), Gaps = 13/125 (10%)

Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
            P GSL +H+ +      PQ L +W V++      AKG+ +L   E ++++R+  A NIL
Sbjct: 90  SPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE--EHRMVHRNLAARNIL 141

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           L ++   +++DFG+A      D+ +  ++      + A E +  GR T +SDV+S+GV +
Sbjct: 142 LKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201

Query: 116 LELLS 120
            E++S
Sbjct: 202 WEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 67.4 bits (165), Expect = 2e-13
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTH-VSTQVMGTH 89
           KGL +LH   +  I+RD KA NILL  + + K++DFG+ A     GDRT  V    +GT 
Sbjct: 113 KGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 90  GYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            + APE +        K+D++SFG+  +EL +G 
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH---VSTQVMGT 88
           K L ++H     VI+RD K SNILL+++   KL+DFGLA++    +      V T  + T
Sbjct: 118 KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 89  HGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 122
             Y APE  + + R T   D++S G +L E+L G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.5 bits (165), Expect = 3e-13
 Identities = 47/123 (38%), Positives = 63/123 (51%), Gaps = 13/123 (10%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 62
           G L  HL++R     S  VR+ +A I  A  L  LH  +  +IYRD K  NILLD+E + 
Sbjct: 90  GELFTHLYQREHFTES-EVRVYIAEIVLA--LDHLH--QLGIIYRDIKLENILLDSEGHV 144

Query: 63  KLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS--DVYSFGVVLLEL 118
            L+DFGL+K       +R +      GT  Y APE +  G        D +S GV+  EL
Sbjct: 145 VLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201

Query: 119 LSG 121
           L+G
Sbjct: 202 LTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.5 bits (165), Expect = 3e-13
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 10/171 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG- 90
           KG+ +L     + ++RD    NIL+++E   K+ DFGL K  P  D+ +   +  G    
Sbjct: 119 KGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPI 175

Query: 91  -YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +   + +  SDV+SFGVVL EL +       +       ++   K        
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDKQGQMIVYH 234

Query: 150 LFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 198
           L  ++  K  G+ P      A   A+  +C NN+P  RP  SE+   +E +
Sbjct: 235 LIELL--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 67.5 bits (165), Expect = 3e-13
 Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 14/132 (10%)

Query: 1   MPKGSLENHLFRRGPQ------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 48
           M  G L   L   GP              L+ +  +++A+  A G+ +L  A    ++RD
Sbjct: 90  MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL--ASQHFVHRD 147

Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 108
               N L+  +   K+ DFG+++   T D   V    M    +  PE +   + TT+SDV
Sbjct: 148 LATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207

Query: 109 YSFGVVLLELLS 120
           +SFGVVL E+ +
Sbjct: 208 WSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 3e-13
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 17/183 (9%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R+   P   A      I  A  L +LH  E  +IYRD K  N+LLD+E + K
Sbjct: 81  GDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIK 136

Query: 64  LSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E+++GR
Sbjct: 137 LTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 182
              D   VG   +      P  + +  LF+++  K   + P+  +  AA++    LN +P
Sbjct: 194 SPFD--IVGSSDN------PDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDP 244

Query: 183 KLR 185
           K R
Sbjct: 245 KER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 3e-13
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 35/176 (19%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A G+ +L       ++RD  A N+LL     AK+SDFG+++A   G   + +T    T G
Sbjct: 105 AMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAG 158

Query: 91  -----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 144
                + APE +  G+ ++KSDV+S+GV L E  S G                  AKPY 
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPY- 199

Query: 145 SDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
             + K   ++     G+    P++      ++ L C    P+ RP  SE+ +   R
Sbjct: 200 -GEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 66.3 bits (162), Expect = 5e-13
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 31/173 (17%)

Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           ++ I   +GL  LH  E ++++RD K++NILL A    K+ D G++K      +    TQ
Sbjct: 107 RIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQ 161

Query: 85  VMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 143
           + GT  Y APE V  GR  + KSD++S G +L E+ +                  +    
Sbjct: 162 I-GTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFA--------------PPFEARS 205

Query: 144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLA 193
           + D R  +++      G+YP      +  L       L  +PKLRP   ++LA
Sbjct: 206 MQDLR--YKVQ----RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.0 bits (164), Expect = 5e-13
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 8/117 (6%)

Query: 10  LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 69
           L +R   P+   +  K+ +   K L +L + +  VI+RD K SNILLDA  N KL DFG+
Sbjct: 103 LLKRIQGPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGI 161

Query: 70  AKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGR 122
             +G   D +   T+  G   Y APE +       +   ++DV+S G+ L+EL +G+
Sbjct: 162 --SGRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.9 bits (163), Expect = 5e-13
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 4/90 (4%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL FLH     +IYRD K  N++LD + + K++DFG+ K    GD    ++   GT  Y 
Sbjct: 108 GLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYI 163

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +   + T   D +SFGV+L E+L G+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 66.9 bits (163), Expect = 5e-13
 Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 20/192 (10%)

Query: 8   NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 67
           ++L     + L+    +  A   ++G+ +L  AE ++++RD  A N+L+      K+SDF
Sbjct: 114 SYLDNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDF 171

Query: 68  GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 127
           GL++     D     ++      + A E +     TT+SDV+SFGV+L E+++       
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 224

Query: 128 TKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 186
             +G          PY      +LF ++ T    + P+  +     L L C   EP  RP
Sbjct: 225 --LG--------GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Query: 187 RMSEVLAILERL 198
             +++   LE++
Sbjct: 275 TFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 6e-13
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 19/185 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G         +  A     GL  LH    +++YRD K  NILLD   
Sbjct: 82  MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYG 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + ++SD GLA   P G+   +  +V GT GY APE V   R T   D +  G ++ E++ 
Sbjct: 140 HIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE 196

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G+    + K  +++  V+             R+ + +   +Y +K +  A ++  Q L  
Sbjct: 197 GKSPFRQRKEKVKREEVER------------RVKEDQ--EEYSEKFSEAARSICRQLLTK 242

Query: 181 EPKLR 185
           +P  R
Sbjct: 243 DPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 6e-13
 Identities = 46/130 (35%), Positives = 66/130 (50%), Gaps = 16/130 (12%)

Query: 1   MPKGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           M KGSL + L + G      L   V M   I  A+G+ +L       I+RD  A NIL+ 
Sbjct: 83  MSKGSLLDFL-KSGEGKKLRLPQLVDMAAQI--AEGMAYLE--SRNYIHRDLAARNILVG 137

Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVV 114
                K++DFGLA+     D  + + +  G      + APE    GR T KSDV+SFG++
Sbjct: 138 ENLVCKIADFGLARL--IEDDEYTARE--GAKFPIKWTAPEAANYGRFTIKSDVWSFGIL 193

Query: 115 LLELLS-GRC 123
           L E+++ GR 
Sbjct: 194 LTEIVTYGRV 203

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 65.9 bits (161), Expect = 7e-13
 Identities = 44/122 (36%), Positives = 68/122 (55%), Gaps = 8/122 (6%)

Query: 1   MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M KGSL    F R P  Q L  A  + +A   A+G+ +L   E   I+RD  A NIL+  
Sbjct: 84  MEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGE 139

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           +   K++DFGLA+     +  ++S+     + + APE  + G  +TKSDV+SFG++L E+
Sbjct: 140 DLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197

Query: 119 LS 120
            +
Sbjct: 198 FT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.6 bits (162), Expect = 8e-13
 Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 19/183 (10%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R+   P   A      I  A  L FLH  E  +IYRD K  N+LLDA+ + K
Sbjct: 81  GDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLH--ERGIIYRDLKLDNVLLDADGHIK 136

Query: 64  LSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E+++GR
Sbjct: 137 LTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 182
              D          +    P ++ +  LF+++  K   + P+  +  A+ +    LN +P
Sbjct: 194 SPFD----------IITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKGFLNKDP 242

Query: 183 KLR 185
           K R
Sbjct: 243 KER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.8 bits (163), Expect = 8e-13
 Identities = 46/127 (36%), Positives = 64/127 (50%), Gaps = 8/127 (6%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L  H+ R+   P   A      I  A  L FLH  E  +IYRD K  N+LLDAE 
Sbjct: 78  VSGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLH--ERGIIYRDLKLDNVLLDAEG 133

Query: 61  NAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           + KL+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E++
Sbjct: 134 HIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 120 SGRCAVD 126
           +GR   D
Sbjct: 191 AGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 9e-13
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 37/201 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP GS+++ L   G   L+  V  K      +G+ +LH     +++RD K +NIL D+  
Sbjct: 86  MPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAG 141

Query: 61  NAKLSDFGLAK------AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 114
           N KL DFG +K      +  TG ++     V GT  + +PE ++      K+DV+S G  
Sbjct: 142 NVKLGDFGASKRLQTICSSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADVWSVGCT 196

Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAA 171
           ++E+L+                    KP  ++      +F+I       Q P   +  A 
Sbjct: 197 VVEMLT-------------------EKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR 237

Query: 172 TLALQCLNNEPKLRPRMSEVL 192
               +      K RP   E+L
Sbjct: 238 NFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 65.8 bits (161), Expect = 9e-13
 Identities = 49/172 (28%), Positives = 74/172 (43%), Gaps = 33/172 (19%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVM-GTH 89
           +GL +LH     +++RD K +NI LD     KL DFG A              Q + GT 
Sbjct: 110 EGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 90  GYAAPEYVATGRLTTK---SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 146
            Y APE +  G+       +D++S G V+LE+ +G+                W++    D
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK--------------RPWSE---LD 210

Query: 147 KRKLFRIMDTKLG-GQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 192
               F+IM   +G G  P        +        +CL ++PK RP  SE+L
Sbjct: 211 NE--FQIM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 1e-12
 Identities = 49/134 (36%), Positives = 66/134 (49%), Gaps = 19/134 (14%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L  LH     +IYRD K  NILLD E + KL+DFGL+K     ++   S    GT  
Sbjct: 108 ALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 163

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA------------VDKTKVGIEQSLVD 138
           Y APE V     T  +D +SFGV++ E+L+G               + K K+G+ Q L  
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSP 223

Query: 139 WAKPYLSDKRKLFR 152
            A+  L   R LF+
Sbjct: 224 EAQSLL---RALFK 234

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 54/183 (29%), Positives = 75/183 (40%), Gaps = 31/183 (16%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PL       +     KGL +LH      I+RD KA+N+LL  + + KL+DFG+  AG 
Sbjct: 95  PGPLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGV--AGQ 150

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
             D        +GT  + APE +       K+D++S G+  +EL  G             
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE------------ 198

Query: 135 SLVDWAKPY--LSDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 189
                  P   L   R LF I       L GQY +            CLN +P+ RP   
Sbjct: 199 ------PPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA----CLNKDPRFRPTAK 248

Query: 190 EVL 192
           E+L
Sbjct: 249 ELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 65.4 bits (160), Expect = 1e-12
 Identities = 31/90 (34%), Positives = 43/90 (47%), Gaps = 5/90 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILLD + +  ++DF +A        T   T   GT GY 
Sbjct: 112 ALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYM 166

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +     +   D +S GV   E L G+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.5 bits (160), Expect = 1e-12
 Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 27/175 (15%)

Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           K+A+   K L +LH ++  VI+RD K SN+L++     KL DFG+  +G   D +   T 
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVD-SVAKTI 162

Query: 85  VMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD 138
             G   Y APE +           KSDV+S G+ ++EL +GR   D  K   +Q   +V+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Query: 139 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
              P L  ++      D                    +CL    K RP   E+L 
Sbjct: 223 EPSPQLPAEKFSPEFQD-----------------FVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (160), Expect = 1e-12
 Identities = 53/179 (29%), Positives = 71/179 (39%), Gaps = 56/179 (31%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------ 85
            GL +LH  E   I+RD KA+NILL  E + KL+DFG            VS Q+      
Sbjct: 109 LGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFG------------VSGQLTSTMSK 154

Query: 86  ----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
               +GT  + APE +       K+D++S G+  +EL  G                   +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG-------------------E 195

Query: 142 PYLSDK---RKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 192
           P LSD    R LF I         P        +         CLN +PK RP   E+L
Sbjct: 196 PPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.6 bits (160), Expect = 1e-12
 Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 22/184 (11%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PLS   ++ +    A G+  L  + ++ ++RD  A N L+ ++   K+S   L+K   
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHL--SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
             +   +   ++    + APE V     +TKSDV+SFGV++ E+ +      + ++    
Sbjct: 169 NSEYYKLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT------QGEL---- 217

Query: 135 SLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
                  P+  LSD+  L R+   KL    P+        L  +C    PK RP  SE++
Sbjct: 218 -------PFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270

Query: 193 AILE 196
           + L 
Sbjct: 271 SALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.2 bits (159), Expect = 2e-12
 Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 4/93 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH     +++RD KA N+L+DA+   K+SDFG++K          +  + G+  +
Sbjct: 119 EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 92  AAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 122
            APE + +     + K D++S G V+LE+ +GR
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 11/97 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L FLH    +VI+RD KA NILL  + + KL+DFG+ AK   T  +       +GT  
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPY 168

Query: 91  YAAPEYVATGRLTT-----KSDVYSFGVVLLELLSGR 122
           + APE VA           K+D++S G+ L+EL    
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 64.5 bits (158), Expect = 3e-12
 Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 20/108 (18%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM------ 86
            L +LH     +I+RD K  NILLD + + K++DFG AK          +          
Sbjct: 114 ALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 87  ------------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                       GT  Y +PE +        SD+++ G ++ ++L+G+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 34/187 (18%)

Query: 4   GSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           G L  H+ + G    PQ + +A  + V      GL FLH     +IYRD K  N++LD+E
Sbjct: 86  GDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLH--RRGIIYRDLKLDNVMLDSE 137

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            + K++DFG+ K       T  +    GT  Y APE +A        D +++GV+L E+L
Sbjct: 138 GHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCL 178
           +G+   D                   D+ +LF+ IM+  +   YP+  +  A ++    +
Sbjct: 196 AGQPPFDG-----------------EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLM 236

Query: 179 NNEPKLR 185
              P  R
Sbjct: 237 TKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 64.6 bits (157), Expect = 3e-12
 Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 17/185 (9%)

Query: 14  GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
            P   S++  + VA+  A G+ +L  +    ++RD    N L+      K++DFG+++  
Sbjct: 132 LPAI-SYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 133
             GD   +  + +    + A E +  G+ TT SDV++FGV L E+L   C         +
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM-LCKEQPYGELTD 247

Query: 134 QSLVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
           + +++ A  +  D+ +   LFR          P         L LQC + + + RP  S+
Sbjct: 248 EQVIENAGEFFRDQGRQVYLFR----------PPPCPQGLYELMLQCWSRDCRERPSFSD 297

Query: 191 VLAIL 195
           + A L
Sbjct: 298 IHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.7 bits (157), Expect = 3e-12
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 19/185 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G         +  A     GL  LH  + +++YRD K  NILLD   
Sbjct: 82  MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHG 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + ++SD GLA   P G    +  +V GT GY APE V   R T   D ++ G +L E+++
Sbjct: 140 HIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 196

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G+    + K  I              KR+    +  ++  +Y +K +  A +L    L  
Sbjct: 197 GQSPFQQRKKKI--------------KREEVERLVKEVQEEYSEKFSPDARSLCKMLLCK 242

Query: 181 EPKLR 185
           +PK R
Sbjct: 243 DPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 64.2 bits (156), Expect = 3e-12
 Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 33/178 (18%)

Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQV 85
           G A G+ +L  ++   ++RD  A NIL+++    K+SDFGL++     P G  T    ++
Sbjct: 115 GIAAGMKYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172

Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 143
                + APE +A  + T+ SDV+SFG+V+ E++S G                   +PY 
Sbjct: 173 --PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE------------------RPYW 212

Query: 144 -LSDKRKLFRIMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILERL 198
            +S+   +  I D   G + P      +A   L LQC   +   RPR  +++ +L++L
Sbjct: 213 DMSNHEVMKAIND---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 4e-12
 Identities = 36/121 (29%), Positives = 55/121 (45%), Gaps = 10/121 (8%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G   + +   G  P  WA   +       G+  LH     +I+RD K  N+L+D   
Sbjct: 79  LNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTG 134

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + KL+DFGL++ G        + + +GT  Y APE +        SD +S G V+ E L 
Sbjct: 135 HLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188

Query: 121 G 121
           G
Sbjct: 189 G 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.1 bits (157), Expect = 4e-12
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 9/90 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  ++YRD K  N+LLD++   K++DFG AK      RT+    + GT  Y 
Sbjct: 113 ALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYL 165

Query: 93  APEYVATGRLTTKS-DVYSFGVVLLELLSG 121
           APE +   +   K+ D ++ G+++ E+L+G
Sbjct: 166 APE-IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.9 bits (156), Expect = 5e-12
 Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 7/101 (6%)

Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           K+A+   K L +L + E ++I+RD K SNILLD   N KL DFG+  +G   D     T+
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSI-AKTR 166

Query: 85  VMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGR 122
             G   Y APE +          +SDV+S G+ L E+ +G+
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.8 bits (155), Expect = 8e-12
 Identities = 36/88 (40%), Positives = 49/88 (55%), Gaps = 4/88 (4%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L FLHD    +IYRD K  N+LLD E + KL+DFG+ K G    +T  ++   GT  Y A
Sbjct: 109 LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIA 164

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +         D ++ GV+L E+L G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.0 bits (153), Expect = 8e-12
 Identities = 49/202 (24%), Positives = 95/202 (47%), Gaps = 32/202 (15%)

Query: 1   MPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N+L    +  QP   +  +++     +G+ +L     Q I+RD  A N L+D 
Sbjct: 81  MSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDD 135

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
           +   K+SDFGL++     D  + S+  +G+     ++ PE +   + ++KSDV++FGV++
Sbjct: 136 QGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLM 191

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E+ S G+   ++         V+     +S   +L+R          P  A+     + 
Sbjct: 192 WEVYSLGKMPYERFN---NSETVE----KVSQGLRLYR----------PHLASEKVYAIM 234

Query: 175 LQCLNNEPKLRPRMSEVLAILE 196
             C + + + RP   ++L+ +E
Sbjct: 235 YSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 8e-12
 Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 18/130 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAE 59
           M  GSL  +L     + L     + +A   A G+ +L   E+Q  I+RD  A N+L+   
Sbjct: 83  MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGEN 139

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGV 113
              K++DFGLA       R           G      + APE     R + KSDV+SFG+
Sbjct: 140 NICKVADFGLA-------RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192

Query: 114 VLLELLS-GR 122
           +L E+++ GR
Sbjct: 193 LLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.4 bits (151), Expect = 1e-11
 Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 23/198 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L     + L     + +A   A G+ ++       I+RD +A+NIL+    
Sbjct: 82  MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNL 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG++L EL 
Sbjct: 140 VCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL- 196

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSD-KRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
                V K +V           PY     R++   ++       PQ    +   L   C 
Sbjct: 197 -----VTKGRV-----------PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCW 240

Query: 179 NNEPKLRPRMSEVLAILE 196
             +P  RP    + + LE
Sbjct: 241 KKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 44/152 (28%), Positives = 61/152 (40%), Gaps = 39/152 (25%)

Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L R+   P   A      + +A+ +   L F+H        RD K  NIL+
Sbjct: 83  MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH--------RDIKPDNILI 134

Query: 57  DAEFNAKLSDFGLAKAGP-TGDRTHVSTQ--------------------------VMGTH 89
           DA+ + KL+DFGL K      DR +                               +GT 
Sbjct: 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE +       + D +S GV+L E+L G
Sbjct: 195 DYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162

Query: 93  APEYVATG-RLTTKSDVYSFGVVLLELLSG 121
           APE +  G    + +D +S G +L +LL G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 85  MDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 141

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 142 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197

Query: 121 GR 122
           GR
Sbjct: 198 GR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H     +++RD K  N+L++ E   KL+DFGLA++  +  R +  T  + T  Y
Sbjct: 109 QGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWY 164

Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  ELLS R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A GL FLH     +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 111 AIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPD 166

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           Y APE +A        D ++FGV+L E+L+G+   +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 27/200 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L     + L     + +A   A G+ ++       I+RD +++NIL+    
Sbjct: 82  MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGL 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K++DFGLA+     D  + + Q  G      + APE    GR T KSDV+SFG++L E
Sbjct: 140 VCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 195

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           L      V K +V           PY   + R++   ++       PQ    +   L LQ
Sbjct: 196 L------VTKGRV-----------PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238

Query: 177 CLNNEPKLRPRMSEVLAILE 196
           C   +P+ RP    + + LE
Sbjct: 239 CWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 8/101 (7%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L ++H  +  VI+RD KA+NIL+    N KL DFG+A A    + +  ST V GT  + A
Sbjct: 114 LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTFV-GTPYWMA 169

Query: 94  PEYVATGRL-TTKSDVYSFGVVLLELLSGR---CAVDKTKV 130
           PE +  G+   TK+D++S G+ + E+ +G      VD  + 
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 27/164 (16%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           L   H     +++RD K  NILLD      K+ DFG++K      ++   T V+GT  Y 
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           +PE         KSD+++ G VL EL S + A +   +           P L     + +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PAL-----VLK 212

Query: 153 IMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
           IM      +  +Y          L L  LN +P  RP++S+++A
Sbjct: 213 IMSGTFAPISDRYSPDLRQ----LILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 46/199 (23%), Positives = 84/199 (42%), Gaps = 21/199 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 84  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 141

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 142 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
              +                 PY   D  +++ +++     + P+        L   C  
Sbjct: 201 YGMS-----------------PYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQ 243

Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 244 WNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 41/129 (31%), Positives = 63/129 (48%), Gaps = 16/129 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL + L       L+    + +A   A+G+ F+       I+RD +A+NIL+    
Sbjct: 82  MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETL 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K++DFGLA       R     +     G      + APE +  G  T KSDV+SFG++
Sbjct: 140 CCKIADFGLA-------RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 192

Query: 115 LLELLS-GR 122
           L E+++ GR
Sbjct: 193 LTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 20/120 (16%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L   H  +  ++YRD K  NILLDA  +  L DFGL+KA  T ++T  +    GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 94  PEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           PE +   +  TK  D +S GV++ E+  G                 W+  Y  D ++++R
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQMYR 207

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 42/124 (33%), Positives = 61/124 (49%), Gaps = 15/124 (12%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH  E  ++YRD K  NILLD E + KL+DFG AK     DRT     + GT  Y A
Sbjct: 114 LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPEYLA 166

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           PE + +       D ++ G+++ E+L G     D    GI + +       L+ K +  R
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LAGKLEFPR 219

Query: 153 IMDT 156
            +D 
Sbjct: 220 HLDL 223

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.5 bits (149), Expect = 4e-11
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 4/121 (3%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL+ +L  R    ++   ++K A+   KG+ +L     Q ++RD  A N+L+++E 
Sbjct: 90  LPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEH 146

Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGL KA  T    + V   +     + APE +   +    SDV+SFGV L ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 120 S 120
           +
Sbjct: 207 T 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 28/192 (14%)

Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           ++ A   A G+ +L  +E Q I+RD  A N+L+     +K++DFGL++    G+  +V  
Sbjct: 122 LQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK- 174

Query: 84  QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           + MG     + A E +     TTKSDV+SFGV+L E++S         +G          
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS---------LG--------GT 217

Query: 142 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LE 199
           PY      +L+  +      + P+        L  QC  + P  RP  +++   L R LE
Sbjct: 218 PYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277

Query: 200 APKNSAKLSQSE 211
           A K    ++  E
Sbjct: 278 ARKAYVNMALFE 289

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 19/185 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G         +  A     GL  L     +++YRD K  NILLD   
Sbjct: 82  MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRG 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + ++SD GLA   P G+   V  +V GT GY APE +   + T   D +  G ++ E++ 
Sbjct: 140 HIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ 196

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G+    K K  +++  VD             R+ + +   +Y +K +  A ++    L  
Sbjct: 197 GQSPFRKRKERVKREEVDR------------RVKEDQ--EEYSEKFSEDAKSICRMLLTK 242

Query: 181 EPKLR 185
            PK R
Sbjct: 243 NPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.1 bits (148), Expect = 5e-11
 Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 19/185 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G         +  A     GL  LH      +YRD K  NILLD   
Sbjct: 82  MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYG 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + ++SD GLA   P G+        +GT GY APE +   R T   D +  G ++ E++ 
Sbjct: 140 HIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE 196

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G+      K  +++  VD             R+++T+    Y  K +  A ++    L  
Sbjct: 197 GQSPFRGRKEKVKREEVDR------------RVLETE--EVYSAKFSEEAKSICKMLLTK 242

Query: 181 EPKLR 185
           +PK R
Sbjct: 243 DPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 5e-11
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 11/93 (11%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   E+  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   +   THG  
Sbjct: 107 GMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAK---THGKW 160

Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 60.5 bits (147), Expect = 5e-11
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 25/162 (15%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           ++++H A   +++RD K  NI L      KL DFG++K    G    ++  V+GT  Y +
Sbjct: 114 VSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMS 169

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE     +   KSD+++ G VL EL      + +T        +              +I
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYEL----LTLKRTFDATNPLNLVV------------KI 213

Query: 154 MDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLA 193
           +    G   P  + +++  ++L    L  +P+ RP   EVL 
Sbjct: 214 VQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 5e-11
 Identities = 43/122 (35%), Positives = 60/122 (49%), Gaps = 14/122 (11%)

Query: 4   GSLENHLFR--RGPQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           G L  HL R    P+P +  +A  +  A+G      +LH     +IYRD K  NILLD++
Sbjct: 81  GELFFHLQRERSFPEPRARFYAAEIASALG------YLH--SLNIIYRDLKPENILLDSQ 132

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            +  L+DFGL K G    +T  ++   GT  Y APE +         D +  G VL E+L
Sbjct: 133 GHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190

Query: 120 SG 121
            G
Sbjct: 191 YG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.2 bits (148), Expect = 6e-11
 Identities = 42/124 (33%), Positives = 70/124 (56%), Gaps = 11/124 (8%)

Query: 1   MPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL+  L   +R P+     +  KV+I   +GL +L + + Q+++RD K SNIL+++
Sbjct: 85  MDGGSLDQVLKEAKRIPE----EILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNS 139

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
               KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+EL
Sbjct: 140 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195

Query: 119 LSGR 122
             GR
Sbjct: 196 AIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 60.8 bits (147), Expect = 6e-11
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 33/167 (19%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH  +   I+RD KA+N+LL  + + KL+DFG+  AG   D        +GT  +
Sbjct: 112 KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFW 167

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD---KR 148
            APE +      +K+D++S G+  +EL  G                   +P  SD    R
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKG-------------------EPPNSDMHPMR 208

Query: 149 KLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            LF I       L G++ +            CLN +P  RP   E+L
Sbjct: 209 VLFLIPKNNPPTLTGEFSK----PFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.5 bits (146), Expect = 7e-11
 Identities = 55/200 (27%), Positives = 81/200 (40%), Gaps = 31/200 (15%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PL       +     KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG 
Sbjct: 95  PGPLDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQ 150

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
             D        +GT  + APE +      +K+D++S G+  +EL  G             
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE------------ 198

Query: 135 SLVDWAKPY--LSDKRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 189
                  P+  L   + LF I       L G Y +            CLN EP  RP   
Sbjct: 199 ------PPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAK 248

Query: 190 EVLAILERLEAPKNSAKLSQ 209
           E+L     +   K ++ L++
Sbjct: 249 ELLKHKFIVRFAKKTSYLTE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.6 bits (147), Expect = 8e-11
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 36/209 (17%)

Query: 1   MPKGSLENHLF--RRGPQPLSWAVRM--KVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           M  G L + L   R G  P    ++   K  +  A G+ +L  +    I+RD  A N +L
Sbjct: 89  MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--SNRNFIHRDLAARNCML 146

Query: 57  DAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
             +    ++DFGL+K   +GD   +  ++   +    + A E +A    T+KSDV++FGV
Sbjct: 147 REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGV 203

Query: 114 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 172
            + E+ + G+        G+E                   I D    G   ++       
Sbjct: 204 TMWEIATRGQTPYP----GVENH----------------EIYDYLRHGNRLKQPEDCLDE 243

Query: 173 L---ALQCLNNEPKLRPRMSEVLAILERL 198
           L      C   +PK RP  +++  +LE +
Sbjct: 244 LYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 60.6 bits (147), Expect = 8e-11
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 24/153 (15%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH     V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y A
Sbjct: 108 LGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 163

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR- 152
           PE +         D +  GVV+ E++ GR                    Y  D  KLF  
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 206

Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           I+  ++  ++P+  +  A +L    L  +PK R
Sbjct: 207 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.4 bits (146), Expect = 9e-11
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 20/169 (11%)

Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +AI  A G+ +L  +    +++D  A NIL+  + + K+SD GL++   + D   V  
Sbjct: 127 LHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 84  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 143
           + +    +  PE +  G+ ++ SD++SFGVVL E+ S          G++        PY
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS---------FGLQ--------PY 227

Query: 144 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
                +++  ++  +      +       +L  +C    P  RPR  ++
Sbjct: 228 YGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.4 bits (146), Expect = 9e-11
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 7/90 (7%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL  +H+    V+YRD K +NILLD   + ++SD GLA    +  + H S   +GTHGY 
Sbjct: 109 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYM 162

Query: 93  APEYVATGR-LTTKSDVYSFGVVLLELLSG 121
           APE +  G    + +D +S G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 49/179 (27%), Positives = 88/179 (49%), Gaps = 33/179 (18%)

Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVM 86
           G A G+ +L  +E   ++RD  A NIL+++    K+SDFGL++     T D T+ S+  +
Sbjct: 114 GIAAGMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--L 169

Query: 87  GTH---GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKP 142
           G      + APE +A  + T+ SDV+S+G+V+ E++S G                   +P
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE------------------RP 211

Query: 143 Y--LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           Y  +S++  +  I  D +L    P         L L C   +   RP+  ++++ L+++
Sbjct: 212 YWDMSNQDVINAIEQDYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 32/201 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L +R  + LS  + + +     +G+ +L    +  I+RD  A N L+ +  
Sbjct: 81  MENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTG 137

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K+SDFG+        R  +  +   + G      ++ PE     + ++KSDV+SFGV+
Sbjct: 138 VVKVSDFGMT-------RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVL 190

Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
           + E+ +      + K+  E+         +S   +L+R          P+ A+ T   + 
Sbjct: 191 MWEVFT------EGKMPFEKKSNYEVVEMISRGFRLYR----------PKLASMTVYEVM 234

Query: 175 LQCLNNEPKLRPRMSEVLAIL 195
             C + +P+ RP  +E+L  +
Sbjct: 235 YSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGTH 89
           GL ++H A   V++RD K  N+L++A+   K+ DFGLA+     P  +   + T+ + T 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR 173

Query: 90  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            Y APE + + +  TK+ DV+S G +L ELL  +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 36/200 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP GS+++ L   G   L+ +V  K      +G+++LH   + +++RD K +NIL D+  
Sbjct: 88  MPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAG 143

Query: 61  NAKLSDFGLAK------AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 114
           N KL DFG +K         TG R+     V GT  + +PE ++      K+DV+S G  
Sbjct: 144 NVKLGDFGASKRLQTICMSGTGIRS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCT 198

Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA--AT 172
           ++E+L+                    KP  ++   +  I         PQ  +H +  A 
Sbjct: 199 VVEMLT-------------------EKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239

Query: 173 LALQCLNNEPKLRPRMSEVL 192
             L C+  E + RP   E+L
Sbjct: 240 DFLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 126 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 181

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            APE V       K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 43/117 (36%), Positives = 61/117 (52%), Gaps = 10/117 (8%)

Query: 10  LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 69
           L   G Q L  A+   +  GA  GL  LH+  +++I+RD K +NILL  E   KL DFG+
Sbjct: 118 LLICG-QRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGV 174

Query: 70  AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSG 121
           + A  T  R   +T V GT  + APE +A  +        + DV+S G+  +EL  G
Sbjct: 175 S-AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 30/170 (17%)

Query: 33  GLTFL-------HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           GL F+       H     +I+RD K++NILL +    KL DFG +K         V    
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205

Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 145
            GT  Y APE       + K+D++S GV+L ELL+ +                  +P+  
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------------------RPF-- 245

Query: 146 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           D   +  +M   L G+Y   P   +     +    L+++PK RP  S++L
Sbjct: 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 35/204 (17%)

Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 82  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 133

Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 134 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-KRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 192 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 234

Query: 173 LALQCLNNEPKLRPRMSEVLAILE 196
           L  QC   EP+ RP    + A LE
Sbjct: 235 LMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 8/111 (7%)

Query: 15  PQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
           PQPLS +  +KV +    +GL +LH A   +++RD K  N+L+++    K+ DFGLA+  
Sbjct: 97  PQPLS-SDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153

Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGR 122
              +  H++ +V+ T  Y APE +  G    T+  D++S G +  ELL  R
Sbjct: 154 EPDESKHMTQEVV-TQYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 8/126 (6%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GS+ + L R GP P    V  K       G+ +LH+  + V++RD K +N++L    
Sbjct: 84  VPGGSISSILNRFGPLP--EPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNG 139

Query: 61  NAKLSDFGLAK----AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
             KL DFG A+     G  G  +++   + GT  + APE +       KSD++S G  + 
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199

Query: 117 ELLSGR 122
           E+ +G+
Sbjct: 200 EMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 28/188 (14%)

Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ + 
Sbjct: 113 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168

Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 214

Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRM 188
             SL +  +PY  LS+++ L  +MD   GG    P         L   C    PK+RP  
Sbjct: 215 -TSLAE--QPYQGLSNEQVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTF 268

Query: 189 SEVLAILE 196
            E++ +L+
Sbjct: 269 LEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 8/96 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-----AGPTGDRTHVSTQVM 86
           KGL +LH+    +I+RD K +NIL+D +   K+SDFG++K     +  T       + + 
Sbjct: 117 KGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQ 173

Query: 87  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           G+  + APE V     T K+D++S G +++E+L+G+
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 51/203 (25%), Positives = 81/203 (39%), Gaps = 27/203 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
                ++N L   G + L+    +      A+G+ FL  A    ++RD  A N+LL    
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGK 274

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFGVVL 115
             K+ DFGLA+     D  H S  V     +      APE +     TT SDV+S+G++L
Sbjct: 275 IVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
            E+                SL     P +      +  + +      P  A      + +
Sbjct: 330 WEIF---------------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMV 374

Query: 176 QCLNNEPKLRPRMSEVLAILERL 198
           +C N+EP+ RP    +  I+E L
Sbjct: 375 KCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 22/186 (11%)

Query: 14  GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
            P PLS   ++ +A   A G+ +L  +E + ++RD    N L+      K++DFGL++  
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180

Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 133
            + D    S        +  PE +   R TT+SDV+++GVVL E+ S          G++
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGMQ 231

Query: 134 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
                   PY  ++ +  ++ + D  +    P         L   C +  P  RP  + +
Sbjct: 232 --------PYYGMAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Query: 192 LAILER 197
             IL+R
Sbjct: 283 NRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 31/202 (15%)

Query: 1   MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M KGSL + L       QPL   +     I  A+G+ F+   +   I+RD +A+NIL+ A
Sbjct: 82  MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIE--QRNYIHRDLRAANILVSA 137

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K++DFGLA+     D  + + +  G      + APE +  G  T KSDV+SFG++L
Sbjct: 138 SLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
           +E+++ GR                   P +S+  ++ R ++       P+        + 
Sbjct: 194 MEIVTYGRIPY----------------PGMSNP-EVIRALERGYRMPRPENCPEELYNIM 236

Query: 175 LQCLNNEPKLRPRMSEVLAILE 196
           ++C  N P+ RP    + ++L+
Sbjct: 237 MRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 7/86 (8%)

Query: 36  FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 95
           +LH     +IYRD K  N+LLD + + K++DFG AK  P  DRT     + GT  Y APE
Sbjct: 133 YLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPE 185

Query: 96  YVATGRLTTKSDVYSFGVVLLELLSG 121
            + +       D ++ GV+L E ++G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 4/93 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 90
           +GL +LH A   VI+RD K SNIL+++  + K+ DFGLA+   P  D     T+ + T  
Sbjct: 114 RGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE + +    TK+ D++S G +  ELL+ +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 58.9 bits (142), Expect = 2e-10
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 34/205 (16%)

Query: 1   MPKGSLENHLFR----------RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 50
           M +G L+++L            + P  L   ++M   I  A G+ +L+   ++ ++RD  
Sbjct: 91  MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI--ADGMAYLN--ANKFVHRDLA 146

Query: 51  ASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 110
           A N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+S
Sbjct: 147 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 206

Query: 111 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAH 168
           FGVVL E+                +L +  +PY  +S+++ L  +M+  L  + P     
Sbjct: 207 FGVVLWEI---------------ATLAE--QPYQGMSNEQVLRFVMEGGLLDK-PDNCPD 248

Query: 169 TAATLALQCLNNEPKLRPRMSEVLA 193
               L   C    PK+RP   E+++
Sbjct: 249 MLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 3e-10
 Identities = 58/191 (30%), Positives = 81/191 (42%), Gaps = 63/191 (32%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ FL  A  + I+RD  A NILL      K+ DFGLA+                   
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-----------------DI 223

Query: 91  YAAPEYVATG--RL---------------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 133
           Y  P+YV  G  RL               TT+SDV+SFGV+L E+ S         +G  
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG-- 272

Query: 134 QSLVDWAKPYLSDK------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 187
                 A PY   +      R+L     T++    P+ A     ++ L C +N P+ RP 
Sbjct: 273 ------ASPYPGVQIDEEFCRRLKE--GTRMRA--PEYATPEIYSIMLDCWHNNPEDRPT 322

Query: 188 MSEVLAILERL 198
            SE++ IL  L
Sbjct: 323 FSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 21/153 (13%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y 
Sbjct: 107 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYL 163

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  KLF 
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFE 206

Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 207 LILME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 58.7 bits (143), Expect = 3e-10
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH   + +++RD K +N+L+ ++   KL+DFGLA++  + +R  ++ QV+ T  Y
Sbjct: 113 RGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV-TRWY 168

Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
            APE +   R      D++S G +  ELL   
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 4e-10
 Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 12/122 (9%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L N L R+    L+    +  +   AKG+ FL  A    I+RD  A N+LL      K
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVK 181

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           + DFGLA+     D  + S  V+  +      + APE +     T +SDV+S+G++L E+
Sbjct: 182 ICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Query: 119 LS 120
            S
Sbjct: 237 FS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 10/101 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGP-TGD----RTHVSTQ 84
            L   H+    +++RD K  NI++       +AK+ DFG+    P   D        +T+
Sbjct: 91  ALACAHNQ--GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148

Query: 85  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 125
           V+GT  Y APE +    +T  SD+Y++G++ LE L+G+  V
Sbjct: 149 VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.4 bits (141), Expect = 4e-10
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 32/205 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL+  L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 87  MENGSLDAFLRKHDGQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILVNS 141

Query: 59  EFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     P    T    ++     + APE +A  + T+ SDV+S+G+V+
Sbjct: 142 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVM 199

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATL 173
            E++S G                   +PY     + + + ++       P         L
Sbjct: 200 WEVMSYGE------------------RPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL 241

Query: 174 ALQCLNNEPKLRPRMSEVLAILERL 198
            L C   +   RP+  ++++IL++L
Sbjct: 242 MLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 5e-10
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 89
           GL  LH  + ++IYRD K  N+LLD + N ++SD GLA   K G +  + +      GT 
Sbjct: 109 GLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTP 161

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           G+ APE +         D ++ GV L E+++ R
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.7 bits (142), Expect = 5e-10
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 49/203 (24%)

Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
                PL     ++ +   A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 72  AGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC-- 123
                D  + S  V+  +      + APE +     T +SDV+S+G++L E+ S G+   
Sbjct: 261 -----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Query: 124 ---AVDK-----TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
               V+       K G + S  D+A P      +++ IM                     
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPP------EIYSIMKM------------------- 350

Query: 176 QCLNNEPKLRPRMSEVLAILERL 198
            C N EP  RP  S++  +++R 
Sbjct: 351 -CWNLEPTERPTFSQISQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.1 bits (140), Expect = 5e-10
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 35/206 (16%)

Query: 1   MPKGSLENHLF----RRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++     R G Q L +W V++      AKG+++L +   ++++RD  A N+L
Sbjct: 90  MPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEEV--RLVHRDLAARNVL 141

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           + +  + K++DFGLA+     +  + +        + A E +   R T +SDV+S+GV +
Sbjct: 142 VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT-- 172
            EL++          G        AKPY     R++  +++   G + PQ    T     
Sbjct: 202 WELMT---------FG--------AKPYDGIPAREIPDLLEK--GERLPQPPICTIDVYM 242

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           + ++C   + + RPR  E++    R+
Sbjct: 243 IMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 6e-10
 Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 11/98 (11%)

Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGT 88
             +GL +LH  E++VI+RD K  NILL      KL DFG+ A+   T  R +      GT
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GT 176

Query: 89  HGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG 121
             + APE +A           +SDV+S G+  +EL  G
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 57.7 bits (139), Expect = 6e-10
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 16/126 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      S    + + +   +G+ +L    S VI+RD  A N L+    
Sbjct: 81  MEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQ 137

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K+SDFG+        R  +  Q   + G      +++PE  +  + ++KSDV+SFGV+
Sbjct: 138 VVKVSDFGMT-------RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVL 190

Query: 115 LLELLS 120
           + E+ S
Sbjct: 191 MWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.8 bits (140), Expect = 6e-10
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH  E+ +I+RD K SN+LL  +   K++DFGLA+    G      T  + T  Y
Sbjct: 119 RGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWY 174

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +      T + D+++ G +L ELL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 11/104 (10%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGP 74
           Q LSW V++ +      GL  +HD   ++++RD K+ NI L      AKL DFG+A+   
Sbjct: 102 QILSWFVQISL------GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-- 151

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             D   ++   +GT  Y +PE         K+D++S G VL EL
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 31/175 (17%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 87
           A+G+ FL  A  + I+RD  A NILL      K+ DFGLA+     P   R   +   + 
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-- 145
              + APE +     TT+SDV+SFGV+L E+ S         +G        A PY    
Sbjct: 242 ---WMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG--------ASPYPGVQ 281

Query: 146 -DKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            ++    R+ D T++  + P+ A      + L C   +PK RP  S ++ IL  L
Sbjct: 282 INEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.8 bits (139), Expect = 7e-10
 Identities = 35/90 (38%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ N+LL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 126 QALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 181

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            APE V       K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 57.7 bits (140), Expect = 7e-10
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 12/100 (12%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVST 83
           G+ +LH  E+ +++RD KA+NIL+D +   K++DFGLA+          G  G  T   T
Sbjct: 127 GINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 84  QVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            ++ T  Y  PE +   R  TT  D++  G V  E+ + R
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.4 bits (138), Expect = 8e-10
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)

Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 167

Query: 84  QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 210

Query: 142 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 211 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 9e-10
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 22/152 (14%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y A
Sbjct: 108 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +  GVV+ E++ GR                    Y  D  +LF +
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFEL 206

Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +  +   ++P+  +  A +L    L  +PK R
Sbjct: 207 ILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.6 bits (139), Expect = 9e-10
 Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 35/179 (19%)

Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RTHVST 83
           ++     KGL FL + E  +I+RD K +N+L++     KL DFG+     +G+    ++ 
Sbjct: 106 RITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAK 159

Query: 84  QVMGTHGYAAPEYV----ATGRLT--TKSDVYSFGVVLLELLSGRCA----VDKTKVGIE 133
             +G   Y APE +         T   +SDV+S G+ +LE+  GR               
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219

Query: 134 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            ++VD   P L                  P   +  A     +CLN  P  RP  +++L
Sbjct: 220 SAIVDGDPPTL------------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.4 bits (138), Expect = 9e-10
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 126 QALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 181

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            APE V       K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 33/180 (18%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           Q L W V++ +A      L  +HD   ++++RD K+ NI L  +   KL DFG+A+    
Sbjct: 102 QILDWFVQICLA------LKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--L 151

Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 135
                ++   +GT  Y +PE         KSD+++ G VL E+ + + A +    G  ++
Sbjct: 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKN 208

Query: 136 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVL 192
           LV           K+ R       G YP  ++H +     L  Q     P+ RP ++ +L
Sbjct: 209 LV----------LKIIR-------GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 6/92 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   V++RD K SN+LL+A  + K+ DFGLA+   T ++    T+ + T  Y
Sbjct: 119 RGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWY 174

Query: 92  AAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +      TT  DV+S G +  ELL GR
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 47/144 (32%), Positives = 68/144 (47%), Gaps = 17/144 (11%)

Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL- 102
           +IYRD K  NILLD+  +  L+DFGL+K     D    +    GT  Y AP+ V  G   
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 103 -TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 161
                D +S GV++ ELL+G  A   T  G + S  + ++          RI+  K    
Sbjct: 185 HDKAVDWWSMGVLMYELLTG--ASPFTVDGEKNSQAEISR----------RIL--KSEPP 230

Query: 162 YPQKAAHTAATLALQCLNNEPKLR 185
           YPQ+ +  A  +  + L  +PK R
Sbjct: 231 YPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 31/204 (15%)

Query: 2   PKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           P G   +    R P + L+    +  A   A+G+ FL  A  + I+RD  A N+L+  + 
Sbjct: 112 PPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDH 169

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K++DFGLA+     D  H+      T+G     + APE +     T +SDV+SFGV+L
Sbjct: 170 VMKIADFGLAR-----DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E+ +         +G          PY      +LF+++      + PQ        L 
Sbjct: 225 WEIFT---------LG--------GSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLM 267

Query: 175 LQCLNNEPKLRPRMSEVLAILERL 198
             C +  P  RP   +++  L+R+
Sbjct: 268 RDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 56.7 bits (138), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 17/98 (17%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL + H    ++++RD K  NIL++ +   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 109 RGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWY 164

Query: 92  AAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE       Y      +T  D++S G +  E+++G+
Sbjct: 165 RAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LHD  + +++RD K SN+LL+     K+ DFGLA+    G      TQ++ T  Y 
Sbjct: 118 GVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYR 173

Query: 93  APE-YVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE  +     +T  D++S G +  ELL+ +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 56.7 bits (136), Expect = 1e-09
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 6/91 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG  A+  P   +    + ++GT  
Sbjct: 127 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 181

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           + APE V       K D++S G++ +E++ G
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   V++RD K SNIL++   + K+ DFGLA+      +    T  + T  Y
Sbjct: 119 RGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYY 171

Query: 92  AAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 122
            APE + T  +   + D++S G +  E+L G+
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 7/109 (6%)

Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
           R  P P+  A+ ++  I   +GL +LH    ++I+RD K  NI ++      + D G A+
Sbjct: 150 RSRPLPIDQALIIEKQI--LEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Query: 72  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             P      +   + GT    APE +A  +  +K+D++S G+VL E+L+
Sbjct: 206 F-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 32  KGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           K L+FLH   +Q VI+RD K+ +ILL ++   KLSDFG                ++GT  
Sbjct: 126 KALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPY 180

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           + APE ++     T+ D++S G++++E++ G
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 28/156 (17%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH    +++YRD K  N++LD + + K++DFGL K G T   T  +    GT  Y 
Sbjct: 107 ALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYL 162

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  KLF 
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFE 205

Query: 153 IM---DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++   D K    +P+  +  A +L    L  +P  R
Sbjct: 206 LILMEDIK----FPRTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 59/202 (29%), Positives = 84/202 (41%), Gaps = 24/202 (11%)

Query: 1   MPKGSLENHLF--RRGPQPLSWAVRMKVAIGA--AKGLTFLHDAESQVIYRDFKASNILL 56
           M  G L + L   R G  P     +M V      A G+ +L  +    I+RD  A N +L
Sbjct: 88  MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL--SSKSFIHRDLAARNCML 145

Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +   N  ++DFGL+K    GD             + A E +A    TTKSDV+SFGV + 
Sbjct: 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205

Query: 117 ELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           E+ + G+        G+E S +     YL    +L +  D  L G Y         +L  
Sbjct: 206 EIATRGQTPYP----GVENSEI---YDYLRQGNRLKQPPDC-LDGLY---------SLMS 248

Query: 176 QCLNNEPKLRPRMSEVLAILER 197
            C    PK RP    +   LE+
Sbjct: 249 SCWLLNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 2/104 (1%)

Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 76
            LS++  + +A   A G+ +L       ++RD    N L+   +  K++DFG+++   + 
Sbjct: 126 SLSFSTLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183

Query: 77  DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           D   V  +      + A E V  G+ TTKSDV++FGV L E+L+
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 2e-09
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 24/203 (11%)

Query: 1   MPKGSLENHLF--RRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           M  G L   L   R G +P +  ++  ++  I  A G+ +L  +    I+RD  A N +L
Sbjct: 89  MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL--SSKNFIHRDLAARNCML 146

Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +      ++DFGL+K   +GD             + A E +A    TT SDV++FGV + 
Sbjct: 147 NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 117 ELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           E+++ G+        G+E S +     YL    +L          + P         L  
Sbjct: 207 EIMTRGQTPY----AGVENSEI---YNYLIKGNRL----------KQPPDCLEDVYELMC 249

Query: 176 QCLNNEPKLRPRMSEVLAILERL 198
           QC + EPK RP    +   LE +
Sbjct: 250 QCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 55/189 (29%), Positives = 80/189 (42%), Gaps = 40/189 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----GPTGDRTHVSTQVMG 87
           + L ++H A   V +RD K  NIL +A+   K+ DFGLA+      PT       T  + 
Sbjct: 114 RALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVA 168

Query: 88  THGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-------- 137
           T  Y APE   +   + T   D++S G +  E+L+G+       V  +  L+        
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228

Query: 138 ---------DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN----EPKL 184
                    + A+ YLS  RK       K    + QK  + A  LAL+ L      +PK 
Sbjct: 229 PETISRVRNEKARRYLSSMRK-------KQPVPFSQKFPN-ADPLALRLLERLLAFDPKD 280

Query: 185 RPRMSEVLA 193
           RP   E LA
Sbjct: 281 RPTAEEALA 289

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)

Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179

Query: 84  QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 222

Query: 142 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 223 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 35/91 (38%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L +LH     ++YRD K  NILLD++ +  L+DFGL K G     T  +T   GT  
Sbjct: 106 ASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPE 161

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 45/118 (38%), Positives = 57/118 (48%), Gaps = 6/118 (5%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L +HL R G   LS A      +  A  L  LH  +  VIYRD K  NILLD + +  
Sbjct: 78  GELFHHLQREGRFDLSRARFYTAELLCA--LENLH--KFNVIYRDLKPENILLDYQGHIA 133

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           L DFGL K     D    +    GT  Y APE +     T   D ++ GV+L E+L+G
Sbjct: 134 LCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 27/100 (27%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------ 85
           KGL +LH  E+  I+RD K +NILL  + + KL+DFG            VS Q+      
Sbjct: 112 KGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAK 157

Query: 86  ----MGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLEL 118
               +GT  + APE  A    G    K D+++ G+  +EL
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 43/122 (35%), Positives = 58/122 (47%), Gaps = 14/122 (11%)

Query: 4   GSLENHLFR----RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           G L  HL R      P+   +A  +  AIG      +LH     +IYRD K  NILLD++
Sbjct: 81  GELFFHLQRERCFLEPRARFYAAEVASAIG------YLHSL--NIIYRDLKPENILLDSQ 132

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            +  L+DFGL K G   + T  ++   GT  Y APE +         D +  G VL E+L
Sbjct: 133 GHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Query: 120 SG 121
            G
Sbjct: 191 YG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 55.9 bits (135), Expect = 3e-09
 Identities = 51/193 (26%), Positives = 78/193 (40%), Gaps = 32/193 (16%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAK 71
           P  L+    +  A   AKG  +L   E+  I+RD  A N LL  +     AK++DFG+A+
Sbjct: 110 PSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Query: 72  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKV 130
                       + M    +  PE    G  T+K+DV+SFGV+L E+ S G         
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM------- 220

Query: 131 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPR 187
                      PY     +   +M+   GG     P+        +   C  + P+ RP 
Sbjct: 221 -----------PYPGRTNQ--EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPN 267

Query: 188 MSEVLAILERLEA 200
            +    ILER++ 
Sbjct: 268 FAT---ILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 47/187 (25%), Positives = 82/187 (43%), Gaps = 24/187 (12%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P  L+ +  + +A   A G+ +L  A    ++RD    N L+      K+ DFG+++   
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 133
           + D   V    M    +  PE +   + TT+SDV+S GVVL E+ + G+           
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------- 220

Query: 134 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
                  +P+  LS+   +  I   ++  Q P+        L L C   EP +R  + E+
Sbjct: 221 -------QPWYQLSNNEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272

Query: 192 LAILERL 198
            ++L+ L
Sbjct: 273 HSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KG+ ++H   + +++RD K +N+L+ A+   K++DFGLA+     +    S QV  T  Y
Sbjct: 110 KGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWY 166

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +   R      D+++ G +  ELL+G 
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 39/134 (29%), Positives = 60/134 (44%), Gaps = 16/134 (11%)

Query: 1   MPKGSLENHLFRRGP--------QP------LSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
           M  G L   L   GP        QP      L  +  + +A   A G+ +L  A    ++
Sbjct: 89  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVH 146

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 106
           RD    N L+ A    K+ DFG+++   + D   V    M    +  PE +   + TT+S
Sbjct: 147 RDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206

Query: 107 DVYSFGVVLLELLS 120
           DV+SFGV+L E+ +
Sbjct: 207 DVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 22/192 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P G   + L R+    L     +K A+ AA G+ +L       I+RD  A N L+    
Sbjct: 74  VPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENN 130

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+++    G  +    + +    + APE +  GR +++SDV+S+G++L E  S
Sbjct: 131 VLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRYSSESDVWSYGILLWETFS 189

Query: 121 -GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
            G C          +  V+          K +R+         PQK       +  +C +
Sbjct: 190 LGVCPYPGMTNQQAREQVE----------KGYRM-------SCPQKCPDDVYKVMQRCWD 232

Query: 180 NEPKLRPRMSEV 191
            +P+ RP+ SE+
Sbjct: 233 YKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 4e-09
 Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 20/178 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + + + H     +I+RD K  NIL+      KL DFG A+A      + ++  V  T  Y
Sbjct: 111 QAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWY 167

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR------CAVDKTKVGIEQSL--VDWAKP 142
            APE +       K  DV++ G ++ ELL G         +D+  + I++ L  +  +  
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQ 226

Query: 143 YLSDKRKLFRIMDT-------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
            L      F  +          L  +YP K +  A      CL  +PK R    E+L 
Sbjct: 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 5e-09
 Identities = 45/131 (34%), Positives = 64/131 (48%), Gaps = 20/131 (15%)

Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           +IYRD K  NILLDA+ + KL+DFGL K     G  TH      GT  Y APE +     
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEILMRSGH 177

Query: 103 TTKSDVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAK----PYLSD------KRK 149
               D +S G ++ ++L+G     A ++ K  I++ L    K    PYL+       K+ 
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKILK--GKLNLPPYLTPEARDLLKKL 234

Query: 150 LFRIMDTKLGG 160
           L R   ++LG 
Sbjct: 235 LKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTHVSTQVMGTH 89
           +GL ++H A   VI+RD K SN+L++ +   ++ DFG+A+   +   +  +  T+ + T 
Sbjct: 118 RGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 90  GYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 122
            Y APE + +    TT  D++S G +  E+L GR
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 2/106 (1%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P  L+    + +A   A G+ +L  A    ++RD    N L+      K+ DFG+++   
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + D   V  + M    +  PE +   + TT+SD++SFGVVL E+ +
Sbjct: 174 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.9 bits (132), Expect = 5e-09
 Identities = 42/130 (32%), Positives = 65/130 (50%), Gaps = 12/130 (9%)

Query: 1   MPKGSLENHL-----FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L ++L      R GP  L+    + + +  AKG  +L       I+RD  A N L
Sbjct: 81  MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCL 138

Query: 56  L-----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 110
           +     DA+   K+ DFGLA+     D      + +    + APE +  G+ TT+SDV+S
Sbjct: 139 VSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWS 198

Query: 111 FGVVLLELLS 120
           FGV++ E+L+
Sbjct: 199 FGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.0 bits (132), Expect = 5e-09
 Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 24/166 (14%)

Query: 38  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 97
           H    +V++RD K +N+ + A    KL D GL +   +  +T  +  ++GT  Y +PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178

Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
                  KSD++S G +L E+               QS      P+  DK  LF +    
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKMNLFSLCQKI 220

Query: 158 LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 199
               YP    +  +     L   C+  +P  RP +  V  I +++ 
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 6e-09
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 34/231 (14%)

Query: 3   KGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L   L  R P              + LS+   +  A   A+G+ +L     + I+RD
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRD 159

Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 108
             A N+L+  +   K++DFGLA+     D    ++       + APE +     T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219

Query: 109 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAA 167
           +SFG+++ E+ +         +G          PY      +LF+++        P    
Sbjct: 220 WSFGILMWEIFT---------LG--------GSPYPGIPVEELFKLLREGHRMDKPSNCT 262

Query: 168 HTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGP 218
           H    L  +C +  P  RP   +++  L+++ A  +   L  S P  Q  P
Sbjct: 263 HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYSP 313

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 54.6 bits (131), Expect = 7e-09
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 3/120 (2%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L       +     +  +   A+G+ ++       I+RD +A+N+L+    
Sbjct: 83  MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESL 140

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+++
Sbjct: 141 MCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 7e-09
 Identities = 38/123 (30%), Positives = 67/123 (54%), Gaps = 5/123 (4%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP GS+++ L   G   L+  V  K      +G+++LH   + +++RD K +NIL D+  
Sbjct: 88  MPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVG 143

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           N KL DFG +K   T   +    + V GT  + +PE ++      K+D++S G  ++E+L
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203

Query: 120 SGR 122
           + +
Sbjct: 204 TEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 54.8 bits (132), Expect = 8e-09
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 111 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWY 166

Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 30/190 (15%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P+   W   +++       L  +H    ++++RD K +N+ + A    KL D GL +   
Sbjct: 104 PERTIWKYFVQLC----SALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF-- 155

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
              +T  +  ++GT  Y +PE +       KSD++S G +L E+ + +            
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------ 203

Query: 135 SLVDWAKPYLSDKRKLFRIMDTKLGGQY-PQKAAHTAATL---ALQCLNNEPKLRPRMSE 190
                  P+  DK  L+ +        Y P  A H +  L     +C+N +P+ RP +S 
Sbjct: 204 ------SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISY 257

Query: 191 VLAILERLEA 200
           VL + + + A
Sbjct: 258 VLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 2/103 (1%)

Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           +S A  + +A+  A G+ +L  A    ++RD    N L+   +  K++DFG+++   +GD
Sbjct: 126 VSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              +  + +    + A E +  G+ TT SDV++FGV L E+ +
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 20/162 (12%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A G+ FL  +   V+++D    N+L+  + N K+SD GL +     D   +    +    
Sbjct: 134 AAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 149
           + +PE +  G+ +  SD++S+GVVL E+ S          G++        PY     + 
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQ--------PYCGYSNQD 234

Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
           +  ++  +     P        TL L+C N  P  RPR  ++
Sbjct: 235 VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 27/173 (15%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 87
           AKG+ FL  A  + I+RD  A NILL      K+ DFGLA+     P   R   +   + 
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 145
              + APE +     T +SDV+SFGV+L E+ S         +G        A PY  + 
Sbjct: 246 --KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVK 286

Query: 146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
              +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.7 bits (129), Expect = 1e-08
 Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 4/85 (4%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH  E ++++RD   +NI+L  +    ++DFGLAK           T V+GT  Y+ 
Sbjct: 126 LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSC 181

Query: 94  PEYVATGRLTTKSDVYSFGVVLLEL 118
           PE V       K+DV++FG +L ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 25/195 (12%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNA 62
           G     L   GP+ L     +++   AA G+ +L   ES+  I+RD  A N L+  +   
Sbjct: 78  GDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVL 133

Query: 63  KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           K+SDFG+++    G              + APE +  GR +++SDV+SFG++L E  S  
Sbjct: 134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS-- 191

Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNN 180
                  +G        A PY +   +  R    + G +   P+        L  +C   
Sbjct: 192 -------LG--------AVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEY 235

Query: 181 EPKLRPRMSEVLAIL 195
           +P  RP  S V   L
Sbjct: 236 DPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 40/167 (23%), Positives = 71/167 (42%), Gaps = 24/167 (14%)

Query: 38  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 97
           H    +V++RD K +N+ + A    KL D GL +   +  +T  +  ++GT  Y +PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178

Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
                  KSD++S G +L E+ +                     P+  DK  L+ +    
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAA------------------LQSPFYGDKMNLYSLCKKI 220

Query: 158 LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
               YP       +     L   C+N +P+ RP ++ V  + +R+ A
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 38/108 (35%), Positives = 52/108 (48%), Gaps = 4/108 (3%)

Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
           R GP PL  A+ ++  +  A  L +LH     +I+RD K  NI LD   NA L DFG A 
Sbjct: 178 RSGPLPLEQAITIQRRLLEA--LAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAAC 233

Query: 72  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
                  T       GT    +PE +A      K+D++S G+VL E+ 
Sbjct: 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 37/121 (30%), Positives = 65/121 (53%), Gaps = 5/121 (4%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP GS+++ L   G   L+  V  +      +G+++LH   + +++RD K +NIL D+  
Sbjct: 88  MPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAG 143

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           N KL DFG +K   T   +    + V GT  + +PE ++      K+DV+S    ++E+L
Sbjct: 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203

Query: 120 S 120
           +
Sbjct: 204 T 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--G 90
           G+ +L       ++RD  A N+LL  +  AK+SDFGL+KA    D ++   +  G     
Sbjct: 107 GMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLK 163

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +   + +++SDV+S+G+ + E  S
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           AKG++FL  A    I+RD  A NILL      K+ DFGLA+         V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 36/97 (37%), Positives = 49/97 (50%), Gaps = 13/97 (13%)

Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ 84
           +  GA +GL +LH  E   I+RD KA NILL      KL+DFG A    P       +  
Sbjct: 120 ICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANS 170

Query: 85  VMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 118
            +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 44/218 (20%)

Query: 3   KGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P              + LS+   +  A   A+G+ +L  A  + I+RD
Sbjct: 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRD 165

Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 166 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 220

Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 221 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 263

Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 264 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 13/102 (12%)

Query: 20  WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 79
           +   M  A+ A   L ++H        RD K  N L+DA  + KL+DFGL+K   T    
Sbjct: 106 YMAEMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153

Query: 80  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             +  V+G+  Y APE +         D +S G +L E L G
Sbjct: 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 24/197 (12%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P G L ++L       L  A  +  +   +  L +L     + ++RD  A N+L+ +   
Sbjct: 89  PLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDC 145

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            KL DFGL++          S   +    + APE +   R T+ SDV+ FGV + E+L  
Sbjct: 146 VKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPESINFRRFTSASDVWMFGVCMWEILM- 203

Query: 122 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLN 179
                   +G+        KP+   K     I   + G +   P     T  +L  +C  
Sbjct: 204 --------LGV--------KPFQGVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWA 246

Query: 180 NEPKLRPRMSEVLAILE 196
            +P  RPR +E+ A L 
Sbjct: 247 YDPSKRPRFTELKAQLS 263

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 35/232 (15%)

Query: 3   KGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P              + L++   +  A   A+G+ +L  A  + I+RD
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRD 159

Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 108
             A N+L+  +   K++DFGLA+     D    +T       + APE +     T +SDV
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219

Query: 109 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAA 167
           +SFGV+L E+ +         +G          PY      +LF+++        P    
Sbjct: 220 WSFGVLLWEIFT---------LG--------GSPYPGIPVEELFKLLKEGHRMDKPANCT 262

Query: 168 HTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQTGP 218
           H    +  +C +  P  RP   +++  L+R L        L  S P  Q  P
Sbjct: 263 HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 27/177 (15%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           Q + W V++ +A      L +LH  E  +++RD K  N+ L      K+ D G+A+    
Sbjct: 103 QVVEWFVQIAMA------LQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--L 152

Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 135
            ++  +++ ++GT  Y +PE  +      KSDV++ G  + E+ + + A +   +    S
Sbjct: 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NS 209

Query: 136 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           LV             +RI++ KL    P+  +     L    L+  P+ RP +  +L
Sbjct: 210 LV-------------YRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.5 bits (126), Expect = 4e-08
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KG+ F H  E++V++RD K  N+L++     KL+DFGLA+A      T  +  V  T  Y
Sbjct: 111 KGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWY 166

Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
            AP+ +   R  +T  D++S G ++ E+++GR
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 23/153 (15%)

Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           ++++RD K++NI L      KL DFG +K         V++   GT  Y APE     R 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 103 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 162
           + K+D++S GV+L ELL+                    +P+    ++   IM   L G+Y
Sbjct: 249 SKKADMWSLGVILYELLT------------------LHRPFKGPSQR--EIMQQVLYGKY 288

Query: 163 ---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
              P   +     L    L+  P LRP   ++L
Sbjct: 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ F H    +V++RD K  N+L+D +   KL+DFGLA+A   G    V T  + T  Y 
Sbjct: 113 GILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEVVTLWYR 168

Query: 93  APE-YVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE  + + R +T  D++S G +  E+ + +
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 40/134 (29%), Positives = 58/134 (43%), Gaps = 19/134 (14%)

Query: 4   GSLENHL--FRRGPQPL--SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           G L +H+  F   P+     WA  M VA+ A      LH     ++ RD   +NILLD  
Sbjct: 70  GKLWSHISKFLNIPEECVKRWAAEMVVALDA------LH--REGIVCRDLNPNNILLDDR 121

Query: 60  FNAKLSDFG-LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
            + +L+ F   ++   + D   V         Y APE       T   D +S G +L EL
Sbjct: 122 GHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEVGGISEETEACDWWSLGAILFEL 175

Query: 119 LSGRCAVDKTKVGI 132
           L+G+  V+    GI
Sbjct: 176 LTGKTLVECHPSGI 189

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 26/169 (15%)

Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           A  GL  LH   ++ I+RD K +NILL  E   KL DFG++ A  T  R   +T V GT 
Sbjct: 133 ALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSV-GTP 188

Query: 90  GYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 144
            + APE +A  +        + DV+S G+  +EL  G           +  L D     L
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DPPLAD-----L 232

Query: 145 SDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
              R LF+I  +       P+  ++       +CL  + + RP +S++L
Sbjct: 233 HPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 6e-08
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +G+ + H    +V++RD K  N+L+D E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 110 QGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWY 165

Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
            APE +   R  +T  D++S G +  E+++ R
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 13/107 (12%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGP 74
           +PL       +  GA +GL +LH     +I+RD KA NILL      KL+DFG A K+ P
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 118
                  +   +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 45/136 (33%), Positives = 60/136 (44%), Gaps = 26/136 (19%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTH 89
           + + F H  +   I+RD K  NIL+  +   KL DFG A+   GP  D     T  + T 
Sbjct: 111 QAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATR 164

Query: 90  GYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 148
            Y APE  V   +     DV++ G V  ELL+G            Q L  W  P  SD  
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG------------QPL--W--PGKSDVD 208

Query: 149 KLFRIMDTKLGGQYPQ 164
           +L+ I  T LG   P+
Sbjct: 209 QLYLIRKT-LGDLIPR 223

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L +LH     ++YRD K  NILLD++ +  L+DFGL K     + T  ++   GT  
Sbjct: 106 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPE 161

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 34/207 (16%)

Query: 1   MPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           +P+ SL      RG         + LS+  ++ +AI   KGL  L+   ++  Y++  + 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-YKNLTSV 152

Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYS 110
           + L+   +  K+   GL K   +    +V+  V     Y + + +       T K D+YS
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYS 207

Query: 111 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY-PQKAAHT 169
            GVVL E+ +G       K+  E              ++++ ++  K      P      
Sbjct: 208 LGVVLWEIFTG-------KIPFEN----------LTTKEIYDLIINKNNSLKLPLDCPLE 250

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILE 196
              +   C +++   RP + E+L  L 
Sbjct: 251 IKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 30/79 (37%), Positives = 47/79 (59%), Gaps = 2/79 (2%)

Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           ++YRD K  NILLD+E +  L+DFGL+K   + ++   +    GT  Y APE +      
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGH 184

Query: 104 TKS-DVYSFGVVLLELLSG 121
            K+ D +S G+++ ELL+G
Sbjct: 185 GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 23/146 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSLE          L+      VA     G+ +LH     +++RD K SN+L+++  
Sbjct: 154 MDGGSLEGTHIADEQF-LA-----DVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAK 205

Query: 61  NAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKS-DVYSFGVV 114
           N K++DFG+++    T D  + S   +GT  Y +PE + T    G     + D++S GV 
Sbjct: 206 NVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262

Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWA 140
           +LE   GR      + G      DWA
Sbjct: 263 ILEFYLGRFPFGVGRQG------DWA 282

Length = 353

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 13/107 (12%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGP 74
           +PL       +  GA +GL +LH     +I+RD KA NILL      KL+DFG A  A P
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 118
                  +   +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 17/121 (14%)

Query: 14  GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
           G  P+  A RM  A      L +LH+    +++RD K  N+L+ +  + KL+DFGL+K G
Sbjct: 96  GALPVDMA-RMYFA-ETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151

Query: 74  -------------PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
                            R  +  QV GT  Y APE +         D ++ G++L E L 
Sbjct: 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 211

Query: 121 G 121
           G
Sbjct: 212 G 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 4/96 (4%)

Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L++LH+    VI+RD K+ +ILL ++   KLSDFG                +
Sbjct: 123 VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKSL 178

Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +GT  + APE ++     T+ D++S G++++E++ G
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 30/203 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L++ L R+    L     M +  G A G+ +L  +E   +++   A  +L++++ 
Sbjct: 88  MSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDL 144

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+S F   +     D++      M       +AAPE +     ++ SDV+SFG+V+ E
Sbjct: 145 VCKISGFRRLQE----DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWE 200

Query: 118 LLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           ++S   R   D +   + +++ D            FR+         P+   +    L L
Sbjct: 201 VMSYGERPYWDMSGQDVIKAVEDG-----------FRL-------PAPRNCPNLLHQLML 242

Query: 176 QCLNNEPKLRPRMSEVLAILERL 198
            C   E   RPR S++ +IL ++
Sbjct: 243 DCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 35/103 (33%), Positives = 47/103 (45%), Gaps = 14/103 (13%)

Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPT 75
           L W V+M + +         H  E +V++RD K+ NI L      KL DFG A+    P 
Sbjct: 103 LQWFVQMCLGVQ--------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154

Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
               +  T V GT  Y  PE         KSD++S G +L EL
Sbjct: 155 ---AYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)

Query: 1   MPKGSL----ENHLFRRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L      H    G Q L +W V++      AKG+ +L   E ++++RD  A N+L
Sbjct: 90  MPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE--ERRLVHRDLAARNVL 141

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           + +  + K++DFGLA+     ++ + +        + A E +   + T +SDV+S+GV +
Sbjct: 142 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201

Query: 116 LELLS 120
            EL++
Sbjct: 202 WELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           +G+ + H    +V++RD K  N+L+D   NA KL+DFGLA+A     RT   T  + T  
Sbjct: 113 RGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLW 168

Query: 91  YAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
           Y APE +   R  +T  D++S G +  E+++ +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 41/168 (24%), Positives = 76/168 (45%), Gaps = 30/168 (17%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFG----LAKAGPTGDRTHVSTQVM 86
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG    LA   P       +    
Sbjct: 119 EGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFT 170

Query: 87  GTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 144
           GT  Y APE +  G       +D++S G  ++E+ +G+              ++  +P  
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK-----------PPFIELGEPQA 219

Query: 145 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           +    +F++   K+  + P+  +  A    L+C   +P  R    ++L
Sbjct: 220 A----MFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 11/93 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L +LH  E+++I+RD KA NIL   + + KL+DFG+ AK   T  R       +GT  
Sbjct: 114 EALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPY 168

Query: 91  YAAPEYV--ATGR---LTTKSDVYSFGVVLLEL 118
           + APE V   T +      K+DV+S G+ L+E+
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 183

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 4/91 (4%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL + H      ++RD K SNILL+ +   KL+DFGLA+   + +    + +V+ T  Y 
Sbjct: 128 GLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYR 184

Query: 93  APE-YVATGRLTTKSDVYSFGVVLLELLSGR 122
            PE  +   R     DV+S G +L EL + +
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 42/187 (22%)

Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
            Q   W +++ +      G+ ++H  + ++++RD KA NI L      K+ DFG+++   
Sbjct: 106 NQVCEWFIQLLL------GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL-- 154

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG--- 131
                 ++T   GT  Y +PE +      +KSD++S G +L E+    C +     G   
Sbjct: 155 LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM----CCLAHAFEGQNF 210

Query: 132 --IEQSLVDWAKPYLSDK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 187
             +   +V+   P L +   R+L  IM +                     LN +P LRP 
Sbjct: 211 LSVVLRIVEGPTPSLPETYSRQLNSIMQSM--------------------LNKDPSLRPS 250

Query: 188 MSEVLAI 194
            +E+L  
Sbjct: 251 AAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 115 RGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWY 170

Query: 92  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 122
             P+  + +   +T+ D++  G +  E+ SGR
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 12/94 (12%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG----LAKAGPTGDRTHVSTQVMG 87
           + L +LH     VI+RD K+ +ILL  +   KLSDFG    ++K  P          ++G
Sbjct: 128 QALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVG 179

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T  + APE ++     T+ D++S G++++E++ G
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   +I+RD K SNI ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEM---TGYVATRWY 181

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 4e-07
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 5/87 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +G+ FLH    ++++RD K  NIL+ ++   K++DFGLA+           T V+ T  Y
Sbjct: 118 RGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWY 172

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLEL 118
            APE +      T  D++S G +  EL
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 4e-07
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 14/95 (14%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           KGL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+           +++ G   T
Sbjct: 129 KGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVT 178

Query: 89  HGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 122
             Y APE +      T   D++S G ++ E+L+G+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L F +     ++YRD K  N+LLD +   K++DFG AK   T  RT+    + GT  Y A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--RTYT---LCGTPEYIA 196

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +        +D ++ G+ + E+L G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T     + T  + T  Y 
Sbjct: 135 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYR 189

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 13/125 (10%)

Query: 1   MPKGSL----ENHLFRRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L      H    G Q L +W V++      AKG+ +L   E ++++RD  A N+L
Sbjct: 90  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE--ERRLVHRDLAARNVL 141

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201

Query: 116 LELLS 120
            EL++
Sbjct: 202 WELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.5 bits (118), Expect = 4e-07
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 35/212 (16%)

Query: 1   MPKGSLENHLFRRGPQP---------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 51
           M  G L   L R  PQ          +S++  + +A   A G+ +L  +    ++RD   
Sbjct: 101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLAT 158

Query: 52  SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 111
            N L+   +  K++DFG+++   +GD   +  + +    + + E +  G+ TT SDV++F
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218

Query: 112 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKR------KLFRIMDTKLGGQYP 163
           GV L E+L+  C         EQ       PY  LSD++      + FR    ++    P
Sbjct: 219 GVTLWEILT-LCK--------EQ-------PYSQLSDEQVIENTGEFFRDQGRQVYLPKP 262

Query: 164 QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
                +   L L C     K RP   E+ A L
Sbjct: 263 ALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 49.7 bits (118), Expect = 5e-07
 Identities = 37/106 (34%), Positives = 50/106 (47%), Gaps = 11/106 (10%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           +PL       V  GA +GL +LH     +I+RD KA NILL      KL DFG A     
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI--- 164

Query: 76  GDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 118
                 +   +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 165 ---MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 49.2 bits (117), Expect = 5e-07
 Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 18/133 (13%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL++ H  + ++++RD K  N+L++ +   KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 114 RGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWY 169

Query: 92  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
             P+  + +   +T  D++  G +L E+ +GR     + V  E  L+             
Sbjct: 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI------------- 216

Query: 151 FRIMDTKLGGQYP 163
           FR++ T     +P
Sbjct: 217 FRLLGTPTEETWP 229

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.4 bits (118), Expect = 5e-07
 Identities = 43/130 (33%), Positives = 57/130 (43%), Gaps = 20/130 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L      P  WA      + +A+ A   + F+H        RD K  N+LL
Sbjct: 125 MPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLL 175

Query: 57  DAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSF 111
           D   + KL+DFG   K    G      T V GT  Y +PE + +    G    + D +S 
Sbjct: 176 DKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233

Query: 112 GVVLLELLSG 121
           GV L E+L G
Sbjct: 234 GVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 7e-07
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 7/84 (8%)

Query: 45  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 104
           ++RD K  N+L+D   + KL+DFG A A  T ++   S   +GT  Y APE + T     
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 105 KS------DVYSFGVVLLELLSGR 122
           K       D +S GV+  E++ GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.8 bits (117), Expect = 7e-07
 Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 7/90 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           K L  +H   + + +RD K  NIL+  +   KL+DFG  +           T+ + T  Y
Sbjct: 111 KSLDHMH--RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWY 164

Query: 92  AAPEYVAT-GRLTTKSDVYSFGVVLLELLS 120
            APE + T G    K D+++ G V  E+LS
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.7 bits (116), Expect = 8e-07
 Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 18/130 (13%)

Query: 2   PKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           P G L+N+L        +  Q     V  ++A   A GL +LH A+   I+ D    N  
Sbjct: 78  PLGDLKNYLRSNRGMVAQMAQKD---VLQRMACEVASGLLWLHQAD--FIHSDLALRNCQ 132

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-------TGRLTTKSDV 108
           L A+ + K+ D+GLA      D             + APE V            T KS++
Sbjct: 133 LTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNI 192

Query: 109 YSFGVVLLEL 118
           +S GV + EL
Sbjct: 193 WSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 8e-07
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 16/132 (12%)

Query: 3   KGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P              + +++   +      A+G+ +L  A  + I+RD
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRD 162

Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 108
             A N+L+      K++DFGLA+     D    +T       + APE +     T +SDV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222

Query: 109 YSFGVVLLELLS 120
           +SFGV++ E+ +
Sbjct: 223 WSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 9e-07
 Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK-AGPTGDRTHVSTQVMGTH 89
           +GL ++H A   V++RD K +N+ ++ E    K+ DFGLA+   P        ++ + T 
Sbjct: 125 RGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 90  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            Y +P  + +    TK+ D+++ G +  E+L+G+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.5 bits (115), Expect = 9e-07
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 121 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 175

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +      T  D++S G +  E+   +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 26/179 (14%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTH 89
           +G+ F H     +I+RD K  NIL+      KL DFG A+  A P G+   V T  + T 
Sbjct: 111 RGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATR 164

Query: 90  GYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR------CAVDKTKVGIEQSLVDWAKP 142
            Y APE  V   +     D+++ G ++ E+L+G         +D+    I + L +    
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY-HIIKCLGNLIPR 223

Query: 143 Y--LSDKRKLFRIM---DTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           +  +  K  LF  M   + K    L  ++P K +     LA QCL  +P  RP  S++L
Sbjct: 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 11/93 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L +LH    ++I+RD KA N+LL  + + KL+DFG+ AK   T  R       +GT  
Sbjct: 121 EALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPY 175

Query: 91  YAAPEYVATGRLTT-----KSDVYSFGVVLLEL 118
           + APE V    +       K+D++S G+ L+E+
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.2 bits (114), Expect = 1e-06
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185

Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 41/125 (32%), Positives = 54/125 (43%), Gaps = 10/125 (8%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G L N L      P  WA      +  A  L  +H     +I+RD K  N+LLD   
Sbjct: 125 MPGGDLVN-LMSNYDVPEKWAKFYTAEVVLA--LDAIHSM--GLIHRDVKPDNMLLDKHG 179

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLL 116
           + KL+DFG              T V GT  Y +PE + +    G    + D +S GV L 
Sbjct: 180 HLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238

Query: 117 ELLSG 121
           E+L G
Sbjct: 239 EMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHG 90
           GL ++H   +++++RD KA+NIL+  +   KL+DFGLA+A       + +  T  + T  
Sbjct: 131 GLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 91  YAAPEYVATGR-LTTKSDVYSFGVVLLEL 118
           Y  PE +   R      D++  G ++ E+
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 115 RGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWY 170

Query: 92  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 122
             P+  + +   +T+ D++  G +  E+ +GR
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 4/96 (4%)

Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   K L+ LH     VI+RD K+ +ILL  +   KLSDFG                +
Sbjct: 121 VCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSL 176

Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +GT  + APE ++      + D++S G++++E++ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+    G    ++  V+ T  Y 
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV-TRYYR 184

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +         D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H     +++RD K  N+L+      KL+DFGLA+A     +T+ S  V  T  Y
Sbjct: 114 RGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWY 169

Query: 92  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 139
             P+  +     ++  D++  G + +E+L G+ A        EQ    W
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.3 bits (112), Expect = 3e-06
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 11/108 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192

Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  G   +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.8 bits (111), Expect = 4e-06
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 14/95 (14%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
            GL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 128 CGLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 177

Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             Y APE +       ++ D++S G ++ E+L+G+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 11/96 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHG 90
           +GL+ LH  + +VI+RD K  N+LL      KL DFG++      DRT       +GT  
Sbjct: 122 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPY 176

Query: 91  YAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 121
           + APE +A           KSD++S G+  +E+  G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 41/129 (31%), Positives = 55/129 (42%), Gaps = 18/129 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L      P  WA      + +A+ A   + F+H        RD K  N+LL
Sbjct: 125 MPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLL 175

Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFG 112
           D   + KL+DFG              T V GT  Y +PE + +    G    + D +S G
Sbjct: 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 113 VVLLELLSG 121
           V L E+L G
Sbjct: 235 VFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A G+ FL  A    ++RD  A N+L+      K+ DFGLA+     D    S  +     
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKGST 301

Query: 91  Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           +      APE +     TT SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.1 bits (109), Expect = 6e-06
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-TQVMGTHG 90
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+         ++ T V+ T  
Sbjct: 119 RGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLW 172

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           Y APE +      T  D++S G +  E+ 
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.2 bits (109), Expect = 7e-06
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 16/116 (13%)

Query: 13  RGPQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 70
           R P+ ++  +   M +AI +   L ++H        RD K  NIL+D   + +L+DFG +
Sbjct: 98  RLPEDMARFYLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-S 148

Query: 71  KAGPTGDRTHVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 121
                 D T  S+  +GT  Y +PE +       G+   + D +S GV + E+L G
Sbjct: 149 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 8e-06
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 20/100 (20%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLA-------KAGPTGDRTHV 81
           G+ +LH   + V++RD K +NIL+  E       K+ D GLA       K     D    
Sbjct: 120 GVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP--- 174

Query: 82  STQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 120
              V+ T  Y APE +   R  TK+ D+++ G +  ELL+
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 9e-06
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL + H    +V++RD K  N+L+      KL+DFGLA+A     +T+ S +V+ T  Y
Sbjct: 114 RGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWY 169

Query: 92  AAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 122
             P+ V  G    +T  D++  G +  E+ +GR
Sbjct: 170 RPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 9e-06
 Identities = 27/106 (25%), Positives = 40/106 (37%), Gaps = 27/106 (25%)

Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV---------------------- 81
           ++YRD K  NILL    +  LSDF L+K                                
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 82  -----STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                S   +GT  Y APE ++     +  D ++ G++L E+L G 
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL F H     V++RD K  N+L++     KL+DFGLA+A     R + S +V+ T  Y
Sbjct: 110 KGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWY 165

Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLELLSG 121
             P+ +   +L +T  D++S G +  EL + 
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 16/104 (15%)

Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVS 82
           M +AI +   L ++H        RD K  N+LLD   + +L+DFG   +    G  T  S
Sbjct: 111 MVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQS 160

Query: 83  TQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 121
              +GT  Y +PE +       GR   + D +S GV + E+L G
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 15/104 (14%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-------AGPTGDRTHVS-- 82
            GL  LH  +   ++RD   +NI ++++   K++DFGLA+       +        +   
Sbjct: 130 NGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 83  ---TQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 122
              T  + T  Y APE +    +     D++S G +  ELL+G+
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+     D     T  + T  Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 32/113 (28%), Positives = 45/113 (39%), Gaps = 36/113 (31%)

Query: 45  IYRDFKASNILLDAEFNAKLSDFGL----------------AKAGPTGDRTHVSTQ---- 84
           I+RD K  N+LLDA+ + KLSDFGL                + A P+     +S      
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 85  ----------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                            +GT  Y APE         + D +S GV++ E+L G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 11/96 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHG 90
           +GL  LH    +VI+RD K  N+LL      KL DFG++      DRT       +GT  
Sbjct: 132 RGLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPY 186

Query: 91  YAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 121
           + APE +A           +SD++S G+  +E+  G
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 44.7 bits (105), Expect = 2e-05
 Identities = 28/94 (29%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL+++H  +  +++RD K  N+L+      KL+DFGLA+A      T+ S +V+ T  Y
Sbjct: 114 RGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWY 169

Query: 92  AAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCA 124
             P+  + +   +T  D++  G + +E++ G  A
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 16/116 (13%)

Query: 13  RGPQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 70
           R P+ ++  +   M +AI +   L ++H        RD K  N+LLD   + +L+DFG +
Sbjct: 98  RLPEDMARFYIAEMVLAIHSIHQLHYVH--------RDIKPDNVLLDMNGHIRLADFG-S 148

Query: 71  KAGPTGDRTHVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 121
                 D T  S+  +GT  Y +PE +       G+   + D +S GV + E+L G
Sbjct: 149 CLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 37/143 (25%), Positives = 54/143 (37%), Gaps = 50/143 (34%)

Query: 45  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVST-------------------- 83
           I+RD K  NIL+D + + KL+DFGL     TG R TH S                     
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 84  ------------------------QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
                                    ++GT  Y APE +     T   D +S GV+L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 120 SGRCA-VDKTKVGIEQSLVDWAK 141
            G+   +  T    +  +++W  
Sbjct: 239 VGQPPFLADTPAETQLKVINWET 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 14/113 (12%)

Query: 14  GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-A 72
            PQ LS    + +AI  A G+++LH     VI++D  A N ++D E   K++D  L++  
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 73  GPT-----GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
            P      GD  +   + M      A E +     ++ SDV+SFGV+L EL++
Sbjct: 168 FPMDYHCLGDNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.5 bits (102), Expect = 5e-05
 Identities = 37/129 (28%), Positives = 49/129 (37%), Gaps = 41/129 (31%)

Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA------------- 72
           +AI A   L F+H        RD K  N+LLDA+ + KLSDFGL                
Sbjct: 112 LAIDAIHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 73  --GPTGD------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
              P  D                  R  ++   +GT  Y APE           D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 113 VVLLELLSG 121
           V++ E+L G
Sbjct: 224 VIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 44/202 (21%), Positives = 69/202 (34%), Gaps = 53/202 (26%)

Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF----GLAKAG---------PT 75
                L ++H      I+R  KAS+ILL  +    LS       + K G         P 
Sbjct: 109 DVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166

Query: 76  GDRTHV---STQVM--GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA----VD 126
               ++   S +V+     GY             KSD+YS G+   EL +G       + 
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGY-----------NEKSDIYSVGITACELANG-HVPFKDMP 214

Query: 127 KTKVGIEQSLVDWAKPYLSDKRKLFRIMD------TKLGGQYPQKAAHTAAT-------- 172
            T++ +E+  V    P L DK       D      +       + +     T        
Sbjct: 215 ATQMLLEK--VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFH 272

Query: 173 -LALQCLNNEPKLRPRMSEVLA 193
                CL  +P+ RP  S++L 
Sbjct: 273 QFVELCLQRDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.1 bits (101), Expect = 6e-05
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           K + + H  ++ +++RD K  N+L+      KL DFG A+    G   +  T+ + T  Y
Sbjct: 111 KAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWY 167

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            +PE +         D++S G +L EL  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.8 bits (101), Expect = 7e-05
 Identities = 47/198 (23%), Positives = 69/198 (34%), Gaps = 44/198 (22%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----D 57
             G L+  L  R    +S   ++ VA   A  L +L D   ++++ +    NIL+     
Sbjct: 83  KFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGL 139

Query: 58  AEFN---AKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSF 111
            E      KLSD G+        +R      +       APE +  G+  LT  +D +SF
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERIPWI-------APECIRNGQASLTIAADKWSF 192

Query: 112 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK---RKLFRIMDTKLGGQYPQKAAH 168
           G  LLE+ S                    +  LS      K     D     + P     
Sbjct: 193 GTTLLEICS------------------NGEEPLSTLSSSEKERFYQD---QHRLPMPDCA 231

Query: 169 TAATLALQCLNNEPKLRP 186
             A L  QC   +P  RP
Sbjct: 232 ELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.5 bits (100), Expect = 9e-05
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG--PTGDRTHVSTQVMGT 88
           KG+   H  +  V++RD K  N+L+D +    K++D GL +A   P    TH   +++ T
Sbjct: 121 KGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV-T 174

Query: 89  HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 121
             Y APE +      +T  D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + + +LH  E+++I+RD KA NI ++   +  L DFG A   P     +      GT   
Sbjct: 193 RAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIAT 249

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +A        D++S G+VL E+ +  
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 58/189 (30%)

Query: 1   MPKGSLENHLFRRG--PQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + + L R G  P+ L+  +   +  A+ +   + F+H        RD K  NIL+
Sbjct: 83  IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--------RDIKPDNILI 134

Query: 57  DAEFNAKLSDFGL---------AKAGPTGD------------------------------ 77
           D + + KL+DFGL         +K   +GD                              
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLER 194

Query: 78  ---RTH---VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-VDKTKV 130
              R H   ++  ++GT  Y APE +     T   D +S GV+L E+L G+   + +T +
Sbjct: 195 RAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL 254

Query: 131 GIEQSLVDW 139
             +  +++W
Sbjct: 255 ETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 15/132 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GS  + L    P+ +S A+   +  GA +GL +LH  ++  I+R+ KAS+IL+  + 
Sbjct: 81  MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDG 138

Query: 61  NAKLSD----FGLAKAGPTG----DRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYS 110
              LS     + L + G       D    ST V+    + +PE +         KSD+YS
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYS 195

Query: 111 FGVVLLELLSGR 122
            G+   EL +GR
Sbjct: 196 VGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 33/110 (30%)

Query: 45  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT------------------------- 79
           I+RD K  N+LLD++ + KLSDFGL        RT                         
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 80  --------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                    ++   +GT  Y APE           D +S GV++ E+L G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 43/171 (25%), Positives = 66/171 (38%), Gaps = 57/171 (33%)

Query: 1   MPKGSLENHLFRRG--PQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + + L R    P+ L+  +   + +AI +   + F+H        RD K  NIL+
Sbjct: 83  IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH--------RDIKPDNILI 134

Query: 57  DAEFNAKLSDFGLAKA---------------------GPT-----------GDRTHVSTQ 84
           D + + KL+DFGL                         P+           GDR     Q
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194

Query: 85  -------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                        ++GT  Y APE +     T   D +S GV+L E+L G+
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 8/107 (7%)

Query: 16  QPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
           +PL    R  MK  + A   + ++HD   ++I+RD K  NI L+ +    L DFG A   
Sbjct: 263 RPLLKQTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317

Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              +R       +GT    +PE +A       +D++S G++LL++LS
Sbjct: 318 EK-EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 33/112 (29%), Positives = 50/112 (44%), Gaps = 3/112 (2%)

Query: 6   LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 65
           L  +L  R  +PL  A    VA      + ++H     +I+RD K  N+L++   +  L 
Sbjct: 246 LYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLG 302

Query: 66  DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
           DFG A        T     + GT    APE +A    T   D++S G+V+ E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 40.2 bits (95), Expect = 5e-04
 Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 46/189 (24%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----THVSTQVM 86
            +GL  +H       +RD K  N+L+      K++DFGLA+      R     +VST+  
Sbjct: 109 LQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-- 162

Query: 87  GTHGYAAPEYVATGRLTTKS---DVYSFGVVLLELLS------GRCAVD---KTKVGIEQ 134
               Y APE +   R T+ S   D+++ G ++ EL +      G   +D   K    I  
Sbjct: 163 ---WYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK----ICS 213

Query: 135 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNNEPK 183
            L    K    +  KL      KLG ++PQ            A+  A  L    L  +PK
Sbjct: 214 VLGTPTKQDWPEGYKLAS----KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK 269

Query: 184 LRPRMSEVL 192
            RP  S+ L
Sbjct: 270 KRPTASQAL 278

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 9/91 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           +GL +LH      ++RD K +NILL    + KL+DFG+ AK   T  +       +GT  
Sbjct: 117 QGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPY 171

Query: 91  YAAPEYVA---TGRLTTKSDVYSFGVVLLEL 118
           + APE  A    G      D+++ G+  +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 16/93 (17%)

Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLA-------------KAGPTGDRTHVST---QVMG 87
           V++RD K  NILL       + D+G A                         T   +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           T  Y APE +     +  +D+Y+ GV+L ++L+
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 38.9 bits (90), Expect = 0.001
 Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 11/119 (9%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           GSL++     GP  LS +    V+    +GL +LH      ++RD K +NILL    + K
Sbjct: 91  GSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVK 146

Query: 64  LSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLEL 118
           L+DFG+ A+   T  +       +GT  + APE  A  R        D+++ G+  +EL
Sbjct: 147 LADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.7 bits (90), Expect = 0.002
 Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 8/45 (17%)

Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 70
           +AI A   L F+H        RD K  NIL+D   + KLSDFGL+
Sbjct: 112 LAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 22/133 (16%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK-----AGPTGDRTHVST 83
           G+ +LH   + V++RD K +NIL+  E       K++D G A+       P  D      
Sbjct: 120 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----D 173

Query: 84  QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 142
            V+ T  Y APE +   R  TK+ D+++ G +  ELL+        +  I+ S      P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS-----NP 228

Query: 143 YLSDK-RKLFRIM 154
           Y  D+  ++F +M
Sbjct: 229 YHHDQLDRIFNVM 241

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	252
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.98
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
PHA03211	461	serine/threonine kinase US3; Provisional	99.98
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.98
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.98
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.98
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.98
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.98
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.89
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.6
PRK09188	365	serine/threonine protein kinase; Provisional	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.55
PRK12274	218	serine/threonine protein kinase; Provisional	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.46
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.44
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.43
COG4248	637	Uncharacterized protein with protein kinase and he	99.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.23
smart00090	237	RIO RIO-like kinase.	99.23
PRK10345	210	hypothetical protein; Provisional	99.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.17
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.17
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.13
PRK14879	211	serine/threonine protein kinase; Provisional	99.11
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.08
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.05
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.92
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.86
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	98.78
KOG1243	690	consensus Protein kinase [General function predict	98.74
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.61
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.49
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.48
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.45
KOG3087	229	consensus Serine/threonine protein kinase [General	98.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.39
PRK09902	216	hypothetical protein; Provisional	98.27
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	97.97
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.92
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.83
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.81
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.45
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.43
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.36
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.28
COG0478	304	RIO-like serine/threonine protein kinase fused to	96.91
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	96.4
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.39
PRK05231	319	homoserine kinase; Provisional	96.27
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.26
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.19
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.13
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.12
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.1
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.92
PF01636	239	APH: Phosphotransferase enzyme family This family	95.9
PRK10271	188	thiK thiamine kinase; Provisional	95.71
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.62
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.54
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	95.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.22
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.97
PHA03111	444	Ser/Thr kinase; Provisional	94.84
KOG1235	538	consensus Predicted unusual protein kinase [Genera	94.84
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.8
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.64
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	94.59
PRK11768	325	serine/threonine protein kinase; Provisional	94.29
PRK06148	1013	hypothetical protein; Provisional	94.28
PLN02236	344	choline kinase	94.27
COG2334	331	Putative homoserine kinase type II (protein kinase	94.15
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	93.26
KOG1093	725	consensus Predicted protein kinase (contains TBC a	92.69
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.65
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	91.93
KOG2268	465	consensus Serine/threonine protein kinase [Signal	91.38
PRK09550	401	mtnK methylthioribose kinase; Reviewed	91.15
COG3178	351	Predicted phosphotransferase related to Ser/Thr pr	91.13
PRK06149	972	hypothetical protein; Provisional	90.85
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	90.14
PRK12396	409	5-methylribose kinase; Reviewed	88.49
PRK10593	297	hypothetical protein; Provisional	88.1
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	87.11

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=278.75  Aligned_cols=175  Identities=30%  Similarity=0.501  Sum_probs=145.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||||++++...+.  +++...-+++.+|++||.|||.. .+||||||||+||||+..|.|||||||.+....+.    
T Consensus       160 MDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            789999999988766  99999999999999999999952 34999999999999999999999999999876443    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.....           ....-...+..++ ....+
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-----------~~~~~~~Ll~~Iv-~~ppP  300 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-----------PYLDIFELLCAIV-DEPPP  300 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-----------CCCCHHHHHHHHh-cCCCC
Confidence            34568899999999999999999999999999999999999999976410           1111112222232 23334


Q ss_pred             CCcHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..|.. +++++.+||..||++||.+||++.++++.
T Consensus       301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            55555 89999999999999999999999999974

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=282.11  Aligned_cols=184  Identities=32%  Similarity=0.522  Sum_probs=156.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.++|++.....|++..++.++.||+.||+|||++++ |||||||++||||+.++ ++||+|||+++......  
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            689999999988534559999999999999999999997654 99999999999999998 99999999998754322  


Q ss_pred             eeeecccccccccCccccc--cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 HVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+..                .......+....
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~----------------~~~~~~~v~~~~  262 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA----------------PVQVASAVVVGG  262 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC----------------HHHHHHHHHhcC
Confidence            1233367999999999999  5589999999999999999999999998753                233344555566


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN  203 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~~  203 (252)
                      .+...+..++..+..||.+||..||.+||++.+++..|+.+.....
T Consensus       263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            7777788899999999999999999999999999999998765443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-41  Score=277.86  Aligned_cols=180  Identities=30%  Similarity=0.470  Sum_probs=158.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+.|+|.+||.+.+...++..+.+.++.|||+|++||++++  +|||||.++||||+++..+||+|||+++...+.. +.
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~  359 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT  359 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCc-ee
Confidence            68999999999866666999999999999999999999876  9999999999999999999999999999544333 32


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......-...|.|||.+..+.++.+||||||||+||||+| |+.|+.+..                 ...+.+.++.+.+
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyR  422 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYR  422 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCc
Confidence            2333334678999999999999999999999999999999 999998763                 4567788899999


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .+.|..|+.+++++|..||..+|++|||++.+...|+.+..
T Consensus       423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            99999999999999999999999999999999999987654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-40  Score=252.43  Aligned_cols=176  Identities=22%  Similarity=0.296  Sum_probs=144.3

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCC--eeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQ--VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      |.+|+|...++..  ..+.+++..+++++.|++.||.++|+.-+.  |+||||||.||+|+.+|.|||+|||+++.+...
T Consensus       102 c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~  181 (375)
T KOG0591|consen  102 CDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK  181 (375)
T ss_pred             hcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence            5689999998643  346699999999999999999999984344  999999999999999999999999999987554


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      .  ......+||+.||+||.+.+.+|+.+|||||+||++|||+.-+.||.+..                 ...+.+.+..
T Consensus       182 ~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----------------~~~L~~KI~q  242 (375)
T KOG0591|consen  182 T--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----------------LLSLCKKIEQ  242 (375)
T ss_pred             h--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----------------HHHHHHHHHc
Confidence            3  23566899999999999999999999999999999999999999998852                 1222333333


Q ss_pred             hcCCCCc-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          157 KLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       157 ~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ..-.+.| .-++.++..||..|+..|++.||+...++..+
T Consensus       243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            3333455 67899999999999999999999854444443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-40  Score=274.80  Aligned_cols=170  Identities=31%  Similarity=0.446  Sum_probs=145.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+.|+|.+++++++.  |++.++..++.||+.||.|||+.+  |+|||||..|+|++++.+|||+|||+|........  
T Consensus       100 C~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--  173 (592)
T KOG0575|consen  100 CHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--  173 (592)
T ss_pred             cCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCccc--
Confidence            678999999986655  999999999999999999999876  99999999999999999999999999988654322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ...+.+||+.|.|||++.....+..+||||+||++|.||.|++||+....                ...+..+....  .
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------------kety~~Ik~~~--Y  235 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------------KETYNKIKLNE--Y  235 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----------------HHHHHHHHhcC--c
Confidence            24567999999999999999999999999999999999999999987532                12222332222  3


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+|..++.++.+||.++|+.||.+|||+++|+..
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            5667899999999999999999999999999963

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=271.40  Aligned_cols=172  Identities=25%  Similarity=0.385  Sum_probs=147.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      .+||+|.++|++.+.  |++..+..++.+|+.||+|||++|  ||||||||+|||++++|+++|+|||.|+.+...... 
T Consensus       156 A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  156 APNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             cCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence            479999999999987  999999999999999999999765  999999999999999999999999999876432221 


Q ss_pred             --------eee--ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           80 --------HVS--TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        80 --------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                              ...  ..++||..|.+||++.....+..+|||+||||+|.|+.|+.||.+.++                ...
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----------------yli  295 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----------------YLI  295 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----------------HHH
Confidence                    111  558999999999999999999999999999999999999999988542                223


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+++.-  ...++.+.+..+.+||.++|..||.+|+|+.+|.+.
T Consensus       296 FqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 FQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            3344433  336778888999999999999999999999998863

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=262.52  Aligned_cols=178  Identities=29%  Similarity=0.462  Sum_probs=145.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCC-CCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPT-GDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~-~~~   78 (252)
                      ++||||.+++.+.+. .|++..+..+..||++||+|||+++  |||+||||+|||++. ++.+||+|||++..... ...
T Consensus        98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            589999999998886 6999999999999999999999765  999999999999999 79999999999987553 111


Q ss_pred             ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           79 THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ........||+.|||||++..+ ....++|||||||++.||+||..||....               ........+....
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~~~~~~ig~~~  239 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EEAEALLLIGRED  239 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------chHHHHHHHhccC
Confidence            1223457899999999999853 33459999999999999999999997630               1122233333333


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ..+..|..++.++.+|+.+|+.+||++|||++++++...
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            445677889999999999999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=256.87  Aligned_cols=169  Identities=29%  Similarity=0.402  Sum_probs=139.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.||.|.-+|.+.+.  +++..+.-++.+|+.||.|||+++  ||||||||+|||++.+|.++|+|||+|+......  .
T Consensus       107 ~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~  180 (357)
T KOG0598|consen  107 LNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--D  180 (357)
T ss_pred             cCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccCC--C
Confidence            579999999988887  999999999999999999999765  9999999999999999999999999998643332  2


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ...+++||+.|||||++.+..|+..+|.||||+++|||++|..||.+.+.                 ..+.+.+......
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----------------~~~~~~I~~~k~~  243 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----------------KKMYDKILKGKLP  243 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----------------HHHHHHHhcCcCC
Confidence            24558999999999999999999999999999999999999999987532                 1222222222223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC----CHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP----RMSEVL  192 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp----t~~~v~  192 (252)
                      ..+.-.+.+..+++.++|..||.+|.    ++.+|.
T Consensus       244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik  279 (357)
T KOG0598|consen  244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK  279 (357)
T ss_pred             CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence            33444788999999999999999995    455544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=262.48  Aligned_cols=197  Identities=57%  Similarity=0.948  Sum_probs=163.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC-CCCeeeccCCCCceeecCCCceEEccccccccCCC-CCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~   78 (252)
                      |++|||.++|+.....+|+|..+++|+.++|+||+|||.. .+.|||||||++|||+|.+.++||+|||+++.... ...
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~  233 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS  233 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc
Confidence            6899999999887643699999999999999999999974 33699999999999999999999999999976543 221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .  .....||.+|+|||++..+..+.++||||||+++.||+||+.+.+......+..+..|..+...+. .+.+++++.+
T Consensus       234 ~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l  310 (361)
T KOG1187|consen  234 V--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRL  310 (361)
T ss_pred             e--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCc
Confidence            1  111179999999999998999999999999999999999998888765444555777776666555 6778888886


Q ss_pred             C-CCCcH-HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          159 G-GQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       159 ~-~~~~~-~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      . ..++. .....+..+..+|++.+|.+||++.+|++.|+.+..
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            6 45553 566778999999999999999999999999966543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=263.11  Aligned_cols=171  Identities=26%  Similarity=0.382  Sum_probs=144.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.|.+....   +++.++..|++++++||+|||.++  |+|||||.+|||++.+|.+||+|||+|..+.....  
T Consensus       352 m~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             cCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            68999999997665   999999999999999999999655  99999999999999999999999999987644332  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh-hhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  159 (252)
                      .....+||+.|||||++....|+.+.||||||++++||+.|..||-....                .+.+..+. .....
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----------------lrAlyLIa~ng~P~  488 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------------LRALYLIATNGTPK  488 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----------------HHHHHHHhhcCCCC
Confidence            35667999999999999999999999999999999999999999965321                11222222 22234


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++..+.+|+.+||+.|+.+|+++.|+|+.
T Consensus       489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            46678899999999999999999999999999973

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=256.53  Aligned_cols=171  Identities=27%  Similarity=0.361  Sum_probs=140.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC---CceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~   77 (252)
                      |.||+|.+++..++.  +.+.....++.|++.|+.|||++|  |+||||||+|||++.+   -.+||+|||+|+..... 
T Consensus       258 v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~-  332 (475)
T KOG0615|consen  258 VEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG-  332 (475)
T ss_pred             ecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhccccc-
Confidence            689999999998887  888888999999999999999876  9999999999999766   56999999999986533 


Q ss_pred             cceeeecccccccccCccccccCCC---CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                        ....+.+||+.|.|||++.+..+   ..++|||||||+||-+++|.+||.+....                ..+.+.+
T Consensus       333 --sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----------------~sl~eQI  394 (475)
T KOG0615|consen  333 --SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----------------PSLKEQI  394 (475)
T ss_pred             --eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----------------ccHHHHH
Confidence              34567899999999999987653   34789999999999999999999875321                1122222


Q ss_pred             h-hhc--CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 D-TKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~-~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      . ..+  ....+..++.+..+||.+||..||++|||+.|+++.
T Consensus       395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            2 221  234456789999999999999999999999999874

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=270.38  Aligned_cols=181  Identities=23%  Similarity=0.288  Sum_probs=151.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |.||+|.|++.++....|++.++++|+.++++|+++||....+|||||||.+||||+.+|..||||||.++..-..... 
T Consensus       124 C~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~  203 (738)
T KOG1989|consen  124 CKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSA  203 (738)
T ss_pred             ccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccH
Confidence            6899999999877666699999999999999999999999899999999999999999999999999998653211110 


Q ss_pred             e------eeecccccccccCcccc---ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           80 H------VSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        80 ~------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                      .      ..-....|+.|+|||++   .+..++.|+|||+|||+||.|+....||++..                    .
T Consensus       204 ~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------------~  263 (738)
T KOG1989|consen  204 QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------------K  263 (738)
T ss_pred             HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------------c
Confidence            0      00112468999999977   56789999999999999999999999998752                    1


Q ss_pred             HHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ..++...+..+..+.++..+.+||..||+.||++||++-++++.+.++...
T Consensus       264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            345555555555578999999999999999999999999999999887543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-37  Score=256.94  Aligned_cols=165  Identities=29%  Similarity=0.422  Sum_probs=130.9

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      ++++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............++..|+|||+
T Consensus       170 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  247 (338)
T cd05102         170 PLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES  247 (338)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence            4888999999999999999999765  99999999999999999999999999976433222222223345678999999


Q ss_pred             cccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHH
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  175 (252)
                      +.+..++.++|||||||++|||++ |..||.+....                ......+........+..++..+.+|+.
T Consensus       248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~  311 (338)
T cd05102         248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----------------EEFCQRLKDGTRMRAPENATPEIYRIML  311 (338)
T ss_pred             hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            988899999999999999999997 99999764321                0111112222222334567788999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHhhc
Q 025440          176 QCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      +||+.||++|||+.++++.|+.+.
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=257.83  Aligned_cols=169  Identities=31%  Similarity=0.437  Sum_probs=141.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      +.||+|.+++.+.++  +.+..+..++.|+++|++|||+++  |+||||||+|||++.+ +++||+|||++....  ...
T Consensus       102 ~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~  175 (370)
T KOG0583|consen  102 CSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GED  175 (370)
T ss_pred             cCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCC
Confidence            578999999998665  999999999999999999999765  9999999999999999 999999999998763  111


Q ss_pred             eeeecccccccccCccccccCC-CC-cccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 HVSTQVMGTHGYAAPEYVATGR-LT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||++...                 ..+... -..
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----------------~~l~~k-i~~  237 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----------------PNLYRK-IRK  237 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------------HHHHHH-Hhc
Confidence            2345678999999999999877 86 689999999999999999999987431                 111111 112


Q ss_pred             cCCCCcHHH-HHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYPQKA-AHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~~~~-~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+|..+ +.++..|+.+||..||.+|+++.++++
T Consensus       238 ~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  238 GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            223556666 999999999999999999999999994

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=263.18  Aligned_cols=185  Identities=26%  Similarity=0.406  Sum_probs=143.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.|.+|+.+|+.... .|+....+.|+.||++|+.|||.++  |||||||..|||+.++++|||+|||++..........
T Consensus       469 CeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             ccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            689999999987764 3999999999999999999999766  9999999999999999999999999997643332222


Q ss_pred             eeecccccccccCccccccC---CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......|...|||||+++.+   +|++.+||||||+++|||+||..||.....+  +-+......+..           .
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIifmVGrG~l~-----------p  612 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIFMVGRGYLM-----------P  612 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEEEecccccC-----------c
Confidence            23445678899999999754   6899999999999999999999999843211  000000000000           0


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .......+++.++.+|+..||.+++++||.+.+|+..|+.+...
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            01122346788999999999999999999999999988887653

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-37  Score=261.90  Aligned_cols=170  Identities=31%  Similarity=0.451  Sum_probs=145.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||.|.+||...++  |.+.++.+++.||+.|+.|+|..+  |+||||||+|+|++..+++||+|||+|.....+.   
T Consensus        94 v~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---  166 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---  166 (786)
T ss_pred             cCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence            689999999999988  999999999999999999999876  9999999999999999999999999998754433   


Q ss_pred             eeecccccccccCccccccCCCC-cccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ...+.||++.|.+||++.|.+|. .++||||.|||||.||||+.||++.+                 .+.+...+.. -.
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----------------ir~LLlKV~~-G~  228 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----------------IRVLLLKVQR-GV  228 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----------------HHHHHHHHHc-Cc
Confidence            34567899999999999999985 68999999999999999999998643                 1222222211 12


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ..+|.+++.++.+||.+||..||++|.|+++|++..
T Consensus       229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            356789999999999999999999999999999854

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=248.12  Aligned_cols=175  Identities=29%  Similarity=0.414  Sum_probs=139.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc-CCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~-~~~~~~~   79 (252)
                      |.+||+.+.+...-+..|++..+..|++++++||.|||.+|  .||||||+.||||+.+|.|||+|||.+-. +..+.+.
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            68999999999888888999999999999999999999655  99999999999999999999999998643 3333333


Q ss_pred             eee-ecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           80 HVS-TQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        80 ~~~-~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ... ..++||+.|||||++..  ..|+.|+||||||++..||.+|..||......                ..+...+..
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm----------------kvLl~tLqn  247 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM----------------KVLLLTLQN  247 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH----------------HHHHHHhcC
Confidence            333 67899999999999644  36999999999999999999999999875421                001111100


Q ss_pred             hc--------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KL--------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..        ........+..+.+++..||++||.+|||++++++
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00        01111235668999999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=243.39  Aligned_cols=169  Identities=27%  Similarity=0.441  Sum_probs=135.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC------CceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~------~~~kl~Dfg~~~~~~   74 (252)
                      |.||+|.+||++++.  +++..+..++.||+.||++||+.+  ||||||||+||||+..      -.+||+|||+|+...
T Consensus        91 C~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            689999999999886  999999999999999999999765  9999999999999764      358999999999875


Q ss_pred             CCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           75 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        75 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                      ...   ...+.+|++.|||||++...+|+.|+|+||+|+|+|++++|+.||+..+..                 .+....
T Consensus       167 ~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-----------------eL~~~~  226 (429)
T KOG0595|consen  167 PGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-----------------ELLLYI  226 (429)
T ss_pred             chh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-----------------HHHHHH
Confidence            432   245678999999999999999999999999999999999999999865421                 111111


Q ss_pred             --hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 --DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        ........+...+..+.+|+...+..++.+|-++.+...
T Consensus       227 ~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  227 KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             hccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence              112223334455666778888888888888877766554

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-36  Score=245.95  Aligned_cols=175  Identities=22%  Similarity=0.342  Sum_probs=142.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+...  +++...+.++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......   
T Consensus       104 ~~~g~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        104 CTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCCcHHHHHhhCCC--CChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            579999999977654  89999999999999999999964 248899999999999999999999999987643221   


Q ss_pred             eeecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                        ....|+..|+|||++.+  ..++.++|||||||++|||++|..||.+...                ......+.....
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----------------~~~~~~i~~~~~  239 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----------------KEIYDLIINKNN  239 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhcCC
Confidence              23457889999999976  6789999999999999999999999986431                111112222223


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+..++..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus       240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            33445567889999999999999999999999999998764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-37  Score=236.73  Aligned_cols=158  Identities=28%  Similarity=0.416  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||.|..+|++.++  +++..+..++.+|+.||+|||+.+  |++|||||+|||+|.+|.+||+|||+++.....    
T Consensus       126 v~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----  197 (355)
T KOG0616|consen  126 VPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----  197 (355)
T ss_pred             cCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence            589999999988877  999999999999999999999766  999999999999999999999999999875432    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ..+.+||+.|+|||++....|+.++|.|||||++|||+.|..||.+...                .....+++..+.  
T Consensus       198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~~~~v--  258 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQIYEKILEGKV--  258 (355)
T ss_pred             -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHHhCcc--
Confidence             4567999999999999999999999999999999999999999987531                233344444444  


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCC
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLR  185 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~R  185 (252)
                      .+|.-.+.++.+|+.++|+.|-.+|
T Consensus       259 ~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            6788889999999999999999999

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=245.60  Aligned_cols=185  Identities=24%  Similarity=0.281  Sum_probs=144.4

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      .||+++++++ ++.|++..+..|+.||++||+|+|.+|  +.||||||+|||+..+..+||+|||+||...+...   .+
T Consensus        94 ~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YT  167 (538)
T KOG0661|consen   94 CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YT  167 (538)
T ss_pred             hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccccCCC---cc
Confidence            5899999888 678999999999999999999999765  99999999999999999999999999998766544   35


Q ss_pred             cccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-----hhcchhhhhhhhHHHHhhhh
Q 025440           84 QVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-----DWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ..+.|.+|+|||++.. +-|+.+.||||+|||++|+.+-+..|.|..+.+.-.-+     ...+..+.....+...+.-.
T Consensus       168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~  247 (538)
T KOG0661|consen  168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR  247 (538)
T ss_pred             hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence            6788999999998755 56899999999999999999999999997754332211     11111111222233333322


Q ss_pred             cCCCCc-------HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGGQYP-------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....+       ..++.++.+||.+||.+||.+|||+.++++.
T Consensus       248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            222111       2378899999999999999999999999974

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-36  Score=233.63  Aligned_cols=171  Identities=30%  Similarity=0.419  Sum_probs=143.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+.|.|.|||...-.  +++....+|+.|+..|++|||..+  ||||||||+|||++++.++||+|||+++....+..  
T Consensus       105 ~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek--  178 (411)
T KOG0599|consen  105 MPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK--  178 (411)
T ss_pred             cccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeeccCCchh--
Confidence            688999999977655  999999999999999999999765  99999999999999999999999999998766554  


Q ss_pred             eeecccccccccCccccccC------CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           81 VSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                       ....+||++|+|||.++..      .|+...|+|++|+|+|.++.|..||....                ..-.+..++
T Consensus       179 -LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----------------QmlMLR~Im  241 (411)
T KOG0599|consen  179 -LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----------------QMLMLRMIM  241 (411)
T ss_pred             -HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----------------HHHHHHHHH
Confidence             3467899999999998643      57889999999999999999999996532                111223334


Q ss_pred             hhhcC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..  .+-+.+++.+..+||.+||+.||.+|.|++|++..
T Consensus       242 eGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  242 EGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             hcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            44433  34456889999999999999999999999999863

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.5e-36  Score=242.72  Aligned_cols=178  Identities=28%  Similarity=0.479  Sum_probs=143.8

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++.....              ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~~L~d  167 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISD  167 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCCcEEECC
Confidence            468999999976532              45889999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+...               
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---------------  232 (283)
T cd05048         168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---------------  232 (283)
T ss_pred             CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---------------
Confidence            999876543332222334456788999999988899999999999999999998 9999976431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                        ......+........+..++.++.+|+.+||+.||.+||++.+|++.|++
T Consensus       233 --~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 --QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              11222222333334566788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=253.21  Aligned_cols=173  Identities=28%  Similarity=0.460  Sum_probs=146.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+.|-|.+.|+....  ++......|..+||.|+.|||.++  |||||||.-||||+.+..|||+|||.++.....   .
T Consensus       194 Ca~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S  266 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S  266 (904)
T ss_pred             cccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence            578999999977665  999999999999999999999877  999999999999999999999999999875443   3


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ....+.||..|||||+++..+.+.|+|||||||+|||||||..||.+-+..    .+            +.-+-...+..
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AI------------IwGVGsNsL~L  330 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AI------------IWGVGSNSLHL  330 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----ee------------EEeccCCcccc
Confidence            355688999999999999999999999999999999999999999764310    00            01111223445


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      +.|..|+..+.-||+.||+..|..||++.+++..|+
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            778889999999999999999999999999998774

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.7e-35  Score=239.02  Aligned_cols=180  Identities=23%  Similarity=0.368  Sum_probs=143.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+|||++.++.+||+|||+++.........
T Consensus        90 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T cd05111          90 SPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY  166 (279)
T ss_pred             CCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence            47899999997654 34899999999999999999999765  9999999999999999999999999998654333222


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++||||||+++||+++ |..||.+...                 ......+.....
T Consensus       167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  229 (279)
T cd05111         167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----------------HEVPDLLEKGER  229 (279)
T ss_pred             ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHCCCc
Confidence            2233456778999999988899999999999999999998 9999976431                 111222222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||..||++||++.++++.|..+..
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            23344456778999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=247.93  Aligned_cols=170  Identities=26%  Similarity=0.360  Sum_probs=140.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||++.+.|.-.+.  +++..+..++.+++.||.|||+++  .+|||||+.|||+..+|.+||+|||++-........ 
T Consensus        93 ~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-  167 (467)
T ss_pred             hcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence            579999999966654  588888899999999999999766  999999999999999999999999999765443332 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ...++||+.|||||++.+..|+.++||||||++.+||++|..||.+.....                 +.-.+.....+
T Consensus       168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------------vlflIpk~~PP  229 (467)
T KOG0201|consen  168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------------VLFLIPKSAPP  229 (467)
T ss_pred             -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------------EEEeccCCCCC
Confidence             367899999999999998899999999999999999999999998765311                 11111122223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....++..+.+|+..||++||+.||++.++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            334467889999999999999999999999985

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.4e-35  Score=242.65  Aligned_cols=182  Identities=21%  Similarity=0.339  Sum_probs=144.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus        90 ~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  166 (316)
T cd05108          90 MPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY  166 (316)
T ss_pred             CCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccccCCCcce
Confidence            578999999976543 4899999999999999999999765  9999999999999999999999999998754433222


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..||.+...                 ......+.....
T Consensus       167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  229 (316)
T cd05108         167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGER  229 (316)
T ss_pred             eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHhCCCC
Confidence            2222334678999999998899999999999999999998 9999976421                 111222233333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK  202 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~  202 (252)
                      ...+..++..+.+++.+||+.||++||++.+++..|.++....
T Consensus       230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            3444556778999999999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-35  Score=246.62  Aligned_cols=169  Identities=27%  Similarity=0.406  Sum_probs=137.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        77 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--  150 (323)
T cd05571          77 ANGGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--  150 (323)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--
Confidence            579999999987654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||......                .....+..  ...
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----------------~~~~~~~~--~~~  212 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILM--EEI  212 (323)
T ss_pred             cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----------------HHHHHHHc--CCC
Confidence            123457899999999999889999999999999999999999999764310                01111111  122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      .++..++.++.+||.+||+.||++||     ++.++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            44566788999999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.7e-35  Score=249.07  Aligned_cols=164  Identities=28%  Similarity=0.429  Sum_probs=130.5

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      ++++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............++..|+|||+
T Consensus       208 ~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  285 (374)
T cd05106         208 PLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES  285 (374)
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHH
Confidence            4888999999999999999999765  99999999999999999999999999976543322222223345678999999


Q ss_pred             cccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHH
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  175 (252)
                      +.+..++.++|||||||++|+|++ |..||.....                ................+...+.++.+++.
T Consensus       286 ~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (374)
T cd05106         286 IFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----------------NSKFYKMVKRGYQMSRPDFAPPEIYSIMK  349 (374)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----------------cHHHHHHHHcccCccCCCCCCHHHHHHHH
Confidence            988899999999999999999997 9999976421                11122222222333344456788999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHhh
Q 025440          176 QCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      +||+.||.+||++.++++.|+++
T Consensus       350 ~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         350 MCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-35  Score=239.52  Aligned_cols=181  Identities=26%  Similarity=0.426  Sum_probs=143.2

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++...+.              ..+++..++.++.||+.||+|||+++  ++||||||+|||++.++.++|+|
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~d  166 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGD  166 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEECC
Confidence            478999999976432              24899999999999999999999665  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||++................++..|+|||++.+..++.++||||||+++|+|+| |..||......              
T Consensus       167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------------  232 (291)
T cd05094         167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------------  232 (291)
T ss_pred             CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------------
Confidence            999976543332222333456788999999988899999999999999999999 99998654311              


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                         .....+........+..++..+.+++.+||+.||++||++.++++.|+++..
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         233 ---EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ---HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence               1111112222222334567789999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=260.07  Aligned_cols=189  Identities=25%  Similarity=0.416  Sum_probs=163.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|+.||.++..+ +++.+...++++|+.|++||-+++  +|||||...||||+.+..+||+|||+++...++....
T Consensus       712 MENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            7899999999988866 999999999999999999999876  9999999999999999999999999999875544221


Q ss_pred             ee-ecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VS-TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .. ....-...|.|||.+...+++.+||+||||+++||.++ |..||.+..                 ++.+.+.++..+
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQdVIkaIe~gy  851 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVIKAIEQGY  851 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hHHHHHHHHhcc
Confidence            11 11122478999999999999999999999999999997 999987753                 455667778889


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCCCCCCCC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ  209 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~~~~~~~~  209 (252)
                      +.+.|.+|+..+.+|++.||++|..+||.+.+|+..|+++.....+.....
T Consensus       852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~  902 (996)
T KOG0196|consen  852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIA  902 (996)
T ss_pred             CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccC
Confidence            999999999999999999999999999999999999999877665544443

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.1e-35  Score=243.02  Aligned_cols=174  Identities=28%  Similarity=0.374  Sum_probs=135.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        87 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-  161 (332)
T cd05614          87 VSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-  161 (332)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-
Confidence            579999999987655  899999999999999999999765  999999999999999999999999999764332221 


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||..|+|||++.+. .++.++|||||||++|+|++|..||........             .......+ ....
T Consensus       162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------------~~~~~~~~-~~~~  227 (332)
T cd05614         162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-------------QSEVSRRI-LKCD  227 (332)
T ss_pred             ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-------------HHHHHHHH-hcCC
Confidence            12345789999999999765 478899999999999999999999975322100             00011111 1122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ...+..++..+.+++.+||+.||++||     ++.++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            344556788899999999999999999     6677775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-35  Score=258.90  Aligned_cols=181  Identities=29%  Similarity=0.467  Sum_probs=155.9

Q ss_pred             CCCCChhhhhhcCCC--------CC----CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccc
Q 025440            1 MPKGSLENHLFRRGP--------QP----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG   68 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------~~----l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg   68 (252)
                      |..|||.+||..+++        .+    |+..+.+.|+.|||.|+.||-++.  +|||||..+|+||+++..|||+|||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VKIsDfG  648 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVKISDFG  648 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEEecccc
Confidence            678999999976643        23    899999999999999999999766  9999999999999999999999999


Q ss_pred             ccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhh
Q 025440           69 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      +++.....+++.......-...||+||.+..++|+.+||||||||+|||+++ |..||.+..                +.
T Consensus       649 LsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS----------------n~  712 (774)
T KOG1026|consen  649 LSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS----------------NQ  712 (774)
T ss_pred             cchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc----------------hH
Confidence            9998777776665544455789999999999999999999999999999998 999998753                22


Q ss_pred             hhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                       .+.+.+..+.-...|.+++.+++.||..||+.+|.+||++.||-..|+....
T Consensus       713 -EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  713 -EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             -HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence             3333334444478899999999999999999999999999999999988643

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-35  Score=239.96  Aligned_cols=174  Identities=28%  Similarity=0.435  Sum_probs=138.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++........  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  157 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--  157 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence            57999999987655556999999999999999999999765  99999999999999999999999999976433221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.......             ......+ .....
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-------------~~~~~~~-~~~~~  222 (285)
T cd05631         158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-------------EEVDRRV-KEDQE  222 (285)
T ss_pred             -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-------------HHHHHHh-hcccc
Confidence             23456899999999999999999999999999999999999999865321100             0011111 11122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ..+..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            345567788999999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.7e-35  Score=243.51  Aligned_cols=165  Identities=30%  Similarity=0.440  Sum_probs=131.2

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++................++..|+|||+
T Consensus       169 ~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         169 PLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            5899999999999999999999755  99999999999999999999999999986533322222233455678999999


Q ss_pred             cccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHH
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  175 (252)
                      +.+..++.++|||||||++|+|++ |..||.+....                ......+........+...+.++.+++.
T Consensus       247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~  310 (337)
T cd05054         247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----------------EEFCRRLKEGTRMRAPEYATPEIYSIML  310 (337)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----------------HHHHHHHhccCCCCCCccCCHHHHHHHH
Confidence            999999999999999999999998 99999763211                1111222222222334456778999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHhhc
Q 025440          176 QCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      +||+.+|++||++.++++.|+++.
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=245.82  Aligned_cols=173  Identities=26%  Similarity=0.374  Sum_probs=149.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+.|.+.....++++.+++++.||+.|+.|||+.  .|+|||||+.|||++.++.|+|+|||+++......  .
T Consensus        86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~--~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~  161 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN--RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S  161 (426)
T ss_pred             cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh--hhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence            6899999999888877899999999999999999999954  49999999999999999999999999999875543  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ...+.+||+.|+.||.+.+.+|+.|+|||||||++|||++-+.+|.+.+.                 ..+..-+......
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------------~~Li~ki~~~~~~  224 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------------SELILKINRGLYS  224 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------------HHHHHHHhhccCC
Confidence            34567899999999999999999999999999999999999999987531                 1222222233356


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      +.+..++.++..+|..||..+|..||++.+++..
T Consensus       225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            7788899999999999999999999999999974

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.5e-35  Score=236.47  Aligned_cols=180  Identities=23%  Similarity=0.372  Sum_probs=141.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.+||+|||+++.........
T Consensus        90 ~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~  166 (279)
T cd05109          90 MPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY  166 (279)
T ss_pred             CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeeccccccee
Confidence            47899999997653 24899999999999999999999765  9999999999999999999999999998654322211


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....                 ......+.....
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  229 (279)
T cd05109         167 HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----------------REIPDLLEKGER  229 (279)
T ss_pred             ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHCCCc
Confidence            1112234678999999988889999999999999999998 8999875321                 111222222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||+.||++||++.++++.|..+..
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            33345567889999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.8e-35  Score=246.43  Aligned_cols=163  Identities=26%  Similarity=0.414  Sum_probs=129.0

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............++..|+|||+
T Consensus       210 ~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  287 (375)
T cd05104         210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPES  287 (375)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhH
Confidence            4889999999999999999999765  99999999999999999999999999976543322222223345678999999


Q ss_pred             cccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHH
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  175 (252)
                      +.+..++.++|||||||++|+|++ |..||......                ....+.+........+...+.++.+|+.
T Consensus       288 ~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~  351 (375)
T cd05104         288 IFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------------SKFYKMIKEGYRMLSPECAPSEMYDIMK  351 (375)
T ss_pred             hcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----------------HHHHHHHHhCccCCCCCCCCHHHHHHHH
Confidence            999899999999999999999998 88898764311                1112222222222334445678999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHh
Q 025440          176 QCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      +||+.||++||++.++++.|++
T Consensus       352 ~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         352 SCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHccCChhHCcCHHHHHHHHHh
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=262.41  Aligned_cols=180  Identities=28%  Similarity=0.392  Sum_probs=151.3

Q ss_pred             CCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRG-----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      |+||+|..||.+..     +..|+....+.++.|||+|++||++++  +|||||..+|+||+....|||+|||+|+-...
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~  854 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLARDIYD  854 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence            78999999998762     245999999999999999999999765  99999999999999999999999999995544


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                      ...+.......-...|||||.+..+.++.|+|||||||++||++| |..||.+..                + ..+...+
T Consensus       855 ~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~----------------n-~~v~~~~  917 (1025)
T KOG1095|consen  855 KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS----------------N-FEVLLDV  917 (1025)
T ss_pred             chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc----------------h-HHHHHHH
Confidence            444443333334578999999999999999999999999999999 999998753                2 2233322


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          155 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...-+...|..|+..++++|..||+.+|++||++..|++.+..+.
T Consensus       918 ~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  918 LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            333377888999999999999999999999999999999887764

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-34  Score=233.85  Aligned_cols=178  Identities=24%  Similarity=0.379  Sum_probs=143.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++......... 
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            47899999997766566999999999999999999999654  999999999999999999999999998765432211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...                 ......+.....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  223 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYELLEKGYR  223 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHCCCC
Confidence            1112234567999999988899999999999999999998 9999876431                 112222223333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            445566788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-35  Score=255.83  Aligned_cols=175  Identities=25%  Similarity=0.337  Sum_probs=140.7

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.++|....  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus       121 ~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~  198 (496)
T PTZ00283        121 ANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS  198 (496)
T ss_pred             CCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEecccCeecccccc
Confidence            47899999996542  346999999999999999999999765  99999999999999999999999999976543322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                 ...........
T Consensus       199 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----------------~~~~~~~~~~~  261 (496)
T PTZ00283        199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----------------EEVMHKTLAGR  261 (496)
T ss_pred             ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHhcCC
Confidence            2223446799999999999998999999999999999999999999976431                 01111111112


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ....+..++.++.+++.+||+.||.+||++.++++.
T Consensus       262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            233456678899999999999999999999999863

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-35  Score=229.59  Aligned_cols=176  Identities=23%  Similarity=0.274  Sum_probs=131.4

Q ss_pred             CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccC
Q 025440           14 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA   93 (252)
Q Consensus        14 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a   93 (252)
                      .+.+++...+.+++.|++.|+.|+|+++  +|||||||+||||+.+|.+||||||+|+.....  ....+..+.|.+|+|
T Consensus        94 ~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YTDYVATRWYRa  169 (396)
T KOG0593|consen   94 YPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYTDYVATRWYRA  169 (396)
T ss_pred             ccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCC--cchhhhhhhhhhccC
Confidence            3456999999999999999999999876  999999999999999999999999999987532  223456788999999


Q ss_pred             cccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhh-hcchhhhhhhhHHHHh--hhhcC-------CCC
Q 025440           94 PEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD-WAKPYLSDKRKLFRIM--DTKLG-------GQY  162 (252)
Q Consensus        94 PE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~-------~~~  162 (252)
                      ||.+.| .+|+..+||||+||++.||++|...|.+..+-+.-+.+. -..........++..-  -.+..       .+.
T Consensus       170 PELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epL  249 (396)
T KOG0593|consen  170 PELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPL  249 (396)
T ss_pred             hhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccch
Confidence            999988 589999999999999999999999999876532222211 0111111111111100  00000       000


Q ss_pred             ---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          163 ---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       163 ---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         -+.++.-+.+|+.+||..||++|++.++++.
T Consensus       250 e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  250 ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             hhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence               1245668899999999999999999999985

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=242.38  Aligned_cols=169  Identities=30%  Similarity=0.404  Sum_probs=135.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||.|||+.+  |+||||||+|||++.++.++|+|||+++.......  
T Consensus        75 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  148 (312)
T cd05585          75 INGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--  148 (312)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--
Confidence            579999999987654  899999999999999999999765  99999999999999999999999999875322221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----------------~~~~~~~~~~--~~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----------------NEMYRKILQE--PL  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----------------HHHHHHHHcC--CC
Confidence            13345789999999999998999999999999999999999999976431                0111111111  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC---HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR---MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||.+||+   +.+++.
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            445667889999999999999999985   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=227.89  Aligned_cols=177  Identities=24%  Similarity=0.278  Sum_probs=143.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||.|...+.+++.+.+++.++..|..||+.|+.|||+.+  |.||||||+|+|...   |..+||+|||+++......
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~  218 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG  218 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence            68999999999999999999999999999999999999887  999999999999954   4569999999998743221


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                         ...+.+.|+.|.|||++...+|+..+|+||+||++|-|++|..||....-          ......  ...++....
T Consensus       219 ---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----------~aispg--Mk~rI~~gq  283 (400)
T KOG0604|consen  219 ---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----------LAISPG--MKRRIRTGQ  283 (400)
T ss_pred             ---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----------ccCChh--HHhHhhccC
Confidence               23455779999999999889999999999999999999999999965321          000111  111222222


Q ss_pred             c--CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 L--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      +  ..+-+..++....++|+.+|..+|.+|.|++++++.
T Consensus       284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            2  223345789999999999999999999999999874

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-34  Score=235.28  Aligned_cols=177  Identities=25%  Similarity=0.428  Sum_probs=140.1

Q ss_pred             CCCCChhhhhhcCCC------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccc
Q 025440            1 MPKGSLENHLFRRGP------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG   68 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg   68 (252)
                      ++||+|.+++...+.            ..+++..+..++.||+.||+|||+.+  ++||||||+||+++.++.++|+|||
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeEEECCcc
Confidence            578999999976532            34889999999999999999999765  9999999999999999999999999


Q ss_pred             ccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhh
Q 025440           69 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      +++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.+....                
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----------------  231 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----------------  231 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----------------
Confidence            9875433222222233345788999999999999999999999999999998 99998764321                


Q ss_pred             hhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                       ..............+..++..+.+++.+||+.||++||++.++++.|+
T Consensus       232 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 -EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             111111222222334567788999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.1e-35  Score=253.37  Aligned_cols=174  Identities=25%  Similarity=0.328  Sum_probs=139.4

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.++|...  ...++++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            5799999988653  2345899999999999999999999765  99999999999999999999999999987544332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+.. ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----------------~~~~~~~~~-~~  287 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----------------REIMQQVLY-GK  287 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHh-CC
Confidence            2234456799999999999988999999999999999999999999976421                111111111 11


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+..++.++.++|.+||..||++||++.+++.
T Consensus       288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            22344567788999999999999999999999874

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=223.19  Aligned_cols=184  Identities=24%  Similarity=0.324  Sum_probs=141.3

Q ss_pred             CCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            2 PKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         2 ~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ..|||.+.+....  ...+++.++++++.+|++||++||+....+.||||||.|||+++++.++|.|||.++...-.-..
T Consensus       106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~  185 (302)
T KOG2345|consen  106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEG  185 (302)
T ss_pred             ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeec
Confidence            3588999886553  23599999999999999999999988778999999999999999999999999998764221110


Q ss_pred             -------eeeecccccccccCccccccC---CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           80 -------HVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        80 -------~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                             .......+|..|+|||.+.-.   ..+.++|||||||++|.|+.|..||+......              ...
T Consensus       186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------------gSl  251 (302)
T KOG2345|consen  186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------------GSL  251 (302)
T ss_pred             hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC--------------CeE
Confidence                   112334579999999988543   56889999999999999999999997532110              001


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+....+..+....++..+.++|..||+.||.+||++.+++..++.+.
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            11122223333334458889999999999999999999999999987653

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-34  Score=233.88  Aligned_cols=179  Identities=27%  Similarity=0.373  Sum_probs=139.4

Q ss_pred             CCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      |++|+|.+++...    ....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.++|+|||+++.....
T Consensus        88 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  165 (272)
T cd05075          88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNG  165 (272)
T ss_pred             CCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcccccCcc
Confidence            4689999988432    2345899999999999999999999754  999999999999999999999999999875443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ..........++..|++||.+.+..++.++||||||+++|+|++ |..||.+...                 ......+.
T Consensus       166 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~  228 (272)
T cd05075         166 DYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----------------SEIYDYLR  228 (272)
T ss_pred             cceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHH
Confidence            32211222345678999999988889999999999999999999 8899976321                 01111122


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      .......+..++..+.++|.+||+.||++|||+.++++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2222233445677899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-34  Score=235.86  Aligned_cols=181  Identities=27%  Similarity=0.422  Sum_probs=141.6

Q ss_pred             CCCCChhhhhhcCCC-----------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccc
Q 025440            1 MPKGSLENHLFRRGP-----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL   69 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~   69 (252)
                      +++|+|.+++...+.           ..+++..++.++.|++.||+|||+++  ++||||||+||+++.++.++|+|||+
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~  166 (288)
T cd05093          89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGM  166 (288)
T ss_pred             CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEeccCCc
Confidence            478999999975431           34899999999999999999999765  99999999999999999999999999


Q ss_pred             cccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           70 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        70 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                      ++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......                .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----------------~  230 (288)
T cd05093         167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----------------E  230 (288)
T ss_pred             cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------H
Confidence            976533322222233345778999999988889999999999999999998 89998654310                1


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ....+ ........+..++.++.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       231 ~~~~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         231 VIECI-TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHH-HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11111 1111122334567789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-34  Score=235.89  Aligned_cols=179  Identities=28%  Similarity=0.430  Sum_probs=141.4

Q ss_pred             CCCCChhhhhhcC--------------CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRR--------------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++...              ....+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~~~~~kL~D  175 (293)
T cd05053          98 AAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIAD  175 (293)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcCCCeEEeCc
Confidence            4789999999653              2345899999999999999999999655  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.+...               
T Consensus       176 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------------  240 (293)
T cd05053         176 FGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---------------  240 (293)
T ss_pred             cccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---------------
Confidence            999986544322221222334678999999988889999999999999999998 9999876431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                        ......+........+..++..+.+|+.+||..||++|||+.++++.|+.+
T Consensus       241 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 --EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence              112222223333344556678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=247.41  Aligned_cols=174  Identities=26%  Similarity=0.444  Sum_probs=146.0

Q ss_pred             CCCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      +|||||.++|... |+..=++...-.+.+||++||+|||...  |||||||-+||||+ -.|.+||+|||.++.....+.
T Consensus       654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP  731 (1226)
T KOG4279|consen  654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP  731 (1226)
T ss_pred             CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence            6999999999654 5533388888899999999999999655  99999999999995 579999999999987655443


Q ss_pred             ceeeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           79 THVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                        ++.++.||..|||||++..+  .|+.++|||||||++.||.||++||-....               ....++++-.-
T Consensus       732 --~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs---------------pqAAMFkVGmy  794 (1226)
T KOG4279|consen  732 --CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS---------------PQAAMFKVGMY  794 (1226)
T ss_pred             --cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC---------------hhHhhhhhcce
Confidence              46678899999999999776  489999999999999999999999965431               22234444445


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      +..++.|..++.++..+|.+|+..||..||++.+++.
T Consensus       795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            5567889999999999999999999999999999986

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-34  Score=241.64  Aligned_cols=170  Identities=26%  Similarity=0.391  Sum_probs=136.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        77 ~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--  150 (328)
T cd05593          77 VNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--  150 (328)
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+..  ...
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----------------~~~~~~~~--~~~  212 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILM--EDI  212 (328)
T ss_pred             ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----------------HHHHHhcc--CCc
Confidence            123456899999999999889999999999999999999999999764311                00111111  122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~  194 (252)
                      ..+..++.++.+||.+||+.||.+|+     ++.++++.
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            34556788899999999999999997     88888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-34  Score=238.41  Aligned_cols=184  Identities=26%  Similarity=0.415  Sum_probs=136.8

Q ss_pred             CCCCChhhhhhcCCC-----------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceE
Q 025440            1 MPKGSLENHLFRRGP-----------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK   63 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~k   63 (252)
                      ++||+|.+++.....                 ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+|
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~~~~~~k  178 (304)
T cd05096         101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIK  178 (304)
T ss_pred             CCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEcCCccEE
Confidence            478999999865321                 24788899999999999999999765  99999999999999999999


Q ss_pred             EccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh--CCCCCCCcccccchhhhhhcc
Q 025440           64 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAK  141 (252)
Q Consensus        64 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt--g~~pf~~~~~~~~~~~~~~~~  141 (252)
                      |+|||+++...............++..|+|||++.++.++.++||||||+++|+|++  +..||......  . ..    
T Consensus       179 l~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~--~-~~----  251 (304)
T cd05096         179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE--Q-VI----  251 (304)
T ss_pred             ECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH--H-HH----
Confidence            999999976544333222334456788999999988899999999999999999987  56777654311  0 00    


Q ss_pred             hhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          142 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                         ..................+..++..+.+|+.+||+.||.+|||+.+|...|+
T Consensus       252 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         252 ---ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             ---HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence               0000000000001111223456788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-34  Score=240.77  Aligned_cols=169  Identities=28%  Similarity=0.413  Sum_probs=136.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        77 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  150 (323)
T cd05595          77 ANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  150 (323)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||...+..                .....+...  ..
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------~~~~~~~~~--~~  212 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RLFELILME--EI  212 (323)
T ss_pred             ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcC--CC
Confidence            123456899999999999889999999999999999999999999764311                111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++.++.++|.+||+.||.+|+     ++.++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            34556788999999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-34  Score=239.41  Aligned_cols=169  Identities=27%  Similarity=0.432  Sum_probs=135.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......  .
T Consensus        78 ~~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          78 LNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            579999999977654  899999999999999999999765  9999999999999999999999999997543222  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+.  ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----------------~~~~~i~--~~~~  213 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----------------ELFDSIL--NDRP  213 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH--cCCC
Confidence            233457899999999999889999999999999999999999999764310                0111111  1123


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH-HHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS-EVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~-~v~~  193 (252)
                      ..+..++.++.+++.+||+.||.+||++. ++++
T Consensus       214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            34556778899999999999999999875 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.3e-34  Score=230.58  Aligned_cols=176  Identities=25%  Similarity=0.345  Sum_probs=141.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.....  +++..++.++.|++.||+|||+++  ++||||||.||+++.++.++|+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            468999999976554  899999999999999999999765  9999999999999999999999999997654332211


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       ......++..|+|||.+....++.++|+|||||++|||++ |..||.....                 ......+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~i~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----------------NEVTQMIESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHCCC
Confidence             1122234578999999988889999999999999999998 9999976421                 11222233333


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ....+..++.++.++|.+||+.||++||++.+|.+.|+.
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            344556778899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=237.37  Aligned_cols=167  Identities=28%  Similarity=0.353  Sum_probs=135.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||++......    
T Consensus        83 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          83 VPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            578999999987654  899999999999999999999765  999999999999999999999999998765332    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...  ..
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----------------~~~~~i~~~--~~  215 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----------------GIYEKILAG--KL  215 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC--Cc
Confidence             12346899999999998888999999999999999999999999764310                111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~~  194 (252)
                      .++..++..+.+||.+||+.||.+|++     +.++++.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            345556778999999999999999995     7777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-35  Score=231.50  Aligned_cols=187  Identities=26%  Similarity=0.285  Sum_probs=138.4

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      -+|...|+.+..  |+...+..++.||+.||+|+|+.+  |+||||||.|+|++.+..+||||||+|+...........+
T Consensus       110 tDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mT  185 (359)
T KOG0660|consen  110 TDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMT  185 (359)
T ss_pred             hHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeeccccCcccchh
Confidence            456777765544  999999999999999999999876  9999999999999999999999999999875432233346


Q ss_pred             cccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhh-------hhhhHHHHhh
Q 025440           84 QVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-------DKRKLFRIMD  155 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~  155 (252)
                      ..+-|.+|+|||++.. ..|+.+.||||+|||+.||++|+..|.|.+.-..-.+.....+..+       ........+.
T Consensus       186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~  265 (359)
T KOG0660|consen  186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIK  265 (359)
T ss_pred             cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH
Confidence            6788999999998754 5799999999999999999999999998765322211111100000       0001111111


Q ss_pred             hh---cCCCCc---HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 TK---LGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~~---~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..   .+.++.   .+.++.+.+|+.+||..||.+|+|++|+++.
T Consensus       266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11   111111   2567889999999999999999999999873

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.2e-34  Score=230.51  Aligned_cols=173  Identities=27%  Similarity=0.435  Sum_probs=139.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+++  ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            47899999998776656899999999999999999999765  9999999999999999999999999987543221   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |..||.....                 ......+.....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  217 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYK  217 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcCCC
Confidence              12234567999999988889999999999999999998 9999865321                 111122222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            34455678899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.9e-34  Score=234.01  Aligned_cols=178  Identities=25%  Similarity=0.389  Sum_probs=139.8

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++++|.+++....              ...+++..++.++.|++.||+|||+++  ++||||||+||+++.++.+||+|
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~kl~D  167 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISD  167 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCceEecc
Confidence            35788888885321              134888999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+...               
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------------  232 (283)
T cd05091         168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------------  232 (283)
T ss_pred             cccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---------------
Confidence            999886543332222333456788999999988889999999999999999998 8888876421               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                        ......+........+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       233 --~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 --QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              11222222222334456788889999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.6e-35  Score=234.74  Aligned_cols=176  Identities=32%  Similarity=0.534  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.++|.......+++..++.++.||+.||.|||+.+  ++|+||+++|||++.++.+||+|||++..........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence            57899999999885556999999999999999999999765  9999999999999999999999999998763333333


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ..........|+|||.+.+..++.++||||||+++|||++ |+.||.+..                 .......+.....
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----------------~~~~~~~~~~~~~  223 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----------------NEEIIEKLKQGQR  223 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----------------HHHHHHHHHTTEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccccccccccc
Confidence            3333456788999999999889999999999999999999 788886642                 1222233334444


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+..++..+.++|.+||+.||++||++.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            556667888999999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.7e-34  Score=238.57  Aligned_cols=187  Identities=24%  Similarity=0.364  Sum_probs=138.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.|++.||.|||+. .+|+||||||+|||++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  158 (331)
T cd06649          85 MDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (331)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence            579999999977654  89999999999999999999974 249999999999999999999999999987643321   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhc--------------------
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA--------------------  140 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~--------------------  140 (252)
                       .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...............                    
T Consensus       159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence             23456899999999999889999999999999999999999999754321110000000                    


Q ss_pred             ----------chhhhhhhhHHHHhhhhcCCC-CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          141 ----------KPYLSDKRKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       141 ----------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                                .+.. ........+....... ....++.++.+||.+||+.||++|||+.++++..
T Consensus       238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         238 RPVSGHGMDSRPAM-AIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccch-hHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                      0000 0001111111111111 1224678899999999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-34  Score=238.54  Aligned_cols=168  Identities=28%  Similarity=0.457  Sum_probs=134.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++.......  
T Consensus        78 ~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          78 LNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            578999999977654  899999999999999999999765  99999999999999999999999999874322111  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.+....                 ...+.+.. ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----------------~~~~~~~~-~~~  213 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----------------ELFESIRV-DTP  213 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHh-CCC
Confidence            133457899999999999999999999999999999999999999764310                 11111111 122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH-HHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS-EVL  192 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~-~v~  192 (252)
                      ..+..++.++.++|.+||+.||.+|+++. +++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            33445778899999999999999999984 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.7e-34  Score=239.49  Aligned_cols=164  Identities=28%  Similarity=0.432  Sum_probs=132.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+...  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++........  
T Consensus        78 ~~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          78 VNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            578999999977654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------------~~~~~i~~~--~~  213 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----------------DLFEAILND--EV  213 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcC--CC
Confidence            133457899999999999889999999999999999999999999764311                111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++.++.++|.+||+.||.+|+++
T Consensus       214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            3344577889999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.3e-34  Score=234.78  Aligned_cols=180  Identities=26%  Similarity=0.387  Sum_probs=142.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++.+++.++.+|+.||+|||+.+  ++|+||||+|||++.++.++|+|||++..........
T Consensus       121 ~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  198 (302)
T cd05055         121 CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV  198 (302)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcccccccCCCcee
Confidence            47899999997655445899999999999999999999765  9999999999999999999999999997654332222


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||......                ....+.......
T Consensus       199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~~  262 (302)
T cd05055         199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----------------SKFYKLIKEGYR  262 (302)
T ss_pred             ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----------------HHHHHHHHcCCc
Confidence            2223345778999999988899999999999999999998 99998764321                111122222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            233345577899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-34  Score=240.45  Aligned_cols=167  Identities=26%  Similarity=0.368  Sum_probs=135.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.......   
T Consensus       100 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---  172 (329)
T PTZ00263        100 VVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---  172 (329)
T ss_pred             CCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence            578999999987665  899999999999999999999765  9999999999999999999999999997653321   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                        ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----------------~~~~~~i~~~--~~  232 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----------------FRIYEKILAG--RL  232 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----------------HHHHHHHhcC--Cc
Confidence              234689999999999998999999999999999999999999976421                0111112111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~~  194 (252)
                      ..+..++..+.+||.+||+.||.+|++     +++++..
T Consensus       233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            344556778999999999999999996     5777643

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-34  Score=230.33  Aligned_cols=177  Identities=23%  Similarity=0.384  Sum_probs=140.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            47899999997765556899999999999999999999755  999999999999999999999999999865432211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|+|+| |..||......                 .....+.....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~  222 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----------------DVMSALQRGYR  222 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----------------HHHHHHHcCCC
Confidence            1222345678999999988889999999999999999998 99999754211                 11111111222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ......++.++.+++.+||..+|++||+++++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            23334567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-34  Score=230.39  Aligned_cols=179  Identities=25%  Similarity=0.412  Sum_probs=141.0

Q ss_pred             CCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      +++|+|..++...    ....+++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||+++.....
T Consensus        89 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  166 (273)
T cd05035          89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSG  166 (273)
T ss_pred             cCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCccceeecccc
Confidence            4789999988543    2245899999999999999999999765  999999999999999999999999999865443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |..||.+...                 ......+.
T Consensus       167 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~  229 (273)
T cd05035         167 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----------------HEIYDYLR  229 (273)
T ss_pred             ccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHH
Confidence            32221222234678999999988889999999999999999999 8899865421                 11122222


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      .......+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2223344556788999999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-34  Score=239.03  Aligned_cols=169  Identities=26%  Similarity=0.326  Sum_probs=134.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +.+..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        78 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          78 INGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            578999999977654  888999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~--~~  213 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYDNILNK--PL  213 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----------------HHHHHHHhC--Cc
Confidence            133457899999999999989999999999999999999999999764311                111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||.+|+++.+.+.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            234467788999999999999999998875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.6e-34  Score=232.84  Aligned_cols=177  Identities=25%  Similarity=0.404  Sum_probs=137.6

Q ss_pred             CCCCChhhhhhcCCC--------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++||+|.+++.+...        ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++.
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l~dfg~~~~  168 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD  168 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEECCCCCccc
Confidence            578999999975321        23678899999999999999999754  99999999999999999999999999876


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............++..|+|||++.+..++.++|||||||++|+|++ |..||.+...                 ....
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----------------~~~~  231 (277)
T cd05062         169 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----------------EQVL  231 (277)
T ss_pred             cCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHH
Confidence            543332222222345778999999988889999999999999999999 7888876431                 1111


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      +..........+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111122334556778999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.3e-35  Score=241.64  Aligned_cols=171  Identities=27%  Similarity=0.390  Sum_probs=136.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        77 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  151 (325)
T cd05594          77 ANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--  151 (325)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence            578999999976654  89999999999999999999962 3499999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+..  ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----------------~~~~~i~~--~~~  213 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILM--EEI  213 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----------------HHHHHHhc--CCC
Confidence            123456899999999999889999999999999999999999999764311                01111111  122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~  194 (252)
                      ..+..++.++.+||.+||+.||++|+     ++.++++.
T Consensus       214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            34556778899999999999999996     89988863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-34  Score=229.15  Aligned_cols=178  Identities=28%  Similarity=0.421  Sum_probs=141.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.....  +++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKRRE--IPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            468999999987763  899999999999999999999765  9999999999999999999999999987653332211


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....                 ......+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----------------~~~~~~~~~~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------------AEVIAMLESGE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHcCC
Confidence             1111223467999999988889999999999999999998 9999975421                 11122222222


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+..++..+.++|.+||..+|++||++.++++.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            23445567788999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.2e-34  Score=238.26  Aligned_cols=165  Identities=27%  Similarity=0.349  Sum_probs=132.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        78 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          78 VNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999875322221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....                ......+...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----------------~~~~~~i~~~--~~  213 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----------------AEMYDNILNK--PL  213 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            23345689999999999998999999999999999999999999976431                0111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS  189 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~  189 (252)
                      ..+..++..+.++|.+||+.||.+||++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         214 RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23445678899999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-34  Score=239.10  Aligned_cols=164  Identities=28%  Similarity=0.443  Sum_probs=133.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 ~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--  156 (323)
T cd05616          83 VNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--  156 (323)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--
Confidence            578999999977665  899999999999999999999765  99999999999999999999999999875322111  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...                ......+...  ..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----------------~~~~~~i~~~--~~  218 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSIMEH--NV  218 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhC--CC
Confidence            12345789999999999999999999999999999999999999976431                1111112211  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      .++..++.++.+++.+||+.||.+|++.
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            3455678899999999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=238.75  Aligned_cols=168  Identities=25%  Similarity=0.423  Sum_probs=147.0

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee-cCCCceEEccccccccCCCCCcce
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      .||+|+|||.++.. +|++..+.+++.||+.|+.|+|...  +|||||||+||.+ .+-|-|||+|||++..+..+..  
T Consensus       100 D~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k--  174 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK--  174 (864)
T ss_pred             CCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence            47999999988764 5999999999999999999999655  9999999999876 5678899999999988766554  


Q ss_pred             eeecccccccccCccccccCCCCc-ccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ....+|+..|.|||++.|..|+. ++||||||+|||-|++|+.||+..+                +.+.+..+++.++ 
T Consensus       175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSETLTmImDCKY-  236 (864)
T KOG4717|consen  175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSETLTMIMDCKY-  236 (864)
T ss_pred             -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhhhhhhhcccc-
Confidence             34678999999999999999975 7899999999999999999998754                4556666776665 


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ..|..++.++.+||..||..||.+|.+.++|..
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             667889999999999999999999999999985

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-34  Score=230.95  Aligned_cols=175  Identities=26%  Similarity=0.370  Sum_probs=147.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCC-----
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-----   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-----   75 (252)
                      |+||+|...++++..+-+++..+..++.+|+.||+|||-.|  ||+|||||+||||.++|.+.|+||.++.....     
T Consensus       159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            79999999999998888999999999999999999999665  99999999999999999999999998742100     


Q ss_pred             ----------------------------CCcc---------------------eeeecccccccccCccccccCCCCccc
Q 025440           76 ----------------------------GDRT---------------------HVSTQVMGTHGYAAPEYVATGRLTTKS  106 (252)
Q Consensus        76 ----------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  106 (252)
                                                  ....                     .....++||-.|.|||+++|...+.++
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV  316 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV  316 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence                                        0000                     012346899999999999999999999


Q ss_pred             ceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCC
Q 025440          107 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP  186 (252)
Q Consensus       107 Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  186 (252)
                      |.|+|||++|||+.|..||.+.+                +...+..++......+-...++..+.+||+++|.+||.+|.
T Consensus       317 DWWtfGIflYEmLyG~TPFKG~~----------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl  380 (459)
T KOG0610|consen  317 DWWTFGIFLYEMLYGTTPFKGSN----------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL  380 (459)
T ss_pred             hHHHHHHHHHHHHhCCCCcCCCC----------------chhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence            99999999999999999999864                44556666666655554557889999999999999999999


Q ss_pred             C----HHHHHH
Q 025440          187 R----MSEVLA  193 (252)
Q Consensus       187 t----~~~v~~  193 (252)
                      .    +.||-+
T Consensus       381 g~~rGA~eIK~  391 (459)
T KOG0610|consen  381 GSKRGAAEIKR  391 (459)
T ss_pred             ccccchHHhhc
Confidence            7    777754

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.3e-34  Score=232.79  Aligned_cols=177  Identities=24%  Similarity=0.395  Sum_probs=138.6

Q ss_pred             CCCCChhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccc
Q 025440            1 MPKGSLENHLFRRGP-------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF   67 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Df   67 (252)
                      +++|+|.+++....+             ..+++..++.++.||+.||+|||+.+  ++|+||||+|||++.++.++|+||
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~~kL~df  166 (280)
T cd05092          89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDF  166 (280)
T ss_pred             CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCCEEECCC
Confidence            468999999976542             34899999999999999999999765  999999999999999999999999


Q ss_pred             cccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhh
Q 025440           68 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        68 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                      |++................++..|+|||++.+..++.++|||||||++|+|++ |..||......               
T Consensus       167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------------  231 (280)
T cd05092         167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---------------  231 (280)
T ss_pred             CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---------------
Confidence            99875433222222223345678999999988899999999999999999998 89998653211               


Q ss_pred             hhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                       . .............+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus       232 -~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 -E-AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -H-HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             0 11111122222334456788999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.5e-34  Score=235.91  Aligned_cols=181  Identities=27%  Similarity=0.443  Sum_probs=141.5

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++.....              ..+++..++.++.||+.||.|||+++  ++|+||||+|||++.++.+||+|
T Consensus       100 ~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~~~~kL~D  177 (314)
T cd05099         100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIAD  177 (314)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcCCCcEEEcc
Confidence            478999999966421              34899999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+...               
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---------------  242 (314)
T cd05099         178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---------------  242 (314)
T ss_pred             ccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---------------
Confidence            999976543222111122234567999999988889999999999999999999 8889866431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        ......+........+..++.++.+++.+||..||++||++.++++.|.++..
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 --EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              11112222222223445667789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.4e-34  Score=235.32  Aligned_cols=186  Identities=24%  Similarity=0.294  Sum_probs=134.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ..
T Consensus        92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~  166 (290)
T cd07862          92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---AL  166 (290)
T ss_pred             CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---cc
Confidence            468899997765556999999999999999999999765  9999999999999999999999999997643321   12


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccc-hhhhhhcc-hhhhhhhhHH----HHhhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAK-PYLSDKRKLF----RIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~-~~~~~~~~-~~~~~~~~~~----~~~~~  156 (252)
                      ....|+..|+|||++.+..++.++|||||||++|+|++|..||.+...... ..+..... +.........    .....
T Consensus       167 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  246 (290)
T cd07862         167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS  246 (290)
T ss_pred             ccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccC
Confidence            345689999999999888999999999999999999999999987543110 00110000 0000000000    00000


Q ss_pred             hcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....   .....++..+.+|+.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000   011235677889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.5e-34  Score=238.68  Aligned_cols=170  Identities=27%  Similarity=0.382  Sum_probs=136.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        78 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  151 (321)
T cd05591          78 VNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--  151 (321)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence            578999999977654  899999999999999999999765  99999999999999999999999999875322221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|+.||.....                ......+...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----------------~~~~~~i~~~--~~  213 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----------------DDLFESILHD--DV  213 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            12345689999999999888999999999999999999999999976431                1111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-------CHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-------RMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-------t~~~v~~~  194 (252)
                      ..+..++.++.+++.+||+.||++|+       ++.++++.
T Consensus       214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            33445678899999999999999999       77777753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.2e-34  Score=234.14  Aligned_cols=181  Identities=25%  Similarity=0.414  Sum_probs=142.6

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++.....              ..+++..++.++.||+.||.|||+.+  ++||||||+||+++.++.+||+|
T Consensus       103 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~~~~~~kl~D  180 (304)
T cd05101         103 ASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD  180 (304)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEcCCCcEEECC
Confidence            468999999976432              34788999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+...               
T Consensus       181 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------------  245 (304)
T cd05101         181 FGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---------------  245 (304)
T ss_pred             CccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---------------
Confidence            999986543332222223345678999999988889999999999999999998 7888865421               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        ......+........+..++..+.+|+.+||..+|++||++.++++.|+++..
T Consensus       246 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         246 --EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             --HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence              11222222222233445677889999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-34  Score=238.40  Aligned_cols=164  Identities=31%  Similarity=0.479  Sum_probs=132.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++........  
T Consensus        83 ~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  156 (324)
T cd05587          83 VNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--  156 (324)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|+||+.||.+...                ......+..  ...
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------------~~~~~~i~~--~~~  218 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------DELFQSIME--HNV  218 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHc--CCC
Confidence            13345789999999999998999999999999999999999999976431                111111111  123


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++.++.+++.+||..||.+|++.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            4455678889999999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-33  Score=234.68  Aligned_cols=168  Identities=27%  Similarity=0.408  Sum_probs=133.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|..++...   .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        84 ~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  156 (324)
T cd05589          84 AAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--  156 (324)
T ss_pred             CCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC--
Confidence            5789999888543   3999999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...  ..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----------------~~~~~i~~~--~~  218 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----------------EVFDSIVND--EV  218 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC--CC
Confidence            123457899999999999889999999999999999999999999764311                111111111  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||.+||     ++.++++
T Consensus       219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            34556788899999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-34  Score=237.90  Aligned_cols=169  Identities=29%  Similarity=0.392  Sum_probs=136.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +.+..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            578999999987665  889999999999999999999765  99999999999999999999999999875322221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----------------~~~~~~~~~~--~~  217 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----------------KKTIDKILKG--KL  217 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            12345689999999999888899999999999999999999999976431                1111112111  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            34556778899999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.9e-34  Score=228.72  Aligned_cols=176  Identities=29%  Similarity=0.446  Sum_probs=142.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++......... 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-  160 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-  160 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence            47899999998766566999999999999999999999655  999999999999999999999999999765332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....++..|++||.+.+..++.++||||||+++|+|++ |+.||.....                 ............
T Consensus       161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  222 (261)
T cd05148         161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----------------HEVYDQITAGYR  222 (261)
T ss_pred             -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----------------HHHHHHHHhCCc
Confidence             123345678999999988889999999999999999998 8999976431                 111222223333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            44556778899999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.8e-34  Score=227.98  Aligned_cols=178  Identities=22%  Similarity=0.339  Sum_probs=141.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+++  ++|+||||+|||++.++.+||+|||++..........
T Consensus        76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            47899999997543 34899999999999999999999765  9999999999999999999999999997643332211


Q ss_pred             e-eecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 V-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      . .....++..|+|||++.+..++.++||||||+++|++++ |..||.+...                 ......+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~  215 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----------------PEVMSFIEQGK  215 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----------------HHHHHHHHCCC
Confidence            1 111223568999999988889999999999999999996 9999976431                 11222333333


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ....+..++.++.++|.+||..||++||++.+|.+.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            4455566788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.1e-34  Score=234.91  Aligned_cols=181  Identities=28%  Similarity=0.428  Sum_probs=142.4

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++.....              ..+++.+++.++.|++.||+|||+.+  ++||||||+||+++.++.++|+|
T Consensus       106 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~~~~~kL~d  183 (307)
T cd05098         106 ASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIAD  183 (307)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEcCCCcEEECC
Confidence            468999999976532              24899999999999999999999755  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||.+...               
T Consensus       184 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---------------  248 (307)
T cd05098         184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---------------  248 (307)
T ss_pred             CcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---------------
Confidence            999876533221111222234568999999988889999999999999999998 8888865421               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        ......+........+..++.++.+|+.+||..+|++||++.++++.|+++..
T Consensus       249 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             --HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence              11222222333334455677899999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=228.16  Aligned_cols=178  Identities=25%  Similarity=0.433  Sum_probs=141.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||+++.........
T Consensus        87 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd05033          87 MENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY  163 (266)
T ss_pred             CCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence            468999999976543 4899999999999999999999755  9999999999999999999999999998764222221


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....                 ......+.....
T Consensus       164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  226 (266)
T cd05033         164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----------------QDVIKAVEDGYR  226 (266)
T ss_pred             eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1222334678999999988899999999999999999998 9999865321                 111111122222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            234456678899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-34  Score=231.54  Aligned_cols=177  Identities=27%  Similarity=0.427  Sum_probs=139.7

Q ss_pred             CCCCChhhhhhcCCC--------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +++|+|.+++.....        ..+++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.+||+|||+++.
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~dfg~~~~  168 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRD  168 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEECCcccchh
Confidence            468999999975432        23788999999999999999999655  99999999999999999999999999876


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............++..|+|||.+.+..++.++|||||||++|++++ |..||.+...                 ....
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----------------~~~~  231 (277)
T cd05032         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----------------EEVL  231 (277)
T ss_pred             hccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----------------HHHH
Confidence            543322222233456788999999988889999999999999999998 9999865431                 1111


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      +..........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            222222223445566889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7e-34  Score=232.68  Aligned_cols=180  Identities=26%  Similarity=0.399  Sum_probs=142.1

Q ss_pred             CCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC
Q 025440            1 MPKGSLENHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA   58 (252)
Q Consensus         1 ~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~   58 (252)
                      ++||+|.+++....                      ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~~  162 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAE  162 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEcC
Confidence            46899999886421                      235889999999999999999999765  999999999999999


Q ss_pred             CCceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhh
Q 025440           59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV  137 (252)
Q Consensus        59 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~  137 (252)
                      ++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...       
T Consensus       163 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------  235 (290)
T cd05045         163 GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-------  235 (290)
T ss_pred             CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-------
Confidence            99999999999976433222111222345678999999988889999999999999999998 9999976431       


Q ss_pred             hhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          138 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                                ..+............+..++.++.+++.+||+.+|++||++.++++.|+++-
T Consensus       236 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ----------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ----------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                      1222223333333445567789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=238.66  Aligned_cols=175  Identities=23%  Similarity=0.267  Sum_probs=136.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.....     
T Consensus        83 ~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          83 VPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----  153 (333)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999976433     


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........          ...............
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----------~i~~~~~~~~~~~~~  223 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE----------NLKYWKETLQRPVYD  223 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH----------HHHhccccccCCCCC
Confidence            1234568999999999999899999999999999999999999997643210000          000000000000000


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....++.++.+||.+||..+|.+||++.++++.
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0012457889999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=227.78  Aligned_cols=177  Identities=26%  Similarity=0.376  Sum_probs=140.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence            36899999997766556899999999999999999999655  999999999999999999999999999865422111 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+...                 ......+.....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  222 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----------------AEVLQQVDQGYR  222 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1111123457999999988889999999999999999999 9999976431                 111122222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+..++..+.+++.+||+.+|++||++.+++..|+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            33445677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=236.47  Aligned_cols=170  Identities=28%  Similarity=0.427  Sum_probs=141.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||+|.-+|.+.+...+++..++.++.+|+.||++||...  ||+|||||+|||+|+.|+++|+|+|+|..+..+... 
T Consensus       267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~-  343 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI-  343 (591)
T ss_pred             ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence            78999999999999888999999999999999999999655  999999999999999999999999999887665443 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                        ...+||.+|||||++..+.|+.+.|.|||||++|||+.|+.||.........             +.+ .........
T Consensus       344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEv-drr~~~~~~  407 (591)
T KOG0986|consen  344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEV-DRRTLEDPE  407 (591)
T ss_pred             --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHH-HHHHhcchh
Confidence              3348999999999999999999999999999999999999999765321110             011 111122234


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS  189 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~  189 (252)
                      .++...+.++.+|++.+|.+||.+|....
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            66788999999999999999999997543

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.7e-34  Score=237.28  Aligned_cols=178  Identities=27%  Similarity=0.427  Sum_probs=135.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......  .
T Consensus        78 ~~~g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~  151 (329)
T cd05588          78 VSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D  151 (329)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence            579999999977654  999999999999999999999765  9999999999999999999999999987422211  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|+|||||++|+|++|+.||.........        ...........+. ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~-~~~~  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP--------DQNTEDYLFQVIL-EKQI  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc--------cccchHHHHHHHH-cCCC
Confidence            123457899999999999989999999999999999999999999743211000        0000011111111 1122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC------HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR------MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt------~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||.+|++      +.++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            345567788999999999999999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9e-34  Score=229.26  Aligned_cols=177  Identities=23%  Similarity=0.390  Sum_probs=139.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.++++|||.+......... 
T Consensus        88 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-  163 (266)
T cd05064          88 MSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-  163 (266)
T ss_pred             CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcccccccccchh-
Confidence            47899999997654 24899999999999999999999655  999999999999999999999999987653222111 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|||||||++|++++ |..||.+...                 ....+.+.....
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----------------~~~~~~~~~~~~  226 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----------------QDVIKAVEDGFR  226 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----------------HHHHHHHHCCCC
Confidence            1112335678999999999999999999999999999875 9999976431                 111122222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            344566788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8e-34  Score=230.83  Aligned_cols=177  Identities=26%  Similarity=0.380  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~   72 (252)
                      ++||+|.+++.....     ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++   .+||+|||+++.
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~  168 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARD  168 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccCccccc
Confidence            468999999976542     24899999999999999999999765  99999999999998765   589999999986


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ...............+..|+|||++.+..++.++|||||||++|+|++ |..||.+....                 ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----------------~~~  231 (277)
T cd05036         169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----------------EVM  231 (277)
T ss_pred             cCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence            532221111112233567999999988899999999999999999997 99999764321                 112


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ..+........+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            222222233445567788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-33  Score=227.74  Aligned_cols=177  Identities=30%  Similarity=0.467  Sum_probs=140.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++..++.++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            46899999998765556899999999999999999999765  999999999999999999999999999765332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...                 ......+.....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  221 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----------------REVLEQVERGYR  221 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1122234567999999988889999999999999999999 8999976421                 111122222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+...+..+.+|+.+||..||++|||+.++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            34455677889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=245.62  Aligned_cols=163  Identities=29%  Similarity=0.434  Sum_probs=134.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.||++..+.+..   .+++..+.-++..|+.||.|||+++  |||||||.+|||+|.+|.+||+|||+++..-.  ...
T Consensus       451 ~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~  523 (694)
T KOG0694|consen  451 VAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGD  523 (694)
T ss_pred             cCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccCC--CCC
Confidence            3688855554333   3999999999999999999999765  99999999999999999999999999986432  222


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .+.+++||+.|+|||++.+..|+.++|.|||||+|||||.|+.||.+.+++                .....++.  ...
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----------------e~FdsI~~--d~~  585 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----------------EVFDSIVN--DEV  585 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHhc--CCC
Confidence            467889999999999999999999999999999999999999999976421                11112222  234


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      .+|..++.+...+++++|.++|++|...
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            6788899999999999999999999854

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.2e-34  Score=237.04  Aligned_cols=169  Identities=28%  Similarity=0.461  Sum_probs=135.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++.......  
T Consensus        78 ~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          78 VNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            579999999977654  999999999999999999999765  99999999999999999999999999865322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+|+..|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+..  ...
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----------------~~~~~i~~--~~~  213 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----------------ELFQSILE--DEV  213 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----------------HHHHHHHc--CCC
Confidence            123346899999999999999999999999999999999999999764310                01111111  112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~v~~  193 (252)
                      ..+..++..+.+||.+||..||.+||++     .++++
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            3445677889999999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-34  Score=239.07  Aligned_cols=167  Identities=23%  Similarity=0.279  Sum_probs=136.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......    
T Consensus       113 ~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----  184 (340)
T PTZ00426        113 VIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----  184 (340)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence            579999999987665  899999999999999999999765  999999999999999999999999999764322    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...  ..
T Consensus       185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------------~~~~~i~~~--~~  245 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----------------LIYQKILEG--II  245 (340)
T ss_pred             -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----------------HHHHHHhcC--CC
Confidence             22356899999999998888999999999999999999999999764310                111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~  194 (252)
                      .++..++..+.++|.+||+.||.+|+     +++++++.
T Consensus       246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            34556677899999999999999995     78888753

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-33  Score=234.01  Aligned_cols=165  Identities=28%  Similarity=0.376  Sum_probs=132.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus        78 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          78 VNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            578999999976554  889999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..                .....+...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~i~~~--~~  213 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----------------QMYDNILHK--PL  213 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----------------HHHHHHhcC--CC
Confidence            133456899999999998889999999999999999999999999764310                011111111  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS  189 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~  189 (252)
                      ..+...+..+.++|.+||+.||.+|+++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34456677899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-33  Score=227.16  Aligned_cols=177  Identities=29%  Similarity=0.446  Sum_probs=140.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            46889999998765556899999999999999999999655  999999999999999999999999999765332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...                 ............
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  221 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----------------REVLEQVERGYR  221 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1122345678999999988889999999999999999999 9999976431                 011111222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+...+..+.+++.+||..||++||+++++++.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            33455677889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.5e-34  Score=236.90  Aligned_cols=173  Identities=27%  Similarity=0.416  Sum_probs=133.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        78 ~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          78 VNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            579999999877654  899999999999999999999765  99999999999999999999999999875322111  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.........        ............. ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~i~-~~~~  222 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL-EKQI  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc--------ccccHHHHHHHHh-cCCC
Confidence            123457899999999999999999999999999999999999999642211000        0000111111111 1123


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++..+.++|.+||+.||.+|+++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            4556678889999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.3e-34  Score=236.83  Aligned_cols=171  Identities=28%  Similarity=0.428  Sum_probs=133.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        78 ~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          78 VNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            579999999976654  999999999999999999999765  99999999999999999999999999875322111  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||..|+|||++.+..++.++|||||||++|+|++|..||........          ............ ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~----------~~~~~~~~~~~~-~~~~  220 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD----------MNTEDYLFQVIL-EKPI  220 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc----------cccHHHHHHHHH-hCCC
Confidence            13345789999999999999999999999999999999999999965322100          001111111111 1122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++..+.+++.+||+.||.+|+++
T Consensus       221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         221 RIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            3555677889999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-33  Score=229.67  Aligned_cols=180  Identities=24%  Similarity=0.329  Sum_probs=141.7

Q ss_pred             CCCCChhhhhhcCCC------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGP------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      +++|+|.+++.....      ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++...
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~g~~~~~~  168 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLF  168 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence            368999999966422      45899999999999999999999655  9999999999999999999999999998654


Q ss_pred             CCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           75 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        75 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                      ............++..|+|||++.+..++.++||||||+++|++++ |+.||.....                 ......
T Consensus       169 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~  231 (280)
T cd05043         169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----------------FEMAAY  231 (280)
T ss_pred             CCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----------------HHHHHH
Confidence            3332222223345778999999988889999999999999999999 9999976421                 111122


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      +........+..++.++.+++.+||..||++|||+.++++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            2222222333456778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-33  Score=226.61  Aligned_cols=177  Identities=29%  Similarity=0.417  Sum_probs=142.9

Q ss_pred             CCCCChhhhhhcCC-------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440            1 MPKGSLENHLFRRG-------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      ++||+|.+++....       ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccc
Confidence            46899999997752       244999999999999999999999654  999999999999999999999999999876


Q ss_pred             CCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           74 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        74 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      .............++..|+|||.+....++.++||||||+++|+|++ |..||.....                 .....
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~  218 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----------------EEVLE  218 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHH
Confidence            54332222334457889999999988889999999999999999999 6999976421                 11122


Q ss_pred             HhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      .+........+..++.++.+++.+||..+|.+||++.++++.|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         219 YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            22223334556667889999999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.1e-34  Score=235.41  Aligned_cols=169  Identities=29%  Similarity=0.453  Sum_probs=134.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++.++..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        78 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          78 LNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.+....                 .....+.. ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----------------~~~~~i~~-~~~  213 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----------------ELFQSIRM-DNP  213 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHh-CCC
Confidence            123456899999999998889999999999999999999999999764311                 11111111 112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH-HHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS-EVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~-~v~~  193 (252)
                      ..+..++.++.+++.+||+.||++|+++. +++.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            33445677899999999999999999996 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-33  Score=226.46  Aligned_cols=176  Identities=26%  Similarity=0.397  Sum_probs=137.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...+. .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            468999999976542 4899999999999999999999655  9999999999999999999999999987543221111


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....                 ......+.....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----------------~~~~~~~~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----------------QQTREAIEQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----------------HHHHHHHHcCCC
Confidence            1111123456999999988889999999999999999998 8888865321                 111222222333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ...+..++..+.+++.+||+.||++||++.++++.|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3445566788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=239.62  Aligned_cols=173  Identities=28%  Similarity=0.344  Sum_probs=137.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC---
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---   77 (252)
                      ++||+|.+++.+.+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.......   
T Consensus        83 ~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          83 MPGGDLMNLLIRKDV--FPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            579999999987744  999999999999999999999755  9999999999999999999999999987654332   


Q ss_pred             ------------------------cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccc
Q 025440           78 ------------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE  133 (252)
Q Consensus        78 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~  133 (252)
                                              .........||+.|+|||++.+..++.++|||||||++|+|++|..||......  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~--  236 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ--  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH--
Confidence                                    001123456899999999999999999999999999999999999999765311  


Q ss_pred             hhhhhhcchhhhhhhhHHHHhh--hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCC-HHHHHHH
Q 025440          134 QSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAI  194 (252)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt-~~~v~~~  194 (252)
                                    .....+..  .....+....++..+.+||.+||. ||.+|++ +.++++.
T Consensus       237 --------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 --------------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             --------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                          11112222  111112222358889999999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.1e-34  Score=237.78  Aligned_cols=166  Identities=30%  Similarity=0.374  Sum_probs=134.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+...  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          80 LRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence            578999999977654  899999999999999999999765  99999999999999999999999999876433221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....                ......+...  ..
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----------------~~~~~~i~~~--~~  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----------------KETMTMILKA--KL  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            12345789999999999888899999999999999999999999976431                1111111111  12


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSE  190 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  190 (252)
                      ..+..++..+.+||.+||+.||.+||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            345567788999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.5e-34  Score=238.27  Aligned_cols=167  Identities=31%  Similarity=0.396  Sum_probs=142.0

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      -|+|..+|...+.  |+++++..++.++++||.|||+.+  |+|||+||.|||++..|.+|+||||+++....  .....
T Consensus        84 ~g~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vl  157 (808)
T KOG0597|consen   84 VGDLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVL  157 (808)
T ss_pred             hhhHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhccc--Cceee
Confidence            3699999988887  999999999999999999999765  99999999999999999999999999998644  33456


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCC
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY  162 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (252)
                      +.+.||+.|||||.+.+..|+..+|+||||||+||+++|++||-....                 ..+.+.+. ......
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----------------~~Lv~~I~-~d~v~~  219 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----------------TQLVKSIL-KDPVKP  219 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------------HHHHHHHh-cCCCCC
Confidence            778899999999999999999999999999999999999999965321                 11112111 112345


Q ss_pred             cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       163 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      |...+..+..|+..+|.+||.+|.+..+++.
T Consensus       220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            6688999999999999999999999999985

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-33  Score=230.07  Aligned_cols=178  Identities=24%  Similarity=0.423  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCC---------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEc
Q 025440            1 MPKGSLENHLFRRG---------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS   65 (252)
Q Consensus         1 ~~ggsL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~   65 (252)
                      +++|+|.+++....               ...+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~~~~kl~  166 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCCCcEEec
Confidence            46899999985432               234889999999999999999999655  9999999999999999999999


Q ss_pred             cccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhh
Q 025440           66 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL  144 (252)
Q Consensus        66 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  144 (252)
                      |||+++...............++..|+|||++.+..++.++|+||||+++|+|++ |..||.+...              
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------------  232 (283)
T cd05090         167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------------  232 (283)
T ss_pred             cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------------
Confidence            9999976543332222333445678999999988889999999999999999998 9989866421              


Q ss_pred             hhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          145 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                         ......+........+..++..+.+++.+||+.||.+||++.++++.|..
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ---QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               11122222222233455677889999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-33  Score=231.06  Aligned_cols=178  Identities=26%  Similarity=0.386  Sum_probs=138.9

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++.....              ..+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.+||+|
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~d  162 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIAD  162 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCeEEECC
Confidence            468999999965431              24889999999999999999999755  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||.+...               
T Consensus       163 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---------------  224 (297)
T cd05089         163 FGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---------------  224 (297)
T ss_pred             cCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------------
Confidence            99986422111   1111223457999999988889999999999999999997 9999976431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        ...............+..++..+.+|+.+||+.+|.+||+++++++.|+.+..
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         225 --AELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             --HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              11112222222333445677889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-33  Score=229.58  Aligned_cols=192  Identities=28%  Similarity=0.424  Sum_probs=143.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      +++|+|.+++....   +++.+++.++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++......... 
T Consensus        90 ~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  164 (283)
T cd05080          90 VPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY  164 (283)
T ss_pred             CCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence            47899999996643   999999999999999999999765  999999999999999999999999998765432221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++||||||+++|+|+||..||........... ..... ................
T Consensus       165 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~  242 (283)
T cd05080         165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQG-QMTVVRLIELLERGMR  242 (283)
T ss_pred             ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-ccccc-ccchhhhhhhhhcCCC
Confidence            111223456679999999888899999999999999999999999865432111110 00000 0011112222223333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            3445567889999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.3e-33  Score=226.41  Aligned_cols=178  Identities=29%  Similarity=0.427  Sum_probs=140.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.+.....+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            47899999998755455899999999999999999999755  999999999999999999999999999765332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||+..+..++.++|+||||+++|+|+| |..||.+....                 ...........
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----------------~~~~~~~~~~~  221 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------EVLDQVERGYR  221 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----------------HHHHHHhcCCC
Confidence            1122345678999999988889999999999999999999 88888764311                 11111112222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++..+.+++.+||+.||++||++.++++.|+..
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            233456778899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.3e-34  Score=230.55  Aligned_cols=177  Identities=26%  Similarity=0.395  Sum_probs=137.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+.+  ++||||||+||+++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            47899999997776667999999999999999999999765  9999999999999999999999999987654322   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......|+..|+|||++.+..++.++|+|||||++|+|++|..||........            ............. .
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~------------~~~~~~~~~~~~~-~  216 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA------------KEELKRRTLEDEV-K  216 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh------------HHHHHHHhhcccc-c
Confidence            12334689999999999888899999999999999999999999975432100            0000111111111 1


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .....++.++.+|+.+||+.||++||++.++++.+
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            11234677899999999999999999998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=239.52  Aligned_cols=169  Identities=29%  Similarity=0.405  Sum_probs=131.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++........  
T Consensus        78 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          78 MSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             CCCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            478999999977655  899999999999999999999765  99999999999999999999999999875322221  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+....                .....+..... 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~~~-  214 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----------------QMYRNIAFGKV-  214 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----------------HHHHHHHcCCC-
Confidence            12345689999999998765 4789999999999999999999999764310                00111111111 


Q ss_pred             CCCc-HHHHHHHHHHHHhhccCCCCCCC----CHHHHHH
Q 025440          160 GQYP-QKAAHTAATLALQCLNNEPKLRP----RMSEVLA  193 (252)
Q Consensus       160 ~~~~-~~~~~~~~~li~~~l~~dp~~Rp----t~~~v~~  193 (252)
                       ..+ ..++..+.++|.+||+.||.+||    ++.++++
T Consensus       215 -~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 -RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112 23577889999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.6e-33  Score=225.24  Aligned_cols=178  Identities=26%  Similarity=0.401  Sum_probs=139.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      +++|+|.+++.+.....+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++......... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            46899999998765445899999999999999999999654  999999999999999999999999999875432211 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||......                .....+.....
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----------------~~~~~~~~~~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----------------QILKKIDKEGE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHhcCC
Confidence            11223456788999999988899999999999999999999 99999653211                11111111112


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ....+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            22234456788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=245.51  Aligned_cols=183  Identities=18%  Similarity=0.256  Sum_probs=130.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----------------ceEEcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------------NAKLSD   66 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----------------~~kl~D   66 (252)
                      |++|.+++.+.+.  +++..+..++.||+.||+|||+. .+||||||||+|||++.++                .+||+|
T Consensus       215 g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~D  291 (467)
T PTZ00284        215 GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD  291 (467)
T ss_pred             CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECC
Confidence            7889999987654  99999999999999999999963 2499999999999998765                499999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~~~~~~~  145 (252)
                      ||++.....     .....+||..|+|||++.+..++.++|||||||++|||++|+.||.+.......... ........
T Consensus       292 fG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~  366 (467)
T PTZ00284        292 LGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS  366 (467)
T ss_pred             CCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCH
Confidence            998764221     123467899999999999999999999999999999999999999875432111100 00000000


Q ss_pred             ---------hhhhHHHHhhh------------hcC-CCCc-HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          146 ---------DKRKLFRIMDT------------KLG-GQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       146 ---------~~~~~~~~~~~------------~~~-~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                               ....+......            ... .... ......+.+||.+||.+||.+|||++|+++
T Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                     00000000000            000 0000 012456789999999999999999999997

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.6e-33  Score=225.69  Aligned_cols=177  Identities=27%  Similarity=0.420  Sum_probs=141.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++.+++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........ .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            46899999997766666999999999999999999999655  99999999999999999999999999876542211 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+.....
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  221 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----------------PEVIQNLERGYR  221 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----------------HHHHHHHHcCCC
Confidence            1222345678999999988889999999999999999999 9999976431                 111222222333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            34445567789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-33  Score=230.52  Aligned_cols=181  Identities=22%  Similarity=0.377  Sum_probs=141.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||+.+  |+|+||||+||+++.++.+||+|||+++.........
T Consensus        90 ~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          90 MPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             cCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccccCccccc
Confidence            47899999997654 24899999999999999999999755  9999999999999999999999999998654332211


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+.....
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  229 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----------------REIPDLLEKGER  229 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHCCCC
Confidence            1222345678999999988889999999999999999997 8999976421                 111122222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++..+.+++.+||..+|++||++.++++.|.++...
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            233344667889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=217.35  Aligned_cols=170  Identities=25%  Similarity=0.301  Sum_probs=139.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC---CceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~   77 (252)
                      |.||+|..-|..+.-  +++..+.....||+.+|+|+|..+  |||||+||+|+|+...   .-+||+|||++.....  
T Consensus        92 m~G~dl~~eIV~R~~--ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--  165 (355)
T KOG0033|consen   92 VTGGELFEDIVAREF--YSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--  165 (355)
T ss_pred             ccchHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence            578888877766644  889999999999999999999755  9999999999999543   3499999999987652  


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       .......+||+.|||||+++..+|+..+|||+-|++||-++.|..||.+.+.                .+....++...
T Consensus       166 -g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----------------~rlye~I~~g~  228 (355)
T KOG0033|consen  166 -GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------------HRLYEQIKAGA  228 (355)
T ss_pred             -ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----------------HHHHHHHhccc
Confidence             2345667899999999999999999999999999999999999999987431                12222333333


Q ss_pred             c--CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 L--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .  ..+....++++..+|+++||..||.+|.|+.|.++
T Consensus       229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2  33456688999999999999999999999999885

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-33  Score=231.28  Aligned_cols=184  Identities=25%  Similarity=0.403  Sum_probs=137.8

Q ss_pred             CCCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccc
Q 025440            1 MPKGSLENHLFRRG---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus         1 ~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      +++++|.+++.+..         ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~  178 (296)
T cd05051         101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR  178 (296)
T ss_pred             CCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhceeecCCCceEEcccccee
Confidence            46899999997654         125899999999999999999999765  9999999999999999999999999987


Q ss_pred             cCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh--CCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           72 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        72 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      ...............++..|+|||++.+..++.++|||||||++|+|++  |..||.......   ..       .....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~-------~~~~~  248 (296)
T cd05051         179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VI-------ENAGH  248 (296)
T ss_pred             ecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HH-------HHHHh
Confidence            6543332222334456788999999988889999999999999999998  677776533110   00       00000


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      .............+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         249 FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            00000011111223345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-33  Score=233.19  Aligned_cols=183  Identities=27%  Similarity=0.413  Sum_probs=143.0

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++....              ...+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.+||+|
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~~~~~kL~D  177 (334)
T cd05100         100 ASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIAD  177 (334)
T ss_pred             CCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECC
Confidence            46899999997542              134888999999999999999999655  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+...               
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------------  242 (334)
T cd05100         178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---------------  242 (334)
T ss_pred             cccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---------------
Confidence            999876543322211222334567999999988899999999999999999998 8888876431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK  202 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~  202 (252)
                        ......+........+..++..+.+++.+||+.+|++||++.++++.|+++....
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 --EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence              1122222222333444566778999999999999999999999999999886443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-34  Score=242.06  Aligned_cols=169  Identities=21%  Similarity=0.383  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |..|+|..|+.+.+.  ++...+..|++||++||.|||++.++|||||||-+||||+.+ |.|||+|+|+|.......  
T Consensus       125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--  200 (632)
T ss_pred             ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence            678999999999887  999999999999999999999999999999999999999764 889999999998754322  


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        ...++||+.|||||++. ..|+..+||||||++++||+|+..||..-.                +..++++.+..+..
T Consensus       201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----------------n~AQIYKKV~SGiK  261 (632)
T KOG0584|consen  201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----------------NPAQIYKKVTSGIK  261 (632)
T ss_pred             --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----------------CHHHHHHHHHcCCC
Confidence              34478999999999985 899999999999999999999999997532                22233333333222


Q ss_pred             C-CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 G-QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      + .+..--.+++.+||.+||.. ..+|+|+.|+|.
T Consensus       262 P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1 11112256899999999999 999999999996

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.2e-33  Score=226.10  Aligned_cols=177  Identities=27%  Similarity=0.414  Sum_probs=138.0

Q ss_pred             CCCCChhhhhhcCC-----CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-----ceEEcccccc
Q 025440            1 MPKGSLENHLFRRG-----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLA   70 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~   70 (252)
                      ++||+|.+++.+..     ...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            47899999997532     234889999999999999999999655  99999999999998877     8999999998


Q ss_pred             ccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           71 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        71 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      ................++..|+|||++.+..++.++|||||||++|+|++ |..||.....                 ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----------------~~  221 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------------QE  221 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----------------HH
Confidence            75433222222223345678999999998899999999999999999998 9999965321                 11


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ....+........+..++..+.++|.+||+.+|.+||++.++++.|+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         222 VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11111222222344567788999999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-33  Score=229.32  Aligned_cols=175  Identities=26%  Similarity=0.416  Sum_probs=135.3

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++...  ....+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            5799999888543  2245899999999999999999999765  99999999999999999999999999876533322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .  .....||..|+|||++.+..++.++|+|||||++|+|++|+.||........            ..........  .
T Consensus       153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~------------~~~~~~~~~~--~  216 (280)
T cd05608         153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------------NKELKQRILN--D  216 (280)
T ss_pred             c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh------------HHHHHHhhcc--c
Confidence            1  2335689999999999999999999999999999999999999976432100            0000001111  1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ....+..++..+.+++.+||+.||++||     +++++++
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1233456788899999999999999999     5666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-33  Score=229.62  Aligned_cols=188  Identities=21%  Similarity=0.214  Sum_probs=131.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|..+....  ..+++..++.++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||++......... 
T Consensus        82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  156 (287)
T cd07848          82 VEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-  156 (287)
T ss_pred             CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence            3556555444333  34899999999999999999999765  999999999999999999999999999865332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhhhhhhHH-------H
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLF-------R  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~-------~  152 (252)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.+........ ......+.........       .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            1234568999999999988889999999999999999999999998754321110 0000000000000000       0


Q ss_pred             Hhhhhc------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 IMDTKL------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 ~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......      .......++..+.+||.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000      00111235678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.4e-33  Score=224.50  Aligned_cols=179  Identities=27%  Similarity=0.378  Sum_probs=136.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      +++|+|.+++.+... .+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.+||+|||+++........ 
T Consensus        79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          79 MKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            468999999976543 3678888999999999999999654  999999999999999999999999998754322111 


Q ss_pred             -eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhC-CCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       .......++..|+|||.+.+..++.++||||||+++|||++| ..||.....                 ......+...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----------------~~~~~~~~~~  218 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----------------FDITVYLLQG  218 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHhcC
Confidence             111223456789999999888899999999999999999995 556654321                 1111122222


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .....+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            222333445678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.5e-34  Score=236.59  Aligned_cols=168  Identities=29%  Similarity=0.350  Sum_probs=133.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        78 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          78 VNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            579999999976654  899999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||...+..                .....+...  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----------------~~~~~~~~~--~~  213 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----------------EMYDNILHK--PL  213 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----------------HHHHHHHcC--Cc
Confidence            123457899999999999989999999999999999999999999764311                111111111  11


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL  192 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~  192 (252)
                      ..+...+..+.++|.+||+.||.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            22335677889999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.5e-33  Score=213.98  Aligned_cols=186  Identities=24%  Similarity=0.243  Sum_probs=137.2

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      -+|+..+++.. ..|+..++.+++.++++||+|||++.  |+||||||.|+|++.+|.+||+|||+++.+.......  .
T Consensus        85 tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--~  159 (318)
T KOG0659|consen   85 TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--T  159 (318)
T ss_pred             ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc--c
Confidence            36777775554 56999999999999999999999765  9999999999999999999999999999987665443  2


Q ss_pred             cccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcch---hhhhhhhHHHHhhhh
Q 025440           84 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKP---YLSDKRKLFRIMDTK  157 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~  157 (252)
                      ..+-|.+|+|||.+.|. .|+...||||.|||+.||+-|...|.+.++-+.-.  +.....|   .+.+...+.....-.
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            23679999999998776 69999999999999999999988888765421111  1111111   111111111111111


Q ss_pred             cC-----CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LG-----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .-     ...-..++.++.+|+.+||..||.+|.++.|++++
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11     11223456778999999999999999999999864

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-33  Score=234.92  Aligned_cols=188  Identities=26%  Similarity=0.353  Sum_probs=133.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc-cee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~   81 (252)
                      +++|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        87 ~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  162 (338)
T cd07859          87 ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF  162 (338)
T ss_pred             CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccccccCcccc
Confidence            5789998876654  899999999999999999999765  99999999999999999999999999976432211 111


Q ss_pred             eecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhh--------hhhh
Q 025440           82 STQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLS--------DKRK  149 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~--------~~~~  149 (252)
                      .....||..|+|||++.+  ..++.++|||||||++|+|++|+.||.+........ ..... .+...        ....
T Consensus       163 ~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  242 (338)
T cd07859         163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR  242 (338)
T ss_pred             ccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence            234578999999999865  578999999999999999999999997654211000 00000 00000        0000


Q ss_pred             HHHHhhhhcCCCCc---HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          150 LFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       150 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ....+.........   ..++..+.+++.+||+.||++|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00111111111111   1345678899999999999999999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-33  Score=232.49  Aligned_cols=184  Identities=25%  Similarity=0.262  Sum_probs=133.5

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeec
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ   84 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~   84 (252)
                      +|.-++...+ ..|++.++..++.||+.||+|||+++  |+|||||.+|||||.+|.+||+|||+|+++....... .+.
T Consensus       203 DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~  278 (560)
T KOG0600|consen  203 DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTS  278 (560)
T ss_pred             hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-ccc
Confidence            3444453332 34999999999999999999999765  9999999999999999999999999999876554433 344


Q ss_pred             ccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hhc----chhhhhhhhHHHHhhhhc
Q 025440           85 VMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA----KPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        85 ~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~  158 (252)
                      .+-|.+|+|||.+.|. .|+.+.|+||.||||.||++|+..|.+.++-..-..+ ...    ..++. ...+......+.
T Consensus       279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp  357 (560)
T KOG0600|consen  279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKP  357 (560)
T ss_pred             ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCC
Confidence            5679999999999886 6999999999999999999999999987653211111 000    00000 000000000000


Q ss_pred             CCCC-------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+       -..++....+|+..+|..||.+|.|+.++++
T Consensus       358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0011       1235677889999999999999999999985

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-33  Score=225.85  Aligned_cols=176  Identities=28%  Similarity=0.412  Sum_probs=136.6

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +++|+|.+++....              ...+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECC
Confidence            47899999997543              124889999999999999999999754  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||++.......   .......+..|+|||++.+..++.++||||||+++|+|++ |..||.+...               
T Consensus       156 fgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---------------  217 (270)
T cd05047         156 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------------  217 (270)
T ss_pred             CCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---------------
Confidence            99986322111   1111223567999999988889999999999999999997 9999965421               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                        ......+........+..++.++.+++.+||..||.+||++.+++..|.++
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         218 --AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --HHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence              111111222222233445667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.4e-33  Score=232.93  Aligned_cols=164  Identities=28%  Similarity=0.450  Sum_probs=133.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 ~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--  156 (323)
T cd05615          83 VNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--  156 (323)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCc--
Confidence            579999999977665  999999999999999999999765  99999999999999999999999999875322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------------~~~~~~i~~~--~~  218 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----------------DELFQSIMEH--NV  218 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhC--CC
Confidence            12345689999999999888899999999999999999999999976431                1111122211  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++.++.+++.+||++||.+|++.
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            3455677889999999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=225.13  Aligned_cols=174  Identities=28%  Similarity=0.401  Sum_probs=138.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...+.  +++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..........
T Consensus        86 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          86 MPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             CCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            478999999987654  899999999999999999999765  9999999999999999999999999987543221111


Q ss_pred             e-eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 V-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      . .....++..|+|||++.+..++.++||||||+++|+|++|+.||.....                .............
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~  225 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----------------MAAIFKIATQPTN  225 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----------------HHHHHHHhccCCC
Confidence            0 1234578899999999998899999999999999999999999965321                1111122222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++..+.++|.+||..+|.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            34556678889999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-33  Score=236.88  Aligned_cols=172  Identities=25%  Similarity=0.317  Sum_probs=134.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus       125 ~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-  198 (370)
T cd05596         125 MPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-  198 (370)
T ss_pred             CCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-
Confidence            5799999999654   2888999999999999999999765  999999999999999999999999998764332211 


Q ss_pred             eeecccccccccCccccccC----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.+...                ......+...
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i~~~  262 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----------------VGTYSKIMDH  262 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----------------HHHHHHHHcC
Confidence            12345789999999998653    378899999999999999999999976432                1112222222


Q ss_pred             hcCCCCcH--HHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          157 KLGGQYPQ--KAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       157 ~~~~~~~~--~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      .....++.  .++.++.+||.+||+.+|.+  |+++.++++.
T Consensus       263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            21222232  46889999999999999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.9e-33  Score=222.82  Aligned_cols=173  Identities=28%  Similarity=0.385  Sum_probs=138.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.......+++..++.++.+++.||.|||+.  +++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~--~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK--KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence            4789999999876445699999999999999999999965  4999999999999999999999999998765433221 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....++..|+|||++.+..++.++|+||||+++|+|++|+.||.....                ......+ ......
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~-~~~~~~  219 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----------------GALILKI-IRGVFP  219 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHH-HcCCCC
Confidence             2334678899999999888899999999999999999999999975431                0111111 112222


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            3344677889999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-33  Score=224.29  Aligned_cols=174  Identities=27%  Similarity=0.393  Sum_probs=136.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++..... .+++..++.++.||+.||+|||+.+  ++||||||+||+++.++.+||+|||+++........ 
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          81 MANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            478999999976543 4899999999999999999999765  999999999999999999999999998764322111 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......                 .....+.....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~  219 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----------------EVVESVSAGYR  219 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----------------HHHHHHHcCCc
Confidence            1111223457999999988899999999999999999999 89999754211                 11111222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+..++..+.+++.+||..+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            334455788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=227.93  Aligned_cols=175  Identities=30%  Similarity=0.460  Sum_probs=138.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.......+++..+..++.|++.||.|||+.+  ++||||||+||++++++.++|+|||++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  157 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--  157 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--
Confidence            57899999987665556999999999999999999999765  99999999999999999999999999876533221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+.....             ........+. ....
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-------------~~~~~~~~~~-~~~~  222 (285)
T cd05605         158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-------------KREEVERRVK-EDQE  222 (285)
T ss_pred             -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-------------HHHHHHHHhh-hccc
Confidence             123468999999999988889999999999999999999999998643210             0001111111 1122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~  194 (252)
                      ..+..++..+.+||.+||..||++||     ++++++..
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            34456778899999999999999999     77787653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.6e-33  Score=236.08  Aligned_cols=121  Identities=27%  Similarity=0.297  Sum_probs=107.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC--ceEEccccccccCCCCCcce
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +-||+++|+.+...+|+...+..++.||+.||.+||..+  |||+||||+||||...+  .+||+|||.++.....-   
T Consensus       271 ~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v---  345 (586)
T KOG0667|consen  271 STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV---  345 (586)
T ss_pred             hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCCcc---
Confidence            458999999999999999999999999999999999655  99999999999996544  59999999998754332   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCccc
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV  130 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~  130 (252)
                        ...+.+..|+|||++.|.+|+.+.||||||||++||++|...|.+..+
T Consensus       346 --ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  346 --YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             --eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence              256778999999999999999999999999999999999999988764

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-33  Score=235.72  Aligned_cols=172  Identities=23%  Similarity=0.268  Sum_probs=134.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.. ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus        83 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          83 QPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-  158 (330)
T ss_pred             CCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence            57999999997763 24999999999999999999999765  999999999999999999999999999765433222 


Q ss_pred             eeecccccccccCccccc------cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           81 VSTQVMGTHGYAAPEYVA------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                      ......||+.|+|||++.      +..++.++|||||||++|+|++|..||......                .....++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------------~~~~~i~  222 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----------------KTYNNIM  222 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----------------HHHHHHH
Confidence            233456899999999986      456789999999999999999999999764321                1111111


Q ss_pred             hhhc--CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  ..+....++..+.+|+.+||. +|.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         223 NFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111  111223467889999999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=237.38  Aligned_cols=181  Identities=31%  Similarity=0.449  Sum_probs=152.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||+|.+||.+.+. .++..+++.++.+.+.||+|||+++  +|||||..+|||++.++.+||+|||+++....   ..
T Consensus       243 ~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---~~  316 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---YV  316 (474)
T ss_pred             cCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccCCcc---ee
Confidence            689999999988775 5999999999999999999999766  99999999999999999999999999986431   11


Q ss_pred             eee-cccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+..                .......+.....
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~----------------~~~v~~kI~~~~~  380 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK----------------NYEVKAKIVKNGY  380 (474)
T ss_pred             eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC----------------HHHHHHHHHhcCc
Confidence            111 1223578999999999999999999999999999999 888998854                2233334446677


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN  203 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~~  203 (252)
                      +...+...+..+..++.+||..||++||++.++.+.|+.+.....
T Consensus       381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            778888899999999999999999999999999999998866543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-33  Score=234.59  Aligned_cols=172  Identities=24%  Similarity=0.314  Sum_probs=137.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC---
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---   77 (252)
                      +|||++..+|.+.+.  |++..+..++.+++.|++.||+.|  +|||||||+|+|||..|.+||+|||||.......   
T Consensus       223 lPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  223 LPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             cCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence            689999999988887  999999999999999999999766  9999999999999999999999999985321100   


Q ss_pred             -------------------cc-----e------------------eeecccccccccCccccccCCCCcccceehhHHHH
Q 025440           78 -------------------RT-----H------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL  115 (252)
Q Consensus        78 -------------------~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  115 (252)
                                         ..     .                  .....+||+.|+|||++.+..|+..+|.||||||+
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im  378 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM  378 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence                               00     0                  01135799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh--cCCCCcHHHHHHHHHHHHhhccCCCCCCCC---HHH
Q 025440          116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSE  190 (252)
Q Consensus       116 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~  190 (252)
                      ||||.|.+||.+.+.                ...+.+++.-.  +..+....++.++.+||.+||. ||++|..   ++|
T Consensus       379 yEmLvGyPPF~s~tp----------------~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  379 YEMLVGYPPFCSETP----------------QETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHhCCCCCCCCCH----------------HHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            999999999987653                12233333333  2233334567899999999999 9999985   555


Q ss_pred             HHH
Q 025440          191 VLA  193 (252)
Q Consensus       191 v~~  193 (252)
                      |.+
T Consensus       442 IK~  444 (550)
T KOG0605|consen  442 IKK  444 (550)
T ss_pred             Hhc
Confidence            554

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-33  Score=224.78  Aligned_cols=180  Identities=21%  Similarity=0.335  Sum_probs=142.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||+++.........
T Consensus        90 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~  166 (279)
T cd05057          90 MPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY  166 (279)
T ss_pred             CCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccccCcccce
Confidence            478999999976543 3899999999999999999999754  9999999999999999999999999998654332211


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+....++.++|+||||+++||+++ |..||.+...                 ......+.....
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  229 (279)
T cd05057         167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----------------VEIPDLLEKGER  229 (279)
T ss_pred             ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----------------HHHHHHHhCCCC
Confidence            1111223567999999988889999999999999999998 9999976431                 112222222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||..||++||++.++++.|.++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            33444566789999999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.7e-33  Score=222.96  Aligned_cols=173  Identities=31%  Similarity=0.504  Sum_probs=139.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++.......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            47899999998776556899999999999999999999654  9999999999999999999999999987532211   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......                 ...........
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~  215 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----------------EVKECVEKGYR  215 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----------------HHHHHHhCCCC
Confidence              12234567999999988889999999999999999998 99999764321                 11122222333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            33445677889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.6e-33  Score=229.29  Aligned_cols=179  Identities=27%  Similarity=0.397  Sum_probs=138.3

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++.+.+.              ..+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.+||+|
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~~kl~d  167 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIAD  167 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCcEEeCc
Confidence            478999999975431              24889999999999999999999665  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||++.......   ......++..|+|||++.+..++.++|||||||++|+|+| |..||......              
T Consensus       168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------------  230 (303)
T cd05088         168 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------------  230 (303)
T ss_pred             cccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------------
Confidence            99986421111   1111223567999999988889999999999999999998 99999754321              


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                         ..............+..++..+.+|+.+||+.+|++||++.+++..|.++...
T Consensus       231 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         231 ---ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             ---HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               11111122222223344667899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.7e-33  Score=227.52  Aligned_cols=184  Identities=25%  Similarity=0.412  Sum_probs=136.7

Q ss_pred             CCCCChhhhhhcCCC---------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccc
Q 025440            1 MPKGSLENHLFRRGP---------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      ++||+|.+++.....         ..+++..++.++.||+.||+|||+.+  ++|+||||+|||++.++.++|+|||+++
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~  178 (296)
T cd05095         101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSR  178 (296)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEEEcCCCCEEeccCcccc
Confidence            468999999976532         23778899999999999999999765  9999999999999999999999999987


Q ss_pred             cCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh--CCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           72 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        72 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      ...............++..|++||...++.++.++|+|||||++|||++  |..||.......  ..        .....
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~--~~--------~~~~~  248 (296)
T cd05095         179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ--VI--------ENTGE  248 (296)
T ss_pred             cccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH--HH--------HHHHH
Confidence            6533322222223344678999999888889999999999999999998  778886543210  00        00000


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ...........+.+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         249 FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00000011111223456688999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.3e-33  Score=222.99  Aligned_cols=174  Identities=26%  Similarity=0.415  Sum_probs=135.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++........ 
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          81 MENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            478999999976433 3899999999999999999999765  999999999999999999999999998764322211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||.....                 ......+.....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----------------~~~~~~i~~~~~  219 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----------------YEVVEMISRGFR  219 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----------------HHHHHHHHCCCC
Confidence            1122234568999999988889999999999999999999 8999976431                 011111111112


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+...+..+.+++.+||+.||++||++.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            222334567889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.4e-33  Score=223.51  Aligned_cols=174  Identities=24%  Similarity=0.392  Sum_probs=136.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05113          81 MSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T  156 (256)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence            468999999976543 5899999999999999999999765  99999999999999999999999999876433221 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|++||++.+..++.++||||||+++|+|++ |..||......                 ...........
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~~~~~~~~~  219 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----------------ETVEKVSQGLR  219 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHhcCCC
Confidence            1112235678999999988889999999999999999998 99998754310                 11111112222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+...+..+.+++.+||+.||.+||++.++++.|
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            233344578899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.8e-33  Score=222.71  Aligned_cols=172  Identities=22%  Similarity=0.360  Sum_probs=138.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.......+++.+++.++.+++.||++||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--  157 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--  157 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence            47899999998765556999999999999999999999665  99999999999999999999999999876533221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|..||...+.                ........ .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----------------~~~~~~~~-~~~~~  220 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----------------NSLVYRII-EGKLP  220 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHHH-hcCCC
Confidence            12345678999999999888899999999999999999999999975421                01111111 11122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++..+.+++.+||+.||++||++.+++.
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            344567788999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-33  Score=226.11  Aligned_cols=173  Identities=24%  Similarity=0.326  Sum_probs=134.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.++|+|||++........  
T Consensus        91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--  166 (272)
T cd06637          91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--  166 (272)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCceecccccc--
Confidence            46899999998765556999999999999999999999765  99999999999999999999999999876432211  


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......|+..|+|||++.     +..++.++|+|||||++|+|++|..||......                ........
T Consensus       167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----------------~~~~~~~~  230 (272)
T cd06637         167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------------RALFLIPR  230 (272)
T ss_pred             cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----------------HHHHHHhc
Confidence            123456889999999986     335788999999999999999999999653211                00111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..........++..+.+|+.+||..||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11112223346678999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.4e-33  Score=232.32  Aligned_cols=187  Identities=25%  Similarity=0.375  Sum_probs=135.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.+++.||.|||+. .+++|+||||+|||++.++.+||+|||++.......   
T Consensus        85 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---  158 (333)
T cd06650          85 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (333)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence            478999999977654  89999999999999999999963 249999999999999999999999999987542221   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhh------hc--------------
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD------WA--------------  140 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~------~~--------------  140 (252)
                       .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||.............      ..              
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence             223468999999999988889999999999999999999999997543211110000      00              


Q ss_pred             ----chhhh---hhhhHHHHhhhhcCCCC-cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          141 ----KPYLS---DKRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       141 ----~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                          .+...   ........+........ ....+.++.+||.+||++||++|||+.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                00000   00001111111111111 11356789999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.6e-33  Score=227.46  Aligned_cols=185  Identities=24%  Similarity=0.267  Sum_probs=132.8

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ...
T Consensus        91 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~  165 (288)
T cd07863          91 QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALT  165 (288)
T ss_pred             cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccccccCcc---cCC
Confidence            57888887765556999999999999999999999765  9999999999999999999999999997653221   122


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc-chhhhhhhhHHHHhhhhcC--
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKRKLFRIMDTKLG--  159 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~--  159 (252)
                      ...++..|+|||++.+..++.++|||||||++|+|++|..||.+....... ...... .+.................  
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (288)
T cd07863         166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPR  245 (288)
T ss_pred             CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCC
Confidence            346789999999998889999999999999999999999999764321100 000000 0000000000000000000  


Q ss_pred             -----CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 -----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 -----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                           ......++..+.++|.+||+.||++|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0011235677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-33  Score=237.56  Aligned_cols=188  Identities=26%  Similarity=0.338  Sum_probs=135.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++....  .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++...........
T Consensus       169 ~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        169 KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence            578889885444  3999999999999999999999765  999999999999999999999999999765443322223


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcc-------hhhhh-hhhHHH-
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-------PYLSD-KRKLFR-  152 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~-------~~~~~-~~~~~~-  152 (252)
                      ....||..|+|||++.+..++.++|||||||++|+|++|..||.+....... .+.....       .+... ...... 
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  324 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH  324 (392)
T ss_pred             cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence            3457899999999999889999999999999999999999999775432111 0100000       00000 000000 


Q ss_pred             --HhhhhcCCCC--c-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          153 --IMDTKLGGQY--P-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       153 --~~~~~~~~~~--~-----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                        ......+..+  +     ...+.++.++|.+||..||++||++.+++..
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              0011111111  1     1245678899999999999999999999974

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-32  Score=222.99  Aligned_cols=181  Identities=21%  Similarity=0.314  Sum_probs=140.2

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++...  ....+++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            4689999998642  2245899999999999999999999765  99999999999999999999999999876533221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .  .....++..|+|||++.+..++.++|+||||+++|+|++|..||.+......              .....+.....
T Consensus       162 ~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~  225 (267)
T cd08229         162 A--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------------SLCKKIEQCDY  225 (267)
T ss_pred             c--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--------------HHhhhhhcCCC
Confidence            1  2234678899999999888899999999999999999999999975432100              00011111111


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .......++..+.+++.+||..||++|||+.+|++.++++.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            11222356788999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.1e-33  Score=228.67  Aligned_cols=177  Identities=14%  Similarity=0.109  Sum_probs=130.0

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-----
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-----   79 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----   79 (252)
                      ++.+.+.....  .++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++.+......     
T Consensus       112 ~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~  187 (294)
T PHA02882        112 NTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK  187 (294)
T ss_pred             CHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCccccccc
Confidence            45555544332  678888999999999999999765  999999999999999999999999999765322111     


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...........       .......+....  
T Consensus       188 ~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~-------~~~~~~~~~~~~--  258 (294)
T PHA02882        188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA-------KCDFIKRLHEGK--  258 (294)
T ss_pred             ccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh-------HHHHHHHhhhhh--
Confidence            11123468999999999999999999999999999999999999998753211000000       000011111111  


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                       .....++..+.+++..||..+|++||++.++++.|
T Consensus       259 -~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        259 -IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             -hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             11234568899999999999999999999999876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-33  Score=235.17  Aligned_cols=174  Identities=25%  Similarity=0.336  Sum_probs=131.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        83 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          83 LPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            579999999987665  999999999999999999999765  999999999999999999999999998754221100 


Q ss_pred             --------------------------------eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCC
Q 025440           80 --------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK  127 (252)
Q Consensus        80 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~  127 (252)
                                                      ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001235799999999999999999999999999999999999999976


Q ss_pred             cccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCc--HHHHHHHHHHHHhhcc--CCCCCCCCHHHHHHH
Q 025440          128 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLN--NEPKLRPRMSEVLAI  194 (252)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~--~dp~~Rpt~~~v~~~  194 (252)
                      ....                .....+........++  ..++.++.++|.+++.  .++..||+++++++.
T Consensus       239 ~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQ----------------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHH----------------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            4311                1111122111111122  2356788899988664  233456899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.1e-33  Score=223.87  Aligned_cols=173  Identities=22%  Similarity=0.305  Sum_probs=138.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            47899999997655556899999999999999999999765  99999999999999999999999999876533221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|..||.....                 ......+......
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~~~  218 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----------------KNLILKVCQGSYK  218 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----------------HHHHHHHhcCCCC
Confidence            12335688899999999888899999999999999999999999976421                 1111111122222


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++..+.+||.+||+.||++||++.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            3445567789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-33  Score=235.35  Aligned_cols=173  Identities=23%  Similarity=0.293  Sum_probs=131.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++...+.  +++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        83 ~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          83 LPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            579999999977654  899999999999999999999765  999999999999999999999999998632110000 


Q ss_pred             --------------------------------------------eeeecccccccccCccccccCCCCcccceehhHHHH
Q 025440           80 --------------------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL  115 (252)
Q Consensus        80 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  115 (252)
                                                                  ......+||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                        000124689999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCc--HHHHHHHHHHHHhhccCCCCCC---CCHHH
Q 025440          116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLR---PRMSE  190 (252)
Q Consensus       116 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R---pt~~~  190 (252)
                      |||++|..||.+....                .....+.........+  ..++.++.+||.+||. +|.+|   +++.+
T Consensus       239 ~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         239 FECLIGWPPFCSENSH----------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhcCCCCCCCCCHH----------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999764321                0111111111111122  2457789999999997 67765   59998


Q ss_pred             HHHH
Q 025440          191 VLAI  194 (252)
Q Consensus       191 v~~~  194 (252)
                      ++..
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-33  Score=222.12  Aligned_cols=173  Identities=28%  Similarity=0.490  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            46899999998776556999999999999999999999765  9999999999999999999999999997652221   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        .....+..|+|||++.+..++.++|+||||+++|+|++ |..||.....                 ......+.....
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  217 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPHVEKGYR  217 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHhcCCC
Confidence              12234567999999988889999999999999999997 9999865421                 111122222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+..++..+.++|.+||..+|++||++.++++.|+.
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            33345567889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=236.97  Aligned_cols=178  Identities=24%  Similarity=0.351  Sum_probs=157.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |..|||.|||.+.+...++.-..+.++.||.+|++||..++  +|||||...|+||.++..|||+|||+++......+. 
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-  421 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-  421 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence            68999999999999888999999999999999999999655  999999999999999999999999999986544332 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......-...|.|||.+..+.++.|+|+|+||++||||.| |-.||.+.+                 ..+++.+++..++
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqVY~LLEkgyR  484 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYGLLEKGYR  484 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHHHHHHhcccc
Confidence            2222334678999999999999999999999999999998 889998753                 4567788889999


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...|..|++.+++||+.||+..|.+||++.|+.+.++.+
T Consensus       485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            999999999999999999999999999999999888654

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.6e-33  Score=236.31  Aligned_cols=179  Identities=26%  Similarity=0.387  Sum_probs=142.0

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.......+++..++.++.||+.||+|||+.+  |+|+||||+|||++.++.+||+|||+++...........
T Consensus       219 ~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~  296 (400)
T cd05105         219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK  296 (400)
T ss_pred             hhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCCCEEEEEeCCcceecccccccccc
Confidence            466778887776677999999999999999999999765  999999999999999999999999999765433222222


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||......                ......+.......
T Consensus       297 ~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----------------~~~~~~~~~~~~~~  360 (400)
T cd05105         297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----------------STFYNKIKSGYRMA  360 (400)
T ss_pred             CCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh----------------HHHHHHHhcCCCCC
Confidence            33456788999999988889999999999999999997 99998754211                11112222222333


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .+..++..+.+++.+||+.||++||++.++.+.|+++.
T Consensus       361 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         361 KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            44567788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-33  Score=233.79  Aligned_cols=171  Identities=25%  Similarity=0.376  Sum_probs=136.7

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      .+|..+|.+.......| .+..+..|++.+++++|.++  |||.||||.|+|+- .|.+||+|||+|.........-...
T Consensus       444 ~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kd  519 (677)
T KOG0596|consen  444 IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKD  519 (677)
T ss_pred             ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeec
Confidence            47888998777654445 77789999999999999876  99999999999885 4789999999999877665555566


Q ss_pred             cccccccccCccccccC-----------CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           84 QVMGTHGYAAPEYVATG-----------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~-----------~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      ..+||+.||+||.+...           +.+.++||||||||||+|+.|+.||...               ......+..
T Consensus       520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------------~n~~aKl~a  584 (677)
T KOG0596|consen  520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------------INQIAKLHA  584 (677)
T ss_pred             cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------------HHHHHHHHh
Confidence            77899999999988543           2568899999999999999999999652               223345556


Q ss_pred             HhhhhcCCCCcHHH-HHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 IMDTKLGGQYPQKA-AHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 ~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      +.+....-+++.-- ..++.+++..||..||++||++.++|+
T Consensus       585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            66665544554422 233999999999999999999999986

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.1e-33  Score=235.00  Aligned_cols=186  Identities=20%  Similarity=0.211  Sum_probs=131.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.....  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....... ...
T Consensus       166 ~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~  240 (391)
T PHA03212        166 KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKY  240 (391)
T ss_pred             CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccc
Confidence            5788888876654  899999999999999999999765  99999999999999999999999999875322211 112


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCccccc-----chhhhhhc---c----hhhhh-hhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-----EQSLVDWA---K----PYLSD-KRK  149 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~-----~~~~~~~~---~----~~~~~-~~~  149 (252)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ...+....   .    .+... ...
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            34578999999999998899999999999999999999998875432110     00000000   0    00000 000


Q ss_pred             HHHHh----hhhcCC----CC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          150 LFRIM----DTKLGG----QY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       150 ~~~~~----~~~~~~----~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....    ......    ..   ...++.++.+||.+||+.||.+|||+.++++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            01000    000000    00   1135678999999999999999999999986

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-32  Score=221.45  Aligned_cols=180  Identities=22%  Similarity=0.336  Sum_probs=140.8

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++...  ....+++.+++.++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            4789999998643  2345899999999999999999999765  99999999999999999999999999876433221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......               ............
T Consensus       162 ~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~~~~  224 (267)
T cd08224         162 A--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------------LYSLCKKIEKCD  224 (267)
T ss_pred             c--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------------HHHHHhhhhcCC
Confidence            1  22345788999999998888999999999999999999999999654311               001111111111


Q ss_pred             CCCCcH-HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~-~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+. .++..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus       225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            222333 56778999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-33  Score=226.41  Aligned_cols=167  Identities=26%  Similarity=0.363  Sum_probs=140.0

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .||.|+||+.+++.  |++.++..++.||++|+.|+|..  +++|||||.+|||+|.++++||+|||++..+...+   .
T Consensus       136 S~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn--rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---f  208 (668)
T KOG0611|consen  136 SGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN--RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---F  208 (668)
T ss_pred             CCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc--cceecccchhheeecCCCCeeeeccchhhhhcccc---H
Confidence            58999999998887  99999999999999999999965  49999999999999999999999999998865543   3


Q ss_pred             eecccccccccCccccccCCCC-cccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh-hhcC
Q 025440           82 STQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLG  159 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  159 (252)
                      ..+++|++.|.+||++.|.+|. +.+|.||||++||.|+.|..||++.+.                 ..+.+.+. ..++
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----------------k~lvrQIs~GaYr  271 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----------------KRLVRQISRGAYR  271 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----------------HHHHHHhhccccc
Confidence            4578999999999999999884 689999999999999999999998642                 22222222 2222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .   +..+.+..-||+.||..||++|.|+++|....
T Consensus       272 E---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 E---PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             C---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            1   23455678899999999999999999998754

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-32  Score=221.32  Aligned_cols=177  Identities=27%  Similarity=0.465  Sum_probs=139.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.+.....+++..++.++.+++.||.|||+.  +++|+||||+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~--~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC--CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence            4689999999876555689999999999999999999965  4999999999999999999999999998765332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|+||||+++|++++ |..||.+....                 .....+.....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------~~~~~~~~~~~  221 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------EVIRALERGYR  221 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----------------HHHHHHhCCCC
Confidence            1222335677999999988889999999999999999999 99999764311                 11111122222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            23344567789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.8e-33  Score=235.19  Aligned_cols=174  Identities=24%  Similarity=0.283  Sum_probs=132.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      ++||+|.+++.+.+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        83 ~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          83 IPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            579999999987664  899999999999999999999765  99999999999999999999999999754311000  


Q ss_pred             -------------------------------------------ceeeecccccccccCccccccCCCCcccceehhHHHH
Q 025440           79 -------------------------------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL  115 (252)
Q Consensus        79 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  115 (252)
                                                                 .......+||..|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                       0001235799999999999888899999999999999


Q ss_pred             HHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh--hcCCCCcHHHHHHHHHHHHhhc--cCCCCCCCCHHHH
Q 025440          116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCL--NNEPKLRPRMSEV  191 (252)
Q Consensus       116 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l--~~dp~~Rpt~~~v  191 (252)
                      |||++|..||......                .....+...  ....+....++.++.+||.+|+  ..++..|+++.++
T Consensus       239 ~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         239 FEMLVGQPPFLAPTPT----------------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHhCCCCCcCCCHH----------------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999764321                111111111  1111222346788999999854  5566669999999


Q ss_pred             HHH
Q 025440          192 LAI  194 (252)
Q Consensus       192 ~~~  194 (252)
                      +..
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-32  Score=225.47  Aligned_cols=180  Identities=24%  Similarity=0.382  Sum_probs=138.8

Q ss_pred             CCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRG--------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++||+|.+++.+..        ...+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||+++.
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L~Dfg~~~~  168 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD  168 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEECcCCcccc
Confidence            47899999997532        133577888999999999999999765  99999999999999999999999999876


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............++..|+|||.+.+..++.++|+|||||++|||++ |..||.+...                 ....
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----------------~~~~  231 (288)
T cd05061         169 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----------------EQVL  231 (288)
T ss_pred             ccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHH
Confidence            433222222223345678999999988889999999999999999998 7888875431                 1111


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ..+........+..++..+.+++.+||+.||++|||+.++++.|.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111111112234456778999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-32  Score=222.30  Aligned_cols=179  Identities=25%  Similarity=0.343  Sum_probs=141.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++........ 
T Consensus        88 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  163 (270)
T cd05056          88 APLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-  163 (270)
T ss_pred             CCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecccccce-
Confidence            478999999976543 4899999999999999999999655  999999999999999999999999998765433211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++||||||+++|++++ |..||.+....                 .....+.....
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~  226 (270)
T cd05056         164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----------------DVIGRIENGER  226 (270)
T ss_pred             ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHHcCCc
Confidence            1122234567999999988889999999999999999996 99999764321                 01111112222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            23455677899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=235.40  Aligned_cols=172  Identities=25%  Similarity=0.328  Sum_probs=133.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++..........
T Consensus        83 ~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          83 LPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            579999999987664  999999999999999999999765  9999999999999999999999999986532211000


Q ss_pred             ------------------------------------eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCC
Q 025440           81 ------------------------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA  124 (252)
Q Consensus        81 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~p  124 (252)
                                                          .....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                01124689999999999888999999999999999999999999


Q ss_pred             CCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCC--cHHHHHHHHHHHHhhccCCCCCCCC---HHHHHH
Q 025440          125 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPR---MSEVLA  193 (252)
Q Consensus       125 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt---~~~v~~  193 (252)
                      |.+....                .....+.........  ...++..+.+||.+||. +|.+|++   +.++++
T Consensus       239 f~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         239 FCSDNPQ----------------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCHH----------------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9764321                111111111111111  12457789999999996 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.5e-33  Score=223.14  Aligned_cols=180  Identities=20%  Similarity=0.298  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      +++|+|.+++...  ....+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            4688999988542  2244899999999999999999999765  99999999999999999999999999876543221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh-h
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-K  157 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  157 (252)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......               .......+.. .
T Consensus       162 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---------------~~~~~~~~~~~~  224 (267)
T cd08228         162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------------LFSLCQKIEQCD  224 (267)
T ss_pred             --HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---------------HHHHHHHHhcCC
Confidence              122345788999999998888999999999999999999999998653211               0011111111 1


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ........++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            112223456778999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-32  Score=220.61  Aligned_cols=176  Identities=28%  Similarity=0.415  Sum_probs=137.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.+... .+++..++.++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            468999999966532 4899999999999999999999654  9999999999999999999999999987643222111


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|+| |..||......                 .....+.....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----------------~~~~~~~~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----------------QTRERIESGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----------------HHHHHHhcCCC
Confidence            1112233567999999988889999999999999999999 88888664321                 11112222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ...+..++..+.+++.+||..+|++||++.++++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3345566789999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.2e-33  Score=227.05  Aligned_cols=174  Identities=31%  Similarity=0.482  Sum_probs=137.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+...+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++........  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence            47899999997766566999999999999999999999765  99999999999999999999999999875432221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++||||||+++|+|++|..||.........             ....... .....
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-------------~~~~~~~-~~~~~  222 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------EEVERLV-KEVQE  222 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-------------HHHHhhh-hhhhh
Confidence             12346899999999999889999999999999999999999999764321100             0011111 11112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ..+..++.++.+|+.+||+.||.+|||     ++++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            234456778999999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-32  Score=226.25  Aligned_cols=184  Identities=23%  Similarity=0.367  Sum_probs=136.0

Q ss_pred             CCCCChhhhhhcCCC----------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccc
Q 025440            1 MPKGSLENHLFRRGP----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA   70 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~   70 (252)
                      ++|++|.+++.....          ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~~~~~~kl~dfg~~  176 (295)
T cd05097          99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMS  176 (295)
T ss_pred             CCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEcCCCcEEecccccc
Confidence            578999999965421          23788999999999999999999765  999999999999999999999999998


Q ss_pred             ccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh--CCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           71 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        71 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                      ................++..|+|||++.+..++.++|+|||||++|+|++  |..||.......  ...        ...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--~~~--------~~~  246 (295)
T cd05097         177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIE--------NTG  246 (295)
T ss_pred             cccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--HHH--------HHH
Confidence            76543322222233445778999999988889999999999999999998  667776533110  000        000


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ..............+..++..+.+|+.+||+.||++||++.+|++.|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         247 EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            000000011111223346678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-32  Score=224.28  Aligned_cols=194  Identities=25%  Similarity=0.341  Sum_probs=140.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+... .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  165 (284)
T cd05081          89 LPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY  165 (284)
T ss_pred             cCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccccCCCcce
Confidence            478999999976532 4899999999999999999999665  9999999999999999999999999998654332211


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ......++..|+|||++.+..++.++||||||+++|||++|..++................ .......+...+.....
T Consensus       166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  244 (284)
T cd05081         166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ-GQMIVYHLIELLKNNGR  244 (284)
T ss_pred             eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc-cccchHHHHHHHhcCCc
Confidence             1111223456999999988889999999999999999999877664432111000000000 00001112222333333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            344556778899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-32  Score=221.78  Aligned_cols=178  Identities=26%  Similarity=0.447  Sum_probs=139.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..........
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          88 MENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence            47899999997654 34899999999999999999999765  9999999999999999999999999987653322211


Q ss_pred             e-eecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 V-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      . ......+..|+|||++.+..++.++|+|||||++|+|++ |..||.....                 ......+....
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~i~~~~  227 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------------HEVMKAINDGF  227 (268)
T ss_pred             eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----------------HHHHHHHhcCC
Confidence            1 111223457999999988889999999999999999998 9999965321                 11122222222


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ..+.+..++..+.+++.+||+.+|++||++.++++.|.++
T Consensus       228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3333445678899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-32  Score=230.31  Aligned_cols=165  Identities=29%  Similarity=0.387  Sum_probs=127.8

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++................++..|+|||.
T Consensus       175 ~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  252 (343)
T cd05103         175 VLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  252 (343)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHH
Confidence            3788889999999999999999765  99999999999999999999999999876433222111222345678999999


Q ss_pred             cccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHH
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  175 (252)
                      +.+..++.++||||||+++|+|++ |..||......                ......+........+...+..+.+++.
T Consensus       253 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (343)
T cd05103         253 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTML  316 (343)
T ss_pred             hcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----------------HHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            988889999999999999999997 99998653211                0111111222222333345678999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHhhc
Q 025440          176 QCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      +||+.||++||++.++++.|+.+.
T Consensus       317 ~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         317 DCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-33  Score=222.65  Aligned_cols=187  Identities=24%  Similarity=0.244  Sum_probs=134.2

Q ss_pred             CChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            4 GSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         4 gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      -+|.+|+.....  +.++...+..++.||+.||+|||+++  |+||||||+||||+.+|.+||+|||+|+.+.-...  .
T Consensus       101 ~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~  176 (323)
T KOG0594|consen  101 RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--T  176 (323)
T ss_pred             ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--c
Confidence            367778866654  46888999999999999999999876  99999999999999999999999999997543322  2


Q ss_pred             eecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh--hhcchhhhhhhhHHHHhhhh-
Q 025440           82 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKPYLSDKRKLFRIMDTK-  157 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-  157 (252)
                      .+..++|.+|+|||++.|. .|+...||||+|||++||++++..|.+......-..+  ....|............+-+ 
T Consensus       177 yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~  256 (323)
T KOG0594|consen  177 YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA  256 (323)
T ss_pred             ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc
Confidence            3456789999999999887 6999999999999999999999999886642111000  00000000000000000000 


Q ss_pred             -cCC-CCc-------HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 -LGG-QYP-------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 -~~~-~~~-------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       ... ..+       ........+++.+||+.+|.+|.++..++..
T Consensus       257 ~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  257 PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             000 001       1122478899999999999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=230.23  Aligned_cols=161  Identities=25%  Similarity=0.337  Sum_probs=129.9

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc---eeeecccccccccCc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---HVSTQVMGTHGYAAP   94 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aP   94 (252)
                      |++.++++++.+++.||+|||.++  ||||||||+|+||+.+|.|||+|||.+..+......   ......+||+.|+||
T Consensus       207 ls~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  207 LSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP  284 (576)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence            899999999999999999999876  999999999999999999999999999876332111   112236899999999


Q ss_pred             cccccCC----CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHH
Q 025440           95 EYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA  170 (252)
Q Consensus        95 E~~~~~~----~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (252)
                      |...++.    .+.+.||||+||+||-|+.|++||.+..                ......+++...+..+....+...+
T Consensus       285 E~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----------------~~~l~~KIvn~pL~fP~~pe~~e~~  348 (576)
T KOG0585|consen  285 ELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----------------ELELFDKIVNDPLEFPENPEINEDL  348 (576)
T ss_pred             HhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----------------HHHHHHHHhcCcccCCCcccccHHH
Confidence            9987743    3568899999999999999999997643                1223334444444444444678899


Q ss_pred             HHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          171 ATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       171 ~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      .+||.+||.+||++|.++.+|.....
T Consensus       349 kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  349 KDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             HHHHHHHhhcChhheeehhhheecce
Confidence            99999999999999999999987653

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-32  Score=222.18  Aligned_cols=177  Identities=30%  Similarity=0.462  Sum_probs=140.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.......+++..++.++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchhhh-
Confidence            47899999998776556999999999999999999999655  999999999999999999999999998765432111 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+...                 ............
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----------------REVLEQVERGYR  222 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1112234568999999988889999999999999999998 9999976421                 111111222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            33445567789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-32  Score=225.26  Aligned_cols=178  Identities=27%  Similarity=0.399  Sum_probs=136.6

Q ss_pred             CCCCChhhhhhcCC--------------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC
Q 025440            1 MPKGSLENHLFRRG--------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF   60 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~   60 (252)
                      +++|+|.+++....                    ...+++..++.++.||+.||+|||+.+  ++||||||+||+++.++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~~~~  167 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENM  167 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheEecCCC
Confidence            46899999996432                    134788899999999999999999654  99999999999999999


Q ss_pred             ceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhh
Q 025440           61 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW  139 (252)
Q Consensus        61 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~  139 (252)
                      .++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....        
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~--------  239 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--------  239 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            999999999875433222111222334667999999988899999999999999999998 88888654210        


Q ss_pred             cchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          140 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                               .....+........+..++..+.+|+.+||+.||++|||+.|+++.|++
T Consensus       240 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ---------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                     1111111111123344567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.1e-33  Score=233.31  Aligned_cols=172  Identities=25%  Similarity=0.315  Sum_probs=132.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus       125 ~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-  198 (370)
T cd05621         125 MPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-  198 (370)
T ss_pred             CCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecccCCce-
Confidence            5799999999654   2889999999999999999999765  999999999999999999999999999865332211 


Q ss_pred             eeecccccccccCccccccCC----CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+...                ......++..
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----------------~~~~~~i~~~  262 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----------------VGTYSKIMDH  262 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhC
Confidence            123457999999999987543    78899999999999999999999976431                1112222222


Q ss_pred             hcCCCCc--HHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          157 KLGGQYP--QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       157 ~~~~~~~--~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      ......+  ..++..+.+++.+||..++.+  |+++.++++.
T Consensus       263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            2222222  245788999999999865543  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=100.00  E-value=2.6e-32  Score=207.37  Aligned_cols=166  Identities=25%  Similarity=0.219  Sum_probs=126.6

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      |||.+++..++ .++++.+++.++.||+.||+|||+.+        ||+|||++.++.+++  ||++......       
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------
Confidence            89999997654 35999999999999999999999653        999999999999999  9998764332       


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc--CCC
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL--GGQ  161 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  161 (252)
                      ...|++.|+|||++.+..++.++|||||||++|||+||..||....... .           .............  ...
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~  130 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-A-----------ILEILLNGMPADDPRDRS  130 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-H-----------HHHHHHHHhccCCccccc
Confidence            1257899999999999999999999999999999999999996532100 0           0000000000000  001


Q ss_pred             CcHHHHH--HHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          162 YPQKAAH--TAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       162 ~~~~~~~--~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .+.....  .+.++|.+||..||.+||++.++++.+..+.
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            2233444  6999999999999999999999999886653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-32  Score=223.34  Aligned_cols=193  Identities=25%  Similarity=0.369  Sum_probs=140.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.+.. ..+++..++.++.||+.||+|||+.+  ++||||||+||+++.++.++|+|||+++........ 
T Consensus        90 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  166 (284)
T cd05079          90 LPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY  166 (284)
T ss_pred             cCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccccCccce
Confidence            47999999996654 24899999999999999999999655  999999999999999999999999999865432221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++||||||+++|+|+++..|+................ . .........+.....
T Consensus       167 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~  244 (284)
T cd05079         167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG-Q-MTVTRLVRVLEEGKR  244 (284)
T ss_pred             eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc-c-ccHHHHHHHHHcCcc
Confidence            11223456778999999988889999999999999999999876543221100000000000 0 000111122222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            334456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-32  Score=221.08  Aligned_cols=178  Identities=24%  Similarity=0.431  Sum_probs=137.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++.+++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..........
T Consensus        87 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          87 MENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             CCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence            468999999976543 4899999999999999999999765  9999999999999999999999999987643322111


Q ss_pred             eeeccc---ccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVM---GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~---gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ......   .+..|+|||.+.+..++.++|||||||++|||++ |..||......                 .....+..
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----------------~~~~~i~~  226 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------------DVINAIEQ  226 (269)
T ss_pred             ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHc
Confidence            111111   2457999999988899999999999999999886 99999754310                 11111112


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ....+.+..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222333456677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-32  Score=233.56  Aligned_cols=164  Identities=23%  Similarity=0.384  Sum_probs=129.6

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .+++..++.++.||+.||+|||+.  +++||||||+|||++.++.++|+|||+++...............++..|+|||.
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  312 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLASK--NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES  312 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcC--CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence            377888899999999999999965  499999999999999999999999999976432221111223356788999999


Q ss_pred             cccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHH
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  175 (252)
                      +.+..++.++||||||+++|||++ |..||.....                .......+........+..++.++.+|+.
T Consensus       313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~----------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~  376 (401)
T cd05107         313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM----------------NEQFYNAIKRGYRMAKPAHASDEIYEIMQ  376 (401)
T ss_pred             hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc----------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            988889999999999999999998 8889865321                11122222233333445567789999999


Q ss_pred             hhccCCCCCCCCHHHHHHHHHhh
Q 025440          176 QCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      +||..+|.+||++.+|++.|+++
T Consensus       377 ~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         377 KCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHcCCChhHCcCHHHHHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.9e-33  Score=227.05  Aligned_cols=186  Identities=22%  Similarity=0.299  Sum_probs=131.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++...+. .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        86 ~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~  160 (288)
T cd07871          86 DSDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY  160 (288)
T ss_pred             CcCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cc
Confidence            3589998866543 4789999999999999999999765  99999999999999999999999999875432221  12


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hh-cc------hhhhhhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AK------PYLSDKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~-~~------~~~~~~~~~~~~  153 (252)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......... .. ..      +...........
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            33467899999998866 46899999999999999999999999775432111100 00 00      000000011111


Q ss_pred             hhhhcCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......    .....++.++.+||.+||..||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1100000    001235678899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-33  Score=218.16  Aligned_cols=185  Identities=23%  Similarity=0.235  Sum_probs=136.4

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeec
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ   84 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~   84 (252)
                      +|...+.+.. +++...++..+..|+++||+|||+..  |+|||||++|+|++..|.+||+|||+|+.+.+....  .+.
T Consensus       162 DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~  236 (419)
T KOG0663|consen  162 DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTP  236 (419)
T ss_pred             hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCccc--Ccc
Confidence            4566665554 67999999999999999999999655  999999999999999999999999999987665332  345


Q ss_pred             ccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-----h---hcchhhhhhhhH-----
Q 025440           85 VMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-----D---WAKPYLSDKRKL-----  150 (252)
Q Consensus        85 ~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-----~---~~~~~~~~~~~~-----  150 (252)
                      .+-|.+|+|||.+.|. .|+.+.|+||+|||+.||++++..|.+...-..-..+     .   ..++.+.....+     
T Consensus       237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f  316 (419)
T KOG0663|consen  237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF  316 (419)
T ss_pred             eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence            6679999999999886 5999999999999999999999999987643221111     0   001111111100     


Q ss_pred             HHHhhhhcCCCCcHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          151 FRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ........+..++.. .+....+|+..+|.+||.+|.|+++.++.
T Consensus       317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            000011111122221 56788999999999999999999998863

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.4e-32  Score=218.77  Aligned_cols=175  Identities=27%  Similarity=0.426  Sum_probs=136.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++........ .
T Consensus        74 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  149 (250)
T cd05085          74 VPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-S  149 (250)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceecccccc-c
Confidence            478999999966543 4899999999999999999999765  99999999999999999999999999875332211 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|++++ |..||.+....                 ...........
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----------------~~~~~~~~~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----------------QAREQVEKGYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----------------HHHHHHHcCCC
Confidence            1112234567999999988889999999999999999998 99999764321                 11111122223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ...+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            3344567788999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=213.67  Aligned_cols=163  Identities=28%  Similarity=0.454  Sum_probs=130.1

Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccc
Q 025440           12 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY   91 (252)
Q Consensus        12 ~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y   91 (252)
                      ++-..++++..+-++...+++||.||-.+ .+|+|||+||+|||+|..|++||||||++....+..   ..+...|.+.|
T Consensus       182 krik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~Y  257 (391)
T KOG0983|consen  182 KRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAY  257 (391)
T ss_pred             HHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccc
Confidence            34445699999999999999999999875 369999999999999999999999999997643322   23455689999


Q ss_pred             cCccccccC---CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCc--HHH
Q 025440           92 AAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKA  166 (252)
Q Consensus        92 ~aPE~~~~~---~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  166 (252)
                      ||||.+.-.   +|+-.+|+||||++++||.||+.||.+...               +...+.++++. .....+  ..+
T Consensus       258 MaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---------------dFe~ltkvln~-ePP~L~~~~gF  321 (391)
T KOG0983|consen  258 MAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---------------DFEVLTKVLNE-EPPLLPGHMGF  321 (391)
T ss_pred             cCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---------------cHHHHHHHHhc-CCCCCCcccCc
Confidence            999998543   588899999999999999999999987432               22333444432 222222  347


Q ss_pred             HHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          167 AHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       167 ~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ++.+.+|+..||.+|+.+||...++++.
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            8999999999999999999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.5e-33  Score=239.46  Aligned_cols=186  Identities=23%  Similarity=0.320  Sum_probs=130.1

Q ss_pred             CCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      +|+|.+++...  ....+++..+..++.||+.||+|||+.+  |+||||||+|||++.++ .+||+|||+++....... 
T Consensus       150 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-  226 (440)
T PTZ00036        150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR-  226 (440)
T ss_pred             CccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC-
Confidence            35677766432  2345899999999999999999999765  99999999999998665 699999999986543222 


Q ss_pred             eeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhh-hcchhhhhhhh----HHH
Q 025440           80 HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLSDKRK----LFR  152 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~-~~~~~~~~~~~----~~~  152 (252)
                        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....... .... ...+.......    ...
T Consensus       227 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~  304 (440)
T PTZ00036        227 --SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD  304 (440)
T ss_pred             --cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence              2235689999999998764 6899999999999999999999999875421100 0000 00000000000    000


Q ss_pred             H-----hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 I-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 ~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      +     ........++...+.++.+||.+||.+||.+|||+.+++.
T Consensus       305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0     0000011123345678999999999999999999999985

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=231.10  Aligned_cols=170  Identities=26%  Similarity=0.364  Sum_probs=126.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+..      .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus       154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            3566664422      2567788899999999999999765  99999999999999999999999999876532211  


Q ss_pred             eeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......||..|+|||++..     ...+.++|||||||++|+|++|+.||.......              .........
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------------~~~~~~~~~  289 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--------------WASLMCAIC  289 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--------------HHHHHHHHh
Confidence            1234568999999998743     234568999999999999999999997432110              000111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .......+..++.++.+||.+||+.||++||++.++++.
T Consensus       290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112223345677889999999999999999999999874

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-32  Score=221.00  Aligned_cols=179  Identities=26%  Similarity=0.403  Sum_probs=137.3

Q ss_pred             CCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      +++|+|.+++...    ....+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~  166 (273)
T cd05074          89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSG  166 (273)
T ss_pred             CCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECcccccccccCC
Confidence            3578998887532    1234789999999999999999999765  999999999999999999999999998865433


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ..........++..|++||.+.+..++.++|||||||++|+|++ |..||.+....                 .......
T Consensus       167 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----------------~~~~~~~  229 (273)
T cd05074         167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----------------EIYNYLI  229 (273)
T ss_pred             cceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----------------HHHHHHH
Confidence            22222223345678999999988889999999999999999999 88888754310                 1111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      .......+..++..+.+++.+||+.+|++||++.+++..|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111222345667899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.8e-32  Score=225.73  Aligned_cols=186  Identities=22%  Similarity=0.259  Sum_probs=128.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  160 (303)
T cd07869          86 HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TY  160 (303)
T ss_pred             CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cC
Confidence            468888886543 34899999999999999999999765  99999999999999999999999999875322211  12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hh-hhcchhhh---hhhhHHHHhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LV-DWAKPYLS---DKRKLFRIMD  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~-~~~~~~~~---~~~~~~~~~~  155 (252)
                      ....++..|+|||++.+. .++.++|||||||++|+|++|..||.+........  .. ....+...   ..........
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            334678999999998654 57889999999999999999999998643211100  00 00000000   0000000000


Q ss_pred             hhcCCCCc---------HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYP---------QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......+         ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000         113457889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-32  Score=234.26  Aligned_cols=172  Identities=25%  Similarity=0.318  Sum_probs=131.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC---
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---   77 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||++..+....   
T Consensus        83 ~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          83 IPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            579999999977654  899999999999999999999765  9999999999999999999999999975321000   


Q ss_pred             ------------------------------------------cceeeecccccccccCccccccCCCCcccceehhHHHH
Q 025440           78 ------------------------------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL  115 (252)
Q Consensus        78 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  115 (252)
                                                                ........+||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                      00001234689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh--hcCCCCcHHHHHHHHHHHHhhccCCCCCCCC---HHH
Q 025440          116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPR---MSE  190 (252)
Q Consensus       116 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~  190 (252)
                      |||++|+.||.+....                .....+...  ....+....++.++.++|.+|+ .+|.+|++   +.+
T Consensus       239 ~elltG~~Pf~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         239 YEMLVGQPPFLAQTPL----------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHhCCCCCCCCCHH----------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999764321                111111111  1111222356788899998876 59999997   777


Q ss_pred             HHH
Q 025440          191 VLA  193 (252)
Q Consensus       191 v~~  193 (252)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.6e-32  Score=222.12  Aligned_cols=174  Identities=29%  Similarity=0.434  Sum_probs=136.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  157 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--  157 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence            47899999997766556999999999999999999999765  99999999999999999999999999875432221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+......             .......+ .....
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-------------~~~~~~~~-~~~~~  222 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-------------REEVDRRV-LETEE  222 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHHhh-hcccc
Confidence             2234689999999999888999999999999999999999999976432100             00011111 11112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ..+..++..+.+|+.+||+.||++||+     +.+++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            334456778899999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.1e-32  Score=224.95  Aligned_cols=174  Identities=21%  Similarity=0.259  Sum_probs=131.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+... .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus        83 ~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-  158 (332)
T cd05623          83 YVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-  158 (332)
T ss_pred             cCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc-
Confidence            579999999976432 3899999999999999999999765  999999999999999999999999998754332221 


Q ss_pred             eeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.....                ......+..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~----------------~~~~~~i~~  222 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL----------------VETYGKIMN  222 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH----------------HHHHHHHhC
Confidence            1234578999999999863     4578899999999999999999999976431                111112222


Q ss_pred             hhcCCCC---cHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          156 TKLGGQY---PQKAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~---~~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      .......   ...++.++.+|+.+||..++++  |+++.++++.
T Consensus       223 ~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         223 HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111112   2346788999999999765544  6789998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-32  Score=223.67  Aligned_cols=173  Identities=24%  Similarity=0.307  Sum_probs=133.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++.......+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus       101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--  176 (282)
T cd06636         101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--  176 (282)
T ss_pred             CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--
Confidence            46889999997765556899999999999999999999765  99999999999999999999999999875432211  


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......|+..|+|||++.     +..++.++|+|||||++|+|++|..||......                ........
T Consensus       177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----------------~~~~~~~~  240 (282)
T cd06636         177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----------------RALFLIPR  240 (282)
T ss_pred             CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----------------hhhhhHhh
Confidence            123356889999999885     345788999999999999999999999653210                01111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..........++..+.+||.+||+.||.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111122346778999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.9e-33  Score=235.21  Aligned_cols=173  Identities=25%  Similarity=0.314  Sum_probs=132.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++..+.....  
T Consensus        83 ~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          83 IPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            579999999977654  899999999999999999999765  99999999999999999999999999753210000  


Q ss_pred             ---------------------------------------ceeeecccccccccCccccccCCCCcccceehhHHHHHHHH
Q 025440           79 ---------------------------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL  119 (252)
Q Consensus        79 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ll  119 (252)
                                                             .......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                   00012347999999999999989999999999999999999


Q ss_pred             hCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh--hhcCCCCcHHHHHHHHHHHHhhccCCCCCCC---CHHHHHHH
Q 025440          120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRP---RMSEVLAI  194 (252)
Q Consensus       120 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~v~~~  194 (252)
                      +|..||.+.....                ....+..  .....+....++.++.++|.+|+ .+|.+|+   ++.++++.
T Consensus       239 ~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAE----------------TQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHH----------------HHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999997653210                0111111  11111222356778899999976 5999999   88998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2e-33  Score=252.95  Aligned_cols=174  Identities=26%  Similarity=0.363  Sum_probs=143.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |.||+|.+.+.....  +++.....+..|++.|++|||.++  ||||||||+|||++.+|.+|++|||.|......... 
T Consensus      1316 C~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             hccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            689999999966554  778888889999999999999766  999999999999999999999999999876543211 


Q ss_pred             -eeeecccccccccCccccccCC---CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                       .......||+.|||||++.+..   -..+.|||||||++.||+||+.||...+                +...+.-.+.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----------------ne~aIMy~V~ 1455 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----------------NEWAIMYHVA 1455 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----------------chhHHHhHHh
Confidence             1123467999999999997654   4568999999999999999999997643                2233333445


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+..+..|..++.+..+||.+||+.||.+|.++.++++.
T Consensus      1456 ~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            556678888999999999999999999999999888874

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.98  E-value=1.9e-32  Score=223.11  Aligned_cols=171  Identities=29%  Similarity=0.392  Sum_probs=135.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++.......   
T Consensus        79 ~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          79 MNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            579999999987665  999999999999999999999765  9999999999999999999999999987543221   


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........              ... ........
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~-~~~~~~~~  215 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEI-DRMTLTVN  215 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--------------HHH-HHHhhcCC
Confidence             123468999999998864 5688999999999999999999999976432110              001 11111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~  194 (252)
                      ...+..++.++.++|.+||..||.+|+     ++.++++.
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            344556788999999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=2.5e-32  Score=230.83  Aligned_cols=173  Identities=24%  Similarity=0.275  Sum_probs=132.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++....   +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       125 ~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-  198 (371)
T cd05622         125 MPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-  198 (371)
T ss_pred             CCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-
Confidence            57999999996543   889999999999999999999765  999999999999999999999999999765332211 


Q ss_pred             eeecccccccccCccccccCC----CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+...                ......++..
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~~~~i~~~  262 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----------------VGTYSKIMNH  262 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----------------HHHHHHHHcC
Confidence            123457999999999987543    78899999999999999999999976432                1111222221


Q ss_pred             hc--CCCCcHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHHH
Q 025440          157 KL--GGQYPQKAAHTAATLALQCLNNEPKL--RPRMSEVLAIL  195 (252)
Q Consensus       157 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~l  195 (252)
                      ..  ..+....++..+.++|.+||..++.+  |++++++++..
T Consensus       263 ~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11  11222357888999999999844433  67899888753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=5.8e-32  Score=218.74  Aligned_cols=178  Identities=25%  Similarity=0.437  Sum_probs=139.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.++|+|||++..........
T Consensus        87 ~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd05066          87 MENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  163 (267)
T ss_pred             CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence            478999999976543 4899999999999999999999765  9999999999999999999999999998654322211


Q ss_pred             e-eecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 V-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      . .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+....                 .....+....
T Consensus       164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----------------~~~~~~~~~~  226 (267)
T cd05066         164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----------------DVIKAIEEGY  226 (267)
T ss_pred             eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----------------HHHHHHhCCC
Confidence            1 111223567999999988889999999999999999886 99999764311                 0111111122


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ..+.+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            2233445677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.98  E-value=7.5e-33  Score=233.30  Aligned_cols=172  Identities=26%  Similarity=0.365  Sum_probs=131.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |+||+|.+++.+.+.  +++..+..++.|++.||+|||+.+  |+||||||+|||++.+|.++|+|||++......... 
T Consensus        83 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          83 LPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            579999999987665  899999999999999999999765  999999999999999999999999998754221100 


Q ss_pred             --------------------------------eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCC
Q 025440           80 --------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK  127 (252)
Q Consensus        80 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~  127 (252)
                                                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001234689999999999999999999999999999999999999976


Q ss_pred             cccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCc--HHHHHHHHHHHHhhccCCCCCCCC---HHHHHH
Q 025440          128 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEVLA  193 (252)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt---~~~v~~  193 (252)
                      ....                .....+........++  ..++.++.+||.+|+ .||.+|++   +.++++
T Consensus       239 ~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         239 ETPQ----------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCHH----------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            4321                1111111111111122  235778899999977 49999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=3.3e-32  Score=220.01  Aligned_cols=172  Identities=26%  Similarity=0.430  Sum_probs=136.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++|++|.+++...+.  +++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||+++........ 
T Consensus        88 ~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06628          88 VPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST  163 (267)
T ss_pred             cCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcccccccccC
Confidence            468999999977654  899999999999999999999755  999999999999999999999999998765422111 


Q ss_pred             ---eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           80 ---HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        80 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                         .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+...                ........ .
T Consensus       164 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~-~  226 (267)
T cd06628         164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------------LQAIFKIG-E  226 (267)
T ss_pred             CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----------------HHHHHHHh-c
Confidence               111234578899999999888899999999999999999999999976321                11111111 1


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......+..++..+.++|.+||+.||.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            2223445567788999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=2.5e-32  Score=224.17  Aligned_cols=171  Identities=26%  Similarity=0.361  Sum_probs=134.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.   .+++.+++.++.|++.||+|||+.+  |+|+||||+||+++.++.++|+|||++......... 
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             cCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            4789999999653   3899999999999999999999765  999999999999999999999999998764332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh-hhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  159 (252)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.......                ...... .....
T Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----------------~~~~~~~~~~~~  235 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----------------ALYLIATNGTPE  235 (296)
T ss_pred             -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----------------hHHHHhcCCCCC
Confidence             223467889999999988889999999999999999999999997643210                000110 11111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++..+.+++.+||..||++||++.++++.
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            12344567789999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=3.2e-32  Score=221.83  Aligned_cols=193  Identities=27%  Similarity=0.378  Sum_probs=143.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..........
T Consensus        90 ~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  166 (284)
T cd05038          90 LPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYY  166 (284)
T ss_pred             CCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccccccCCcce
Confidence            468999999977653 3899999999999999999999765  9999999999999999999999999998764322211


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ......++..|++||.+.+..++.++||||||+++|+|++|..||............. . ............+.....
T Consensus       167 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~  244 (284)
T cd05038         167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVTRLLELLKEGER  244 (284)
T ss_pred             eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHHHHHHHHHcCCc
Confidence             1112234567999999988889999999999999999999999986543211110000 0 000011222233333333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            344556678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2.8e-32  Score=235.02  Aligned_cols=189  Identities=23%  Similarity=0.256  Sum_probs=131.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.... ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++...........
T Consensus       243 ~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            478888886543 35999999999999999999999765  999999999999999999999999999765433222223


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCccccc-----chhhh---hhcch----hhh--hhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-----EQSLV---DWAKP----YLS--DKR  148 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~-----~~~~~---~~~~~----~~~--~~~  148 (252)
                      ....||..|+|||++.+..++.++|||||||++|||++|..++.......     ...+.   .....    +..  ...
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            34579999999999999999999999999999999999876553322110     00010   00000    000  000


Q ss_pred             hHHHHhh---hhcCCC----Cc---HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          149 KLFRIMD---TKLGGQ----YP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       149 ~~~~~~~---~~~~~~----~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .......   ......    ..   ...+..+.+||.+||+.||.+|||+.|+++.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000000   000000    00   1234578899999999999999999999874

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.3e-32  Score=228.90  Aligned_cols=182  Identities=24%  Similarity=0.283  Sum_probs=129.5

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .|++|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....     
T Consensus       102 ~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----  171 (343)
T cd07878         102 MGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----  171 (343)
T ss_pred             CCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceecCCC-----
Confidence            367888877543   3899999999999999999999765  999999999999999999999999999864332     


Q ss_pred             eecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc-chhhhh-----hhhHHHH
Q 025440           82 STQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSD-----KRKLFRI  153 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~-~~~~~~-----~~~~~~~  153 (252)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .+.... .+....     .......
T Consensus       172 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (343)
T cd07878         172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY  251 (343)
T ss_pred             cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHH
Confidence            223468999999999876 46889999999999999999999999764321100 000000 000000     0000000


Q ss_pred             hhhhcCCC-------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          154 MDTKLGGQ-------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       154 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .. .....       .....+..+.+||.+||..||.+|||+.++++.
T Consensus       252 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         252 IQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 00000       001234567899999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.98  E-value=5.7e-32  Score=217.18  Aligned_cols=175  Identities=30%  Similarity=0.468  Sum_probs=138.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.......+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            46899999997765444899999999999999999999765  9999999999999999999999999997654432221


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .. ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....                 ............
T Consensus       161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  222 (258)
T smart00219      161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----------------EEVLEYLKKGYR  222 (258)
T ss_pred             cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcCCC
Confidence            11 2236788999999988889999999999999999998 7888865321                 111222222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+..++.++.+++.+||..||++|||+.++++.|
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            344455788899999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.98  E-value=5.7e-32  Score=218.64  Aligned_cols=172  Identities=29%  Similarity=0.427  Sum_probs=133.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc-c
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-T   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~   79 (252)
                      ++|++|.+++...+.  +++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........ .
T Consensus        88 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  163 (266)
T cd06651          88 MPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG  163 (266)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccccccccC
Confidence            468999999977654  899999999999999999999665  99999999999999999999999999875432111 1


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++|+|||||++|+|++|..||.....                .............
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----------------~~~~~~~~~~~~~  227 (266)
T cd06651         164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----------------MAAIFKIATQPTN  227 (266)
T ss_pred             CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----------------HHHHHHHhcCCCC
Confidence            112234578899999999888899999999999999999999999975321                1111111111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..+...+.+++ +||..+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            334555677788888 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.98  E-value=1.4e-31  Score=223.03  Aligned_cols=174  Identities=21%  Similarity=0.288  Sum_probs=131.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.. ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus        83 ~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-  158 (331)
T cd05624          83 YVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-  158 (331)
T ss_pred             CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-
Confidence            57999999997643 23899999999999999999999765  999999999999999999999999998765332221 


Q ss_pred             eeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.....                ......+..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----------------~~~~~~i~~  222 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----------------VETYGKIMN  222 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----------------HHHHHHHHc
Confidence            1233568999999999875     4678899999999999999999999976431                111112221


Q ss_pred             hhcCCCCc---HHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          156 TKLGGQYP---QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      .......+   ..++.++.+++.+||..++.+  |++++++++.
T Consensus       223 ~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         223 HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11111222   245788999999999876544  4578888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.98  E-value=7.1e-32  Score=216.74  Aligned_cols=173  Identities=25%  Similarity=0.347  Sum_probs=138.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence            57899999998764455899999999999999999999765  99999999999999999999999999876533321  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....                ......+.. ....
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----------------~~~~~~~~~-~~~~  219 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----------------LNLVVKIVQ-GNYT  219 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHc-CCCC
Confidence            22345688999999999888889999999999999999999999976421                011111111 1112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++.++.+++.+||..+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            2334567889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.98  E-value=6.5e-32  Score=218.68  Aligned_cols=178  Identities=24%  Similarity=0.299  Sum_probs=130.3

Q ss_pred             CCCCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++....   ...+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            57899999997542   234677888899999999999999765  9999999999999999999999999987543332


Q ss_pred             cceeeecccccccccCccccccC-------CCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      .........++..|+|||++.+.       .++.++||||||+++|+|++ |..||.........               
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---------------  219 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---------------  219 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---------------
Confidence            22222234567889999988542       35789999999999999996 99999764321000               


Q ss_pred             HHHHhhhhc---CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          150 LFRIMDTKL---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       150 ~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      .........   ........+..+.+++.+|| .+|++|||+++|+..|+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         220 TYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            000000001   11112235667889999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=7.1e-32  Score=217.18  Aligned_cols=167  Identities=26%  Similarity=0.363  Sum_probs=129.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc--------eEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~~~   72 (252)
                      +++|+|.+++...+. .+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            578999999976653 4899999999999999999999765  999999999999987765        69999998865


Q ss_pred             CCCCCcceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCC-CCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                      ...      .....++..|+|||++.+. .++.++||||||+++|+|++|. .||......                 ..
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----------------~~  214 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----------------KK  214 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----------------HH
Confidence            432      1224578889999999764 5789999999999999999984 555443210                 00


Q ss_pred             HHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .....  .....+.....++.+|+.+||+.||++|||++++++.|
T Consensus       215 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         215 LQFYE--DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHH--ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            11111  12233444567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.98  E-value=4.2e-32  Score=219.75  Aligned_cols=176  Identities=27%  Similarity=0.323  Sum_probs=129.8

Q ss_pred             CCCCChhhhhhcCCC---CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      +++|+|.+++.....   ...++...+.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccch
Confidence            478999999976542   23567888999999999999999765  9999999999999999999999999986533222


Q ss_pred             cceeeecccccccccCcccccc-------CCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      .........++..|+|||++..       ..++.++|||||||++|+|++ |..||......                ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------------~~  218 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----------------QV  218 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----------------HH
Confidence            1111222345678999998743       356789999999999999999 78888654210                01


Q ss_pred             HHHHhhhh----cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          150 LFRIMDTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       150 ~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ........    .....+..++..+.+++..|| .||++|||+++|++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         219 LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             HHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            11111110    011223456778888999999 5999999999999877

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.1e-31  Score=225.93  Aligned_cols=186  Identities=23%  Similarity=0.335  Sum_probs=128.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+++......   ..
T Consensus       140 ~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~  213 (357)
T PHA03209        140 SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AF  213 (357)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc---cc
Confidence            478888886543 35999999999999999999999765  9999999999999999999999999987532211   12


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCC-CCCcccccchh-------hhhhcc-------hhh--h
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQS-------LVDWAK-------PYL--S  145 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~p-f~~~~~~~~~~-------~~~~~~-------~~~--~  145 (252)
                      ....||..|+|||++.+..++.++|||||||++|||+++..+ |..........       +.....       .+.  .
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence            335689999999999998999999999999999999985444 44322211100       000000       000  0


Q ss_pred             hhhhHHHHhhhh--cCCCC-------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          146 DKRKLFRIMDTK--LGGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       146 ~~~~~~~~~~~~--~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ........+...  ...+.       ...++..+.+||.+||+.||.+|||+.++++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000000011000  00000       01345567789999999999999999999863

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=8.4e-32  Score=226.83  Aligned_cols=182  Identities=23%  Similarity=0.266  Sum_probs=128.1

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++..    .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......   ...
T Consensus       110 ~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~  180 (359)
T cd07876         110 ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMT  180 (359)
T ss_pred             cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCC
Confidence            455555532    3788999999999999999999765  9999999999999999999999999997543221   123


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcchhhhhhh----hHHHHhhhh
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKR----KLFRIMDTK  157 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~  157 (252)
                      ...||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+......  ......+......    .........
T Consensus       181 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (359)
T cd07876         181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENR  260 (359)
T ss_pred             CCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhC
Confidence            3468999999999999999999999999999999999999998754211000  0000000000000    000000000


Q ss_pred             cC------------------CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LG------------------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..                  .......+..+.+||.+||..||++|||+.++++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00                  00111235678999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=1.2e-31  Score=218.61  Aligned_cols=173  Identities=24%  Similarity=0.352  Sum_probs=132.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|..++.+.. .++++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          84 CAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             cCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            46889998886533 35999999999999999999999765  99999999999999999999999999875432211  


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......++..|+|||++.     +..++.++|+|||||++|+|++|..||.....                .........
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----------------~~~~~~~~~  222 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----------------MRVLLKIAK  222 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----------------HHHHHHHhh
Confidence            123346889999999874     34578899999999999999999999975321                111111111


Q ss_pred             h-hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 T-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      . ......+..++..+.++|.+||+.||.+||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1 11112344567889999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.8e-32  Score=205.41  Aligned_cols=170  Identities=26%  Similarity=0.350  Sum_probs=144.4

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      ++|+|...|.......+++.....+..|+|.||.|+|..  +||||||||+|+|++.+|.+||+|||-+.......    
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k--~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----  178 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----  178 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC--CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC----
Confidence            579999999877666799999999999999999999955  59999999999999999999999999987644322    


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ....+||..|.+||+..+..++...|+|++|++.||++.|..||....                ......++...  ...
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~----------------~~etYkrI~k~--~~~  240 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS----------------HSETYKRIRKV--DLK  240 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh----------------hHHHHHHHHHc--ccc
Confidence            456789999999999999999999999999999999999999997643                12223333322  335


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      +|..++.++.++|.+||.++|.+|.+..++++.-
T Consensus       241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            6688899999999999999999999999998753

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=1.5e-31  Score=221.51  Aligned_cols=125  Identities=23%  Similarity=0.306  Sum_probs=100.4

Q ss_pred             CCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee----cCCCceEEccccccc
Q 025440            3 KGSLENHLFRR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAK   71 (252)
Q Consensus         3 ggsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~   71 (252)
                      +++|.+++...       ....+++..+..++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            56777776432       1235899999999999999999999765  9999999999999    456789999999998


Q ss_pred             cCCCCCc-ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcc
Q 025440           72 AGPTGDR-THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTK  129 (252)
Q Consensus        72 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~  129 (252)
                      ....... ........+|..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            6543221 1112345789999999998774 58899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=232.85  Aligned_cols=177  Identities=28%  Similarity=0.374  Sum_probs=151.5

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      +-|.|.+||..+.. .|+......++.||+.||+|||+.+  +|||||...||||....-|||+|||+++.......+..
T Consensus       473 ~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka  549 (974)
T KOG4257|consen  473 PLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA  549 (974)
T ss_pred             cchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhccccchhhc
Confidence            57899999987764 4899999999999999999999876  99999999999999999999999999998876665543


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      . ...-...|||||.+....++.++|+|.||+++||++. |..||.+-..                 ..+.-.++.+.+.
T Consensus       550 S-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDVI~~iEnGeRl  611 (974)
T KOG4257|consen  550 S-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDVIGHIENGERL  611 (974)
T ss_pred             c-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cceEEEecCCCCC
Confidence            3 3334678999999999999999999999999999987 9999987532                 1222334566778


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ++|++|++.++.|+.+||.++|.+||++.++...|..+.
T Consensus       612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            999999999999999999999999999999998887653

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1e-31  Score=215.79  Aligned_cols=174  Identities=26%  Similarity=0.418  Sum_probs=135.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          81 MEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            468999999976542 4899999999999999999999765  999999999999999999999999998754322111 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....                 ......+.....
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  219 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----------------SEVVETINAGFR  219 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----------------HHHHHHHhCCCC
Confidence            1112234578999999988889999999999999999998 9999975431                 111111111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            222334567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=8e-32  Score=221.22  Aligned_cols=170  Identities=26%  Similarity=0.376  Sum_probs=134.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.   .+++.+++.++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655          98 LAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             cCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            4789999998654   3899999999999999999999765  999999999999999999999999998764332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh-hcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  159 (252)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....                .....+... ...
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----------------~~~~~~~~~~~~~  234 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------------RALYLIATNGTPE  234 (296)
T ss_pred             -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCcc
Confidence             22346788999999998888999999999999999999999999764321                011111111 111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.++|.+||..||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1234456778999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=7.6e-32  Score=226.77  Aligned_cols=182  Identities=21%  Similarity=0.252  Sum_probs=128.9

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++..    .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ...
T Consensus       106 ~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~  176 (355)
T cd07874         106 ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMT  176 (355)
T ss_pred             ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccC
Confidence            455555532    3788999999999999999999765  9999999999999999999999999997643321   123


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcchhh---hhh-hhHHHHhhhh
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYL---SDK-RKLFRIMDTK  157 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~~~---~~~-~~~~~~~~~~  157 (252)
                      ...||..|+|||++.+..++.++|||||||++|+|++|+.||.+........  ......+..   ... ..........
T Consensus       177 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (355)
T cd07874         177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR  256 (355)
T ss_pred             CccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcC
Confidence            4568999999999998899999999999999999999999998754321100  000000000   000 0000000000


Q ss_pred             c------------------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 L------------------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .                  ........+..+.+||.+||..||++|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0                  001112235678999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.3e-31  Score=215.35  Aligned_cols=167  Identities=27%  Similarity=0.362  Sum_probs=130.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-------ceEEccccccccC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~~~~~   73 (252)
                      ++||+|.+++..... .+++..++.++.||+.||+|||+++  |+|+||||+|||++.++       .++|+|||++...
T Consensus        82 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          82 VKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             CCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            578999999977653 4899999999999999999999655  99999999999999887       7999999998764


Q ss_pred             CCCCcceeeecccccccccCccccccC--CCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           74 PTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        74 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                      ..      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.......                 .
T Consensus       159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-----------------~  215 (259)
T cd05037         159 LS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-----------------K  215 (259)
T ss_pred             cc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-----------------H
Confidence            33      1223466789999999876  78999999999999999999 577776542110                 0


Q ss_pred             HHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .......  ...+......+.+++.+||..+|.+||++.++++.|
T Consensus       216 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         216 ERFYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             HHHHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0000001  111111227889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=1.2e-31  Score=217.62  Aligned_cols=177  Identities=27%  Similarity=0.361  Sum_probs=137.2

Q ss_pred             CCCCChhhhhhcCCC-------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440            1 MPKGSLENHLFRRGP-------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      +++|+|.+++.....       ..+++..++.++.|++.||+|||+.+  |+|+||||+||+++.++.++|+|||++...
T Consensus        90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046          90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEccccccccc
Confidence            468999999976652       25899999999999999999999765  999999999999999999999999998654


Q ss_pred             CCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           74 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        74 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....                ......
T Consensus       168 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----------------~~~~~~  230 (275)
T cd05046         168 YNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----------------EEVLNR  230 (275)
T ss_pred             Cccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----------------HHHHHH
Confidence            322111 1223345778999999988888999999999999999999 8888865321                111111


Q ss_pred             HhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ..........+..++..+.+++.+||+.+|.+||++.+++..|.
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11112222234456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=224.35  Aligned_cols=170  Identities=25%  Similarity=0.307  Sum_probs=143.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC----CCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~~   76 (252)
                      +.||.|.+.|... .  +++..+..++.||+.+++|||+.+  |+||||||+|+|+..    ++.+|++|||++..... 
T Consensus       118 ~~GGeLfd~i~~~-~--~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  118 CEGGELFDRIVKK-H--YSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             cCCchHHHHHHHc-c--CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            5799999999887 2  999999999999999999999865  999999999999943    35799999999988655 


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                        .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+....                .....+...
T Consensus       192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----------------~~~~~i~~~  253 (382)
T KOG0032|consen  192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----------------EIFLAILRG  253 (382)
T ss_pred             --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----------------HHHHHHHcC
Confidence              22356678999999999998899999999999999999999999999886531                112233322


Q ss_pred             h--cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 K--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .  ........++..+.++|.+||..||.+|+|+.++++.
T Consensus       254 ~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            2  3345567789999999999999999999999999984

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=2.7e-32  Score=217.77  Aligned_cols=190  Identities=25%  Similarity=0.328  Sum_probs=136.9

Q ss_pred             ChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCccee
Q 025440            5 SLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         5 sL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      ||.+++...  .++.++.-.+.-+..||.+||+|||+.+  |+||||||.|+|+|.+ |.+||||||.|+....+..   
T Consensus       107 tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---  181 (364)
T KOG0658|consen  107 TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---  181 (364)
T ss_pred             HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---
Confidence            566777532  2345888888889999999999999765  9999999999999886 8999999999998655443   


Q ss_pred             eecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh---
Q 025440           82 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK---  157 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  157 (252)
                      .....+|..|+|||.+.|. .|+.+.||||.||++.||+-|+..|.|.+..  .++.....-+..........+...   
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            2345679999999998876 6999999999999999999999999985432  111111111000000000111110   


Q ss_pred             -----c-----CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhcCC
Q 025440          158 -----L-----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEAP  201 (252)
Q Consensus       158 -----~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~--~l~~~~~~  201 (252)
                           .     ..-+....++++.+|+.++|.++|.+|.++.+++.  .++.+..+
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                 0     01133457889999999999999999999999985  34444433

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=2.5e-31  Score=215.23  Aligned_cols=177  Identities=20%  Similarity=0.269  Sum_probs=129.6

Q ss_pred             CCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++.+...  ..+++..++.++.||+.||+|||+.+  ++||||||+|||++.++.++|+|||++........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            578999999976532  34677788899999999999999765  99999999999999999999999999864322221


Q ss_pred             ceeeecccccccccCcccccc-------CCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           79 THVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                      ........++..|+|||++..       ..++.++||||||+++|||++ |..||......                ...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------------~~~  218 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----------------EVL  218 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----------------HHH
Confidence            112234467889999998743       235779999999999999997 56787653210                111


Q ss_pred             HHHhhhh----cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          151 FRIMDTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       151 ~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      ...+...    .........+..+.+++..|| .+|++||+++++++.|.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         219 NHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111111    112223346678889999999 68999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.1e-31  Score=226.55  Aligned_cols=182  Identities=22%  Similarity=0.256  Sum_probs=128.7

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++..    .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ...
T Consensus       113 ~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~  183 (364)
T cd07875         113 ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMT  183 (364)
T ss_pred             CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---ccc
Confidence            466666632    3788999999999999999999765  9999999999999999999999999997643321   123


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-h-hhhcchhhh---hhhh-HHHHhhhh
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-L-VDWAKPYLS---DKRK-LFRIMDTK  157 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~-~~~~~~~~~---~~~~-~~~~~~~~  157 (252)
                      ...+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+...... . .....+...   .... ........
T Consensus       184 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (364)
T cd07875         184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR  263 (364)
T ss_pred             CCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhC
Confidence            3568999999999999999999999999999999999999998754321100 0 000000000   0000 00000000


Q ss_pred             c------------------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 L------------------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .                  ...........+.+||.+||+.||.+|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0                  000011134578899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=1.1e-31  Score=227.13  Aligned_cols=187  Identities=25%  Similarity=0.333  Sum_probs=132.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.....  +++..+..++.||+.||+|||+.+  ++||||||+|||++.++.+||+|||+++........ ..
T Consensus        87 ~~~l~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~  161 (372)
T cd07853          87 QSDLHKIIVSPQP--LSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HM  161 (372)
T ss_pred             ccCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cC
Confidence            4577777765543  999999999999999999999765  999999999999999999999999999764332211 12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cchhhhhh----hhHHHHhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLSDK----RKLFRIMD  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~~~~~~~----~~~~~~~~  155 (252)
                      ....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+........ +... ..+.....    ......+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  241 (372)
T cd07853         162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL  241 (372)
T ss_pred             CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHH
Confidence            334678899999998775 47899999999999999999999998754321110 0000 00000000    00001110


Q ss_pred             h-hcCC-------CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 T-KLGG-------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~-~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      . ....       ......+.++.+||.+||+.||.+|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         242 RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0 0000       1112346788999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.6e-31  Score=215.89  Aligned_cols=172  Identities=28%  Similarity=0.405  Sum_probs=135.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.....  +++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++........ 
T Consensus        88 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  163 (265)
T cd06652          88 MPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSG  163 (265)
T ss_pred             cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccccccccccc
Confidence            468999999977654  889999999999999999999765  999999999999999999999999998754321111 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++|+|||||++|+|++|..||.....                .............
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~  227 (265)
T cd06652         164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----------------MAAIFKIATQPTN  227 (265)
T ss_pred             cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----------------HHHHHHHhcCCCC
Confidence            112234578899999999888899999999999999999999999975321                1111122222223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+...+..+.+++.+||. +|++||++++++.
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            34456677889999999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.3e-31  Score=218.06  Aligned_cols=170  Identities=30%  Similarity=0.424  Sum_probs=134.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++.......   
T Consensus        79 ~~g~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          79 MNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            579999999976554  999999999999999999999765  9999999999999999999999999987543221   


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....|+..|+|||++.++ .++.++||||||+++|+|++|..||.+......              ...... .....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~-~~~~~  215 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRM-TLTMA  215 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--------------HHHHHH-hhccC
Confidence             2234689999999998754 689999999999999999999999976432100              001111 11122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ...+..++..+.+++.+||..+|.+||     ++.++++
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            334555678999999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-31  Score=222.38  Aligned_cols=175  Identities=26%  Similarity=0.337  Sum_probs=135.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.|++|.+++.......+++..+..++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            46899999998665556999999999999999999999765  9999999999999999999999999986542211100


Q ss_pred             ---------------------------eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccc
Q 025440           81 ---------------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE  133 (252)
Q Consensus        81 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~  133 (252)
                                                 ......|+..|+|||++.+..++.++||||||+++|+|++|..||.+...   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---  237 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR---  237 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch---
Confidence                                       01134678899999999988899999999999999999999999976432   


Q ss_pred             hhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCC----HHHHHH
Q 025440          134 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLA  193 (252)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~v~~  193 (252)
                                   ......+.............+..+.++|.+||+.||++||+    +++++.
T Consensus       238 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 -------------DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -------------HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence                         11122222222222222236789999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2e-31  Score=215.09  Aligned_cols=167  Identities=25%  Similarity=0.375  Sum_probs=127.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc-------eEEccccccccC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-------AKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~-------~kl~Dfg~~~~~   73 (252)
                      +++|+|..++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.       ++++|||++...
T Consensus        86 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~  162 (262)
T cd05077          86 VEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV  162 (262)
T ss_pred             ccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence            46889999886543 24899999999999999999999765  999999999999987664       899999998654


Q ss_pred             CCCCcceeeecccccccccCccccc-cCCCCcccceehhHHHHHHHH-hCCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           74 PTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        74 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ...      ....++..|+|||++. +..++.++|||||||++|+|+ +|..||.......                 ..
T Consensus       163 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----------------~~  219 (262)
T cd05077         163 LSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----------------KE  219 (262)
T ss_pred             cCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----------------HH
Confidence            221      2235788899999886 456889999999999999998 5888886542110                 00


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .......  ........++.+||.+||+.||.+||++.+|++.+
T Consensus       220 ~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            1111111  11122356789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.2e-31  Score=215.15  Aligned_cols=172  Identities=27%  Similarity=0.375  Sum_probs=135.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.... ..+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            46899999996544 34899999999999999999999765  99999999999999999999999999876543321  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh-hhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||.......                ....... ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~~~  218 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----------------AIFMIPNKPPPT  218 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----------------hhhhhccCCCCC
Confidence            1233457889999999988899999999999999999999999997643210                0000000 0011


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.++|.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1223456678999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.2e-31  Score=216.69  Aligned_cols=171  Identities=26%  Similarity=0.342  Sum_probs=131.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++.+++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++.......  .
T Consensus        88 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06645          88 CGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A  161 (267)
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence            468999999977664  899999999999999999999765  9999999999999999999999999986543221  1


Q ss_pred             eeecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||.......                .........
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----------------~~~~~~~~~  225 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----------------ALFLMTKSN  225 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----------------hHHhhhccC
Confidence            123456899999999874   4468889999999999999999999986532110                000000001


Q ss_pred             cCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...   .....++..+.++|.+||+.+|++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         226 FQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            100   011134567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=3.8e-32  Score=219.71  Aligned_cols=173  Identities=27%  Similarity=0.329  Sum_probs=131.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++...+.  +++..+..++.|++.||+|||+.+  |+|+||||+||+++.++.++|+|||++........  
T Consensus        88 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          88 CGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            478999999976654  899999999999999999999765  99999999999999999999999999876432211  


Q ss_pred             eeecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......++..|+|||.+.   ...++.++|+|||||++|+|++|..||.........                .......
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----------------~~~~~~~  225 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----------------FLMSKSN  225 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----------------eeeecCC
Confidence            122345788999999874   345788999999999999999999998653211000                0000000


Q ss_pred             cC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          158 LG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       158 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ..   ......++..+.++|.+||..||++||+++++++.|
T Consensus       226 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 FQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00   011123567899999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=1.2e-31  Score=216.47  Aligned_cols=173  Identities=27%  Similarity=0.399  Sum_probs=135.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC---
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---   77 (252)
                      ++||+|.+++.+.+.  +++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        84 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          84 VPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            478999999977654  899999999999999999999765  9999999999999999999999999987542211   


Q ss_pred             -cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           78 -RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        78 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                       .........++..|+|||++.+..++.++|+||||+++|+|++|..||......                .........
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~~  223 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------------AAMFYIGAH  223 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----------------HHHHHhhhc
Confidence             111122346888999999998888999999999999999999999999753211                001111111


Q ss_pred             -hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 -KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ......+..++.++.++|.+||..+|++||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1122344567788999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-31  Score=217.50  Aligned_cols=169  Identities=26%  Similarity=0.356  Sum_probs=134.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...   .+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||+++.......  
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence            4689999999765   4899999999999999999999765  99999999999999999999999999976543321  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|+||..||......                 .....+......
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----------------~~~~~~~~~~~~  216 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----------------RVLFLIPKNNPP  216 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----------------HHHHHhhhcCCC
Confidence            123446788999999998888999999999999999999999999753210                 011111111122


Q ss_pred             CCcHH-HHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+.. ++..+.+++.+||..||++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            22222 6778999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=2e-31  Score=213.93  Aligned_cols=171  Identities=27%  Similarity=0.406  Sum_probs=136.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|.+++.......+++..++.++.+++.||+|||+.+  ++|+||||+||+++.+ +.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence            46899999998766566899999999999999999999765  9999999999999765 4589999999986543321 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......                 ...........
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----------------~~~~~~~~~~~  218 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----------------ALVLKIMSGTF  218 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----------------HHHHHHHhcCC
Confidence              22346788999999998888899999999999999999999999764321                 01111111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.+++.+||..||++|||+.+++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            2344557788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.9e-31  Score=214.86  Aligned_cols=175  Identities=25%  Similarity=0.306  Sum_probs=139.4

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcC---CCCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDA---ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      +++++|.+++...  ....+++..++.++.+|+.||+|||..   ..+++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            4689999999654  124599999999999999999999932   23499999999999999999999999999987544


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ....  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....                 ......+.
T Consensus       163 ~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~~  223 (265)
T cd08217         163 DSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----------------LQLASKIK  223 (265)
T ss_pred             Cccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----------------HHHHHHHh
Confidence            3321  2234688999999999888899999999999999999999999976431                 11122222


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .......+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            222334555678899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=229.08  Aligned_cols=176  Identities=23%  Similarity=0.356  Sum_probs=150.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|||.+.|++.....|-......++.||+.|+.||.+++  +|||||...|+|+.....|||+|||+.+.+.......
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            47899999999855556888888999999999999999866  9999999999999999999999999999876554333


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       ......-...|+|||.++..+++.++|+|+|||++|||+| |..||.+..                 ...+.+.++.+.
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qIL~~iD~~e  332 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQILKNIDAGE  332 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHHHHhccccc
Confidence             2223334567999999999999999999999999999998 899998753                 344556666777


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      +...|..|+.++++++.+||..+|.+|||+..|.+.+
T Consensus       333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            7888999999999999999999999999999998544

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1.4e-31  Score=219.33  Aligned_cols=170  Identities=24%  Similarity=0.348  Sum_probs=132.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...   .+++..++.++.||+.||+|||+.+  ++||||||+||+++.++.++|+|||++........  
T Consensus       101 ~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         101 LEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence            4789999988543   3899999999999999999999765  99999999999999999999999999875432221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......                ... ..+......
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~~~-~~~~~~~~~  236 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----------------QAM-RRIRDNLPP  236 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHH-HHHHhcCCC
Confidence            122346789999999998888999999999999999999999999754210                000 011111111


Q ss_pred             --CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 --QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                        ......+..+.+++.+||..||.+|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              1122456788999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3e-31  Score=213.65  Aligned_cols=172  Identities=28%  Similarity=0.363  Sum_probs=133.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.... ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--  156 (262)
T cd06613          82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--  156 (262)
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence            36789999987652 23899999999999999999999765  99999999999999999999999999876433211  


Q ss_pred             eeecccccccccCccccccC---CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||.+....                ..........
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----------------~~~~~~~~~~  220 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----------------RALFLISKSN  220 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcc
Confidence            12334678899999999776   7889999999999999999999999764321                0111111110


Q ss_pred             ---cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 ---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         .........+.++.+++.+||..+|.+|||+.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               011223456778999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=3.7e-32  Score=218.58  Aligned_cols=174  Identities=30%  Similarity=0.483  Sum_probs=133.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.+++.....  +++..++.++.||+.||++||+.+  ++|+||||+||+++.++.++|+|||++......  ..
T Consensus        80 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NE  153 (260)
T ss_dssp             ETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTST--TS
T ss_pred             ccccccccccccccc--cccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc--cc
Confidence            357799999984444  899999999999999999999865  999999999999999999999999998753111  12


Q ss_pred             eeecccccccccCccccc-cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc-
Q 025440           81 VSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  158 (252)
                      ......++..|+|||++. +..++.++|+||||+++|+|++|..||........             ............ 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-------------~~~~~~~~~~~~~  220 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-------------LEIIEKILKRPLP  220 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-------------HHHHHHHHHTHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhh-------------hhhhhhccccccc
Confidence            234556899999999998 77899999999999999999999999987521100             001111111000 


Q ss_pred             -CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 -GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ...........+.++|.+||+.||++||++.++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00111112378999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=229.12  Aligned_cols=165  Identities=26%  Similarity=0.317  Sum_probs=130.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee-cCCCceEEccccccccCCCCCcce
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      .||-|.+.+....   ....++..|+.+|+.|+.|||+++  +|||||||+|||+ +..|.++|+|||.++.....    
T Consensus       399 ~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  399 DGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             cccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            3555555554433   233777889999999999999765  9999999999999 68999999999999875443    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ....+-|..|.|||++....|+.++||||||++||+||+|+.||.....+                   .++.......
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~~i~~~  529 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHTRIQMP  529 (612)
T ss_pred             -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHHhhcCC
Confidence             11224478899999999889999999999999999999999999875421                   2222233333


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .+...++.++++|+..||+.||.+|+++.++...-
T Consensus       530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             ccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence            44477899999999999999999999999998643

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=2.1e-31  Score=219.97  Aligned_cols=188  Identities=25%  Similarity=0.415  Sum_probs=136.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+.  +++..+..++.|++.||+|||+. .+++|+||||+|||++.++.++|+|||++.......   
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  154 (308)
T cd06615          81 MDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  154 (308)
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence            468999999977654  89999999999999999999973 249999999999999999999999999986542221   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhh---------------
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS---------------  145 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---------------  145 (252)
                       .....++..|+|||++.+..++.++|+||||+++|+|++|..||....................               
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence             2335688999999999888899999999999999999999999975432111111100000000               


Q ss_pred             -hhhhHHHHhh---hhcCCCCc-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          146 -DKRKLFRIMD---TKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       146 -~~~~~~~~~~---~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                       ..........   .......+ ..++.++.+|+.+||..||++||++.+++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence             0000011111   11111111 13567899999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=2.1e-31  Score=214.02  Aligned_cols=172  Identities=22%  Similarity=0.332  Sum_probs=137.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL-  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence            46899999997765555899999999999999999999765  999999999999999999999999998765332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.....                ......+. .....
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----------------~~~~~~~~-~~~~~  219 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----------------KNLVLKII-RGSYP  219 (256)
T ss_pred             -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----------------HHHHHHHh-cCCCC
Confidence             2234578899999999888899999999999999999999999865321                01111111 11222


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            345567788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.9e-31  Score=222.00  Aligned_cols=191  Identities=20%  Similarity=0.248  Sum_probs=131.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc-c
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-T   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~   79 (252)
                      |++|+|.+++..+....+++..++.++.||+.||+|||+++  |+||||||+|||++.++.++++||+.+........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            57899999997665556999999999999999999999765  99999999999999999999999986543221110 0


Q ss_pred             ----eeeecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhhhhhh-H-
Q 025440           80 ----HVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRK-L-  150 (252)
Q Consensus        80 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~-~-  150 (252)
                          .......++..|+|||++.+  ..++.++|||||||++|+|++|..||.......... ......+...+... . 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                01122346778999999876  358899999999999999999999997543211000 00000000000000 0 


Q ss_pred             HHH-------------------------hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          151 FRI-------------------------MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       151 ~~~-------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...                         ............++..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000                         0000001112245678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=3.6e-31  Score=215.23  Aligned_cols=170  Identities=25%  Similarity=0.374  Sum_probs=136.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...   ++++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            4789999999643   3899999999999999999999755  99999999999999999999999999876533221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|..||......                 ............
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----------------~~~~~~~~~~~~  219 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----------------RVLFLIPKNNPP  219 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----------------hHhhhhhcCCCC
Confidence            122345788999999998888999999999999999999999999764311                 011111112223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++..+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            3455678889999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=221.52  Aligned_cols=174  Identities=21%  Similarity=0.243  Sum_probs=129.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.. ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++......... 
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  158 (331)
T cd05597          83 YVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-  158 (331)
T ss_pred             CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-
Confidence            57999999997643 23899999999999999999999765  999999999999999999999999998764332221 


Q ss_pred             eeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+....                .....+..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----------------~~~~~i~~  222 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------ETYGKIMN  222 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----------------HHHHHHHc
Confidence            1223468999999999863     35788999999999999999999999764310                11111111


Q ss_pred             hhcCC---CCcHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          156 TKLGG---QYPQKAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~---~~~~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      .....   .....++..+.++|.+||..++++  |+++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         223 HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11111   111236778999999988654443  7899998874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=2.7e-31  Score=215.92  Aligned_cols=170  Identities=26%  Similarity=0.375  Sum_probs=134.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...   .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          84 LGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             cCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            4789999998543   3899999999999999999999654  99999999999999999999999999876433221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||++.+..++.++|+|||||++|+|++|..||.......                 ...........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------------~~~~~~~~~~~  219 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----------------VLFLIPKNSPP  219 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----------------HHhhhhcCCCC
Confidence            1223457889999999988889999999999999999999999986532110                 00111111122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....++..+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            2334567789999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-31  Score=215.82  Aligned_cols=173  Identities=27%  Similarity=0.372  Sum_probs=132.3

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~  168 (275)
T cd06608          91 CGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG  168 (275)
T ss_pred             CCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCccceecccchh
Confidence            46889999986543  345899999999999999999999765  99999999999999999999999999875433221


Q ss_pred             ceeeecccccccccCccccccC-----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           79 THVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                        ......++..|+|||++...     .++.++||||||+++|+|++|..||......                .....+
T Consensus       169 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~  230 (275)
T cd06608         169 --RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM----------------RALFKI  230 (275)
T ss_pred             --hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH----------------HHHHHh
Confidence              12334688899999987542     4678999999999999999999999653210                111111


Q ss_pred             hhhhc-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..... ....+..++..+.+||.+||..||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111 11223346678999999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=4.2e-31  Score=239.72  Aligned_cols=173  Identities=23%  Similarity=0.314  Sum_probs=131.4

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCC-----CCeeeccCCCCceeecC---------------
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLDA---------------   58 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~ivH~dlkp~Nill~~---------------   58 (252)
                      +++|+|.++|....  ...+++..++.|+.||+.||+|||+.+     .+||||||||+||||+.               
T Consensus        96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~  175 (1021)
T PTZ00266         96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL  175 (1021)
T ss_pred             CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence            57899999997532  235999999999999999999999743     45999999999999954               


Q ss_pred             --CCceEEccccccccCCCCCcceeeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccch
Q 025440           59 --EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ  134 (252)
Q Consensus        59 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~  134 (252)
                        .+.+||+|||++.......   ......||+.|+|||++.+.  .++.++||||||||+|+|+||..||.....    
T Consensus       176 ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~----  248 (1021)
T PTZ00266        176 NGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN----  248 (1021)
T ss_pred             CCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc----
Confidence              2348999999997643322   12345789999999998653  588999999999999999999999975321    


Q ss_pred             hhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          135 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                                  ...+...+..... ......+..+.+||..||..+|.+||++.+++.
T Consensus       249 ------------~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        249 ------------FSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             ------------HHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                        1111111111111 111235678999999999999999999999984

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=6.4e-32  Score=226.55  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=151.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |++|+|.+||.++....+.-+..+.|+.||++|++||.+.+  +|||||.+.|||++.++++||+|||+++-+.....+.
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            67899999998886543566777889999999999999877  9999999999999999999999999999888888887


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh--CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .....+-...|||+|.+.-++++.++|+|+||+++||+++  ...||...+..   ...       .+...+........
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vv-------en~~~~~~~~~~~~  764 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVV-------ENAGEFFRDQGRQV  764 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHH-------HhhhhhcCCCCcce
Confidence            7777788899999999999999999999999999999975  78888765421   111       11111111111112


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      -...|.-|+..++++|.+||..|-.+||+++++...|++.
T Consensus       765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            2345677899999999999999999999999999988764

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=4.1e-31  Score=214.22  Aligned_cols=174  Identities=25%  Similarity=0.407  Sum_probs=134.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+.  +++..+..++.||+.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..........
T Consensus        90 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  165 (272)
T cd06629          90 VPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND  165 (272)
T ss_pred             CCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeecccccccccccccc
Confidence            478999999987754  899999999999999999999765  9999999999999999999999999987643322211


Q ss_pred             eeecccccccccCccccccCC--CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ......++..|+|||.+....  ++.++|+||||+++|++++|..||......                ...........
T Consensus       166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~  229 (272)
T cd06629         166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------------AAMFKLGNKRS  229 (272)
T ss_pred             ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----------------HHHHHhhcccc
Confidence            223345788999999987654  789999999999999999999999653210                01111111111


Q ss_pred             CC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 GG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..    .....++..+.+++.+||..+|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11    1223457889999999999999999999998863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=2.8e-31  Score=214.91  Aligned_cols=169  Identities=24%  Similarity=0.301  Sum_probs=134.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++||+|.+++....  .+++..++.++.||++||.|||+.+  ++||||||+||+++.++ .++|+|||++......   
T Consensus        91 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         91 IKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            57999999997765  4999999999999999999999765  99999999999999988 9999999998764322   


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                         ....++..|+|||++.+..++.++|+||||+++|+|++|..||....... .           ....+....  ...
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~-----------~~~~~~~~~--~~~  226 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-L-----------DLESLLKRQ--QKK  226 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-h-----------hHHHHHHhh--ccc
Confidence               12357889999999988889999999999999999999999997543211 0           001111111  111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCC-HHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt-~~~v~~  193 (252)
                      ...+..++..+.++|.+||+.||.+|++ ++++++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            2334467889999999999999999995 688874

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=226.39  Aligned_cols=172  Identities=24%  Similarity=0.395  Sum_probs=137.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||-++..+..-+ .+|++.++..+++|++.||.|||+.+  |||||||..|||+.-+|.++|+|||++-...  ....
T Consensus       111 C~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ  185 (1187)
T ss_pred             cCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence            67888888887665 46999999999999999999999876  9999999999999999999999999975421  1222


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ....++||+.|||||++.     ..+|+.++||||||++|.||..+.+|.....                ..+.+.++..
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----------------pMRVllKiaK  249 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----------------PMRVLLKIAK  249 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----------------hHHHHHHHhh
Confidence            345689999999999874     4579999999999999999999998876532                1222222222


Q ss_pred             hhcC-CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .... ...|...+..+.+|+.+||.+||..||++.++++
T Consensus       250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            2211 1235567889999999999999999999999985

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=4e-31  Score=213.92  Aligned_cols=176  Identities=22%  Similarity=0.349  Sum_probs=137.0

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++...  ....+++..++.++.|++.||.|||+. .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  168 (269)
T cd08528          91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-  168 (269)
T ss_pred             CCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEecccceeeccccc-
Confidence            4689999988542  224589999999999999999999962 359999999999999999999999999997644332 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                        ......++..|++||.+.+..++.++|+||||+++|+|++|..||......                .....+.....
T Consensus       169 --~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~  230 (269)
T cd08528         169 --KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----------------SLATKIVEAVY  230 (269)
T ss_pred             --ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----------------HHHHHHhhccC
Confidence              233456888999999998888999999999999999999999999653210                01111111111


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      .......++..+.++|.+||+.||++||++.++.++++
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11112245678999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=3.7e-31  Score=213.33  Aligned_cols=172  Identities=27%  Similarity=0.367  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+...  +++..+..++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            478999999977654  899999999999999999999755  9999999999999999999999999998654432   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|..||......              .......+.......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--------------PMEIYNDILKGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--------------HHHHHHHHhccCCCC
Confidence            123346788999999998888999999999999999999999999764320              111111222222334


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ..+...+..+.++|.+||+.||++||+     +.++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            455556789999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=3.3e-31  Score=218.40  Aligned_cols=177  Identities=22%  Similarity=0.308  Sum_probs=133.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      ++||+|.+++...+.  +++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||+++.......  
T Consensus        83 ~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          83 VEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            478999999977654  899999999999999999999765  99999999999999999999999999864211100  


Q ss_pred             -----------ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           79 -----------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        79 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                                 ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....                
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----------------  222 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----------------  222 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------
Confidence                       00111235788899999998888999999999999999999999999754210                


Q ss_pred             hhHHHHhhhhcC-CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          148 RKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       148 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ............ ......++.++.++|.+||+.||++||+..++.+.|+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            011111111111 11112467789999999999999999997666665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=4.6e-31  Score=216.06  Aligned_cols=173  Identities=28%  Similarity=0.363  Sum_probs=131.3

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++...  ....+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........
T Consensus       106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  183 (291)
T cd06639         106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  183 (291)
T ss_pred             CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence            4689999988642  2235899999999999999999999765  99999999999999999999999999876433221


Q ss_pred             ceeeecccccccccCccccccC-----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           79 THVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                      .  .....++..|+|||++...     .++.++|||||||++|+|++|+.||......                .....+
T Consensus       184 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----------------~~~~~~  245 (291)
T cd06639         184 R--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----------------KTLFKI  245 (291)
T ss_pred             c--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----------------HHHHHH
Confidence            1  2234578899999988543     3688999999999999999999999764310                011111


Q ss_pred             hhhh-cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .... .....+......+.++|.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1010 011123345667999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=214.08  Aligned_cols=169  Identities=24%  Similarity=0.298  Sum_probs=132.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....     
T Consensus        79 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          79 LNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             cCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            478999999977654  899999999999999999999765  99999999999999999999999999875332     


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh--c
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--L  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  158 (252)
                       .....++..|++||.+.+..++.++|+||||+++|+|++|..||......                ..........  .
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~  212 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----------------AVFDNILSRRINW  212 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhcccCC
Confidence             22345788999999998888899999999999999999999999764321                0011111111  1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .......++..+.+++.+||+.||++||++.++.+.|
T Consensus       213 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            1122335678899999999999999999776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=6.9e-31  Score=215.14  Aligned_cols=172  Identities=24%  Similarity=0.368  Sum_probs=130.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|..++.+.. ..+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++........  
T Consensus        91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--  165 (292)
T cd06644          91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--  165 (292)
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccccc--
Confidence            47899988886543 34899999999999999999999765  99999999999999999999999999865322211  


Q ss_pred             eeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......++..|+|||++.+     ..++.++|+|||||++|+|++|..||.....                .........
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~  229 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLLKIAK  229 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----------------HHHHHHHhc
Confidence            1223457889999999853     3467899999999999999999999965321                000111111


Q ss_pred             hhc-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ... ....+..++.++.++|.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         230 SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            100 11223456678999999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=3.6e-31  Score=216.03  Aligned_cols=175  Identities=26%  Similarity=0.339  Sum_probs=132.1

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++...  ....+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||+++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (286)
T cd06638         102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  179 (286)
T ss_pred             cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence            4789999988632  2235899999999999999999999765  99999999999999999999999999876433221


Q ss_pred             ceeeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           79 THVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                        ......|+..|+|||++..     ..++.++|+|||||++|+|++|..||......                ......
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----------------~~~~~~  241 (286)
T cd06638         180 --RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----------------RALFKI  241 (286)
T ss_pred             --ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----------------HHHhhc
Confidence              1223468899999998753     34788999999999999999999999754310                000010


Q ss_pred             hhh-hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          154 MDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       154 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ... ......+..++..+.+||.+||+.||++||++.++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            000 001112233566799999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=2.8e-31  Score=219.78  Aligned_cols=189  Identities=22%  Similarity=0.241  Sum_probs=127.4

Q ss_pred             CCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee----cCCCceEEccccccc
Q 025440            3 KGSLENHLFRR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAK   71 (252)
Q Consensus         3 ggsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~   71 (252)
                      +++|.+++...       ....+++..+..++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            45777776422       1235889999999999999999999765  9999999999999    556789999999998


Q ss_pred             cCCCCCcc-eeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-------hhhh---
Q 025440           72 AGPTGDRT-HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-------LVDW---  139 (252)
Q Consensus        72 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-------~~~~---  139 (252)
                      ........ .......+|..|+|||++.+. .++.++|||||||++|+|+||..||..........       +...   
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            65432211 112345689999999998764 57899999999999999999999997644321110       0000   


Q ss_pred             -cchhhhhhhhH---------HHHhh-hhc--------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          140 -AKPYLSDKRKL---------FRIMD-TKL--------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       140 -~~~~~~~~~~~---------~~~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ..+........         ..... ...        ...........+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence             00000000000         00000 000        00001123456889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=4.5e-31  Score=212.03  Aligned_cols=170  Identities=30%  Similarity=0.459  Sum_probs=135.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.+...  +++..++.++.||+.||+|||+.+  ++|+||+|+||+++.++.+||+|||++.......   
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---  156 (258)
T cd06632          84 VPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---  156 (258)
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc---
Confidence            468999999977654  899999999999999999999765  9999999999999999999999999987643322   


Q ss_pred             eeecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|++||.+.... ++.++|+||||+++|+|++|..||.....                .............
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----------------~~~~~~~~~~~~~  220 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----------------VAAVFKIGRSKEL  220 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----------------HHHHHHHHhcccC
Confidence            123456788999999987766 89999999999999999999999976431                0111111111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            3344566788999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=5.5e-31  Score=215.13  Aligned_cols=170  Identities=25%  Similarity=0.341  Sum_probs=132.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.. +  .+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648          98 LEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             cCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            468999999977 3  3899999999999999999999765  99999999999999999999999998865433221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh-cC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  159 (252)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......                .....+.... ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----------------~~~~~~~~~~~~~  234 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----------------QAMKRIRDNLPPK  234 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----------------HHHHHHHhcCCCC
Confidence            123346889999999998888999999999999999999999999653210                0011111110 00


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.+++.+||..+|++||++.++++
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         235 LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1112236678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=1.9e-31  Score=219.15  Aligned_cols=170  Identities=25%  Similarity=0.359  Sum_probs=133.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.+.   .+++..+..++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++......... 
T Consensus        98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            4789999999653   3899999999999999999999765  999999999999999999999999998764332211 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh-hhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-TKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  159 (252)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........                ...... ....
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----------------~~~~~~~~~~~  234 (297)
T cd06656         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----------------LYLIATNGTPE  234 (297)
T ss_pred             -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----------------eeeeccCCCCC
Confidence             2234578899999999888899999999999999999999999976432100                000000 0001


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.+++.+||..||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1223456677899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=6.2e-31  Score=212.57  Aligned_cols=176  Identities=26%  Similarity=0.444  Sum_probs=136.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|.+++.+.++  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.++ .++|+|||++.........
T Consensus        85 ~~~~~L~~~l~~~~~--~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          85 MAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             cCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            478999999977654  899999999999999999999765  99999999999998776 5999999998765432111


Q ss_pred             --eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 --HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                        .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......             ............
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------------~~~~~~~~~~~~  227 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-------------HLALIFKIASAT  227 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-------------hHHHHHHHhccC
Confidence              11223467889999999988889999999999999999999999996532110             011111111122


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....+...+.++.+++.+||..+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            233455667889999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=215.20  Aligned_cols=186  Identities=21%  Similarity=0.212  Sum_probs=137.0

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC--------------------CCc
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--------------------EFN   61 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~--------------------~~~   61 (252)
                      -|-|+.++|..++..+++..++..++.|++++++|||+.+  ++|.||||+|||+.+                    +-.
T Consensus       173 lG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~  250 (415)
T KOG0671|consen  173 LGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTA  250 (415)
T ss_pred             cChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcc
Confidence            3568999999999899999999999999999999999766  999999999999932                    223


Q ss_pred             eEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc
Q 025440           62 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA  140 (252)
Q Consensus        62 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~  140 (252)
                      ++|+|||.++......     ...+.|..|+|||++.+-.++..+||||+||||+|+.||...|+..+..+.- -+....
T Consensus       251 I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl  325 (415)
T KOG0671|consen  251 IKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL  325 (415)
T ss_pred             eEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence            8999999998754432     4567899999999999999999999999999999999999999887632100 000011


Q ss_pred             chhhhhhhh---HHHHhhhh----------------cCC--------CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          141 KPYLSDKRK---LFRIMDTK----------------LGG--------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       141 ~~~~~~~~~---~~~~~~~~----------------~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .+.......   ..++...+                ...        ........++.+||++||..||.+|+|+.|++.
T Consensus       326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            111110000   00000000                000        111234557999999999999999999999986


Q ss_pred             H
Q 025440          194 I  194 (252)
Q Consensus       194 ~  194 (252)
                      .
T Consensus       406 H  406 (415)
T KOG0671|consen  406 H  406 (415)
T ss_pred             C
Confidence            3

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=4.3e-31  Score=218.14  Aligned_cols=186  Identities=23%  Similarity=0.298  Sum_probs=131.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .++|.+++...+. .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        87 ~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  161 (309)
T cd07872          87 DKDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TY  161 (309)
T ss_pred             CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCcc--cc
Confidence            3578888866543 4899999999999999999999765  99999999999999999999999999875432221  12


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-h-hcch------hhhhhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D-WAKP------YLSDKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~-~~~~------~~~~~~~~~~~  153 (252)
                      ....++..|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+........ . ...+      ...........
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23457889999998865 45889999999999999999999999875432111100 0 0000      00000000000


Q ss_pred             hhhhcCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......    .....++.++.+||.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000    011235678899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=3.9e-31  Score=217.25  Aligned_cols=171  Identities=24%  Similarity=0.336  Sum_probs=133.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...   .+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus       100 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         100 LQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence            4789999988543   3899999999999999999999765  99999999999999999999999999875432221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh-hcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  159 (252)
                      ......++..|+|||++.+..++.++|+|||||++|+|++|..||......                .....+... ...
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~~  236 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----------------QAMKRLRDSPPPK  236 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhccCCCC
Confidence            123356889999999998888999999999999999999999999754311                000010000 001


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......++..+.++|.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            11223456778999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=5.9e-31  Score=213.74  Aligned_cols=167  Identities=29%  Similarity=0.400  Sum_probs=127.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-------ceEEccccccccC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~~~~~   73 (252)
                      ++||+|..++.+... .+++..++.++.||+.||+|||+.+  |+||||||+|||++..+       .++++|||++...
T Consensus        98 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076          98 VEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence            579999999965432 4899999999999999999999654  99999999999997644       3899999987643


Q ss_pred             CCCCcceeeecccccccccCcccccc-CCCCcccceehhHHHHHHHH-hCCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           74 PTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        74 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ...      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.......                 ..
T Consensus       175 ~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~  231 (274)
T cd05076         175 LSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-----------------KE  231 (274)
T ss_pred             ccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-----------------HH
Confidence            221      12346788999998865 46899999999999999995 6999987643210                 00


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ......  ...+......+.++|.+||+.+|++||++.++++.|
T Consensus       232 ~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 RFYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            111111  122233445789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=3.5e-31  Score=239.15  Aligned_cols=183  Identities=19%  Similarity=0.229  Sum_probs=135.6

Q ss_pred             CCCCChhhhhhcCC---------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccc
Q 025440            1 MPKGSLENHLFRRG---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus         1 ~~ggsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      ++||+|.+++....         ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCcce
Confidence            57999999986421         123667788999999999999999765  9999999999999999999999999997


Q ss_pred             cCCCCCc----------------ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh
Q 025440           72 AGPTGDR----------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS  135 (252)
Q Consensus        72 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~  135 (252)
                      .......                .......+||+.|+|||++.+..++.++|||||||++|+|+||..||......... 
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~-  240 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS-  240 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh-
Confidence            6421100                00112346899999999999999999999999999999999999999763211000 


Q ss_pred             hhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcC
Q 025440          136 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEA  200 (252)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-t~~~v~~~l~~~~~  200 (252)
                                    ................++..+.+++.+||+.||++|+ +++++++.|+....
T Consensus       241 --------------~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        241 --------------YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             --------------hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                          0000000000011234667889999999999999997 66778888877543

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=4.4e-31  Score=213.12  Aligned_cols=175  Identities=29%  Similarity=0.426  Sum_probs=135.9

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|.+++....+ ..+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            478999999976543 45899999999999999999999765  999999999999999999999999998765443222


Q ss_pred             --eeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           80 --HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        80 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                        .......++..|+|||++... .++.++|+||||+++|+|++|..||......                .........
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----------------~~~~~~~~~  222 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----------------KVLMLTLQN  222 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----------------hhHHHHhcC
Confidence              122344688999999998776 7889999999999999999999999764321                001111111


Q ss_pred             h---cCCC-CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 K---LGGQ-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~---~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .   .... ....++..+.+++.+||..||++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0   0000 11256788999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=211.56  Aligned_cols=168  Identities=29%  Similarity=0.422  Sum_probs=139.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .||.|.-+|.+..-  +++.....+-..|+.||.|||+.+  ||+||||.+|.|+|.+|.+||+|||+|+..  ......
T Consensus       251 nGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t  324 (516)
T KOG0690|consen  251 NGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDT  324 (516)
T ss_pred             cCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhc--ccccce
Confidence            58888888866543  999999999999999999999865  999999999999999999999999999863  233344


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ...++||+.|+|||++....|+.++|.|.+|+++|||++|+.||...+                 ...+++.+.- ....
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------------h~kLFeLIl~-ed~k  386 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------------HEKLFELILM-EDLK  386 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------------hhHHHHHHHh-hhcc
Confidence            678899999999999999999999999999999999999999997643                 2333333211 1236


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      +|..++++...|+..+|.+||.+|.     .+.||.+
T Consensus       387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            7888999999999999999999995     4455543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.2e-30  Score=212.92  Aligned_cols=175  Identities=27%  Similarity=0.411  Sum_probs=134.4

Q ss_pred             CCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|..++.... ...+++..+..++.+|+.||.|||+. .+++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            57899999986642 23589999999999999999999963 359999999999999999999999999987543221  


Q ss_pred             eeeecccccccccCccccccCC------CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           80 HVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                        .....++..|+|||++.+..      ++.++|+|||||++|+|++|..||.......             .......+
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------------~~~~~~~~  222 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-------------IFAQLSAI  222 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-------------HHHHHHHH
Confidence              22345788999999986543      4789999999999999999999996532100             00011111


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       ........+..++.++.++|.+||+.+|++||++.++++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 -VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             1122234455678899999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=221.16  Aligned_cols=164  Identities=26%  Similarity=0.364  Sum_probs=142.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |-||.|-..|.+++.  ++...+..++..+++|++|||+++  ||+|||||+|.+++.+|-+||.|||+++....+..  
T Consensus       502 ClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--  575 (732)
T KOG0614|consen  502 CLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--  575 (732)
T ss_pred             hcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccCCc--
Confidence            458999999998887  999999999999999999999766  99999999999999999999999999998766554  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       +.+++||+.|.|||++.....+.++|.||||+++|||++|.+||.+.+.                ......++......
T Consensus       576 -TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----------------mktYn~ILkGid~i  638 (732)
T KOG0614|consen  576 -TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----------------MKTYNLILKGIDKI  638 (732)
T ss_pred             -eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----------------HHHHHHHHhhhhhh
Confidence             4578999999999999999999999999999999999999999998542                12222333333445


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR  187 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt  187 (252)
                      .+|..+.....+||+++...+|.+|..
T Consensus       639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hcccccchhHHHHHHHHHhcCcHhhhc
Confidence            778889999999999999999999975

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=4.9e-31  Score=212.83  Aligned_cols=174  Identities=30%  Similarity=0.429  Sum_probs=134.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-CCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|.+++.... ..+++..+..++.|++.||+|||+ .  +++|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC--CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            46799999997653 458999999999999999999997 5  499999999999999999999999999865432211 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                         ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........           ......... ....
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~-~~~~  221 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-----------IFELLQYIV-NEPP  221 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-----------HHHHHHHHh-cCCC
Confidence               1256788999999998889999999999999999999999999754311000           000111111 1111


Q ss_pred             CCCcHH-HHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+.. ++.++.++|.+||..||++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            222333 6788999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=7e-31  Score=213.80  Aligned_cols=172  Identities=26%  Similarity=0.380  Sum_probs=128.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|..+.      .+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||++.......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            4677775542      3788899999999999999999765  9999999999999999999999999987643221   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....++..|+|||++.+..++.++|+||||+++|+|++|..||..........          ...............
T Consensus       150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~  218 (279)
T cd06619         150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL----------MPLQLLQCIVDEDPP  218 (279)
T ss_pred             -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc----------chHHHHHHHhccCCC
Confidence             233568999999999998899999999999999999999999997532111000          000011111111111


Q ss_pred             C-CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 Q-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      . .....+.++.+++.+||+.||.+||+++++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1 122356788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.1e-30  Score=211.22  Aligned_cols=174  Identities=25%  Similarity=0.440  Sum_probs=131.7

Q ss_pred             CCCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++... .....++..+..++.||+.||+|||+.+  |+||||||+||+++. ++.++|+|||++........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            4789999999764 3311288889999999999999999654  999999999999976 67899999999875433221


Q ss_pred             ceeeecccccccccCccccccCC--CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           79 THVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                        ......++..|+|||.+.+..  ++.++|+||||+++|+|++|..||......               ..........
T Consensus       165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---------------~~~~~~~~~~  227 (268)
T cd06624         165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---------------QAAMFKVGMF  227 (268)
T ss_pred             --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---------------hhhHhhhhhh
Confidence              122335788999999986643  788999999999999999999999653210               0001111111


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......+..++.++.+++.+||+.+|++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1223345567788999999999999999999999886

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=6e-31  Score=213.92  Aligned_cols=174  Identities=31%  Similarity=0.460  Sum_probs=135.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence            46899999998776556999999999999999999999765  9999999999999999999999999987643311   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||++.+..++.++|+||||+++|+|++|+.||........             ........ .....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~~~~-~~~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------------KEELKRRT-LEMAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------------HHHHHhcc-ccccc
Confidence            12234578899999999888899999999999999999999999976432100             00011100 01122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||.+||     ++.+++.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            34455678899999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=6.4e-31  Score=214.37  Aligned_cols=186  Identities=23%  Similarity=0.226  Sum_probs=128.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..++.++.||++||.|||+++  ++|+||||+||+++.++.++|+|||++........  ..
T Consensus        82 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  156 (284)
T cd07839          82 DQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CY  156 (284)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--Cc
Confidence            468888886543 24899999999999999999999765  99999999999999999999999999876433221  12


Q ss_pred             ecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhh-hcchhhhhhhhHHHHhhhhc
Q 025440           83 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVD-WAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ....++..|+|||++.+.. ++.++|||||||++|+|+||..||..........  +.. ...+................
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            2345688999999987654 6899999999999999999988864332211100  000 00000000000000000000


Q ss_pred             CC---------CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GG---------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..         .....++.++.++|.+||+.||.+|||+++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00         111235678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=9e-31  Score=214.30  Aligned_cols=166  Identities=25%  Similarity=0.384  Sum_probs=134.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  ++|+||+|.|||++.++.+||+|||++......    
T Consensus        83 ~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          83 VPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            468999999987754  899999999999999999999755  999999999999999999999999998765433    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....                ......+.  ....
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~--~~~~  215 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----------------IQIYEKIL--EGKV  215 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHh--cCCc
Confidence             2234678999999999888889999999999999999999999976431                01111111  1122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+...+..+.++|.+||..||.+|+     +++++++
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            34455678899999999999999999     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.7e-30  Score=214.84  Aligned_cols=192  Identities=20%  Similarity=0.250  Sum_probs=135.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      +++|+|.+++.......+++..+..++.|++.||+|||+++  |+|+||||+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            47899999998765556899999999999999999999765  99999999999999999999999998865432211  


Q ss_pred             ---ceeeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccch--hhhhhcchhhh------
Q 025440           79 ---THVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLS------  145 (252)
Q Consensus        79 ---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~--~~~~~~~~~~~------  145 (252)
                         ........++..|+|||++.+.  .++.++|+|||||++|+|++|..||.........  ...........      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence               0111234567789999998663  5889999999999999999999999764321100  00000000000      


Q ss_pred             hhh--------hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          146 DKR--------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       146 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...        .................++.++.+|+.+||..||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            000        0000000011112234566789999999999999999999999973

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=1.2e-30  Score=210.28  Aligned_cols=174  Identities=27%  Similarity=0.403  Sum_probs=138.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-CCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|.+++.....  +++..++.++.|++.||+|||+ .+  ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            468999999987644  9999999999999999999996 55  999999999999999999999999998765432221


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......              ........+.....
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--------------~~~~~~~~~~~~~~  220 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--------------SFFELMQAICDGPP  220 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--------------CHHHHHHHHhcCCC
Confidence              12345788999999998888999999999999999999999999765320              00111111112222


Q ss_pred             CCCcHH-HHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+.. ++..+.++|.+||..+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            233444 77889999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=3.9e-31  Score=215.69  Aligned_cols=186  Identities=22%  Similarity=0.203  Sum_probs=130.3

Q ss_pred             CChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            4 GSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         4 gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |+|.+++..... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  ..
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  158 (285)
T cd07861          83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VY  158 (285)
T ss_pred             CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cc
Confidence            688888865433 45899999999999999999999765  99999999999999999999999999875432211  12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcch---h---hhhhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKP---Y---LSDKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~---~---~~~~~~~~~~  153 (252)
                      ....++..|+|||++.+. .++.++|+|||||++|+|+||+.||.+........  ...+..+   .   ..........
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            233568899999988664 47889999999999999999999997653211000  0000000   0   0000000000


Q ss_pred             hhhh---cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....   ........++.++.++|.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000   000111235778899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.9e-30  Score=209.25  Aligned_cols=173  Identities=28%  Similarity=0.423  Sum_probs=133.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.....  +++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            468999999977644  889999999999999999999765  9999999999999999999999999987654332211


Q ss_pred             e--eecccccccccCccccccCC---CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 V--STQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      .  .....++..|+|||++.+..   ++.++||||||+++|++++|..||......               ...... ..
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------------~~~~~~-~~  220 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------------FQIMFH-VG  220 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------------HHHHHH-Hh
Confidence            1  11245788999999998766   889999999999999999999999754210               000111 11


Q ss_pred             hhcCCCCcH--HHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYPQ--KAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......+.  .++..+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         221 AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             cCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111222233  34778899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=212.57  Aligned_cols=173  Identities=28%  Similarity=0.400  Sum_probs=133.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+ ..+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            47899999987654 34999999999999999999999765  99999999999999999999999999865432221  


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......++..|+|||.+.     ...++.++|+||||+++|+|++|..||......                ........
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~  222 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----------------RVLLKILK  222 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----------------HHHHHHhc
Confidence            123346889999999875     334678999999999999999999999764210                01111111


Q ss_pred             hh-cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 TK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .. .....+..++.++.++|.+||+.+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         223 SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            10 0112234567789999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.4e-30  Score=209.24  Aligned_cols=172  Identities=24%  Similarity=0.357  Sum_probs=135.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc-eEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++. ++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence            46899999998766556899999999999999999999765  999999999999988865 69999999876543221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......                ........ ...
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~-~~~  219 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----------------QLVLKICQ-GYF  219 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHhc-ccC
Confidence             122345788999999998888999999999999999999999999754210                11111111 111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......+..+.+++.+||..+|++|||+.+++.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2223455678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-31  Score=221.27  Aligned_cols=165  Identities=29%  Similarity=0.406  Sum_probs=133.2

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ||-.|.|.-. .++|.+..+..|+.+.++||+|||+++  .||||||..|||+++.|.|||+|||.+.....      ..
T Consensus       110 GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An  180 (948)
T KOG0577|consen  110 GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN  180 (948)
T ss_pred             ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence            5555666433 357999999999999999999999987  99999999999999999999999999876543      34


Q ss_pred             cccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           84 QVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .++||+.|||||++.   .+.|+.++||||||+++.||...++|+...+.                ...++.+.......
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----------------MSALYHIAQNesPt  244 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESPT  244 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----------------HHHHHHHHhcCCCC
Confidence            578999999999885   46899999999999999999999999866432                12222222222222


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......+..+..|+..||++-|.+|||.++++.
T Consensus       245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            224567889999999999999999999999875

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.4e-30  Score=212.43  Aligned_cols=182  Identities=27%  Similarity=0.433  Sum_probs=135.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+.  +++..+..++.+++.||.|||+. .+++|+||||+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            478999999977654  89999999999999999999963 249999999999999999999999999986532211   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........   ..  .........+... ...
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~---~~--~~~~~~~~~~~~~-~~~  231 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD---DP--MGILDLLQQIVQE-PPP  231 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh---hh--hHHHHHHHHHhhc-cCC
Confidence             2234689999999999888899999999999999999999999976432110000   00  0000001111111 111


Q ss_pred             CCc-HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          161 QYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       161 ~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ..+ ..++..+.+|+.+||+.||++||++.++++..
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            222 23667899999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=2.3e-30  Score=211.44  Aligned_cols=173  Identities=28%  Similarity=0.399  Sum_probs=135.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.... ..+++..++.++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614          97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            46899999998765 34999999999999999999999754  99999999999999999999999998865432211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC-
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (252)
                      ......++..|++||++.+..++.++|+||||+++|+|++|..||......                .....+...... 
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~  235 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----------------RALFLITTKGIPP  235 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhcCCCC
Confidence            122335788999999998888999999999999999999999999753211                011111111111 


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......++..+.++|.+||+.+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11223367789999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.5e-30  Score=227.53  Aligned_cols=189  Identities=21%  Similarity=0.271  Sum_probs=128.2

Q ss_pred             CCChhhhhhcCCC---CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      +++|.+++.....   .......+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++.+......
T Consensus       246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  323 (501)
T PHA03210        246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA  323 (501)
T ss_pred             ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc
Confidence            4567777654321   12345677889999999999999765  999999999999999999999999999865433221


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCC-CCCcccccchhhhhhc-------chhhhhhhhHH
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWA-------KPYLSDKRKLF  151 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~p-f~~~~~~~~~~~~~~~-------~~~~~~~~~~~  151 (252)
                       ......||..|+|||++.+..++.++|||||||++|||++|..+ |..........+....       ..+......+.
T Consensus       324 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~  402 (501)
T PHA03210        324 -FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLF  402 (501)
T ss_pred             -ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHH
Confidence             12345789999999999999999999999999999999998754 4332211111111100       00111111111


Q ss_pred             HHhhhhcCC----CCc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          152 RIMDTKLGG----QYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       152 ~~~~~~~~~----~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+......    ..+     ..++..+.++|.+||+.||.+|||+.|++..
T Consensus       403 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        403 DYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            211111000    000     1234567889999999999999999999863

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=2.1e-30  Score=211.10  Aligned_cols=172  Identities=28%  Similarity=0.384  Sum_probs=129.6

Q ss_pred             CCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            3 KGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         3 ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      .|+|.+++...  ....+++..++.++.||+.||+|||++ .+++||||||+||+++.++.+||+|||++.......   
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  158 (283)
T cd06617          83 DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---  158 (283)
T ss_pred             cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeeccccccccccc---
Confidence            46788887543  224589999999999999999999974 249999999999999999999999999987643221   


Q ss_pred             eeecccccccccCcccccc----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ......++..|+|||++.+    ..++.++|+|||||++|+|++|+.||......               ..........
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~~~~  223 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---------------FQQLKQVVEE  223 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---------------HHHHHHHHhc
Confidence            1122457889999998865    34688999999999999999999999653210               0111111111


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .........++.++.++|.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111112346778999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.8e-30  Score=208.26  Aligned_cols=174  Identities=28%  Similarity=0.420  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++....  .+++..++.++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+..........
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          83 VSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            36899999998766  4999999999999999999999754  9999999999999999999999999988765443211


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|..||.....               ...............
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~  223 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---------------PMAALYKIGSSGEPP  223 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------------hHHHHHhccccCCCc
Confidence            12334678899999999888899999999999999999999999976431               011111222122233


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+...+..+.+++.+||+.||++||++.+++.
T Consensus       224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            445566889999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-30  Score=208.96  Aligned_cols=172  Identities=27%  Similarity=0.364  Sum_probs=136.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc-c
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-T   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~   79 (252)
                      ++|++|.+++...+.  +++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.++|+|||+++....... .
T Consensus        88 ~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  163 (264)
T cd06653          88 MPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG  163 (264)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccccccccccC
Confidence            468999999977654  889999999999999999999765  99999999999999999999999999976432111 1


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++|+|||||++|+|++|+.||.....                .............
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~~~~~  227 (264)
T cd06653         164 TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----------------MAAIFKIATQPTK  227 (264)
T ss_pred             ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----------------HHHHHHHHcCCCC
Confidence            112234678899999999888899999999999999999999999975321                1112222222233


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.+++.+||. ++..||++.+++.
T Consensus       228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            44567788899999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.4e-30  Score=209.84  Aligned_cols=173  Identities=28%  Similarity=0.410  Sum_probs=134.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      ++|++|.+++.+.+  .+++..++.++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            46899999998766  3899999999999999999999655  99999999999999999999999999876433211  


Q ss_pred             ----ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           79 ----THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        79 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                          ........++..|++||.+.+..++.++|+||||+++|++++|..||......                .......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~  214 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----------------EIFQNIL  214 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHh
Confidence                11223345788999999998888999999999999999999999999754310                0111111


Q ss_pred             hhhcCCCCcHH--HHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          155 DTKLGGQYPQK--AAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       155 ~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...  ...+..  .+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus       215 ~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         215 NGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            111  122222  378899999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.7e-31  Score=208.67  Aligned_cols=157  Identities=25%  Similarity=0.284  Sum_probs=126.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+...  +++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++++|||.+......    
T Consensus        67 ~~~~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----  138 (237)
T cd05576          67 AEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----  138 (237)
T ss_pred             CCCCCHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc----
Confidence            578999999977654  899999999999999999999655  999999999999999999999999987654322    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....++..|+|||.+.+..++.++|+||+|+++|+|++|..+|......                      .......
T Consensus       139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------------------~~~~~~~  195 (237)
T cd05576         139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------------------INTHTTL  195 (237)
T ss_pred             -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------------------ccccccc
Confidence             11234567799999998888999999999999999999999887542110                      0000111


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++..+.++|.+||+.||++|+++
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            2344567789999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=2.4e-30  Score=207.51  Aligned_cols=172  Identities=24%  Similarity=0.368  Sum_probs=138.2

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++....  ...+++..++.++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            46889999997753  345999999999999999999999764  9999999999999999999999999987654432 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....                 ...........
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~  219 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----------------LELALKILKGQ  219 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----------------HHHHHHHhcCC
Confidence             123334678899999999888899999999999999999999999965431                 11111111222


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+..++..+.+++.+||..+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            23344567788999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=2.4e-30  Score=211.05  Aligned_cols=187  Identities=21%  Similarity=0.252  Sum_probs=130.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|..++.....  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~~l~~~~~~~~~--~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-  156 (286)
T cd07847          82 CDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-  156 (286)
T ss_pred             cCccHHHHHHhCCCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence            467777777655443  899999999999999999999755  999999999999999999999999999765433211 


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhhhhhhH------HH
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKL------FR  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~------~~  152 (252)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+........ ...............      ..
T Consensus       157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence             223457889999999876 457889999999999999999999998654211100 000000000000000      00


Q ss_pred             -HhhhhcCCC-----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 -IMDTKLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 -~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       .........     .....+..+.+|+.+||+.||++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             000000000     01234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-30  Score=210.87  Aligned_cols=169  Identities=25%  Similarity=0.365  Sum_probs=131.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...   .+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        84 ~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06917          84 AEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--  156 (277)
T ss_pred             CCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--
Confidence            4689999998653   4899999999999999999999665  99999999999999999999999999876544331  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.+......                 .........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----------------~~~~~~~~~  219 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----------------MMLIPKSKP  219 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----------------hhccccCCC
Confidence            12334688899999988654 468899999999999999999999976432100                 000000011


Q ss_pred             CCCcH-HHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~-~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+. ..+.++.+++.+||+.||++||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11111 25678999999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.9e-30  Score=206.19  Aligned_cols=170  Identities=29%  Similarity=0.434  Sum_probs=134.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.... ..+++..+..++.+++.||+|||+.  +++|+||+|+||+++.++.++|+|||++........  
T Consensus        79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC--CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            46899999997763 3599999999999999999999965  499999999999999999999999999876543321  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....++..|++||.+.+..++.++|+||||+++|+|++|..||...+..                ........ ....
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~-~~~~  215 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----------------KALFKIAT-NGPP  215 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----------------HHHHHHHh-cCCC
Confidence             23346788999999998888999999999999999999999999764210                00111111 1111


Q ss_pred             CC--cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..  ...++..+.++|.+||+.||++|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11  1223678999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.4e-30  Score=208.11  Aligned_cols=170  Identities=25%  Similarity=0.329  Sum_probs=135.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.|++|.+++....  ++++..+..++.||++||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        82 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---  154 (258)
T cd05578          82 LLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---  154 (258)
T ss_pred             CCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence            47899999997764  4899999999999999999999765  9999999999999999999999999987654332   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......              ......... ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~~~~-~~~~  219 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--------------RDQIRAKQE-TADV  219 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--------------HHHHHHHhc-cccc
Confidence            1233457889999999988889999999999999999999999998654210              011111111 1233


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH--HHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM--SEVL  192 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~--~~v~  192 (252)
                      ..+...+..+.++|.+||+.||.+||++  .+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            4555677899999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=3.1e-30  Score=210.39  Aligned_cols=188  Identities=22%  Similarity=0.267  Sum_probs=132.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++........ ...
T Consensus        82 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (286)
T cd07832          82 PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY  157 (286)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence            899999987654 45999999999999999999999765  99999999999999999999999999886543321 112


Q ss_pred             ecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcchhh------hhhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKPYL------SDKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~~~------~~~~~~~~~  153 (252)
                      ....++..|+|||++.+.. ++.++||||||+++|+|++|..+|.+........  ......+..      ........+
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            2346888999999986654 6889999999999999999988886543211000  000000000      000000000


Q ss_pred             hhhhcCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          154 MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       154 ~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .......    ....+.+..+.++|.+||..||++||++++++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000    0112346789999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2e-30  Score=238.32  Aligned_cols=170  Identities=19%  Similarity=0.206  Sum_probs=120.7

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-------------------Cce
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------FNA   62 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-------------------~~~   62 (252)
                      .+++|.++|.... ..+++.+++.++.||+.||+|||+++  |+||||||+||||+..                   +.+
T Consensus        62 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~  138 (793)
T PLN00181         62 EDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATT  138 (793)
T ss_pred             CCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcccccccCcc
Confidence            3689999996543 45999999999999999999999765  9999999999999653                   445


Q ss_pred             EEccccccccCCCCCc--------------ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCc
Q 025440           63 KLSDFGLAKAGPTGDR--------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT  128 (252)
Q Consensus        63 kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~  128 (252)
                      |++|||+++.......              .......+||+.|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus       139 ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        139 KSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             cccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            6666666653211000              00011245788999999999999999999999999999999988776532


Q ss_pred             ccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          129 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..                  .......... .............++.+||..||.+||++.++++
T Consensus       219 ~~------------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        219 SR------------------TMSSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HH------------------HHHHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            10                  0000000000 0001112334568899999999999999999975

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=4.4e-30  Score=206.06  Aligned_cols=170  Identities=26%  Similarity=0.366  Sum_probs=136.9

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++.+..  ...+++..++.++.+++.||+|||+.+  ++|+||+|.||+++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            46899999986632  245899999999999999999999765  999999999999999999999999999775443  


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                        ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..                 ..........
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~  217 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------DLRYKVQRGK  217 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcCC
Confidence              122345788999999998888999999999999999999999999764321                 1111112222


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+..++.++.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            23344567888999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=2.2e-30  Score=212.36  Aligned_cols=171  Identities=25%  Similarity=0.345  Sum_probs=133.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+..   +++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            47899999996543   789999999999999999999765  99999999999999999999999998875433222  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh-hhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  159 (252)
                      ......++..|++||.+.+..++.++|+||||+++|++++|..||.........                .... .....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~----------------~~~~~~~~~~  234 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------------YLIATNGTPE  234 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe----------------eehhcCCCCC
Confidence            122346788999999998888999999999999999999999999764321000                0000 00011


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++..+.++|.+||..+|++||++.+++..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11233456789999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=7.9e-31  Score=214.31  Aligned_cols=161  Identities=27%  Similarity=0.402  Sum_probs=123.3

Q ss_pred             CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCc
Q 025440           15 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP   94 (252)
Q Consensus        15 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP   94 (252)
                      ...+++..+..++.+++.||+|||+. .+++||||||+||+++.++.++|+|||+++.......   .....|+..|+||
T Consensus       101 ~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP  176 (288)
T cd06616         101 KSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAP  176 (288)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCH
Confidence            34599999999999999999999963 2499999999999999999999999999875432211   1233578899999


Q ss_pred             cccccC---CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh---hhcCCCCcHHHHH
Q 025440           95 EYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD---TKLGGQYPQKAAH  168 (252)
Q Consensus        95 E~~~~~---~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  168 (252)
                      |++.+.   .++.++|||||||++|+|++|..||.....               ......+...   .......+..++.
T Consensus       177 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd06616         177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---------------VFDQLTQVVKGDPPILSNSEEREFSP  241 (288)
T ss_pred             HHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---------------HHHHHhhhcCCCCCcCCCcCCCccCH
Confidence            998776   688999999999999999999999975321               0001111110   0111112234677


Q ss_pred             HHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          169 TAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       169 ~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ++.+||.+||+.||++|||+++++..
T Consensus       242 ~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         242 SFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            89999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-30  Score=228.51  Aligned_cols=179  Identities=25%  Similarity=0.399  Sum_probs=148.8

Q ss_pred             CCCCChhhhhhcCC------------C--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG------------P--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      +..|+|.+||....            .  ..|+....+.++.||+.|++||++..  +|||||..+|||+..+..+||+|
T Consensus       384 ~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~~~~~kIaD  461 (609)
T KOG0200|consen  384 AEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITKNKVIKIAD  461 (609)
T ss_pred             ccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecCCCEEEEcc
Confidence            46899999997665            0  13899999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeeccc--ccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchh
Q 025440           67 FGLAKAGPTGDRTHVSTQVM--GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY  143 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  143 (252)
                      ||+++.......+.... ..  -...|||||.+....|+.++||||||+++|||+| |..||.+..              
T Consensus       462 FGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--------------  526 (609)
T KOG0200|consen  462 FGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--------------  526 (609)
T ss_pred             ccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--------------
Confidence            99998654444332111 12  2356999999999999999999999999999999 889987621              


Q ss_pred             hhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                        ....+.+.+..+.+...|..++.+++++|+.||+.+|++||++.++.+.++..
T Consensus       527 --~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 --PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              12233556777778888999999999999999999999999999999999874

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=1.9e-30  Score=213.45  Aligned_cols=183  Identities=21%  Similarity=0.293  Sum_probs=130.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++..... .+++..+..++.||+.||+|||+.+  ++|+||||+|||++.++.++|+|||++........  ..
T Consensus        87 ~~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~  161 (301)
T cd07873          87 DKDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TY  161 (301)
T ss_pred             ccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cc
Confidence            3688888876543 4899999999999999999999765  99999999999999999999999999875432221  12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhhhhhhHHHHhh----
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLFRIMD----  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~----  155 (252)
                      ....++..|+|||++.+. .++.++|||||||++|+|++|..||...+...... ..... .+..   ..+.....    
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  238 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE---ETWPGILSNEEF  238 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh---hhchhhhccccc
Confidence            233568899999988654 47889999999999999999999998654321100 00000 0000   00000000    


Q ss_pred             -----hhcCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 -----TKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 -----~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                           .....    .....++..+.+||.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 00000    011235678899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-30  Score=211.15  Aligned_cols=187  Identities=24%  Similarity=0.300  Sum_probs=130.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      +++.|..++....  .+++..++.++.+|+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++......... .
T Consensus        83 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~  157 (288)
T cd07833          83 ERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-P  157 (288)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-c
Confidence            4555655554433  3899999999999999999999765  999999999999999999999999998775443321 1


Q ss_pred             eecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhhhhh-------hHHH
Q 025440           82 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKR-------KLFR  152 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~-------~~~~  152 (252)
                      .....++..|+|||++.+. .++.++|+||||+++|+|++|..||.+........ .............       ....
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            2335678899999999888 78999999999999999999999997643211000 0000000000000       0000


Q ss_pred             --Hh----hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 --IM----DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 --~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        ..    .......++..++.++.+||.+||..+|++||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence              00    000000122234788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=3.1e-30  Score=214.76  Aligned_cols=191  Identities=23%  Similarity=0.309  Sum_probs=131.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC-cc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~   79 (252)
                      +.+|+|.+++.+.....+++..+..++.||+.||+|||+.+  ++||||||+|||++.++.++++||+.+....... ..
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            46789999998776666999999999999999999999655  9999999999999999999999998653321111 00


Q ss_pred             e----eeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc--ch----hhhh
Q 025440           80 H----VSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA--KP----YLSD  146 (252)
Q Consensus        80 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~--~~----~~~~  146 (252)
                      .    ......++..|+|||++.+.  .++.++|||||||++|+|++|..||.......... .....  .+    ....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence            0    01112345679999998764  47889999999999999999999997653211000 00000  00    0000


Q ss_pred             hhhHH----------------------HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          147 KRKLF----------------------RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       147 ~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....                      ..............++..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            00000                      000001111223456788999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-30  Score=205.13  Aligned_cols=170  Identities=30%  Similarity=0.480  Sum_probs=136.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...+.  +++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            468899999977654  999999999999999999999765  999999999999999999999999999875443321 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....++..|+|||.+.+..++.++|+|+||+++|+|++|..||.....                ........ .....
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----------------~~~~~~~~-~~~~~  217 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----------------MAALFRIV-QDDHP  217 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----------------HHHHHHHh-ccCCC
Confidence             2234578899999999888889999999999999999999999975321                01111111 12223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++..+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            445567789999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=7.9e-30  Score=207.94  Aligned_cols=187  Identities=22%  Similarity=0.251  Sum_probs=130.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.......+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~  157 (284)
T cd07860          82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--Y  157 (284)
T ss_pred             ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--c
Confidence            357888887655556999999999999999999999765  999999999999999999999999998764332211  2


Q ss_pred             ecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcc-h------hhhhhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-P------YLSDKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~-~------~~~~~~~~~~~  153 (252)
                      ....++..|+|||++.+.. ++.++|+||||+++|+|+||..||.+....... ....... +      ...........
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            2234678899999887654 588999999999999999999999764321100 0000000 0      00000000000


Q ss_pred             hhhhcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......   .....++.++.++|.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000   001234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=6e-30  Score=209.16  Aligned_cols=178  Identities=28%  Similarity=0.369  Sum_probs=135.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.|++.||.|||+.+  ++|+||||.||+++.++.++|+|||+++........ 
T Consensus        87 ~~~~~L~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-  161 (288)
T cd05583          87 VNGGELFTHLYQREH--FTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-  161 (288)
T ss_pred             CCCCcHHHHHhhcCC--cCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccccccccc-
Confidence            468999999976543  899999999999999999999655  999999999999999999999999998764332211 


Q ss_pred             eeecccccccccCccccccCC--CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ......|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||.......             .......... ..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------------~~~~~~~~~~-~~  227 (288)
T cd05583         162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-------------SQSEISRRIL-KS  227 (288)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-------------hHHHHHHHHH-cc
Confidence            122345788999999987665  7889999999999999999999996432100             0000111111 11


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ....+..++..+.+++.+||+.||++|||+.++.+.|..
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            234455567889999999999999999998888776643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-29  Score=206.76  Aligned_cols=186  Identities=23%  Similarity=0.246  Sum_probs=132.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.......+++..++.++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........   .
T Consensus        89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~  163 (287)
T cd07838          89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---L  163 (287)
T ss_pred             ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---c
Confidence            357888887655445999999999999999999999765  99999999999999999999999999876533221   1


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhh---h-hhhhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYL---S-DKRKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~---~-~~~~~~~~~~~  156 (252)
                      ....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+........ ..+.. .+..   . ...........
T Consensus       164 ~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (287)
T cd07838         164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPS  243 (287)
T ss_pred             ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccc
Confidence            22346888999999988899999999999999999999999997644211000 00000 0000   0 00000000000


Q ss_pred             hcC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...   .......+..+.++|.+||+.||.+||++.+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000   0111245678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=3.5e-30  Score=214.80  Aligned_cols=187  Identities=25%  Similarity=0.311  Sum_probs=130.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--e
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--H   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~   80 (252)
                      +++|.+++.....  +++..++.++.||+.||+|||+.+  ++||||||+|||++.++.++|+|||+++........  .
T Consensus        89 ~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (332)
T cd07857          89 EADLHQIIRSGQP--LTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG  164 (332)
T ss_pred             cCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccc
Confidence            5788888866544  899999999999999999999765  999999999999999999999999999764332211  1


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccc-hhhhhh-cchhhh------hh--hh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDW-AKPYLS------DK--RK  149 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~-~~~~~~-~~~~~~------~~--~~  149 (252)
                      ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||........ ...... ..+...      ..  ..
T Consensus       165 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (332)
T cd07857         165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN  244 (332)
T ss_pred             cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHH
Confidence            1233568999999998766 4688999999999999999999999976542100 000000 000000      00  00


Q ss_pred             HHHHhhhhcCCC---CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          150 LFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       150 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ............   ....++..+.+++.+||+.||.+|||+.+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000   01124678999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=9e-30  Score=214.02  Aligned_cols=183  Identities=22%  Similarity=0.271  Sum_probs=129.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++...    ++...+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++.......   .
T Consensus       104 ~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~  174 (353)
T cd07850         104 DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---M  174 (353)
T ss_pred             CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---C
Confidence            35677776432    888999999999999999999765  99999999999999999999999999976433211   2


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhh-hcchhh---hhhh-hHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYL---SDKR-KLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~-~~~~~~---~~~~-~~~~~~~~  156 (252)
                      ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..... .+.. ...+..   .... ........
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (353)
T cd07850         175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVEN  254 (353)
T ss_pred             CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhc
Confidence            2345788999999999989999999999999999999999999765421100 0000 000000   0000 00000000


Q ss_pred             hc-------------------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 KL-------------------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~~-------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..                   ....+...+..+.++|.+||+.||++|||+.++++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         255 RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00                   000012346678999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=8.4e-30  Score=207.20  Aligned_cols=170  Identities=27%  Similarity=0.386  Sum_probs=134.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...   .+++..+..++.+++.|+.|||+.+  ++|+||||.||+++.++.++|+|||++........  
T Consensus        84 ~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          84 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            4689999998643   3899999999999999999999755  99999999999999999999999999876433221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|+|||.+.+..++.++|+|||||++|+|++|..||......                 .....+......
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----------------~~~~~~~~~~~~  219 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----------------KVLFLIPKNNPP  219 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----------------HHHHHHhcCCCC
Confidence            122345788999999998888899999999999999999999999653210                 011111111222


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....++.++.+++.+||+.+|.+||++.+++..
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            3344567889999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-30  Score=206.67  Aligned_cols=177  Identities=23%  Similarity=0.312  Sum_probs=151.7

Q ss_pred             CCChhhhhh-----c-CCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            3 KGSLENHLF-----R-RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         3 ggsL~~~l~-----~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      -|||+.||.     + .+.+.++-.+...++.|++.|++|||+++  +||.||..+|++|++...|||+|-.+++-.-..
T Consensus       372 ~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~  449 (563)
T KOG1024|consen  372 VGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPG  449 (563)
T ss_pred             cchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhheeEEeccchhccccCcc
Confidence            489999997     2 23467888899999999999999999776  999999999999999999999999998875555


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      +.............||++|.+....|+.++|+||||+++|||+| |+.|+...+                 ...+...+.
T Consensus       450 DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-----------------PfEm~~ylk  512 (563)
T KOG1024|consen  450 DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-----------------PFEMEHYLK  512 (563)
T ss_pred             cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-----------------HHHHHHHHh
Confidence            44433344445778999999999999999999999999999999 999986642                 344566777


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      .+.+...|.+|++++..+|.-||..+|++||++++++..|.+.
T Consensus       513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            7788888999999999999999999999999999999988765

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-30  Score=208.02  Aligned_cols=163  Identities=31%  Similarity=0.467  Sum_probs=138.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.||+|-=++++.+.  +.+..+..++.+|+-||=+||+++  ||+||||.+||+++.+|.+||+|||+++.---.  ..
T Consensus       432 vnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~  505 (683)
T KOG0696|consen  432 VNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GV  505 (683)
T ss_pred             ecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeecccccccccC--Cc
Confidence            469999999988887  888999999999999999999765  999999999999999999999999999763222  22


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .+.+++||+.|+|||++...+|+.++|.||+|++||||+.|+.||++.+.                ......+++.  ..
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----------------~elF~aI~eh--nv  567 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------DELFQAIMEH--NV  567 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHHc--cC
Confidence            35678999999999999999999999999999999999999999998642                1222233333  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR  187 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt  187 (252)
                      .+|..++.++.+++...|.+.|.+|..
T Consensus       568 syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cCcccccHHHHHHHHHHhhcCCccccC
Confidence            678889999999999999999999953

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=1.3e-29  Score=208.01  Aligned_cols=187  Identities=23%  Similarity=0.240  Sum_probs=131.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.... ..+++..++.++.||++||.|||+++  ++|+||||+||+++.++.++|+|||+++........  .
T Consensus        85 ~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~  159 (298)
T cd07841          85 ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--M  159 (298)
T ss_pred             CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--c
Confidence            789999997665 35999999999999999999999765  999999999999999999999999999765433211  1


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhh-hcchhhhh---hhhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLSD---KRKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~-~~~~~~~~---~~~~~~~~~~  156 (252)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..+|.+....... .... ...+....   ..........
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            22346788999998855 35788999999999999999998877654321100 0000 00000000   0000000000


Q ss_pred             hcCCC-----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 KLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....     .....+..+.++|.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000     112346789999999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=206.32  Aligned_cols=197  Identities=25%  Similarity=0.349  Sum_probs=143.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-------CCCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-------AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      +.|||.+||+.+-   ++|....+++..+++||+|||+       .+++|+|||||..||||.+|+++.|+|||+|..+.
T Consensus       291 ~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            6899999998776   8999999999999999999996       34569999999999999999999999999998876


Q ss_pred             CCCcceeeecccccccccCccccccCC-CC-----cccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcchhhhhh
Q 025440           75 TGDRTHVSTQVMGTHGYAAPEYVATGR-LT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDK  147 (252)
Q Consensus        75 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~  147 (252)
                      ...........+||..|||||++.+.- +.     .+.||||+|.++|||++.-..+........+ -+........ ..
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP-t~  446 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP-TL  446 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC-CH
Confidence            554433344478999999999997642 22     3589999999999999965544321111111 1111111111 11


Q ss_pred             hhHHH-HhhhhcCCCCcHH-----HHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 025440          148 RKLFR-IMDTKLGGQYPQK-----AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK  202 (252)
Q Consensus       148 ~~~~~-~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~  202 (252)
                      ..+.. .+..+.++.++..     -..-+.+.+..||..|++.|.|+.=+.+++.++....
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            22222 3344445555442     3567889999999999999999999999998876544

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=2e-29  Score=207.98  Aligned_cols=168  Identities=29%  Similarity=0.381  Sum_probs=128.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..+..++.||+.||.|||+.+  ++|+||+|+||+++.++.++|+|||++......      
T Consensus        98 ~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------  168 (307)
T cd06607          98 LGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------  168 (307)
T ss_pred             CCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC------
Confidence            367777775433 34899999999999999999999765  999999999999999999999999998754322      


Q ss_pred             ecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           83 TQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ....++..|+|||++.   ...++.++||||||+++|+|++|..||.+.....                ....+......
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----------------~~~~~~~~~~~  232 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALYHIAQNDSP  232 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----------------HHHHHhcCCCC
Confidence            2345788999999874   3568889999999999999999999997643110                01111111111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+..++..+.++|.+||+.||++||++.+++...
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            111234667899999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=9.1e-30  Score=206.84  Aligned_cols=171  Identities=26%  Similarity=0.400  Sum_probs=136.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++|++|.+++.+.+.  +++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++......... 
T Consensus        84 ~~~~~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          84 APNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            368999999987764  999999999999999999999765  999999999999999999999999998765432211 


Q ss_pred             -----------------eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcch
Q 025440           80 -----------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP  142 (252)
Q Consensus        80 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  142 (252)
                                       .......++..|+|||++.+..++.++|+||||+++|++++|..||.....            
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------  227 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------------  227 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------------
Confidence                             112334578899999999888899999999999999999999999976431            


Q ss_pred             hhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCH----HHHHH
Q 025440          143 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM----SEVLA  193 (252)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~----~~v~~  193 (252)
                          ........  ......+..++..+.++|.+||+.||++||++    ++++.
T Consensus       228 ----~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 ----YLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ----HHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                01111111  12234455667889999999999999999999    76654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=8.4e-30  Score=207.66  Aligned_cols=187  Identities=22%  Similarity=0.203  Sum_probs=130.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.......+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  ..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~  156 (283)
T cd07835          81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY  156 (283)
T ss_pred             CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence            468999987766445999999999999999999999765  99999999999999999999999999875432211  11


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcc-hhhh---hhhhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLS---DKRKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~-~~~~---~~~~~~~~~~~  156 (252)
                      ....++..|+|||++.+. .++.++|+||||+++|+|++|..||......... ....... +...   ...........
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            223468889999988665 4688999999999999999999999764321100 0000000 0000   00000000000


Q ss_pred             h--c----CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 K--L----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~--~----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .  .    .......++..+.++|.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0  0    00112345578899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=1.2e-29  Score=206.46  Aligned_cols=181  Identities=23%  Similarity=0.251  Sum_probs=129.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++. +.+||+|||++........   .
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~  155 (282)
T cd07831          83 DMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---Y  155 (282)
T ss_pred             CccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC---c
Confidence            468888886643 34899999999999999999999765  999999999999999 9999999999976533221   1


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcchhhhhhhhHHHHhhhh--c
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRIMDTK--L  158 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--~  158 (252)
                      ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..... ........   ....+.......  .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT---PDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCC---CCHHHHHhhcccccc
Confidence            23457889999997654 45788999999999999999999999765421100 00000000   000000000000  0


Q ss_pred             CCCC-----------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQY-----------PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....           ...++..+.++|.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000           1245789999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=1.4e-29  Score=207.54  Aligned_cols=169  Identities=23%  Similarity=0.335  Sum_probs=132.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.+++...   .+++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--  171 (292)
T cd06657          99 LEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  171 (292)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence            4788999987543   3899999999999999999999765  99999999999999999999999999865433221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC-
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (252)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|..||.+....                 .....+..... 
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----------------~~~~~~~~~~~~  234 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------------KAMKMIRDNLPP  234 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhhCCc
Confidence            123346788999999998888999999999999999999999999764211                 00011111111 


Q ss_pred             -CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 -GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ......++..+.+++.+||..||.+||++.++++
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence             1112345677899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=7.5e-30  Score=209.09  Aligned_cols=186  Identities=22%  Similarity=0.258  Sum_probs=131.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++..... .+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++.........  .
T Consensus        89 ~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~  163 (293)
T cd07843          89 EHDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--Y  163 (293)
T ss_pred             CcCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--c
Confidence            3588888866543 5899999999999999999999765  999999999999999999999999998765433211  1


Q ss_pred             ecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchh-h-hhhcchhhhhhh-----------
Q 025440           83 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-L-VDWAKPYLSDKR-----------  148 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~-~~~~~~~~~~~~-----------  148 (252)
                      ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.......... + ..+..+......           
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK  243 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence            2335688899999987654 6889999999999999999999997654211100 0 000000000000           


Q ss_pred             hHHHHhhhhcCCCCcHH-HHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          149 KLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .............++.. ++..+.++|.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000000111122222 4778899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=7e-30  Score=213.39  Aligned_cols=186  Identities=26%  Similarity=0.290  Sum_probs=132.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++...+.  +++..+..++.||+.||.|||+.+  ++|+||||+||+++.++.+||+|||++.......  ...
T Consensus        92 ~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  165 (337)
T cd07858          92 DTDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFM  165 (337)
T ss_pred             CCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccc
Confidence            4688888876554  999999999999999999999765  9999999999999999999999999997653322  112


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcch-hhh-----hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKP-YLS-----DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~-~~~-----~~~~~~~~~  154 (252)
                      ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+...... ....... ...     ........+
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (337)
T cd07858         166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI  245 (337)
T ss_pred             cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHH
Confidence            33457889999998865 468899999999999999999999997653211100 0000000 000     000011111


Q ss_pred             hhhcC---C---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DTKLG---G---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~~~~---~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....   .   .....++..+.++|.+||+.||++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            10000   0   0122467789999999999999999999999975

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.9e-29  Score=206.22  Aligned_cols=176  Identities=28%  Similarity=0.352  Sum_probs=132.4

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++...  ....+++..+..++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-  159 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence            4689999887542  2344899999999999999999999765  9999999999999999999999999986543221 


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh--
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--  156 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  156 (252)
                         .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..........            ......+..  
T Consensus       160 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~~~~~~  224 (287)
T cd06621         160 ---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP------------IELLSYIVNMP  224 (287)
T ss_pred             ---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh------------HHHHHHHhcCC
Confidence               123356888999999988899999999999999999999999997653200000            000011000  


Q ss_pred             --hcCCCCc--HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 --KLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 --~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                        .......  ...+..+.++|.+||..+|.+|||+.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence              0000111  2346789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=1.3e-29  Score=207.84  Aligned_cols=186  Identities=20%  Similarity=0.242  Sum_probs=127.8

Q ss_pred             CChhhhhhcCC---CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCcc
Q 025440            4 GSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         4 gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++|.+++....   ...+++..++.++.||+.||.|||+.+  ++||||||+||+++. ++.++|+|||++.........
T Consensus        90 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~  167 (295)
T cd07837          90 SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS  167 (295)
T ss_pred             cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecCCCccc
Confidence            57888886543   245899999999999999999999765  999999999999998 889999999998754322111


Q ss_pred             eeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhh-cchhh---hhhhhHHHH
Q 025440           80 HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYL---SDKRKLFRI  153 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~-~~~~~---~~~~~~~~~  153 (252)
                        .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+....... .+... ..+..   .........
T Consensus       168 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T cd07837         168 --YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW  245 (295)
T ss_pred             --cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccch
Confidence              1223467889999988654 5789999999999999999999999764321100 00000 00000   000000000


Q ss_pred             hh-hhcC----CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MD-TKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~-~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .. ....    ......++..+.++|.+||..||.+||++.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00 0000    0001235678999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=1.5e-29  Score=206.41  Aligned_cols=187  Identities=23%  Similarity=0.331  Sum_probs=131.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.++......  +++..++.++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07846          82 VDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  155 (286)
T ss_pred             CCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence            457778877755443  899999999999999999999765  99999999999999999999999999876533321  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcchhhhhhhhHHH---Hhh
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFR---IMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~  155 (252)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|..||......... ..................   ...
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            12334578899999988654 4788999999999999999999999754321100 000000000000000000   000


Q ss_pred             h----hcCC-----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 T----KLGG-----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~----~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .    ....     .....++..+.+|+.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0    0000     011245778999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=3.8e-29  Score=207.25  Aligned_cols=170  Identities=28%  Similarity=0.398  Sum_probs=131.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... .++++..+..++.+|+.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....      .
T Consensus       108 ~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~  178 (317)
T cd06635         108 LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP------A  178 (317)
T ss_pred             CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence            367877775443 34899999999999999999999665  99999999999999999999999999865332      1


Q ss_pred             ecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           83 TQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ....++..|+|||++.   .+.++.++|+|||||++|+|++|..||.....                ......+......
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----------------~~~~~~~~~~~~~  242 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESP  242 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH----------------HHHHHHHHhccCC
Confidence            2345788999999874   45688999999999999999999999865321                1111112111111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ......++..+.+++.+||+.+|.+||++.++++.+..
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            22233466789999999999999999999999986544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=219.98  Aligned_cols=180  Identities=22%  Similarity=0.347  Sum_probs=154.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ||+|+|.||++.+. ..+-....+.|+.||++|+.|||.++  +|||||..+||||..-..+||.|||+++.........
T Consensus       779 mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             cccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            79999999997754 45888999999999999999999654  9999999999999999999999999999876544333


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......-.+.|||-|.+....|+.++|||||||++||++| |..|+++..                 ...+...+....+
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------~~eI~dlle~geR  918 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------AEEIPDLLEKGER  918 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------HHHhhHHHhcccc
Confidence            2333334678999999999999999999999999999999 999998864                 2345566666777


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...|+.++.+++.++.+||..|++.||+++++.+.+.++..
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            78899999999999999999999999999999998887653

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=1.8e-29  Score=210.85  Aligned_cols=187  Identities=26%  Similarity=0.318  Sum_probs=128.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc-cee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~   81 (252)
                      +++|.+++...   .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++........ ...
T Consensus        91 ~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  165 (336)
T cd07849          91 ETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF  165 (336)
T ss_pred             ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeeccccccccCC
Confidence            34666666432   3899999999999999999999765  99999999999999999999999999876433221 111


Q ss_pred             eecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhhhhh--------hH
Q 025440           82 STQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKR--------KL  150 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~--------~~  150 (252)
                      .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+........ ..... .+......        ..
T Consensus       166 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (336)
T cd07849         166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY  245 (336)
T ss_pred             cCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhH
Confidence            233467899999998755 468899999999999999999999997654211000 00000 00000000        00


Q ss_pred             HHHhhhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          151 FRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       151 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ............   ....+.++.++|.+||+.||++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         246 IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000000   11346678999999999999999999999975

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=3.1e-29  Score=201.86  Aligned_cols=171  Identities=25%  Similarity=0.348  Sum_probs=133.4

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++|++|.+++...  ....+++..++.++.|++.||.|||+.+  ++|+||||+||+++. +.++|+|||++........
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          84 CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             CCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            4789999988642  2245999999999999999999999765  999999999999975 5699999999876533221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....                ...... .....
T Consensus       161 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~----------------~~~~~~-~~~~~  221 (260)
T cd08222         161 --LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF----------------LSVVLR-IVEGP  221 (260)
T ss_pred             --cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----------------HHHHHH-HHcCC
Confidence              12334578899999999888889999999999999999999999965321                001111 11122


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+..++.++.++|.+||..||++||++.++++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            23345567789999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=1.8e-29  Score=206.52  Aligned_cols=174  Identities=28%  Similarity=0.359  Sum_probs=132.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..+..++.||+.||.|||+.+  ++||||+|+|||++.++.++|+|||++........ .
T Consensus        87 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~  161 (290)
T cd05613          87 INGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-E  161 (290)
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceecccccc-c
Confidence            578999999987654  889999999999999999999755  99999999999999999999999999876533221 1


Q ss_pred             eeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.......             ........+.. .
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------------~~~~~~~~~~~-~  227 (290)
T cd05613         162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-------------SQAEISRRILK-S  227 (290)
T ss_pred             ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-------------cHHHHHHHhhc-c
Confidence            12335688899999998653  46789999999999999999999996432100             00111111111 1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ....+..++..+.+++.+||+.||++|+     +++++++
T Consensus       228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            2234555778899999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=1.7e-29  Score=206.72  Aligned_cols=186  Identities=22%  Similarity=0.267  Sum_probs=127.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.+... .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++.......  ..
T Consensus        86 ~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~  160 (291)
T cd07844          86 DTDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TY  160 (291)
T ss_pred             CCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cc
Confidence            3589998876543 5899999999999999999999765  99999999999999999999999999875322111  11


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcc-hhhh---hhhhHHHHhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAK-PYLS---DKRKLFRIMD  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~-~~~~---~~~~~~~~~~  155 (252)
                      ....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.....+..  ...... +...   ..........
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            223467889999988764 57889999999999999999999997654211110  000000 0000   0000000000


Q ss_pred             hhcCC-------CCcHHH--HHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGG-------QYPQKA--AHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~-------~~~~~~--~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....       ......  ...+.+++.+||+.||.+||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000       000012  267889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-29  Score=200.89  Aligned_cols=166  Identities=31%  Similarity=0.411  Sum_probs=133.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.+++.....  +++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--  148 (250)
T cd05123          75 APGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--  148 (250)
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--
Confidence            368999999977654  899999999999999999999755  99999999999999999999999999876533221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|++||.+.+...+.++|+||||+++|++++|..||.....                ......+..  ...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----------------~~~~~~~~~--~~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----------------KEIYEKILK--DPL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHhc--CCC
Confidence            12334678899999999888889999999999999999999999965431                011111111  223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSE  190 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  190 (252)
                      ..+...+..+.+++.+||..||++||++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            455566788999999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=8.4e-30  Score=212.66  Aligned_cols=188  Identities=24%  Similarity=0.335  Sum_probs=132.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--e
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--H   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~   80 (252)
                      +|+|.+++...+.  +++..+..++.||+.||+|||+.+  ++||||||+||+++.++.+||+|||++.........  .
T Consensus        91 ~~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  166 (334)
T cd07855          91 ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY  166 (334)
T ss_pred             hhhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCc
Confidence            4688888866554  999999999999999999999765  999999999999999999999999998764332211  1


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhh--cchh---hh--hhhhHHH
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPY---LS--DKRKLFR  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~--~~~~---~~--~~~~~~~  152 (252)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+............  ..+.   ..  .......
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~  246 (334)
T cd07855         167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK  246 (334)
T ss_pred             ccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHH
Confidence            1223468889999998865 4588999999999999999999999976543211000000  0000   00  0000001


Q ss_pred             Hhhh-hcCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          153 IMDT-KLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       153 ~~~~-~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .... ......     ....+..+.++|.+||+.||.+||++.+++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         247 YIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1100 000111     12357789999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=3e-29  Score=206.86  Aligned_cols=188  Identities=22%  Similarity=0.276  Sum_probs=128.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--e
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--H   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~   80 (252)
                      +++|.+++...+ ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++.........  .
T Consensus       102 ~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  178 (310)
T cd07865         102 EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN  178 (310)
T ss_pred             CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCC
Confidence            457888876554 34899999999999999999999765  999999999999999999999999999765332211  1


Q ss_pred             eeecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hhc----chhhhhhh--hHHH
Q 025440           81 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA----KPYLSDKR--KLFR  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~~----~~~~~~~~--~~~~  152 (252)
                      ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.......... ...    ........  ....
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (310)
T cd07865         179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK  258 (310)
T ss_pred             CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhh
Confidence            122345688899999886654 688999999999999999999999765421110000 000    00000000  0000


Q ss_pred             Hhh--hhcCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 IMD--TKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 ~~~--~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...  .......     +......+.+||.+||..||.+|||++++++
T Consensus       259 ~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000  0000000     0112456789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=2.4e-29  Score=206.49  Aligned_cols=172  Identities=28%  Similarity=0.414  Sum_probs=127.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..+..++.+|+.||+|||+. .+|+||||+|+||+++.++.++|+|||++........   .
T Consensus        97 ~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~  171 (296)
T cd06618          97 STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---K  171 (296)
T ss_pred             CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---c
Confidence            456666665433 2589999999999999999999963 2599999999999999999999999999875433221   1


Q ss_pred             ecccccccccCccccccCC----CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           83 TQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......               ............
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~~~~~~~~~~  236 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------------FEVLTKILQEEP  236 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------------HHHHHHHhcCCC
Confidence            2234678999999987654    788999999999999999999999653210               011111111111


Q ss_pred             -CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 -GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       .......++.++.+|+.+||..||++||++.+++..
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             011112357789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=3.6e-29  Score=203.71  Aligned_cols=186  Identities=26%  Similarity=0.273  Sum_probs=132.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~  155 (283)
T cd05118          81 DTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PY  155 (283)
T ss_pred             CCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cc
Confidence            458888886654 35999999999999999999999765  99999999999999999999999999876544321  12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh--hhcchhhhhhhhHHH---Hh--
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKPYLSDKRKLFR---IM--  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~--  154 (252)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+........  ....+..........   ..  
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            234578889999998776 6889999999999999999999999765431110000  000000000000000   00  


Q ss_pred             --hhhcC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 --DTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 --~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        .....   ......++.++.++|.+||+.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              00000   0112346788999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=1.8e-29  Score=210.96  Aligned_cols=187  Identities=27%  Similarity=0.339  Sum_probs=131.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc---
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT---   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---   79 (252)
                      +++|.+++...   .+++..++.++.||+.||+|||+.+  |+|+||||+||+++.++.+||+|||++.........   
T Consensus        92 ~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~  166 (337)
T cd07852          92 ETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN  166 (337)
T ss_pred             ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccC
Confidence            35788888654   4899999999999999999999755  999999999999999999999999998765433221   


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhhhhhh-----HH
Q 025440           80 HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRK-----LF  151 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~-----~~  151 (252)
                      .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+........ ..... .+.......     ..
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (337)
T cd07852         167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAA  246 (337)
T ss_pred             cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHH
Confidence            12234568899999998765 457889999999999999999999997643221110 00000 000000000     00


Q ss_pred             HHhhh---hcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          152 RIMDT---KLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       152 ~~~~~---~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..   ....   .....++.++.++|.+||+.||++|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         247 TMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00100   0000   0112257789999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=3.8e-29  Score=206.43  Aligned_cols=168  Identities=29%  Similarity=0.369  Sum_probs=129.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++......      
T Consensus        98 ~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------  168 (308)
T cd06634          98 LGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------  168 (308)
T ss_pred             CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc------
Confidence            467877775443 34899999999999999999999655  999999999999999999999999998754321      


Q ss_pred             ecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           83 TQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ....++..|+|||.+.   ...++.++|||||||++|+|++|..||......                ............
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~  232 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNESP  232 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----------------HHHHHHhhcCCC
Confidence            2345788999999874   346788999999999999999999998653210                011111111111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ......++..+.+||.+||..+|++||++.++++..
T Consensus       233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            112335677899999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=3.2e-29  Score=206.91  Aligned_cols=187  Identities=25%  Similarity=0.251  Sum_probs=129.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++.........  .
T Consensus        91 ~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~  165 (309)
T cd07845          91 EQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--M  165 (309)
T ss_pred             CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--C
Confidence            457888886543 45899999999999999999999765  999999999999999999999999999765432211  1


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcc-h---hhhhhhhHH---HH
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-P---YLSDKRKLF---RI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~-~---~~~~~~~~~---~~  153 (252)
                      ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+...... +..... +   .+.......   ..
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07845         166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF  245 (309)
T ss_pred             CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence            22345778999999866 457899999999999999999999997654321100 000000 0   000000000   00


Q ss_pred             hhhhcCCC----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          154 MDTKLGGQ----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       154 ~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ........    .....+..+.++|.+||+.||++|||+.+++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000    001246778899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=3e-29  Score=205.31  Aligned_cols=186  Identities=23%  Similarity=0.251  Sum_probs=127.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..+..++.||+.||+|||+.+  |+|+||||+|||++.++.++|+|||+++........  .
T Consensus        86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~  160 (291)
T cd07870          86 HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--Y  160 (291)
T ss_pred             cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--C
Confidence            467777775543 34788899999999999999999765  999999999999999999999999998754322211  2


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhc---chhhhhhhhHH---HHhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA---KPYLSDKRKLF---RIMD  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~  155 (252)
                      ....++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.....+.....+.   .+.........   ....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            233568899999998764 5788999999999999999999999765432111111000   00000000000   0000


Q ss_pred             hhcCCCCc---------HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYP---------QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......+         ...+..+.+++.+||..||.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000         012467889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=5.2e-29  Score=207.47  Aligned_cols=193  Identities=26%  Similarity=0.313  Sum_probs=136.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-ee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~   81 (252)
                      +++|.+++....  .+++..++.++.+|+.||+|||+.+  |+|+||||.|||++.++.++|+|||++......... ..
T Consensus        87 ~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~  162 (330)
T cd07834          87 ETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF  162 (330)
T ss_pred             hhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccc
Confidence            357888886655  4999999999999999999999765  999999999999999999999999999865443210 11


Q ss_pred             eecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhh------hhhhHHHH
Q 025440           82 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLS------DKRKLFRI  153 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~  153 (252)
                      .....++..|+|||++.+. .++.++|+||||+++|+|++|..||.+........ +.........      ........
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  242 (330)
T cd07834         163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNY  242 (330)
T ss_pred             ccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhH
Confidence            2334678899999999887 78999999999999999999999997764321100 0000000000      00000001


Q ss_pred             hhh-hcCC-----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhhc
Q 025440          154 MDT-KLGG-----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI--LERLE  199 (252)
Q Consensus       154 ~~~-~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~--l~~~~  199 (252)
                      +.. ....     ......+..+.++|.+||+.+|.+||++.+++..  ++.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            100 0000     0112356789999999999999999999999974  55443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=1.6e-29  Score=226.86  Aligned_cols=171  Identities=27%  Similarity=0.404  Sum_probs=123.4

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCC----C--
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP----T--   75 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~----~--   75 (252)
                      +.-+|.+++.++.... .....++++.+|+.||.|+|+++  ||||||||.|||++.++.|||+|||+++...    .  
T Consensus       679 E~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d  755 (1351)
T KOG1035|consen  679 EKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESID  755 (1351)
T ss_pred             hhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHh
Confidence            4445666776655311 46788999999999999999766  9999999999999999999999999997611    0  


Q ss_pred             ----------CCcceeeecccccccccCccccccCC---CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcch
Q 025440           76 ----------GDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP  142 (252)
Q Consensus        76 ----------~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  142 (252)
                                .......+..+||..|+|||++.+..   |+.|+||||||++++||+.   ||...-+            
T Consensus       756 ~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------------  820 (1351)
T KOG1035|consen  756 QDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------------  820 (1351)
T ss_pred             hccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH------------
Confidence                      01111245678999999999997654   9999999999999999984   4644211            


Q ss_pred             hhhhhhhHHHHhhhhcCCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          143 YLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         ....+.......+..+  +..+....-..+|+.|++.||.+|||+.|++.
T Consensus       821 ---Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  821 ---RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ---HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence               1111111111112111  12334455678999999999999999999985

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=5.9e-29  Score=233.62  Aligned_cols=186  Identities=33%  Similarity=0.522  Sum_probs=136.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC-CCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.+++..     ++|..+..++.||+.||+|||+. .++|+||||||+||+++.++..++. ||.......    
T Consensus       765 ~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            579999999952     89999999999999999999954 3469999999999999998888775 555443211    


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                        .....++..|+|||++.+..++.++|||||||++|||+||+.||+.... .......|....... ......++....
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~  910 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPSIR  910 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCcccc
Confidence              1223578999999999988999999999999999999999999954321 112222232211111 111112222221


Q ss_pred             C--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 G--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .  ..+.....++.+++.+||+.||++||++.++++.|+++..
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            1  2234556678899999999999999999999999988754

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-29  Score=207.41  Aligned_cols=189  Identities=22%  Similarity=0.238  Sum_probs=129.4

Q ss_pred             CCChhhhhhcCC---CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC----CCceEEccccccccCCC
Q 025440            3 KGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         3 ggsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~   75 (252)
                      +++|.+++....   ...+++..++.++.||+.||+|||+.+  ++||||||+||+++.    ++.+||+|||++.....
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~  164 (316)
T cd07842          87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA  164 (316)
T ss_pred             CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCccccccCC
Confidence            456777664332   235899999999999999999999765  999999999999999    89999999999886543


Q ss_pred             CCc-ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-------hhhhhcc----h
Q 025440           76 GDR-THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLVDWAK----P  142 (252)
Q Consensus        76 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-------~~~~~~~----~  142 (252)
                      ... ........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.......       .+.....    +
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  244 (316)
T cd07842         165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTP  244 (316)
T ss_pred             CcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCC
Confidence            322 1112334678899999988764 5789999999999999999999999865543200       0000000    0


Q ss_pred             hhh------hhhhHHHHhhhhcCCCCc-----------HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          143 YLS------DKRKLFRIMDTKLGGQYP-----------QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       143 ~~~------~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...      .................+           ...+..+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         245 TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             chhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000      000000000000011111           034567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=224.15  Aligned_cols=172  Identities=25%  Similarity=0.313  Sum_probs=141.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|-.++.+.+.  +++.-+..++..|+.||+-+|+.|  +|||||||+|||||..|.+||+|||.|-........ 
T Consensus       157 ~pGGDlltLlSk~~~--~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-  231 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFDR--LPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-  231 (1317)
T ss_pred             ccCchHHHHHhhcCC--ChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-
Confidence            799999999998884  999999999999999999999876  999999999999999999999999998766543333 


Q ss_pred             eeecccccccccCccccc----c-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA----T-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~----~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      .....+|||-|.+||++.    + +.|+..+|.||+||++|||+.|..||....                -...+.+++.
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----------------lveTY~KIm~  295 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----------------LVETYGKIMN  295 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----------------HHHHHHHHhc
Confidence            345678999999999985    2 568999999999999999999999997532                2334445555


Q ss_pred             hhcCCCCc--HHHHHHHHHHHHhhccCCCCCCCC---HHHHHHH
Q 025440          156 TKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt---~~~v~~~  194 (252)
                      -+-...+|  ..++.++.+||.+.+. +|+.|..   ++++...
T Consensus       296 hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  296 HKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            54444555  5689999999998665 7778877   8888763

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=7.8e-29  Score=205.03  Aligned_cols=167  Identities=29%  Similarity=0.408  Sum_probs=127.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... .++++..++.++.||+.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....      .
T Consensus       104 ~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~  174 (313)
T cd06633         104 LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------A  174 (313)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC------C
Confidence            467778776543 35899999999999999999999765  99999999999999999999999999864322      1


Q ss_pred             ecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           83 TQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ....|+..|+|||++.   ...++.++|+||||+++|+|++|..||......                ............
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----------------~~~~~~~~~~~~  238 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALYHIAQNDSP  238 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHHhcCCC
Confidence            2346788999999984   356888999999999999999999998764310                111111111111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......++..+.+|+.+||+.+|.+||++.+++..
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11123355678999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=200.53  Aligned_cols=186  Identities=24%  Similarity=0.298  Sum_probs=131.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.......+++..++.++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||++........   .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  155 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---Y  155 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---c
Confidence            789999997766455899999999999999999999765  99999999999999999999999999876433221   1


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhh----hhhhhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYL----SDKRKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~  156 (252)
                      ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......... .........    ............
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            23457889999998854 457899999999999999999999997654311110 000000000    000000000000


Q ss_pred             hcCC-------CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGG-------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....       ......+..+.++|.+||+.||++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000       000112567899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=5.9e-30  Score=216.05  Aligned_cols=167  Identities=25%  Similarity=0.374  Sum_probs=139.9

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .||.+++||.+++.  +.+..+..++.|+++|++|||+++  |||||||.+||||+.+.++||+|||++..+....   .
T Consensus       138 ~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---~  210 (596)
T KOG0586|consen  138 SGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---M  210 (596)
T ss_pred             cCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeecccc---c
Confidence            58999999999987  777999999999999999999765  9999999999999999999999999998875432   3


Q ss_pred             eecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           82 STQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ....+|++.|.|||++.+.+| .+.+|+||+|+++|.|++|..||++.......                .+.+..++  
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr----------------~rvl~gk~--  272 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR----------------PRVLRGKY--  272 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc----------------chheeeee--
Confidence            456789999999999999887 46899999999999999999999986532111                11111222  


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+.-++.++.++|+++|..+|.+|++.+++.+
T Consensus       273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            334556788999999999999999999999975

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=9.8e-29  Score=203.87  Aligned_cols=188  Identities=23%  Similarity=0.260  Sum_probs=127.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce--
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--   80 (252)
                      +++|.+++.... ..+++..+..++.||++||+|||+.+  ++|+||||+||+++.++.++|+|||+++.........  
T Consensus        98 ~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  174 (311)
T cd07866          98 DHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG  174 (311)
T ss_pred             CcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccchhccCCCccccc
Confidence            346666665443 34999999999999999999999765  9999999999999999999999999997643322111  


Q ss_pred             -------eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcc-hhhhhhhhH
Q 025440           81 -------VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-PYLSDKRKL  150 (252)
Q Consensus        81 -------~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~-~~~~~~~~~  150 (252)
                             ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+........ +..... +........
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T cd07866         175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGW  254 (311)
T ss_pred             CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence                   11234568889999988654 57899999999999999999999997654321100 000000 000000000


Q ss_pred             ---HHHhhhhcCCCCc-------HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          151 ---FRIMDTKLGGQYP-------QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       151 ---~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         ............+       ......+.++|.+||+.||.+|||+.+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         255 RSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence               0000000000001       123367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=203.13  Aligned_cols=173  Identities=28%  Similarity=0.345  Sum_probs=138.3

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      --||+.|.+.-+. ++|++.++..++...++||+|||...  =||||||..|||++-+|..||+|||.+..+.+.  ...
T Consensus       111 GAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK  185 (502)
T ss_pred             CCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence            3578888886554 57999999999999999999999765  799999999999999999999999999764332  122


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ...++||+.|||||++..-.|+.++||||||++..||..|+.||.+.........+.-               .+..-..
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---------------~PPPTF~  250 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---------------KPPPTFK  250 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---------------CCCCCCC
Confidence            4567899999999999999999999999999999999999999987543111110000               0001112


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      -|...+.++.+++++||.++|++|-|+.++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            356678899999999999999999999998863

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.3e-29  Score=198.56  Aligned_cols=188  Identities=22%  Similarity=0.237  Sum_probs=131.9

Q ss_pred             ChhhhhhcC---CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC----CceEEccccccccCCCCC
Q 025440            5 SLENHLFRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         5 sL~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~   77 (252)
                      +|.+.|+-+   ..+.++...+..|+.||+.|+.|||+.-  |+||||||.||||..+    |.|||+|||+++.+.+.-
T Consensus       113 DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~pl  190 (438)
T KOG0666|consen  113 DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPL  190 (438)
T ss_pred             hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccc
Confidence            455555322   1245889999999999999999999865  9999999999999877    899999999999876543


Q ss_pred             cce-eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-------hh----------h
Q 025440           78 RTH-VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-------LV----------D  138 (252)
Q Consensus        78 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-------~~----------~  138 (252)
                      ... ....++-|.+|+|||.+.|. .|+.+.|+||.|||+.||+|-...|.+.....+..       +.          +
T Consensus       191 kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~  270 (438)
T KOG0666|consen  191 KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTD  270 (438)
T ss_pred             cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCcc
Confidence            322 23445679999999999887 58999999999999999999999998766543221       00          0


Q ss_pred             hcchhhhhhhhHHHHhhh---hcCCCC--c------HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          139 WAKPYLSDKRKLFRIMDT---KLGGQY--P------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~---~~~~~~--~------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..++...+.......+..   .....+  .      ..-++...+|+.++|..||-+|.|+++.++.
T Consensus       271 ~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  271 KDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             ccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            111111111111011100   000000  0      0123347899999999999999999999874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=3e-29  Score=221.11  Aligned_cols=187  Identities=17%  Similarity=0.176  Sum_probs=120.3

Q ss_pred             CCCCChhhhhhcCCCC------------------CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCc
Q 025440            1 MPKGSLENHLFRRGPQ------------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFN   61 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~   61 (252)
                      +.+|+|.+++......                  ......+..++.||+.||+|||+.+  |+||||||+|||++. ++.
T Consensus       217 ~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~~~~~~  294 (566)
T PLN03225        217 EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGS  294 (566)
T ss_pred             cCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEeCCCCc
Confidence            3578898888654310                  0123446679999999999999765  999999999999985 578


Q ss_pred             eEEccccccccCCCCCcceeeecccccccccCccccccC----------------------CCCcccceehhHHHHHHHH
Q 025440           62 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----------------------RLTTKSDVYSFGVVLLELL  119 (252)
Q Consensus        62 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di~slG~il~~ll  119 (252)
                      +||+|||+++....... .......+++.|+|||.+...                      .++.++|||||||++|||+
T Consensus       295 ~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~  373 (566)
T PLN03225        295 FKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA  373 (566)
T ss_pred             EEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH
Confidence            99999999976433221 123456789999999976432                      2344679999999999999


Q ss_pred             hCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       120 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ++..+++.........+...    ..+...+...........      ..........+||.+||++||.+|||+.++++
T Consensus       374 ~~~~~~~~~~~~~~~~l~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        374 FPNLRSDSNLIQFNRQLKRN----DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             hCcCCCchHHHHHHHHHHhc----CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence            98766543211100000000    000011111111110000      00111234568999999999999999999997


Q ss_pred             H
Q 025440          194 I  194 (252)
Q Consensus       194 ~  194 (252)
                      .
T Consensus       450 H  450 (566)
T PLN03225        450 H  450 (566)
T ss_pred             C
Confidence            4

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=1.1e-28  Score=202.23  Aligned_cols=187  Identities=21%  Similarity=0.217  Sum_probs=128.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCccee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      +++|.+++.......+++..+..++.||+.||+|||+++  ++|+||+|+||+++. ++.+||+|||++........  .
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~  159 (294)
T PLN00009         84 DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--T  159 (294)
T ss_pred             cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--c
Confidence            467888886666555788899999999999999999765  999999999999985 55799999999975432211  1


Q ss_pred             eecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcchh---hhhhhhHHHHh-
Q 025440           82 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY---LSDKRKLFRIM-  154 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~~---~~~~~~~~~~~-  154 (252)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|+||..||.......... ... ...+.   +.....+.... 
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            2233568899999988664 57889999999999999999999997643211100 000 00000   00000000000 


Q ss_pred             -hhhcCCC----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 -DTKLGGQ----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 -~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       .......    .....+..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000000    11235677899999999999999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.3e-28  Score=206.35  Aligned_cols=183  Identities=23%  Similarity=0.284  Sum_probs=129.1

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .|++|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+||+++.++.++|+|||+++.....     
T Consensus       104 ~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----  173 (345)
T cd07877         104 MGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----  173 (345)
T ss_pred             cccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccccccc-----
Confidence            467888877543   3899999999999999999999765  999999999999999999999999998764321     


Q ss_pred             eecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc---c----hhhhh--hhhH
Q 025440           82 STQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA---K----PYLSD--KRKL  150 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~---~----~~~~~--~~~~  150 (252)
                      .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ......   .    .....  ....
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (345)
T cd07877         174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  253 (345)
T ss_pred             ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHH
Confidence            223457889999998866 46788999999999999999999999764321100 000000   0    00000  0000


Q ss_pred             HHHhhhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          151 FRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       151 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+.......+   ....+..+.++|.+||+.||.+||++.+++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         254 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000000000000   11246678999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=198.34  Aligned_cols=169  Identities=30%  Similarity=0.501  Sum_probs=135.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|--++.+...  |+++.+..+...|+.||.|||+.|  ||+||||.+|||++..|.+||+|+|+++...  ....
T Consensus       333 v~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l--~~gd  406 (593)
T KOG0695|consen  333 VNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGD  406 (593)
T ss_pred             ecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCC--CCCc
Confidence            578999888876655  999999999999999999999765  9999999999999999999999999998632  2233


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHH-HhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  159 (252)
                      .+.+++||+.|.|||++++..|..+.|.|+||++++||+.|+.||+--...         .+..+...-++. +++..+ 
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~---------n~d~ntedylfqvilekqi-  476 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD---------NPDMNTEDYLFQVILEKQI-  476 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC---------CcccchhHHHHHHHhhhcc-
Confidence            467789999999999999999999999999999999999999999743211         111111122222 233333 


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRP  186 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rp  186 (252)
                       ..|..++-....++..-|++||.+|.
T Consensus       477 -riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -cccceeehhhHHHHHHhhcCCcHHhc
Confidence             55666777888999999999999995

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.8e-29  Score=207.54  Aligned_cols=181  Identities=25%  Similarity=0.320  Sum_probs=129.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|.+++...   .+++..++.++.||+.||+|||+.+  |+|+||||+||+++.++.++|+|||++......     .
T Consensus       103 ~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~  172 (343)
T cd07851         103 GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----M  172 (343)
T ss_pred             CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccccccc-----c
Confidence            67898888652   3899999999999999999999765  999999999999999999999999998764332     2


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcc-h---hhh--hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-P---YLS--DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~-~---~~~--~~~~~~~~~  154 (252)
                      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+....... .+..... +   ...  ........+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07851         173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI  252 (343)
T ss_pred             cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHH
Confidence            234578889999988653 6788999999999999999999999765421100 0000000 0   000  000000010


Q ss_pred             hhh---cCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTK---LGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~---~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...   ....+   ....+..+.++|.+||+.||++|||+.+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000   00001   1134678999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=9.2e-29  Score=201.58  Aligned_cols=186  Identities=23%  Similarity=0.283  Sum_probs=129.9

Q ss_pred             CChhhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            4 GSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         4 gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |+|.+++.... ...+++..+..++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  ..
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  157 (284)
T cd07836          82 KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TF  157 (284)
T ss_pred             ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cc
Confidence            58888886654 245899999999999999999999765  99999999999999999999999999875432211  12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hh-hhcchhhhhhhhHHHH--hhhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LV-DWAKPYLSDKRKLFRI--MDTK  157 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~--~~~~  157 (252)
                      ....++..|++||++.+. .++.++|+||||+++|+|++|..||.+........ .. ....+.......+...  ....
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            234568889999988664 46889999999999999999999998654321100 00 0000000000000000  0000


Q ss_pred             cC-------CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..       ......++..+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00       0011234678899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-28  Score=198.14  Aligned_cols=184  Identities=24%  Similarity=0.283  Sum_probs=130.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++.... ..+++..++.++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        81 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~  155 (282)
T cd07829          81 DMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--Y  155 (282)
T ss_pred             CcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--c
Confidence            468999997763 34999999999999999999999765  999999999999999999999999998765432211  2


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcchhhhhhhhHHHH-------
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKRKLFRI-------  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-------  153 (252)
                      ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... ........  .....+...       
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGT--PTEESWPGVTKLPDYK  233 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCC--CcHHHHHhhccccccc
Confidence            223457789999998776 7899999999999999999999999765421100 00000000  000000000       


Q ss_pred             -hhhhcCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 -MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 -~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       .......    ......+..+.++|.+||..||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             0000000    001123678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-28  Score=199.82  Aligned_cols=186  Identities=24%  Similarity=0.292  Sum_probs=129.3

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++......... ...
T Consensus        84 ~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~  159 (287)
T cd07840          84 HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYT  159 (287)
T ss_pred             ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-ccc
Confidence            57888886653 35999999999999999999999765  999999999999999999999999999765443211 122


Q ss_pred             cccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhh---hhhhH--HHHh-
Q 025440           84 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLS---DKRKL--FRIM-  154 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~---~~~~~--~~~~-  154 (252)
                      ...++..|+|||.+.+. .++.++||||||+++|+|++|..||.......... +.... .+...   ....+  .... 
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence            33567889999987654 57899999999999999999999997654311100 00000 00000   00000  0000 


Q ss_pred             -----hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 -----DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                           ...........++..+.+++.+||..+|.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 000000001113678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-29  Score=194.69  Aligned_cols=187  Identities=25%  Similarity=0.297  Sum_probs=136.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~   77 (252)
                      |.||+|..+|.++.-  +++.++..+..+|+.||+|||.+  ||.||||||+|||......   ||||||.+..-.....
T Consensus       158 m~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k--gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK--GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc--CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            679999999988866  99999999999999999999965  4999999999999965443   8999998864321111


Q ss_pred             c-----ceeeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           78 R-----THVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        78 ~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      .     .....+.+|+..|||||+..-     ..|+.++|.||||+|+|-|++|..||.+.=..  +=-.+-..+.....
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~--dCGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA--DCGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC--cCCccCCCccHHHH
Confidence            1     111234678999999997632     35899999999999999999999999874211  00000011222233


Q ss_pred             hhHHHHh-hhhcC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          148 RKLFRIM-DTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       148 ~~~~~~~-~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+++-+ +..+.  ..-+..++.+..+++..+|..|+.+|.++.+++.
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            3344333 22222  1223468999999999999999999999999887

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=2.6e-28  Score=200.64  Aligned_cols=186  Identities=24%  Similarity=0.227  Sum_probs=127.1

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++.... ..+++..++.++.||+.||+|||+.+  |+|+||||+||+++.++.+||+|||++......... ...
T Consensus       100 ~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~  175 (302)
T cd07864         100 HDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYT  175 (302)
T ss_pred             ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccc
Confidence            46777775542 35899999999999999999999765  999999999999999999999999998765433211 112


Q ss_pred             cccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc-chhhhhhhhHHHH-----hh
Q 025440           84 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLSDKRKLFRI-----MD  155 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~-----~~  155 (252)
                      ...++..|+|||++.+. .++.++|||||||++|+|++|+.||......... .+.... .+...........     .+
T Consensus       176 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T cd07864         176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK  255 (302)
T ss_pred             cceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccc
Confidence            23457789999988654 4688999999999999999999999754321100 000000 0000000000000     00


Q ss_pred             hh--cC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TK--LG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~--~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..  ..   ......++..+.+++.+||..||.+||++.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         256 PKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00  00   0011134678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=1.7e-28  Score=204.79  Aligned_cols=187  Identities=22%  Similarity=0.235  Sum_probs=128.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc----
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----   78 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----   78 (252)
                      .|+|.+++.....  +++..+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++........    
T Consensus       103 ~~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~  178 (335)
T PTZ00024        103 ASDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL  178 (335)
T ss_pred             ccCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCccceeecccccccccc
Confidence            4689999876554  899999999999999999999765  99999999999999999999999999876431100    


Q ss_pred             --------ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc-chh---h
Q 025440           79 --------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPY---L  144 (252)
Q Consensus        79 --------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~-~~~---~  144 (252)
                              ........++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+....... .+.... .+.   +
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~  258 (335)
T PTZ00024        179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNW  258 (335)
T ss_pred             cccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhC
Confidence                    0111223467889999998764 4688999999999999999999999765421100 000000 000   0


Q ss_pred             hhhhhHHHHh--hhhcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          145 SDKRKLFRIM--DTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       145 ~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..........  ......   ......+..+.++|.+||+.+|++||++++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        259 PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             cchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            0000000000  000000   001234677899999999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=4.3e-28  Score=192.35  Aligned_cols=170  Identities=32%  Similarity=0.421  Sum_probs=134.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.+++.....  +++..++.++.+++.++.|||+.+  ++|+||+|.||+++.++.++|+|||.+.......   
T Consensus        69 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---  141 (244)
T smart00220       69 CDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---  141 (244)
T ss_pred             CCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---
Confidence            356799999977654  899999999999999999999765  9999999999999999999999999998754432   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......++..|++||.+.+..++.++|+|+||+++|+|++|..||....                +.......+......
T Consensus       142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----------------~~~~~~~~~~~~~~~  205 (244)
T smart00220      142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----------------QLLELFKKIGKPKPP  205 (244)
T ss_pred             ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----------------cHHHHHHHHhccCCC
Confidence            1234457889999999988888999999999999999999999996631                111112222111111


Q ss_pred             CCcHH--HHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQK--AAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~--~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....  ++.++.+++.+||..+|++||++.++++
T Consensus       206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            11111  6678999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.2e-28  Score=206.38  Aligned_cols=175  Identities=22%  Similarity=0.319  Sum_probs=122.5

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||+++.....     .....++..|+|||+
T Consensus       113 ~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~  185 (342)
T cd07879         113 PLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEV  185 (342)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhh
Confidence            4899999999999999999999765  999999999999999999999999998754221     123456888999999


Q ss_pred             ccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcc---hhhhh---hhhHHHHhhhh--c-CCC---C
Q 025440           97 VAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK---PYLSD---KRKLFRIMDTK--L-GGQ---Y  162 (252)
Q Consensus        97 ~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~---~~~~~---~~~~~~~~~~~--~-~~~---~  162 (252)
                      +.+ ..++.++|+|||||++|+|++|+.||.+........ ......   +....   ...........  . ...   .
T Consensus       186 ~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (342)
T cd07879         186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL  265 (342)
T ss_pred             hcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHH
Confidence            866 468899999999999999999999998654211000 000000   00000   00000000000  0 000   0


Q ss_pred             cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH--HHhh
Q 025440          163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI--LERL  198 (252)
Q Consensus       163 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~--l~~~  198 (252)
                      ....+..+.+||.+||+.||++||++.+++..  ++.+
T Consensus       266 ~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         266 FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            11345678899999999999999999999853  5544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=2.4e-28  Score=204.50  Aligned_cols=186  Identities=22%  Similarity=0.300  Sum_probs=125.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCcce-
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTH-   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~-   80 (252)
                      +++|.+++...   .+++..+..++.||+.||+|||+.+  ++||||||+||+++. ++.++|+|||+++......... 
T Consensus        99 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~  173 (342)
T cd07854          99 ETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG  173 (342)
T ss_pred             cccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCcccccc
Confidence            35777777543   3899999999999999999999765  999999999999974 5578999999987643221111 


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhh--hhhhHH----HH
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS--DKRKLF----RI  153 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~----~~  153 (252)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+..............+...  ......    ..
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (342)
T cd07854         174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSF  253 (342)
T ss_pred             ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence            1122357889999998754 4578899999999999999999999976543111110000000000  000000    00


Q ss_pred             hh-hhcCCC-----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MD-TKLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~-~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .. ......     .....+.++.+||.+||+.||.+|||+.+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         254 VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00 000000     01235678899999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.6e-28  Score=187.59  Aligned_cols=188  Identities=23%  Similarity=0.262  Sum_probs=133.7

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--eee
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVS   82 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~   82 (252)
                      +|.-.|.+.. ..++..++.+++.+++.||.|+|...  |+|||+|++|+||+.+|.+||+|||+++.+......  ...
T Consensus       109 DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpry  185 (376)
T KOG0669|consen  109 DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRY  185 (376)
T ss_pred             hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCc
Confidence            4555554442 34899999999999999999999765  999999999999999999999999999876433221  112


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh--------hhcchhhhhhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--------DWAKPYLSDKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~  153 (252)
                      ++.+-|.+|++||.+.|. .|+.+.|||..|||+.||+||...|++.+....-.++        ...+|...+...+..+
T Consensus       186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~si  265 (376)
T KOG0669|consen  186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSI  265 (376)
T ss_pred             ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhc
Confidence            344569999999999886 5899999999999999999999999887653221111        1222222222111111


Q ss_pred             hhhhcCC----CC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          154 MDTKLGG----QY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       154 ~~~~~~~----~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      -......    ..     |..-.++..+|+.++|..||.+|++++++++.-
T Consensus       266 e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  266 ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            0000000    00     111245788999999999999999999998743

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.5e-28  Score=203.62  Aligned_cols=181  Identities=22%  Similarity=0.259  Sum_probs=127.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|.+++...   .+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.++|+|||++......     .
T Consensus       103 ~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~  172 (343)
T cd07880         103 GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----M  172 (343)
T ss_pred             CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccccccccC-----c
Confidence            56787777542   3899999999999999999999765  999999999999999999999999998764322     1


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcchhhhh------hhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD------KRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~  154 (252)
                      ....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+....... ............      ........
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (343)
T cd07880         173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV  252 (343)
T ss_pred             cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHH
Confidence            23356889999999876 35888999999999999999999999765321000 000000000000      00000000


Q ss_pred             hhh--cC----CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTK--LG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~--~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...  ..    ......++..+.++|.+||+.||++|||+.+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000  00    0011245667899999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=199.32  Aligned_cols=178  Identities=22%  Similarity=0.319  Sum_probs=138.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+|.+|+-||+.+..  +++.++..|+.||+.||.||.....+|||.||||.|||+..   .|.+||+|||++++.....
T Consensus       550 ceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddS  627 (775)
T KOG1151|consen  550 CEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDS  627 (775)
T ss_pred             cCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCc
Confidence            689999999988766  99999999999999999999998889999999999999943   4779999999999875544


Q ss_pred             cc-----eeeecccccccccCccccccC----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           78 RT-----HVSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        78 ~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                      ..     .......||.+|++||++.-+    +.+.++||||+|||+|..+.|+.||...-..  +.+.           
T Consensus       628 y~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL-----------  694 (775)
T KOG1151|consen  628 YNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL-----------  694 (775)
T ss_pred             cCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH-----------
Confidence            33     335567899999999988544    4789999999999999999999999764210  0000           


Q ss_pred             hHHHHhhh-hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          149 KLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       149 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....++.. ....+..+.++.+..+||++||++.-++|..+.++..
T Consensus       695 qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  695 QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            00011111 1122333467889999999999999999988777653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-29  Score=195.14  Aligned_cols=167  Identities=22%  Similarity=0.340  Sum_probs=125.6

Q ss_pred             hhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeeccccc
Q 025440            9 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT   88 (252)
Q Consensus         9 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt   88 (252)
                      +++.-....+++...-+|....+.||+||-.. -.|||||+||+|||++..|.+||||||++..+.+.-   ..+...|.
T Consensus       155 ~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGC  230 (361)
T KOG1006|consen  155 RVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGC  230 (361)
T ss_pred             HHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCC
Confidence            33333334588888888999999999999864 359999999999999999999999999997543221   12344688


Q ss_pred             ccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC-CCc--
Q 025440           89 HGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG-QYP--  163 (252)
Q Consensus        89 ~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--  163 (252)
                      ..|||||.+...  .|+-+||+||||++|||+.||..|+.+...               ...++..++...... ..+  
T Consensus       231 rpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------------vfeql~~Vv~gdpp~l~~~~~  295 (361)
T KOG1006|consen  231 RPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------------VFEQLCQVVIGDPPILLFDKE  295 (361)
T ss_pred             ccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------------HHHHHHHHHcCCCCeecCccc
Confidence            899999998543  589999999999999999999999987542               112222222222111 111  


Q ss_pred             -HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          164 -QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       164 -~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       ...+..+..+|.-||-+|...||.+.++.+.
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             2367789999999999999999999998763

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=5.9e-28  Score=201.04  Aligned_cols=182  Identities=27%  Similarity=0.363  Sum_probs=128.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +++|.+++...   .+++..+..++.|++.||+|||+.+  ++|+||+|.||+++.++.++|+|||++......     .
T Consensus        93 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~  162 (328)
T cd07856          93 GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----M  162 (328)
T ss_pred             ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC-----c
Confidence            67888887543   3788889999999999999999765  999999999999999999999999998754221     1


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcchhhhh------hhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD------KRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~  154 (252)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ............      ........
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            23456888999998766 56899999999999999999999999765321100 000000000000      00000000


Q ss_pred             hh-hcCCCCc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DT-KLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~-~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .. ......+     ..++..+.++|.+||+.+|++||++.+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 0011111     2356789999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=212.46  Aligned_cols=168  Identities=30%  Similarity=0.413  Sum_probs=124.6

Q ss_pred             CChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CC--ceEEccccccccCCCC
Q 025440            4 GSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EF--NAKLSDFGLAKAGPTG   76 (252)
Q Consensus         4 gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~--~~kl~Dfg~~~~~~~~   76 (252)
                      .||.|++.....  ........+.++.|+++||++||+.+  ||||||||.||||+.   ++  +++|+|||+++....+
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            478888876411  11111345788999999999999876  999999999999966   34  5899999999987554


Q ss_pred             Ccc-eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhC-CCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           77 DRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        77 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                      ... .......||.+|+|||++....-+.++|||||||++|+.++| ..||.+.-.                  ....++
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~------------------R~~NIl  726 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE------------------RQANIL  726 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH------------------hhhhhh
Confidence            432 224456799999999999998888899999999999999995 999976421                  001111


Q ss_pred             hhhcC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....   .....++  ++.+||.+|++.||..||++.+|+.
T Consensus       727 ~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 TGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            11110   0111112  8899999999999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=194.82  Aligned_cols=185  Identities=25%  Similarity=0.337  Sum_probs=137.1

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-----C-CCCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-----A-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-----~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      +.|||+|||.+..   ++.+..++++..+|.||+|||.     + ++.|.|||||..||||.++|.+.|+|+|+|-....
T Consensus       292 e~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~  368 (513)
T KOG2052|consen  292 EHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  368 (513)
T ss_pred             cCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence            6899999997743   9999999999999999999994     2 34599999999999999999999999999976544


Q ss_pred             CC-cce-eeecccccccccCccccccCC----C--CcccceehhHHHHHHHHhC----------CCCCCCcccccchhhh
Q 025440           76 GD-RTH-VSTQVMGTHGYAAPEYVATGR----L--TTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSLV  137 (252)
Q Consensus        76 ~~-~~~-~~~~~~gt~~y~aPE~~~~~~----~--~~~~Di~slG~il~~lltg----------~~pf~~~~~~~~~~~~  137 (252)
                      .. ... .....+||..|||||++...-    +  -..+||||||.++||+...          +.||.+.         
T Consensus       369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~---------  439 (513)
T KOG2052|consen  369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV---------  439 (513)
T ss_pred             cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC---------
Confidence            32 111 234568999999999985431    2  1368999999999999762          3344332         


Q ss_pred             hhcchhhhhhhhHHHHhhhhcCCCCcH-----HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          138 DWAKPYLSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        .....+.......+...+.++..|.     ..-..+.++|+.||..+|..|.|+-.+.+.|.++..
T Consensus       440 --Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  440 --VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             --CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence              1222222222222334444444443     355678899999999999999999999999988753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-27  Score=202.52  Aligned_cols=123  Identities=28%  Similarity=0.373  Sum_probs=107.4

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee--cCCCc--eEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFN--AKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill--~~~~~--~kl~Dfg~~~~~~~   75 (252)
                      |.||||...|.+..+ .+|++.+.+.++.+++.||.|||..  +||||||||.||++  ..+|+  -||+|||.|+...+
T Consensus        99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn--~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d  176 (732)
T KOG4250|consen   99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN--GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD  176 (732)
T ss_pred             cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEEeecCCCceEEeeecccccccCCC
Confidence            689999999976643 6799999999999999999999955  49999999999999  33444  79999999998766


Q ss_pred             CCcceeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCc
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKT  128 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~  128 (252)
                      +.   .....+||..|.+||++.. ..|+..+|.|||||++|+.+||..||...
T Consensus       177 ~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  177 NS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             CC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            54   3567899999999999984 78999999999999999999999999653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=2.5e-27  Score=213.47  Aligned_cols=67  Identities=33%  Similarity=0.482  Sum_probs=61.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      |+||+|.+++...+.  +++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            579999999977654  899999999999999999999764  9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=187.24  Aligned_cols=182  Identities=22%  Similarity=0.284  Sum_probs=129.4

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      +||.+.+.    ..++-..+..++.|++.|++|||+.+  |+||||||+||++..+..+||.|||+++.....   ...+
T Consensus       105 ~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mt  175 (369)
T KOG0665|consen  105 ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMT  175 (369)
T ss_pred             hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccCcc---cccC
Confidence            34555554    23788889999999999999999765  999999999999999999999999999864322   2345


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-----hhhhhcchhhhhhhhHHHHh----
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-----SLVDWAKPYLSDKRKLFRIM----  154 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~----  154 (252)
                      ..+.|..|.|||++.+..+...+||||+||++.||++|...|.+.+.-...     .+......+...-....++.    
T Consensus       176 pyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~  255 (369)
T KOG0665|consen  176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENR  255 (369)
T ss_pred             chhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcC
Confidence            567899999999999999999999999999999999999999875431110     00000001111100000000    


Q ss_pred             hh----hcCCCC-----------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DT----KLGGQY-----------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~----~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..    .....+           +..-...+.+++.+||..||++|.++++++..
T Consensus       256 ~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  256 PQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            00    000001           11234568899999999999999999999863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.3e-27  Score=202.68  Aligned_cols=166  Identities=28%  Similarity=0.389  Sum_probs=128.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCC------
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP------   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~------   74 (252)
                      ++||++-.+|-+.+-  |.+..+..++.++..|+++.|.+|  +|||||||+|||||.+|.+||+|||||+-+.      
T Consensus       711 IPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             cCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            589999999988886  999999999999999999999765  9999999999999999999999999996421      


Q ss_pred             ---CCCcce-------------------------------eeecccccccccCccccccCCCCcccceehhHHHHHHHHh
Q 025440           75 ---TGDRTH-------------------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS  120 (252)
Q Consensus        75 ---~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt  120 (252)
                         .++...                               .....+||..|+|||++....|+..+|.||.|||||||+.
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence               111000                               0113479999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccchh-hhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCC
Q 025440          121 GRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP  186 (252)
Q Consensus       121 g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  186 (252)
                      |+.||...+....+. +..|               ...+...+..+++.++.++|.++. .+++.|.
T Consensus       867 g~~pf~~~tp~~tq~kv~nw---------------~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINW---------------RNFLHIPYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             CCCCccCCCCCcceeeeeeh---------------hhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence            999998765543332 1111               111222344567788888888743 4556665

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=2e-28  Score=203.88  Aligned_cols=170  Identities=21%  Similarity=0.256  Sum_probs=135.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~   79 (252)
                      +|+..+.|.......|++.....++.||+.||.|||.++  |+|.||||+|||+....   .+||||||++++..+.   
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---  720 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---  720 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence            466777776555555999999999999999999999665  99999999999996653   4999999999986543   


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+||+.|+|||+++...|..+-|+||.|+|+|--++|..||...++-.             +   ..+.....+.
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-------------d---QIQNAaFMyP  784 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-------------D---QIQNAAFMYP  784 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-------------H---HhhccccccC
Confidence            23556789999999999999999999999999999999999999997643210             0   0111111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++.+..+||..+|+..-.+|.+++..+.
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            3345678889999999999999999999988775

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=184.36  Aligned_cols=179  Identities=26%  Similarity=0.379  Sum_probs=128.4

Q ss_pred             CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccC
Q 025440           14 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA   93 (252)
Q Consensus        14 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a   93 (252)
                      .++.|+...+.-+++||++||+|||+.+  |+||||||.|.|++.|-.+||||||+++......... .+..+-|..|+|
T Consensus       149 SPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRA  225 (449)
T KOG0664|consen  149 SPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRA  225 (449)
T ss_pred             cCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHHhcc
Confidence            3567999999999999999999999876  9999999999999999999999999999865544333 344556899999


Q ss_pred             ccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hh-cchhhhhhhh-----HHHHhhhhcCCC-C--
Q 025440           94 PEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKPYLSDKRK-----LFRIMDTKLGGQ-Y--  162 (252)
Q Consensus        94 PE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~-----~~~~~~~~~~~~-~--  162 (252)
                      ||++.|. .|+.+.||||.|||+.|++..+..|+....-..-.++ +. ..+.....+.     ...++....+.+ .  
T Consensus       226 PEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v  305 (449)
T KOG0664|consen  226 PELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR  305 (449)
T ss_pred             HHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc
Confidence            9999876 5999999999999999999999999765432111111 11 1111111110     111111111111 1  


Q ss_pred             ------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          163 ------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       163 ------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                            +..-..+...++..++..||++|.+.++.+..+
T Consensus       306 LYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  306 LYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             eeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                  112334667888899999999999999888654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=177.58  Aligned_cols=110  Identities=31%  Similarity=0.420  Sum_probs=93.0

Q ss_pred             CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcc
Q 025440           16 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE   95 (252)
Q Consensus        16 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE   95 (252)
                      ..+++...-+|+..++.||.|||++ -.++|||+||.||||+.+|+||+||||++..+.+.--   .+...|...|||||
T Consensus       143 ~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPE  218 (282)
T KOG0984|consen  143 GTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPE  218 (282)
T ss_pred             CcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCccCChh
Confidence            3489999999999999999999985 4599999999999999999999999999976533211   12235778899999


Q ss_pred             ccccC----CCCcccceehhHHHHHHHHhCCCCCCCcc
Q 025440           96 YVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTK  129 (252)
Q Consensus        96 ~~~~~----~~~~~~Di~slG~il~~lltg~~pf~~~~  129 (252)
                      .+..+    .|+-++||||||+++.||.+++.||+...
T Consensus       219 ri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  219 RINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            88543    68999999999999999999999997653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-27  Score=205.80  Aligned_cols=173  Identities=25%  Similarity=0.347  Sum_probs=140.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.|||..|++++.....+.|..+..|++.++.||.+||..  .++|||||-.|||++.+|.|||+|||++......-  .
T Consensus       103 C~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n--kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--g  178 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN--KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--G  178 (953)
T ss_pred             cCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc--ceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--c
Confidence            6799999999877777799999999999999999999954  49999999999999999999999999987653322  2


Q ss_pred             eeecccccccccCccccccC-----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh-
Q 025440           81 VSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  154 (252)
                      ...+.+||+.|||||++...     .|+..+|+||||++..||..|.+|+-+...                ...++.+. 
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----------------mraLF~IpR  242 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----------------MRALFLIPR  242 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------------hhhhccCCC
Confidence            24567899999999999754     377899999999999999999999977542                11111111 


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ++......+...+.++.++|..||.+|..+||+..++++
T Consensus       243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            111112335677899999999999999999999999875

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.3e-26  Score=197.08  Aligned_cols=186  Identities=20%  Similarity=0.207  Sum_probs=125.5

Q ss_pred             CCCCChhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC
Q 025440            1 MPKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA   58 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~   58 (252)
                      +++|+|.++|+....                      ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.
T Consensus       267 ~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~  344 (507)
T PLN03224        267 ESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTV  344 (507)
T ss_pred             CCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECC
Confidence            467888888864311                      13567888999999999999999765  999999999999999


Q ss_pred             CCceEEccccccccCCCCCcceeeecccccccccCccccccCC--------------------C--CcccceehhHHHHH
Q 025440           59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--------------------L--TTKSDVYSFGVVLL  116 (252)
Q Consensus        59 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~--~~~~Di~slG~il~  116 (252)
                      ++.+||+|||++.......... .....+++.|+|||.+....                    +  ..+.||||+||++|
T Consensus       345 ~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~  423 (507)
T PLN03224        345 DGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLM  423 (507)
T ss_pred             CCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHH
Confidence            9999999999986543322111 11223578999999875432                    1  13479999999999


Q ss_pred             HHHhCCC-CCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCC---CCCCCHHHHH
Q 025440          117 ELLSGRC-AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP---KLRPRMSEVL  192 (252)
Q Consensus       117 ~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rpt~~~v~  192 (252)
                      +|++|.. ||.+...... ..    ..+..+...+................+....+|+.+||.++|   .+|+|+.+++
T Consensus       424 em~~~~l~p~~~~~~f~~-~~----~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL  498 (507)
T PLN03224        424 QMCVPELRPVANIRLFNT-EL----RQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL  498 (507)
T ss_pred             HHHhCCCCCccchhhhhh-HH----hhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence            9999875 6654221100 00    000011111111111222223334567889999999999876   6899999998


Q ss_pred             HH
Q 025440          193 AI  194 (252)
Q Consensus       193 ~~  194 (252)
                      ++
T Consensus       499 ~H  500 (507)
T PLN03224        499 SH  500 (507)
T ss_pred             CC
Confidence            63

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-26  Score=166.19  Aligned_cols=184  Identities=23%  Similarity=0.269  Sum_probs=130.2

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeec
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ   84 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~   84 (252)
                      +|..|...-+ ..++.+.+..++.|+++||.++|+++  ++||||||.|.||+.+|.+|++|||+++.+.-.  ..+...
T Consensus        86 dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgip--vrcysa  160 (292)
T KOG0662|consen   86 DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSA  160 (292)
T ss_pred             HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeec
Confidence            3445554333 24899999999999999999999887  999999999999999999999999999986543  233455


Q ss_pred             ccccccccCccccccCC-CCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhh--cchhhhhhhhHHHHhhhhcCC
Q 025440           85 VMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW--AKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        85 ~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .+-|.+|++|.++.|.+ |+.+.|+||.|||+.|+.. |+..|.+.+....-..+-+  ..+.......+...-+-..-+
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp  240 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP  240 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence            56799999999998875 8899999999999999986 8888888765322111100  000000000000110111111


Q ss_pred             CC---------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QY---------PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~---------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .+         .+.....-.++++++|..+|.+|.++++.++
T Consensus       241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11         1234556789999999999999999998775

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.2e-26  Score=192.89  Aligned_cols=185  Identities=21%  Similarity=0.187  Sum_probs=133.4

Q ss_pred             CChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCccee
Q 025440            4 GSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         4 gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      -||.+.|.+.+. .+|....+..++.|+..||..|-.++  |+|.||||+||||++. ..+||||||.|........   
T Consensus       518 lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei---  592 (752)
T KOG0670|consen  518 LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASENEI---  592 (752)
T ss_pred             chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccccccccc---
Confidence            478888887764 56889999999999999999999554  9999999999999875 4589999999876544322   


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhcch------------------
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKP------------------  142 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~------------------  142 (252)
                       +.+.-+..|.|||++.|..|+...|+||.||+||||.||+..|.+.+....- .+.+.-.+                  
T Consensus       593 -tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~  671 (752)
T KOG0670|consen  593 -TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQ  671 (752)
T ss_pred             -cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhccc
Confidence             2234467899999999999999999999999999999999999987642110 00000000                  


Q ss_pred             ---h-------------------hhhhhhHHHHhhhhc-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          143 ---Y-------------------LSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       143 ---~-------------------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                         +                   ......+...+.... ...-...+...+.+|+.+||..||++|.|..+.|..
T Consensus       672 d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  672 DLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             ccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence               0                   000011111111110 011123456789999999999999999999988753

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=185.44  Aligned_cols=185  Identities=19%  Similarity=0.306  Sum_probs=134.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC----------------------
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----------------------   59 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~----------------------   59 (252)
                      -|.+|..+|.+.+.++++...+..|+.||+.||.|||.+ .+|||.||||+|||+..+                      
T Consensus       168 LGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s  246 (590)
T KOG1290|consen  168 LGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMS  246 (590)
T ss_pred             hhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeeccccchhhhhhhhccccccCCCCC
Confidence            377899999999889999999999999999999999974 679999999999999300                      


Q ss_pred             --------------------------------------------------------------------------------
Q 025440           60 --------------------------------------------------------------------------------   59 (252)
Q Consensus        60 --------------------------------------------------------------------------------   59 (252)
                                                                                                      
T Consensus       247 ~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~  326 (590)
T KOG1290|consen  247 PSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSN  326 (590)
T ss_pred             cccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------CceEEccccccccCCC
Q 025440           60 ----------------------------------------------------------------FNAKLSDFGLAKAGPT   75 (252)
Q Consensus        60 ----------------------------------------------------------------~~~kl~Dfg~~~~~~~   75 (252)
                                                                                      -+|||+|||-|+....
T Consensus       327 ~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k  406 (590)
T KOG1290|consen  327 ENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK  406 (590)
T ss_pred             cccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh
Confidence                                                                            0145555555544211


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcc---cccch-hhhh-------hc----
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK---VGIEQ-SLVD-------WA----  140 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~---~~~~~-~~~~-------~~----  140 (252)
                           ..+..+.|..|+|||++.|..|+..+||||++|++|||+||...|+...   ...+. .+..       ..    
T Consensus       407 -----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia  481 (590)
T KOG1290|consen  407 -----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIA  481 (590)
T ss_pred             -----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHH
Confidence                 1234456889999999999999999999999999999999999996433   22221 1111       00    


Q ss_pred             ------chhhhhh-----------hhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          141 ------KPYLSDK-----------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       141 ------~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                            ..++...           ..+.+++..++  .++.....++.+|+.-||+.+|++|||+.++++.
T Consensus       482 ~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY--~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  482 LGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKY--EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             hcCcchHhhhccccceecccccCCCcHHHHHHHHh--CCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence                  1111111           11222222222  4556778899999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-25  Score=171.32  Aligned_cols=169  Identities=24%  Similarity=0.349  Sum_probs=120.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec--CCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      +|-|+|..-+...|   +.+.....++.|+++||.|||+++  +||||||.+||||-  +..+|||||||+.+..+..- 
T Consensus       104 aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-  177 (378)
T KOG1345|consen  104 APRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-  177 (378)
T ss_pred             CccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence            46788888776544   899999999999999999999876  99999999999993  34579999999987643321 


Q ss_pred             ceeeecccccccccCccccccC-----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           79 THVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                          ...--+..|.+||.....     ...+.+|||.||+++|..+||..||+.....+..+.. |            ..
T Consensus       178 ----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~-~------------~~  240 (378)
T KOG1345|consen  178 ----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE-W------------EQ  240 (378)
T ss_pred             ----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH-H------------HH
Confidence                112235678999976432     3467899999999999999999999854332222111 1            01


Q ss_pred             hhhhcCCCCc---HHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 025440          154 MDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVL  192 (252)
Q Consensus       154 ~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~v~  192 (252)
                      .........|   ...+..+..+.++-|..++++|=-+.++.
T Consensus       241 w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  241 WLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             HhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            1111111222   23567788899999999999994444333

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=2.4e-23  Score=161.25  Aligned_cols=139  Identities=35%  Similarity=0.534  Sum_probs=118.1

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCcce
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      .|++|.+++.... ..+++..++.++.+++++|++||+.+  ++|+||+|.||+++. ++.++|+|||.+........  
T Consensus        74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            5789999997653 24899999999999999999999765  999999999999999 89999999999876543321  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+...|++||.+... .++.+.|+|+||+++++|                                         
T Consensus       149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------  187 (215)
T cd00180         149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------  187 (215)
T ss_pred             hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence            12234567889999999777 788999999999999998                                         


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                              ..+.+++.+|++.||++||++.++++.
T Consensus       188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                    357789999999999999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.9e-24  Score=188.61  Aligned_cols=179  Identities=20%  Similarity=0.252  Sum_probs=137.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |++ +|..++...+.  ++...+-.++.|++.|++|||+++  |.|||||++|+++..+|.+||+|||.+..+...... 
T Consensus       403 ~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  403 CPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             ccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            456 88888877754  888899999999999999999876  999999999999999999999999998775443332 


Q ss_pred             -eeeecccccccccCccccccCCCCc-ccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGRLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       ......+|+..|+|||++.+..|+. ..||||.|+++..|++|+.||.............       .......+  ..
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~~--~~  548 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRNI--FE  548 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------cccccccc--cc
Confidence             4456678999999999999999976 6899999999999999999997654332221000       00000000  00


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ........++.....+|.+||+.||.+|.|+++|++
T Consensus       549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            001122356778889999999999999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.89  E-value=3.5e-24  Score=180.09  Aligned_cols=117  Identities=23%  Similarity=0.335  Sum_probs=103.1

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      +|.+|.+||.....  +++.++..|+.||+.|+++||+++  |||||||-+||+++.+|.+||+|||.+-...++.    
T Consensus       653 ~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----  724 (772)
T KOG1152|consen  653 EGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----  724 (772)
T ss_pred             CCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccchhhhcCCC----
Confidence            57899999977665  999999999999999999999876  9999999999999999999999999986644332    


Q ss_pred             eecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCC
Q 025440           82 STQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVD  126 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~  126 (252)
                      ...++||..|.|||++.|.+| ....|||+||++||.++...-||.
T Consensus       725 fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  725 FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            345789999999999999887 567899999999999998877764

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=9.5e-23  Score=154.04  Aligned_cols=171  Identities=20%  Similarity=0.207  Sum_probs=121.3

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCcceeeecccccccccCcc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE   95 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE   95 (252)
                      .|+.-.+...+.++++||.|+||+|  |+|||+||.|++|+.. -.++|+|+|+|..+..+....   ..+.+..|--||
T Consensus       128 tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPE  202 (338)
T KOG0668|consen  128 TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPE  202 (338)
T ss_pred             hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCch
Confidence            3677778889999999999999887  9999999999999875 459999999998876554432   234567788999


Q ss_pred             ccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhh-------------hhhhhHHHHhhhhcCCC
Q 025440           96 YVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL-------------SDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        96 ~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~  161 (252)
                      .+... .|+.+-|+|||||++..|+..+.||.......++ +........             .-......++....+..
T Consensus       203 LLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~  281 (338)
T KOG0668|consen  203 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKP  281 (338)
T ss_pred             heeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcccccc
Confidence            88765 5899999999999999999999998654432221 111111000             00111111121111111


Q ss_pred             --------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          162 --------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       162 --------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                              ...-.++++.+|+.++|..|..+|+|+.|.+.
T Consensus       282 w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  282 WSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                    11224578999999999999999999999886

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.87  E-value=2e-22  Score=172.05  Aligned_cols=171  Identities=27%  Similarity=0.352  Sum_probs=132.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |-||+|.+..+-.++  |++.++..+++..++||+|||+++  =+|||||-.|||++..|.+|+.|||.+-.+...  ..
T Consensus        94 cgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA  167 (829)
T ss_pred             cCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhh--hh
Confidence            468999998887777  999999999999999999999765  799999999999999999999999997553221  22


Q ss_pred             eeecccccccccCcccc---ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ....++||+.|||||+.   +.+.|...+|||++|++..|+-.-+.|......                .+.++-.-...
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----------------mr~l~LmTkS~  231 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----------------MRALFLMTKSG  231 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----------------HHHHHHhhccC
Confidence            24567899999999976   345799999999999999999877766543211                11111111111


Q ss_pred             cC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..   ...+...+..+.+|++.||-++|.+||+++.++.
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11   1223456788999999999999999999987763

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=8.4e-22  Score=152.61  Aligned_cols=174  Identities=22%  Similarity=0.361  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEc--cccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS--DFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~   78 (252)
                      ||-|||+..|++...--++..++.+++.+|+.|++|||+..+-|...-|....|+|+++.+.+|.  |--++..  .   
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--e---  343 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--E---  343 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--c---
Confidence            68899999999988877888999999999999999999987656666799999999999887764  3222221  0   


Q ss_pred             ceeeecccccccccCccccccCCC---CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                          ....-.+.|++||.+...+-   -.++|+|||++++||+.|...||.+...                .+--.++..
T Consensus       344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp----------------mecgmkial  403 (448)
T KOG0195|consen  344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP----------------MECGMKIAL  403 (448)
T ss_pred             ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc----------------hhhhhhhhh
Confidence                11123688999999976653   3579999999999999999999987432                222234445


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ..++...|+.++..+..|+.-|++.||.+||.++.|+-.|+++.
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            66777889999999999999999999999999999999998864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.85  E-value=3.8e-21  Score=156.45  Aligned_cols=174  Identities=30%  Similarity=0.354  Sum_probs=117.4

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCC-------------------CC
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPT-------------------GD   77 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~-------------------~~   77 (252)
                      ++..++..+++.+..||+++|+.|  ||||||||.|+|.+.. ++-.|+|||++.....                   +.
T Consensus       129 l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~  206 (418)
T KOG1167|consen  129 LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGK  206 (418)
T ss_pred             CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccC
Confidence            778899999999999999999655  9999999999999764 6689999999861100                   00


Q ss_pred             -----------------------cceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccc
Q 025440           78 -----------------------RTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE  133 (252)
Q Consensus        78 -----------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~  133 (252)
                                             +........||++|+|||++... ..+.+.||||.|+|+..+++++.||-....+..
T Consensus       207 ~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~  286 (418)
T KOG1167|consen  207 DVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD  286 (418)
T ss_pred             cccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccc
Confidence                                   00011234689999999998665 468899999999999999999999965543211


Q ss_pred             hh-----------hh----------hhcch---hhhhhhhHHHHh-----hhh-----cCCCCcHHHHHHHHHHHHhhcc
Q 025440          134 QS-----------LV----------DWAKP---YLSDKRKLFRIM-----DTK-----LGGQYPQKAAHTAATLALQCLN  179 (252)
Q Consensus       134 ~~-----------~~----------~~~~~---~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~li~~~l~  179 (252)
                      ..           +.          -|...   .......-++.+     .+.     .........+..+.+|+.+||+
T Consensus       287 al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le  366 (418)
T KOG1167|consen  287 ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLE  366 (418)
T ss_pred             hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHcc
Confidence            10           00          01000   000000011111     000     0001112245588999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 025440          180 NEPKLRPRMSEVLA  193 (252)
Q Consensus       180 ~dp~~Rpt~~~v~~  193 (252)
                      .||.+|.|+++.|.
T Consensus       367 ~np~kRitAEeALk  380 (418)
T KOG1167|consen  367 LNPQKRITAEDALK  380 (418)
T ss_pred             CChhhcccHHHHhc
Confidence            99999999999986

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=5.3e-22  Score=165.94  Aligned_cols=165  Identities=28%  Similarity=0.394  Sum_probs=120.4

Q ss_pred             CCCCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC--
Q 025440            1 MPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--   77 (252)
                      |.-++|.+||..+ .....++...+.++.|++.|++|   ++  .+|+|+||.||+...+..+||.|||+........  
T Consensus       338 c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~  412 (516)
T KOG1033|consen  338 CEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETV  412 (516)
T ss_pred             hhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhheeecccCCcc
Confidence            3457899999644 33457888999999999999999   34  9999999999999999999999999987654443  


Q ss_pred             --cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           78 --RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        78 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                        .....+..+||..||+||++.+..|+.++||||||+|++|++. -...|.-                   ...+..+.
T Consensus       413 ~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------------~~t~~d~r  473 (516)
T KOG1033|consen  413 APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------------IATLTDIR  473 (516)
T ss_pred             cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------------HHhhhhhh
Confidence              1223456689999999999999999999999999999999997 3322221                   11111111


Q ss_pred             hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHH
Q 025440          155 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE  190 (252)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  190 (252)
                      +..+...+..+. +.-..|+++++...|.+||++.+
T Consensus       474 ~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  474 DGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             cCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence            111111111111 23458999999999999995443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.84  E-value=5.9e-21  Score=149.87  Aligned_cols=123  Identities=32%  Similarity=0.380  Sum_probs=102.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++++|.+++...... +++..+..++.+++.+|.+||+.  +++|+||++.||+++.++.++|+|||++......... 
T Consensus        79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~--~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL--GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            3577999999765432 78999999999999999999976  4999999999999999999999999998775443200 


Q ss_pred             eeecccccccccCcccc-ccCCCCcccceehhHHHHHHHHhCCCCCCC
Q 025440           81 VSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDK  127 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~lltg~~pf~~  127 (252)
                      ......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            12334567889999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=7.2e-20  Score=151.94  Aligned_cols=185  Identities=22%  Similarity=0.187  Sum_probs=137.2

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-----CceEEccccccc--cCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-----FNAKLSDFGLAK--AGP   74 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~~~--~~~   74 (252)
                      -|.||.++......+.++...++.++.|++.+|++||+.|  ++||||||+|+++...     -.++|.|||+++  .+.
T Consensus       103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~  180 (322)
T KOG1164|consen  103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYV  180 (322)
T ss_pred             cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCcccccc
Confidence            4789999886666567999999999999999999999765  9999999999999765     359999999998  322


Q ss_pred             CCCc----ce-e-eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           75 TGDR----TH-V-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        75 ~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                      ....    .. . .....||..|+++.+..+...+.+.|+||++.++.+++.|..||.+......             ..
T Consensus       181 ~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------------~~  247 (322)
T KOG1164|consen  181 GDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------------KS  247 (322)
T ss_pred             CCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------------HH
Confidence            2211    11 1 2235699999999999999999999999999999999999999976542111             11


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ..................+.++.++...+-..+...+|....+...|+.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            11111111111112233456677777777779999999999999988765433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=4.2e-20  Score=165.64  Aligned_cols=170  Identities=25%  Similarity=0.296  Sum_probs=121.4

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccC--CCCCccee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG--PTGDRTHV   81 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~--~~~~~~~~   81 (252)
                      -||+|.|..+.-  |...+...|+.|++.||..+|..+  |+|||||.+||||+.=..+.|+||...+..  ..++....
T Consensus       105 hnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  105 HNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             hhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            478888877765  888899999999999999999655  999999999999999999999999876542  22222211


Q ss_pred             ---eecccccccccCccccccC----------C-CCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhh
Q 025440           82 ---STQVMGTHGYAAPEYVATG----------R-LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        82 ---~~~~~gt~~y~aPE~~~~~----------~-~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                         ..+...-..|.|||.+...          . .+++-||||+||+++||++ |+.+|.-.      ++..+......+
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~~~~~  254 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSGNADD  254 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhccCccC
Confidence               1112233579999987541          1 4678899999999999998 78888532      122221111111


Q ss_pred             hhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+...+    .+       ....++.||..|++.||.+|.++++.++.
T Consensus       255 ~e~~Le----~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLE----KI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHH----hC-------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            111111    11       12257899999999999999999999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.5e-19  Score=153.52  Aligned_cols=187  Identities=22%  Similarity=0.350  Sum_probs=135.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.-|+|.|.+... ...+++.....+.++|+.||+|+|+.. ...|+.|+..|++++....+||+|||+...........
T Consensus        29 c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~  106 (484)
T KOG1023|consen   29 CSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPE  106 (484)
T ss_pred             ecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccccceeeeeEEEEechhhhccccccccccc
Confidence            4679999999774 456999999999999999999999653 23999999999999999999999999987653211111


Q ss_pred             eeecccccccccCccccccCC-------CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           81 VSTQVMGTHGYAAPEYVATGR-------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                      ......-...|.|||.+++..       .+.+.||||||++++|+++.+.||.........            .+....+
T Consensus       107 ~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~------------~eii~~~  174 (484)
T KOG1023|consen  107 AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP------------DEIILRV  174 (484)
T ss_pred             ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCCh------------HHHHHHH
Confidence            112222356799999997641       467799999999999999999999875432111            0011111


Q ss_pred             hh---hhcCCCCc-H-HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          154 MD---TKLGGQYP-Q-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       154 ~~---~~~~~~~~-~-~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ..   ...++... . ....++..++.+||..+|.+||+++++...++.+...
T Consensus       175 ~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  175 KKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             HhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            11   01111111 1 3444789999999999999999999999888766543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=3.9e-20  Score=148.06  Aligned_cols=139  Identities=21%  Similarity=0.298  Sum_probs=95.8

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   97 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   97 (252)
                      +....++.+..|+++.+++||+.|  +||+||+|+|+|++.+|.++|+||+.......  ..  .. ...+..|.+||..
T Consensus       142 l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~--~~-~~~~~~~~PPe~~  214 (288)
T PF14531_consen  142 LAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RY--RC-SEFPVAFTPPELE  214 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EE--EG-GGS-TTTS-HHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCCCCEEEcChHHHeecCc--ee--ec-cCCCcccCChhhh
Confidence            455566778899999999999876  99999999999999999999999988765322  11  11 2345789999976


Q ss_pred             ccC--------CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHH
Q 025440           98 ATG--------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT  169 (252)
Q Consensus        98 ~~~--------~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (252)
                      ...        .++.+.|.|+||+++|.|++|..||...........                    .. ..+. +++..
T Consensus       215 ~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~  272 (288)
T PF14531_consen  215 SCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEP  272 (288)
T ss_dssp             HHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------------------GG-TTSS----HH
T ss_pred             hhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------------------cc-hhcC-CcCHH
Confidence            442        478899999999999999999999986532111100                    11 2344 78899


Q ss_pred             HHHHHHhhccCCCCCC
Q 025440          170 AATLALQCLNNEPKLR  185 (252)
Q Consensus       170 ~~~li~~~l~~dp~~R  185 (252)
                      +..||..+|+.||.+|
T Consensus       273 v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  273 VQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHccCCcccC
Confidence            9999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=6.5e-19  Score=143.12  Aligned_cols=168  Identities=21%  Similarity=0.270  Sum_probs=119.8

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec--CCC--ceEEccccccccCCCCC---
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEF--NAKLSDFGLAKAGPTGD---   77 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~~~~~~~~~---   77 (252)
                      +|.+|+-.+.   .+.....-++.|+++|+.|||.++  |.|||||.+||||.  .|+  .++|+|||.+-......   
T Consensus       328 tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlql  402 (598)
T KOG4158|consen  328 TLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQL  402 (598)
T ss_pred             hHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeecccccccc
Confidence            6777886665   566777889999999999999876  99999999999993  333  37899999875432211   


Q ss_pred             -cceeeecccccccccCccccccCC-----C-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           78 -RTHVSTQVMGTHGYAAPEYVATGR-----L-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        78 -~~~~~~~~~gt~~y~aPE~~~~~~-----~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                       ........-|.-.-||||+....+     . -.++|.|+.|.+.||+++..-||.+.....-            +... 
T Consensus       403 py~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------------~~r~-  469 (598)
T KOG4158|consen  403 PYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------------DTRT-  469 (598)
T ss_pred             ccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------------chhh-
Confidence             111112234667789999885432     1 2589999999999999999999976332100            0011 


Q ss_pred             HHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         .....-+..+..++..+.+++...|+.||++|++..-..+
T Consensus       470 ---Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  470 ---YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             ---hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence               1112234567788899999999999999999997654433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=9e-20  Score=155.50  Aligned_cols=153  Identities=29%  Similarity=0.372  Sum_probs=125.4

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .||.|...+.+...  +++.....+...++.+++++|+.+  ++|||+|++||+++.+|.+++.|||+++.....+..  
T Consensus        80 rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             ccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            35667666655554  777778888999999999999765  999999999999999999999999999875443322  


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                          +||..|||||++.  ....++|.||||++.++|+||..||..                    .....++.  ....
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~--~~~~  205 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK--AELE  205 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh--hccC
Confidence                7899999999997  667899999999999999999999975                    11222222  2346


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      .|......+.+++..++..+|..|.-.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            788899999999999999999999754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.79  E-value=1.2e-18  Score=143.59  Aligned_cols=179  Identities=32%  Similarity=0.438  Sum_probs=131.4

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~   78 (252)
                      +.|++|.+++..... ..+.......++.|++.+++|+|+.+  ++||||||+||+++..+ .++++|||++........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            467888877765542 14899999999999999999999766  99999999999999988 799999999975443322


Q ss_pred             ce----eeecccccccccCcccccc---CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           79 TH----VSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        79 ~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..    ......|+..|++||.+.+   ..++...|+|++|++++++++|..||......             .......
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-------------~~~~~~~  224 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-------------SATSQTL  224 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-------------ccHHHHH
Confidence            11    2356679999999999987   57888999999999999999999997664321             0001111


Q ss_pred             HHhhhhc----CCCCc----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          152 RIMDTKL----GGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       152 ~~~~~~~----~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+....    .....    ......+.+++.+|+..+|..|.+..+....
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111111    00111    1223578899999999999999988776653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=4.5e-18  Score=135.22  Aligned_cols=179  Identities=20%  Similarity=0.227  Sum_probs=135.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-----ceEEccccccccCCCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~~~~~~   77 (252)
                      |-||+|+..-.+++ ++...+.-++.|++.-++|+|++.  +|+|||||+|+||...+     .+.++|||+|+.+.+..
T Consensus       107 GPSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             CcCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            67888877655543 999999999999999999999776  99999999999996543     48999999999876543


Q ss_pred             cc-----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           78 RT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        78 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      ..     .......||..||+--...|.+.+..-|+-|||-++++.|-|..||++....             .+.....+
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~-------------tnK~kYeK  250 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD-------------TNKEKYEK  250 (449)
T ss_pred             ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc-------------chHHHHHH
Confidence            22     2345677999999999999999999999999999999999999999986432             12223333


Q ss_pred             HhhhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          153 IMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       153 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      +-+.+..-+.   -.+++.++..-+.-.-..+-.+-|..+-+...+..
T Consensus       251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~d  298 (449)
T KOG1165|consen  251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDD  298 (449)
T ss_pred             hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            3333222211   12456677777777777777888888777665544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=2.6e-19  Score=160.21  Aligned_cols=138  Identities=25%  Similarity=0.352  Sum_probs=105.3

Q ss_pred             HHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC-------------cceeeecccccccccCcccc
Q 025440           31 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-------------RTHVSTQVMGTHGYAAPEYV   97 (252)
Q Consensus        31 ~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~   97 (252)
                      +.+++|||+.+  |+|||+||+|.+|..-|.+|++|||+++......             .......++||+.|.|||++
T Consensus       153 vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  153 VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            78999999655  9999999999999999999999999987532111             01123456899999999999


Q ss_pred             ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc-CCCCcHHHHHHHHHHHHh
Q 025440           98 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQ  176 (252)
Q Consensus        98 ~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~  176 (252)
                      ....|...+|.|++|+|+||.+-|..||.+.+.+.                .+..++.... -..-....+.++.++|.+
T Consensus       231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee----------------lfg~visd~i~wpE~dea~p~Ea~dli~~  294 (1205)
T KOG0606|consen  231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----------------LFGQVISDDIEWPEEDEALPPEAQDLIEQ  294 (1205)
T ss_pred             hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH----------------HHhhhhhhhccccccCcCCCHHHHHHHHH
Confidence            99999999999999999999999999998864311                0011111000 011123456789999999


Q ss_pred             hccCCCCCCC
Q 025440          177 CLNNEPKLRP  186 (252)
Q Consensus       177 ~l~~dp~~Rp  186 (252)
                      +|..+|..|-
T Consensus       295 LL~qnp~~Rl  304 (1205)
T KOG0606|consen  295 LLRQNPLCRL  304 (1205)
T ss_pred             HHHhChHhhc
Confidence            9999999996

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=2.9e-17  Score=125.42  Aligned_cols=178  Identities=20%  Similarity=0.198  Sum_probs=134.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC---CceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |-||++++.-.. +.++...++-++.|++.-++|+|.++  +|||||||+|+|..-+   ..+.++|||+++.+.+....
T Consensus        94 GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~  170 (341)
T KOG1163|consen   94 GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR  170 (341)
T ss_pred             CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence            678888775444 33899999999999999999999655  9999999999999543   45899999999886554321


Q ss_pred             -----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           80 -----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        80 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                           .......||..|.+-....+...+...|+-|+|.++.++.-|..||++....             ...++..++.
T Consensus       171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-------------tk~QKyEkI~  237 (341)
T KOG1163|consen  171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-------------TKKQKYEKIS  237 (341)
T ss_pred             ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-------------hHHHHHHHHH
Confidence                 2234567999999988887788899999999999999999999999986431             1233344444


Q ss_pred             hhhcCCCCc---HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          155 DTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       155 ~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      +.+...+..   ...+.++...+.-|-..--++-|....+.+.+.
T Consensus       238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            444433322   245778888888888888888888877766554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=5.7e-15  Score=134.24  Aligned_cols=118  Identities=19%  Similarity=0.165  Sum_probs=97.7

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-------CCceEEccccccccCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAKAGP   74 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~   74 (252)
                      +-|||.+++..  .+.+++..++.+..|++..+++||.++  |||+||||+|+||..       +-.++|+|||.+.-..
T Consensus       777 ~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  777 PYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             ccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            56999999974  445999999999999999999999876  999999999999932       2348999999885322


Q ss_pred             CCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCC
Q 025440           75 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC  123 (252)
Q Consensus        75 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~  123 (252)
                      --.........++|-.+--+|+..|..++...|.|.|+.+++-||.|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            1122223455678899999999999999999999999999999999963

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.56  E-value=4.5e-15  Score=123.82  Aligned_cols=84  Identities=20%  Similarity=0.184  Sum_probs=64.1

Q ss_pred             HHHHHHHHHHhHHHhcCCCCeeeccC-CCCceeecCCCceEEccccccccCCCCCcce------eeecccccccccCccc
Q 025440           24 MKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRTH------VSTQVMGTHGYAAPEY   96 (252)
Q Consensus        24 ~~i~~~i~~~l~~lH~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~gt~~y~aPE~   96 (252)
                      ..++.+++++|+|||+.+  |+|||| ||+|||++.++.+||+|||+++.+.......      ......++..|+|||.
T Consensus       114 ~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~  191 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA  191 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence            467899999999999765  999999 9999999999999999999998654332111      0134567888999999


Q ss_pred             cccCC------CCccccee
Q 025440           97 VATGR------LTTKSDVY  109 (252)
Q Consensus        97 ~~~~~------~~~~~Di~  109 (252)
                      +....      .+..+|-|
T Consensus       192 ~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        192 LTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CChhhhccccccccccCcE
Confidence            86542      23446666

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=1.2e-15  Score=135.01  Aligned_cols=176  Identities=26%  Similarity=0.283  Sum_probs=131.3

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCC-CCcc
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPT-GDRT   79 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~-~~~~   79 (252)
                      .||++.+-+........+...+-.++.|+..++.|+|. +.++.|+||||+|.+++..+ ..++.|||++..+.. ....
T Consensus       104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~  182 (601)
T KOG0590|consen  104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAE  182 (601)
T ss_pred             cccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcc
Confidence            46777777732222246677778899999999999994 23499999999999999999 999999999988766 3333


Q ss_pred             eeeecccc-cccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 HVSTQVMG-THGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 ~~~~~~~g-t~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......+| +..|+|||...+.. .....|+||.|+++.-+++|..||.........+ .              ......
T Consensus       183 ~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~--------------~~~~~~  247 (601)
T KOG0590|consen  183 RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-S--------------SWKSNK  247 (601)
T ss_pred             eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-e--------------eecccc
Confidence            44455678 99999999998754 4678999999999999999999997654322111 0              001111


Q ss_pred             --cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 --LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        ........+.....+++.+++..+|..|.+.+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence              112334566778889999999999999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.52  E-value=9.1e-15  Score=111.85  Aligned_cols=103  Identities=19%  Similarity=0.160  Sum_probs=76.1

Q ss_pred             HHHHHHHHHHhHHHhcCCCCeeeccC-CCCceeecCCCceEEccccccccCCCCCcc---ee--------eecccccccc
Q 025440           24 MKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGLAKAGPTGDRT---HV--------STQVMGTHGY   91 (252)
Q Consensus        24 ~~i~~~i~~~l~~lH~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~--------~~~~~gt~~y   91 (252)
                      ..++.+++.+|+++|+.|  |+|||| ||+|||++.+|.++|+|||++.........   ..        ......++.|
T Consensus        94 ~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~  171 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAA  171 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            457889999999999765  999999 799999999999999999999864433210   00        0111246777


Q ss_pred             cCccccccC-CCC-cccceehhHHHHHHHHhCCCCCCCc
Q 025440           92 AAPEYVATG-RLT-TKSDVYSFGVVLLELLSGRCAVDKT  128 (252)
Q Consensus        92 ~aPE~~~~~-~~~-~~~Di~slG~il~~lltg~~pf~~~  128 (252)
                      +.|+..... ..+ ...+.++.|+-+|.++|+..++.+.
T Consensus       172 l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        172 LTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            888754332 233 4567788999999999998887553

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=6.2e-14  Score=111.85  Aligned_cols=173  Identities=22%  Similarity=0.316  Sum_probs=115.9

Q ss_pred             CCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC-
Q 025440            1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-   77 (252)
                      |..|+|..+|++...  +.+......+|+.||.+||.|||+..+.|+|+++.-+.|++..+|-+|+.----........ 
T Consensus       154 mssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~  233 (458)
T KOG1266|consen  154 MSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNS  233 (458)
T ss_pred             ccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhh
Confidence            567899999975533  55788888899999999999999999999999999999999999988886421111100000 


Q ss_pred             -cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           78 -RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        78 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                       .........+.++|.+||.-.....+.++|||+||....+|..+..--........            ........   
T Consensus       234 ~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~------------~ee~ia~~---  298 (458)
T KOG1266|consen  234 TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVE------------VEENIANV---  298 (458)
T ss_pred             hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceee------------hhhhhhhh---
Confidence             00111223457889999987666778899999999999999887643222111000            00000000   


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .+...     ..--..++.+|++-.|..||++.+++-
T Consensus       299 i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  299 IIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeecc-----CccccCcCcccccCCCCCCcchhhhhc
Confidence            00000     011236788999999999999998863

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.46  E-value=9e-14  Score=106.59  Aligned_cols=68  Identities=13%  Similarity=0.188  Sum_probs=55.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHH-hcCCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL-HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      ++|++|...+....  .++...+..++.|++.+|.|+ |+.+  |+||||||+|||++ ++.++|+|||++...
T Consensus        99 i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147          99 IGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             eCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            35666655433333  489999999999999999999 6655  99999999999998 478999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.44  E-value=3.5e-14  Score=110.69  Aligned_cols=92  Identities=13%  Similarity=0.126  Sum_probs=66.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|.+|.++..      ++.    ....+++.+|..+|+.+  ++|||+||.||+++.+| ++|+|||............
T Consensus       125 i~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d  191 (232)
T PRK10359        125 IEGVELNDMPE------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD  191 (232)
T ss_pred             ECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH
Confidence            35667766631      232    34669999999999765  99999999999999988 9999999886542211110


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHH
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL  119 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ll  119 (252)
                                    ..+....+..++|+|+||+++....
T Consensus       192 --------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        192 --------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             --------------HHHHHhHhcccccccceeEeehHHH
Confidence                          0333445667999999999987664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.43  E-value=2.6e-13  Score=104.25  Aligned_cols=68  Identities=15%  Similarity=0.071  Sum_probs=54.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-CCCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      +|+++........  .++......++.+++.+|.++|+ .+  |+||||||+|||++ ++.++|+|||++....
T Consensus       100 ~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         100 GDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             cCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            4554443322233  37888999999999999999997 55  99999999999999 8899999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.28  E-value=4.9e-11  Score=98.74  Aligned_cols=175  Identities=18%  Similarity=0.238  Sum_probs=117.4

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      ..+|...+.++..++.+.+.||.+|  .+-+|+.++|+|+++++.|.|.|-.....-.++.   ...-.+|...|++||.
T Consensus       113 ~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPEl  187 (637)
T COG4248         113 HCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPEL  187 (637)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceeeccCCc---eEecccCccccCCHHH
Confidence            3789999999999999999999765  8889999999999999999999844333221211   1223468899999996


Q ss_pred             cc-----cCCCCcccceehhHHHHHHHHhC-CCCCCCcccccch------hhhhhcchhhhhhhhHHHHhhhhcCCCCcH
Q 025440           97 VA-----TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQ------SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ  164 (252)
Q Consensus        97 ~~-----~~~~~~~~Di~slG~il~~lltg-~~pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (252)
                      -.     +..-+...|.|.||+++++++.| +.||.+.......      .+......+.++   ...-...........
T Consensus       188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~---~~~g~~p~P~~~P~~  264 (637)
T COG4248         188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD---QRRGLKPPPRSIPLS  264 (637)
T ss_pred             hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh---ccCCCCCCCCCCChh
Confidence            54     33456789999999999999985 9999875432110      111100000000   000000000011112


Q ss_pred             HHHHHHHHHHHhhccCC--CCCCCCHHHHHHHHHhhc
Q 025440          165 KAAHTAATLALQCLNNE--PKLRPRMSEVLAILERLE  199 (252)
Q Consensus       165 ~~~~~~~~li~~~l~~d--p~~Rpt~~~v~~~l~~~~  199 (252)
                      -+++.+..|..+|+...  +.-|||++..+..|..+.
T Consensus       265 ~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         265 MLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            45778889999999763  568999999998887654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=3.6e-12  Score=110.81  Aligned_cols=156  Identities=20%  Similarity=0.290  Sum_probs=109.7

Q ss_pred             HHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee-------eecccccccccCcc
Q 025440           23 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-------STQVMGTHGYAAPE   95 (252)
Q Consensus        23 ~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE   95 (252)
                      ...=+.+++.|+.|+|.. .++||++|.|++|.++.+|.+||+.|+++..........+       ..-..-...|.|||
T Consensus       101 ~f~nl~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE  179 (700)
T KOG2137|consen  101 GFANLGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE  179 (700)
T ss_pred             hhhhhhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence            334456677999999974 4699999999999999999999999998865433221111       11112356799999


Q ss_pred             ccccCCCCcccceehhHHHHHHHH-hCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHH
Q 025440           96 YVATGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA  174 (252)
Q Consensus        96 ~~~~~~~~~~~Di~slG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  174 (252)
                      ++.+...+.++|+||||+++|.+. .|+..+.........              .............+..+++.++.+=+
T Consensus       180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l  245 (700)
T KOG2137|consen  180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESL  245 (700)
T ss_pred             hhccccccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHH
Confidence            998888899999999999999999 566655443211110              11111111112233467888999999


Q ss_pred             HhhccCCCCCCCCHHHHHH
Q 025440          175 LQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       175 ~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .+++..+...||++.++..
T Consensus       246 ~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  246 KKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHhcCCcccCcchhhhhc
Confidence            9999999999998777654

>smart00090 RIO RIO-like kinase

Probab=99.23  E-value=1.4e-11  Score=97.61  Aligned_cols=68  Identities=10%  Similarity=0.070  Sum_probs=54.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++|++|..++.....  +....+..++.||+.+|.+||+.+ +++|+||||+||+++ ++.++|+|||.+..
T Consensus       130 ~~g~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      130 IGGDGLPAPRLKDVE--PEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             ecCCcccccccccCC--cchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence            356677666533332  566677899999999999999542 299999999999999 88999999999875

>PRK10345 hypothetical protein; Provisional

Probab=99.22  E-value=1.5e-11  Score=95.36  Aligned_cols=62  Identities=19%  Similarity=0.134  Sum_probs=48.7

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHh-HHHhcCCCCeeeccCCCCceeecC----CCceEEcccccc
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL-TFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLA   70 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~   70 (252)
                      ++|||.+++.+. .  +++.  ..++.+++.++ +|||+++  |+||||||+|||++.    ++.++|+||+.+
T Consensus        90 ~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         90 PSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             cchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            468999999653 2  6655  35678888888 9999766  999999999999964    347999995544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=1.3e-11  Score=105.77  Aligned_cols=171  Identities=25%  Similarity=0.324  Sum_probs=122.6

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHH----HhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAK----GLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~   76 (252)
                      .|.+|.++.+.... -++....+..+.+..+    ||.++|+.+  ++|-|+||+||++..+ ...+++|||+...+...
T Consensus       200 ~~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~  276 (524)
T KOG0601|consen  200 CGESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDG  276 (524)
T ss_pred             ccchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEEccCC
Confidence            45677777766553 2778888888888888    999999765  9999999999999999 78999999999876554


Q ss_pred             Ccc---eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           77 DRT---HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        77 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                      .-.   .......|...|++||.. .+-++..+|||+||.++.+..++.........      ..|           ..+
T Consensus       277 ~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W-----------~~~  338 (524)
T KOG0601|consen  277 NFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSW-----------SQL  338 (524)
T ss_pred             ccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCc-----------ccc
Confidence            422   112333577889999987 45778999999999999999998776644311      001           000


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      -...+...+-...+..+...+..|++.++-.|++...+..
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0000111222233455666899999999999999887764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.17  E-value=4.7e-11  Score=94.86  Aligned_cols=62  Identities=31%  Similarity=0.262  Sum_probs=50.9

Q ss_pred             CC-CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            2 PK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         2 ~g-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +| ++|.+++.+. .  ++..    .+.+|+.+|.+||+.+  |+|+||||.|||++.++.++|+|||.+..
T Consensus       129 ~G~~~L~~~l~~~-~--l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        129 EGARDLVALLQEA-P--LSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCCCHHHHHhcC-C--CCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            45 6888887543 2  5544    3678999999999765  99999999999999999999999998875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.17  E-value=3.3e-11  Score=109.13  Aligned_cols=167  Identities=25%  Similarity=0.307  Sum_probs=123.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC------
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG------   76 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------   76 (252)
                      |++|...|+..+.  .+.+-+......+.++++|||+..  ++|+|++|.|+|+..+|..++.|||........      
T Consensus       888 ~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~  963 (1205)
T KOG0606|consen  888 GGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL  963 (1205)
T ss_pred             cCCchhhhhcCCC--cccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence            5677777766664  666677778888999999999754  899999999999999999999999843211100      


Q ss_pred             ----C-------------------cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccc
Q 025440           77 ----D-------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE  133 (252)
Q Consensus        77 ----~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~  133 (252)
                          +                   .........+|+.|.+||...+......+|.|++|++++|.++|..||......  
T Consensus       964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq-- 1041 (1205)
T KOG0606|consen  964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ-- 1041 (1205)
T ss_pred             ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh--
Confidence                0                   001123457899999999999999999999999999999999999999764321  


Q ss_pred             hhhhhhcchhhhhhhhHHHHhhhhcC-CCCcHHHHHHHHHHHHhhccCCCCCCCCHH
Q 025440          134 QSLVDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMS  189 (252)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~  189 (252)
                                    +....+...... ..-+...+....+++...+..++.+|-.+.
T Consensus      1042 --------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 --------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             --------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                          111111111221 122345677889999999999999998765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.13  E-value=7.4e-11  Score=91.20  Aligned_cols=52  Identities=15%  Similarity=0.077  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440           22 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus        22 ~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      ....++.+++.++.++|+.+  ++|+||||+||+++.++.++|+|||++.....
T Consensus       126 ~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            45678899999999999755  99999999999999999999999999965433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.11  E-value=1.2e-10  Score=90.89  Aligned_cols=63  Identities=25%  Similarity=0.350  Sum_probs=54.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++|++|.+++....     . .+..++.+++.+|.+||+.+  ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            46889999885432     1 77899999999999999765  99999999999999 78899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.08  E-value=1.4e-10  Score=89.56  Aligned_cols=60  Identities=23%  Similarity=0.313  Sum_probs=50.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++|++|.+++.....         .++.+++.+|.+||+.+  ++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            468888887754321         78999999999999765  99999999999999 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.05  E-value=1.7e-10  Score=102.20  Aligned_cols=59  Identities=24%  Similarity=0.284  Sum_probs=50.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++|++|.+++.          ....++.+++.+|.+||+.+  ++||||||+|||+ .++.++|+|||+++.
T Consensus       418 ~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        418 IGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            46778877774          35678999999999999765  9999999999999 678899999999875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.92  E-value=1.5e-09  Score=83.00  Aligned_cols=50  Identities=18%  Similarity=0.050  Sum_probs=45.1

Q ss_pred             HHHHHHHHHHHHHhHHHhc-CCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440           21 AVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus        21 ~~~~~i~~~i~~~l~~lH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      ..+..++.+++.++.++|+ .  +|+|+||||+||+++ ++.++|+|||.+...
T Consensus       114 ~~~~~~~~~~~~~l~~lh~~~--~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         114 EDPEELYDQILELMRKLYREA--GLVHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ccHHHHHHHHHHHHHHHhhcc--CcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            5678899999999999997 5  499999999999999 899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.86  E-value=1.5e-09  Score=93.23  Aligned_cols=165  Identities=21%  Similarity=0.192  Sum_probs=110.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |.|+++...+..  .+-+++..++.+..|++.++.++|++.  ++|+|+||+||++..+ +..++.|||....+.-.   
T Consensus       348 ~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---  420 (524)
T KOG0601|consen  348 CEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---  420 (524)
T ss_pred             hcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccccccee---
Confidence            345666555522  234788889999999999999999765  9999999999999886 77899999987532111   


Q ss_pred             eeeeccccccccc--CccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 HVSTQVMGTHGYA--APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 ~~~~~~~gt~~y~--aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                        .....+...+.  +++......+..+.|+|+||..+.+.++|...-....                   .+..+....
T Consensus       421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------------~~~~i~~~~  479 (524)
T KOG0601|consen  421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------------QSLTIRSGD  479 (524)
T ss_pred             --cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------------cceeeeccc
Confidence              11112233344  4555555677889999999999999999864322211                   111111111


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      .  .........+..+...++..++..||.+.++....
T Consensus       480 ~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  480 T--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             c--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            1  11222336777888889999999999988776544

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=98.78  E-value=1.4e-08  Score=74.30  Aligned_cols=54  Identities=24%  Similarity=0.161  Sum_probs=47.4

Q ss_pred             CHHHHHHHHHHHHHHhHHHhcCC-CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           19 SWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        19 ~~~~~~~i~~~i~~~l~~lH~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +......++.+++.+|++||... .+++|+||+|.||+++..+.+++.|||.+..
T Consensus        84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            45677889999999999999742 4699999999999999989999999998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.74  E-value=8.1e-08  Score=83.99  Aligned_cols=97  Identities=14%  Similarity=0.224  Sum_probs=70.8

Q ss_pred             HHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcccccc
Q 025440           20 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT   99 (252)
Q Consensus        20 ~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~   99 (252)
                      ......-+.||+.||.|||.. ++++|++|.-..|+|+..|..||++|.++.........  .....--..|..|+.+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCc
Confidence            445566789999999999863 46999999999999999999999999988654332210  111112234666765432


Q ss_pred             CCCCcccceehhHHHHHHHHhC
Q 025440          100 GRLTTKSDVYSFGVVLLELLSG  121 (252)
Q Consensus       100 ~~~~~~~Di~slG~il~~lltg  121 (252)
                      ..  -..|.|-|||++++++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  346999999999999998

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.61  E-value=9.1e-08  Score=77.07  Aligned_cols=66  Identities=20%  Similarity=0.179  Sum_probs=53.9

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-------CCceEEcccccccc
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAKA   72 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~   72 (252)
                      +|.+++......+.+...+..++.+++..+.-||..|  |+|+||++.|||++.       ++.+.|+||+.+..
T Consensus       122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            6888875432334677788899999999999999765  999999999999975       46799999998753

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.57  E-value=1e-07  Score=72.96  Aligned_cols=52  Identities=12%  Similarity=0.074  Sum_probs=43.8

Q ss_pred             CCHHHHHHHHHHHHHHhHHH-hcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFL-HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~l-H~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++......+..+++.+|..| |..  ++||+||++.|||++ ++.++|+|||.+..
T Consensus       121 ~~~~~~~~i~~~i~~~l~~l~H~~--glVHGDLs~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         121 LNDEEMKNAYYQVLSMMKQLYKEC--NLVHADLSEYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence            45556678889999999998 755  499999999999997 46799999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.49  E-value=1.7e-07  Score=80.96  Aligned_cols=68  Identities=18%  Similarity=0.111  Sum_probs=49.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHH-HhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK-GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      ++|++|.+++..... .++   ...++..++. .+..+|..+  ++|+|+||.||+++.+|.++++|||++....
T Consensus       240 i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       240 IDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            467888777643211 122   2345566555 467888654  9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=2.7e-07  Score=68.94  Aligned_cols=59  Identities=25%  Similarity=0.305  Sum_probs=46.8

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +|..|.+++...         ...++..+-.-+.-||..+  |||+||.++||++..++ +.++|||++..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            455566666444         2467888888899999655  99999999999997765 99999999874

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.45  E-value=3.3e-07  Score=71.24  Aligned_cols=64  Identities=27%  Similarity=0.271  Sum_probs=54.4

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEcccccccc
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA   72 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~   72 (252)
                      +|.+++.....  ++......++.+++..++-||..|  |+|+|+++.|||++.++   .+.++||+-++.
T Consensus       104 ~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  104 DLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             cHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            67777766443  667778899999999999999765  99999999999998887   799999987765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.43  E-value=4.3e-07  Score=67.73  Aligned_cols=66  Identities=26%  Similarity=0.322  Sum_probs=52.5

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEcccccccc
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKA   72 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~   72 (252)
                      ++.+|+......+........++..|-+.+.-||..+  |||+||..+||++..+|.   +.++|||++..
T Consensus        97 ~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   97 TVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence            6778887665444444555789999999999999655  999999999999966554   58999999864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.39  E-value=4.5e-07  Score=67.98  Aligned_cols=48  Identities=27%  Similarity=0.153  Sum_probs=40.0

Q ss_pred             HHHHHHHHHHhHHHhcCC---CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           24 MKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        24 ~~i~~~i~~~l~~lH~~~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++.+++.+|+.||+.+   .+++|+|+++.||+++ ++.++++|||.+..
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            346789999999999754   1259999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK09902 hypothetical protein; Provisional

Probab=98.27  E-value=2.1e-06  Score=66.12  Aligned_cols=67  Identities=16%  Similarity=0.116  Sum_probs=56.3

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc--eEEcccccccc
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKA   72 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~   72 (252)
                      -||.+++.+..-.+.+..++..++.+|+..++-||+.+  +.|+|+.+.|||++.+|.  ++++||--++.
T Consensus       111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            47888886654445788888999999999999999766  999999999999987677  99999976653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=97.97  E-value=5.8e-06  Score=72.78  Aligned_cols=66  Identities=15%  Similarity=0.057  Sum_probs=43.2

Q ss_pred             CCCCChhhh--hhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----ceEEcccccccc
Q 025440            1 MPKGSLENH--LFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~--l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~   72 (252)
                      |.|++|.++  +...+.  ..+....+..++.|+.       ..|  ++|+|+||.||+++.+|    .++++|||++..
T Consensus       243 i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        243 MYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             ecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            467777664  322221  1133333334444443       224  99999999999999888    899999999876


Q ss_pred             CCC
Q 025440           73 GPT   75 (252)
Q Consensus        73 ~~~   75 (252)
                      ...
T Consensus       314 l~~  316 (537)
T PRK04750        314 LNK  316 (537)
T ss_pred             CCH
Confidence            543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.92  E-value=2.1e-05  Score=59.95  Aligned_cols=49  Identities=24%  Similarity=0.310  Sum_probs=36.3

Q ss_pred             HHHHHHHHHHHHHhHH-HhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           21 AVRMKVAIGAAKGLTF-LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        21 ~~~~~i~~~i~~~l~~-lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .....++.+++..+.. +|..  ||+|+||.+.|||++.+ .+.|+|||.+..
T Consensus       106 ~~~~~~~~~il~~~~~~~~~~--givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  106 EEPKELLEEILEEIIKMLHKA--GIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             STHHHHHHHHHHHHHHHHHCT--TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             hhHHHHHHHHHHHHHHHHHhc--CceecCCChhhEEeecc-eEEEEecCccee
Confidence            3456678888885555 5655  49999999999999887 899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.83  E-value=4.1e-05  Score=59.77  Aligned_cols=31  Identities=19%  Similarity=0.353  Sum_probs=26.6

Q ss_pred             CCeeeccCCCCceeecC--CCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDA--EFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            34799999999999988  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.81  E-value=0.00011  Score=63.30  Aligned_cols=86  Identities=16%  Similarity=0.259  Sum_probs=67.0

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .++++..|.++.|+..||.++|+.|  +..+-|.+.+||++.+.+++|...|+.........                |.
T Consensus       389 ~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------------~~  450 (655)
T KOG3741|consen  389 KAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------------EP  450 (655)
T ss_pred             CchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCCC----------------cc
Confidence            4788999999999999999999876  88899999999999998899887776554322210                11


Q ss_pred             cccCCCCcccceehhHHHHHHHHhCCC
Q 025440           97 VATGRLTTKSDVYSFGVVLLELLSGRC  123 (252)
Q Consensus        97 ~~~~~~~~~~Di~slG~il~~lltg~~  123 (252)
                      +.+   -.+-|.=.||.+++.|.||..
T Consensus       451 le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  451 LES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             hhH---HhhhhHHHHHHHHHHHhhccc
Confidence            111   235688889999999999853

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.45  E-value=0.0005  Score=64.61  Aligned_cols=159  Identities=20%  Similarity=0.243  Sum_probs=104.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCC---ceeecCCCceEEc--cccccccCCCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS---NILLDAEFNAKLS--DFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~   77 (252)
                      +-++...+..-+.  ++.+..+.+..++..||+|+|+..  ..|.-|...   +-.++..+.+...  ||+.........
T Consensus       270 ~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~  345 (1351)
T KOG1035|consen  270 KVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE  345 (1351)
T ss_pred             ccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence            4455555655554  788888889999999999999764  555555444   3444555666666  888877654433


Q ss_pred             cceeeecccccccccCccccccCCCCc--ccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTT--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ..   .....+..|.++|......++.  ..|+|.+|.....+..|..+-...                   .....++.
T Consensus       346 ~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~-------------------~~~~~~l~  403 (1351)
T KOG1035|consen  346 KS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS-------------------AVPVSLLD  403 (1351)
T ss_pred             cc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc-------------------cchhhhhc
Confidence            22   1223456678888876665544  479999999999998875432211                   00111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                              ........+...+|+..+.++|+++.+++...
T Consensus       404 --------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  404 --------VLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             --------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence                    11112577889999999999999999998754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.43  E-value=0.00021  Score=55.51  Aligned_cols=44  Identities=16%  Similarity=0.132  Sum_probs=37.0

Q ss_pred             HHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           26 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        26 i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +...|++++.-||+.|  ++|+|.+|.|++++.++ +++.||+..+.
T Consensus       140 ~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEEECccccc
Confidence            5567788899999776  99999999999998655 99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.36  E-value=0.0023  Score=48.90  Aligned_cols=55  Identities=20%  Similarity=0.191  Sum_probs=47.7

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCC-CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      -+|..+.+|+.++++.+.+++..- ..+.-.|++++|+-++++|++|++|...+..
T Consensus        56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            589999999999999999999631 1277789999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.28  E-value=1.8e-05  Score=75.78  Aligned_cols=122  Identities=13%  Similarity=0.054  Sum_probs=90.6

Q ss_pred             CCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcC---CCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            2 PKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDA---ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         2 ~ggsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      .+|++.+.|.+.-.  .+++...+...-.+.+.+..-+|+.   +.-.+|++||+-|.+|..+..+++.++|+.+.... 
T Consensus      1314 ~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp- 1392 (2724)
T KOG1826|consen 1314 EFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP- 1392 (2724)
T ss_pred             HHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-
Confidence            46777777755432  3345444444444447777777764   23379999999999999999999999999984221 


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCC
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV  125 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf  125 (252)
                       .....+..++++.|+.+++...-+++.++|+|..|+.+|+...|..+|
T Consensus      1393 -~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1393 -VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             -hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence             122345567888999999998888999999999999999998887665

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=96.91  E-value=0.0012  Score=52.66  Aligned_cols=50  Identities=12%  Similarity=0.035  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccc
Q 025440           20 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus        20 ~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      ....-.++..|+.-+..+-.  .|+||+|+..-||+++.+|.++++||--+.
T Consensus       201 ~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         201 VENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             ccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEecCCCEEEEeCcccc
Confidence            33344455555554444442  349999999999999999999999996554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.69  E-value=0.0028  Score=50.04  Aligned_cols=53  Identities=17%  Similarity=0.133  Sum_probs=42.9

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +.......+..++++.+.-|-. ..++||+||..-|||+. ++.+.++|||-+..
T Consensus       163 ~e~~e~~~~~~~~v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         163 LELEEAEGLYEDVVEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             cCchhHHHHHHHHHHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            3344677788888888887775 23599999999999999 88999999987754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=96.40  E-value=0.0062  Score=53.71  Aligned_cols=54  Identities=17%  Similarity=0.129  Sum_probs=37.8

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      ++...+.....++.--.-+-|  |  +.|.|.+|.||+++.+|++.+.|||+......
T Consensus       264 ~d~k~ia~~~~~~f~~q~~~d--g--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         264 IDRKELAELLVRAFLRQLLRD--G--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CCHHHHHHHHHHHHHHHHHhc--C--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            554444333333332222333  4  99999999999999999999999999876543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.39  E-value=0.0069  Score=50.60  Aligned_cols=55  Identities=24%  Similarity=0.238  Sum_probs=48.0

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      .-.+++++.++.+.+..++-+.. +-.+=|||+.-.||||+ +|+|.|+||-+++..
T Consensus       317 ~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            35788999999999988888876 35689999999999999 999999999999853

>PRK05231 homoserine kinase; Provisional

Probab=96.27  E-value=0.0089  Score=49.63  Aligned_cols=31  Identities=26%  Similarity=0.308  Sum_probs=26.6

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .++||+|+++.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4699999999999998766568999998864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.26  E-value=0.0026  Score=56.49  Aligned_cols=95  Identities=22%  Similarity=0.184  Sum_probs=72.4

Q ss_pred             HHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccccccCC
Q 025440           22 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR  101 (252)
Q Consensus        22 ~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  101 (252)
                      +...++..-+++++++|+..  =+|+|    ||+..+ +..+..||+....+....   ......+++.|+|||+..++.
T Consensus       337 ~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~  406 (829)
T KOG0576|consen  337 QFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENT  406 (829)
T ss_pred             hhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccc
Confidence            34455666778999999753  48888    777655 678999999887654332   345567899999999999999


Q ss_pred             CCcccceehhHHHHHHHHhCCCCCC
Q 025440          102 LTTKSDVYSFGVVLLELLSGRCAVD  126 (252)
Q Consensus       102 ~~~~~Di~slG~il~~lltg~~pf~  126 (252)
                      +..+.|.|++|.--.++--|..|-.
T Consensus       407 ~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  407 IDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCccCCCcchhhcCCCCCCCC
Confidence            9999999999987666766766653

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.19  E-value=0.011  Score=48.63  Aligned_cols=32  Identities=28%  Similarity=0.228  Sum_probs=27.5

Q ss_pred             CCCeeeccCCCCceeecCC----CceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+.+.|||++.+    +.++++||..+..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            3469999999999999875    8899999988754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.13  E-value=0.0053  Score=47.79  Aligned_cols=39  Identities=26%  Similarity=0.184  Sum_probs=34.9

Q ss_pred             HHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccc
Q 025440           31 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL   69 (252)
Q Consensus        31 ~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~   69 (252)
                      +++|...|+...+.+|+|-.|+||+-|..|-+||.|=+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            577888998777899999999999999999999999653

The function of this family is unknown.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.12  E-value=0.018  Score=44.36  Aligned_cols=55  Identities=24%  Similarity=0.225  Sum_probs=35.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC--C--ceEEcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--F--NAKLSD   66 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~--~--~~kl~D   66 (252)
                      .-||.+++.+..   ++. ...+.+.+..+-|   -+.+  |+.+||+|.||++...  +  .+.|+|
T Consensus       107 s~TL~~~l~~~~---~~~-~~~~~L~~f~~~l---~~~~--Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  107 SPTLEDYLKEGG---LTE-ELRQALDEFKRYL---LDHH--IVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CccHHHHHHcCC---ccH-HHHHHHHHHHHHH---HHcC--CeecCCCcccEEEEecCCCceEEEEEe
Confidence            357888885443   555 4445555555444   4333  9999999999999432  2  477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.10  E-value=0.0093  Score=49.29  Aligned_cols=32  Identities=28%  Similarity=0.327  Sum_probs=27.8

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            35699999999999999888778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.06  E-value=0.011  Score=46.62  Aligned_cols=31  Identities=19%  Similarity=0.209  Sum_probs=26.9

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+.|.||+++.++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34589999999999999888 99999988764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.02  E-value=0.0057  Score=48.46  Aligned_cols=31  Identities=19%  Similarity=0.243  Sum_probs=26.2

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.||+++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3499999999999998766667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.92  E-value=0.013  Score=46.20  Aligned_cols=31  Identities=19%  Similarity=0.252  Sum_probs=26.8

Q ss_pred             CCeeeccCCCCceeecC-CCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDA-EFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.|||++. ++.+.|+||..+..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            35999999999999998 57899999987753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=95.90  E-value=0.01  Score=46.40  Aligned_cols=31  Identities=29%  Similarity=0.362  Sum_probs=21.5

Q ss_pred             CCCeeeccCCCCceeec-CCCceEEccccccc
Q 025440           41 ESQVIYRDFKASNILLD-AEFNAKLSDFGLAK   71 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~   71 (252)
                      ...++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccce
Confidence            44699999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.71  E-value=0.008  Score=45.69  Aligned_cols=29  Identities=24%  Similarity=0.251  Sum_probs=25.5

Q ss_pred             CeeeccCCCCceeecCCCceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..+|+|+.|.||+++++| ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            379999999999998877 88999998864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.62  E-value=0.028  Score=46.37  Aligned_cols=30  Identities=23%  Similarity=0.307  Sum_probs=25.8

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            56999999999999987 6789999987653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.54  E-value=0.025  Score=45.82  Aligned_cols=48  Identities=19%  Similarity=0.129  Sum_probs=36.7

Q ss_pred             HHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           25 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        25 ~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      +.+..+-.++.-.+....-++|+|+.+.|++.+..+.++|+||..|..
T Consensus       136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            345555556666654313499999999999999999999999988764

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.43  E-value=0.025  Score=46.36  Aligned_cols=31  Identities=29%  Similarity=0.329  Sum_probs=27.2

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4599999999999999887788999988754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=95.39  E-value=0.013  Score=46.68  Aligned_cols=31  Identities=23%  Similarity=0.154  Sum_probs=27.0

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.|||+++++.+.|+||+.+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            4599999999999999987788999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.22  E-value=0.013  Score=46.97  Aligned_cols=29  Identities=24%  Similarity=0.274  Sum_probs=25.7

Q ss_pred             CeeeccCCCCceeecCCCceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .++|+|+.+.||+++.++ +.|+||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.97  E-value=0.015  Score=45.22  Aligned_cols=29  Identities=31%  Similarity=0.418  Sum_probs=20.8

Q ss_pred             CeeeccCCCCceee-cCCCceEEccccccc
Q 025440           43 QVIYRDFKASNILL-DAEFNAKLSDFGLAK   71 (252)
Q Consensus        43 ~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~   71 (252)
                      .++|+||.+.|||+ +.++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.84  E-value=0.032  Score=46.12  Aligned_cols=36  Identities=17%  Similarity=0.028  Sum_probs=23.2

Q ss_pred             HHHHHHHHHHHHhHHH-hcC-CCCeeeccCCCCceeec
Q 025440           22 VRMKVAIGAAKGLTFL-HDA-ESQVIYRDFKASNILLD   57 (252)
Q Consensus        22 ~~~~i~~~i~~~l~~l-H~~-~~~ivH~dlkp~Nill~   57 (252)
                      -+..++.||+.-.-.+ .-. -..++|-||||+||||-
T Consensus       280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            3456677776544222 111 12499999999999993

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.84  E-value=0.074  Score=47.09  Aligned_cols=53  Identities=21%  Similarity=0.113  Sum_probs=38.2

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC----CCceEEccccccccCC
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGP   74 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~   74 (252)
                      ++...+...+.++..-+-+.|  |  ++|.|=+|.||++..    ++.+.+.|||+.....
T Consensus       300 i~~~~i~~~l~~~~~~qIf~~--G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  300 ISPHDILNKLVEAYLEQIFKT--G--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CCHHHHHHHHHHHHHHHHHhc--C--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            666655555554444444444  5  999999999999983    6779999999987643

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.80  E-value=0.039  Score=45.84  Aligned_cols=50  Identities=20%  Similarity=0.196  Sum_probs=30.8

Q ss_pred             HHHHHHHHHHHhH---HHhcCCCCeeeccCCCCceeecCC------------------CceEEccccccccC
Q 025440           23 RMKVAIGAAKGLT---FLHDAESQVIYRDFKASNILLDAE------------------FNAKLSDFGLAKAG   73 (252)
Q Consensus        23 ~~~i~~~i~~~l~---~lH~~~~~ivH~dlkp~Nill~~~------------------~~~kl~Dfg~~~~~   73 (252)
                      +..++.||+.-.-   .|-.+ ..++|-||||+||||-..                  -.++|.||.+++..
T Consensus       277 vkfifLQiaLLyikIYelp~c-~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  277 VKFIFLQIALLYIKIYELPCC-TNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHeeeecCCCc-ceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            3455666654321   11112 249999999999999322                  23677788887653

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.73  E-value=0.051  Score=44.95  Aligned_cols=31  Identities=16%  Similarity=0.200  Sum_probs=28.1

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .+++|+|+.+.|||++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4699999999999999999999999988765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.64  E-value=0.029  Score=45.68  Aligned_cols=31  Identities=26%  Similarity=0.419  Sum_probs=26.1

Q ss_pred             CCeeeccCCCCceeecCCCc-eEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFN-AKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~   72 (252)
                      ..++|+|+++.|||++.++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35999999999999987555 56999998875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=94.59  E-value=0.03  Score=43.06  Aligned_cols=31  Identities=26%  Similarity=0.314  Sum_probs=25.6

Q ss_pred             CCeeeccCCCCceeecCCC-----ceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEF-----NAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~   72 (252)
                      ..++|||+.+.||++..++     .+.++||..++.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4599999999999997543     589999988764

subfamily of choline kinases

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.29  E-value=0.068  Score=44.61  Aligned_cols=30  Identities=20%  Similarity=0.252  Sum_probs=24.9

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            34589999999999995 4 578999998764

>PRK06148 hypothetical protein; Provisional

Probab=94.28  E-value=0.082  Score=50.96  Aligned_cols=32  Identities=44%  Similarity=0.454  Sum_probs=26.3

Q ss_pred             CCCeeeccCCCCceeecCCC--ce-EEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEF--NA-KLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~--~~-kl~Dfg~~~~   72 (252)
                      ..++||+|+.+.|||++.++  .+ -|+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            34599999999999998875  45 4999998764

>PLN02236 choline kinase

Probab=94.27  E-value=0.078  Score=44.64  Aligned_cols=30  Identities=20%  Similarity=0.297  Sum_probs=26.1

Q ss_pred             CeeeccCCCCceeecC-CCceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDA-EFNAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~   72 (252)
                      .++|+|+++.|||+++ ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5999999999999976 46799999988764

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.15  E-value=0.038  Score=46.09  Aligned_cols=29  Identities=28%  Similarity=0.450  Sum_probs=25.9

Q ss_pred             eeeccCCCCceeecCCCc-eEEcccccccc
Q 025440           44 VIYRDFKASNILLDAEFN-AKLSDFGLAKA   72 (252)
Q Consensus        44 ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~   72 (252)
                      +||+|+.+.||+++.+.. +.+.||+-++.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            899999999999998874 89999998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=93.26  E-value=0.078  Score=43.91  Aligned_cols=32  Identities=22%  Similarity=0.467  Sum_probs=28.8

Q ss_pred             CCeeeccCCCCceeecCCCceEEccccccccC
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      ..++|+|+++.|++++.++.+-|.||+++...
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            35999999999999999988999999998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=92.69  E-value=0.078  Score=46.56  Aligned_cols=83  Identities=30%  Similarity=0.324  Sum_probs=46.0

Q ss_pred             cccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCC
Q 025440          104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK  183 (252)
Q Consensus       104 ~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  183 (252)
                      .|+|||++|.++.++.-|...|........  ......-+..+.....-....    ...-.+.....++..+|+...|.
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~--l~~i~k~~~~d~~~~~~a~e~----~~~~~~d~~~~~~~~~c~~~~~~  183 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEY--LEILLKYYTDDQELLSTAMEH----LIQLLADKKRLPLLKKCLWLEPI  183 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHH--HHHHHHhccCchhHHHHHHHH----HHHHhhhHhHHHHhccCCccccc
Confidence            599999999999999988766644322110  000000001111000000000    11234566677889999999999


Q ss_pred             CCCCHHHHH
Q 025440          184 LRPRMSEVL  192 (252)
Q Consensus       184 ~Rpt~~~v~  192 (252)
                      .||...++.
T Consensus       184 ir~l~~~~~  192 (725)
T KOG1093|consen  184 IRPLPMELS  192 (725)
T ss_pred             cccchhHHh
Confidence            988655544

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.65  E-value=0.22  Score=41.62  Aligned_cols=30  Identities=20%  Similarity=0.257  Sum_probs=25.8

Q ss_pred             CeeeccCCCCceeecC-CCceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDA-EFNAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~   72 (252)
                      .++|.|+.+.|||++. ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4899999999999974 57899999988754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=91.93  E-value=0.22  Score=40.79  Aligned_cols=30  Identities=33%  Similarity=0.398  Sum_probs=24.8

Q ss_pred             CeeeccCCCCceeecCC--C---ceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDAE--F---NAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~~--~---~~kl~Dfg~~~~   72 (252)
                      -++|||++..|||+..+  |   .+++.||.+++.
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence            49999999999999654  3   589999987754

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=91.38  E-value=0.31  Score=40.59  Aligned_cols=44  Identities=18%  Similarity=0.147  Sum_probs=33.4

Q ss_pred             HHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccc
Q 025440           26 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus        26 i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      +...++.-+--|-.+  |+||+|..--||+|..++.++++||--+.
T Consensus       207 ly~~lm~~Iv~la~~--GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  207 LYDDLMGLIVRLANH--GLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             HHHHHHHHHHHHHHc--CceecccchheeEEecCCCEEEeechHhh
Confidence            444444445555533  49999999999999999999999997543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=91.15  E-value=0.44  Score=40.91  Aligned_cols=31  Identities=19%  Similarity=0.278  Sum_probs=26.0

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+.+.||++..+ .++|+||-++..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            4459999999999999776 589999987754

>COG3178 Predicted phosphotransferase related to Ser/Thr protein kinases [General function prediction only]

Probab=91.13  E-value=0.53  Score=38.44  Aligned_cols=60  Identities=25%  Similarity=0.261  Sum_probs=38.7

Q ss_pred             cCCCCCCCHHHHHHHHHHHHHH-hHHHhcCCCCeeeccCCCCceeecCC----CceEEcccccccc
Q 025440           12 RRGPQPLSWAVRMKVAIGAAKG-LTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   72 (252)
Q Consensus        12 ~~~~~~l~~~~~~~i~~~i~~~-l~~lH~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~   72 (252)
                      ..-..+++..++..+.. |..+ +.-+-.+.+.++|||..+.|++...+    +++-|.||.=+..
T Consensus       170 r~~g~~l~~~~r~~~~a-iwd~Lid~~~~~~~vlvhRDfh~~NLmw~~~~~g~~rvGvlDFQDA~i  234 (351)
T COG3178         170 RHLGRPLTDAERQAWEA-IWDGLIDSLLAQPKVLVHRDFHSRNLMWTADRAGADRVGVLDFQDALI  234 (351)
T ss_pred             HHhCCCCCHHHHHHHHH-HHHHHHHHHhcCCceeeeccccCccceecCCccCCCCCceeehhhhhc
Confidence            33345677776654432 2222 33344445679999999999999655    5688999976544

>PRK06149 hypothetical protein; Provisional

Probab=90.85  E-value=0.37  Score=46.44  Aligned_cols=32  Identities=19%  Similarity=0.202  Sum_probs=25.6

Q ss_pred             CCCeeeccCCCCceeecCCC--c---eEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEF--N---AKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~--~---~kl~Dfg~~~~   72 (252)
                      ..++||+|++..|||++.+.  .   .-|+|||-+..
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            34699999999999998652  3   47999998754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=90.14  E-value=0.27  Score=41.52  Aligned_cols=31  Identities=16%  Similarity=0.205  Sum_probs=25.4

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+||.+.||+++.++ ++++|+.++..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             cceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            34599999999999997764 77999987654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=88.49  E-value=0.38  Score=41.20  Aligned_cols=30  Identities=17%  Similarity=0.283  Sum_probs=25.0

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+||.+.|||++.+ .+|++|.-++..
T Consensus       227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy  256 (409)
T PRK12396        227 QALIHGDLHTGSVFVKND-STKVIDPEFAFY  256 (409)
T ss_pred             hhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence            459999999999999886 489999776654

>PRK10593 hypothetical protein; Provisional

Probab=88.10  E-value=0.64  Score=38.27  Aligned_cols=28  Identities=14%  Similarity=0.241  Sum_probs=22.0

Q ss_pred             CCCeeeccCCCCceeecCC-Cc-eEEcccc
Q 025440           41 ESQVIYRDFKASNILLDAE-FN-AKLSDFG   68 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~-~~-~kl~Dfg   68 (252)
                      ...++|+|+.+.||+++.+ +. +.|.|..
T Consensus       192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa  221 (297)
T PRK10593        192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG  221 (297)
T ss_pred             CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence            3569999999999999865 43 6677764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=87.11  E-value=0.83  Score=35.30  Aligned_cols=41  Identities=27%  Similarity=0.399  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccc
Q 025440           23 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA   70 (252)
Q Consensus        23 ~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~   70 (252)
                      ..+-+.+|.+-|..+|..+  |+-+|+++.|..     .-+|+|||.+
T Consensus       166 ~~~~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  166 QIRDIPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             chhHHHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence            4556788889999999665  999999999986     3488999864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	252
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-38
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-33
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-32
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-29
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		8e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  153 bits (386), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 86/202 (42%), Positives = 126/202 (62%), Gaps = 9/202 (4%)
Query: 1   MPKGSLENHLFRRGPQ---PLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILL 56
           M  GS+ + L R  P+   PL W  R ++A+G+A+GL +LHD  + ++I+RD KA+NILL
Sbjct: 117 MANGSVASCL-RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D EF A + DFGLAK     D  HV   V GT G+ APEY++TG+ + K+DV+ +GV+LL
Sbjct: 176 DEEFEAVVGDFGLAKLMDYKD-XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 234
Query: 117 ELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
           EL++G+ A D  ++  +    L+DW K  L +K KL  ++D  L G Y  +       +A
Sbjct: 235 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVA 293
Query: 175 LQCLNNEPKLRPRMSEVLAILE 196
           L C  + P  RP+MSEV+ +LE
Sbjct: 294 LLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 88/221 (39%), Positives = 131/221 (59%), Gaps = 9/221 (4%)
Query: 1   MPKGSLENHLFRRGPQ---PLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILL 56
           M  GS+ + L R  P+   PL W  R ++A+G+A+GL +LHD  + ++I+RD KA+NILL
Sbjct: 109 MANGSVASCL-RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D EF A + DFGLAK     D  HV   V G  G+ APEY++TG+ + K+DV+ +GV+LL
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKD-XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLL 226
Query: 117 ELLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
           EL++G+ A D  ++  +    L+DW K  L +K KL  ++D  L G Y  +       +A
Sbjct: 227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVA 285
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 215
           L C  + P  RP+MSEV+ +LE     +   +  + E  RQ
Sbjct: 286 LLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 326

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  136 bits (343), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 79/198 (39%), Positives = 114/198 (57%), Gaps = 5/198 (2%)
Query: 1   MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G+L+ HL+        +SW  R+++ IGAA+GL +LH     +I+RD K+ NILLD 
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDE 174
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
            F  K++DFG++K G   D+TH+   V GT GY  PEY   GRLT KSDVYSFGVVL E+
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           L  R A+ ++      +L +WA     +  +L +I+D  L  +   ++       A++CL
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 179 NNEPKLRPRMSEVLAILE 196
               + RP M +VL  LE
Sbjct: 294 ALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  133 bits (335), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 78/198 (39%), Positives = 113/198 (57%), Gaps = 5/198 (2%)
Query: 1   MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G+L+ HL+        +SW  R+++ IGAA+GL +LH     +I+RD K+ NILLD 
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDE 174
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
            F  K++DFG++K G    +TH+   V GT GY  PEY   GRLT KSDVYSFGVVL E+
Sbjct: 175 NFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           L  R A+ ++      +L +WA     +  +L +I+D  L  +   ++       A++CL
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 179 NNEPKLRPRMSEVLAILE 196
               + RP M +VL  LE
Sbjct: 294 ALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  127 bits (319), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 122/201 (60%), Gaps = 7/201 (3%)
Query: 1   MPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           MP GSL + L    G  PLSW +R K+A GAA G+ FLH  E+  I+RD K++NILLD  
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEA 169
Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           F AK+SDFGLA+A     +T + ++++GT  Y APE +  G +T KSD+YSFGVVLLE++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +G  AVD+ +    Q L+D  +    +++ +   +D K+       +     ++A QCL+
Sbjct: 229 TGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLH 285
Query: 180 NEPKLRPRMSEVLAILERLEA 200
            +   RP + +V  +L+ + A
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 121/201 (60%), Gaps = 7/201 (3%)
Query: 1   MPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           MP GSL + L    G  PLSW +R K+A GAA G+ FLH  E+  I+RD K++NILLD  
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEA 169
Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           F AK+SDFGLA+A     +T +  +++GT  Y APE +  G +T KSD+YSFGVVLLE++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +G  AVD+ +    Q L+D  +    +++ +   +D K+       +     ++A QCL+
Sbjct: 229 TGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLH 285
Query: 180 NEPKLRPRMSEVLAILERLEA 200
            +   RP + +V  +L+ + A
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 79/201 (39%), Positives = 120/201 (59%), Gaps = 7/201 (3%)
Query: 1   MPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           MP GSL + L    G  PLSW +R K+A GAA G+ FLH  E+  I+RD K++NILLD  
Sbjct: 106 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEA 163
Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           F AK+SDFGLA+A     +  +  +++GT  Y APE +  G +T KSD+YSFGVVLLE++
Sbjct: 164 FTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 222
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +G  AVD+ +    Q L+D  +    +++ +   +D K+       +     ++A QCL+
Sbjct: 223 TGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLH 279
Query: 180 NEPKLRPRMSEVLAILERLEA 200
            +   RP + +V  +L+ + A
Sbjct: 280 EKKNKRPDIKKVQQLLQEMTA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/200 (39%), Positives = 116/200 (58%), Gaps = 7/200 (3%)
Query: 2   PKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           P GSL + L    G  PLSW  R K+A GAA G+ FLH  E+  I+RD K++NILLD  F
Sbjct: 104 PNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 161
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
            AK+SDFGLA+A     +    ++++GT  Y APE +  G +T KSD+YSFGVVLLE+++
Sbjct: 162 TAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIIT 220
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G  AVD+ +    Q L+D  +    +++ +   +D K        +     ++A QCL+ 
Sbjct: 221 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHE 277
Query: 181 EPKLRPRMSEVLAILERLEA 200
           +   RP + +V  +L+   A
Sbjct: 278 KKNKRPDIKKVQQLLQEXTA 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 1   MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           + +GSL   L + G  + L    R+ +A   AKG+ +LH+    +++RD K+ N+L+D +
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKK 175
Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           +  K+ DFGL++          S    GT  + APE +       KSDVYSFGV+L EL 
Sbjct: 176 YTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL- 232
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                + +    +  + V  A  +   + ++ R ++       PQ AA         C  
Sbjct: 233 ---ATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN-------PQVAAIIEG-----CWT 277
Query: 180 NEPKLRPRMSEVLAILERL 198
           NEP  RP  + ++ +L  L
Sbjct: 278 NEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 1   MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           + +GSL   L + G  + L    R+ +A   AKG+ +LH+    +++R+ K+ N+L+D +
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175
Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           +  K+ DFGL++   +   T +S++   GT  + APE +       KSDVYSFGV+L EL
Sbjct: 176 YTVKVCDFGLSRLKAS---TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
                 + +    +  + V  A  +   + ++ R ++       PQ AA         C 
Sbjct: 233 ----ATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN-------PQVAAIIEG-----CW 276
Query: 179 NNEPKLRPRMSEVLAILERL 198
            NEP  RP  + ++ +L  L
Sbjct: 277 TNEPWKRPSFATIMDLLRPL 296

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---- 56
           +P G L + L  +   P+ W+V++++ +  A G+ ++ +    +++RD ++ NI L    
Sbjct: 103 VPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161
Query: 57  -DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGV 113
            +A   AK++DFGL++        H  + ++G   + APE +       T K+D YSF +
Sbjct: 162 ENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAAT 172
           +L  +L+G    D+   G               K K   ++ +  L    P+        
Sbjct: 217 ILYTILTGEGPFDEYSYG---------------KIKFINMIREEGLRPTIPEDCPPRLRN 261
Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           +   C + +PK RP  S ++  L  L
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 25/202 (12%)
Query: 1   MPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M KGSL + L       QPL   +     I  A+G+ F+   +   I+RD +A+NIL+ A
Sbjct: 91  MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIE--QRNYIHRDLRAANILVSA 146
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
               K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L+E+
Sbjct: 147 SLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSFGILLMEI 205
Query: 119 LS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           ++ GR                   P +S+  ++ R ++       P+        + ++C
Sbjct: 206 VTYGRIPY----------------PGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRC 248
Query: 178 LNNEPKLRPRMSEVLAILERLE 199
             N P+ RP    + ++L+  E
Sbjct: 249 WKNRPEERPTFEYIQSVLDDFE 270

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 140 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 141 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 132 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 133 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 133 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 143 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 135 RGLKYIHSA--NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 119 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 173
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 174 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 233
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 234 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 277
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 278 CWHPKAEMRPSFSELVS 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 112 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 166
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 167 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 226
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 227 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 270
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 271 CWHPKAEMRPSFSELVS 287

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 114 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 168
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 228
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 229 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 272
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 273 CWHPKAEMRPSFSELVS 289

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+L++   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 155 RGLKYIHSA--NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 115 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 169
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 170 KFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 229
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 230 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 273
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 274 CWHPKAEMRPSFSELVS 290

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 115 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 169
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 170 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 229
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 230 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 273
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 274 CWHPKAEMRPSFSELVS 290

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 137 RGLKYIHSA--NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 114 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 168
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 169 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 228
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 229 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 272
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 273 CWHPKAEMRPSFSELVS 289

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 5/138 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G      A  +  A     GL  LH    +++YRD K  NILLD   
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHG 323
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + ++SD GLA   P G         +GT GY APE V   R T   D ++ G +L E+++
Sbjct: 324 HIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 121 GRCAVDKTKVGIEQSLVD 138
           G+    + K  I++  V+
Sbjct: 381 GQSPFQQRKKKIKREEVE 398

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 5/138 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L+ H++  G      A  +  A     GL  LH    +++YRD K  NILLD   
Sbjct: 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHG 323
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + ++SD GLA   P G         +GT GY APE V   R T   D ++ G +L E+++
Sbjct: 324 HIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 121 GRCAVDKTKVGIEQSLVD 138
           G+    + K  I++  V+
Sbjct: 381 GQSPFQQRKKKIKREEVE 398

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ FL  A  + ++RD  A N +LD 
Sbjct: 173 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDE 227
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 228 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 288 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 331
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 332 CWHPKAEMRPSFSELVS 348

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---- 56
           +P G L + L  +   P+ W+V++++ +  A G+ ++ +    +++RD ++ NI L    
Sbjct: 103 VPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161
Query: 57  -DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGV 113
            +A   AK++DFG ++        H  + ++G   + APE +       T K+D YSF +
Sbjct: 162 ENAPVCAKVADFGTSQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAAT 172
           +L  +L+G    D+   G               K K   ++ +  L    P+        
Sbjct: 217 ILYTILTGEGPFDEYSYG---------------KIKFINMIREEGLRPTIPEDCPPRLRN 261
Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           +   C + +PK RP  S ++  L  L
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/102 (40%), Positives = 59/102 (57%), Gaps = 10/102 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +   +  A+G+ +L  AE + ++RD  A N +LD  F  K++DFGLA+     DR + S 
Sbjct: 127 ISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182
Query: 84  QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           Q    H      + A E + T R TTKSDV+SFGV+L ELL+
Sbjct: 183 Q-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD    + +  GT  Y 
Sbjct: 131 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYI 186
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +   +     D +SFGV+L E+L G+
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 45/189 (23%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFN--------AKLSDFG 68
           ++WAV++      A+G+ +LHD A   +I+RD K+SNIL+  +           K++DFG
Sbjct: 108 VNWAVQI------ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161
Query: 69  LAKAGPTGDRTHVSTQV--MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC--- 123
           LA+        H +T++   G + + APE +     +  SDV+S+GV+L ELL+G     
Sbjct: 162 LAR------EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 124 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 183
            +D   V                    + +   KL    P       A L   C N +P 
Sbjct: 216 GIDGLAVA-------------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPH 256
Query: 184 LRPRMSEVL 192
            RP  + +L
Sbjct: 257 SRPSFTNIL 265

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 1   MPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M KGSL + L       QPL   +     I  A+G+ F+   +   I+RD +A+NIL+ A
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIE--QRNYIHRDLRAANILVSA 319
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
               K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L+E+
Sbjct: 320 SLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 119 LS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           ++ GR                   P +S+  ++ R ++       P+        + ++C
Sbjct: 379 VTYGRIPY----------------PGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRC 421
Query: 178 LNNEPKLRPRMSEVLAILE 196
             N P+ RP    + ++L+
Sbjct: 422 WKNRPEERPTFEYIQSVLD 440

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 1   MPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M KGSL + L       QPL   +     I  A+G+ F+   +   I+RD +A+NIL+ A
Sbjct: 258 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIE--QRNYIHRDLRAANILVSA 313
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
               K++DFGLA+ G                 + APE +  G  T KSDV+SFG++L+E+
Sbjct: 314 SLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIKSDVWSFGILLMEI 362
Query: 119 LS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           ++ GR                   P +S+  ++ R ++       P+        + ++C
Sbjct: 363 VTYGRIPY----------------PGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRC 405
Query: 178 LNNEPKLRPRMSEVLAILE 196
             N P+ RP    + ++L+
Sbjct: 406 WKNRPEERPTFEYIQSVLD 424

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 4   GSLENHLFRRGPQPLSWAVR-MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFN 61
           GSL N L    P P   A   M   +  ++G+ +LH  + + +I+RD K  N+LL A   
Sbjct: 85  GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 144
Query: 62  A-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+ DFG A       +TH+ T   G+  + APE       + K DV+S+G++L E+++
Sbjct: 145 VLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 199
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQC 177
            R                  KP+       FRIM     G  P   +       +L  +C
Sbjct: 200 RR------------------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC 241
Query: 178 LNNEPKLRPRMSEVLAILERL 198
            + +P  RP M E++ I+  L
Sbjct: 242 WSKDPSQRPSMEEIVKIMTHL 262

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 134 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 191
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 192 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 250
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 251 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 297

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---- 56
           +P G L + L  +   P+ W+V++++ +  A G+ ++ +    +++RD ++ NI L    
Sbjct: 103 VPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161
Query: 57  -DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGV 113
            +A   AK++DF L++        H  + ++G   + APE +       T K+D YSF +
Sbjct: 162 ENAPVCAKVADFSLSQQS-----VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAM 216
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYPQKAAHTAAT 172
           +L  +L+G    D+   G               K K   ++ +  L    P+        
Sbjct: 217 ILYTILTGEGPFDEYSYG---------------KIKFINMIREEGLRPTIPEDCPPRLRN 261
Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           +   C + +PK RP  S ++  L  L
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 135 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 192
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 251
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 252 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 298

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 223
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 224 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 270

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 109 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 166
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 167 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 225
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 226 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 272

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 127 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 185 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 243
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 244 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 290

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 223
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 224 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 270

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 112 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 228
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 229 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 112 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 228
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 229 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 275

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 135 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 251
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 252 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 298

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 75
           P++    ++V   A + L F H  ++ +I+RD K +NIL+ A    K+ DFG+A+A   +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADS 169
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 170 GNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 4   GSLENHLFRRGPQPLSWAVR-MKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFN 61
           GSL N L    P P   A   M   +  ++G+ +LH  + + +I+RD K  N+LL A   
Sbjct: 84  GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143
Query: 62  A-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+ DFG A       +TH+ T   G+  + APE       + K DV+S+G++L E+++
Sbjct: 144 VLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQC 177
            R                  KP+       FRIM     G  P   +       +L  +C
Sbjct: 199 RR------------------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC 240
Query: 178 LNNEPKLRPRMSEVLAILERL 198
            + +P  RP M E++ I+  L
Sbjct: 241 WSKDPSQRPSMEEIVKIMTHL 261

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 60/110 (54%), Gaps = 11/110 (10%)
Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
           +R P P++     +V +     L +LH  +  +IYRD K  NILLD   + K++DFG AK
Sbjct: 101 QRFPNPVAKFYAAEVCLA----LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAK 154
Query: 72  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             P      V+  + GT  Y APE V+T       D +SFG+++ E+L+G
Sbjct: 155 YVPD-----VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 17/178 (9%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 107 IDIARQTAQGMDYLH-AKS-IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 164
Query: 84  QVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
           Q+ G+  + APE +        + +SDVY+FG+VL EL++G+          +Q +    
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG 223
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           + YLS          +K+    P+      A    +CL  +   RP   ++LA +E L
Sbjct: 224 RGYLSPDL-------SKVRSNCPKAMKRLMA----ECLKKKRDERPLFPQILASIELL 270

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T    + + T  
Sbjct: 139 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T    + + T  
Sbjct: 140 RGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD    +    GT  Y 
Sbjct: 130 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYI 185
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           APE +   +     D +SFGV+L E+L G+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R+   P   A      I  A  L +LH  E  +IYRD K  N+LLD+E + K
Sbjct: 106 GDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIK 161
Query: 64  LSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E+++GR
Sbjct: 162 LTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218
Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 182
              D   VG   +      P  + +  LF+++  K   + P+  +  AA++    LN +P
Sbjct: 219 SPFD--IVGSSDN------PDQNTEDYLFQVILEK-QIRIPRSMSVKAASVLKSFLNKDP 269
Query: 183 KLR 185
           K R
Sbjct: 270 KER 272

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R+   P   A      I  A  L +LH  E  +IYRD K  N+LLD+E + K
Sbjct: 91  GDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIK 146
Query: 64  LSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E+++GR
Sbjct: 147 LTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203
Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 182
              D   VG   +      P  + +  LF+++  K   + P+  +  AA++    LN +P
Sbjct: 204 SPFD--IVGSSDN------PDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDP 254
Query: 183 KLR 185
           K R
Sbjct: 255 KER 257

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R+   P   A      I  A  L +LH  E  +IYRD K  N+LLD+E + K
Sbjct: 138 GDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIK 193
Query: 64  LSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E+++GR
Sbjct: 194 LTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 182
              D   VG   +      P  + +  LF+++  K   + P+  +  AA++    LN +P
Sbjct: 251 SPFD--IVGSSDN------PDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDP 301
Query: 183 KLR 185
           K R
Sbjct: 302 KER 304

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 17/183 (9%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L  H+ R+   P   A      I  A  L +LH  E  +IYRD K  N+LLD+E + K
Sbjct: 95  GDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIK 150
Query: 64  LSDFGLAKAGPT-GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L+D+G+ K G   GD T   +   GT  Y APE +         D ++ GV++ E+++GR
Sbjct: 151 LTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 182
              D   VG   +      P  + +  LF+++  K   + P+  +  AA++    LN +P
Sbjct: 208 SPFD--IVGSSDN------PDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDP 258
Query: 183 KLR 185
           K R
Sbjct: 259 KER 261

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 111 IDIARQTARGMDYLH-AKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE 168
Query: 84  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGR 122
           Q+ G+  + APE +    +   + +SDVY+FG+VL EL++G+
Sbjct: 169 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 75
           P++    ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 75
           P++    ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 75
           P++    ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 75
           P++    ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 66/121 (54%), Gaps = 9/121 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDN 326
Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL K A  T D   +  +      + APE +   + +TKSDV+SFG++L E+ 
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 120 S 120
           S
Sbjct: 381 S 381

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 123 IDIARQTARGMDYLH-AKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 84  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGR 122
           Q+ G+  + APE +    +   + +SDVY+FG+VL EL++G+
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 5/102 (4%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH A+S +I+RD K++NI L  +   K+ DFGLA        +H   
Sbjct: 123 IDIARQTARGMDYLH-AKS-IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 84  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGR 122
           Q+ G+  + APE +    +   + +SDVY+FG+VL EL++G+
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 66/121 (54%), Gaps = 9/121 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 82  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDN 139
Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL K A  T D   +  +      + APE +   + +TKSDV+SFG++L E+ 
Sbjct: 140 VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIY 193
Query: 120 S 120
           S
Sbjct: 194 S 194

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 75
           P++    ++V   A + L F H  ++ +I+RD K +NI++ A    K+ DFG+A+A   +
Sbjct: 129 PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 186
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L+G
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 66/121 (54%), Gaps = 9/121 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 97  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDN 154
Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL K A  T D   +  +      + APE +   + +TKSDV+SFG++L E+ 
Sbjct: 155 VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIY 208
Query: 120 S 120
           S
Sbjct: 209 S 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 67/127 (52%), Gaps = 14/127 (11%)
Query: 4   GSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           G L  H+ + G    PQ + +A  + +      GL FLH  +  +IYRD K  N++LD+E
Sbjct: 105 GDLMYHIQQVGKFKEPQAVFYAAEISI------GLFFLH--KRGIIYRDLKLDNVMLDSE 156
Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            + K++DFG+ K       T  + +  GT  Y APE +A        D +++GV+L E+L
Sbjct: 157 GHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 214
Query: 120 SGRCAVD 126
           +G+   D
Sbjct: 215 AGQPPFD 221

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQVMG 87
           G A G+ +L  A    ++RD  A NIL+++    K+SDFGL++      + T+ ++    
Sbjct: 155 GIAAGMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-D 146
              + APE ++  + T+ SDV+SFG+V+ E+++                    +PY    
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG-----------------ERPYWELS 255
Query: 147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSA 205
             ++ + ++       P         L +QC   E   RP+ +++++IL++L  AP +  
Sbjct: 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315
Query: 206 KLSQSEP 212
            L+  +P
Sbjct: 316 TLADFDP 322

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 88/197 (44%), Gaps = 8/197 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L R     +  A  +  A    +G+ +LH      I+RD  A N+LLD + 
Sbjct: 117 VPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDR 171
Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGLAKA P G   + V         + APE +   +    SDV+SFGV L ELL
Sbjct: 172 LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +  C   ++       L+  A+  ++  R L  +++       P K       L   C  
Sbjct: 232 T-HCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMKNCWE 289
Query: 180 NEPKLRPRMSEVLAILE 196
            E   RP    ++ IL+
Sbjct: 290 TEASFRPTFENLIPILK 306

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 71/122 (58%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 89  MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 145
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++ + +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 146 EIKLCDFGVS--GQLIDE--MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 201
Query: 121 GR 122
           GR
Sbjct: 202 GR 203

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ + 
Sbjct: 121 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 176
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 177 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 222
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    PK+RP   E
Sbjct: 223 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLE 278
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 279 IVNLLK 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ + 
Sbjct: 124 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 225
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    PK+RP   E
Sbjct: 226 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 282 IVNLLK 287

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/100 (40%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ + H     V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YA
Sbjct: 128 GVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYA 182
Query: 93  APEYVATGRLTT--KSDVYSFGVVLLELLSGRCAVDKTKV 130
           APE V +GRL    + D++S GV+L  LL G    D   V
Sbjct: 183 APE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 9/121 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 88  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDN 145
Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL K A  T D   +  +      + APE +     +TKSDV+SFG++L E+ 
Sbjct: 146 VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKSDVWSFGILLWEIY 199
Query: 120 S 120
           S
Sbjct: 200 S 200

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 1   MPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           M  GSL+  L    G   +   V M   +GA  G+ +L D     ++RD  A N+L+D+ 
Sbjct: 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGA--GMRYLSDL--GYVHRDLAARNVLVDSN 187
Query: 60  FNAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
              K+SDFGL++      D  + +T       + APE +A    ++ SDV+SFGVV+ E+
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247
Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           L+                    +PY +   R +   ++       P    H    L L C
Sbjct: 248 LAYG-----------------ERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDC 290
Query: 178 LNNEPKLRPRMSEVLAILERL 198
            + +   RPR S+++++L+ L
Sbjct: 291 WHKDRAQRPRFSQIVSVLDAL 311

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 113 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 167
Query: 59  EFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+          H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 168 KFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 227
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 228 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 271
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 272 CWHPKAEMRPSFSELVS 288

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 114 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 168
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 169 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 228
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 229 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 272
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 273 CWHPKAEMRPSFSELVS 289

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 111 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 165
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 166 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 225
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 226 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 269
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 270 CWHPKAEMRPSFSELVS 286

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 109 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 163
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 224 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 267
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 268 CWHPKAEMRPSFSELVS 284

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 133 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 187
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 188 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 247
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 248 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 291
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 292 CWHPKAEMRPSFSELVS 308

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 106 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 160
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 161 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 220
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 221 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 264
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 265 CWHPKAEMRPSFSELVS 281

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 114 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 168
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 169 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 228
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 229 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 272
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 273 CWHPKAEMRPSFSELVS 289

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 113 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 167
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 168 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 227
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 228 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 271
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 272 CWHPKAEMRPSFSELVS 288

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 132 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 186
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 187 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 246
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 247 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 290
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 291 CWHPKAEMRPSFSELVS 307

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 25/197 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIG--AAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G L N +      P    V+  +  G   AKG+ +L  A  + ++RD  A N +LD 
Sbjct: 112 MKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDE 166
Query: 59  EFNAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           +F  K++DFGLA+     +    H  T       + A E + T + TTKSDV+SFGV+L 
Sbjct: 167 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 226
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           EL++ R A     V      V     YL   R+L +          P+        + L+
Sbjct: 227 ELMT-RGAPPYPDVNTFDITV-----YLLQGRRLLQ----------PEYCPDPLYEVMLK 270
Query: 177 CLNNEPKLRPRMSEVLA 193
           C + + ++RP  SE+++
Sbjct: 271 CWHPKAEMRPSFSELVS 287

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 148 MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 204
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 205 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 260
Query: 121 GR 122
           GR
Sbjct: 261 GR 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 113 MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 169
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 170 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 121 GR 122
           GR
Sbjct: 226 GR 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 22/187 (11%)
Query: 14  GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
           GP PLS A ++ +A   A G+ +L  +E + ++RD    N L+      K++DFGL++  
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 133
            + D             +  PE +   R TT+SDV+++GVVL E+ S          G++
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGLQ 275
Query: 134 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
                   PY  ++ +  ++ + D  +    P+        L   C +  P  RP    +
Sbjct: 276 --------PYYGMAHEEVIYYVRDGNILAC-PENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 192 LAILERL 198
             IL+R+
Sbjct: 327 HRILQRM 333

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 28/152 (18%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YAAPE V +GRL 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLY 187
Query: 104 T--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 161
              + D++S GV+L  LL G    D   V           P L  K +         GG 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PTLFKKIR---------GGV 227
Query: 162 Y--PQKAAHTAATLALQCLNNEPKLRPRMSEV 191
           +  P+    + ATL +  L  +P  R  + ++
Sbjct: 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL+ +L  +    ++   ++K A+   KG+ +L     Q ++RD  A N+L+++E 
Sbjct: 107 LPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEH 163
Query: 61  NAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGL KA  T  +   V         + APE +   +    SDV+SFGV L ELL
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 120 SGRCAVDKT 128
           +  C  D +
Sbjct: 224 T-YCDSDSS 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL+ +L  +    ++   ++K A+   KG+ +L     Q ++RD  A N+L+++E 
Sbjct: 95  LPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEH 151
Query: 61  NAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGL KA  T  +   V         + APE +   +    SDV+SFGV L ELL
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211
Query: 120 SGRCAVDKT 128
           +  C  D +
Sbjct: 212 T-YCDSDSS 219

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 8/197 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L R     +  A  +  A    +G+ +LH      I+R+  A N+LLD + 
Sbjct: 100 VPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHS--QHYIHRNLAARNVLLDNDR 154
Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGLAKA P G   + V         + APE +   +    SDV+SFGV L ELL
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +  C   ++       L+  A+  ++  R L  +++       P K       L   C  
Sbjct: 215 T-HCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDKCPCEVYHLMKNCWE 272
Query: 180 NEPKLRPRMSEVLAILE 196
            E   RP    ++ IL+
Sbjct: 273 TEASFRPTFENLIPILK 289

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ + 
Sbjct: 124 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 225
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    PK+RP   E
Sbjct: 226 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 282 IVNLLK 287

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 86  MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 143 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 121 GR 122
           GR
Sbjct: 199 GR 200

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGLA+     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLARV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 86  MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 143 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 121 GR 122
           GR
Sbjct: 199 GR 200

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 105 MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 161
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 162 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 217
Query: 121 GR 122
           GR
Sbjct: 218 GR 219

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 1   MPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           M  GSL+  L    G   +   V M   +GA  G+ +L D     ++RD  A N+L+D+ 
Sbjct: 132 MENGSLDTFLRTHDGQFTIMQLVGMLRGVGA--GMRYLSDL--GYVHRDLAARNVLVDSN 187
Query: 60  FNAKLSDFGLAKA---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
              K+SDFGL++     P    T    ++     + APE +A    ++ SDV+SFGVV+ 
Sbjct: 188 LVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           E+L+                    +PY +   R +   ++       P    H    L L
Sbjct: 246 EVLAYG-----------------ERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLML 288
Query: 176 QCLNNEPKLRPRMSEVLAILERL 198
            C + +   RPR S+++++L+ L
Sbjct: 289 DCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ + 
Sbjct: 123 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 178
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 179 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 224
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    PK+RP   E
Sbjct: 225 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLE 280
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 281 IVNLLK 286

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 86  MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 143 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 121 GR 122
           GR
Sbjct: 199 GR 200

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 84  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 135
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 114
           L+      K++DFGLA+     + T           + APE    GR T KSDV+SFG++
Sbjct: 136 LVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGIL 194
Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATL 173
           L EL +      K +V           PY     R++   ++       P +   +   L
Sbjct: 195 LTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHDL 237
Query: 174 ALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
             QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 238 MCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 273

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 8/197 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L R     +  A  +  A    +G+ +LH      I+R+  A N+LLD + 
Sbjct: 100 VPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLH--AQHYIHRNLAARNVLLDNDR 154
Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGLAKA P G   + V         + APE +   +    SDV+SFGV L ELL
Sbjct: 155 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +  C   ++       L+  A+  ++  R L  +++       P K       L   C  
Sbjct: 215 T-HCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLERGERLPRPDKCPCEVYHLMKNCWE 272
Query: 180 NEPKLRPRMSEVLAILE 196
            E   RP    ++ IL+
Sbjct: 273 TEASFRPTFENLIPILK 289

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 95  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 152
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 153 NCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 212
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 213 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 254
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 255 LELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 299

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/78 (44%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +IYRD K  NILLD E + KL+DFGL+K   + D    +    GT  Y APE V     T
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 104 TKSDVYSFGVVLLELLSG 121
             +D +SFGV++ E+L+G
Sbjct: 205 QSADWWSFGVLMFEMLTG 222

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 86  MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 143 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 121 GR 122
           GR
Sbjct: 199 GR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 70/122 (57%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G  P    +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 86  MDGGSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++  G   D   ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 143 EIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 121 GR 122
           GR
Sbjct: 199 GR 200

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/78 (44%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +IYRD K  NILLD E + KL+DFGL+K   + D    +    GT  Y APE V     T
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 104 TKSDVYSFGVVLLELLSG 121
             +D +SFGV++ E+L+G
Sbjct: 205 QSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/78 (44%), Positives = 47/78 (60%), Gaps = 2/78 (2%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +IYRD K  NILLD E + KL+DFGL+K   + D    +    GT  Y APE V     T
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 104 TKSDVYSFGVVLLELLSG 121
             +D +SFGV++ E+L+G
Sbjct: 206 QSADWWSFGVLMFEMLTG 223

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 87  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 138
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 139 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 196
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 197 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 239
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 240 LMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 276

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 104 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 161
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 162 NCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 221
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 222 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 263
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 264 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 308

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D  +  ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMGA--VHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+ + 
Sbjct: 124 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 225
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    P +RP   E
Sbjct: 226 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 282 IVNLLK 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 103 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 160
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 161 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 220
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 221 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 262
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR-QTGPV 219
             L   C    PK+RP   E++ +I E +E          SE ++ +  PV
Sbjct: 263 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKMENNPV 313

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 31/229 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 110 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 167
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 228 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 269
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHRQTGP 218
             L   C    PK+RP   E++ +I E +E          SE ++   P
Sbjct: 270 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEP 318

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 394
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 395 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 453 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 495
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQXQPG 532

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GFVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 72/152 (47%), Gaps = 28/152 (18%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YAAPE V +GRL 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-VISGRLY 187
Query: 104 T--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 161
              + D++S GV+L  LL G    D   V           P L  K +         GG 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHV-----------PTLFKKIR---------GGV 227
Query: 162 Y--PQKAAHTAATLALQCLNNEPKLRPRMSEV 191
           +  P+    + ATL +  L  +P  R  + ++
Sbjct: 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 99  MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 153
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 154 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 211
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 212 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 255 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 294

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 91
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y
Sbjct: 153 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 207
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 258
Query: 152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 259 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 91
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y
Sbjct: 151 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 205
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 256
Query: 152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 257 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 116 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 170
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 171 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 228
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 229 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 271
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 272 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 311

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 311
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 312 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 370 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQXQPG 449

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 63/119 (52%), Gaps = 7/119 (5%)
Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 64
           +L  ++   GP  +  A+     I    G+   HD   ++++RD K  NIL+D+    K+
Sbjct: 97  TLSEYIESHGPLSVDTAINFTNQI--LDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKI 152
Query: 65  SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK-SDVYSFGVVLLELLSGR 122
            DFG+AKA      T  +  V+GT  Y +PE  A G  T + +D+YS G+VL E+L G 
Sbjct: 153 FDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQ-AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 99  MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 153
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 154 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 211
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 212 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 254
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 255 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 294

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 126 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 180
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 181 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 238
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 239 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 281
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 282 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 321

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 139 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 192
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 139 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 192
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 129 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 182
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 117 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 170
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 311
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 312 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 370 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQXQPG 449

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 34/191 (17%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++RD  A N ++  +F  K+ DFG+   
Sbjct: 124 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGM--- 176
Query: 73  GPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 127
             T D    +    G  G     + APE +  G  TT SD++SFGVVL E+         
Sbjct: 177 --TRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI--------- 225
Query: 128 TKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
                  SL +  +PY  LS+++ L  +MD     Q P         L   C    PK+R
Sbjct: 226 ------TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMR 276
Query: 186 PRMSEVLAILE 196
           P   E++ +L+
Sbjct: 277 PTFLEIVNLLK 287

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 103 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 160
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 161 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 220
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 221 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 262
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 263 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 307

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 123 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 176
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 311
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 312 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 370 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 412
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 449

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 137 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 190
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 119 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 172
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 97  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 154
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 155 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 214
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 215 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 256
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 257 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 301

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 104 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 161
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 162 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 221
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 222 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 263
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 264 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 308

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 101 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 158
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 159 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 218
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 219 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 260
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 261 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 305

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH      I+RD KA NILL+ E +AKL+DFG+  AG   D       V+GT  +
Sbjct: 136 KGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFW 191
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +        +D++S G+  +E+  G+
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL++ L +   Q   + V   V +  G A G+ +L D     ++RD  A NIL+++
Sbjct: 128 MENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINS 182
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL +     D    +    G      + +PE +A  + T+ SDV+S+G+VL
Sbjct: 183 NLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + +D       P         L 
Sbjct: 241 WEVMSYG-----------------ERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM 283
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           L C   +   RP+  ++++IL++L     S K+  S   R
Sbjct: 284 LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L FLHD    +IYRD K  N+LLD E + KL+DFG+ K G     T  +    GT  Y A
Sbjct: 137 LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIA 192
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +         D ++ GV+L E+L G
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 91
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R  V   + GT  Y
Sbjct: 127 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNY 181
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 232
Query: 152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 233 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 83  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 134
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 135 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 192
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 193 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 235
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 236 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 272

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 132 MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 189
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 190 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 249
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 250 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 291
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 292 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 336

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 59/98 (60%), Gaps = 5/98 (5%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           KV+I   +GL +L + + Q+++RD K SNIL+++    KL DFG++  G   D   ++  
Sbjct: 118 KVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 172
Query: 85  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            +GT  Y APE +     + +SD++S G+ L+EL  GR
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 85  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 136
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 137 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 194
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 195 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 237
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 238 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 274

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 95  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 150
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 151 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 119 LS 120
           ++
Sbjct: 210 VT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 97  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 152
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 153 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 211
Query: 119 LS 120
           ++
Sbjct: 212 VT 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 482 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 535
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  + ++   +   + + ++H        RD +A+NI
Sbjct: 91  MNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH--------RDLRAANI 142
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 143 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 200
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 201 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 243
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 244 LMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 280

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 114
           L+      K++DFGLA+     + T           + APE    GR T KSDV+SFG++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGIL 204
Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATL 173
           L EL +      K +V           PY     R++   ++       P +   +   L
Sbjct: 205 LTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 174 ALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
             QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 248 MCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 89  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 144
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 145 TLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 119 LS 120
           ++
Sbjct: 204 VT 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D  +   Q   THG  
Sbjct: 481 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQ---THGKW 534
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 90
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 207
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 258
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           + +         P+     A+ L  + L+ +P LRP ++E+L
Sbjct: 259 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 98  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 153
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 154 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 212
Query: 119 LS 120
           ++
Sbjct: 213 VT 214

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 34/205 (16%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L N+L R   + L  +  +++     +G+ FL     Q I+RD  A N L+D + 
Sbjct: 85  ISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDL 141
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFG+ +     D  +VS+  +GT     ++APE     + ++KSDV++FG+++ E
Sbjct: 142 CVKVSDFGMTRY--VLDDQYVSS--VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWE 197
Query: 118 LLS-GRCAVD---KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 173
           + S G+   D    ++V ++          +S   +L+R          P  A+ T   +
Sbjct: 198 VFSLGKMPYDLYTNSEVVLK----------VSQGHRLYR----------PHLASDTIYQI 237
Query: 174 ALQCLNNEPKLRPRMSEVLAILERL 198
              C +  P+ RP   ++L+ +E L
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A GL  LH     +IYRD K  NILLD E + KL+DFGL+K     D    +    GT  
Sbjct: 140 ALGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVE 195
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y APE V     +  +D +S+GV++ E+L+G
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 91  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 146
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 147 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 205
Query: 119 LS 120
           ++
Sbjct: 206 VT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 89  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 144
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 145 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 119 LS 120
           ++
Sbjct: 204 VT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 95  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 150
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 151 TLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 119 LS 120
           ++
Sbjct: 210 VT 211

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 90  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 145
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 146 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 204
Query: 119 LS 120
           ++
Sbjct: 205 VT 206

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 14  GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 73
            P  LS  ++M   I  A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +  
Sbjct: 133 APPSLSKMIQMAGEI--ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 133
              D      + +    + +PE +  G  TT SDV+SFGVVL E+               
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI--------------- 233
Query: 134 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
            +L +  +PY  LS+++ L  +M+  L  + P         L   C    PK+RP   E+
Sbjct: 234 ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEI 290
Query: 192 L-AILERLEAPKNSAKLSQSEPHRQTGP 218
           + +I E +E          SE ++   P
Sbjct: 291 ISSIKEEMEPGFREVSFYYSEENKLPEP 318

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 89  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 144
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 145 TLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 119 LS 120
           ++
Sbjct: 204 VT 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 94  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 149
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 150 TLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 208
Query: 119 LS 120
           ++
Sbjct: 209 VT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 99  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 154
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 155 TLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 213
Query: 119 LS 120
           ++
Sbjct: 214 VT 215

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 24/163 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 90
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 137 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 191
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 242
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
           + +         P+     A+ L  + L+ +P LRP ++E+L 
Sbjct: 243 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELLT 276

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A GL FL      +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 452 AIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPD 507
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           Y APE +A        D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 89  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 144
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 119 LS 120
           ++
Sbjct: 204 VT 205

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  + ++   +   + + ++H        RD +A+NI
Sbjct: 91  MNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVH--------RDLRAANI 142
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV 114
           L+      K++DFGLA+     + T           + APE    GR T KSDV+SFG++
Sbjct: 143 LVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGIL 201
Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATL 173
           L EL +      K +V           PY     R++   ++       P +   +   L
Sbjct: 202 LTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHDL 244
Query: 174 ALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
             QC   EP+ RP    + A LE           + +EP  Q G
Sbjct: 245 MCQCWRKEPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 280

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+RD +A+NIL+  
Sbjct: 84  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSD 139
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 140 TLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 198
Query: 119 LS 120
           ++
Sbjct: 199 VT 200

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 71/125 (56%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           +P GSL +H+ +     GPQ L +W V++      AKG+ +L   E  +++R+  A N+L
Sbjct: 114 LPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYLE--EHGMVHRNLAARNVL 165
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           L +    +++DFG+A   P  D+  + ++      + A E +  G+ T +SDV+S+GV +
Sbjct: 166 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 225
Query: 116 LELLS 120
            EL++
Sbjct: 226 WELMT 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 90
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPN 207
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 258
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           + +         P+     A+ L  + L+ +P LRP ++E+L
Sbjct: 259 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 90
           +G+ +LH+  ++VI+RD K  N+ L+ + + K+ DFGLA K    G+R      + GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPN 207
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y APE +     + + D++S G +L  LL G       K   E S +   + Y+  K+  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVG-------KPPFETSCL--KETYIRIKKNE 258
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           + +         P+     A+ L  + L+ +P LRP ++E+L
Sbjct: 259 YSV---------PRHINPVASALIRRMLHADPTLRPSVAELL 291

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P  LS  ++M   I  A G+ +L+   ++ ++RD  A N ++  +F  K+ DFG+ +   
Sbjct: 124 PPSLSKMIQMAGEI--ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
             D      + +    + +PE +  G  TT SDV+SFGVVL E+                
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------A 224
Query: 135 SLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           +L +  +PY  LS+++ L  +M+  L  + P         L   C    PK+RP   E++
Sbjct: 225 TLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII 281
Query: 193 -AILERLEAPKNSAKLSQSEPHR 214
            +I E +E          SE ++
Sbjct: 282 SSIKEEMEPGFREVSFYYSEENK 304

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 71/125 (56%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           +P GSL +H+ +     GPQ L +W V++      AKG+ +L   E  +++R+  A N+L
Sbjct: 96  LPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYLE--EHGMVHRNLAARNVL 147
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           L +    +++DFG+A   P  D+  + ++      + A E +  G+ T +SDV+S+GV +
Sbjct: 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
Query: 116 LELLS 120
            EL++
Sbjct: 208 WELMT 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 115 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 231
Query: 150 L 150
           +
Sbjct: 232 I 232

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L     + L     + +A   A G+ ++       I+RD +++NIL+    
Sbjct: 85  MNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGNGL 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGLA+     + T           + APE    GR T KSDV+SFG++L EL  
Sbjct: 143 ICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFGILLTEL-- 199
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
               V K +V           PY   + R++   ++       PQ    +   L + C  
Sbjct: 200 ----VTKGRV-----------PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWK 244
Query: 180 NEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
            +P+ RP    + + LE           + +EP  Q G
Sbjct: 245 KDPEERPTFEYLQSFLEDY--------FTATEPQYQPG 274

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 31/225 (13%)
Query: 1   MPKGSLENHLFRRGPQ--------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P+        P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 97  MTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 154
Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N  +  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 155 NCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 214
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTA 170
           VVL E+                +L +  +PY  LS+++ L  +M+  L  + P       
Sbjct: 215 VVLWEI---------------ATLAE--QPYQGLSNEQVLRFVMEGGLLDK-PDNCPDML 256
Query: 171 ATLALQCLNNEPKLRPRMSEVL-AILERLEAPKNSAKLSQSEPHR 214
             L   C    PK+RP   E++ +I E +E          SE ++
Sbjct: 257 LELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK 301

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 11/93 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 90
           G+ +L   ES  ++RD  A N+LL  +  AK+SDFGL+KA    D      Q   THG  
Sbjct: 123 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENXYKAQ---THGKW 176
Query: 91  ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + APE +   + ++KSDV+SFGV++ E  S
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 91
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y
Sbjct: 129 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNY 183
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 234
Query: 152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 235 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A GL FL      +IYRD K  N++LD+E + K++DFG+ K       T  +    GT  
Sbjct: 131 AIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPD 186
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           Y APE +A        D ++FGV+L E+L+G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PL       +     KGL +LH      I+RD KA+N+LL  + + KL+DFG+  AG 
Sbjct: 110 PGPLEETYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGV--AGQ 165
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
             D        +GT  + APE +       K+D++S G+  +EL  G             
Sbjct: 166 LTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG------------- 212
Query: 135 SLVDWAKPYLSD---KRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRM 188
                 +P  SD    R LF I       L GQ+ +            CLN +P+ RP  
Sbjct: 213 ------EPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEA----CLNKDPRFRPTA 262
Query: 189 SEVL 192
            E+L
Sbjct: 263 KELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 91
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y
Sbjct: 129 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNY 183
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 234
Query: 152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 235 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 91
           G  +LH   ++VI+RD K  N+ L+ +   K+ DFGLA K    G+R      + GT  Y
Sbjct: 133 GCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNY 187
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE ++    + + DV+S G ++  LL G+   + + +          + YL  K+  +
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETYLRIKKNEY 238
Query: 152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I         P+     AA+L  + L  +P  RP ++E+L
Sbjct: 239 SI---------PKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-XQEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 116 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 232
Query: 150 L 150
           +
Sbjct: 233 I 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 93  APEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLSDKRK 149
           APE +       +  DV+S G+VL  +L+G    D+      Q   DW   K YL+  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKK 233
Query: 150 L 150
           +
Sbjct: 234 I 234

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           + +A   A+G+ +LH     +I+RD K++NI L      K+ DFGLA        +    
Sbjct: 135 IDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 84  QVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSG 121
           Q  G+  + APE +        + +SDVYS+G+VL EL++G
Sbjct: 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD  A+NI
Sbjct: 94  MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLAAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 130 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFW 185
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 229
Query: 152 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 230 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 269

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L  HL + G    S A     A     GL  +H+    V+YRD K +NILLD   
Sbjct: 274 MNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHG 329
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELL 119
           + ++SD GLA    +  + H S   +GTHGY APE +  G    + +D +S G +L +LL
Sbjct: 330 HVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 120 SG 121
            G
Sbjct: 386 RG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L  HL + G    S A     A     GL  +H+    V+YRD K +NILLD   
Sbjct: 274 MNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHG 329
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELL 119
           + ++SD GLA    +  + H S   +GTHGY APE +  G    + +D +S G +L +LL
Sbjct: 330 HVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 120 SG 121
            G
Sbjct: 386 RG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L  HL + G    S A     A     GL  +H+    V+YRD K +NILLD   
Sbjct: 274 MNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHG 329
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELL 119
           + ++SD GLA    +  + H S   +GTHGY APE +  G    + +D +S G +L +LL
Sbjct: 330 HVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 120 SG 121
            G
Sbjct: 386 RG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L  HL + G    S A     A     GL  +H+    V+YRD K +NILLD   
Sbjct: 273 MNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHG 328
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELL 119
           + ++SD GLA    +  + H S   +GTHGY APE +  G    + +D +S G +L +LL
Sbjct: 329 HVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384
Query: 120 SG 121
            G
Sbjct: 385 RG 386

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 29/194 (14%)
Query: 3   KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 62
           KG+LE  + +R  + L   + +++     KG+ ++H    ++I+RD K SNI L      
Sbjct: 118 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLIHRDLKPSNIFLVDTKQV 175
Query: 63  KLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           K+ DFGL  +    G RT    +  GT  Y +PE +++     + D+Y+ G++L ELL  
Sbjct: 176 KIGDFGLVTSLKNDGKRT----RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH- 230
Query: 122 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 181
              V  T     +   D     +SD      I D K              TL  + L+ +
Sbjct: 231 ---VCDTAFETSKFFTDLRDGIISD------IFDKK------------EKTLLQKLLSKK 269
Query: 182 PKLRPRMSEVLAIL 195
           P+ RP  SE+L  L
Sbjct: 270 PEDRPNTSEILRTL 283

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 21/152 (13%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y A
Sbjct: 264 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 320
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 363
Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +  +   ++P+     A +L    L  +PK R
Sbjct: 364 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL++     D     +
Sbjct: 153 ISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 84  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 143
           Q      + A E +     TT+SDV+SFGV+L E+++         +G          PY
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPY 253
Query: 144 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                 +LF ++ T    + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KG L + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KG L + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 94  MSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 145
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGLA+     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 146 LVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 204 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 246
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 247 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 283

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 21/152 (13%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T  +    GT  Y A
Sbjct: 261 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 317
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 360
Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +  +   ++P+     A +L    L  +PK R
Sbjct: 361 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 115 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNXFVGTPFW 170
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 214
Query: 152 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 215 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 254

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L R+     +    + +  G   G+ +L D  +  ++RD  A NIL+++  
Sbjct: 112 MENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA--VHRDLAARNILVNSNL 168
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFG+++     D    +    G      + APE +A  + T+ SDV+S+G+V+ E
Sbjct: 169 VCKVSDFGMSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 226
Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           ++S                    +PY     + + + ++       P         L L 
Sbjct: 227 VMSYG-----------------ERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD 269
Query: 177 CLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 211
           C   E   RP+  +++ +L++L    NS K + SE
Sbjct: 270 CWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSE 304

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 20/176 (11%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   ++G+ +L  AE ++++RD  A NIL+      K+SDFGL++     D     +
Sbjct: 153 ISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 84  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 143
           Q      + A E +     TT+SDV+SFGV+L E+++         +G          PY
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPY 253
Query: 144 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                 +LF ++ T    + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L R     +  A  +  A    +G+ +LH      I+R   A N+LLD + 
Sbjct: 95  VPLGSLRDYLPR---HCVGLAQLLLFAQQICEGMAYLH--AQHYIHRALAARNVLLDNDR 149
Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGLAKA P G   + V         + APE +   +    SDV+SFGV L ELL
Sbjct: 150 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209
Query: 120 S 120
           +
Sbjct: 210 T 210

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 115 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFW 170
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 171 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 214
Query: 152 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 215 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 254

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++R+  A N ++  +F  K+ DFG+ + 
Sbjct: 124 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 225
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    P +RP   E
Sbjct: 226 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLE 281
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 282 IVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
           R P  L   ++M   I  A G+ +L+    + ++R+  A N ++  +F  K+ DFG+ + 
Sbjct: 125 RPPPTLQEMIQMAAEI--ADGMAYLN--AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRD 180
Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 132
               D      + +    + APE +  G  TT SD++SFGVVL E+              
Sbjct: 181 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------------- 226
Query: 133 EQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
             SL +  +PY  LS+++ L  +MD     Q P         L   C    P +RP   E
Sbjct: 227 -TSLAE--QPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLE 282
Query: 191 VLAILE 196
           ++ +L+
Sbjct: 283 IVNLLK 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L R     +  A  +  A    +G+ +LH      I+R   A N+LLD + 
Sbjct: 94  VPLGSLRDYLPR---HCVGLAQLLLFAQQICEGMAYLH--AQHYIHRALAARNVLLDNDR 148
Query: 61  NAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGLAKA P G   + V         + APE +   +    SDV+SFGV L ELL
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208
Query: 120 S 120
           +
Sbjct: 209 T 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 182
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE V       K D++S G++ +E++ G 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 23/180 (12%)
Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G A G+ +L  A+   ++RD  A NIL+++    K+SDFGL++     D   V T   G 
Sbjct: 153 GIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-IEDDPEAVYTTTGGK 209
Query: 89  H--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS- 145
               + APE +   + T+ SDV+S+G+V+ E++S                    +PY   
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----------------ERPYWDM 252
Query: 146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSA 205
             + + + ++       P         L L C   E   RP+  +++ IL+++    NSA
Sbjct: 253 SNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIRNPNSA 312

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   ++G+ +L  AE  +++RD  A NIL+      K+SDFGL++     D     +
Sbjct: 153 ISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 84  QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 143
           Q      + A E +     TT+SDV+SFGV+L E+++         +G          PY
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------LG--------GNPY 253
Query: 144 LS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                 +LF ++ T    + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 82/190 (43%), Gaps = 37/190 (19%)
Query: 10  LFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 68
           L R GP      A  +K  +   KGL +LH  +   I+RD KA+N+LL  + + KL+DFG
Sbjct: 111 LLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFG 165
Query: 69  LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 128
           +  AG   D        +GT  + APE +      +K+D++S G+  +EL  G       
Sbjct: 166 V--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG------- 216
Query: 129 KVGIEQSLVDWAKPYLSD---KRKLFRIMDTK---LGGQYPQKAAHTAATLALQCLNNEP 182
                       +P  SD    R LF I       L G + +    +       CLN +P
Sbjct: 217 ------------EPPNSDMHPMRVLFLIPKNNPPTLVGDFTK----SFKEFIDACLNKDP 260
Query: 183 KLRPRMSEVL 192
             RP   E+L
Sbjct: 261 SFRPTAKELL 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 1   MPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 54
           M KGSL + L      + R PQ +  A ++   +   + + ++H        RD +A+NI
Sbjct: 261 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH--------RDLRAANI 312
Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
           L+      K++DFGL +     D  + + Q       + APE    GR T KSDV+SFG+
Sbjct: 313 LVGENLVCKVADFGLGRL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 370
Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           +L EL +      K +V           PY     R++   ++       P +   +   
Sbjct: 371 LLTELTT------KGRV-----------PYPGMVNREVLDQVERGYRMPCPPECPESLHD 413
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
           L  QC   +P+ RP    + A LE           + +EP  Q G
Sbjct: 414 LMCQCWRKDPEERPTFEYLQAFLEDY--------FTSTEPQXQPG 450

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 76/140 (54%), Gaps = 28/140 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA---------ESQVIYRDFKASN 53
           KGSL ++L  +G   ++W     VA   ++GL++LH+          +  + +RDFK+ N
Sbjct: 97  KGSLTDYL--KG-NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKN 153
Query: 54  ILLDAEFNAKLSDFGLAK----AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT------ 103
           +LL ++  A L+DFGLA       P GD TH   QV GT  Y APE V  G +       
Sbjct: 154 VLLKSDLTAVLADFGLAVRFEPGKPPGD-TH--GQV-GTRRYMAPE-VLEGAINFQRDAF 208
Query: 104 TKSDVYSFGVVLLELLSGRC 123
            + D+Y+ G+VL EL+S RC
Sbjct: 209 LRIDMYAMGLVLWELVS-RC 227

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G A G+ +L  AE   ++RD  A NIL+++    K+SDFGL++           T  +G 
Sbjct: 126 GIASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGG 183
Query: 89  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 145
                + APE +A  + T+ SD +S+G+V+ E++S                    +PY  
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG-----------------ERPYWD 226
Query: 146 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
              + +   ++       P     +   L L C   +   RPR  +V++ L+++
Sbjct: 227 MSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL +  F + P  +   +   + +A   A+G+ F+   E   I+R+ +A+NIL+  
Sbjct: 85  MENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRNLRAANILVSD 140
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             + K++DFGLA+     + T           + APE +  G  T KSDV+SFG++L E+
Sbjct: 141 TLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEI 199
Query: 119 LS 120
           ++
Sbjct: 200 VT 201

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y A
Sbjct: 123 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLA 179
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 222
Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +  +   ++P+     A +L    L  +PK R
Sbjct: 223 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y A
Sbjct: 121 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLA 177
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 220
Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +  +   ++P+     A +L    L  +PK R
Sbjct: 221 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T       GT  Y A
Sbjct: 122 LDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLA 178
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           PE +         D +  GVV+ E++ GR                    Y  D  KLF +
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFEL 221
Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +  +   ++P+     A +L    L  +PK R
Sbjct: 222 ILME-EIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH  +   I+RD KA+N+LL      KL+DFG+  AG   D        +GT  +
Sbjct: 135 KGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFW 190
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 151
            APE +      +K+D++S G+  +EL  G     +                L   + LF
Sbjct: 191 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE----------------LHPMKVLF 234
Query: 152 RIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            I       L G Y +            CLN EP  RP   E+L
Sbjct: 235 LIPKNNPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 274

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P G L + L R   + L  +  +  +    KG+ +L     + ++RD  A NIL+++E 
Sbjct: 95  LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEA 151
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           + K++DFGLAK  P  D+ +   +  G     + APE ++    + +SDV+SFGVVL EL
Sbjct: 152 HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210
Query: 119 LS 120
            +
Sbjct: 211 FT 212

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L R+     +    + +  G   G+ +L D     ++RD  A NIL+++  
Sbjct: 91  MENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLSDM--SYVHRDLAARNILVNSNL 147
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFG+++     D    +    G      + APE +A  + T+ SDV+S+G+V+ E
Sbjct: 148 VCKVSDFGMSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 205
Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           ++S                    +PY     + + + ++       P         L L 
Sbjct: 206 VMSYG-----------------ERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD 248
Query: 177 CLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 211
           C   E   RP+  +++ +L++L    NS K + SE
Sbjct: 249 CWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSE 283

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L R+     +    + +  G   G+ +L D     ++RD  A NIL+++  
Sbjct: 97  MENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSGMKYLSDM--SYVHRDLAARNILVNSNL 153
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFG+++     D    +    G      + APE +A  + T+ SDV+S+G+V+ E
Sbjct: 154 VCKVSDFGMSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 211
Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           ++S                    +PY     + + + ++       P         L L 
Sbjct: 212 VMSYG-----------------ERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD 254
Query: 177 CLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 211
           C   E   RP+  +++ +L++L    NS K + SE
Sbjct: 255 CWQKERSDRPKFGQIVNMLDKLIRNPNSLKRTGSE 289

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P G L + L R   + L  +  +  +    KG+ +L     + ++RD  A NIL+++E 
Sbjct: 96  LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEA 152
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           + K++DFGLAK  P  D+ +   +  G     + APE ++    + +SDV+SFGVVL EL
Sbjct: 153 HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211
Query: 119 LS 120
            +
Sbjct: 212 FT 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL++ L R+     +    + +  G A G+ +L  A+   ++RD  A NIL+++  
Sbjct: 116 MENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL--ADMNYVHRDLAARNILVNSNL 172
Query: 61  NAKLSDFGLAK--AGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGL++     T D T+  T  +G      + APE +   + T+ SDV+S+G+V+
Sbjct: 173 VCKVSDFGLSRFLEDDTSDPTY--TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 230
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + +   ++       P         L 
Sbjct: 231 WEVMSYG-----------------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 273
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 206
           L C   +   RP+  +++  L+++    NS K
Sbjct: 274 LDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 305

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P G L + L R   + L  +  +  +    KG+ +L     + ++RD  A NIL+++E 
Sbjct: 108 LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEA 164
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           + K++DFGLAK  P  D+ +   +  G     + APE ++    + +SDV+SFGVVL EL
Sbjct: 165 HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 119 LS 120
            +
Sbjct: 224 FT 225

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 29  GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G A G+ +L  AE   ++RD  A NIL+++    K+SDFGL++           T  +G 
Sbjct: 124 GIASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 89  H---GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 145
                + APE +A  + T+ SD +S+G+V+ E++S                    +PY  
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFG-----------------ERPYWD 224
Query: 146 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
              + +   ++       P     +   L L C   +   RPR  +V++ L+++
Sbjct: 225 MSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 6/86 (6%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V  G+L
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKL 183
Query: 103 TT--KSDVYSFGVVLLELLSGRCAVD 126
               + DV+S G+VL  +L GR   D
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P G L + L R   + L  +  +  +    KG+ +L     + ++RD  A NIL+++E 
Sbjct: 92  LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEA 148
Query: 61  NAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           + K++DFGLAK  P   D   V         + APE ++    + +SDV+SFGVVL EL 
Sbjct: 149 HVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208
Query: 120 S 120
           +
Sbjct: 209 T 209

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  GSL+  L +   Q   + V   V +  G + G+ +L D     ++RD  A NIL+++
Sbjct: 105 MENGSLDTFLKKNDGQ---FTVIQLVGMLRGISAGMKYLSDM--GYVHRDLAARNILINS 159
Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
               K+SDFGL++     D    +    G      + APE +A  + T+ SDV+S+G+V+
Sbjct: 160 NLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVM 217
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + + + ++       P         L 
Sbjct: 218 WEVVSYG-----------------ERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQLM 260
Query: 175 LQCLNNEPKLRPRMSEVLAILERL 198
           L C   E   RP+  E++ +L++L
Sbjct: 261 LDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 58/120 (48%), Gaps = 17/120 (14%)
Query: 20  WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA------KAG 73
           W+ R+  A   A G+ +LH     +I+RD  + N L+    N  ++DFGLA      K  
Sbjct: 107 WSQRVSFAKDIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164
Query: 74  PTG-------DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           P G       DR    T V+G   + APE +       K DV+SFG+VL E++ GR   D
Sbjct: 165 PEGLRSLKKPDRKKRYT-VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  RT +S    GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLD 172
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 219
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQS 210
            R+  T     +P      A  L  + L + P  RP + EV   LE      NS+K S S
Sbjct: 220 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWITANSSKPSNS 271
Query: 211 E 211
           +
Sbjct: 272 Q 272

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T++ GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+R+ K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 128 QALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 183
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE V       K D++S G++ +E++ G 
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG  A+  P   +    ++++GT  
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPY 181
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           + APE V       K D++S G++ +E++ G 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 1   MPKGSLENHL----FRRGPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +H+     R G Q L +W +++      AKG+++L D   ++++RD  A N+L
Sbjct: 100 MPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYLEDV--RLVHRDLAARNVL 151
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           + +  + K++DFGLA+     +  + +        + A E +   R T +SDV+S+GV +
Sbjct: 152 VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTV 211
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHT--AAT 172
            EL++                   AKPY     R++  +++   G + PQ    T     
Sbjct: 212 WELMTFG-----------------AKPYDGIPAREIPDLLEK--GERLPQPPICTIDVYM 252
Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           + ++C   + + RPR  E+++   R+
Sbjct: 253 IMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  S  V GT  +
Sbjct: 128 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYW 183
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE V       K D++S G++ +E++ G 
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  S  V GT  +
Sbjct: 127 QALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSXMV-GTPYW 182
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE V       K D++S G++ +E++ G 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 144 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 197
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 244
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 245 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 95  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 151
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 152 RVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 211 FT---YIEKSK 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 89
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 89
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 2/106 (1%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PL     + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   
Sbjct: 129 PGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 186
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + D   V  + M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 187 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 89
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTH 89
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA   KAG T  + +      GT 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTP 353
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           G+ APE +         D ++ GV L E+++ R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 93  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 149
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 150 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 208
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 209 FT---YIEKSK 216

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 2/106 (1%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PL     + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   
Sbjct: 123 PGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 180
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + D   V  + M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 181 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 27/194 (13%)
Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            KG+LE  + +R  + L   + +++     KG+ ++H    ++I RD K SNI L     
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQ 160
Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            K+ DFGL  +     +   S    GT  Y +PE +++     + D+Y+ G++L ELL  
Sbjct: 161 VKIGDFGLVTSLKNDGKRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLH- 216
Query: 122 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 181
              V  T     +   D     +SD      I D K              TL  + L+ +
Sbjct: 217 ---VCDTAFETSKFFTDLRDGIISD------IFDKK------------EKTLLQKLLSKK 255
Query: 182 PKLRPRMSEVLAIL 195
           P+ RP  SE+L  L
Sbjct: 256 PEDRPNTSEILRTL 269

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 94  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 150
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 151 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 210 FT---YIEKSK 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 98  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 154
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 155 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 214 FT---YIEKSK 221

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 95  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 151
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 152 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 211 FT---YIEKSK 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 100 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 156
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 157 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 215
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 216 FT---YIEKSK 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 99  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 155
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 156 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 214
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 215 FT---YIEKSK 222

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 2/106 (1%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P PL     + VA   A G+ +L  A    ++RD    N L+      K+ DFG+++   
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + D   V  + M    +  PE +   + TT+SDV+SFGVVL E+ +
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 113 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 169
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 170 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 229 FT---YIEKSK 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 176
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 95  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 151
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 152 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 211 FT---YIEKSK 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++     +  G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYD 190
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 101 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 157
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 158 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 216
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 217 FT---YIEKSK 224

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 126 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 182
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 183 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 242 FT---YIEKSK 249

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 102 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 158
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 159 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 217
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 218 FT---YIEKSK 225

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 113 LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 169
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 170 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 229 FT---YIEKSK 236

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 135 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 188
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 236 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 2/109 (1%)
Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
           R+    L  +  + +A   A G+ +L  A    ++RD    N L+ A    K+ DFG+++
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 72  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              + D   V    M    +  PE +   + TT+SDV+SFGV+L E+ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 176
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D   +    +    
Sbjct: 155 AAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 149
           + APE +  G+ +  SD++S+GVVL E+ S          G++        PY     + 
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQ--------PYCGYSNQD 255
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
           +  ++  +     P         L ++C N  P  RPR  ++
Sbjct: 256 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L ++  + +     ++      KG+ +L     + I+R+    NIL++ E 
Sbjct: 96  LPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRNLATRNILVENEN 152
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+ +   +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 153 RVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 211
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 212 FT---YIEKSK 219

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           +P++    +  +   A+G+ FL  +  + I+RD  A NILL      K+ DFGLA+    
Sbjct: 194 EPITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 135
                          + APE +     +TKSDV+S+GV+L E+ S          G    
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS--------LGGSPYP 303
Query: 136 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
            V   + + S  R+  R+       + P+ +      + L C + +PK RPR +E++  L
Sbjct: 304 GVQMDEDFCSRLREGMRM-------RAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356
Query: 196 ERL 198
             L
Sbjct: 357 GDL 359

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLD 172
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 219
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 220 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 174
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 176
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A G+ +L  +   V+++D    N+L+  + N K+SD GL +     D   +    +    
Sbjct: 138 AAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 149
           + APE +  G+ +  SD++S+GVVL E+ S          G++        PY     + 
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YGLQ--------PYCGYSNQD 238
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
           +  ++  +     P         L ++C N  P  RPR  ++
Sbjct: 239 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 176
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 178
Query: 103 TT--KSDVYSFGVVLLELLSGRCAVDKTKV 130
               + DV+S GV+L  +L  R   D   +
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 117 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 170
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 217
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 218 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 182
Query: 103 TT--KSDVYSFGVVLLELLSGRCAVDKTKV 130
               + DV+S GV+L  +L  R   D   +
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 188
Query: 103 TT--KSDVYSFGVVLLELLSGRCAVDKTKV 130
               + DV+S GV+L  +L  R   D   +
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 218

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL  +L ++  + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 98  LPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 154
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 155 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 214 FT---YIEKSK 221

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 122 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 175
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 222
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 223 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YAAPE V +G+L
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 187
Query: 103 TT--KSDVYSFGVVLLELLSGRCAVDKTKV 130
               + DV+S GV+L  +L  R   D   +
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFDDESI 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 170 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 227
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 228 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 270
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 271 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 122 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 177
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 220
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 221 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 41  ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           + ++++RD KA N+LLDA+ N K++DFG +     G +        G+  YAAPE     
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGK 185
Query: 101 RLTT-KSDVYSFGVVLLELLSGRCAVD 126
           +    + DV+S GV+L  L+SG    D
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 174
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y 
Sbjct: 120 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 175
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 218
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 219 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 115 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLD 168
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 215
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 216 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T       GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYL 172
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 24/187 (12%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 74
           P  L+ +  + +A   A G+ +L  A    ++RD    N L+      K+ DFG+++   
Sbjct: 122 PTELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 179
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 133
           + D   V    M    +  PE +   + TT+SDV+S GVVL E+ + G+           
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------- 228
Query: 134 QSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
                  +P+  LS+   +  I   ++  Q P+        L L C   EP +R  +  +
Sbjct: 229 -------QPWYQLSNNEVIECITQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280
Query: 192 LAILERL 198
             +L+ L
Sbjct: 281 HTLLQNL 287

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH  +  V+YRD K  N++LD + + K++DFGL K G +   T  +    GT  Y 
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 152
           APE +         D +  GVV+ E++ GR                    Y  D  +LF 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFE 215
Query: 153 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  +   ++P+  +  A +L    L  +PK R
Sbjct: 216 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 190
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 190
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 190
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 172 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 229
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 230 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 272
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 273 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 177 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 234
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 235 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 277
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 278 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 177 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV 234
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 235 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 277
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 278 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT--GDRTHVSTQVMGTH 89
           +GL ++H A  QVI+RD K SN+L++     K+ DFG+A+   T   +  +  T+ + T 
Sbjct: 170 RGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 90  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            Y APE + +    T++ D++S G +  E+L+ R
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYD 183
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           K+ +   K L  L +   ++I+RD K SNILLD   N KL DFG+  +G   D     T+
Sbjct: 129 KITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSI-AKTR 184
Query: 85  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGR 122
             G   Y APE +    +      +SDV+S G+ L EL +GR
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 146
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 147 LVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 206 ---------YGM--------SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 249 WNPSDRPSFAEIHQAFETM 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 96  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 153
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 154 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 213 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 256 WNPSDRPSFAEIHQAFETM 274

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 144 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLD 197
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 244
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 245 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 146
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 147 LVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 206 ---------YGM--------SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 249 WNPSDRPSFAEIHQAFETM 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 197
Query: 84  QVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 240
Query: 142 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 241 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   A+G+ +L  ++ Q I+RD  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 135 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 187
Query: 84  QVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 230
Query: 142 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 231 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 21/170 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A    I+RD  A NILL      K+ DFGLA+         V        
Sbjct: 154 VAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+S+G+ L EL S         +G        + PY  +   
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFS---------LG--------SSPYPGMPVD 254
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            K ++++        P+ A      +   C + +P  RP   +++ ++E+
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 36/190 (18%)
Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           Q L W V++ +A      L  +HD   ++++RD K+ NI L  +   +L DFG+A+    
Sbjct: 126 QILDWFVQICLA------LKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--L 175
Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 135
                ++   +GT  Y +PE         KSD+++ G VL EL + + A +         
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------- 228
Query: 136 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVL 192
                    S K  + +I    + G +P  + H +    +L  Q     P+ RP ++ +L
Sbjct: 229 ---------SMKNLVLKI----ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275
Query: 193 A---ILERLE 199
               I +R+E
Sbjct: 276 EKGFIAKRIE 285

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 9/131 (6%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L +   + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 98  LPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 154
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K+ DFGL K  P  D+     +  G     + APE +   + +  SDV+SFGVVL EL
Sbjct: 155 RVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213
Query: 119 LSGRCAVDKTK 129
            +    ++K+K
Sbjct: 214 FT---YIEKSK 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG---DRTHVSTQVMGT 88
           +GL +LH  ++  I+RD KA NILL  + + +++DFG++    TG    R  V    +GT
Sbjct: 127 EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 89  HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 121
             + APE +   R    K+D++SFG+  +EL +G
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 41  ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           + ++++RD KA N+LLDA+ N K++DFG +     G +        G   YAAPE     
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGK 188
Query: 101 RLTT-KSDVYSFGVVLLELLSGRCAVD 126
           +    + DV+S GV+L  L+SG    D
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG---DRTHVSTQVMGT 88
           +GL +LH  ++  I+RD KA NILL  + + +++DFG++    TG    R  V    +GT
Sbjct: 132 EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 89  HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 121
             + APE +   R    K+D++SFG+  +EL +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 45/231 (19%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 118 KGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 175
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 231 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 273
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-PKNSAKLSQSEP 212
           P    +    +   C +  P  RP   +++  L+R+ A   N   L  S P
Sbjct: 274 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEXLDLSMP 324

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 69/138 (50%), Gaps = 25/138 (18%)
Query: 3   KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA--------ESQVIYRDFKASNI 54
           KGSL + L       +SW     +A   A+GL +LH+         +  + +RD K+ N+
Sbjct: 106 KGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162
Query: 55  LLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT------TK 105
           LL     A ++DFGLA   +AG +   TH   QV GT  Y APE V  G +        +
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTH--GQV-GTRRYMAPE-VLEGAINFQRDAFLR 218
Query: 106 SDVYSFGVVLLELLSGRC 123
            D+Y+ G+VL EL S RC
Sbjct: 219 IDMYAMGLVLWELAS-RC 235

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL++ L R+     +    + +  G A G+ +L  A+   ++R   A NIL+++  
Sbjct: 90  MENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL--ADMNYVHRALAARNILVNSNL 146
Query: 61  NAKLSDFGLAK--AGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGL++     T D T+  T  +G      + APE +   + T+ SDV+S+G+V+
Sbjct: 147 VCKVSDFGLSRFLEDDTSDPTY--TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 204
Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLA 174
            E++S                    +PY     + +   ++       P         L 
Sbjct: 205 WEVMSYG-----------------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 247
Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 206
           L C   +   RP+  +++  L+++    NS K
Sbjct: 248 LDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 279

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT--GDRTHVSTQVMGTH 89
           +GL ++H A  QVI+RD K SN+L++     K+ DFG+A+   T   +  +  T+ + T 
Sbjct: 169 RGLKYMHSA--QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 90  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            Y APE + +    T++ D++S G +  E+L+ R
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 149 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 208 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 251 WNPSDRPSFAEIHQAFETM 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 149 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 208 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 251 WNPSDRPSFAEIHQAFETM 269

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++        G   YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYD 190
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 149 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 208 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 251 WNPSDRPSFAEIHQAFETM 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLD + N K++DFG +     G++        G+  YAAPE     +  
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPELFQGKKYD 191
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 149 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 208 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 251 WNPSDRPSFAEIHQAFETM 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 146
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 147 LVKVADFGLSRL-MTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 206 ---------YGM--------SPYPGIDPSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 248
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 249 WNPSDRPSFAEIHQAFETM 267

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 118 KGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 175
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 231 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 273
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 274 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 311

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 107 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 164
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 165 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 219
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 220 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 262
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 263 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 300

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L +                 +  A   A+G+ +L  A  + I+RD
Sbjct: 103 KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 160
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 161 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 216 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 258
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 259 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 45/231 (19%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L +                 +  A   A+G+ +L  A  + I+RD
Sbjct: 118 KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 175
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 231 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 273
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA-PKNSAKLSQSEP 212
           P    +    +   C +  P  RP   +++  L+R+ A   N   L  S P
Sbjct: 274 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMP 324

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 79/193 (40%), Gaps = 30/193 (15%)
Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
           R  P+   W    K  +     L  +H    +V++RD K +N+ + A    KL D GL +
Sbjct: 131 RLIPERTVW----KYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 72  AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 131
              +  +T  +  ++GT  Y +PE +       KSD++S G +L E+ +           
Sbjct: 185 FFSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA----------- 231
Query: 132 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPR 187
                     P+  DK  L+ +        YP       +     L   C+N +P+ RP 
Sbjct: 232 -------LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 284
Query: 188 MSEVLAILERLEA 200
           ++ V  + +R+ A
Sbjct: 285 VTYVYDVAKRMHA 297

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 111 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 168
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 169 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 223
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 224 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 266
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 267 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 304

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 118 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 175
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 231 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 273
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 274 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 311

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 110 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 167
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 168 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 222
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 223 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 265
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 266 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 303

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 123 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLD 176
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 223
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 224 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K+++FG +   P+  R    T + GT  
Sbjct: 120 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLD 173
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 220
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 221 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--G 90
           G+ +L   E   ++RD  A N+LL     AK+SDFGL+KA    D ++ + +  G     
Sbjct: 122 GMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLK 178
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +   + +++SDV+S+GV + E LS
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLD 174
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K+++FG +   P+  R    T + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLD 174
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 175 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 232
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 233 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 277
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 278 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 325

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 120 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLD 173
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 220
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 221 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 153
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 154 LVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 213 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 256 WNPSDRPSFAEIHQAFETM 274

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ ++       I+RD +A+N+L+      K++DFGLA+     + T           
Sbjct: 120 AEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 176
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +  G  T KSDV+SFG++L E+++
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 98
           D    V++RD K +N+ LD + N KL DFGLA+       T  +   +GT  Y +PE + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 99  TGRLTTKSDVYSFGVVLLELLSGRCAV 125
                 KSD++S G +L EL    CA+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL----CAL 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 44/218 (20%)
Query: 3   KGSLENHLFRRGPQPLSWAVR--------------MKVAIGAAKGLTFLHDAESQVIYRD 48
           KG+L  +L  R P  L ++                +  A   A+G+ +L  A  + I+RD
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRD 216
Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +     T
Sbjct: 217 LAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271
Query: 104 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQY 162
            +SDV+SFGV+L E+ +         +G          PY      +LF+++        
Sbjct: 272 HQSDVWSFGVLLWEIFT---------LG--------GSPYPGVPVEELFKLLKEGHRMDK 314
Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
           P    +    +   C +  P  RP   +++  L+R+ A
Sbjct: 315 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + ++FLH   + +++RD K  NILLD     +LSDFG +     G++     ++ GT GY
Sbjct: 211 EAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGY 265
Query: 92  AAPEYVATGRLTT------KSDVYSFGVVLLELLSG 121
            APE +      T      + D+++ GV+L  LL+G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 149
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 150 LVKVADFGLSRL-MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 209 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 252 WNPSDRPSFAEIHQAFETM 270

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLD 174
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L +A   VI+RD  A N L+    
Sbjct: 84  MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--SVIHRDLAARNCLVGENQ 140
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 141 VIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 4/84 (4%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT 103
           +++RD KA N+LLDA+ N K++DFG +     G++        G   YAAPE     +  
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYD 190
Query: 104 T-KSDVYSFGVVLLELLSGRCAVD 126
             + DV+S GV+L  L+SG    D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 121 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLD 174
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 221
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 222 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 98
           D    V++RD K +N+ LD + N KL DFGLA+       T  +   +GT  Y +PE + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMN 189
Query: 99  TGRLTTKSDVYSFGVVLLELLSGRCAV 125
                 KSD++S G +L EL    CA+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL----CAL 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 118 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 153
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 154 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 213 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 256 WNPSDRPSFAEIHQAFETM 274

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 153
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 154 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 213 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 256 WNPSDRPSFAEIHQAFETM 274

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 118 ANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLD 171
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQDTYKRI 218
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 219 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 95  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 152
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 153 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 212 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 254
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 255 WNPSDRPSFAEIHQAFETM 273

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 153
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 154 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 213 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 255
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 256 WNPSDRPSFAEIHQAFETM 274

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 167 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 224
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 225 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 269
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 270 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 317

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+R+  A N L+    
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENH 355
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 356 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 415 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 457
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 458 WNPSDRPSFAEIHQAFETM 476

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 24/162 (14%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLD 172
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           Y  PE +       K D++S GV+  E L G+   +             A  Y    +++
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRI 219
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            R+  T     +P      A  L  + L + P  RP + EVL
Sbjct: 220 SRVEFT-----FPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L +A   VI+RD  A N L+    
Sbjct: 85  MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQ 141
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 142 VIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 149 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 208 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 251 WNPSDRPSFAEIHQAFETM 269

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L +A   VI+RD  A N L+    
Sbjct: 82  MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQ 138
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 139 VIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           K+A+   K L  LH   S VI+RD K SN+L++A    K+ DFG+  +G   D     T 
Sbjct: 157 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDSV-AKTI 212
Query: 85  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
             G   Y APE +         + KSD++S G+ ++EL   R   D            W 
Sbjct: 213 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WG 261
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            P+    ++L ++++         K +        QCL    K RP   E++
Sbjct: 262 TPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 17/191 (8%)
Query: 7   ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 66
           E  L +   +PL     +  +   A+G+ FL  A    I+RD  A N+LL     AK+ D
Sbjct: 138 EADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGD 195
Query: 67  FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           FGLA+         V         + APE +     T +SDV+S+G++L E+ S      
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------ 249
Query: 127 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 186
              +G+         P +    K ++++        P  A     ++   C   EP  RP
Sbjct: 250 ---LGLN------PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 300
Query: 187 RMSEVLAILER 197
              ++ + L+ 
Sbjct: 301 TFQQICSFLQE 311

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L++LH+    VI+RD K+ +ILL ++   KLSDFG            VS +V
Sbjct: 146 VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEV 195
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++     T+ D++S G++++E++ G
Sbjct: 196 PKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L +A   VI+RD  A N L+    
Sbjct: 84  MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQ 140
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 141 VIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 150
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 151 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 210 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 253 WNPSDRPSFAEIHQAFETM 271

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L +A   VI+RD  A N L+    
Sbjct: 87  MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQ 143
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 144 VIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 149 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 208 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 250
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 251 WNPSDRPSFAEIHQAFETM 269

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H  E+++++RD K  N+L++     KL DFGLA+A      T  S  V  T  Y
Sbjct: 119 QGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWY 174
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            AP+ +   R  +T  D++S G +L E+++G+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 275
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 17/191 (8%)
Query: 7   ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 66
           E  L +   +PL     +  +   A+G+ FL  A    I+RD  A N+LL     AK+ D
Sbjct: 146 EADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGD 203
Query: 67  FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           FGLA+         V         + APE +     T +SDV+S+G++L E+ S      
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------ 257
Query: 127 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 186
              +G+         P +    K ++++        P  A     ++   C   EP  RP
Sbjct: 258 ---LGLN------PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP 308
Query: 187 RMSEVLAILER 197
              ++ + L+ 
Sbjct: 309 TFQQICSFLQE 319

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 150
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 151 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 210 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 253 WNPSDRPSFAEIHQAFETM 271

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 98
           D    V++RD K +N+ LD + N KL DFGLA+          + + +GT  Y +PE + 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQMN 189
Query: 99  TGRLTTKSDVYSFGVVLLELLSGRCAV 125
                 KSD++S G +L EL    CA+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL----CAL 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            A+G+ FL  A    I+RD  A N+LL     AK+ DFGLA+         V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +     T +SDV+S+G++L E+ S         +G+         P +    K
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------LGLN------PYPGILVNSK 275
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 197
            ++++        P  A     ++   C   EP  RP   ++ + L+ 
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 150
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 151 LVKVADFGLSRL-MTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 210 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 253 WNPSDRPSFAEIHQAFETM 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 104 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 161
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 162 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 221 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 263
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 264 WNPSDRPSFAEIHQAFETM 282

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 149
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 150 LVKVADFGLSRL-MTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 209 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 252 WNPSDRPSFAEIHQAFETM 270

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 4/120 (3%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L +A   VI+RD  A N L+    
Sbjct: 104 MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQ 160
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 161 VIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/80 (41%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-- 101
           +IYRD K  NILLD+  +  L+DFGL+K     D T  +    GT  Y AP+ V  G   
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 102 LTTKSDVYSFGVVLLELLSG 121
                D +S GV++ ELL+G
Sbjct: 239 HDKAVDWWSLGVLMYELLTG 258

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 67/125 (53%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L  ++       G Q L +W V++      AKG+ +L   E ++++RD  A N+L
Sbjct: 121 MPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE--ERRLVHRDLAARNVL 172
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           + +  + K++DFGLA+     ++ + +        + A E +   + T +SDV+S+GV +
Sbjct: 173 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 232
Query: 116 LELLS 120
            EL++
Sbjct: 233 WELMT 237

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 24  MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 83
           +  A   A+G+ +L  ++ Q I+R+  A NIL+   + AK++DFGL++    G   +V  
Sbjct: 142 LHFAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK- 194
Query: 84  QVMGTH--GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           + MG     + A E +     TT SDV+S+GV+L E++S         +G          
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 237
Query: 142 PYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           PY      +L+  +      + P         L  QC   +P  RP  +++L  L R+
Sbjct: 238 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L +LH     ++YRD K  NILLD++ +  L+DFGL K     + T  ++   GT  
Sbjct: 149 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 67/125 (53%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L  ++       G Q L +W V++      AKG+ +L   E ++++RD  A N+L
Sbjct: 98  MPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE--ERRLVHRDLAARNVL 149
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           + +  + K++DFGLA+     ++ + +        + A E +   + T +SDV+S+GV +
Sbjct: 150 VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 209
Query: 116 LELLS 120
            EL++
Sbjct: 210 WELMT 214

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 37/192 (19%)
Query: 21  AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 80
            V + + I  A+ + FLH     +++RD K SNI    +   K+ DFGL  A    +   
Sbjct: 164 GVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 81  VSTQVM----------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL-SGRCAVDKTK 129
                M          GT  Y +PE +     + K D++S G++L ELL S    +++ +
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281
Query: 130 VGIEQSLVDWAKPYLSDKRKL-FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 188
           +             ++D R L F ++ T+   +YPQ+       +    L+  P  RP  
Sbjct: 282 I-------------ITDVRNLKFPLLFTQ---KYPQE-----HMMVQDMLSPSPTERPEA 320
Query: 189 SEVL--AILERL 198
           ++++  AI E L
Sbjct: 321 TDIIENAIFENL 332

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL+F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLSFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 159 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 259
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 260 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 118 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 173
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q ++  V + +A   +  + +L   +   I+R+  A N L+    
Sbjct: 337 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENH 394
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 395 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                     G+         PY   D  +++ +++     + P+        L   C  
Sbjct: 454 ---------YGM--------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 496
Query: 180 NEPKLRPRMSEVLAILERL 198
             P  RP  +E+    E +
Sbjct: 497 WNPSDRPSFAEIHQAFETM 515

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 3/118 (2%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G+L ++L     + ++  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 110 MPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 167
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K++DFGL++   TGD             + APE +A    + KSDV++FGV+L E+
Sbjct: 168 VVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL +LH  +  +++RD K +N+LLD     KL+DFGLAK+  + +R +    V  T  Y
Sbjct: 123 QGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWY 178
Query: 92  AAPEYVATGRLT-TKSDVYSFGVVLLELL 119
            APE +   R+     D+++ G +L ELL
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 157 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 257
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 87
           +  L +LH  E+++I+RD K  NI+L         K+ D G AK    G+   + T+ +G
Sbjct: 132 SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 186
Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T  Y APE +   + T   D +SFG +  E ++G
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 87
           +  L +LH  E+++I+RD K  NI+L         K+ D G AK    G+   + T+ +G
Sbjct: 131 SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T  Y APE +   + T   D +SFG +  E ++G
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 42  SQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYA 92
           S VI+RD K SN+L+++  + K+ DFGLA+         + PTG ++ + T+ + T  Y 
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TEYVATRWYR 189
Query: 93  APEYVAT-GRLTTKSDVYSFGVVLLELLSGR 122
           APE + T  + +   DV+S G +L EL   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 168
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 42  SQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYA 92
           S VI+RD K SN+L+++  + K+ DFGLA+         + PTG ++ + T+ + T  Y 
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TEXVATRWYR 189
Query: 93  APEYVAT-GRLTTKSDVYSFGVVLLELLSGR 122
           APE + T  + +   DV+S G +L EL   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 170
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 207 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 307
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRC 123
            APE +   +  +T  D++S G +  E+++ R 
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 121 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM---TGYVATRWY 195
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 209 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 309
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+  T  + T  Y
Sbjct: 121 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGRC 123
            APE +   +  +T  D++S G +  E+++ R 
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ ++       I+RD +A+N+L+      K++DFGLA+     + T           
Sbjct: 119 AEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK- 175
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +  G  T KS+V+SFG++L E+++
Sbjct: 176 WTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM---TGYVATRWY 195
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 148 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 248
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 119 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 85  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 208
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 255
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 256 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 288

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM---TGYVATRWY 195
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 194 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 294
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 149
           + APE +     T +SDV+SFGV++ E+ +         +G          PY      +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LG--------GSPYPGIPVEE 267
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLS 208
           LF+++        P    +    +   C +  P  RP   +++  L+R L    N   L 
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 209 QSEPHRQ 215
            S+P  Q
Sbjct: 328 LSQPLEQ 334

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 302
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 211
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 258
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 259 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 291

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 207
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 254
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 255 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 287

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 165 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 217
Query: 92  AAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 122
            APE +          D++S G ++ ELL+GR
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 300
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRK 149
           + APE +     T +SDV+SFGV++ E+ +         +G          PY      +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LG--------GSPYPGIPVEE 267
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLS 208
           LF+++        P    +    +   C +  P  RP   +++  L+R L    N   L 
Sbjct: 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327
Query: 209 QSEPHRQ 215
            S+P  Q
Sbjct: 328 LSQPLEQ 334

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 168
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 240
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 241 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 273

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 115 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 85  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 115 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172
Query: 85  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 199
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 246
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 247 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 279

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 240
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 241 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 273

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--G 90
           G+ +L   E   ++R+  A N+LL     AK+SDFGL+KA    D ++ + +  G     
Sbjct: 448 GMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLK 504
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +   + +++SDV+S+GV + E LS
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 207
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 168
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 198
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 61/135 (45%), Gaps = 9/135 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G+    L +R   P+   +  K+ +   K L +L +    VI+RD K SNILLD     K
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIK 165
Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLEL 118
           L DFG+  +G   D      +  G   Y APE +            ++DV+S G+ L+EL
Sbjct: 166 LCDFGI--SGRLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
Query: 119 LSGRCAVDKTKVGIE 133
            +G+      K   E
Sbjct: 223 ATGQFPYKNCKTDFE 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 200
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 247
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 248 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 280

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 135 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 187
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 200
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 247
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 248 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 280

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 118 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 173
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 125 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 85  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 115 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 199
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 246
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 247 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 279

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 23/172 (13%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           K+A+   K L  LH   S VI+RD K SN+L++A    K+ DFG+  +G   D       
Sbjct: 113 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDID 169
Query: 85  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
             G   Y APE +         + KSD++S G+ ++EL   R   D            W 
Sbjct: 170 A-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WG 217
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            P+    ++L ++++         K +        QCL    K RP   E++
Sbjct: 218 TPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D  +V  +
Sbjct: 119 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 176
Query: 85  VMGT-HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
                  + APE + T   +  SD + FGV L E+ +
Sbjct: 177 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 208
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 117 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 241
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 242 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 274

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 116 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 193
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGXVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 200
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 247
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 248 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 280

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           AA G+ +L       I+RD  A N L+  +   K+SDFG+++    G             
Sbjct: 222 AAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV 279
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +  GR +++SDV+SFG++L E  S         +G        A PY +   +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS---------LG--------ASPYPNLSNQ 322
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 198
             R    K GG+ P       A   L  QC   EP  RP  S +   L+ +
Sbjct: 323 QTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 195
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL F H    +V++RD K  N+L++ E   KL+DFGLA+A     RT+    V  T  Y
Sbjct: 114 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 92  AAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 122
            APE +   +  +T  D++S G +  E+++ R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 184
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D       
Sbjct: 115 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHX 168
Query: 85  VMGTH-----GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           VM  H      + APE + T   +  SD + FGV L E+ +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 184
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 185
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 185
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 134 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 186
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 233
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 234 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 266

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWY 184
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 153 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 253
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEM---TGYVATRWY 190
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 237
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 238 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 270

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+   T D     T  + T  Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEM---TGYVATRWY 194
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 241
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 242 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 274

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           AA G+ +L       I+RD  A N L+  +   K+SDFG+++    G             
Sbjct: 222 AAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            + APE +  GR +++SDV+SFG++L E  S         +G        A PY +   +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS---------LG--------ASPYPNLSNQ 322
Query: 150 LFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 198
             R    K GG+ P       A   L  QC   EP  RP  S +   L+ +
Sbjct: 323 QTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 30/186 (16%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAK--AGPTGDRTHVSTQVMGT 88
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG +K  AG        +    GT
Sbjct: 133 EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI----NPCTETFTGT 186
Query: 89  HGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 146
             Y APE +  G       +D++S G  ++E+ +G+               +  +P    
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK-----------PPFYELGEP---- 231
Query: 147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAK 206
           +  +F++   K+  + P+  +  A    L+C   +P  R   +++L      E  K S+K
Sbjct: 232 QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD----EFLKVSSK 287
Query: 207 LSQSEP 212
             +++P
Sbjct: 288 KKKTQP 293

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 122 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            AKG+ FL  A  + I+RD  A NILL  +   K+ DFGLA+                  
Sbjct: 153 VAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 147
            + APE +     T +SDV+SFGV+L E+ S         +G        A PY  +   
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVKID 253
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +  R +      + P           L C + EP  RP  SE++  L  L
Sbjct: 254 EEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 121 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           + A+  A+G+ +L     + I+RD  A N+LL      K+ DFGL +A P  D       
Sbjct: 125 RYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHX 178
Query: 85  VMGTH-----GYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           VM  H      + APE + T   +  SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 49/89 (55%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +     +  SD+++ G ++ +L++G
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 47/98 (47%), Gaps = 4/98 (4%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     +++RD   SN+LL    N K++DFGLA         H +  + GT  Y 
Sbjct: 124 GMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 130
           +PE         +SDV+S G +   LL GR   D   V
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVAT 205
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T     + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ EL+ G C + +    I+Q
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG-CVIFQGTDHIDQ 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 11/91 (12%)
Query: 42  SQVIYRDFKASNILLDAEFNAKLSDFGLAK---------AGPTGDRTHVSTQVMGTHGYA 92
           S VI+RD K SN+L+++  + K+ DFGLA+         + PTG ++ +  + + T  Y 
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-VEFVATRWYR 189
Query: 93  APEYVAT-GRLTTKSDVYSFGVVLLELLSGR 122
           APE + T  + +   DV+S G +L EL   R
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H  +  +++RD K  NILL++   + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTA 187
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H  +  +++RD K  NILL++   + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTA 187
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 62/127 (48%), Gaps = 13/127 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KG L ++L  +    LS     K+     + +  LH  +  +++RD K  NILLD + 
Sbjct: 93  MKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDM 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVV 114
           N KL+DFG +     G++     +V GT  Y APE +             + D++S GV+
Sbjct: 149 NIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 205
Query: 115 LLELLSG 121
           +  LL+G
Sbjct: 206 MYTLLAG 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 30/169 (17%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFG----LAKAGPTGDRTHVSTQVM 86
           +GL +LHD  +Q+++RD K  N+L++      K+SDFG    LA   P       +    
Sbjct: 119 EGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC------TETFT 170
Query: 87  GTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 144
           GT  Y APE +  G       +D++S G  ++E+ +G+               +  +P  
Sbjct: 171 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK-----------PPFYELGEP-- 217
Query: 145 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
             +  +F++   K+  + P+  +  A    L+C   +P  R   +++L 
Sbjct: 218 --QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 264

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 149 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 62/127 (48%), Gaps = 13/127 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KG L ++L  +    LS     K+     + +  LH  +  +++RD K  NILLD + 
Sbjct: 106 MKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDM 161
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVV 114
           N KL+DFG +     G++     +V GT  Y APE +             + D++S GV+
Sbjct: 162 NIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 115 LLELLSG 121
           +  LL+G
Sbjct: 219 MYTLLAG 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGYVAT 208
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R    T + GT  
Sbjct: 122 ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLD 175
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y  PE +       K D++S GV+  E L G
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 144 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 198
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 199 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 28/186 (15%)
Query: 17  PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 76
           PL   VR  V I  A G+ +L  +    I+RD  A N +L  +    ++DFGL++   +G
Sbjct: 135 PLQTLVRFMVDI--ACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 77  DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 135
           D             + A E +A    T  SDV++FGV + E+++ G+        GIE +
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ----TPYAGIENA 246
Query: 136 LVDWAKPYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
                            I +  +GG   + P +       L  QC + +PK RP  + + 
Sbjct: 247 ----------------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290
Query: 193 AILERL 198
             LE +
Sbjct: 291 MELENI 296

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 185
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 34/177 (19%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           KGL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 155 KGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 204
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 147
             Y APE + +     ++ D++S G ++ E+L+G+                  K YL   
Sbjct: 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK-------------GKDYLDQL 251
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK-----LRPRMS-EVLAILERL 198
            ++ ++     G ++ QK    AA   +Q L   P+     L PR S +   +LE++
Sbjct: 252 TQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 307

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H  +  +++RD K  NILL++   + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +        SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 148 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +        SD+++ G ++ +L++G
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D+GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 14/95 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVAT 181
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             Y APE +       ++ D++S G ++ ELL+GR
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 154 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 205
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 206 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V     + L +LH     VI+RD K+ +ILL  +   KLSDFG   A  + D       +
Sbjct: 146 VCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPK-RKXL 201
Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +GT  + APE ++     T+ D++S G++++E++ G
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 53/86 (61%), Gaps = 3/86 (3%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 97
           H  + ++++RD K  N+L++++   KL+DFGLA+A     R++  T  + T  Y AP+ +
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVL 191
Query: 98  -ATGRLTTKSDVYSFGVVLLELLSGR 122
             + + +T  D++S G +  E+++G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 53/86 (61%), Gaps = 3/86 (3%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 97
           H  + ++++RD K  N+L++++   KL+DFGLA+A     R++  T  + T  Y AP+ +
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVL 191
Query: 98  -ATGRLTTKSDVYSFGVVLLELLSGR 122
             + + +T  D++S G +  E+++G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 130 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 181
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 182 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGL +   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 145 LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +        SD+++ G ++ +L++G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 2/89 (2%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +PE +        SD+++ G ++ +L++G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 34/177 (19%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---T 88
           KGL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        H   ++ G   T
Sbjct: 137 KGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 186
Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 147
             Y APE + +     ++ D++S G ++ E+L+G+                  K YL   
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK-------------GKDYLDQL 233
Query: 148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK-----LRPRMS-EVLAILERL 198
            ++ ++     G ++ QK    AA   +Q L   P+     L PR S +   +LE++
Sbjct: 234 TQILKVTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 139 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 193
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 137 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 191
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 149
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
Query: 116 LELLS 120
            EL++
Sbjct: 210 WELMT 214

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 139 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 193
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 24/196 (12%)
Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P G L  H   R    L     +  ++   K + +L       ++RD    NIL+ +   
Sbjct: 107 PYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPEC 163
Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 120
            KL DFGL++     D    S   +    + +PE +   R TT SDV+ F V + E+LS 
Sbjct: 164 VKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESINFRRFTTASDVWMFAVCMWEILSF 222
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           G+                  +P+   + + +  +++       P        TL  +C +
Sbjct: 223 GK------------------QPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 264
Query: 180 NEPKLRPRMSEVLAIL 195
            +P  RPR +E++  L
Sbjct: 265 YDPSDRPRFTELVCSL 280

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 149
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
Query: 116 LELLS 120
            EL++
Sbjct: 210 WELMT 214

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 132 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 186
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 138 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 192
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 131 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 12/109 (11%)
Query: 21  AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 80
           +V + + +  A+ + FLH     +++RD K SNI    +   K+ DFGL  A    +   
Sbjct: 118 SVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 81  V----------STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
                       T  +GT  Y +PE +     + K D++S G++L ELL
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 99  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 150
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 151 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 210
Query: 116 LELLS 120
            EL++
Sbjct: 211 WELMT 215

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 24/196 (12%)
Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P G L  H   R    L     +  ++   K + +L       ++RD    NIL+ +   
Sbjct: 95  PYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPEC 151
Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 120
            KL DFGL++     D    S   +    + +PE +   R TT SDV+ F V + E+LS 
Sbjct: 152 VKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESINFRRFTTASDVWMFAVCMWEILSF 210
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           G+                  +P+   + + +  +++       P        TL  +C +
Sbjct: 211 GK------------------QPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 252
Query: 180 NEPKLRPRMSEVLAIL 195
            +P  RPR +E++  L
Sbjct: 253 YDPSDRPRFTELVCSL 268

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 132 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 186
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 156
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 157 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 216
Query: 116 LELLS 120
            EL++
Sbjct: 217 WELMT 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 24/196 (12%)
Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P G L  H   R    L     +  ++   K + +L       ++RD    NIL+ +   
Sbjct: 91  PYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPEC 147
Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS- 120
            KL DFGL++     D    S   +    + +PE +   R TT SDV+ F V + E+LS 
Sbjct: 148 VKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESINFRRFTTASDVWMFAVCMWEILSF 206
Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           G+                  +P+   + + +  +++       P        TL  +C +
Sbjct: 207 GK------------------QPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWD 248
Query: 180 NEPKLRPRMSEVLAIL 195
            +P  RPR +E++  L
Sbjct: 249 YDPSDRPRFTELVCSL 264

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 98  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 149
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
Query: 116 LELLS 120
            EL++
Sbjct: 210 WELMT 214

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGY 91
            L +LHD  +++I+RD KA NIL   + + KL+DFG+ AK   T  R       +GT  +
Sbjct: 147 ALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYW 201
Query: 92  AAPEYVATGR-----LTTKSDVYSFGVVLLEL 118
            APE V            K+DV+S G+ L+E+
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 152
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 153 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 212
Query: 116 LELLS 120
            EL++
Sbjct: 213 WELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 101 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 152
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 153 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 212
Query: 116 LELLS 120
            EL++
Sbjct: 213 WELMT 217

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 172
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 233 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 274
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 275 YRIMTQCWQHQPEDRPNFA---IILERIE 300

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 172
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 233 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 274
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 275 YRIMTQCWQHQPEDRPNFA---IILERIE 300

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 124 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 175
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 176 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 156
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 157 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 216
Query: 116 LELLS 120
            EL++
Sbjct: 217 WELMT 221

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 32  KGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ----- 84
           + L+++H   SQ +I+RD K  NI +D   N K+ DFGLAK    + D   + +Q     
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 85  ------VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 119
                  +GT  Y A E +  TG    K D+YS G++  E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 123 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 175 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 121 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 173 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 151
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 152 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 211
Query: 116 LELLS 120
            EL++
Sbjct: 212 WELMT 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 213 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 270
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 100 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 151
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 152 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 211
Query: 116 LELLS 120
            EL++
Sbjct: 212 WELMT 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 44  VIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           +++RD K  N+L    D E    +SDFGL+K    GD   V +   GT GY APE +A  
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEVLAQK 197
Query: 101 RLTTKSDVYSFGVVLLELLSG 121
             +   D +S GV+   LL G
Sbjct: 198 PYSKAVDCWSIGVIAYILLCG 218

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ------ 84
           + L+++H     +I+RD K  NI +D   N K+ DFGLAK    + D   + +Q      
Sbjct: 127 EALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 85  -----VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 119
                 +GT  Y A E +  TG    K D+YS G++  E++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 46  YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 105
           +RD K  NIL+ A+  A L DFG+A A      T +   V GT  Y APE  +    T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 106 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 142
           +D+Y+   VL E L+G       ++ +  + ++ A P
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIP 252

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 142 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 199
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 200 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 259
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 260 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 301
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 302 YRIMTQCWQHQPEDRPNFA---IILERIE 327

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 105 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 156
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 157 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 216
Query: 116 LELLS 120
            EL++
Sbjct: 217 WELMT 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 6/122 (4%)
Query: 1   MPKGSLENHLF----RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           M  G L  +L       GP+ +     +K  +  A G+ +L  +    ++RD  A N +L
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML 180
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
             +    ++DFGL+K   +GD             + A E +A    T+KSDV++FGV + 
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240
Query: 117 EL 118
           E+
Sbjct: 241 EI 242

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 123 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 175 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 MPGGDMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 92  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 143
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203
Query: 116 LELLS 120
            EL++
Sbjct: 204 WELMT 208

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 120 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 107 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 164
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 165 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 224
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 225 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 266
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 267 YRIMTQCWQHQPEDRPNFA---IILERIE 292

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFGLAK     +
Sbjct: 120 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 104 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 155
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 156 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 215
Query: 116 LELLS 120
            EL++
Sbjct: 216 WELMT 220

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 116 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 173
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 174 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 234 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 275
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 276 YRIMTQCWQHQPEDRPNFA---IILERIE 301

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 176 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 230
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 MPGGDMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 132 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 189
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 190 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 249
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 250 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 291
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 292 YRIMTQCWQHQPEDRPNFA---IILERIE 317

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 161 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 215
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 216 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 116 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 173
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 174 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 234 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 275
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 276 YRIMTQCWQHQPEDRPNFA---IILERIE 301

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 61/127 (48%), Gaps = 13/127 (10%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KG L ++L  +    LS     K+     + +  LH  +  +++RD K  NILLD + 
Sbjct: 106 MKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDM 161
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVV 114
           N KL+DFG +     G++      V GT  Y APE +             + D++S GV+
Sbjct: 162 NIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 115 LLELLSG 121
           +  LL+G
Sbjct: 219 MYTLLAG 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 2/84 (2%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 97
           H  +  +IYRD K  NI+L+ + + KL+DFGL K     D T V+    GT  Y APE +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHXFCGTIEYMAPEIL 193
Query: 98  ATGRLTTKSDVYSFGVVLLELLSG 121
                    D +S G ++ ++L+G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 19/97 (19%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVST-----Q 84
           G+T++H  ++++++RD K  N+LL++   + N ++ DFGL+        TH         
Sbjct: 162 GITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKKMKD 211
Query: 85  VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 212 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 123 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 174
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 175 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 234
Query: 116 LELLS 120
            EL++
Sbjct: 235 WELMT 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 187
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 247
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 248 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 289
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 290 YRIMTQCWQHQPEDRPNFA---IILERIE 315

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 176 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 230
Query: 93  APEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E      L  GR  +D+    IEQ
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y 
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYR 167
Query: 93  APEYV-ATGRLTTKSDVYSFGVVLLELLSG 121
           AP+ +  + + +T  D++S G +  E+++G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 252 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 301
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 302 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 122 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 179
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 180 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 239
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 240 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 281
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 282 YRIMTQCWQHQPEDRPNFA---IILERIE 307

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 187
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 247
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 248 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 289
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 290 YRIMTQCWQHQPEDRPNFA---IILERIE 315

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 66/130 (50%), Gaps = 19/130 (14%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLD 57
           GSL + L R+  +P    + +++A+ AA GL  LH        +  + +RDFK+ N+L+ 
Sbjct: 91  GSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVK 147
Query: 58  AEFNAKLSDFGLAKAGPTG-DRTHVSTQ-VMGTHGYAAPEYVATGRLTTK-------SDV 108
           +     ++D GLA     G D   +     +GT  Y APE V   ++ T        +D+
Sbjct: 148 SNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE-VLDEQIRTDCFESYKWTDI 206
Query: 109 YSFGVVLLEL 118
           ++FG+VL E+
Sbjct: 207 WAFGLVLWEI 216

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEY 96
           H  +  +IYRD K  NI+L+ + + KL+DFGL K     G  TH      GT  Y APE 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGTIEYMAPEI 192
Query: 97  VATGRLTTKSDVYSFGVVLLELLSG 121
           +         D +S G ++ ++L+G
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 154 ARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 211
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 212 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 130 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 187
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 188 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 247
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 248 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 289
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 290 YRIMTQCWQHQPEDRPNFA---IILERIE 315

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 156 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 213
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 214 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 133 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 190
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 191 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 250
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 251 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 292
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 293 YRIMTQCWQHQPEDRPNFA---IILERIE 318

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 116 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 173
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 174 LTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 234 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 275
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 276 YRIMTQCWQHQPEDRPNFA---IILERIE 301

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 33/209 (15%)
Query: 1   MPKGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P+P     L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCL 213
Query: 56  LDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           L        AK+ DFG+A+              M    +  PE    G  T+K+D +SFG
Sbjct: 214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTA 170
           V+L E+ S         +G          PY S   +      T  GG+   P+      
Sbjct: 274 VLLWEIFS---------LGY--------MPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPV 315
Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERLE 199
             +  QC  ++P+ RP  +    ILER+E
Sbjct: 316 YRIMTQCWQHQPEDRPNFA---IILERIE 341

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 159 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 216
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y 
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYR 167
Query: 93  APEYV-ATGRLTTKSDVYSFGVVLLELLSG 121
           AP+ +  + + +T  D++S G +  E+++G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 143 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 197
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLS------GRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E++       GR  +D+    IEQ
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A     R +  T  + T  Y 
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYR 167
Query: 93  APEYV-ATGRLTTKSDVYSFGVVLLELLSG 121
           AP+ +  + + +T  D++S G +  E+++G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 139 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 193
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      K++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T     + T  + T  Y 
Sbjct: 136 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN---FMMTPYVVTRYYR 190
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ EL+ G
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 132 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 186
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLS------GRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E++       GR  +D+    IEQ
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           +PL       V  GA +GL +LH     +I+RD KA NILL      KL DFG A     
Sbjct: 149 KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206
Query: 76  GDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 118
            +        +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 207 AN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT 
Sbjct: 128 AVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           GY APE +A    +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 34  LTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT G
Sbjct: 129 VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y APE +A    +   D +S GV+   LL G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT 
Sbjct: 128 AVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           GY APE +A    +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 75
           +PL       V  GA +GL +LH     +I+RD KA NILL      KL DFG A     
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167
Query: 76  GDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLEL 118
            +        +GT  + APE +     G+   K DV+S G+  +EL
Sbjct: 168 AN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L++   +  A   AKG+ FL       ++RD  A N+L+      K+ DFGLA+   +  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
              V         + APE +  G  T KSDV+S+G++L E+ S
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DF LA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 175 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 224
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 225 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPEVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 9/91 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LHD  +++I+RD KA NIL   + + KL+DFG++       +   S   +GT  + 
Sbjct: 147 ALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWM 202
Query: 93  APEYVATGR-----LTTKSDVYSFGVVLLEL 118
           APE V            K+DV+S G+ L+E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALTPVVVTLWY 185
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+  FGLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LHD    +++RD K  N+L   LD +    +SDFGL+K    G    V +   GT 
Sbjct: 128 AVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTP 182
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           GY APE +A    +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+           T V+ T  Y
Sbjct: 131 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 185
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T+ H  ++++++RD K  N+LL++   + N ++ DFGL+       +       +GT 
Sbjct: 138 GITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX---KDKIGTA 192
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 130 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 179
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 180 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L++ H    +VI+RD K  N+LL +    K++DFG +   P+  R      + GT  
Sbjct: 122 ANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLD 175
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y  PE +       K D++S GV+  E L G
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 132 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 181
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 182 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 10  LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSD 66
           + R+    +  AV MK  +    G T+LH  +  +++RD K  N+LL+++      K+ D
Sbjct: 113 ILRQKFSEVDAAVIMKQVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVD 167
Query: 67  FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           FGL+     G +     + +GT  Y APE V   +   K DV+S GV+L  LL G
Sbjct: 168 FGLSAHFEVGGKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDATLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 66/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      A+G+ +L D   ++++RD  A N+L
Sbjct: 95  MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGMNYLED--RRLVHRDLAARNVL 146
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 147 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 206
Query: 116 LELLS 120
            EL++
Sbjct: 207 WELMT 211

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 7/95 (7%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KG+ +LH    ++I+RD K SN+L+  + + K++DFG++      D    +T  +GT  +
Sbjct: 148 KGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--VGTPAF 203
Query: 92  AAPEYVATGR--LTTKS-DVYSFGVVLLELLSGRC 123
            APE ++  R   + K+ DV++ GV L   + G+C
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A+G+ +L  A  + I+RD  A N+L+      +++DFGLA+     D    +T       
Sbjct: 167 ARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVK 224
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + APE +     T +SDV+SFGV++ E+ +
Sbjct: 225 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 58/130 (44%), Gaps = 20/130 (15%)
Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L      P  WA      + +A+ A   +  +H        RD K  N+LL
Sbjct: 157 MPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--------RDVKPDNMLL 207
Query: 57  DAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSF 111
           D   + KL+DFG   K   TG   H  T V GT  Y +PE + +    G    + D +S 
Sbjct: 208 DKHGHLKLADFGTCMKMDETG-MVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 265
Query: 112 GVVLLELLSG 121
           GV L E+L G
Sbjct: 266 GVFLFEMLVG 275

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNIL-LDAEFNAKL--SDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +++RD K  N+L L  E N+K+  +DFGL+K    G    + +   GT 
Sbjct: 118 AVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           GY APE +A    +   D +S GV+   LL G
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 9/92 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDA-EFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T+LH  +  +++RD K  N+LL++ E +A  K+ DFGL+       +     + +GT 
Sbjct: 148 GVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTA 202
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V   +   K DV+S GV+L  LL+G
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + +    + T  Y 
Sbjct: 140 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMVPFVVTRYYR 194
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE +         D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 70/171 (40%), Gaps = 23/171 (13%)
Query: 25  KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 84
           K+A+   K L  LH   S VI+RD K SN+L++A    K  DFG+  +G   D       
Sbjct: 140 KIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGI--SGYLVDDVAKDID 196
Query: 85  VMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 140
             G   Y APE +         + KSD++S G+  +EL   R   D            W 
Sbjct: 197 A-GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS-----------WG 244
Query: 141 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
            P+    ++L ++++         K +        QCL    K RP   E+
Sbjct: 245 TPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 10  LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSD 66
           + R+    +  AV MK  +    G T+LH  +  +++RD K  N+LL+++      K+ D
Sbjct: 96  ILRQKFSEVDAAVIMKQVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVD 150
Query: 67  FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           FGL+     G +     + +GT  Y APE V   +   K DV+S GV+L  LL G
Sbjct: 151 FGLSAHFEVGGKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 9/91 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LHD  +++I+RD KA NIL   + + KL+DFG++               +GT  + 
Sbjct: 147 ALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--XIQRRDXFIGTPYWM 202
Query: 93  APEYVATGR-----LTTKSDVYSFGVVLLEL 118
           APE V            K+DV+S G+ L+E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 175
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFGLAK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 176 QQGYIKVTDFGLAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 118 LLSG 121
           + +G
Sbjct: 231 MAAG 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 22/117 (18%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT---------- 75
           V     K + +LH     +++RD K SNILL+AE + K++DFGL+++             
Sbjct: 114 VVYQLIKVIKYLHSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 76  ---------GDRTHVSTQVMGTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 122
                     D   + T  + T  Y APE  + + + T   D++S G +L E+L G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+   +     V T+      Y
Sbjct: 139 KGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WY 191
Query: 92  AAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 122
            APE +    R T   D++S G ++ E+++G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 121 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 170
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 171 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 11/93 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L FLH    ++I+RD KA N+L+  E + +L+DFG+ AK   T  +       +GT  
Sbjct: 128 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPY 182
Query: 91  YAAPEYVATGRLTT-----KSDVYSFGVVLLEL 118
           + APE V    +       K+D++S G+ L+E+
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 16/102 (15%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 85
           V +   + L+ LH     VI+RD K+ +ILL  +   KLSDFG            VS +V
Sbjct: 125 VCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--------AQVSKEV 174
Query: 86  ------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                 +GT  + APE ++      + D++S G++++E++ G
Sbjct: 175 PRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 11/96 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           +GL+ LH  + +VI+RD K  N+LL      KL DFG+ A+   T  R +     +GT  
Sbjct: 140 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPY 194
Query: 91  YAAPEYVATGR-----LTTKSDVYSFGVVLLELLSG 121
           + APE +A           KSD++S G+  +E+  G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+    G    +  +V+ T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-TRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLS------GRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E++       GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 67/127 (52%), Gaps = 13/127 (10%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           +G+ +LH  ++ +++ D K  NILL + +   + K+ DFG+++    G    +  ++MGT
Sbjct: 142 EGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGT 196
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 143
             Y APE +    +TT +D+++ G++   LL+           +T + I Q  VD+++  
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 144 LSDKRKL 150
            S   +L
Sbjct: 257 FSSVSQL 263

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ D GLA+   T D     T  + T  Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARH--TDDEM---TGYVATRWY 188
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +       ++ D++S G ++ ELL+GR     T              ++   + +
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-------------HIDQLKLI 235
Query: 151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 184
            R++ T  G +  +K +  +A   +Q L   PK+
Sbjct: 236 LRLVGTP-GAELLKKISSESARNYIQSLTQMPKM 268

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+        +V+T+      Y
Sbjct: 134 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WY 186
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 11/93 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHG 90
           + L FLH    ++I+RD KA N+L+  E + +L+DFG+ AK   T  +       +GT  
Sbjct: 120 EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPY 174
Query: 91  YAAPEYVATGRLTT-----KSDVYSFGVVLLEL 118
           + APE V    +       K+D++S G+ L+E+
Sbjct: 175 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+D
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLID 176
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 177 QQGYIKVADFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 118 LLSG 121
           + +G
Sbjct: 232 MAAG 235

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     +
Sbjct: 122 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 65/125 (52%), Gaps = 13/125 (10%)
Query: 1   MPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           MP G L +++       G Q L +W V++      AKG+ +L D   ++++RD  A N+L
Sbjct: 102 MPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLED--RRLVHRDLAARNVL 153
Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           +    + K++DFG AK     ++ + +        + A E +     T +SDV+S+GV +
Sbjct: 154 VKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 213
Query: 116 LELLS 120
            EL++
Sbjct: 214 WELMT 218

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     +
Sbjct: 122 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 17/96 (17%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGL----AKAGPTGDRTHVSTQV 85
           G+ +LH  +  +++RD K  NILL+ +    N K+ DFGL    +K     DR       
Sbjct: 158 GICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR------- 208
Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +GT  Y APE V   +   K DV+S GV++  LL G
Sbjct: 209 LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     +
Sbjct: 127 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 178
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 179 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     +
Sbjct: 122 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 18  LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 77
           L+W V++      AKG+ +L D   ++++RD  A N+L+    + K++DFG AK     +
Sbjct: 120 LNWCVQI------AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 171
Query: 78  RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+        +V+T+      Y
Sbjct: 142 RGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 123
            APE +       ++ D++S G ++ ELL G+ 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A   +I+RD K SN+ ++ +   ++ DFGLA+        +V+T+      Y
Sbjct: 142 RGLKYIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC 123
            APE +       ++ D++S G ++ ELL G+ 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR- 101
           ++I+RD K  NILLD   +  ++DF +A   P    T ++T + GT  Y APE  ++ + 
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPYMAPEMFSSRKG 191
Query: 102 --LTTKSDVYSFGVVLLELLSGR 122
              +   D +S GV   ELL GR
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+    G    +  +V+ T  Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-TRYYR 192
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLS------GRCAVDKTKVGIEQ 134
           APE +         D++S G ++ E++       GR  +D+    IEQ
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 175
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 176 QQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 118 LLSG 121
           + +G
Sbjct: 231 MAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 176
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 177 QQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 118 LLSG 121
           + +G
Sbjct: 232 MAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 125 PGGEMFSHLRRIGRFXEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 176
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 177 QQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 118 LLSG 121
           + +G
Sbjct: 232 MAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 176
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 177 QQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 118 LLSG 121
           + +G
Sbjct: 232 MAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 175
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 176 QQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 118 LLSG 121
           + +G
Sbjct: 231 MAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 144 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 195
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 196 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 250
Query: 117 ELLSG 121
           E+ +G
Sbjct: 251 EMAAG 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 176 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 117 ELLSG 121
           E+ +G
Sbjct: 231 EMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 176
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   K++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 177 QQGYIKVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231
Query: 118 LLSG 121
           + +G
Sbjct: 232 MAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFXEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 212 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 266
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 324
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 325 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 374
Query: 208 SQSE 211
           +  E
Sbjct: 375 TPLE 378

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 176 DQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 117 ELLSG 121
           E+ +G
Sbjct: 231 EMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 175
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   +++DFGLAK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 176 QQGYIQVTDFGLAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 118 LLSG 121
           + +G
Sbjct: 231 MAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 23/109 (21%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------- 85
           G  F+H  ES +I+RD K +N LL+ + + K+ DFGLA+   +   T++   +       
Sbjct: 141 GENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 86  -------------MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 120
                        + T  Y APE +      TKS D++S G +  ELL+
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 116 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 167
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 168 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 117 ELLSG 121
           E+ +G
Sbjct: 223 EMAAG 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 176 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 117 ELLSG 121
           E+ +G
Sbjct: 231 EMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 176 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 117 ELLSG 121
           E+ +G
Sbjct: 231 EMAAG 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 169 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 223
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 281
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 282 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 331
Query: 208 SQSE 211
           +  E
Sbjct: 332 TPLE 335

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 221
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 279
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 329
Query: 208 SQSE 211
           +  E
Sbjct: 330 TPLE 333

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 124 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 176 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 117 ELLSG 121
           E+ +G
Sbjct: 231 EMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 124 VPGGEMFSHLRRIGRFXEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 175
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 176 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 117 ELLSG 121
           E+ +G
Sbjct: 231 EMAAG 235

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 171 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 225
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 283
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 284 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 333
Query: 208 SQSE 211
           +  E
Sbjct: 334 TPLE 337

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+             V+ T  Y
Sbjct: 123 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALAPVVVTLWY 177
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 116 VPGGEMFSHLRRIGRFXEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 167
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 168 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 117 ELLSG 121
           E+ +G
Sbjct: 223 EMAAG 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            ++ +HD    V++RD K  N+L   E      K+ DFG A+  P  D   + T     H
Sbjct: 118 AVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTLH 174
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            YAAPE +         D++S GV+L  +LSG+
Sbjct: 175 -YAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 123 VPGGEMFSHLRRIGRFXEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 174
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 175 DQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 229
Query: 117 ELLSG 121
           E+ +G
Sbjct: 230 EMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 17/125 (13%)
Query: 1   MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           +P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+L+
Sbjct: 109 VPGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLLI 160
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
           D +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ 
Sbjct: 161 DQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 215
Query: 117 ELLSG 121
           E+ +G
Sbjct: 216 EMAAG 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + L + HD  + +I+RD K  N+LL ++ N+   KL DFG+A     G+   V+   +GT
Sbjct: 141 EALRYCHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGT 196
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V         DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 141 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 195
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 253
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 254 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 303
Query: 208 SQSE 211
           +  E
Sbjct: 304 TPLE 307

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 221
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 279
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 329
Query: 208 SQSE 211
           +  E
Sbjct: 330 TPLE 333

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 17/102 (16%)
Query: 32  KGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQ----- 84
           + L+++H   SQ +I+R+ K  NI +D   N K+ DFGLAK    + D   + +Q     
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 85  ------VMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELL 119
                  +GT  Y A E +  TG    K D YS G++  E +
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYA 92
           LTF +     +IYRD K  N+L+D +   +++DFG AK      R   +T  + GT  Y 
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGATWTLCGTPEYL 226
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE + +       D ++ GV++ E+ +G
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 146 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 200
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 258
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 259 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 308
Query: 208 SQSE 211
           +  E
Sbjct: 309 TPLE 312

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 134 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 188
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 246
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 247 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 296
Query: 208 SQSE 211
           +  E
Sbjct: 297 TPLE 300

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 152 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 206
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 264
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 265 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 314
Query: 208 SQSE 211
           +  E
Sbjct: 315 TPLE 318

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+             V+ T  Y
Sbjct: 123 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALDPVVVTLWY 177
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 161 RSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 215
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 273
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 274 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 323
Query: 208 SQSE 211
           +  E
Sbjct: 324 TPLE 327

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 16/117 (13%)
Query: 13  RGPQPLS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 70
           R P+ ++  +   M +AI +   L ++H        RD K  NIL+D   + +L+DFG +
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-S 221
Query: 71  KAGPTGDRTHVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGR 122
                 D T  S+  +GT  Y +PE +       GR   + D +S GV + E+L G 
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 137 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 191
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 249
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 250 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 299
Query: 208 SQSE 211
           +  E
Sbjct: 300 TPLE 303

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           KGL FLH     +I+RD K  NI +     + K+ D GLA    T  R   +  V+GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPE 195
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLE 117
           + APE     +     DVY+FG   LE
Sbjct: 196 FXAPEXYEE-KYDESVDVYAFGXCXLE 221

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 15  PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--A 72
           P  L + V  K       G+ F H     +I+RD K  NIL+      KL DFG A+  A
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
Query: 73  GPTGDRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR------CAV 125
            P      V    + T  Y APE  V   +     DV++ G ++ E+  G         +
Sbjct: 176 AP----GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231
Query: 126 DKTKVGIEQSLVDWAKPY--LSDKRKLF---RIMDTK----LGGQYPQKAAHTAATLALQ 176
           D+    I   L +    +  L +K  +F   R+ + K    L  +YP K +     LA +
Sbjct: 232 DQL-YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYP-KLSEVVIDLAKK 289
Query: 177 CLNNEPKLRPRMSEVL 192
           CL+ +P  RP  +E+L
Sbjct: 290 CLHIDPDKRPFCAELL 305

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 36/207 (17%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP GSL N L       +  +  +K A+  A+G+ FLH  E  +      + ++++D + 
Sbjct: 91  MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK--------SDVYSFG 112
            A++S   +  +  +  R +            AP +VA   L  K        +D++SF 
Sbjct: 151 TARISMADVKFSFQSPGRMY------------APAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           V+L EL++            E    D     LS+     ++    L    P   +   + 
Sbjct: 199 VLLWELVTR-----------EVPFAD-----LSNMEIGMKVALEGLRPTIPPGISPHVSK 242
Query: 173 LALQCLNNEPKLRPRMSEVLAILERLE 199
           L   C+N +P  RP+   ++ ILE+++
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 145 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 199
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 257
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 307
Query: 208 SQSE 211
           +  E
Sbjct: 308 TPLE 311

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 145 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 199
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 257
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 307
Query: 208 SQSE 211
           +  E
Sbjct: 308 TPLE 311

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 33  GLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            L + H     V+++D K  NIL  D   ++  K+ DFGLA+   + +    ST   GT 
Sbjct: 136 ALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190
Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKR 148
            Y APE V    +T K D++S GVV+  LL+G      T +   Q    + +P Y  + R
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249
Query: 149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            L            PQ     A  L  Q L  +P+ RP  ++VL
Sbjct: 250 PL-----------TPQ-----AVDLLKQMLTKDPERRPSAAQVL 277

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 138 RSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 192
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 250
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+      ++PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 251 QIREMNPNYTEFKFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 300
Query: 208 SQSE 211
           +  E
Sbjct: 301 TPLE 304

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+             V+ T  Y
Sbjct: 123 RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALFPVVVTLWY 177
Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELL 119
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ A    KL DFGL++          ST    + G     + APE +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 184
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 185 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 225
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 226 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 55/129 (42%), Gaps = 18/129 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L      P  WA      + +A+ A   + F+H        RD K  N+LL
Sbjct: 151 MPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLL 201
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFG 112
           D   + KL+DFG              T V GT  Y +PE + +    G    + D +S G
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 113 VVLLELLSG 121
           V L E+L G
Sbjct: 261 VFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 55/129 (42%), Gaps = 18/129 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L      P  WA      + +A+ A   + F+H        RD K  N+LL
Sbjct: 156 MPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLL 206
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFG 112
           D   + KL+DFG              T V GT  Y +PE + +    G    + D +S G
Sbjct: 207 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 265
Query: 113 VVLLELLSG 121
           V L E+L G
Sbjct: 266 VFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 55/129 (42%), Gaps = 18/129 (13%)
Query: 1   MPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           MP G L N L      P  WA      + +A+ A   + F+H        RD K  N+LL
Sbjct: 156 MPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLL 206
Query: 57  DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFG 112
           D   + KL+DFG              T V GT  Y +PE + +    G    + D +S G
Sbjct: 207 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 265
Query: 113 VVLLELLSG 121
           V L E+L G
Sbjct: 266 VFLYEMLVG 274

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L + H  E +VI+RD K  N+L+  +   K++DFG +   P+  R      + GT  
Sbjct: 124 ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLD 177
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           Y  PE +       K D++  GV+  E L G    D
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 34/159 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVS--TQVMGTHGYAAP 94
           H     V++RD K  NIL+D     AKL DFG      +G   H    T   GT  Y+ P
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG------SGALLHDEPYTDFDGTRVYSPP 207
Query: 95  EYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 153
           E+++  +     + V+S G++L +++ G    ++ +  +E  L                 
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL----------------- 250
Query: 154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
                   +P   +     L  +CL  +P  RP + E+L
Sbjct: 251 -------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 6/96 (6%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L + H  E +VI+RD K  N+L+  +   K++DFG +   P+  R      + GT  
Sbjct: 125 ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGTLD 178
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 126
           Y  PE +       K D++  GV+  E L G    D
Sbjct: 179 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 23/156 (14%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           + ++RD  A N+L+ +    KL DFGL++          S   +    + APE +   R 
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESINFRRF 189
Query: 103 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ- 161
           T+ SDV+ FGV + E+                 L+   KP+   K     ++     G+ 
Sbjct: 190 TSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRIENGER 230
Query: 162 --YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
              P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 266

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 187
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 188 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 228
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 229 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 269

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ A    KL DFGL++          ST    + G     + APE +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 564
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 565 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 605
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 193
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 227
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 207
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+       +PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLXGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+    +   + +  
Sbjct: 133 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY 187
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      T+  DV+S G VL ELL G+  +     G++Q LV+  K   +  R+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQ-LVEIIKVLGTPTRE 245
Query: 150 LFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             R M+       +PQ  AH    +           RPR   E +A+  RL     +A+L
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKV----------FRPRTPPEAIALCSRLLEYTPTARL 295
Query: 208 SQSE 211
           +  E
Sbjct: 296 TPLE 299

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 201
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 186
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 187 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 227
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 228 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 268

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 189
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 190 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 230
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 2   PKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           P G + +HL R G    P    +A ++         LTF +     +IYRD K  N+++D
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIV--------LTFEYLHSLDLIYRDLKPENLMID 175
Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +   +++DFG AK      RT     + GT  Y APE + +       D ++ GV++ E
Sbjct: 176 QQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 118 LLSG 121
           + +G
Sbjct: 231 MAAG 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 11/82 (13%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 184
Query: 98  ATGRLTTKSDVYSFGVVLLELL 119
              R T+ SDV+ FGV + E+L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 11/82 (13%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 184
Query: 98  ATGRLTTKSDVYSFGVVLLELL 119
              R T+ SDV+ FGV + E+L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 212
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 213 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 253
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 254 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 294

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 33/161 (20%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 181
Query: 98  ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 157
              R T+ SDV+ FGV + E+                 L+   KP+   K     ++   
Sbjct: 182 NFRRFTSASDVWMFGVCMWEI-----------------LMHGVKPFQGVKNN--DVIGRI 222
Query: 158 LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 195
             G+    P     T  +L  +C   +P  RPR +E+ A L
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYA 92
           LTF +     +IYRD K  N+L+D +   +++DFG AK      R    T  + GT  Y 
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLAGTPEYL 205
Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSG 121
           APE + +       D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 26/112 (23%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------- 85
           G  F+H  ES +I+RD K +N LL+ + + K+ DFGLA+   +    H+   +       
Sbjct: 143 GEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 86  ----------------MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 120
                           + T  Y APE +      T S D++S G +  ELL+
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+++D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFG---------LAKAGPTGDRT 79
           A +GL +LH    ++++ D KA N+LL ++  +A L DFG         L K+  TGD  
Sbjct: 194 ALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD-- 249
Query: 80  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                + GT  + APE V       K DV+S   ++L +L+G
Sbjct: 250 ----YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 11/82 (13%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYV 97
           + ++RD  A N+L+ +    KL DFGL++          ST    + G     + APE +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESI 564
Query: 98  ATGRLTTKSDVYSFGVVLLELL 119
              R T+ SDV+ FGV + E+L
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y
Sbjct: 111 RGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWY 166
Query: 92  AAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 122
             P+  + +   +T+ D++  G +  E+ +GR
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL F H     V++RD K  N+L++     KL+DFGLA+A     R + +  V  T  Y
Sbjct: 112 KGLGFCH--SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWY 167
Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLEL 118
             P+ +   +L +T  D++S G +  EL
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 23  RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 82
            M +AI +   L ++H        RD K  N+LLD   + +L+DFG +      D T  S
Sbjct: 183 EMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQS 233
Query: 83  TQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGR 122
           +  +GT  Y +PE +       G+   + D +S GV + E+L G 
Sbjct: 234 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + L ++H     + +RD K  N+LLD      KL DFG AK    G+    +   + +  
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICSRY 206
Query: 91  YAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
           Y APE +      TT  D++S G V+ EL+ G+  +   + GI+Q LV+  K   +  R+
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQ-LVEIIKVLGTPSRE 264
Query: 150 LFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM-SEVLAILERLEAPKNSAKL 207
             + M+   +  ++PQ   H  + +           RPR   + + ++ RL     SA+L
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKV----------FRPRTPPDAIDLISRLLEYTPSARL 314
Query: 208 SQSE 211
           +  E
Sbjct: 315 TAIE 318

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 23  RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 82
            M +AI +   L ++H        RD K  N+LLD   + +L+DFG +      D T  S
Sbjct: 199 EMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQS 249
Query: 83  TQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSGR 122
           +  +GT  Y +PE +       G+   + D +S GV + E+L G 
Sbjct: 250 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 64/146 (43%), Gaps = 25/146 (17%)
Query: 1   MPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           M  GS+ +H+  RR    L  +V   V    A  L FLH+    + +RD K  NIL +  
Sbjct: 93  MRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHN--KGIAHRDLKPENILCEHP 147
Query: 60  FNA---KLSDFGLAKAGP-TGDRTHVSTQVM----GTHGYAAPEYVAT-----GRLTTKS 106
                 K+ DFGL       GD + +ST  +    G+  Y APE V            + 
Sbjct: 148 NQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207
Query: 107 DVYSFGVVLLELLS------GRCAVD 126
           D++S GV+L  LLS      GRC  D
Sbjct: 208 DLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ ++ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           Q ++RD  A N L++ +   K+SDFGL++     + T           ++ PE +   + 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMYSKF 198
Query: 103 TTKSDVYSFGVVLLELLS 120
           ++KSD+++FGV++ E+ S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R           +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 81  MANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQG 137
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++     D  + S+  +G+     ++ PE +   + ++KSD+++FGV++ E
Sbjct: 138 VVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 193
Query: 118 LLS 120
           + S
Sbjct: 194 IYS 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R           +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 85  MANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQG 141
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++     D  + S+  +G+     ++ PE +   + ++KSD+++FGV++ E
Sbjct: 142 VVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 197
Query: 118 LLS 120
           + S
Sbjct: 198 IYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R           +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 86  MANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++     D  + S+  +G+     ++ PE +   + ++KSD+++FGV++ E
Sbjct: 143 VVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 198
Query: 118 LLS 120
           + S
Sbjct: 199 IYS 201

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R           +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 86  MANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQG 142
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++     D  + S++  G+     ++ PE +   + ++KSD+++FGV++ E
Sbjct: 143 VVKVSDFGLSRY--VLDDEYTSSR--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 198
Query: 118 LLS 120
           + S
Sbjct: 199 IYS 201

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLA---KAGPTGDRTHVSTQV 85
           A +GL +LH    ++++ D KA N+LL ++  +A L DFG A   +    G        +
Sbjct: 175 ALEGLEYLHS--RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            GT  + APE V       K DV+S   ++L +L+G
Sbjct: 233 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/81 (30%), Positives = 49/81 (60%), Gaps = 7/81 (8%)
Query: 43  QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVAT 99
           Q ++RD  A N L++ +   K+SDFGL++     D  + S+  +G+     ++ PE +  
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMY 195
Query: 100 GRLTTKSDVYSFGVVLLELLS 120
            + ++KSD+++FGV++ E+ S
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYS 216

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 98  GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 155
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   + +     T+   T  Y APE +   +     D++S GV++  LL 
Sbjct: 156 ILKLTDFGFAKETTSHNSL---TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 212
Query: 121 G 121
           G
Sbjct: 213 G 213

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 10/123 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R           +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 92  MANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQG 148
Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++     D  + S+  +G+     ++ PE +   + ++KSD+++FGV++ E
Sbjct: 149 VVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWE 204
Query: 118 LLS 120
           + S
Sbjct: 205 IYS 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 5/91 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + + F H  +   I+RD K  NIL+      KL DFG A+   TG   +   +V  T  Y
Sbjct: 113 QAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARL-LTGPSDYYDDEV-ATRWY 168
Query: 92  AAPE-YVATGRLTTKSDVYSFGVVLLELLSG 121
            +PE  V   +     DV++ G V  ELLSG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFG---------LAKAGPTGDRT 79
           A +GL +LH    ++++ D KA N+LL ++ + A L DFG         L K+  TGD  
Sbjct: 175 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD-- 230
Query: 80  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                + GT  + APE V       K D++S   ++L +L+G
Sbjct: 231 ----YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 126 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 180
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 132 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 186
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 125 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 179
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFG---------LAKAGPTGDRT 79
           A +GL +LH    ++++ D KA N+LL ++ + A L DFG         L K+  TGD  
Sbjct: 159 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD-- 214
Query: 80  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                + GT  + APE V       K D++S   ++L +L+G
Sbjct: 215 ----YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 126 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 180
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFG---------LAKAGPTGDRT 79
           A +GL +LH    ++++ D KA N+LL ++ + A L DFG         L K+  TGD  
Sbjct: 173 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD-- 228
Query: 80  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
                + GT  + APE V       K D++S   ++L +L+G
Sbjct: 229 ----YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 126 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 180
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 201
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 202 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
Query: 121 G 121
           G
Sbjct: 259 G 259

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 11/125 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-E 59
           M  G L + +  RG Q  +     ++       + FLH     + +RD K  N+L  + E
Sbjct: 89  MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKE 146
Query: 60  FNA--KLSDFGLAKAGPTGDRTHVSTQV-MGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
            +A  KL+DFG AK     + T  + Q    T  Y APE +   +     D++S GV++ 
Sbjct: 147 KDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 201
Query: 117 ELLSG 121
            LL G
Sbjct: 202 ILLCG 206

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 100 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 157
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 158 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 214
Query: 121 G 121
           G
Sbjct: 215 G 215

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 11/125 (8%)
Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-E 59
           M  G L + +  RG Q  +     ++       + FLH     + +RD K  N+L  + E
Sbjct: 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKE 165
Query: 60  FNA--KLSDFGLAKAGPTGDRTHVSTQV-MGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
            +A  KL+DFG AK     + T  + Q    T  Y APE +   +     D++S GV++ 
Sbjct: 166 KDAVLKLTDFGFAK-----ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 117 ELLSG 121
            LL G
Sbjct: 221 ILLCG 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT  Y A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEYLA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           P  + +       D ++ GV++ E+ +G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 150 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 207
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 208 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 264
Query: 121 G 121
           G
Sbjct: 265 G 265

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 98  GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 155
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 156 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 212
Query: 121 G 121
           G
Sbjct: 213 G 213

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 5/88 (5%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL F H     V++RD K  N+L++     KL++FGLA+A     R + +  V  T  Y
Sbjct: 112 KGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWY 167
Query: 92  AAPEYVATGRL-TTKSDVYSFGVVLLEL 118
             P+ +   +L +T  D++S G +  EL
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 105 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 162
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 163 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 219
Query: 121 G 121
           G
Sbjct: 220 G 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 104 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 161
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 162 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 218
Query: 121 G 121
           G
Sbjct: 219 G 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 106 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 163
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 164 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 220
Query: 121 G 121
           G
Sbjct: 221 G 221

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 100 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 157
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 158 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 214
Query: 121 G 121
           G
Sbjct: 215 G 215

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD        KL DFG+A     G+       + GT
Sbjct: 127 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 143
             + APE V    L  ++D++S GV+   LLSG          +T   I     D+ + Y
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 173
            S+  +L +    +L  + P++    A +L
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRMXIAQSL 271

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 99  GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 156
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 157 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 213
Query: 121 G 121
           G
Sbjct: 214 G 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 114 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 171
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D++S GV++  LL 
Sbjct: 172 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 228
Query: 121 G 121
           G
Sbjct: 229 G 229

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 251 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 305
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 37/199 (18%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 148
             + APE V    L  ++D++S GV+   LLSG                  A P+L D +
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGDTK 222
Query: 149 K--LFRI--MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 204
           +  L  +  ++ +   +Y    +  A     + L  +PK R      + I + L+ P   
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR------MTIQDSLQHPWIK 276
Query: 205 AKLSQSEPHRQTGPVTVRK 223
            K +Q    R+   V + K
Sbjct: 277 PKDTQQALSRKASAVNMEK 295

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 26/113 (23%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAK---AGP 74
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 125 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSFGVVLLELLS 120
           +  RT+++    GT G+ APE +          RLT   D++S G V   +LS
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD        KL DFG+A     G+       + GT
Sbjct: 120 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 174
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 143
             + APE V    L  ++D++S GV+   LLSG          +T   I     D+ + Y
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 173
            S+  +L +    +L  + P++    A +L
Sbjct: 235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 14/150 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD        KL DFG+A     G+       + GT
Sbjct: 141 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 195
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-----DKTKVGIEQSLVDWAKPY 143
             + APE V    L  ++D++S GV+   LLSG          +T   I     D+ + Y
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 255
Query: 144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 173
            S+  +L +    +L  + P++    A +L
Sbjct: 256 FSNTSELAKDFIRRLLVKDPKRRMXIAQSL 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 247
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 248 -IIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 247
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 248 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH  E+ +I+RD K  N+LL ++      K++DFG +K    G+ + + T + GT 
Sbjct: 265 AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTP 319
Query: 90  GYAAPEY---VATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 215
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 216 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 248
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 249 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +   R   +S  V+S G++L +++ G                    P+  D+        
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEE------- 247
Query: 156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEV 191
             +GGQ  + Q+ +     L   CL   P  RP   E+
Sbjct: 248 -IIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 125 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 179
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 125 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 179
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 37  LHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LH  +  V++RD K  N+LL ++      KL+DFGLA     GD+        GT GY +
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLS 174
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +         D+++ GV+L  LL G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 86
           + + +LH  E+ +++RD K  N+L      DA    K++DFGL+K     +   +   V 
Sbjct: 159 EAVAYLH--ENGIVHRDLKPENLLYATPAPDAPL--KIADFGLSK---IVEHQVLMKTVC 211
Query: 87  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           GT GY APE +       + D++S G++   LL G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LTF +     +IYRD K  N+L+D +   +++DFG AK      RT     + GT    A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT---WXLCGTPEALA 206
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE + +       D ++ GV++ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI LLD      + KL DFGLA     G        + GT
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 33  GLTFLHDAESQVIYRDFKASNI-LLDAEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI LLD        K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 1   MPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           M  GS+ +H+  RR    L  +V   V    A  L FLH+    + +RD K  NIL +  
Sbjct: 93  MRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHN--KGIAHRDLKPENILCEHP 147
Query: 60  FNA---KLSDFGLAKAGP-TGDRTHVSTQVM----GTHGYAAPEYVAT-----GRLTTKS 106
                 K+ DF L       GD + +ST  +    G+  Y APE V            + 
Sbjct: 148 NQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207
Query: 107 DVYSFGVVLLELLS------GRCAVD 126
           D++S GV+L  LLS      GRC  D
Sbjct: 208 DLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 22/109 (20%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAKAGPTGD 77
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 143 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 78  ---RTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLS 120
              R +++    GT G+ APE +      RLT   D++S G V   +LS
Sbjct: 201 XXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 52/109 (47%), Gaps = 22/109 (20%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAKAGPTGD 77
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 143 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200
Query: 78  ---RTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLS 120
              R +++    GT G+ APE +      RLT   D++S G V   +LS
Sbjct: 201 XXFRXNLNNPS-GTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 24  MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 76
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 77  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 128
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 202 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 257
Query: 129 KVGIEQSLVDWAKPY 143
             GI +   D+  PY
Sbjct: 258 --GIHE---DYQLPY 267

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 24  MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 76
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 103 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162
Query: 77  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 128
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 163 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 218
Query: 129 KVGIEQSLVDWAKPY 143
             GI +   D+  PY
Sbjct: 219 --GIHE---DYQLPY 228

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 24  MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 76
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 104 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 163
Query: 77  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 128
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 164 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 219
Query: 129 KVGIEQSLVDWAKPY 143
             GI +   D+  PY
Sbjct: 220 --GIHE---DYQLPY 229

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 8/121 (6%)
Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 62
           G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++  NA
Sbjct: 144 GELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNA 201
Query: 63  --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFG AK   T     ++T    T  Y APE +   +     D +S GV+   LL 
Sbjct: 202 ILKLTDFGFAKE--TTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLC 258
Query: 121 G 121
           G
Sbjct: 259 G 259

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 24  MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 76
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 109 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 168
Query: 77  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 128
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 169 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 224
Query: 129 KVGIEQSLVDWAKPY 143
             GI +   D+  PY
Sbjct: 225 --GIHE---DYQLPY 234

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 24  MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 76
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 129 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 188
Query: 77  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 128
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 189 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 244
Query: 129 KVGIEQSLVDWAKPY 143
             GI +   D+  PY
Sbjct: 245 --GIHE---DYQLPY 254

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 26/143 (18%)
Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-------ESQVIYRDFKASNI 54
           P GSL  +L         W    ++A    +GL +LH         +  + +RD  + N+
Sbjct: 95  PNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151
Query: 55  LLDAEFNAKLSDFGLA------KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-- 106
           L+  +    +SDFGL+      +    G+  + +   +GT  Y APE V  G +  +   
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXE 210
Query: 107 ------DVYSFGVVLLELLSGRC 123
                 D+Y+ G++  E+   RC
Sbjct: 211 SALKQVDMYALGLIYWEIFM-RC 232

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 24/135 (17%)
Query: 24  MKVAIGAAKGLTFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTG 76
           +K+A+  A GL  LH        +  + +RD K+ NIL+       ++D GLA +     
Sbjct: 106 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 165
Query: 77  DRTHVS-TQVMGTHGYAAPEYVATGRLTTK-------SDVYSFGVVLLELLSGRCAVDKT 128
           D   ++    +GT  Y APE V    +  K       +D+Y+ G+V  E ++ RC++   
Sbjct: 166 DTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG-- 221
Query: 129 KVGIEQSLVDWAKPY 143
             GI +   D+  PY
Sbjct: 222 --GIHE---DYQLPY 231

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + L + HD  + +I+RD K   +LL ++ N+   KL  FG+A     G+   V+   +GT
Sbjct: 143 EALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 198
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V         DV+  GV+L  LLSG
Sbjct: 199 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 28/114 (24%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-------------GPTGDRT 79
           G+ ++H A   +++RD K +N L++ + + K+ DFGLA+               P  D  
Sbjct: 168 GVKYVHSA--GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 80  HVST---------QVMG---THGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 120
           ++ T         Q+ G   T  Y APE +      T++ DV+S G +  ELL+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + L + HD  + +I+RD K   +LL ++ N+   KL  FG+A     G+   V+   +GT
Sbjct: 141 EALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 196
Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V         DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           A  L + H    +VI+RD K  N+LL  +   K++DFG +   P+  R      + GT  
Sbjct: 133 ADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGTLD 186
Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           Y  PE +       K D++  GV+  ELL G
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 232
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 219
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 199
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 37  LHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           LH  +  V++RD K  N+LL ++      KL+DFGLA       +        GT GY +
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLS 192
Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLSG 121
           PE +         D+++ GV+L  LL G
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 200
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 200
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 199
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 200
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 207
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 184
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 183
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 184
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 22/133 (16%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK-----AGPTGDRTHVST 83
           G+ +LH   + V++RD K +NIL+  E       K++D G A+       P  D      
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----D 193
Query: 84  QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 142
            V+ T  Y APE +   R  TK+ D+++ G +  ELL+        +  I+ S      P
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS-----NP 248
Query: 143 YLSDK-RKLFRIM 154
           Y  D+  ++F +M
Sbjct: 249 YHHDQLDRIFNVM 261

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           G+++ H    QV +RD K  N LLD       K++DFG +KA     +       +GT  
Sbjct: 127 GVSYAH--AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPA 181
Query: 91  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 121
           Y APE +       K +DV+S GV L  +L G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 20/198 (10%)
Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P GSL N L       +  +  +K A+  A+G  FLH  E  +      + ++ +D +  
Sbjct: 92  PYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXT 151
Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           A++S   +  +  +  R +    V        PE   T R +  +D +SF V+L EL++ 
Sbjct: 152 ARISXADVKFSFQSPGRXYAPAWVAPEALQKKPE--DTNRRS--ADXWSFAVLLWELVTR 207
Query: 122 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNE 181
                      E    D +   +  K  L  +  T   G  P       + L   C N +
Sbjct: 208 -----------EVPFADLSNXEIGXKVALEGLRPTIPPGISPH-----VSKLXKICXNED 251
Query: 182 PKLRPRMSEVLAILERLE 199
           P  RP+   ++ ILE+ +
Sbjct: 252 PAKRPKFDXIVPILEKXQ 269

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 15/89 (16%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG----LAKAGPTGDRTHVSTQVMGT 88
             +++H+ E  + +RD K SNIL+D     KLSDFG    +      G R        GT
Sbjct: 163 SFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--------GT 213
Query: 89  HGYAAPEYVATGRLTT--KSDVYSFGVVL 115
           + +  PE+ +        K D++S G+ L
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGY 91
           GL  LH  E+ V++RD    NILL    +  + DF LA+      ++TH  T       Y
Sbjct: 146 GLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWY 199
Query: 92  AAPEYVATGRLTTK-SDVYSFGVVLLELLS 120
            APE V   +  TK  D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT-GDRTHVSTQVMGTHGY 91
           GL  LH  E+ V++RD    NILL    +  + DF LA+      ++TH  T       Y
Sbjct: 146 GLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWY 199
Query: 92  AAPEYVATGRLTTK-SDVYSFGVVLLELLS 120
            APE V   +  TK  D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMG 87
           A +GL  +H  E  +++ D K  NI+ + +   + K+ DFGLA      +   V+T    
Sbjct: 158 ACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---A 212
Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T  +AAPE V    +   +D+++ GV+   LLSG
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 44  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 205
Query: 101 RLTTKSDVYSFGVVLLELLSG 121
             +   D+++ GV+L  LL G
Sbjct: 206 PYSKPVDIWACGVILYILLVG 226

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           G+++ H    Q+ +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 128 GVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 182
Query: 91  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 121
           Y APE +       K +DV+S GV L  +L G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 26/113 (23%)
Query: 31  AKGLTFLHDAESQVIYRDFKASNILLD--AEFNAK-----------LSDFGLAKAGPTGD 77
           A G+  LH    ++I+RD K  NIL+   + F A            +SDFGL K   +G 
Sbjct: 125 ASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 78  ---RTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSFGVVLLELLS 120
              R +++    GT G+ APE +          RLT   D++S G V   +LS
Sbjct: 183 XXFRXNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 44  VIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 101 RLTTKSDVYSFGVVLLELLSG 121
             +   D+++ GV+L  LL G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 96
           H     V++RD K  NIL+D      KL DFG   +G     T V T   GT  Y+ PE+
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 97  VATGRLTTKS-DVYSFGVVLLELLSG 121
           +   R   +S  V+S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           G+++ H    QV +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 127 GVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 181
Query: 91  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 121
           Y APE +       K +DV+S GV L  +L G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 44  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 101 RLTTKSDVYSFGVVLLELLSG 121
             +   D+++ GV+L  LL G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 44  VIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 100
           +++R+ K  N+LL ++      KL+DFGLA      +  H      GT GY +PE +   
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 181
Query: 101 RLTTKSDVYSFGVVLLELLSG 121
             +   D+++ GV+L  LL G
Sbjct: 182 PYSKPVDIWACGVILYILLVG 202

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 38/85 (44%), Gaps = 4/85 (4%)
Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L   H     +++ D K +NI L      KL DFGL     T     V     G   Y A
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMA 224
Query: 94  PEYVATGRLTTKSDVYSFGVVLLEL 118
           PE +  G   T +DV+S G+ +LE+
Sbjct: 225 PELL-QGSYGTAADVFSLGLTILEV 248

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 27/217 (12%)
Query: 26  VAIGAAKGLTFLHDAESQVIYRDFKASNIL-LDAEFN---AKLSDFGLAKAGPTGDRTHV 81
           V     K + +LH     V++RD K SNIL +D   N    ++ DFG AK     +   +
Sbjct: 121 VLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 82  STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           +     T  + APE +         D++S GV+L  +L+G                    
Sbjct: 179 TP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN-------------G 223
Query: 142 PYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL---AILE 196
           P  + +  L RI   K  L G Y    + TA  L  + L+ +P  R   + VL    I+ 
Sbjct: 224 PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283
Query: 197 RLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPL 233
             + P+      Q  PH   G +    S + + +SP+
Sbjct: 284 WDQLPQYQLN-RQDAPHLVKGAMAATYSALNRNQSPV 319

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 33  GLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           G+++ H    QV +RD K  N LLD       K+ DFG +K+     +       +GT  
Sbjct: 126 GVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 180
Query: 91  YAAPEYVATGRLTTK-SDVYSFGVVLLELLSG 121
           Y APE +       K +DV+S GV L  +L G
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 38  HDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 94
           H  +  +++RD K  N+LL ++      KL+DFGLA       +        GT GY +P
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPGYLSP 202
Query: 95  EYVATGRLTTKSDVYSFGVVLLELLSG 121
           E +         D+++ GV+L  LL G
Sbjct: 203 EVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 87
             KGL  +H  E+  ++ D K  NI+   + +   KL DFGL           V+T   G
Sbjct: 264 VCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---G 318
Query: 88  THGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 121
           T  +AAPE VA G+ +   +D++S GV+   LLSG
Sbjct: 319 TAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 30  AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 87
             KGL  +H  E+  ++ D K  NI+   + +   KL DFGL           V+T   G
Sbjct: 158 VCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---G 212
Query: 88  THGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 121
           T  +AAPE VA G+ +   +D++S GV+   LLSG
Sbjct: 213 TAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSG 246

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	252
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-124
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-116
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-102
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-52
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-37
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-23
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-22
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-19
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-18
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-18
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-17
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-16
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-14
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-14
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-12
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-11
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-11
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-11
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-10
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-10
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-10
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-10
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-10
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-10
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-09
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-09
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  354 bits (911), Expect = e-124
 Identities = 80/201 (39%), Positives = 123/201 (61%), Gaps = 7/201 (3%)

Query: 1   MPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           MP GSL + L    G  PLSW +R K+A GAA G+ FLH  E+  I+RD K++NILLD  
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEA 169

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           F AK+SDFGLA+A     +T ++++++GT  Y APE +  G +T KSD+YSFGVVLLE++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +G  AVD+ +    Q L+D  +    +++ +   +D K+       +     ++A QCL+
Sbjct: 229 TGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLH 285

Query: 180 NEPKLRPRMSEVLAILERLEA 200
            +   RP + +V  +L+ + A
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  334 bits (858), Expect = e-116
 Identities = 82/207 (39%), Positives = 118/207 (57%), Gaps = 5/207 (2%)

Query: 1   MPKGSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
           M  G+L+ HL+        +SW  R+++ IGAA+GL +LH     +I+RD K+ NILLD 
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDE 174

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
            F  K++DFG++K G   D+TH+ST V GT GY  PEY   GRLT KSDVYSFGVVL E+
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           L  R A+ ++      +L +WA     +  +L +I+D  L  +   ++       A++CL
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293

Query: 179 NNEPKLRPRMSEVLAILERLEAPKNSA 205
               + RP M +VL  LE     + S 
Sbjct: 294 ALSSEDRPSMGDVLWKLEYALRLQESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  299 bits (767), Expect = e-102
 Identities = 88/220 (40%), Positives = 132/220 (60%), Gaps = 7/220 (3%)

Query: 1   MPKGSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLD 57
           M  GS+ + L  R     PL W  R ++A+G+A+GL +LH   + ++I+RD KA+NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168

Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            EF A + DFGLAK     D THV+T V GT G+ APEY++TG+ + K+DV+ +GV+LLE
Sbjct: 169 EEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227

Query: 118 LLSGRCAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           L++G+ A D  ++  +    L+DW K  L +K+ L  ++D  L G Y  +       +AL
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVAL 286

Query: 176 QCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 215
            C  + P  RP+MSEV+ +LE     +   +  + E  RQ
Sbjct: 287 LCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 326

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  172 bits (438), Expect = 1e-52
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 21/217 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ--------VIYRDFKAS 52
             KGSL + L       +SW     +A   A+GL +LH+            + +RD K+ 
Sbjct: 104 HEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160

Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSD 107
           N+LL     A ++DFGLA     G     +   +GT  Y APE +            + D
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220

Query: 108 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVD--WAKPYLSDKRKL--FRIMDTKLGGQYP 163
           +Y+ G+VL EL S   A D           +     P L D +++   +     L   + 
Sbjct: 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ 280

Query: 164 QKAAHTA-ATLALQCLNNEPKLRPRMSEVLAILERLE 199
           + A          +C +++ + R     V   + +++
Sbjct: 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  143 bits (362), Expect = 1e-41
 Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 29/224 (12%)

Query: 1   MPKGSLENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDA 58
              GSL N L    P P  + A  M   +  ++G+ +LH  + + +I+RD K  N+LL A
Sbjct: 81  AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA 140

Query: 59  EFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
                K+ DFG A      D     T   G+  + APE       + K DV+S+G++L E
Sbjct: 141 GGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 195

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ--KAAHTA-ATLA 174
           +++ R                  KP+       FRIM     G  P   K       +L 
Sbjct: 196 VITRR------------------KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237

Query: 175 LQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGP 218
            +C + +P  RP M E++ I+  L      A      P + + P
Sbjct: 238 TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  140 bits (354), Expect = 9e-41
 Identities = 44/204 (21%), Positives = 82/204 (40%), Gaps = 30/204 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP GSL N L       +  +  +K A+  A+G+ FLH  E  +      + ++++D + 
Sbjct: 91  MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLE 117
            A++S   +         +  S   M    + APE             +D++SF V+L E
Sbjct: 151 TARISMADVK-------FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           L++                     P+  LS+     ++    L    P   +   + L  
Sbjct: 204 LVTRE------------------VPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245

Query: 176 QCLNNEPKLRPRMSEVLAILERLE 199
            C+N +P  RP+   ++ ILE+++
Sbjct: 246 ICMNEDPAKRPKFDMIVPILEKMQ 269

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  140 bits (354), Expect = 3e-40
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 29/217 (13%)

Query: 1   MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           + +GSL   L + G  + L    R+ +A   AKG+ +LH+    +++R+ K+ N+L+D +
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
           +  K+ DFGL++   +   +  S    GT  + APE +       KSDVYSFGV+L EL 
Sbjct: 176 YTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           + +                  +P+  L+  + +  +       + P+      A +   C
Sbjct: 234 TLQ------------------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGC 275

Query: 178 LNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
             NEP  RP  + ++ +L  L       K +   P+R
Sbjct: 276 WTNEPWKRPSFATIMDLLRPL------IKSAVPPPNR 306

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  136 bits (345), Expect = 4e-39
 Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 29/206 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--- 57
           +P G L + L      P+ W+V++++ +  A G+ ++ +    +++RD ++ NI L    
Sbjct: 103 VPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161

Query: 58  --AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFG 112
             A   AK++DFGL++        H  + ++G   + APE          T K+D YSF 
Sbjct: 162 ENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFA 215

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           ++L  +L+G    D          + +      +  +             P+        
Sbjct: 216 MILYTILTGEGPFD----EYSYGKIKFINMIREEGLRP----------TIPEDCPPRLRN 261

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           +   C + +PK RP  S ++  L  L
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  134 bits (340), Expect = 2e-38
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 30/207 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
               SL +HL     +       + +A   A+G+ +LH     +I+RD K++NI L  + 
Sbjct: 101 CEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDN 157

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLE 117
             K+ DFGLA        +H   Q+ G+  + APE      +   + +SDVY+FG+VL E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL----GGQYPQKAAHTAA 171
           L++G+                   PY  ++++ ++  ++          +          
Sbjct: 218 LMTGQL------------------PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259

Query: 172 TLALQCLNNEPKLRPRMSEVLAILERL 198
            L  +CL  +   RP    +LA +E L
Sbjct: 260 RLMAECLKKKRDERPSFPRILAEIEEL 286

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  134 bits (340), Expect = 3e-38
 Identities = 44/231 (19%), Positives = 80/231 (34%), Gaps = 30/231 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G+L   + +       W+ R+  A   A G+ +LH     +I+RD  + N L+    
Sbjct: 89  IKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENK 145

Query: 61  NAKLSDFGLAK------------AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 108
           N  ++DFGLA+                         V+G   + APE +       K DV
Sbjct: 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV 205

Query: 109 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 168
           +SFG+VL E++    A            +D+         +             P     
Sbjct: 206 FSFGIVLCEIIGRVNADP----DYLPRTMDFGLNVRGFLDRYC-----------PPNCPP 250

Query: 169 TAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPV 219
           +   + ++C + +P+ RP   ++   LE L            +  +     
Sbjct: 251 SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGF 301

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  133 bits (336), Expect = 2e-37
 Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 33/242 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-------VIYRDFKASN 53
            P GSL  +L         W    ++A    +GL +LH    +       + +RD  + N
Sbjct: 94  YPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150

Query: 54  ILLDAEFNAKLSDFGLAK------AGPTGDRTHVSTQVMGTHGYAAPEY-------VATG 100
           +L+  +    +SDFGL+           G+  + +   +GT  Y APE            
Sbjct: 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210

Query: 101 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK-----PYLSDKRKLFRIMD 155
               + D+Y+ G++  E+   RC        + +  + +       P   D + L     
Sbjct: 211 SALKQVDMYALGLIYWEIFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK 269

Query: 156 TKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 211
            +       +    A  +       C + + + R         +  L       K     
Sbjct: 270 QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329

Query: 212 PH 213
            H
Sbjct: 330 AH 331

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  125 bits (316), Expect = 4e-35
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 36/209 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAE 59
              G L   L  +    +   + +  A+  A+G+ +LHD A   +I+RD K+SNIL+  +
Sbjct: 88  ARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144

Query: 60  F--------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 111
                      K++DFGLA+      RT   +   G + + APE +     +  SDV+S+
Sbjct: 145 VENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSY 200

Query: 112 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHT 169
           GV+L ELL+G                    P+  +      + +   KL    P      
Sbjct: 201 GVLLWELLTGEV------------------PFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL 198
            A L   C N +P  RP  + +L  L  +
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  126 bits (318), Expect = 5e-35
 Identities = 44/225 (19%), Positives = 81/225 (36%), Gaps = 42/225 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
               +L + + R     L      ++A    KG+ +LH     ++++D K+ N+  D   
Sbjct: 111 CKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NG 166

Query: 61  NAKLSDFGLAK---AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---------TTKSDV 108
              ++DFGL         G R        G   + APE +              +  SDV
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226

Query: 109 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 168
           ++ G +  EL +                     P+    +    I+     G  P  +  
Sbjct: 227 FALGTIWYELHAREW------------------PF--KTQPAEAIIWQMGTGMKPNLSQI 266

Query: 169 TA----ATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ 209
                 + + L C   E + RP  ++++ +LE+L  PK + +LS 
Sbjct: 267 GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL--PKRNRRLSH 309

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  124 bits (312), Expect = 3e-34
 Identities = 47/223 (21%), Positives = 79/223 (35%), Gaps = 33/223 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNI 54
              GSL ++L       L     +++ +  A GL  LH           + +RD K+ NI
Sbjct: 88  HEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144

Query: 55  LLDAEFNAKLSDFGLA--KAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKS 106
           L+       ++D GLA   +  T      +   +GT  Y APE       V       + 
Sbjct: 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204

Query: 107 DVYSFGVVLLELLSGRCAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDT 156
           D+++FG+VL E+   R   +             V  + S  D  K    D+++   I + 
Sbjct: 205 DIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNR 262

Query: 157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 199
                     A     L  +C    P  R     +   L +++
Sbjct: 263 WFSDPTLTSLAK----LMKECWYQNPSARLTALRIKKTLTKID 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  123 bits (311), Expect = 9e-34
 Identities = 48/228 (21%), Positives = 79/228 (34%), Gaps = 35/228 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNI 54
              GSL ++L       L     +K+A  +  GL  LH           + +RD K+ NI
Sbjct: 117 HENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173

Query: 55  LLDAEFNAKLSDFGLA--KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-------TTK 105
           L+       ++D GLA      T +        +GT  Y  PE V    L          
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIM 232

Query: 106 SDVYSFGVVLLELLSGRCAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMD 155
           +D+YSFG++L E+   RC                V  + S  D  +     K +     +
Sbjct: 233 ADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRP-SFPN 290

Query: 156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 203
                +  ++       L  +C  + P  R     V   L ++   ++
Sbjct: 291 RWSSDECLRQMGK----LMTECWAHNPASRLTALRVKKTLAKMSESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  119 bits (299), Expect = 5e-32
 Identities = 46/222 (20%), Positives = 79/222 (35%), Gaps = 23/222 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNI 54
              GSL ++L R     ++    +K+A+  A GL  LH           + +RD K+ NI
Sbjct: 122 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 55  LLDAEFNAKLSDFGLA--KAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKS 106
           L+       ++D GLA      T          +GT  Y APE       +       ++
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

Query: 107 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-----GGQ 161
           D+Y+ G+V  E+   RC++       +    D      S +     + + KL        
Sbjct: 239 DIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297

Query: 162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 203
              +A    A +  +C       R     +   L +L   + 
Sbjct: 298 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (264), Expect = 1e-26
 Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 40/213 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G     L R     L     +++   AA G+ +L       I+RD  A N L+  + 
Sbjct: 194 VQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKN 250

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFG+++    G          G          APE +  GR +++SDV+SFG++L
Sbjct: 251 VLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTA 170
            E  S G                    PY  LS+++    +     GG    P+      
Sbjct: 306 WETFSLGAS------------------PYPNLSNQQTREFVEK---GGRLPCPELCPDAV 344

Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERL-EAPK 202
             L  QC   EP  RP  S +   L+ + +  +
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  101 bits (254), Expect = 6e-26
 Identities = 47/192 (24%), Positives = 81/192 (42%), Gaps = 29/192 (15%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            KG+LE  + +R  + L   + +++     KG+ ++H    ++I RD K SNI L     
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQ 160

Query: 62  AKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
            K+ DFGL  +    G RT       GT  Y +PE +++     + D+Y+ G++L ELL 
Sbjct: 161 VKIGDFGLVTSLKNDGKRT---RSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
                                      +    + D  +   + +K       L  + L+ 
Sbjct: 217 V------------------CDTAFETSKFFTDLRDGIISDIFDKKEKT----LLQKLLSK 254

Query: 181 EPKLRPRMSEVL 192
           +P+ RP  SE+L
Sbjct: 255 KPEDRPNTSEIL 266

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  100 bits (251), Expect = 4e-25
 Identities = 51/264 (19%), Positives = 92/264 (34%), Gaps = 40/264 (15%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
             L + L ++              +   + +  +H     +++ D K +N L+  +   K
Sbjct: 93  IDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLK 147

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFG 112
           L DFG+A        + V    +GT  Y  PE             +  +++ KSDV+S G
Sbjct: 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 207

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHT 169
            +L  +  G+                   P+   ++   KL  I+D     ++P      
Sbjct: 208 CILYYMTYGKT------------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKD 249

Query: 170 AATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPM 226
              +   CL  +PK R  + E+LA   +  +       AK +  E     G +    SP 
Sbjct: 250 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 309

Query: 227 RQQRSPLNMTPTASPLPSHRQSPR 250
              ++   +    S   SH  S  
Sbjct: 310 SILKAAKTLYEHYSGGESHNSSSS 333

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 98.9 bits (247), Expect = 8e-25
 Identities = 43/190 (22%), Positives = 64/190 (33%), Gaps = 26/190 (13%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
            SL+ H    G   L  A            L  LH     +++ D K +NI L      K
Sbjct: 141 PSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCK 197

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 123
           L DFGL     T        Q  G   Y APE +  G   T +DV+S G+ +LE+     
Sbjct: 198 LGDFGLLVELGTAGAGE--VQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACN-- 251

Query: 124 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 183
                                       ++    L  ++    +    ++ +  L  +PK
Sbjct: 252 -----------------MELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294

Query: 184 LRPRMSEVLA 193
           LR     +LA
Sbjct: 295 LRATAEALLA 304

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.5 bits (246), Expect = 1e-24
 Identities = 39/118 (33%), Positives = 53/118 (44%), Gaps = 5/118 (4%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 64
            L   L R+GP     AV   +       L   H A     +RD K  NIL+ A+  A L
Sbjct: 120 DLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYL 175

Query: 65  SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            DFG+A A      T +    +GT  Y APE  +    T ++D+Y+   VL E L+G 
Sbjct: 176 VDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 99.0 bits (247), Expect = 2e-24
 Identities = 45/258 (17%), Positives = 93/258 (36%), Gaps = 36/258 (13%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G L   +  +          +   +     L  +HD   ++++RD K+ NI L  +   +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQ 165

Query: 64  LSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           L DFG+A+    T +       + GT  Y +PE         KSD+++ G VL EL + +
Sbjct: 166 LGDFGIARVLNSTVELAR--ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

Query: 123 CAVDKTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLGGQY---PQKAAHTAATLALQC 177
                               + +   K  + +I+     G +       ++   +L  Q 
Sbjct: 223 ------------------HAFEAGSMKNLVLKIIS----GSFPPVSLHYSYDLRSLVSQL 260

Query: 178 LNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 234
               P+ RP ++ +L    I +R+E   +   +++    +       +  P ++  S  N
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQN 320

Query: 235 MTPTASPLPSHRQSPRVR 252
                      + + +  
Sbjct: 321 SISVMPAQKITKPAAKYG 338

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.1 bits (240), Expect = 9e-24
 Identities = 37/118 (31%), Positives = 58/118 (49%), Gaps = 5/118 (4%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 64
           +L  ++   GP  +  A+          G+   HD   ++++RD K  NIL+D+    K+
Sbjct: 97  TLSEYIESHGPLSVDTAIN--FTNQILDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKI 152

Query: 65  SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            DFG+AKA      T  +  V+GT  Y +PE          +D+YS G+VL E+L G 
Sbjct: 153 FDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 95.8 bits (239), Expect = 1e-23
 Identities = 48/216 (22%), Positives = 86/216 (39%), Gaps = 29/216 (13%)

Query: 4   GSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           G L   +  F++  + +      K  +     L  +H    +V++RD K +N+ + A   
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGV 174

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            KL D GL +   +   T   + V GT  Y +PE +       KSD++S G +L E+ + 
Sbjct: 175 VKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

Query: 122 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQC 177
           +                   P+  DK  L+ +        YP       +     L   C
Sbjct: 233 Q------------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274

Query: 178 LNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 213
           +N +P+ RP ++ V  + +R+ A   ++ L     H
Sbjct: 275 INPDPEKRPDVTYVYDVAKRMHACT-ASSLEHHHHH 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 95.5 bits (238), Expect = 2e-23
 Identities = 40/203 (19%), Positives = 74/203 (36%), Gaps = 37/203 (18%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
             L + L ++              +   + +  +H     +++ D K +N L+  +   K
Sbjct: 112 IDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLK 166

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFG 112
           L DFG+A        + V    +GT  Y  PE             +  +++ KSDV+S G
Sbjct: 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHT 169
            +L  +  G+                   P+   ++   KL  I+D     ++P      
Sbjct: 227 CILYYMTYGKT------------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268

Query: 170 AATLALQCLNNEPKLRPRMSEVL 192
              +   CL  +PK R  + E+L
Sbjct: 269 LQDVLKCCLKRDPKQRISIPELL 291

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 97.1 bits (242), Expect = 3e-23
 Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 36/225 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+R+  A N L+    
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENH 355

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++   TGD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 356 LVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

Query: 121 -GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAAT 172
            G                    PY  +   +    +     M+       P+        
Sbjct: 415 YGM------------------SPYPGIDLSQVYELLEKDYRMER------PEGCPEKVYE 450

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAKLSQSEPHRQT 216
           L   C    P  RP  +E+    E + +    S ++ +    R T
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 495

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 95.7 bits (238), Expect = 5e-23
 Identities = 50/264 (18%), Positives = 92/264 (34%), Gaps = 40/264 (15%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
             L + L ++              +   + +  +H  +  +++ D K +N L+  +   K
Sbjct: 140 IDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH--QHGIVHSDLKPANFLIV-DGMLK 194

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFG 112
           L DFG+A        + V    +G   Y  PE             +  +++ KSDV+S G
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHT 169
            +L  +  G+                   P+   ++   KL  I+D     ++P      
Sbjct: 255 CILYYMTYGK------------------TPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 296

Query: 170 AATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPM 226
              +   CL  +PK R  + E+LA   +  +       AK +  E     G +    SP 
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 356

Query: 227 RQQRSPLNMTPTASPLPSHRQSPR 250
              ++   +    S   SH  S  
Sbjct: 357 SILKAAKTLYEHYSGGESHNSSSS 380

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.0 bits (239), Expect = 5e-23
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L     + L     + +A   A G+ ++       ++RD +A+NIL+    
Sbjct: 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENL 317

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGLA+     + T           + APE    GR T KSDV+SFG++L EL +
Sbjct: 318 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

Query: 121 -GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAAT 172
            GR                   PY  + ++  L ++     M        P +   +   
Sbjct: 377 KGR------------------VPYPGMVNREVLDQVERGYRMPC------PPECPESLHD 412

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           L  QC   EP+ RP    + A LE  
Sbjct: 413 LMCQCWRKEPEERPTFEYLQAFLEDY 438

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 94.2 bits (235), Expect = 5e-23
 Identities = 40/119 (33%), Positives = 60/119 (50%), Gaps = 5/119 (4%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 64
           +L + +   GP     A+   V   A + L F H     +I+RD K +NI++ A    K+
Sbjct: 102 TLRDIVHTEGPMTPKRAIE--VIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKV 157

Query: 65  SDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            DFG+A+A      +   T  V+GT  Y +PE      +  +SDVYS G VL E+L+G 
Sbjct: 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 95.9 bits (239), Expect = 5e-23
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 45/209 (21%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDN 326

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            AK+SDFGL K          S+          + APE +   + +TKSDV+SFG++L E
Sbjct: 327 VAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 378

Query: 118 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHT 169
           + S GR                   PY  +  K  + R+     MD       P      
Sbjct: 379 IYSFGRV------------------PYPRIPLKDVVPRVEKGYKMDA------PDGCPPA 414

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL 198
              +   C + +   RP   ++   LE +
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 94.6 bits (235), Expect = 6e-23
 Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 38/205 (18%)

Query: 2   PKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
            K +L++ + RR   +     V + + I  A+ + FLH     +++RD K SNI    + 
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDD 201

Query: 61  NAKLSDFGLAKA----------GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 110
             K+ DFGL  A                    T  +GT  Y +PE +     + K D++S
Sbjct: 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261

Query: 111 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH-- 168
            G++L ELL            +E+  +      ++D R            ++P       
Sbjct: 262 LGLILFELLYSFST------QMERVRI------ITDVRN----------LKFPLLFTQKY 299

Query: 169 -TAATLALQCLNNEPKLRPRMSEVL 192
                +    L+  P  RP  ++++
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDII 324

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 92.8 bits (231), Expect = 1e-22
 Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 29/196 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L+ +L R     +   V         KGL FLH     +I+RD K  NI +    
Sbjct: 111 MTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168

Query: 61  -NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            + K+ D GLA       R   +  V+GT  + APE           DVY+FG+ +LE+ 
Sbjct: 169 GSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMA 223

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAAT-LALQ 176
           +                     PY    +  +++R + + +      K A      +   
Sbjct: 224 TSEY------------------PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265

Query: 177 CLNNEPKLRPRMSEVL 192
           C+      R  + ++L
Sbjct: 266 CIRQNKDERYSIKDLL 281

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 93.6 bits (233), Expect = 3e-22
 Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 41/209 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L             +  +   A+G+ F+   +   I+RD +A+NIL+ A  
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASL 321

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K++DFGLA+     D  + + +  G      + APE +  G  T KSDV+SFG++L+E
Sbjct: 322 VCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 377

Query: 118 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHT 169
           +++ GR                   PY  +S+   +  +     M        P+     
Sbjct: 378 IVTYGRI------------------PYPGMSNPEVIRALERGYRMPR------PENCPEE 413

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL 198
              + ++C  N P+ RP    + ++L+  
Sbjct: 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 91.6 bits (228), Expect = 4e-22
 Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 40/225 (17%)

Query: 2   PKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
            K +L++ +  R   +    +V + + +  A+ + FLH     +++RD K SNI    + 
Sbjct: 98  RKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDD 155

Query: 61  NAKLSDFGLAKA----------GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 110
             K+ DFGL  A                    T  +GT  Y +PE +     + K D++S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215

Query: 111 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH-- 168
            G++L ELL            +E+               L  + +     ++P       
Sbjct: 216 LGLILFELLYPFST------QMERVRT------------LTDVRN----LKFPPLFTQKY 253

Query: 169 -TAATLALQCLNNEPKLRPRMSEVLA--ILERLEAPKNSAKLSQS 210
                +    L+  P  RP    ++   + E L+ P  +    +S
Sbjct: 254 PCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRS 298

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 93.4 bits (232), Expect = 5e-22
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L     + L     + +A   A G+ ++       ++RD +A+NIL+    
Sbjct: 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILVGENL 400

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGLA+     + T           + APE    GR T KSDV+SFG++L EL +
Sbjct: 401 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

Query: 121 -GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----MDTKLGGQYPQKAAHTAAT 172
            GR                   PY  + ++  L ++     M        P +   +   
Sbjct: 460 KGR------------------VPYPGMVNREVLDQVERGYRMPC------PPECPESLHD 495

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           L  QC   EP+ RP    + A LE  
Sbjct: 496 LMCQCWRKEPEERPTFEYLQAFLEDY 521

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 90.8 bits (226), Expect = 7e-22
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 44/229 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENH 148

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGV 113
             K++DFGL++         ++      H  A       APE +A  + + KSDV++FGV
Sbjct: 149 LVKVADFGLSRL--------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200

Query: 114 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAH 168
           +L E+ + G                    PY  +   +    +         + P+    
Sbjct: 201 LLWEIATYGMS------------------PYPGIDLSQVYELLEK---DYRMERPEGCPE 239

Query: 169 TAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAKLSQSEPHRQT 216
               L   C    P  RP  +E+    E + +    S ++ +    R T
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 288

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.8 bits (226), Expect = 9e-22
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 18/205 (8%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL+ +L  +    ++   ++K A+   KG+ +L     Q ++RD  A N+L+++E 
Sbjct: 107 LPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLVESEH 163

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+ DFGL KA  T    +               + APE +   +    SDV+SFGV L
Sbjct: 164 QVKIGDFGLTKAIETDKEYYTVKD----DRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TL 173
            ELL+  C  D + + +   ++      ++  R +  + +   G + P           L
Sbjct: 220 HELLT-YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE---GKRLPCPPNCPDEVYQL 275

Query: 174 ALQCLNNEPKLRPRMSEVLAILERL 198
             +C   +P  R     ++   E L
Sbjct: 276 MRKCWEFQPSNRTSFQNLIEGFEAL 300

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 89.7 bits (223), Expect = 2e-21
 Identities = 35/178 (19%), Positives = 67/178 (37%), Gaps = 39/178 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-------------AGPTGDR 78
           + L+++H     +I+RD K  NI +D   N K+ DFGLAK                 G  
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 79  THVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 137
            ++++ + GT  Y A E +  TG    K D+YS G++  E++                  
Sbjct: 185 DNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF--------------- 228

Query: 138 DWAKPYLSDKRKLFRIM---DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
                   ++  + + +     +    +          +    ++++P  RP    +L
Sbjct: 229 ----STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.0 bits (224), Expect = 2e-21
 Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 37/207 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G L +++ R     +     +   +  AKG+ +L   + ++++RD  A N+L+    
Sbjct: 98  MPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQ 154

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
           + K++DFGLAK     ++ +         G     + A E +     T +SDV+S+GV +
Sbjct: 155 HVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAA 171
            EL++ G                   KPY  D      I      G+    P        
Sbjct: 210 WELMTFGS------------------KPY--DGIPASEISSILEKGERLPQPPICTIDVY 249

Query: 172 TLALQCLNNEPKLRPRMSEVLAILERL 198
            +  +C   +   RP+  E++    ++
Sbjct: 250 MIMRKCWMIDADSRPKFRELIIEFSKM 276

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 29/112 (25%), Positives = 45/112 (40%), Gaps = 14/112 (12%)

Query: 12  RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
           +    P++ A+     +     L++LH     ++Y D K  NI+L  E   KL D G   
Sbjct: 175 KGQKLPVAEAIA--YLLEILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229

Query: 72  A-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                G        + GT G+ APE +     T  +D+Y+ G  L  L    
Sbjct: 230 RINSFG-------YLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL 273

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 88.0 bits (219), Expect = 5e-21
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 47/210 (22%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 97  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDN 154

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMG------THGYAAPEYVATGRLTTKSDVYSFGVV 114
            AK+SDFGL        +   STQ  G      T    APE +   + +TKSDV+SFG++
Sbjct: 155 VAKVSDFGLT-------KEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGIL 203

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQY---PQKAAH 168
           L E+ S GR                   PY  +  K  + R+      G     P     
Sbjct: 204 LWEIYSFGRV------------------PYPRIPLKDVVPRVEK----GYKMDAPDGCPP 241

Query: 169 TAATLALQCLNNEPKLRPRMSEVLAILERL 198
               +   C + +  +RP   ++   LE +
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 90.2 bits (224), Expect = 7e-21
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 31/159 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL  LH    +++YRD K  NILLD   + ++SD GLA   P G       +V GT GY 
Sbjct: 298 GLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL-- 150
           APE V   R T   D ++ G +L E+++G+                   P+   K+K+  
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS------------------PFQQRKKKIKR 394

Query: 151 ----FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
                 + +     +Y ++ +  A +L  Q L  +P  R
Sbjct: 395 EEVERLVKEVPE--EYSERFSPQARSLCSQLLCKDPAER 431

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 87.7 bits (218), Expect = 7e-21
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 43/210 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL + L       L+    + +A   A+G+ F+   E   I+RD +A+NIL+    
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYIHRDLRAANILVSDTL 146

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGV 113
           + K++DFGLA+         +          A       APE +  G  T KSDV+SFG+
Sbjct: 147 SCKIADFGLAR--------LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198

Query: 114 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAH 168
           +L E+++ GR                   PY  +++   +  +     G +   P     
Sbjct: 199 LLTEIVTHGRI------------------PYPGMTNPEVIQNLER---GYRMVRPDNCPE 237

Query: 169 TAATLALQCLNNEPKLRPRMSEVLAILERL 198
               L   C    P+ RP    + ++LE  
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 89.0 bits (221), Expect = 8e-21
 Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 40/236 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL++ L +   Q  +    + +  G A G+ +L  ++   ++RD  A NIL+++  
Sbjct: 128 MENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNL 184

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL +          +T+  G      + +PE +A  + T+ SDV+S+G+VL E
Sbjct: 185 VCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242

Query: 118 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHT 169
           ++S G                   +PY  +S++  +  + +   G + P       A + 
Sbjct: 243 VMSYGE------------------RPYWEMSNQDVIKAVDE---GYRLPPPMDCPAALY- 280

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 225
              L L C   +   RP+  ++++IL++L     S K+  S   R +  +  + + 
Sbjct: 281 --QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNV 334

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.1 bits (219), Expect = 8e-21
 Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 21/207 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L +   + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 95  LPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENEN 151

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+ DFGL K  P         +     G     + APE +   + +  SDV+SFGVVL
Sbjct: 152 RVKIGDFGLTKVLPQDKEFFKVKE----PGESPIFWYAPESLTESKFSVASDVWSFGVVL 207

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY----PQKAAHTAA 171
            EL +             + +          +  +F +++  L        P        
Sbjct: 208 YELFTYIEKSKSPPAEFMRMI--GNDKQ--GQMIVFHLIE-LLKNNGRLPRPDGCPDEIY 262

Query: 172 TLALQCLNNEPKLRPRMSEVLAILERL 198
            +  +C NN    RP   ++   ++++
Sbjct: 263 MIMTECWNNNVNQRPSFRDLALRVDQI 289

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 55/192 (28%), Positives = 77/192 (40%), Gaps = 36/192 (18%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK---GLTFLHDAESQVIYRDFKASNILLD 57
           M  G L  HL + G    +          AA+   GL  +H     V+YRD K +NILLD
Sbjct: 274 MNGGDLHYHLSQHGVFSEADMR-----FYAAEIILGLEHMH--NRFVVYRDLKPANILLD 326

Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLL 116
              + ++SD GLA       + H    V GTHGY APE +  G     S D +S G +L 
Sbjct: 327 EHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382

Query: 117 ELLSGRC--AVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATL 173
           +LL G       KTK                DK ++ R  +   +  + P   +    +L
Sbjct: 383 KLLRGHSPFRQHKTK----------------DKHEIDRMTLTMAV--ELPDSFSPELRSL 424

Query: 174 ALQCLNNEPKLR 185
               L  +   R
Sbjct: 425 LEGLLQRDVNRR 436

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 87.3 bits (217), Expect = 1e-20
 Identities = 51/224 (22%), Positives = 83/224 (37%), Gaps = 36/224 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L   L  +  + +  +   ++    + G+ +L   E   ++RD  A N+LL    
Sbjct: 91  AGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL--EEKNFVHRDLAARNVLLVNRH 147

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
            AK+SDFGL+KA    D  + +       G     + APE +   + +++SDV+S+GV +
Sbjct: 148 YAKISDFGLSKALGADDSYYTARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAA 171
            E LS G+                  KPY   K K   +M     G+    P +      
Sbjct: 204 WEALSYGQ------------------KPY--KKMKGPEVMAFIEQGKRMECPPECPPELY 243

Query: 172 TLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 215
            L   C   + + RP    V   +        S        H  
Sbjct: 244 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHHH 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.8 bits (218), Expect = 2e-20
 Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 19/206 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L +   + +     ++      KG+ +L     + I+RD    NIL++ E 
Sbjct: 126 LPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENEN 182

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+ DFGL K  P     +         G     + APE +   + +  SDV+SFGVVL
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAAT 172
            EL +             + + +  +  +     +  + +          P         
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----NGRLPRPDGCPDEIYM 294

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           +  +C NN    RP   ++   ++++
Sbjct: 295 IMTECWNNNVNQRPSFRDLALRVDQI 320

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 87.8 bits (218), Expect = 2e-20
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 19/220 (8%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P G L + L R   + L  +  +  +    KG+ +L     + ++RD  A NIL+++E 
Sbjct: 108 LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEA 164

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
           + K++DFGLAK  P          V+   G     + APE ++    + +SDV+SFGVVL
Sbjct: 165 HVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAA--TL 173
            EL +  C    +       ++   +   +  R L  + +   G + P   A  A    L
Sbjct: 221 YELFT-YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE---GQRLPAPPACPAEVHEL 276

Query: 174 ALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAKLSQSEP 212
              C    P+ RP  S +   L+ L    +     + +  
Sbjct: 277 MKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAH 316

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 87.4 bits (217), Expect = 2e-20
 Identities = 52/246 (21%), Positives = 100/246 (40%), Gaps = 37/246 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL +H+ R+    L   + +   +  AKG+ +L   E  +++R+  A N+LL +  
Sbjct: 96  LPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPS 152

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             +++DFG+A   P  D      Q++ +       + A E +  G+ T +SDV+S+GV +
Sbjct: 153 QVQVADFGVADLLPPDD-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAA 171
            EL++ G                   +PY     +L  + D    G+    PQ       
Sbjct: 208 WELMTFGA------------------EPY--AGLRLAEVPDLLEKGERLAQPQICTIDVY 247

Query: 172 TLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRS 231
            + ++C   +  +RP   E+     R+        + + E      P         ++  
Sbjct: 248 MVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLE 307

Query: 232 PLNMTP 237
            + + P
Sbjct: 308 EVELEP 313

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 88.7 bits (220), Expect = 2e-20
 Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 30/159 (18%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL  LH  +  +IYRD K  N+LLD + N ++SD GLA     G          GT G+ 
Sbjct: 301 GLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFM 356

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK--- 149
           APE +         D ++ GV L E+++ R                   P+ +   K   
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARG------------------PFRARGEKVEN 398

Query: 150 --LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
             L + +++  +   YP K +  +       L  +P+ R
Sbjct: 399 KELKQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKR 435

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 86.6 bits (215), Expect = 4e-20
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 40/229 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L+  L R      S    + +  G A G+ +L  A    ++RD  A NIL+++  
Sbjct: 128 MENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILVNSNL 184

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++          +T   G      + APE ++  + T+ SDV+SFG+V+ E
Sbjct: 185 VCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242

Query: 118 LLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAAHT 169
           +++ G                   +PY  LS+   +  I D   G + P       A + 
Sbjct: 243 VMTYGE------------------RPYWELSNHEVMKAIND---GFRLPTPMDCPSAIY- 280

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGP 218
              L +QC   E   RP+ +++++IL++L    +S K       R +  
Sbjct: 281 --QLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIR 327

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.1 bits (214), Expect = 4e-20
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 39/209 (18%)

Query: 1   MPKGSLENHLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
            P GSL + L +      L    R   A+  A+G+ +L     + I+RD  A N+LL   
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYL--ESKRFIHRDLAARNLLLATR 157

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVV 114
              K+ DFGL +A P  D  +V  +    H      + APE + T   +  SD + FGV 
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQE----HRKVPFAWCAPESLKTRTFSHASDTWMFGVT 213

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGGQYPQKAAHTAA 171
           L E+ + G+                  +P+        +I+    K G + P+       
Sbjct: 214 LWEMFTYGQ------------------EPW--IGLNGSQILHKIDKEGERLPRPEDCPQD 253

Query: 172 --TLALQCLNNEPKLRPRMSEVLAILERL 198
              + +QC  ++P+ RP    +   L   
Sbjct: 254 IYNVMVQCWAHKPEDRPTFVALRDFLLEA 282

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.8 bits (213), Expect = 4e-20
 Identities = 53/219 (24%), Positives = 82/219 (37%), Gaps = 54/219 (24%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  GSL+ +L ++    ++   +++VA   A  + FL   E+ +I+ +  A NILL  E 
Sbjct: 94  VKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL--EENTLIHGNVCAKNILLIREE 150

Query: 61  N--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGY------AAPEYVATGRL-TTK 105
           +         KLSD G++              V+             PE +   +     
Sbjct: 151 DRKTGNPPFIKLSDPGISIT------------VLPKDILQERIPWVPPECIENPKNLNLA 198

Query: 106 SDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQY 162
           +D +SFG  L E+ S G                   KP   L  +RKL    D     Q 
Sbjct: 199 TDKWSFGTTLWEICSGGD------------------KPLSALDSQRKLQFYED---RHQL 237

Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 201
           P   A   A L   C++ EP  RP    ++  L  L  P
Sbjct: 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.6 bits (215), Expect = 4e-20
 Identities = 44/207 (21%), Positives = 83/207 (40%), Gaps = 37/207 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G L +++       +     +   +  AKG+ +L   + ++++RD  A N+L+    
Sbjct: 98  MPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQ 154

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
           + K++DFGLAK     ++ +         G     + A E +     T +SDV+S+GV +
Sbjct: 155 HVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAA 171
            EL++ G                   KPY  D      I      G+    P        
Sbjct: 210 WELMTFGS------------------KPY--DGIPASEISSILEKGERLPQPPICTIDVY 249

Query: 172 TLALQCLNNEPKLRPRMSEVLAILERL 198
            + ++C   +   RP+  E++    ++
Sbjct: 250 MIMVKCWMIDADSRPKFRELIIEFSKM 276

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 85.5 bits (212), Expect = 8e-20
 Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 22/206 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +P GSL ++L  R    L+  +    A    +G+ +LH      I+RD  A N+LLD + 
Sbjct: 117 VPLGSLRDYL-PRHSIGLAQLLLF--AQQICEGMAYLH--AQHYIHRDLAARNVLLDNDR 171

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+ DFGLAKA P G         +   G     + APE +   +    SDV+SFGV L
Sbjct: 172 LVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAAT 172
            ELL+  C  D ++    + L          +  + R+ +    G+    P K       
Sbjct: 228 YELLT-HC--DSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERGERLPRPDKCPAEVYH 282

Query: 173 LALQCLNNEPKLRPRMSEVLAILERL 198
           L   C   E   RP    ++ IL+ +
Sbjct: 283 LMKNCWETEASFRPTFENLIPILKTV 308

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 86.2 bits (213), Expect = 8e-20
 Identities = 20/132 (15%), Positives = 41/132 (31%), Gaps = 21/132 (15%)

Query: 4   GSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            +    L         L    R+++ +   + L  LH     +++   +  +I+LD    
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGG 244

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYS 110
             L+ F          R         + G+  PE  A              +T   D ++
Sbjct: 245 VFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 111 FGVVLLELLSGR 122
            G+V+  +    
Sbjct: 299 LGLVIYWIWCAD 310

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 85.0 bits (211), Expect = 9e-20
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 13/125 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L  +L +         + +      + G+ +L   ES  ++RD  A N+LL  + 
Sbjct: 99  AELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYL--EESNFVHRDLAARNVLLVTQH 154

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
            AK+SDFGL+KA    +  + +      HG     + APE +   + ++KSDV+SFGV++
Sbjct: 155 YAKISDFGLSKALRADENYYKAQT----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210

Query: 116 LELLS 120
            E  S
Sbjct: 211 WEAFS 215

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 84.5 bits (210), Expect = 1e-19
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 42/209 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L N+L   G   L  +  +++     +G+ FL     Q I+RD  A N L+D + 
Sbjct: 85  ISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDL 141

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K+SDFG+        R  +  Q + + G      ++APE     + ++KSDV++FG++
Sbjct: 142 CVKVSDFGMT-------RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGIL 194

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHT 169
           + E+ S G+                   PY   ++   + ++     G     P  A+ T
Sbjct: 195 MWEVFSLGK------------------MPYDLYTNSEVVLKVSQ---GHRLYRPHLASDT 233

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL 198
              +   C +  P+ RP   ++L+ +E L
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.0 bits (211), Expect = 1e-19
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 43/211 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N +        +    +   +  AKG+ +L  A  + ++RD  A N +LD +F
Sbjct: 109 MKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKF 165

Query: 61  NAKLSDFGLAKAGPTGD--RTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFG 112
             K++DFGLA+     +    H  T        M      A E + T + TTKSDV+SFG
Sbjct: 166 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM------ALESLQTQKFTTKSDVWSFG 219

Query: 113 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAA 167
           V+L EL++ G                    PY  ++       ++    G     P+   
Sbjct: 220 VLLWELMTRGA------------------PPYPDVNTFDITVYLLQ---GRRLLQPEYCP 258

Query: 168 HTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                + L+C + + ++RP  SE+++ +  +
Sbjct: 259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 85.2 bits (211), Expect = 1e-19
 Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 15/132 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGA------AKGLTFLHDAESQVIYRDFKASNI 54
           M   S+            ++   + + +            +++H  E  + +RD K SNI
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNI 183

Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT---KSDVYSF 111
           L+D     KLSDFG ++               GT+ +  PE   +   +    K D++S 
Sbjct: 184 LMDKNGRVKLSDFGESEYMVDKKIK---G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSL 238

Query: 112 GVVLLELLSGRC 123
           G+ L  +     
Sbjct: 239 GICLYVMFYNVV 250

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 85.9 bits (212), Expect = 2e-19
 Identities = 21/131 (16%), Positives = 41/131 (31%), Gaps = 20/131 (15%)

Query: 4   GSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            +    L         L    R+++ +   + L  LH     +++   +  +I+LD    
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGG 249

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA----------TGRLTTKSDVYSF 111
             L+ F          R   S       G+A PE  A             +T   D ++ 
Sbjct: 250 VFLTGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303

Query: 112 GVVLLELLSGR 122
           G+ +  +    
Sbjct: 304 GLAIYWIWCAD 314

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G     T   T    GT  Y
Sbjct: 122 ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 176

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +  G     S D ++ GV++ E+++GR   D               P  + +  L
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNPDQNTEDYL 227

Query: 151 FR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           F+ I++ ++  + P+  +  AA++    LN +PK R
Sbjct: 228 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 84.4 bits (209), Expect = 3e-19
 Identities = 49/247 (19%), Positives = 83/247 (33%), Gaps = 43/247 (17%)

Query: 3   KGSLENHLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           KG L   L +   + PLS    +K+     + +  +H  +  +I+RD K  N+LL  +  
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176

Query: 62  AKLSDFGLAKA---GPTGDRTHVSTQVM-------GTHGYAAPEYVATGR---LTTKSDV 108
            KL DFG A      P    +     ++        T  Y  PE +       +  K D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236

Query: 109 YSFGVVLLELLSGRCA-VDKTKVGIEQSLVDW--AKPYLSDKRKLFRIMDTKLGGQYPQK 165
           ++ G +L  L   +    D  K+ I              +    L R M           
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAM----------- 285

Query: 166 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 225
                       L   P+ R  ++EV+  L+ + A +N   ++   P  +          
Sbjct: 286 ------------LQVNPEERLSIAEVVHQLQEIAAARN---VNPKSPITELLEQNGGYGS 330

Query: 226 MRQQRSP 232
               R P
Sbjct: 331 ATLSRGP 337

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 84.8 bits (210), Expect = 3e-19
 Identities = 41/175 (23%), Positives = 63/175 (36%), Gaps = 31/175 (17%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRT-HVSTQ 84
             GL  LH     +++RD K  NIL+       +  A +SDFGL K    G  +    + 
Sbjct: 128 TSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185

Query: 85  VMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 141
           V GT G+ APE +        T   D++S G V   ++S                     
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH----------------- 228

Query: 142 PYLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEVLA 193
           P+    ++   I+             H    A  L  + +  +P+ RP    VL 
Sbjct: 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.4 bits (207), Expect = 3e-19
 Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 43/218 (19%)

Query: 1   MPKGSLENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
            P G L ++L R      +   V    ++   K + +L       ++RD    NIL+ + 
Sbjct: 94  YPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL--ESINCVHRDIAVRNILVASP 149

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVV 114
              KL DFGL++     D  +               + +PE +   R TT SDV+ F V 
Sbjct: 150 ECVKLGDFGLSRY--IEDEDYYKAS----VTRLPIKWMSPESINFRRFTTASDVWMFAVC 203

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHT 169
           + E+LS G+                  +P+  L +K  +  +     G     P      
Sbjct: 204 MWEILSFGK------------------QPFFWLENKDVIGVLEK---GDRLPKPDLCPPV 242

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAK 206
             TL  +C + +P  RPR +E++  L  + +  K+ A 
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 85.3 bits (211), Expect = 3e-19
 Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 40/208 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L + L +     L  A  +  A   +  L +L     + ++RD  A N+L+ +  
Sbjct: 472 CTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSND 528

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             KL DFGL++          ST    + G     + APE +   R T+ SDV+ FGV +
Sbjct: 529 CVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTA 170
            E+L  G                   KP+  + +   + RI +   G     P     T 
Sbjct: 583 WEILMHGV------------------KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTL 621

Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERL 198
            +L  +C   +P  RPR +E+ A L  +
Sbjct: 622 YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 83.0 bits (206), Expect = 4e-19
 Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 42/209 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++L R      +    + + +   +G+ +L   E+ VI+RD  A N L+    
Sbjct: 85  MEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEACVIHRDLAARNCLVGENQ 141

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K+SDFG+        R  +  Q   + G      +A+PE  +  R ++KSDV+SFGV+
Sbjct: 142 VIKVSDFGMT-------RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 194

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHT 169
           + E+ S G+                   PY   S+   +  I     G     P+ A+  
Sbjct: 195 MWEVFSEGK------------------IPYENRSNSEVVEDIST---GFRLYKPRLASTH 233

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL 198
              +   C    P+ RP  S +L  L  +
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 83.1 bits (206), Expect = 4e-19
 Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 27/174 (15%)

Query: 33  GLTFLHD---AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGT 88
            L   H        V++RD K +N+ LD + N KL DFGLA+            T V GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GT 179

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 148
             Y +PE +       KSD++S G +L EL +                   A        
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFSQKELAG 226

Query: 149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLE 199
           K+      ++  +Y  +       +  + LN +   RP + E+L    ILE   
Sbjct: 227 KIREGKFRRIPYRYSDELNE----IITRMLNLKDYHRPSVEEILENPLILEHHH 276

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 83.5 bits (207), Expect = 4e-19
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 44/211 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L R      +    + +  G   G+ +L  ++   ++RD  A N+L+D+  
Sbjct: 132 MENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNL 188

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             K+SDFGL++          +T      G     + APE +A    ++ SDV+SFGVV+
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYTTT----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQ-----KAA 167
            E+L+ G                   +PY  ++++  +  + +   G + P       A 
Sbjct: 245 WEVLAYGE------------------RPYWNMTNRDVISSVEE---GYRLPAPMGCPHAL 283

Query: 168 HTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           H    L L C + +   RPR S+++++L+ L
Sbjct: 284 H---QLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.0 bits (210), Expect = 5e-19
 Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 12/125 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L   L  +  + +  +   ++    + G+ +L   E   ++R+  A N+LL    
Sbjct: 417 AGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLLVNRH 473

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
            AK+SDFGL+KA    D  + +       G     + APE +   + +++SDV+S+GV +
Sbjct: 474 YAKISDFGLSKALGADDSYYTARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529

Query: 116 LELLS 120
            E LS
Sbjct: 530 WEALS 534

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 83.9 bits (207), Expect = 5e-19
 Identities = 22/183 (12%), Positives = 44/183 (24%), Gaps = 18/183 (9%)

Query: 13  RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 72
                        +     +    L      +++  F   N+ +  +    L D      
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 73  GPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 130
             T               YA  E++  +T   T   + +  G+ +  +            
Sbjct: 244 VGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 131 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 190
           GI+             +  L       L             TL  + LN + + R    E
Sbjct: 299 GIKG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349

Query: 191 VLA 193
            + 
Sbjct: 350 AME 352

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 83.9 bits (208), Expect = 6e-19
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L +LH  E  +IYRD K  N+LLD+E + KL+D+G+ K G     T   T    GT  Y
Sbjct: 165 ALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 219

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
            APE +  G     S D ++ GV++ E+++GR   D               P  + +  L
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNPDQNTEDYL 270

Query: 151 FR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           F+ I++ ++  + P+  +  AA++    LN +PK R
Sbjct: 271 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 304

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.7 bits (207), Expect = 6e-19
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 23/130 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+     +    +   +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 113 MDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 169

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQ--------VMGTHGYAAPEYVATGRLTTKSDVYSFG 112
             KL DFG            VS Q         +GT  Y +PE +     + +SD++S G
Sbjct: 170 EIKLCDFG------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 217

Query: 113 VVLLELLSGR 122
           + L+E+  GR
Sbjct: 218 LSLVEMAVGR 227

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 82.7 bits (205), Expect = 7e-19
 Identities = 43/209 (20%), Positives = 83/209 (39%), Gaps = 42/209 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L R           +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 101 MANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQG 157

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAPEYVATGRLTTKSDVYSFGVV 114
             K+SDFGL+       R  +  +   + G      ++ PE +   + ++KSD+++FGV+
Sbjct: 158 VVKVSDFGLS-------RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210

Query: 115 LLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHT 169
           + E+ S G+                   PY   ++      I     G     P  A+  
Sbjct: 211 MWEIYSLGK------------------MPYERFTNSETAEHIAQ---GLRLYRPHLASEK 249

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERL 198
             T+   C + +   RP    +L+ +  +
Sbjct: 250 VYTIMYSCWHEKADERPTFKILLSNILDV 278

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.8 bits (205), Expect = 8e-19
 Identities = 48/225 (21%), Positives = 87/225 (38%), Gaps = 44/225 (19%)

Query: 1   MPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           M  G L   L           L     ++  +  A G+ +L  +    I+RD  A N +L
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCML 170

Query: 57  DAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYS 110
             +    ++DFGL++   +GD  R   ++++    +      A E +A    T  SDV++
Sbjct: 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL------ALESLADNLYTVHSDVWA 224

Query: 111 FGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQK 165
           FGV + E+++ G+                   PY  + +      ++    G   + P +
Sbjct: 225 FGVTMWEIMTRGQ------------------TPYAGIENAEIYNYLIG---GNRLKQPPE 263

Query: 166 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQS 210
                  L  QC + +PK RP  + +   LE +    +    SQ 
Sbjct: 264 CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 82.7 bits (205), Expect = 8e-19
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 43/211 (20%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L   +        +    +   +  A+G+ +L  AE + ++RD  A N +LD  F
Sbjct: 105 MCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESF 161

Query: 61  NAKLSDFGLAK----AGPTGDRTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFG 112
             K++DFGLA+          + H   ++           A E + T R TTKSDV+SFG
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWT------ALESLQTYRFTTKSDVWSFG 215

Query: 113 VVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAA 167
           V+L ELL+ G                    PY  +        +     G     P+   
Sbjct: 216 VLLWELLTRGA------------------PPYRHIDPFDLTHFLAQ---GRRLPQPEYCP 254

Query: 168 HTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +   +  QC   +P +RP    ++  +E++
Sbjct: 255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.9 bits (203), Expect = 1e-18
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 40/208 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L + L  R    L  A  +  A   +  L +L     + ++RD  A N+L+ +  
Sbjct: 97  CTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL--ESKRFVHRDIAARNVLVSSND 153

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVL 115
             KL DFGL++          ST    + G     + APE +   R T+ SDV+ FGV +
Sbjct: 154 CVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207

Query: 116 LELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTA 170
            E+L  G                   KP+  + +   + RI +   G     P     T 
Sbjct: 208 WEILMHGV------------------KPFQGVKNNDVIGRIEN---GERLPMPPNCPPTL 246

Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERL 198
            +L  +C   +P  RPR +E+ A L  +
Sbjct: 247 YSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 41/210 (19%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N +        +    +   +  AKG+ FL  A  + ++RD  A N +LD +F
Sbjct: 173 MKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKF 229

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGV 113
             K++DFGLA+     D        +     A       A E + T + TTKSDV+SFGV
Sbjct: 230 TVKVADFGLAR-----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284

Query: 114 VLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAH 168
           +L EL++ G                    PY  ++       ++    G     P+    
Sbjct: 285 LLWELMTRGA------------------PPYPDVNTFDITVYLLQ---GRRLLQPEYCPD 323

Query: 169 TAATLALQCLNNEPKLRPRMSEVLAILERL 198
               + L+C + + ++RP  SE+++ +  +
Sbjct: 324 PLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 30/157 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L FLH  +  +IYRD K  N+LLD E + KL+DFG+ K G     T   T    GT  Y
Sbjct: 136 ALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDY 190

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE +    L   + D ++ GV+L E+L G                    P    ++  
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHA------------------PFEAENEDD 231

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           LF  I++ ++   YP      A  +    +   P +R
Sbjct: 232 LFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 30/157 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L +LH     V+YRD K  N++LD + + K++DFGL K G +   T    +   GT  Y
Sbjct: 117 ALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEY 171

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE V       ++ D +  GVV+ E++ GR                   P Y  D  +
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PFYNQDHER 212

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           LF  I+  ++  ++P+  +  A +L    L  +PK R
Sbjct: 213 LFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 247

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 81.2 bits (201), Expect = 3e-18
 Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 44/213 (20%)

Query: 1   MPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 56
           M  G L  +L       GP+ +     +K  +  A G+ +L  +    ++RD  A N +L
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML 180

Query: 57  DAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYS 110
             +    ++DFGL+K   +GD  R     ++    +      A E +A    T+KSDV++
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWA 234

Query: 111 FGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQK 165
           FGV + E+ + G                    PY  + +      ++    G   + P+ 
Sbjct: 235 FGVTMWEIATRGM------------------TPYPGVQNHEMYDYLLH---GHRLKQPED 273

Query: 166 AAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                  +   C   +P  RP  S +   LE+L
Sbjct: 274 CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.4 bits (202), Expect = 3e-18
 Identities = 49/158 (31%), Positives = 67/158 (42%), Gaps = 32/158 (20%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L  LH     +IYRD K  NILLD E + KL+DFGL+K     ++         GT  Y
Sbjct: 138 ALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEY 192

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--YLSDKR 148
            APE V   R  T+S D +SFGV++ E+L+G                          D++
Sbjct: 193 MAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT-------------------LPFQGKDRK 232

Query: 149 KLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           +    I+  KL    PQ  +  A +L        P  R
Sbjct: 233 ETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 81.2 bits (201), Expect = 3e-18
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 49/238 (20%)

Query: 1   MPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P         P S +  +++A   A G+ +L    ++ ++RD  A 
Sbjct: 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAAR 167

Query: 53  NILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKS 106
           N ++  +F  K+ DFG+ +     D  R      +    M      +PE +  G  TT S
Sbjct: 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM------SPESLKDGVFTTYS 221

Query: 107 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 161
           DV+SFGVVL E+ +                     +PY  LS+++ L  +M+   GG   
Sbjct: 222 DVWSFGVVLWEIATLAE------------------QPYQGLSNEQVLRFVME---GGLLD 260

Query: 162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQTGP 218
            P         L   C    PK+RP   E+++ ++  +E          SE ++   P
Sbjct: 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEP 318

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.1 bits (201), Expect = 4e-18
 Identities = 51/157 (32%), Positives = 71/157 (45%), Gaps = 30/157 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
           GL FLH     ++YRD K  NILLD + + K++DFG+ K    GD     T    GT  Y
Sbjct: 130 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE +  G+    S D +SFGV+L E+L G+                   P +  D+ +
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEE 225

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           LF  I        YP+     A  L ++    EP+ R
Sbjct: 226 LFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKR 260

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.1 bits (201), Expect = 4e-18
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 30/157 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
           GL FL      +IYRD K  N++LD+E + K++DFG+ K       T   T+   GT  Y
Sbjct: 133 GLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 187

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE +   +   KS D ++FGV+L E+L+G+                   P    D+ +
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGEDEDE 228

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           LF+ IM+  +   YP+  +  A  +    +   P  R
Sbjct: 229 LFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 80.9 bits (200), Expect = 4e-18
 Identities = 37/162 (22%), Positives = 63/162 (38%), Gaps = 27/162 (16%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK--AGPTGDRTHVSTQVM-G 87
           +GL +LH    ++++ D KA N+LL ++   A L DFG A         ++ ++   + G
Sbjct: 161 EGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 145
           T  + APE V       K D++S   ++L +L+G                    P+    
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------------------HPWTQYF 260

Query: 146 DKRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 186
                 +I  +     + P   A   A    + L  EP  R 
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.4 bits (199), Expect = 7e-18
 Identities = 54/222 (24%), Positives = 84/222 (37%), Gaps = 53/222 (23%)

Query: 1   MPKGSLENHLFRRGP-------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 47
           M  G L   L   GP              PL     + VA   A G+ +L  A    ++R
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AGLHFVHR 182

Query: 48  DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGR 101
           D    N L+      K+ DFG+++   + D   V  +       M       PE +   +
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYRK 236

Query: 102 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL 158
            TT+SDV+SFGVVL E+ + G+                  +P+  LS+   +  I     
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGK------------------QPWYQLSNTEAIDCITQ--- 275

Query: 159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           G   + P+        +   C   EP+ R  + +V A L+ L
Sbjct: 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 80.1 bits (198), Expect = 9e-18
 Identities = 45/212 (21%), Positives = 77/212 (36%), Gaps = 29/212 (13%)

Query: 2   PKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
            +G+L N +   +     L+    + + +G  +GL  +H       +RD K +NILL  E
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDE 170

Query: 60  FNAKLSDFGLAKA---GPTGDRTHVSTQVM----GTHGYAAPEYVATGR---LTTKSDVY 109
               L D G          G R  ++ Q       T  Y APE  +      +  ++DV+
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230

Query: 110 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 169
           S G VL  ++ G    D      +           S    +   +      ++       
Sbjct: 231 SLGCVLYAMMFGEGPYDMVFQKGD-----------SVALAVQNQLSIPQSPRHSSALWQ- 278

Query: 170 AATLALQCLNNEPKLRPRMSEVLAILERLEAP 201
              L    +  +P  RP +  +L+ LE L+ P
Sbjct: 279 ---LLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 79.6 bits (197), Expect = 9e-18
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 39/202 (19%)

Query: 4   GSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            SL+          Q +   +  K+A+   K L  LH  +  VI+RD K SN+L++A   
Sbjct: 90  TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQ 148

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL----TTKSDVYSFGVVLLE 117
            K+ DFG+  +G   D         G   Y APE +         + KSD++S G+ ++E
Sbjct: 149 VKMCDFGI--SGYLVDDVAKDIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDK---RKLFRIMDT---KL-GGQYPQKAAHTA 170
           L   R                   PY S     ++L ++++    +L   ++  +     
Sbjct: 206 LAILR------------------FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247

Query: 171 ATLALQCLNNEPKLRPRMSEVL 192
           +    QCL    K RP   E++
Sbjct: 248 S----QCLKKNSKERPTYPELM 265

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.5 bits (199), Expect = 1e-17
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 29/157 (18%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L +LH +E  V+YRD K  N++LD + + K++DFGL K G     T    +   GT  Y
Sbjct: 260 ALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEY 315

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE V       ++ D +  GVV+ E++ GR                   P Y  D  K
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PFYNQDHEK 356

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           LF  I+  ++  ++P+     A +L    L  +PK R
Sbjct: 357 LFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 30/157 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
           GL FL      +IYRD K  N++LD+E + K++DFG+ K       T   T+   GT  Y
Sbjct: 454 GLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 508

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE +   +   KS D ++FGV+L E+L+G+                   P    D+ +
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGEDEDE 549

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           LF+ IM+  +   YP+  +  A  +    +   P  R
Sbjct: 550 LFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.0 bits (198), Expect = 1e-17
 Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 30/157 (19%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L +LH     ++YRD K  NILLD++ +  L+DFGL K     + T   T    GT  Y
Sbjct: 151 ALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEY 205

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRK 149
            APE V   +   ++ D +  G VL E+L G                    P Y  +  +
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLP------------------PFYSRNTAE 246

Query: 150 LFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           ++  I++  L  Q      ++A  L    L  +   R
Sbjct: 247 MYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKR 281

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.0 bits (197), Expect = 1e-17
 Identities = 55/202 (27%), Positives = 77/202 (38%), Gaps = 37/202 (18%)

Query: 7   ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 66
           E          L+    +  +   AKG+ FL  A  + I+RD  A NILL  +   K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICD 236

Query: 67  FGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           FGLA+                    M      APE +     T +SDV+SFGV+L E+ S
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 290

Query: 121 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQ 176
                    +G        A PY  +    +  R +  K G +   P           L 
Sbjct: 291 ---------LG--------ASPYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLD 331

Query: 177 CLNNEPKLRPRMSEVLAILERL 198
           C + EP  RP  SE++  L  L
Sbjct: 332 CWHGEPSQRPTFSELVEHLGNL 353

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 40/158 (25%), Positives = 61/158 (38%), Gaps = 32/158 (20%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGY 91
            L  LH  +  +IYRD K  NI+L+ + + KL+DFGL K           T    GT  Y
Sbjct: 133 ALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEY 187

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--YLSDKR 148
            APE +       ++ D +S G ++ ++L+G                    P     +++
Sbjct: 188 MAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA-------------------PPFTGENRK 227

Query: 149 KLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
           K    I+  KL    P      A  L  + L      R
Sbjct: 228 KTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 78.4 bits (194), Expect = 2e-17
 Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 8/121 (6%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P+G L   L + G      +      +  A  L + H  E +VI+RD K  N+L+  +  
Sbjct: 97  PRGELYKELQKHGRFDEQRSATFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGE 152

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            K++DFG +   P   R        GT  Y  PE +       K D++  GV+  E L G
Sbjct: 153 LKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

Query: 122 R 122
            
Sbjct: 209 M 209

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 33/201 (16%)

Query: 1   MPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           +P GSL   L  + GP   +            +GL +LHD  +Q+++RD K  N+L++  
Sbjct: 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTY 158

Query: 60  F-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVL 115
               K+SDFG +K          +    GT  Y APE +     G     +D++S G  +
Sbjct: 159 SGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTI 215

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK----LFRIMDTKLGGQYPQKAAHTAA 171
           +E+ +G+                   P+  +  +    +F++   K+  + P+  +  A 
Sbjct: 216 IEMATGK------------------PPF-YELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256

Query: 172 TLALQCLNNEPKLRPRMSEVL 192
              L+C   +P  R   +++L
Sbjct: 257 AFILKCFEPDPDKRACANDLL 277

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.5 bits (194), Expect = 3e-17
 Identities = 58/238 (24%), Positives = 91/238 (38%), Gaps = 56/238 (23%)

Query: 1   MPKGSLENHLFRRGPQ--------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
            P G+L + L +                   LS    +  A   A+G+ +L  ++ Q I+
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIH 165

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGR 101
           RD  A NIL+   + AK++DFGL++             V  T G     + A E +    
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSV 217

Query: 102 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL 158
            TT SDV+S+GV+L E++S G                    PY  ++      ++     
Sbjct: 218 YTTNSDVWSYGVLLWEIVSLGG------------------TPYCGMTCAELYEKLPQ--- 256

Query: 159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPH 213
           G   + P         L  QC   +P  RP  +++L  L R LE  K     +  E  
Sbjct: 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 314

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.5 bits (194), Expect = 3e-17
 Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 51/221 (23%)

Query: 1   MPKGSLENHLFRRGP------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 48
              G L N L R+                 S    +  +   A+G+ FL  A    I+RD
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRD 189

Query: 49  FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLT 103
             A N+LL     AK+ DFGLA+     D  + S  ++  +      + APE +     T
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244

Query: 104 TKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLG 159
            +SDV+S+G++L E+ S G                    PY   L + +    + D   G
Sbjct: 245 VQSDVWSYGILLWEIFSLGLN------------------PYPGILVNSKFYKLVKD---G 283

Query: 160 GQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            Q   P  A     ++   C   EP  RP   ++ + L+  
Sbjct: 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 78.6 bits (194), Expect = 3e-17
 Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 58/233 (24%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
              E  L +R   P+   +  K+ +   K L +L + +  VI+RD K SNILLD     K
Sbjct: 108 TCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIK 165

Query: 64  LSDFGLAKAGPTG--DRTHVSTQVMGTHGYAAPEYVATGRL-----TTKSDVYSFGVVLL 116
           L DFG++     G         +  G   Y APE +            ++DV+S G+ L+
Sbjct: 166 LCDFGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220

Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL- 175
           EL +G+                   PY  + +  F ++   L  + P    H   +    
Sbjct: 221 ELATGQ------------------FPY-KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261

Query: 176 ----QCLNNEPKLRPRMSEVLA--------------------ILERLEAPKNS 204
                CL  + + RP+ +++L                     ++ + E+P++ 
Sbjct: 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSG 314

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 3e-17
 Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 41/196 (20%)

Query: 1   MPKGSLENHLFRRG--PQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLD 57
           +  G L  HL +     +     V++ +  +  A  L +L     ++I+RD K  NILLD
Sbjct: 97  LLGGDLRYHLQQNVHFKEE---TVKLFICELVMA--LDYLQ--NQRIIHRDMKPDNILLD 149

Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT--TKS-DVYSFGVV 114
              +  ++DF +A   P   +    T + GT  Y APE  ++ +    + + D +S GV 
Sbjct: 150 EHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206

Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYL----SDKRKLFR-IMDTKLGGQYPQKAAHT 169
             ELL GR                  +PY     +  +++      T +   YP   +  
Sbjct: 207 AYELLRGR------------------RPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQE 246

Query: 170 AATLALQCLNNEPKLR 185
             +L  + L   P  R
Sbjct: 247 MVSLLKKLLEPNPDQR 262

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.0 bits (193), Expect = 4e-17
 Identities = 53/223 (23%), Positives = 83/223 (37%), Gaps = 54/223 (24%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
           M  G L   L   GP                L  +  + +A   A G+ +L  A    ++
Sbjct: 99  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVH 156

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATG 100
           RD    N L+ A    K+ DFG+++   + D   V          M       PE +   
Sbjct: 157 RDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM------PPESIMYR 210

Query: 101 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK 157
           + TT+SDV+SFGV+L E+ + G+                   P+  LS+   +  I    
Sbjct: 211 KFTTESDVWSFGVILWEIFTYGKQ------------------PWFQLSNTEVIECITQ-- 250

Query: 158 LGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            G   + P+        + L C   EP+ R  + E+  IL  L
Sbjct: 251 -GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 38/135 (28%), Positives = 58/135 (42%), Gaps = 29/135 (21%)

Query: 4   GSLEN---HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
            S +    +++      +   +  K+ +   K L  L +   ++I+RD K SNILLD   
Sbjct: 105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSG 163

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVM---------GTHGYAAPEYVATGRL----TTKSD 107
           N KL DFG            +S Q++         G   Y APE +           +SD
Sbjct: 164 NIKLCDFG------------ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 211

Query: 108 VYSFGVVLLELLSGR 122
           V+S G+ L EL +GR
Sbjct: 212 VWSLGITLYELATGR 226

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 77.3 bits (191), Expect = 5e-17
 Identities = 34/121 (28%), Positives = 54/121 (44%), Gaps = 8/121 (6%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
           P G++   L +               +  A  L++ H    +VI+RD K  N+LL +   
Sbjct: 92  PLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCH--SKRVIHRDIKPENLLLGSAGE 147

Query: 62  AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            K++DFG +   P+  RT     + GT  Y  PE +       K D++S GV+  E L G
Sbjct: 148 LKIADFGWSVHAPSSRRT---D-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

Query: 122 R 122
           +
Sbjct: 204 K 204

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 77.4 bits (191), Expect = 9e-17
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 52/222 (23%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
             KG+L  +L  R P              + +++   +      A+G+ +L  A  + I+
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIH 226

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGR 101
           RD  A N+L+      K++DFGLA+     D  ++      T+G     + APE +    
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRV 281

Query: 102 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL 158
            T +SDV+SFGV++ E+ + G                    PY  +  +     + +   
Sbjct: 282 YTHQSDVWSFGVLMWEIFTLGGS------------------PYPGIPVEELFKLLKE--- 320

Query: 159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           G     P    +    +   C +  P  RP   +++  L+R+
Sbjct: 321 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 54/232 (23%), Positives = 83/232 (35%), Gaps = 46/232 (19%)

Query: 1   MPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P       L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCL 213

Query: 56  LDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSD 107
           L        AK+ DFG+A+               G           PE    G  T+K+D
Sbjct: 214 LTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTD 268

Query: 108 VYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QY 162
            +SFGV+L E+ S G                    PY   S++  L  +     GG    
Sbjct: 269 TWSFGVLLWEIFSLGY------------------MPYPSKSNQEVLEFVTS---GGRMDP 307

Query: 163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
           P+        +  QC  ++P+ RP  + +L  +E      +    +    + 
Sbjct: 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 359

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 53/240 (22%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
             KG+L  +L  R P              + +++   +      A+G+ +L  A  + I+
Sbjct: 123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIH 180

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGR 101
           RD  A N+L+      K++DFGLA+     D  ++      T+G     + APE +    
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRV 235

Query: 102 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL 158
            T +SDV+SFGV++ E+ + G                    PY  +  +     + +   
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGS------------------PYPGIPVEELFKLLKE--- 274

Query: 159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPHRQ 215
           G     P    +    +   C +  P  RP   +++  L+R L    N   L  S+P  Q
Sbjct: 275 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQ 334

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 76.6 bits (189), Expect = 1e-16
 Identities = 55/233 (23%), Positives = 85/233 (36%), Gaps = 48/233 (20%)

Query: 1   MPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 55
           M  G L++ L    P       L+    + VA   A G  +L   E+  I+RD  A N L
Sbjct: 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNCL 172

Query: 56  LDAE---FNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATGRLTTKS 106
           L        AK+ DFG+A+        R      +    M       PE    G  T+K+
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM------PPEAFMEGIFTSKT 226

Query: 107 DVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--Q 161
           D +SFGV+L E+ S G                    PY   S++  L  +     GG   
Sbjct: 227 DTWSFGVLLWEIFSLGY------------------MPYPSKSNQEVLEFVTS---GGRMD 265

Query: 162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 214
            P+        +  QC  ++P+ RP  + +L  +E      +    +    + 
Sbjct: 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYG 318

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 28/90 (31%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
           L +LH     +I+RD K  NILL+ + + +++DFG AK      +   +   +GT  Y +
Sbjct: 143 LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 94  PEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           PE + T +   KS D+++ G ++ +L++G 
Sbjct: 201 PE-LLTEKSACKSSDLWALGCIIYQLVAGL 229

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 54/221 (24%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
              G L   L  R P                L     + +    A G+ +L  +   V++
Sbjct: 94  CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVH 151

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYAAPEYVATG 100
           +D    N+L+  + N K+SD GL +     D  +   ++ +    M      APE +  G
Sbjct: 152 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM------APEAIMYG 205

Query: 101 RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK 157
           + +  SD++S+GVVL E+ S G                   +PY   S++  +  I +  
Sbjct: 206 KFSIDSDIWSYGVVLWEVFSYGL------------------QPYCGYSNQDVVEMIRN-- 245

Query: 158 LGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 196
                  P         L ++C N  P  RPR  ++ + L 
Sbjct: 246 -RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 76.6 bits (188), Expect = 2e-16
 Identities = 23/137 (16%), Positives = 46/137 (33%), Gaps = 18/137 (13%)

Query: 1   MPKGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL- 56
              G+L N +        + +   + +  A+     +  +HD E  +I+ D K  N +L 
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG 206

Query: 57  ----------DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTK 105
                     D      L D G +       +  + T    T G+   E + + +    +
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQ 265

Query: 106 SDVYSFGVVLLELLSGR 122
            D +     +  +L G 
Sbjct: 266 IDYFGVAATVYCMLFGT 282

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 75.8 bits (187), Expect = 3e-16
 Identities = 57/222 (25%), Positives = 82/222 (36%), Gaps = 51/222 (22%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
              G+L  +L  +                  L+    +  +   AKG+ FL  A  + I+
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIH 171

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGR 101
           RD  A NILL  +   K+ DFGLA+     D       V          + APE +    
Sbjct: 172 RDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRV 226

Query: 102 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL 158
            T +SDV+SFGV+L E+ S G                    PY  +    +  R +  K 
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGAS------------------PYPGVKIDEEFCRRL--KE 266

Query: 159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           G   + P           L C + EP  RP  SE++  L  L
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 75.9 bits (187), Expect = 4e-16
 Identities = 55/239 (23%), Positives = 95/239 (39%), Gaps = 52/239 (21%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
             KG+L  +L  R P              + LS    +  A   A+G+ +L  A  + I+
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIH 214

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAPEYVATGR 101
           RD  A N+L+  +   K++DFGLA+     D  H+      T+G     + APE +    
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269

Query: 102 LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKL 158
            T +SDV+SFGV+L E+ + G                    PY  +  +     + +   
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGS------------------PYPGVPVEELFKLLKE--- 308

Query: 159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 215
           G     P    +    +   C +  P  RP   +++  L+R+ A  ++ ++     H  
Sbjct: 309 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHH 367

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 74.9 bits (185), Expect = 5e-16
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 34/196 (17%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            + SL     RR       A      I    G  +LH   ++VI+RD K  N+ L+ +  
Sbjct: 98  RRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLE 153

Query: 62  AKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELL 119
            K+ DFGLA K    G+R  V     GT  Y APE V + +  + + DV+S G ++  LL
Sbjct: 154 VKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLL 209

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF-RIMDTKLGGQY--PQKAAHTAATLALQ 176
            G+   + + +                 ++ + RI       +Y  P+     AA+L  +
Sbjct: 210 VGKPPFETSCL-----------------KETYLRIKK----NEYSIPKHINPVAASLIQK 248

Query: 177 CLNNEPKLRPRMSEVL 192
            L  +P  RP ++E+L
Sbjct: 249 MLQTDPTARPTINELL 264

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.0 bits (185), Expect = 5e-16
 Identities = 53/231 (22%), Positives = 81/231 (35%), Gaps = 67/231 (29%)

Query: 1   MPKGSLENHLFRRGP----------------QPLSWAVRMKVAIGAAKGLTFLHDAESQV 44
              G L N L R+                    L     +  +   AKG+ FL  A    
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNC 166

Query: 45  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA------------ 92
           I+RD  A NILL      K+ DFGLA+             +     Y             
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLAR------------DIKNDSNYVVKGNARLPVKWM 214

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 149
           APE +     T +SDV+S+G+ L EL S G                    PY  +    K
Sbjct: 215 APESIFNCVYTFESDVWSYGIFLWELFSLGSS------------------PYPGMPVDSK 256

Query: 150 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            ++++  K G     P+ A      +   C + +P  RP   +++ ++E+ 
Sbjct: 257 FYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 76.3 bits (187), Expect = 5e-16
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMG 87
           +  L +LH  E+++I+RD K  NI+L         K+ D G AK    G    + T+ +G
Sbjct: 131 SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVG 185

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           T  Y APE +   + T   D +SFG +  E ++G 
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.4 bits (186), Expect = 5e-16
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 27/159 (16%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L  LH  +  +IYRD K  NILLD+  +  L+DFGL+K     +         GT  Y 
Sbjct: 171 ALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYM 227

Query: 93  APEYVATGRL-TTKS-DVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAKPYLSDK 147
           AP+ V  G     K+ D +S GV++ ELL+G        +                   +
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----------------SQ 271

Query: 148 RKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
            ++ R I+ ++    YPQ+ +  A  L  + L  +PK R
Sbjct: 272 AEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKR 308

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 74.1 bits (183), Expect = 7e-16
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTH 89
             G+ +LH     +++RD   SN+LL    N K++DFGLA +     ++ +      GT 
Sbjct: 122 ITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTP 176

Query: 90  GYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
            Y +PE +AT      +SDV+S G +   LL GR
Sbjct: 177 NYISPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 74.3 bits (183), Expect = 9e-16
 Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 10/123 (8%)

Query: 2   PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 61
            + SL     RR       A      I    G  +LH   ++VI+RD K  N+ L+ +  
Sbjct: 124 RRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLE 179

Query: 62  AKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELL 119
            K+ DFGLA K    G+R  V     GT  Y APE V + +  + + DV+S G ++  LL
Sbjct: 180 VKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLL 235

Query: 120 SGR 122
            G+
Sbjct: 236 VGK 238

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 73.8 bits (182), Expect = 1e-15
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 33  GLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           G+ +LH    Q +I+RD K SN+L+  + + K++DFG++     G    +S  V GT  +
Sbjct: 149 GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLSNTV-GTPAF 203

Query: 92  AAPEYVATGRLT---TKSDVYSFGVVLLELLSGRC 123
            APE ++  R        DV++ GV L   + G+C
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 46/191 (24%), Positives = 73/191 (38%), Gaps = 48/191 (25%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKLSDFGLAK---AGP 74
           A G+  LH    ++I+RD K  NIL+                    +SDFGL K   +G 
Sbjct: 125 ASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 75  TGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 127
           +  RT+++    GT G+ APE            RLT   D++S G V   +LS       
Sbjct: 183 SSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK------ 235

Query: 128 TKVGIEQSLVDWAKPYLSDKRKLFRIMD-----TKLGGQYPQKAAHTAATLALQCLNNEP 182
              G          P+     +   I+       ++   + +     A  L  Q ++++P
Sbjct: 236 ---GKH--------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284

Query: 183 KLRPRMSEVLA 193
             RP   +VL 
Sbjct: 285 LKRPTAMKVLR 295

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 72.7 bits (179), Expect = 4e-15
 Identities = 47/236 (19%), Positives = 77/236 (32%), Gaps = 72/236 (30%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVR---------------------MKVAIGAAKGLTFLHD 39
              G L N+L  +  +     +                      +  A   AKG+ FL  
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL-- 188

Query: 40  AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA------- 92
                ++RD  A N+L+      K+ DFGLA+             +M    Y        
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR------------DIMSDSNYVVRGNARL 236

Query: 93  -----APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--L 144
                APE +  G  T KSDV+S+G++L E+ S G                    PY  +
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------------PYPGI 278

Query: 145 SDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                 ++++  + G     P  A      +   C   + + RP    + + L   
Sbjct: 279 PVDANFYKLI--QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 72.7 bits (179), Expect = 4e-15
 Identities = 49/231 (21%), Positives = 84/231 (36%), Gaps = 62/231 (26%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVR----------------------MKVAIGAAKGLTFLH 38
           M  G L   L    P  +                           + +A   A G+ +L 
Sbjct: 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL- 190

Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV----MGTHGYA 92
            +E + ++RD    N L+      K++DFGL++   + D  +   +  +    M      
Sbjct: 191 -SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM------ 243

Query: 93  APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 149
            PE +   R TT+SDV+++GVVL E+ S G                    PY  ++ +  
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------------------PYYGMAHEEV 285

Query: 150 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
           ++ + D   G     P+        L   C +  P  RP    +  IL+R+
Sbjct: 286 IYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 72.3 bits (178), Expect = 5e-15
 Identities = 54/230 (23%), Positives = 89/230 (38%), Gaps = 60/230 (26%)

Query: 1   MPKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLH 38
              GSL   L                           + L+    +  A   ++G+ +L 
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL- 166

Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAA 93
            AE ++++RD  A NIL+      K+SDFGL++     D     + V  + G     + A
Sbjct: 167 -AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYEEDSYVKRSQGRIPVKWMA 220

Query: 94  PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKL 150
            E +     TT+SDV+SFGV+L E+++ G                    PY  +  +R  
Sbjct: 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------------------PYPGIPPERLF 262

Query: 151 FRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
             +     G   + P   +     L LQC   EP  RP  +++   LE++
Sbjct: 263 NLLKT---GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 71.6 bits (176), Expect = 6e-15
 Identities = 30/211 (14%), Positives = 66/211 (31%), Gaps = 50/211 (23%)

Query: 4   GSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---- 57
           GSL + +    R       A    + +   +GL ++H     +++ D K SNI +     
Sbjct: 96  GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSI 153

Query: 58  ---------------AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGR 101
                           +   K+ D G          +    +  G   + A E +     
Sbjct: 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTR-----ISSPQVEE-GDSRFLANEVLQENYT 207

Query: 102 LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ 161
              K+D+++  + ++                        +P   +  +   I   +L  +
Sbjct: 208 HLPKADIFALALTVVCAAGA-------------------EPLPRNGDQWHEIRQGRL-PR 247

Query: 162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            PQ  +     L    ++ +P+ RP    ++
Sbjct: 248 IPQVLSQEFTELLKVMIHPDPERRPSAMALV 278

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 72.2 bits (177), Expect = 8e-15
 Identities = 38/196 (19%), Positives = 61/196 (31%), Gaps = 37/196 (18%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHV----STQVM 86
           K L ++H      ++R  KAS+IL+  +    LS           G R  V        +
Sbjct: 139 KALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 87  GTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR---CAVDKTKV------GIEQS 135
               + +PE +         KSD+YS G+   EL +G      +  T++      G    
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

Query: 136 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL-------------------Q 176
           L+D +     +            G       +    +                      Q
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316

Query: 177 CLNNEPKLRPRMSEVL 192
           CL   P  RP  S +L
Sbjct: 317 CLQRNPDARPSASTLL 332

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.5 bits (176), Expect = 8e-15
 Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           GL +LH     ++++D K  N+LL      K+S  G+A+A              G+  + 
Sbjct: 121 GLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 93  APEYVATGRLT---TKSDVYSFGVVLLELLSGR 122
            PE +A G  T    K D++S GV L  + +G 
Sbjct: 179 PPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.1 bits (177), Expect = 9e-15
 Identities = 34/131 (25%), Positives = 50/131 (38%), Gaps = 15/131 (11%)

Query: 1   MPKGSLENHLFRRGPQ-PLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDA 58
              G L   L + G + P   A R  +A I  A  +  +H      ++RD K  NILLD 
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLDR 197

Query: 59  EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY-------SF 111
             + +L+DFG                V GT  Y +PE +        +  Y       + 
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256

Query: 112 GVVLLELLSGR 122
           GV   E+  G+
Sbjct: 257 GVFAYEMFYGQ 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 4/90 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH   +QVI+RD K+ NILL  + + KL+DFG   A  T +++  ST V GT  +
Sbjct: 127 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYW 182

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            APE V       K D++S G++ +E++ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.5 bits (171), Expect = 3e-14
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 93  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 122
           APE +   R       DV+S G+VL  +L+G 
Sbjct: 175 APE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 70.1 bits (172), Expect = 3e-14
 Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 11/104 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            + +L      +I+RD K  NI++  +F  KL DFG A     G   +      GT  Y 
Sbjct: 142 AVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYC 196

Query: 93  APEYVATGRLTT--KSDVYSFGVVLLELLSGR---CAVDKTKVG 131
           APE V  G      + +++S GV L  L+      C +++T   
Sbjct: 197 APE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 3e-14
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 5/91 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
            G+  LH A   +I+RD K SNI++ ++   K+ DFGLA    T   + + T  + T  Y
Sbjct: 138 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 192

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +         D++S G ++ E++ G 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.9 bits (172), Expect = 3e-14
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 33/157 (21%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            L +LH     +IYRD K  NILLD   + K++DFG AK     D T+  T + GT  Y 
Sbjct: 118 ALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY--T-LCGTPDYI 170

Query: 93  APEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--YLSDKRK 149
           APE V + +   KS D +SFG+++ E+L+G                       Y S+  K
Sbjct: 171 APE-VVSTKPYNKSIDWWSFGILIYEMLAGY-------------------TPFYDSNTMK 210

Query: 150 LF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 185
            + +I++ +L  ++P         L  + +  +   R
Sbjct: 211 TYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQR 245

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 69.8 bits (171), Expect = 3e-14
 Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 17/104 (16%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 86
             G+  L   E+ +++R+ K  NI+     D +   KL+DFG A+     D     +   
Sbjct: 122 VGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY- 176

Query: 87  GTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 122
           GT  Y  P+      L            D++S GV      +G 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 69.7 bits (171), Expect = 4e-14
 Identities = 50/167 (29%), Positives = 73/167 (43%), Gaps = 33/167 (19%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH    + I+RD KA+N+LL      KL+DFG+A    T  +   +T  +GT  +
Sbjct: 130 KGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-FVGTPFW 185

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK---R 148
            APE +      +K+D++S G+  +EL  G                   +P  S+    +
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARG-------------------EPPHSELHPMK 226

Query: 149 KLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
            LF I       L G Y +            CLN EP  RP   E+L
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 70.3 bits (172), Expect = 4e-14
 Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 17/104 (16%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 86
             G+  L   E+ +++R+ K  NI+     D +   KL+DFG A+     D     +   
Sbjct: 122 VGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY- 176

Query: 87  GTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 122
           GT  Y  P+      L            D++S GV      +G 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.6 bits (171), Expect = 4e-14
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
           G+ +LH     + +RD K  N+LLD   N K+SDFGLA      +R  +  ++ GT  Y 
Sbjct: 117 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 93  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 122
           APE +   R       DV+S G+VL  +L+G 
Sbjct: 175 APE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 69.3 bits (170), Expect = 5e-14
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L +LH     VI+RD K+ +ILL  +   KLSDFG   A  + D     + V GT  +
Sbjct: 152 QALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLV-GTPYW 207

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            APE ++     T+ D++S G++++E++ G
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 6e-14
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)

Query: 34  LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 93
             +LH  +  +IYRD K  N+L+D +   +++DFG AK      RT   T + GT    A
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCGTPEALA 206

Query: 94  PEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           PE +   +   K+ D ++ GV++ E+ +G 
Sbjct: 207 PE-IILSKGYNKAVDWWALGVLIYEMAAGY 235

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 8/95 (8%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            +  +H  +   ++RD K  NIL+D   + +L+DFG             S  V GT  Y 
Sbjct: 187 AIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 243

Query: 93  APEYVATGRLTTKS-----DVYSFGVVLLELLSGR 122
           +PE +              D +S GV + E+L G 
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 27/165 (16%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+ +LH     +++RD K  NILL   ++  N K+ DFGL+       +       +GT 
Sbjct: 158 GICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTA 212

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 149
            Y APE V   +   K DV+S GV++  LL G                   +   +D+  
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF-------------GGQ---NDQDI 255

Query: 150 LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
           + ++   K        +  +  A  L    L  +   R    E L
Sbjct: 256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.6 bits (168), Expect = 1e-13
 Identities = 42/127 (33%), Positives = 54/127 (42%), Gaps = 12/127 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           MP G L N +      P  WA R   A +  A  L  +H      I+RD K  N+LLD  
Sbjct: 151 MPGGDLVNLM-SNYDVPEKWA-RFYTAEVVLA--LDAIH--SMGFIHRDVKPDNMLLDKS 204

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVL 115
            + KL+DFG              T V GT  Y +PE +      G    + D +S GV L
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263

Query: 116 LELLSGR 122
            E+L G 
Sbjct: 264 YEMLVGD 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 67.6 bits (166), Expect = 1e-13
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            + + H     V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YA
Sbjct: 123 AVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177

Query: 93  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 122
           APE V +GRL    + D++S GV+L  LL G 
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            + + H    ++++RD K  N+LLD   N K++DFGL+     G+    S    G+  YA
Sbjct: 120 AIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174

Query: 93  APEYVATGRL--TTKSDVYSFGVVLLELLSGR 122
           APE V  G+L    + DV+S G+VL  +L GR
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.1 bits (167), Expect = 2e-13
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 30/164 (18%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 92
            + + H  + ++++RD KA N+LLDA+ N K++DFG +     G +        G   YA
Sbjct: 126 AVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYA 180

Query: 93  APEYVATGRLTT--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 150
           APE +  G+     + DV+S GV+L  L+SG    D       Q+L           ++L
Sbjct: 181 APE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNL-----------KEL 222

Query: 151 FRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
              +   L G+Y  P   +     L  + L   P  R  + +++
Sbjct: 223 RERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 68.2 bits (167), Expect = 2e-13
 Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 34/190 (17%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
            G+T+LH     +++RD K  N+LL   + +   K+ DFGL+       +     + +GT
Sbjct: 147 SGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGT 201

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDK 147
             Y APE V   +   K DV+S GV+L  LL+G                    P      
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------------------PPFGGQTD 242

Query: 148 RKLFR-IMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAP 201
           +++ R +   K        +  +  A  L  Q L  + + R    + L    I E     
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

Query: 202 KNSAKLSQSE 211
           ++  +L    
Sbjct: 303 ESGIELPSLA 312

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 67.8 bits (166), Expect = 3e-13
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 9/94 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
            G+T++H    ++++RD K  N+LL     + N ++ DFGL+       +       +GT
Sbjct: 137 SGITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
             Y APE V  G    K DV+S GV+L  LLSG 
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 66.6 bits (163), Expect = 4e-13
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL +LH    + I+RD KA NILL+ E +AKL+DFG+A    T      +T + GT  +
Sbjct: 136 KGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVI-GTPFW 191

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            APE +        +D++S G+  +E+  G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.2 bits (164), Expect = 5e-13
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 5/91 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
            G+  LH A   +I+RD K SNI++ ++   K+ DFGLA+   T   + + T  + T  Y
Sbjct: 175 CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229

Query: 92  AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            APE +         D++S G ++ E++  +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 66.4 bits (162), Expect = 5e-13
 Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAK---AGPTGDRTHVSTQVMG 87
            L +LH     + +RD K  N L     +   KL DFGL+K       G+   ++T+  G
Sbjct: 180 ALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-G 236

Query: 88  THGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 122
           T  + APE + T       K D +S GV+L  LL G 
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 66.1 bits (162), Expect = 6e-13
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 11/96 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + +  LH     +++RD K  NILLD + N KL+DFG +     G++     +V GT  Y
Sbjct: 135 EVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSY 189

Query: 92  AAPE------YVATGRLTTKSDVYSFGVVLLELLSG 121
            APE               + D++S GV++  LL+G
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.2 bits (162), Expect = 8e-13
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 10/94 (10%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           G+++ H    Q+ +RD K  N LLD       K+ DFG +K+     +    + V GT  
Sbjct: 128 GVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPA 182

Query: 91  YAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 122
           Y APE V   +      +DV+S GV L  +L G 
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.3 bits (162), Expect = 9e-13
 Identities = 36/81 (44%), Positives = 49/81 (60%), Gaps = 6/81 (7%)

Query: 44  VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL- 102
           V++RD K  N+LLDA  NAK++DFGL+     G+    S    G+  YAAPE V +GRL 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLY 192

Query: 103 -TTKSDVYSFGVVLLELLSGR 122
              + D++S GV+L  LL G 
Sbjct: 193 AGPEVDIWSSGVILYALLCGT 213

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+T++H     +++RD K  NILL   + + + K+ DFGL+       +       +GT 
Sbjct: 133 GITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y APE V  G    K DV+S GV+L  LLSG 
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 65.0 bits (159), Expect = 2e-12
 Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGT 88
           +GL +LH  ++  I+RD KA NILL  + + +++DFG++     G    R  V    +GT
Sbjct: 132 EGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 89  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
             + APE +   R    K+D++SFG+  +EL +G 
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 6/81 (7%)

Query: 44  VIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           V++RD K  NIL+D      KL DFG   A              GT  Y+ PE++   R 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWIRYHRY 225

Query: 103 T-TKSDVYSFGVVLLELLSGR 122
               + V+S G++L +++ G 
Sbjct: 226 HGRSAAVWSLGILLYDMVCGD 246

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 64.2 bits (157), Expect = 3e-12
 Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 9/92 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            L + H     V+++D K  NIL          K+ DFGLA+   + + +   T   GT 
Sbjct: 136 ALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE V    +T K D++S GVV+  LL+G
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 45/173 (26%), Positives = 69/173 (39%), Gaps = 39/173 (22%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL+ LH  + +VI+RD K  N+LL      KL DFG++ A         +T  +GT  +
Sbjct: 140 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRRNT-FIGTPYW 195

Query: 92  AAPEYVATGRLT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 146
            APE +A           KSD++S G+  +E+  G                    P L D
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-------------------APPLCD 236

Query: 147 K---RKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 192
               R LF I      +L   ++ +K           CL      RP   +++
Sbjct: 237 MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE----SCLVKNHSQRPATEQLM 285

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.2 bits (157), Expect = 3e-12
 Identities = 39/93 (41%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHG 90
           +GL ++H A   V++RD K SN+LL+   + K+ DFGLA+ A P  D T   T+ + T  
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 91  YAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
           Y APE +   +  TKS D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 64.1 bits (157), Expect = 3e-12
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 9/94 (9%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 87
              + +LH+  + +++RD K  N+L    +      ++DFGL+K    G    + +   G
Sbjct: 116 LSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACG 169

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T GY APE +A    +   D +S GV+   LL G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 64.3 bits (157), Expect = 4e-12
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
             + +LH+  + +I+RD K  N+LL   + +   K++DFG +K             + GT
Sbjct: 250 LAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGT 304

Query: 89  HGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 121
             Y APE    V T       D +S GV+L   LSG
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.5 bits (155), Expect = 5e-12
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 6/81 (7%)

Query: 44  VIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 102
           V++RD K  NIL+D      KL DFG   A    +         GT  Y+ PE+++  + 
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYSPPEWISRHQY 215

Query: 103 T-TKSDVYSFGVVLLELLSGR 122
               + V+S G++L +++ G 
Sbjct: 216 HALPATVWSLGILLYDMVCGD 236

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 63.9 bits (156), Expect = 5e-12
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
            GL  LH+A   V++RD    NILL    +  + DF LA+           T  +    Y
Sbjct: 145 LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWY 199

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE V   +  TK  D++S G V+ E+ + +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 63.2 bits (154), Expect = 9e-12
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 11/96 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + ++FLH   + +++RD K  NILLD     +LSDFG +     G++     ++ GT GY
Sbjct: 211 EAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---RELCGTPGY 265

Query: 92  AAPE------YVATGRLTTKSDVYSFGVVLLELLSG 121
            APE               + D+++ GV+L  LL+G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 62.6 bits (153), Expect = 9e-12
 Identities = 28/93 (30%), Positives = 39/93 (41%), Gaps = 9/93 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
             + + H     V +RD K  N L      +   KL DFGLA     G         +GT
Sbjct: 117 SAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGT 171

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             Y +P+ V  G    + D +S GV++  LL G
Sbjct: 172 PYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 62.3 bits (152), Expect = 1e-11
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + L FLH    ++I+RD KA N+L+  E + +L+DFG++ A          + + GT  +
Sbjct: 128 EALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFI-GTPYW 183

Query: 92  AAPEYVATGRLT-----TKSDVYSFGVVLLELLSG 121
            APE V    +       K+D++S G+ L+E+   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 62.2 bits (152), Expect = 1e-11
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 9/93 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
            G+T++H     +++RD K  NILL   + + + K+ DFGL+       +       +GT
Sbjct: 132 SGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGT 186

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 27/94 (28%), Positives = 52/94 (55%), Gaps = 5/94 (5%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAK-AGPTGDRTHVSTQVMGTH 89
           +GL ++H A   V++RD K +N+ ++ E    K+ DFGLA+   P        ++ + T 
Sbjct: 131 RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 90  GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            Y +P  + +    TK+ D+++ G +  E+L+G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 62.4 bits (152), Expect = 2e-11
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 9/94 (9%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 87
              + FLH     + +RD K  N+L    E +A  KL+DFG AK         + T    
Sbjct: 138 GTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-Y 191

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T  Y APE +   +     D++S GV++  LL G
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 62.0 bits (151), Expect = 2e-11
 Identities = 30/99 (30%), Positives = 42/99 (42%), Gaps = 23/99 (23%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ------V 85
           +GL +LH     +I+RD KA NILL      KL DFG             ++        
Sbjct: 165 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFG------------SASIMAPANSF 210

Query: 86  MGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSG 121
           +GT  + APE +          K DV+S G+  +EL   
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 61.8 bits (151), Expect = 2e-11
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 21/129 (16%)

Query: 3   KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 62
           K  +++      P+ L   +         +GL F H+  +++++RD K  N+L++     
Sbjct: 90  KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQL 147

Query: 63  KLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGV 113
           KL DFGLA+A   P    +    +V+ T  Y AP+       Y      +T  D++S G 
Sbjct: 148 KLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPDVLMGSRTY------STSIDIWSCGC 197

Query: 114 VLLELLSGR 122
           +L E+++G+
Sbjct: 198 ILAEMITGK 206

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 50/230 (21%), Positives = 84/230 (36%), Gaps = 35/230 (15%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVM 86
            K + +LH     V++RD K SNIL  D   N    ++ DFG AK     +   +     
Sbjct: 126 TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPC 181

Query: 87  GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 146
            T  + APE +         D++S GV+L  +L+G                    P  + 
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF-------------ANGPDDTP 228

Query: 147 KRKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILER 197
           +  L RI      G++          + TA  L  + L+ +P  R   + VL    I+  
Sbjct: 229 EEILARIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

Query: 198 LEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 247
            + P+       +    +   +    S + + +SP+      S L   R 
Sbjct: 285 DQLPQYQLNRQDAPHLVKGA-MAATYSALNRNQSPVLEPVGRSTLAQRRG 333

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 27/95 (28%), Positives = 44/95 (46%), Gaps = 9/95 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGT 88
           + +  LH     V +RD K  N+L++      KL DFG AK   P+      + ++    
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--- 196

Query: 89  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
             Y APE +   +  TT  D++S G +  E++ G 
Sbjct: 197 --YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 22/111 (19%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           K + +LH     +++RD K SNILL+AE + K++DFGL+++     R   +  +      
Sbjct: 120 KVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 92  AAP--------EYVAT------------GRLTTKSDVYSFGVVLLELLSGR 122
                      +YVAT             + T   D++S G +L E+L G+
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 61.1 bits (149), Expect = 3e-11
 Identities = 25/92 (27%), Positives = 44/92 (47%), Gaps = 7/92 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           + L FLH     + + D +  NI+     ++  K+ +FG A+    GD   +   +    
Sbjct: 113 EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE      ++T +D++S G ++  LLSG
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 61.1 bits (149), Expect = 3e-11
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 90
           +GL FLH    +V++RD K  NIL+ +    KL+DFGLA+        T     V+ T  
Sbjct: 131 RGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-TLW 184

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           Y APE +      T  D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.1 bits (149), Expect = 4e-11
 Identities = 29/103 (28%), Positives = 46/103 (44%), Gaps = 17/103 (16%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           + +  LH +   VI+RD K SN+L+++  + K+ DFGLA+     D +            
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR---IIDESAADNSEPTGQQS 177

Query: 92  AAPEYVAT------------GRLTTKSDVYSFGVVLLELLSGR 122
              E+VAT             + +   DV+S G +L EL   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 9/93 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI+L   +      KL DFG+A     G+       + GT
Sbjct: 120 GVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGT 174

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 41/216 (18%), Positives = 70/216 (32%), Gaps = 33/216 (15%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 87
              ++ +HD    V++RD K  N+L    +     K+ DFG A+  P  +          
Sbjct: 116 VSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCF 171

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 147
           T  YAAPE +         D++S GV+L  +LSG+                 +       
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTC 218

Query: 148 RKLFRIMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERL 198
                IM     G +       +  +  A  L    L  +P  R +MS +     + +  
Sbjct: 219 TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

Query: 199 EAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 234
           +   N        P           + ++      N
Sbjct: 279 QLSSN----PLMTPDILGSSGAAVHTCVKATFHAFN 310

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 61.3 bits (149), Expect = 4e-11
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           GL  +H  E  +++ D K  NI+ + +  +  K+ DFGLA      +   +      T  
Sbjct: 161 GLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAE 215

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           +AAPE V    +   +D+++ GV+   LLSG
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHG 90
           +GL FLH   + +++RD K  NIL+ +    KL+DFGLA+        T     V+ T  
Sbjct: 131 RGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLW 184

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
           Y APE +      T  D++S G +  E+   +
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 60.8 bits (148), Expect = 5e-11
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL ++H A   V++RD K  N+ ++ +   K+ DFGLA+        +V T+      Y
Sbjct: 137 KGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----Y 189

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE + +     ++ D++S G ++ E+L+G+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.8 bits (148), Expect = 5e-11
 Identities = 28/92 (30%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           KGL ++H A   +I+RD K  N+ ++ +   K+ DFGLA+   +    +V T+      Y
Sbjct: 139 KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +      T++ D++S G ++ E+++G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 60.7 bits (148), Expect = 5e-11
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           G+ +LH  ++ +++ D K  NILL       + K+ DFG+++             +MGT 
Sbjct: 143 GVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE +    +TT +D+++ G++   LL+ 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 60.3 bits (147), Expect = 6e-11
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 9/93 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI+L D        KL DFGLA     G        + GT
Sbjct: 127 GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 60.4 bits (147), Expect = 6e-11
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 9/93 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    ++ + D K  NI+L D        KL DFGLA     G        + GT
Sbjct: 127 GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGT 181

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 60.4 bits (147), Expect = 7e-11
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 87
            + + +LH  E+ +++RD K  N+L      +   K++DFGL+K             V G
Sbjct: 158 LEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCG 212

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T GY APE +       + D++S G++   LL G
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 60.4 bits (147), Expect = 8e-11
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
           +GL ++H A+  +I+RD K SN+ ++ +   K+ DFGLA+           T  + T  Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVATRWY 195

Query: 92  AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
            APE +       ++ D++S G ++ ELL+GR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 7/92 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           KGL  +H  E+  ++ D K  NI+         KL DFGL           V     GT 
Sbjct: 266 KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 320

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            +AAPE      +   +D++S GV+   LLSG
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 26/121 (21%), Positives = 47/121 (38%), Gaps = 23/121 (19%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
            G  F+H++   +I+RD K +N LL+ + + K+ DFGLA+   +   T++   +      
Sbjct: 140 LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 92  AAP---------EYVAT------------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 130
                        +V T               T   D++S G +  ELL+   +      
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 131 G 131
            
Sbjct: 258 N 258

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 59.9 bits (146), Expect = 1e-10
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 21/100 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
           +GL + H    +V++RD K  N+L++     KL+DFGLA+A   PT    +   +V+ T 
Sbjct: 111 RGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y  P+       Y      +T+ D++  G +  E+ +GR
Sbjct: 165 WYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 59.4 bits (145), Expect = 1e-10
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 21/100 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
            G+ + HD   +V++RD K  N+L++ E   K++DFGLA+A   P    TH   +++ T 
Sbjct: 111 NGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TL 164

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y AP+       Y      +T  D++S G +  E+++G 
Sbjct: 165 WYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 22/104 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLAKA--GPTGDRTHVSTQV 85
            G+ +LH   + V++RD K +NIL+  E       K++D G A+    P      +   V
Sbjct: 139 DGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 86  MGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
           + T  Y APE       Y      T   D+++ G +  ELL+  
Sbjct: 197 V-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 59.5 bits (145), Expect = 1e-10
 Identities = 30/100 (30%), Positives = 54/100 (54%), Gaps = 21/100 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
           +G+   H    ++++RD K  N+L++++   KL+DFGLA+A   P    TH   +V+ T 
Sbjct: 130 RGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TL 183

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y AP+       Y      +T  D++S G +  E+++G+
Sbjct: 184 WYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 11/95 (11%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 89
            + +LH+  + +I+RD K  N+LL   + +   K++DFG +K             + GT 
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTP 180

Query: 90  GYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 121
            Y APE    V T       D +S GV+L   LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 59.1 bits (144), Expect = 1e-10
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + + + H   + +++R+ K  N+LL ++      KL+DFGLA      +         GT
Sbjct: 116 ESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 170

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            GY +PE +     +   D+++ GV+L  LL G
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 23/95 (24%), Positives = 47/95 (49%), Gaps = 11/95 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG-PTGDRTH-VSTQVMGT 88
           K L + H     +++RD K  N+++D E    +L D+GLA+   P  +    V+++    
Sbjct: 141 KALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--- 195

Query: 89  HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 122
             +  PE +   ++   S D++S G +L  ++  +
Sbjct: 196 --FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 34/104 (32%), Positives = 46/104 (44%), Gaps = 15/104 (14%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 86
           A  L FLH+    + +RD K  NIL    +     K+ DF L       GD + +ST  +
Sbjct: 121 ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 87  ----GTHGYAAPEYVATGRLTTKS-----DVYSFGVVLLELLSG 121
               G+  Y APE V              D++S GV+L  LLSG
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 26/100 (26%), Positives = 48/100 (48%), Gaps = 17/100 (17%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
            GL ++H   +++++RD KA+N+L+  +   KL+DFGLA+A       + +  T  + T 
Sbjct: 135 NGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y  PE       Y          D++  G ++ E+ +  
Sbjct: 193 WYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           + + F+H     + +RD K  N+L++++ N  KL DFG AK     +   V+     +  
Sbjct: 152 RAVGFIHSL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC--SRF 206

Query: 91  YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
           Y APE +      T   D++S G V  EL+ G+
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 9/93 (9%)

Query: 33  GLTFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           G+ +LH    Q+ + D K  NI+L   +      K+ DFGLA     G+       + GT
Sbjct: 126 GVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGT 180

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V    L  ++D++S GV+   LLSG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 59.1 bits (144), Expect = 2e-10
 Identities = 36/100 (36%), Positives = 50/100 (50%), Gaps = 21/100 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
           +GL +LH     +++RD K +N+LLD     KL+DFGLAK+   P    TH   QV+ T 
Sbjct: 123 QGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TR 176

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y APE       Y          D+++ G +L ELL   
Sbjct: 177 WYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 7/91 (7%)

Query: 33  GLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHG 90
           G+  +H  +  +++ D K  NIL         K+ DFGLA+     ++        GT  
Sbjct: 199 GIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPE 253

Query: 91  YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           + APE V    ++  +D++S GV+   LLSG
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 58.3 bits (142), Expect = 3e-10
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 21/100 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
           KGL F H     V++RD K  N+L++     KL++FGLA+A   P    +    +V+ T 
Sbjct: 112 KGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TL 165

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y  P+       Y      +T  D++S G +  EL +  
Sbjct: 166 WYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAG 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 58.6 bits (142), Expect = 3e-10
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 8/94 (8%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 87
            + + +LH     + +RD K  N+L      NA  KL+DFG AK   + +   ++T    
Sbjct: 171 GEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-Y 225

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
           T  Y APE +   +     D++S GV++  LL G
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 58.5 bits (142), Expect = 4e-10
 Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 11/95 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGT 88
           + L ++H     + +RD K  N+LLD      KL DFG AK           + ++    
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--- 206

Query: 89  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
             Y APE +      TT  D++S G V+ EL+ G+
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 57.3 bits (139), Expect = 7e-10
 Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + + + H   + +++R+ K  N+LL ++      KL+DFGLA      +         GT
Sbjct: 139 ESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HGFAGT 193

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            GY +PE +     +   D+++ GV+L  LL G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 57.4 bits (139), Expect = 8e-10
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 11/95 (11%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGD--RTHVSTQVMGT 88
           + L ++H     + +RD K  N+LLD +    KL DFG AK    G+   +++ ++    
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221

Query: 89  HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 122
             Y APE +      T+  DV+S G VL ELL G+
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 56.4 bits (137), Expect = 1e-09
 Identities = 32/100 (32%), Positives = 42/100 (42%), Gaps = 21/100 (21%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
           + + F H      I+RD K  NIL+      KL DFG A+   GP+        +V  T 
Sbjct: 113 QAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVA-TR 166

Query: 90  GYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y +PE       Y          DV++ G V  ELLSG 
Sbjct: 167 WYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 30/93 (32%), Positives = 45/93 (48%), Gaps = 7/93 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + L + H  ++ +I+RD K   +LL   +     KL  FG+A     G+   V+   +GT
Sbjct: 141 EALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGT 196

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
             + APE V         DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 7/93 (7%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGT 88
           + +   H  +  V++R+ K  N+LL      A  KL+DFGLA                GT
Sbjct: 121 EAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGT 176

Query: 89  HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
            GY +PE +         D+++ GV+L  LL G
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 55.7 bits (135), Expect = 2e-09
 Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 9/94 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTH 89
            G+ F H     +I+RD K  NIL+      KL DFG A+    P         +V  T 
Sbjct: 135 NGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---EVA-TR 188

Query: 90  GYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 122
            Y APE  V   +     DV++ G ++ E+  G 
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 55.3 bits (134), Expect = 3e-09
 Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 26/105 (24%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA-----KLSDFGLAKA--GPTGDRTHVSTQ 84
            G+ F H    + ++RD K  N+LL     +     K+ DFGLA+A   P    TH   +
Sbjct: 143 NGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---E 197

Query: 85  VMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 122
           ++ T  Y  PE       Y      +T  D++S   +  E+L   
Sbjct: 198 II-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.2 bits (133), Expect = 5e-09
 Identities = 24/115 (20%), Positives = 44/115 (38%), Gaps = 28/115 (24%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 91
            G+ ++H A   +++RD K +N L++ + + K+ DFGLA+     +  +    +      
Sbjct: 167 VGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 92  AAP--------------EYVAT------------GRLTTKSDVYSFGVVLLELLS 120
                             +V T               T   DV+S G +  ELL+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 7/109 (6%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAG 73
           + +S  +  K A      L FL   E  +I+ D K  NILL     +  K+ DFG +   
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--- 208

Query: 74  PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                  +   +     Y +PE +         D++S G +L+E+ +G 
Sbjct: 209 -CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.9 bits (117), Expect = 4e-07
 Identities = 21/97 (21%), Positives = 41/97 (42%), Gaps = 12/97 (12%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGPTGDRTHVSTQV 85
            GL ++H     +I+ D K  N+L++           K++D G A         H +  +
Sbjct: 142 LGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196

Query: 86  MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                Y +PE +        +D++S   ++ EL++G 
Sbjct: 197 QTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 45.1 bits (107), Expect = 8e-06
 Identities = 16/113 (14%), Positives = 26/113 (23%), Gaps = 34/113 (30%)

Query: 10  LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 69
           +    P P+  A+R       A      H A   V       S + +  + +  L+    
Sbjct: 121 VADTSPSPV-GAIR--AMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA- 174

Query: 70  AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                                              + D+   G  L  LL  R
Sbjct: 175 ---------------------TMPDA-------NPQDDIRGIGASLYALLVNR 199

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 9/93 (9%)

Query: 32  KGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTH 89
           + L  LH    ++I+ D K  NILL  +  +  K+ DFG +      +   V T +    
Sbjct: 211 QCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264

Query: 90  GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
            Y APE +   R     D++S G +L ELL+G 
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 28/167 (16%), Positives = 48/167 (28%), Gaps = 55/167 (32%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----- 59
            L   + +   Q L      K+     +GL +LH  + ++I+ D K  NILL        
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIR 188

Query: 60  --------------------------------------------FNAKLSDFGLAKAGPT 75
                                                          K++D G A     
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248

Query: 76  GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 122
                + T+      Y + E +      T +D++S   +  EL +G 
Sbjct: 249 HFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.9 bits (99), Expect = 9e-05
 Identities = 25/94 (26%), Positives = 37/94 (39%), Gaps = 29/94 (30%)

Query: 31  AKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMG 87
            + + +LH     + +RD K  N+L      NA  KL+DFG AK            +  G
Sbjct: 127 GEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTG 172

Query: 88  THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 121
              Y               D++S GV++  LL G
Sbjct: 173 -EKY-----------DKSCDMWSLGVIMYILLCG 194

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 39.7 bits (93), Expect = 5e-04
 Identities = 37/165 (22%), Positives = 58/165 (35%), Gaps = 30/165 (18%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK- 63
           SLE  LF    +  S    + +A      + ++H      I+RD K  N L+        
Sbjct: 90  SLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNL 146

Query: 64  --LSDFGLAKA-GPTGDRTHV----STQVMGTHGYA---APEYVATGRLTTKSDVYSFGV 113
             + DFGLAK         H+    +  + GT  YA       +   R   + D+ S G 
Sbjct: 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR---RDDLESLGY 203

Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 158
           VL+    G       K               + ++K  RI + K+
Sbjct: 204 VLMYFNLGSLPWQGLKAA-------------TKRQKYERISEKKM 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 39.8 bits (93), Expect = 5e-04
 Identities = 29/128 (22%), Positives = 56/128 (43%), Gaps = 16/128 (12%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK- 63
            L+  ++    +  S    +++++     L ++H+ E   ++ D KASN+LL+ +   + 
Sbjct: 137 DLQ-KIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQV 193

Query: 64  -LSDFGLAKA-GPTGDRTHVS----TQVMGTHGYA---APEYVATGRLTTKSDVYSFGVV 114
            L D+GLA    P G     +        GT  +    A   VA  R   + D+   G  
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYC 250

Query: 115 LLELLSGR 122
           +++ L+G 
Sbjct: 251 MIQWLTGH 258

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 38.9 bits (91), Expect = 8e-04
 Identities = 35/167 (20%), Positives = 59/167 (35%), Gaps = 32/167 (19%)

Query: 5   SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK- 63
           SLE  L     +  S       A      +  +H+    ++YRD K  N L+    +   
Sbjct: 91  SLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNA 147

Query: 64  ----LSDFGLAKA-GPTGDRTHV----STQVMGTHGYAAPEYVAT--GR-LTTKSDVYSF 111
               + DFG+ K       + H+       + GT  Y +   + T  GR  + + D+ + 
Sbjct: 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEAL 204

Query: 112 GVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 158
           G V +  L G       K               ++K+K  RI + K 
Sbjct: 205 GHVFMYFLRGSLPWQGLKAA-------------TNKQKYERIGEKKQ 238

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	252
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.98
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.98
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.98
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.98
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.98
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.78
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.58
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.23
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.84
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.38
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.15
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	97.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	97.96
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	97.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.01
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	96.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.13
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	95.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	95.48
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	95.3
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	95.29
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.11
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.69
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	94.42
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	94.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.28
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	93.96
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	93.64
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	92.35
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.07
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.45
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	91.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	90.9
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.51
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.17
3mes_A	424	Choline kinase; malaria, structural genomics, stru	88.82

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=311.73  Aligned_cols=182  Identities=25%  Similarity=0.435  Sum_probs=143.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||||.++|..... .+++.+++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+|+.........
T Consensus       113 ~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          113 CEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             CCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            689999999976543 4999999999999999999999865  9999999999999999999999999998754433333


Q ss_pred             eeecccccccccCcccccc---CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .....+||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+...                .......+...
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----------------~~~~~~~~~~~  253 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----------------RDQIIFMVGRG  253 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------------HHHHHHHHHTT
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----------------HHHHHHHHhcC
Confidence            3455689999999999964   3589999999999999999999999976432                11122222222


Q ss_pred             cC----CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          158 LG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       158 ~~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ..    ...+..++.++.+||.+||+.||++|||+.+|++.|+.++.+
T Consensus       254 ~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          254 YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            21    234557888999999999999999999999999999888643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-48  Score=319.96  Aligned_cols=172  Identities=22%  Similarity=0.332  Sum_probs=144.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|...+...+++.+++.++.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+......  .
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--E  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--H
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc--c
Confidence            68999999998777666899999999999999999999866  9999999999999999999999999998753321  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.                ...+..++.. ...
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~~-~~~  243 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----------------KNLVLKIISG-SFP  243 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHHT-CCC
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHcC-CCC
Confidence            23456899999999999999999999999999999999999999987531                1122222222 223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++.++.+||.+||++||++|||+.++++
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            455678899999999999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=312.99  Aligned_cols=181  Identities=27%  Similarity=0.413  Sum_probs=144.3

Q ss_pred             CCCCChhhhhhcCCC-------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccc
Q 025440            1 MPKGSLENHLFRRGP-------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF   67 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Df   67 (252)
                      |+||||.++|.+...             .+|++.+++.++.||+.||+|||+++  ||||||||+||||+.++.+||+||
T Consensus       125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~Ki~DF  202 (329)
T 4aoj_A          125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDF  202 (329)
T ss_dssp             CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcEEEccc
Confidence            689999999976532             35999999999999999999999765  999999999999999999999999


Q ss_pred             cccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhh
Q 025440           68 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        68 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                      |+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...                
T Consensus       203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----------------  266 (329)
T 4aoj_A          203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----------------  266 (329)
T ss_dssp             C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----------------
T ss_pred             ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----------------
Confidence            99987655444444456679999999999999999999999999999999999 8999987431                


Q ss_pred             hhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                       ......+....+...|..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       267 -~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          267 -TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             -HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence             11223333444556778889999999999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-47  Score=312.03  Aligned_cols=181  Identities=25%  Similarity=0.429  Sum_probs=152.6

Q ss_pred             CCCCChhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccc
Q 025440            1 MPKGSLENHLFRRG-----------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL   69 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~   69 (252)
                      |+||||.++|.+.+           ...|++.+++.++.||++||+|||+++  ||||||||+||||+.++.+||+|||+
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki~DFGl  174 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGM  174 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEECCccc
Confidence            68999999997653           356999999999999999999999765  99999999999999999999999999


Q ss_pred             cccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           70 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        70 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                      ++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...                 .
T Consensus       175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----------------~  237 (299)
T 4asz_A          175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----------------N  237 (299)
T ss_dssp             HHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------H
T ss_pred             ceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------------H
Confidence            986544333333344568999999999999999999999999999999999 8999987431                 1


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .+...+........|..++.++.+||.+||+.||++|||+.+|++.|+++..
T Consensus       238 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          238 EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2233333444456677889999999999999999999999999999988753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.1e-47  Score=311.68  Aligned_cols=179  Identities=24%  Similarity=0.399  Sum_probs=151.3

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      |+||||.++|..+.+              ..|++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCCCEEECC
Confidence            689999999976432              35999999999999999999999866  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............||+.|||||++.++.|+.++|||||||++|||+| |..||.+...               
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---------------  253 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---------------  253 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---------------
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---------------
Confidence            999986544333333445679999999999999999999999999999999998 8999987531               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                        ..+...+......+.|..++.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       254 --~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          254 --QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              123333344445567788999999999999999999999999999999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.4e-47  Score=314.25  Aligned_cols=181  Identities=28%  Similarity=0.367  Sum_probs=155.3

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      |+||||.++|.+..              ...|++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus       151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~vKi~D  228 (353)
T 4ase_A          151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD  228 (353)
T ss_dssp             CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeCCCCCEEECc
Confidence            68999999997642              234899999999999999999999876  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+...               
T Consensus       229 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~---------------  293 (353)
T 4ase_A          229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------------  293 (353)
T ss_dssp             CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---------------
T ss_pred             chhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH---------------
Confidence            999987655544444556789999999999999999999999999999999998 9999987432               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                       ...+...+....+...|..++.++.+||.+||+.||++|||+.+|++.|+++.
T Consensus       294 -~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          294 -DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             -SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence             12234445555666778888999999999999999999999999999998864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-46  Score=301.83  Aligned_cols=170  Identities=24%  Similarity=0.416  Sum_probs=138.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.++|.+.+.  +++..+..++.||+.||+|||+++.+||||||||+||||+. +|.+||+|||+|+.....   
T Consensus       111 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---  185 (290)
T 3fpq_A          111 MTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---  185 (290)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence            689999999987765  99999999999999999999987666999999999999974 799999999999864332   


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc-
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  158 (252)
                       .....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+...                ...+...+.... 
T Consensus       186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----------------~~~~~~~i~~~~~  247 (290)
T 3fpq_A          186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------------AAQIYRRVTSGVK  247 (290)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------------HHHHHHHHTTTCC
T ss_pred             -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----------------HHHHHHHHHcCCC
Confidence             2345689999999999864 699999999999999999999999976431                111222222211 


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+..+++++.+||.+||++||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11233445678999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.9e-46  Score=307.96  Aligned_cols=179  Identities=25%  Similarity=0.258  Sum_probs=143.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.++|.+.+.  |++..+..++.||+.||+|||+++  ||||||||+||||+.+| .+||+|||+|+........
T Consensus       132 ~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            689999999988765  999999999999999999999765  99999999999999988 5999999999876433211


Q ss_pred             ---eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           80 ---HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        80 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                         ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.....                ....+...
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----------------~~~~i~~~  271 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----------------LCLKIASE  271 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----------------CHHHHHHS
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----------------HHHHHHcC
Confidence               12334679999999999999999999999999999999999999998754211                11111111


Q ss_pred             hc-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          157 KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       157 ~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .. ....+..++..+.+||.+||++||.+|||+.|+++.|....
T Consensus       272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            11 11345678889999999999999999999999999887653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-46  Score=305.93  Aligned_cols=171  Identities=22%  Similarity=0.338  Sum_probs=145.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|.+.+.  +++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|+.........
T Consensus       114 ~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          114 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            689999999988765  999999999999999999999866  9999999999999999999999999998765444333


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|||||++.+..|+.++|||||||++|+|+||..||.+.+.                ......+...  ..
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i~~~--~~  251 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----------------GLIFAKIIKL--EY  251 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHT--CC
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            35567899999999999999999999999999999999999999986431                1122223322  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .++..++.++.+||.+||++||++|||++|++.
T Consensus       252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            556778899999999999999999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-45  Score=302.85  Aligned_cols=170  Identities=22%  Similarity=0.310  Sum_probs=141.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.   .+++.++..++.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+.......  
T Consensus       153 ~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  225 (346)
T 4fih_A          153 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  225 (346)
T ss_dssp             CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--
Confidence            6899999999764   2999999999999999999999876  99999999999999999999999999987543322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh-cC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  159 (252)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.                ...+..+.... ..
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i~~~~~~~  289 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------------LKAMKMIRDNLPPR  289 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHSSCCC
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHcCCCCC
Confidence            23457899999999999999999999999999999999999999976432                11111121111 12


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++.++.+||.+||++||++|||+.|+++
T Consensus       290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2345678899999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.4e-45  Score=298.08  Aligned_cols=169  Identities=30%  Similarity=0.375  Sum_probs=139.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|.+.+.  +++.++..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+|+.......  
T Consensus       108 ~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--  181 (304)
T 3ubd_A          108 LRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  181 (304)
T ss_dssp             CTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--
Confidence            689999999988765  999999999999999999999876  99999999999999999999999999986433222  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.                ......+...  ..
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~~--~~  243 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----------------KETMTMILKA--KL  243 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC--CC
T ss_pred             cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----------------HHHHHHHHcC--CC
Confidence            23456899999999999999999999999999999999999999987532                1112222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~v~~  193 (252)
                      ..|..++.++.+||.+||++||++|||+     +|+++
T Consensus       244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            5567788999999999999999999985     56654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=304.46  Aligned_cols=171  Identities=22%  Similarity=0.304  Sum_probs=141.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++....   +++.++..++.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+.......  
T Consensus       230 ~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          230 LEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             CTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            68999999997543   999999999999999999999876  99999999999999999999999999987544322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh-cC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-LG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  159 (252)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+...                ...+..+.... ..
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----------------~~~~~~i~~~~~~~  366 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----------------LKAMKMIRDNLPPR  366 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHSCCCC
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHcCCCCC
Confidence            23457899999999999999999999999999999999999999976432                11111121111 12


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++.++.+||.+||.+||++|||+.|+++.
T Consensus       367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            23345678899999999999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-44  Score=288.35  Aligned_cols=167  Identities=25%  Similarity=0.354  Sum_probs=131.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.+.+.  +++.++..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+|+......   ..
T Consensus        96 ~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~  168 (275)
T 3hyh_A           96 GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FL  168 (275)
T ss_dssp             CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred             CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC---cc
Confidence            7899999988765  999999999999999999999876  9999999999999999999999999998654322   23


Q ss_pred             ecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           83 TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+.+.                ......+...  ...
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----------------~~~~~~i~~~--~~~  230 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----------------PVLFKNISNG--VYT  230 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHT--CCC
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHcC--CCC
Confidence            45689999999999988876 5799999999999999999999976431                1111112221  234


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+..++.++.+||.+||+.||++|||++|+++.
T Consensus       231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            566788999999999999999999999999873

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-44  Score=293.60  Aligned_cols=196  Identities=23%  Similarity=0.279  Sum_probs=142.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC------CCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      |+||||.++|.+..   +++..++.++.|++.||+|||++      ..+||||||||+||||+.++.+||+|||+++...
T Consensus        83 ~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           83 HEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            68999999997653   99999999999999999999975      2369999999999999999999999999998654


Q ss_pred             CCCcc--eeeecccccccccCccccccC------CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhh
Q 025440           75 TGDRT--HVSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        75 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                      .....  ......+||+.|||||++.+.      .++.++|||||||++|||+||..||.......... ..........
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~~~~  238 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSV  238 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSSCCH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccccchH
Confidence            33221  122346799999999999764      36789999999999999999988876543211110 0000000001


Q ss_pred             hhhHHHHhhhhcCCCCcH-----HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          147 KRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ......+.....+...|.     .++..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            111122233333444433     356788999999999999999999999999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-42  Score=282.16  Aligned_cols=169  Identities=24%  Similarity=0.390  Sum_probs=125.4

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.+++..... ...++..++.++.||++||+|||+++  ||||||||+|||++.+|.+||+|||+|+........
T Consensus        97 ~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~  174 (299)
T 4g31_A           97 CRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE  174 (299)
T ss_dssp             CCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCCCC---------
T ss_pred             CCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEccCccceecCCCccc
Confidence            579999999987654 23567788999999999999999876  999999999999999999999999999875433211


Q ss_pred             ----------eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           80 ----------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        80 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                                ......+||+.|||||++.+..|+.++|||||||++|||++   ||.+...               ....
T Consensus       175 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---------------~~~~  236 (299)
T 4g31_A          175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---------------RVRT  236 (299)
T ss_dssp             -----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---------------HHHH
T ss_pred             cccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---------------HHHH
Confidence                      11234579999999999999999999999999999999996   7754210               0011


Q ss_pred             HHHHhhhhcCCCCc---HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          150 LFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       150 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      +..+    .....+   ...++.+.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 LTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111    111222   334566789999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=280.50  Aligned_cols=188  Identities=23%  Similarity=0.288  Sum_probs=135.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC--cce
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTH   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~   80 (252)
                      +|+|.+++.+.+.  +++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+++.+....  ...
T Consensus       142 ~g~L~~~i~~~~~--l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~  217 (398)
T 4b99_A          142 ESDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY  217 (398)
T ss_dssp             SEEHHHHHTSSSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CC
T ss_pred             CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeecccCcccccc
Confidence            4789999987665  999999999999999999999876  9999999999999999999999999998754322  112


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhh-----hhhhHHH
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLS-----DKRKLFR  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~-----~~~~~~~  152 (252)
                      .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+...... +.... .+...     .......
T Consensus       218 ~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~  297 (398)
T 4b99_A          218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRA  297 (398)
T ss_dssp             CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHH
T ss_pred             ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence            23457899999999998876 46899999999999999999999998765321111 00000 00000     0000001


Q ss_pred             Hhhhhc-CCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          153 IMDTKL-GGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       153 ~~~~~~-~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+.... ....     ...++.++.+||.+||.+||.+|||+.|+++.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          298 YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            110000 0011     12356789999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-40  Score=294.11  Aligned_cols=170  Identities=30%  Similarity=0.407  Sum_probs=140.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|.+.+.  +++..+..++.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+......   
T Consensus       274 ~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~---  346 (689)
T 3v5w_A          274 MNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  346 (689)
T ss_dssp             CCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC---
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeeecCCCC---
Confidence            689999999988766  999999999999999999999765  9999999999999999999999999998754432   


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.....              ...+... .....
T Consensus       347 -~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--------------~~~i~~~-i~~~~  410 (689)
T 3v5w_A          347 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------------KHEIDRM-TLTMA  410 (689)
T ss_dssp             -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--------------HHHHHHH-HHHCC
T ss_pred             -CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHHHh-hcCCC
Confidence             235689999999999964 579999999999999999999999997643211              0111111 11223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ..++..++.++.+||.+||.+||.+|++     +++|++
T Consensus       411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            4567778999999999999999999998     677775

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.3e-40  Score=276.95  Aligned_cols=186  Identities=26%  Similarity=0.295  Sum_probs=131.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDR-   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~-   78 (252)
                      |+||+|.+++.     .+++.++..++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+|+....... 
T Consensus       102 ~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          102 LEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             CCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             CCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            57999999993     2899999999999999999999876  9999999999999876 7999999999976433211 


Q ss_pred             -------------------------ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCccccc
Q 025440           79 -------------------------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI  132 (252)
Q Consensus        79 -------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~  132 (252)
                                               .......+||+.|+|||++.+. .|+.++||||+||++|||+||+.||.......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~  254 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL  254 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence                                     0112345799999999999876 48999999999999999999999996554321


Q ss_pred             chh--hhhhcc-h-------------------hhhhhhhHHHHhh---------------hhcCCCCcHHHHHHHHHHHH
Q 025440          133 EQS--LVDWAK-P-------------------YLSDKRKLFRIMD---------------TKLGGQYPQKAAHTAATLAL  175 (252)
Q Consensus       133 ~~~--~~~~~~-~-------------------~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~  175 (252)
                      ...  +..... +                   ...+.....+.+.               ..........++.++.+||.
T Consensus       255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~  334 (361)
T 4f9c_A          255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD  334 (361)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence            110  000000 0                   0000000000000               00001122346778999999


Q ss_pred             hhccCCCCCCCCHHHHHH
Q 025440          176 QCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       176 ~~l~~dp~~Rpt~~~v~~  193 (252)
                      +||+.||.+|+|++|+++
T Consensus       335 ~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          335 KLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHTCSCTTTSCCHHHHHT
T ss_pred             HHCcCChhHCcCHHHHhc
Confidence            999999999999999986

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.1e-39  Score=284.97  Aligned_cols=172  Identities=22%  Similarity=0.268  Sum_probs=140.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC--CceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.++|.+... .|++.++..++.||+.||+|||+++  |+||||||+|||++.+  +.+||+|||+++.......
T Consensus       236 ~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            689999999975532 3999999999999999999999876  9999999999999754  8899999999987654332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                         ....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+...                ...+..+.....
T Consensus       313 ---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----------------~~~~~~i~~~~~  373 (573)
T 3uto_A          313 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------------DETLRNVKSCDW  373 (573)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHHHHTTCC
T ss_pred             ---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----------------HHHHHHHHhCCC
Confidence               3456899999999999999999999999999999999999999987542                111222222222


Q ss_pred             --CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 --GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 --~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                        .......++.++.+||.+||..||.+|||+.|+++.
T Consensus       374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              122234678899999999999999999999999873

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.3e-39  Score=269.20  Aligned_cols=180  Identities=26%  Similarity=0.413  Sum_probs=149.2

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++.....              ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus       169 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~D  246 (370)
T 2psq_A          169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD  246 (370)
T ss_dssp             CTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECC
T ss_pred             CCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEECCCCCEEEcc
Confidence            578999999987542              34899999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...               
T Consensus       247 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---------------  311 (370)
T 2psq_A          247 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---------------  311 (370)
T ss_dssp             CSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------------
T ss_pred             ccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---------------
Confidence            999986544333222334457889999999999999999999999999999999 9999976432               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                        ......+........+..++.++.+||.+||+.||.+||++.++++.|+++.
T Consensus       312 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          312 --EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             --GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1222333334445566778889999999999999999999999999998864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.1e-39  Score=265.99  Aligned_cols=181  Identities=23%  Similarity=0.400  Sum_probs=147.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus        96 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  172 (325)
T 3kex_A           96 LPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL  172 (325)
T ss_dssp             CTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC
T ss_pred             CCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccCcccccc
Confidence            57899999997653 24899999999999999999999876  9999999999999999999999999998765544433


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...                 ......+.....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  235 (325)
T 3kex_A          173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----------------AEVPDLLEKGER  235 (325)
T ss_dssp             C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----------------THHHHHHHTTCB
T ss_pred             cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----------------HHHHHHHHcCCC
Confidence            3445668889999999999999999999999999999999 9999987532                 112233333334


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++..+.++|.+||+.||.+||++.++++.|+++...
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            455566777899999999999999999999999999988654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.7e-39  Score=264.29  Aligned_cols=196  Identities=23%  Similarity=0.321  Sum_probs=145.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC--------CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA--------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      |+||+|.+++....   +++..++.++.||+.||+|||+.        ..+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~  180 (322)
T 3soc_A          104 HEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK  180 (322)
T ss_dssp             CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence            57899999997643   99999999999999999999975        11599999999999999999999999999976


Q ss_pred             CCCCCcceeeecccccccccCccccccC-----CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      ..............||+.|+|||++.+.     .++.++|||||||++|+|+||..||.+................. ..
T Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~  259 (322)
T 3soc_A          181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-SL  259 (322)
T ss_dssp             ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-CH
T ss_pred             cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-ch
Confidence            5443332223345789999999999763     45678899999999999999999998754322211111100000 11


Q ss_pred             hhHHHH-hhhhcCCCCc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          148 RKLFRI-MDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       148 ~~~~~~-~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...... .........+     ...+.++.+||.+||+.||++|||+.++++.|+++..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111111 1222222222     2456779999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-38  Score=261.63  Aligned_cols=183  Identities=28%  Similarity=0.447  Sum_probs=140.6

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++||+|.+++...+. ..+++..++.++.||+.||+|||+.+.+|+||||||+|||++.++.+||+|||+++......  
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--  193 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--  193 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence            578999999977643 34899999999999999999999765459999999999999999999999999997643321  


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                .............
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----------------~~~~~~~~~~~~~  257 (309)
T 3p86_A          194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----------------AQVVAAVGFKCKR  257 (309)
T ss_dssp             --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----------------HHHHHHHHHSCCC
T ss_pred             cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhcCCC
Confidence            113345789999999999999999999999999999999999999976432                1111122222334


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            456677888999999999999999999999999999987653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-38  Score=263.95  Aligned_cols=181  Identities=22%  Similarity=0.344  Sum_probs=148.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.........
T Consensus        98 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  174 (327)
T 3poz_A           98 MPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  174 (327)
T ss_dssp             CTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--
T ss_pred             cCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEccCCcccc
Confidence            578999999987543 4999999999999999999999875  9999999999999999999999999998754443333


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+|..|+|||++.+..++.++|||||||++|+|+| |..||.+...                 ......+.....
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~~~~~~~~~~  237 (327)
T 3poz_A          175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGER  237 (327)
T ss_dssp             -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHHTTCC
T ss_pred             cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----------------HHHHHHHHcCCC
Confidence            3334557889999999999999999999999999999999 9999976432                 123334444444


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++..+.+++.+||+.||.+||++.++++.|+++...
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            556667888999999999999999999999999999887643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.8e-38  Score=260.22  Aligned_cols=196  Identities=41%  Similarity=0.669  Sum_probs=151.4

Q ss_pred             CCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++.....  ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ  194 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            578999999976542  35999999999999999999999765  99999999999999999999999999986543332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...........+..... ........+....
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  273 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNL  273 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSSSC
T ss_pred             cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccHHHhcChhh
Confidence            222344568999999999999999999999999999999999999998754432222222211100 0011111222233


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            34456778899999999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=262.22  Aligned_cols=181  Identities=22%  Similarity=0.336  Sum_probs=143.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.........
T Consensus        98 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~  174 (327)
T 3lzb_A           98 MPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  174 (327)
T ss_dssp             CSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC-----------
T ss_pred             cCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc
Confidence            578999999987543 4999999999999999999999876  9999999999999999999999999998754433332


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+...                 ......+.....
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~~~~~~~  237 (327)
T 3lzb_A          175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGER  237 (327)
T ss_dssp             -----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHHTTCC
T ss_pred             cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            3334457889999999999999999999999999999999 9999987532                 122333444444


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++.++.+||.+||+.||.+||++.++++.|+++...
T Consensus       238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            556667888999999999999999999999999999988654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3e-38  Score=264.46  Aligned_cols=164  Identities=29%  Similarity=0.397  Sum_probs=137.5

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   97 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   97 (252)
                      +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............||..|+|||++
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  267 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  267 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhh
Confidence            899999999999999999999875  999999999999999999999999999876444443344556789999999999


Q ss_pred             ccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHh
Q 025440           98 ATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQ  176 (252)
Q Consensus        98 ~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  176 (252)
                      .+..++.++|||||||++|+|+| |..||.+...                .......+........+..++.++.++|.+
T Consensus       268 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  331 (359)
T 3vhe_A          268 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLD  331 (359)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred             cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----------------hHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            99999999999999999999998 9999977532                112233333444455666788899999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHhhc
Q 025440          177 CLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       177 ~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ||+.||.+|||+.++++.|+++.
T Consensus       332 ~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          332 CWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HccCChhhCCCHHHHHHHHHHHH
Confidence            99999999999999999998864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-38  Score=264.19  Aligned_cols=182  Identities=28%  Similarity=0.412  Sum_probs=151.5

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++.....              ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       157 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~D  234 (382)
T 3tt0_A          157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIAD  234 (382)
T ss_dssp             CTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECS
T ss_pred             cCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEcCCCcEEEcc
Confidence            578999999987652              35999999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............+|..|+|||++.+..++.++|||||||++|+|++ |..||.+...               
T Consensus       235 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---------------  299 (382)
T 3tt0_A          235 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---------------  299 (382)
T ss_dssp             CSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------
T ss_pred             cCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------------
Confidence            999987654433333344567889999999999999999999999999999999 9999976431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                        ......+........+..++.++.+||.+||+.||++|||+.++++.|+++...
T Consensus       300 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          300 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             --HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence              223333444444555667888999999999999999999999999999987643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.9e-38  Score=258.56  Aligned_cols=181  Identities=27%  Similarity=0.433  Sum_probs=146.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       132 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  208 (325)
T 3kul_A          132 MENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA  208 (325)
T ss_dssp             CTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC----CC
T ss_pred             CCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccccccCccce
Confidence            57899999997654 24999999999999999999999765  999999999999999999999999999876443221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+...                 ......+....
T Consensus       209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~~~~~~  271 (325)
T 3kul_A          209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----------------RDVISSVEEGY  271 (325)
T ss_dssp             EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHHHHHHTTC
T ss_pred             eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHcCC
Confidence            12223356788999999998999999999999999999999 9999976431                 12223333344


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ....+..++..+.+||.+||..||.+|||+.++++.|+.+...
T Consensus       272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            4556677889999999999999999999999999999988643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-38  Score=266.75  Aligned_cols=179  Identities=25%  Similarity=0.369  Sum_probs=146.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+. .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus       194 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             CTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             CCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            579999999976542 3899999999999999999999866  9999999999999999999999999998643322111


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|||+| |..||.+...                 ......+.....
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  333 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----------------QQTREFVEKGGR  333 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----------------HHHHHHHHTTCC
T ss_pred             cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1122235678999999998899999999999999999998 9999976431                 122333444445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+||.+||+.||++|||+.++++.|+++.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            5667778889999999999999999999999999998875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=259.90  Aligned_cols=183  Identities=25%  Similarity=0.340  Sum_probs=149.5

Q ss_pred             CCCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC
Q 025440            1 MPKGSLENHLFRRGP---------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE   59 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~   59 (252)
                      ++||+|.+++.....                     ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.+
T Consensus       131 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~  208 (344)
T 1rjb_A          131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG  208 (344)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEETT
T ss_pred             CCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEcCC
Confidence            578999999976543                     23899999999999999999999765  9999999999999999


Q ss_pred             CceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhh
Q 025440           60 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD  138 (252)
Q Consensus        60 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~  138 (252)
                      +.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|+| |..||.+...        
T Consensus       209 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------  280 (344)
T 1rjb_A          209 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--------  280 (344)
T ss_dssp             TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------
T ss_pred             CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc--------
Confidence            9999999999986544433333445567889999999999999999999999999999998 9999977532        


Q ss_pred             hcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          139 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                              .......+........+..++..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       281 --------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          281 --------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             --------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             --------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                    1122233334444455667788999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-37  Score=253.92  Aligned_cols=171  Identities=26%  Similarity=0.371  Sum_probs=140.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+..   +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        99 ~~~~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            57999999997753   899999999999999999999765  99999999999999999999999999876543322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh-hhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  159 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+. .....
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~~~~~~~~~  235 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYLIATNGTPE  235 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHHCSCC
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCCCC
Confidence            234457999999999999999999999999999999999999999764321                1111111 11223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            34466788899999999999999999999999863

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-37  Score=256.49  Aligned_cols=180  Identities=28%  Similarity=0.392  Sum_probs=148.9

Q ss_pred             CCCCChhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC
Q 025440            1 MPKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA   58 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~   58 (252)
                      ++||+|.+++.....                      ..+++..++.++.||+.||+|||+++  |+||||||+|||++.
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~~  185 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE  185 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEET
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEcC
Confidence            468999999987543                      34899999999999999999999765  999999999999999


Q ss_pred             CCceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhh
Q 025440           59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV  137 (252)
Q Consensus        59 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~  137 (252)
                      ++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+...       
T Consensus       186 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------  258 (314)
T 2ivs_A          186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-------  258 (314)
T ss_dssp             TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-------
T ss_pred             CCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence            99999999999987644433333334457889999999999899999999999999999999 9999976532       


Q ss_pred             hhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          138 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                                ......+........+..++..+.++|.+||+.||.+||++.++++.|+++.
T Consensus       259 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 ----------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             ----------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      1222333333344556678889999999999999999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7e-38  Score=258.73  Aligned_cols=182  Identities=24%  Similarity=0.372  Sum_probs=139.9

Q ss_pred             CCCCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      ++||+|.+++....    ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~  190 (323)
T 3qup_A          113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG  190 (323)
T ss_dssp             CTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEeecccccccccc
Confidence            47899999996442    225999999999999999999999875  999999999999999999999999999875444


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ..........++..|+|||++.+..++.++|||||||++|+|++ |..||.+...                 ......+.
T Consensus       191 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~~~~~  253 (323)
T 3qup_A          191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----------------AEIYNYLI  253 (323)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHH
T ss_pred             ccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----------------HHHHHHHh
Confidence            33333334456889999999999999999999999999999999 9999987532                 11222222


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .......+..++..+.+||.+||+.||.+|||+.++++.|+++...
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            2333455667788999999999999999999999999999987543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-37  Score=254.86  Aligned_cols=182  Identities=27%  Similarity=0.398  Sum_probs=150.4

Q ss_pred             CCCCChhhhhhcCCC----------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEE
Q 025440            1 MPKGSLENHLFRRGP----------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL   64 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl   64 (252)
                      ++||+|.+++.....                ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl  186 (313)
T 1t46_A          109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKI  186 (313)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEEE
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEcCCCCEEE
Confidence            468999999987643                24899999999999999999999765  999999999999999999999


Q ss_pred             ccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchh
Q 025440           65 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY  143 (252)
Q Consensus        65 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  143 (252)
                      +|||+++...............+|..|+|||++.+..++.++||||||+++|+|+| |..||.+....            
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------  254 (313)
T 1t46_A          187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------------  254 (313)
T ss_dssp             CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------------
T ss_pred             ccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch------------
Confidence            99999987655444333444567889999999999999999999999999999999 99999765321            


Q ss_pred             hhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                          ......+........+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       255 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          255 ----SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ----HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                12223333344444556778899999999999999999999999999988643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=259.35  Aligned_cols=182  Identities=26%  Similarity=0.374  Sum_probs=146.2

Q ss_pred             CCCCChhhhhhcCCC----------------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC
Q 025440            1 MPKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA   58 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~   58 (252)
                      ++||+|.+++.....                      ..+++..++.++.||+.||+|||+++  |+||||||+|||++.
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~  209 (343)
T 1luf_A          132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE  209 (343)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred             CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEECC
Confidence            578999999987531                      45999999999999999999999875  999999999999999


Q ss_pred             CCceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhh
Q 025440           59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV  137 (252)
Q Consensus        59 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~  137 (252)
                      ++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|+|++ |..||.+...       
T Consensus       210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------  282 (343)
T 1luf_A          210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-------  282 (343)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------
T ss_pred             CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-------
Confidence            99999999999876433222222334567899999999999999999999999999999999 9999976431       


Q ss_pred             hhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          138 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                                ......+........+..++..+.+||.+||+.||.+||++.++++.|+++...
T Consensus       283 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          283 ----------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             ----------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             ----------HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence                      111222222233345667788999999999999999999999999999987643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-37  Score=249.21  Aligned_cols=178  Identities=26%  Similarity=0.544  Sum_probs=143.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc-----eEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~   75 (252)
                      ++||+|.+++.... ..+++..++.++.|++.||+|||+++.+|+||||||+|||++.++.     +||+|||+++....
T Consensus       103 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~  181 (287)
T 4f0f_A          103 VPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH  181 (287)
T ss_dssp             CTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS
T ss_pred             cCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc
Confidence            46899999997654 3599999999999999999999976545999999999999988776     99999999975332


Q ss_pred             CCcceeeecccccccccCccccc--cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                           ......||+.|+|||++.  ...++.++|||||||++|+|++|..||......              ........
T Consensus       182 -----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------------~~~~~~~~  242 (287)
T 4f0f_A          182 -----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--------------KIKFINMI  242 (287)
T ss_dssp             -----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC--------------HHHHHHHH
T ss_pred             -----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc--------------HHHHHHHH
Confidence                 134457899999999984  445788999999999999999999999764321              11112222


Q ss_pred             hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          154 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      .........+..++..+.+||.+||+.||.+|||+.++++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            333444556677889999999999999999999999999999764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-37  Score=256.66  Aligned_cols=175  Identities=24%  Similarity=0.298  Sum_probs=140.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus        87 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           87 CSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            578999999976655  999999999999999999999765  9999999999999999999999999998654333333


Q ss_pred             eeecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....               ............
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------------~~~~~~~~~~~~  227 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------------QEYSDWKEKKTY  227 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---------------HHHHHHHTTCTT
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---------------HHHHHHhccccc
Confidence            3345679999999999988776 778999999999999999999997654211               011111111222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......++..+.+||.+||+.||.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            22335678889999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5e-37  Score=247.14  Aligned_cols=177  Identities=23%  Similarity=0.374  Sum_probs=146.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+.+..++||||||+|||++.++.++|+|||+......     
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-----  165 (271)
T 3kmu_A           91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----  165 (271)
T ss_dssp             CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-----
T ss_pred             cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-----
Confidence            578999999988776679999999999999999999997655599999999999999999999999888754322     


Q ss_pred             eeecccccccccCccccccCCCCc---ccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                        ....||+.|+|||++.+..++.   ++||||||+++|+|++|..||.+...                ...........
T Consensus       166 --~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~  227 (271)
T 3kmu_A          166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----------------MEIGMKVALEG  227 (271)
T ss_dssp             --TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----------------HHHHHHHHHSC
T ss_pred             --cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----------------HHHHHHHHhcC
Confidence              2245799999999998765544   79999999999999999999976431                12223333344


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .....+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            4556667788999999999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.7e-37  Score=251.40  Aligned_cols=182  Identities=18%  Similarity=0.183  Sum_probs=142.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc-----eEEccccccccCCCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~   77 (252)
                      ||+|.+++...+ ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.     +||+|||+++......
T Consensus        89 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           89 GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            899999998764 34999999999999999999999765  999999999999987776     9999999998654332


Q ss_pred             cc-----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           78 RT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        78 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      ..     .......||..|+|||++.+..++.++||||||+++|+|++|+.||.+........             ....
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-------------~~~~  232 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-------------KYER  232 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-------------HHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-------------HHHH
Confidence            21     11344578999999999999999999999999999999999999998754221111             1111


Q ss_pred             HhhhhcCCC---CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          153 IMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       153 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      +........   ....++.++.+|+.+||+.||++||++.+|++.|+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            111111111   112457789999999999999999999999999988754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-37  Score=262.71  Aligned_cols=178  Identities=22%  Similarity=0.270  Sum_probs=134.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++...+...+++..+..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+++......
T Consensus       141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~  218 (400)
T 1nxk_A          141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  218 (400)
T ss_dssp             CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred             CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence            57899999998876667999999999999999999999765  999999999999987   7889999999998654322


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                         .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......            ......+....
T Consensus       219 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------------~~~~~~i~~~~  283 (400)
T 1nxk_A          219 ---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQ  283 (400)
T ss_dssp             -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC------------CSHHHHHHHTC
T ss_pred             ---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc------------HHHHHHHHcCc
Confidence               123457899999999999999999999999999999999999999764321100            00011111111


Q ss_pred             cCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          158 LGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       158 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...  .....++.++.+||.+||..||.+|||+.++++..
T Consensus       284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            111  12245788899999999999999999999999853

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.6e-37  Score=266.42  Aligned_cols=176  Identities=26%  Similarity=0.431  Sum_probs=147.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....    
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            57999999998876666899999999999999999999765  999999999999999999999999999854322    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....++..|+|||++.+..++.++|||||||++|||+| |..||.+...                 ......+.....
T Consensus       343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~  404 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYK  404 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----------------TTHHHHHHTTCC
T ss_pred             -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence             122356889999999999999999999999999999998 9999976532                 112223334445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            56677889999999999999999999999999999988753

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.8e-38  Score=269.35  Aligned_cols=180  Identities=26%  Similarity=0.454  Sum_probs=148.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~  340 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  340 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-H
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-e
Confidence            57999999997654445899999999999999999999875  99999999999999999999999999986533211 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|||+| |..||.+...                 ......+.....
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~  403 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------------PEVIRALERGYR  403 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHHHHHHHTCC
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1122346788999999998999999999999999999999 9999976431                 122233334445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            56677888999999999999999999999999999988754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-37  Score=255.98  Aligned_cols=196  Identities=43%  Similarity=0.742  Sum_probs=150.1

Q ss_pred             CCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcC-CCCeeeccCCCCceeecCCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  ..+++..++.++.||+.||+|||+. ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  188 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD  188 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence            578999999987643  4599999999999999999999986 1149999999999999999999999999998754332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccc--cchhhhhhcchhhhhhhhHHHHhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG--IEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|..||......  .......+...... .........
T Consensus       189 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  266 (326)
T 3uim_A          189 T-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVD  266 (326)
T ss_dssp             S-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS-SCCSTTSSC
T ss_pred             c-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh-chhhhhhcC
Confidence            2 2234456999999999998889999999999999999999999999642211  11111111111111 111122223


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            3334456677889999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.4e-37  Score=254.46  Aligned_cols=170  Identities=28%  Similarity=0.410  Sum_probs=140.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus        87 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--  160 (337)
T 1o6l_A           87 ANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  160 (337)
T ss_dssp             CTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--
Confidence            579999999987655  999999999999999999999765  99999999999999999999999999986332221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+...                ......+...  ..
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~~i~~~--~~  222 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------ERLFELILME--EI  222 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC--CC
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            23456799999999999999999999999999999999999999976431                1111122221  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~  194 (252)
                      .++..++.++.+||.+||+.||.+||     ++.++++.
T Consensus       223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            45667888999999999999999999     89999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=255.87  Aligned_cols=182  Identities=24%  Similarity=0.384  Sum_probs=142.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            579999999987543 4999999999999999999999866  9999999999999999999999999998654332211


Q ss_pred             ------------eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           81 ------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        81 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                                  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........           .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-----------~  234 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-----------L  234 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----------B
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----------h
Confidence                        01145799999999999999999999999999999999999999876432111100           0


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ........    ..+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       235 ~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          235 NVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             CHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            01111111    2344566789999999999999999999999999988753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=263.62  Aligned_cols=181  Identities=26%  Similarity=0.369  Sum_probs=146.0

Q ss_pred             CCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~   72 (252)
                      |+||+|.+++.....     ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.+|   .+||+|||+++.
T Consensus       156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            578999999976542     34999999999999999999999765  99999999999998655   499999999974


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...                 ....
T Consensus       234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----------------~~~~  296 (367)
T 3l9p_A          234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----------------QEVL  296 (367)
T ss_dssp             HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHH
T ss_pred             cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHH
Confidence            322111122334567899999999999999999999999999999998 9999976431                 2223


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..+........+..++..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            3333334445566778899999999999999999999999999988754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-37  Score=255.98  Aligned_cols=169  Identities=24%  Similarity=0.373  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        96 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  169 (328)
T 3fe3_A           96 ASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--  169 (328)
T ss_dssp             CTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence            579999999987765  999999999999999999999865  99999999999999999999999999976543322  


Q ss_pred             eeecccccccccCccccccCCCC-cccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+....                .....+...  .
T Consensus       170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~--~  230 (328)
T 3fe3_A          170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----------------ELRERVLRG--K  230 (328)
T ss_dssp             -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHC--C
T ss_pred             -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhC--C
Confidence             3446799999999999888875 7999999999999999999999875321                111112221  2


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++.++.+||.+||..||.+|||++++++.
T Consensus       231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            24455678889999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.9e-37  Score=251.61  Aligned_cols=181  Identities=21%  Similarity=0.307  Sum_probs=137.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHh--------cCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH--------DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH--------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++||+|.+++...   .+++..++.++.||+.||+|||        +.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  162 (301)
T 3q4u_A           88 HEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIADLGLAVM  162 (301)
T ss_dssp             CTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence            5789999999543   3999999999999999999999        554  99999999999999999999999999976


Q ss_pred             CCCCCcce--eeecccccccccCccccccC------CCCcccceehhHHHHHHHHhC----------CCCCCCcccccch
Q 025440           73 GPTGDRTH--VSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQ  134 (252)
Q Consensus        73 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~lltg----------~~pf~~~~~~~~~  134 (252)
                      ........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||........ 
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~-  241 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP-  241 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc-
Confidence            43322211  12234789999999999876      455789999999999999999          677754321100 


Q ss_pred             hhhhhcchhhhhhhhHHHHh-hhhcCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          135 SLVDWAKPYLSDKRKLFRIM-DTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                                 ......... ........     ...++..+.+||.+||+.||.+|||+.++++.|+++
T Consensus       242 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          242 -----------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             -----------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                       011111111 11111222     234778999999999999999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.6e-37  Score=259.44  Aligned_cols=181  Identities=25%  Similarity=0.432  Sum_probs=136.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+ ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus       128 ~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  204 (373)
T 2qol_A          128 MENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA  204 (373)
T ss_dssp             CTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccccCCccc
Confidence            57999999997654 34999999999999999999999765  9999999999999999999999999998754332111


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...                 ......+....
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----------------~~~~~~i~~~~  267 (373)
T 2qol_A          205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----------------QDVIKAVDEGY  267 (373)
T ss_dssp             ---------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------------HHHHHHHHTTE
T ss_pred             eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence             1122245778999999999999999999999999999998 9999976431                 12223333444


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ....+..++..+.+||.+||+.||.+||++.++++.|+++...
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            4455667788999999999999999999999999999987543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.9e-37  Score=268.93  Aligned_cols=179  Identities=23%  Similarity=0.368  Sum_probs=150.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...... ..
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  374 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  374 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCc-ee
Confidence            57899999998876667999999999999999999999865  9999999999999999999999999998754332 11


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|||+| |..||.+...                 ......+.....
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  437 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYELLEKDYR  437 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGHHHHHHTTCC
T ss_pred             ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            2223346788999999999999999999999999999999 9999987532                 122334444555


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            5667788899999999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-37  Score=254.17  Aligned_cols=181  Identities=28%  Similarity=0.366  Sum_probs=148.8

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++.....              ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D  191 (316)
T 2xir_A          114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD  191 (316)
T ss_dssp             CTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEECC
Confidence            468999999977653              22899999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............+|..|+|||++.+..++.++||||||+++|+|+| |..||.+....              
T Consensus       192 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------------  257 (316)
T 2xir_A          192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------  257 (316)
T ss_dssp             CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--------------
T ss_pred             CccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--------------
Confidence            999987654443333445567899999999999999999999999999999998 99999764321              


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                        ......+........+..++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       258 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          258 --EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             --HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1122223333334455667889999999999999999999999999998874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3e-37  Score=250.19  Aligned_cols=178  Identities=26%  Similarity=0.353  Sum_probs=135.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  172 (281)
T 1mp8_A           97 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-  172 (281)
T ss_dssp             CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccccCccccc-
Confidence            46899999997654 34999999999999999999999765  999999999999999999999999999875433221 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....                 .....+.....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----------------~~~~~i~~~~~  235 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIGRIENGER  235 (281)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHHHHHTTCC
T ss_pred             ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----------------HHHHHHHcCCC
Confidence            1233456789999999998999999999999999999997 99999764321                 11122222333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.++|.+||+.||++|||+.++++.|+++.
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4456678889999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.4e-37  Score=250.28  Aligned_cols=181  Identities=27%  Similarity=0.466  Sum_probs=133.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          101 CEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             cCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccccccc
Confidence            46899999996554 34999999999999999999999765  9999999999999999999999999997654332222


Q ss_pred             eeecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......||..|+|||++.   +..++.++||||||+++|+|++|..||.+...                .......+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~~~~~~~~~  241 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----------------RDQIIEMVGRG  241 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC----------------HHHHHHHHHHT
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch----------------HHHHHHHhccc
Confidence            334457899999999986   56788899999999999999999999976432                11112222111


Q ss_pred             c-C---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          158 L-G---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       158 ~-~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      . .   ......++..+.+||.+||+.||.+|||+.++++.|+++..
T Consensus       242 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            1 1   12234677899999999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=257.10  Aligned_cols=175  Identities=23%  Similarity=0.347  Sum_probs=136.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.+|+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++ ++.+||+|||+++.........
T Consensus        90 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           90 CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             CCSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence            468899999988765  999999999999999999999765  99999999999997 6789999999998765443333


Q ss_pred             eeecccccccccCcccccc-----------CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....               ....
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------------~~~~  229 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------QISK  229 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------------HHHH
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---------------HHHH
Confidence            3445679999999999865           6788999999999999999999999975321               1122


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ....+........+...+..+.+||.+||+.||.+|||+.++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            3334444444555666677899999999999999999999999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-37  Score=253.91  Aligned_cols=181  Identities=25%  Similarity=0.411  Sum_probs=148.4

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++.....              ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~D  200 (334)
T 2pvf_A          123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD  200 (334)
T ss_dssp             CTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECC
T ss_pred             CCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEcCCCCEEEcc
Confidence            468999999976542              24899999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...               
T Consensus       201 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---------------  265 (334)
T 2pvf_A          201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---------------  265 (334)
T ss_dssp             CTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------
T ss_pred             ccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---------------
Confidence            999987654433333334457889999999988889999999999999999999 9999976431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        ......+........+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       266 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 --EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              11222333333445566778899999999999999999999999999988753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.3e-37  Score=258.48  Aligned_cols=173  Identities=27%  Similarity=0.422  Sum_probs=136.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++......  .
T Consensus       135 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~  208 (396)
T 4dc2_A          135 VNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D  208 (396)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecccCC--C
Confidence            579999999987665  999999999999999999999776  9999999999999999999999999998632222  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.........        .......+...+ .....
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~~~~~~i-~~~~~  279 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVI-LEKQI  279 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHHHHH-HHCCC
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHHHHHHHH-hcccc
Confidence            234568999999999999999999999999999999999999999753221100        000111111111 12234


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      .++..++.++.+||.+||+.||.+||++
T Consensus       280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            5667788999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.7e-37  Score=252.06  Aligned_cols=196  Identities=22%  Similarity=0.323  Sum_probs=147.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        95 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (295)
T 3ugc_A           95 LPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF  171 (295)
T ss_dssp             CTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC---------
T ss_pred             CCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCcccccccCCccee
Confidence            579999999977643 4899999999999999999999765  999999999999999999999999999875433221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++||||||+++|+|+||..||................ ...........+.....
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  250 (295)
T 3ugc_A          172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-GQMIVFHLIELLKNNGR  250 (295)
T ss_dssp             ----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC-THHHHHHHHHHHHTTCC
T ss_pred             eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc-cchhHHHHHHHHhccCc
Confidence            12233457788999999999999999999999999999999999987643211111111000 00011123333444445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++.++.+||.+||+.||++|||+.++++.|+++..
T Consensus       251 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            56677888999999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-37  Score=266.03  Aligned_cols=180  Identities=29%  Similarity=0.426  Sum_probs=144.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~  336 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  336 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCce-e
Confidence            57899999997654445999999999999999999999765  99999999999999999999999999986543221 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..||.+...                 ......+.....
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~  399 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYR  399 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCC
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1223456789999999999999999999999999999999 9999976431                 122233334445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+||.+||+.||++|||+.++++.|+.+..
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            56677888999999999999999999999999999988753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=259.32  Aligned_cols=169  Identities=28%  Similarity=0.415  Sum_probs=136.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++......  .
T Consensus       106 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~  179 (353)
T 3txo_A          106 VNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--V  179 (353)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecccCC--c
Confidence            579999999987765  999999999999999999999875  9999999999999999999999999998533222  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~--~~  241 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----------------DDLFEAILND--EV  241 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC--CC
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence            23456799999999999988999999999999999999999999987532                1112222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH------HHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM------SEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~------~~v~~  193 (252)
                      .++..++..+.+||.+||..||.+||++      .++++
T Consensus       242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            4556678899999999999999999998      67765

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.7e-37  Score=250.83  Aligned_cols=181  Identities=24%  Similarity=0.377  Sum_probs=140.2

Q ss_pred             CCCCChhhhhhcC----CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      ++||+|.+++...    ....+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~  200 (313)
T 3brb_A          123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG  200 (313)
T ss_dssp             CTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEEECSCSCC------
T ss_pred             ccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEEeecCcceecccc
Confidence            4689999999532    3355999999999999999999999765  999999999999999999999999999865443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ..........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+.
T Consensus       201 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~  263 (313)
T 3brb_A          201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----------------HEMYDYLL  263 (313)
T ss_dssp             ----------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGHHHHHH
T ss_pred             cccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----------------HHHHHHHH
Confidence            32222334457889999999999999999999999999999999 8999976432                 11222222


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .......+..++..+.++|.+||..||.+|||+.++++.|+++..
T Consensus       264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          264 HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            333445566788899999999999999999999999999988753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.3e-37  Score=246.99  Aligned_cols=180  Identities=25%  Similarity=0.391  Sum_probs=145.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+ ..+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.+||+|||++......... 
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-  160 (268)
T ss_dssp             CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred             cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence            57899999997654 34899999999999999999999765  999999999999999999999999999875443322 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.....                 ............
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  223 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------------SEVVLKVSQGHR  223 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHTTCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----------------HHHHHHHHcCCC
Confidence            2233456778999999998899999999999999999999 9999976432                 111122222333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            344556678899999999999999999999999999988653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-37  Score=260.23  Aligned_cols=174  Identities=23%  Similarity=0.349  Sum_probs=136.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.+|+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++ ++.+||+|||+++.........
T Consensus       137 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          137 CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             CCSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            457899999988764  899999999999999999999765  99999999999995 5889999999998764433322


Q ss_pred             eeecccccccccCcccccc-----------CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....               ....
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---------------~~~~  276 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------QISK  276 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------------HHHH
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---------------HHHH
Confidence            3345679999999999865           3688999999999999999999999975321               1122


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      +..++........+...+..+.+||.+||+.||.+|||+.++++.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            333344444444555567789999999999999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=257.72  Aligned_cols=187  Identities=17%  Similarity=0.169  Sum_probs=139.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC--ceEEccccccccCCCCCcc-
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ||+|.+++...+  .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++  .+||+|||+++........ 
T Consensus       135 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~  210 (345)
T 2v62_A          135 GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK  210 (345)
T ss_dssp             EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCC
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccc
Confidence            789999998766  4999999999999999999999765  99999999999998877  9999999999765322111 


Q ss_pred             ----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           80 ----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        80 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                          .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.......... ........   ....+.
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~---~~~~~~  286 (345)
T 2v62_A          211 QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT-AKTNLLDE---LPQSVL  286 (345)
T ss_dssp             CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH-HHHHHHHT---TTHHHH
T ss_pred             cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH-HHHhhccc---ccHHHH
Confidence                1113457899999999999999999999999999999999999999653211110000 00000000   000000


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..   .....++.++.++|.+||+.||++||++.+|++.|+.+..
T Consensus       287 ~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          287 KW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             hh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            00   0011466789999999999999999999999999987654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-37  Score=256.84  Aligned_cols=181  Identities=27%  Similarity=0.369  Sum_probs=147.1

Q ss_pred             CCCCChhhhhhcCC------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccc
Q 025440            1 MPKGSLENHLFRRG------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG   68 (252)
Q Consensus         1 ~~ggsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg   68 (252)
                      ++||+|.+++....            ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus       132 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg  209 (333)
T 2i1m_A          132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFG  209 (333)
T ss_dssp             CTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGGGEEEBCCCG
T ss_pred             CCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCCCeEEECccc
Confidence            46899999997542            235899999999999999999999765  9999999999999999999999999


Q ss_pred             ccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhh
Q 025440           69 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      +++...............+|..|+|||++.+..++.++||||||+++|+|+| |..||.+...                .
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----------------~  273 (333)
T 2i1m_A          210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----------------N  273 (333)
T ss_dssp             GGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----------------S
T ss_pred             cccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----------------h
Confidence            9986543333333344567889999999999999999999999999999998 9999976432                1


Q ss_pred             hhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          148 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...............+..++..+.+||.+||+.||.+|||+.++++.|+++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1222333334444555667889999999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.1e-37  Score=249.05  Aligned_cols=182  Identities=21%  Similarity=0.198  Sum_probs=142.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ||+|.+++..... .+++..++.++.||+.||+|||+++  |+||||||+|||+   +.++.+||+|||+++........
T Consensus        88 ~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            8999999975443 4999999999999999999999876  9999999999999   78899999999999865443221


Q ss_pred             -----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           80 -----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        80 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                           .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........             ...+.
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------------~~~~~  231 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-------------YERIS  231 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-------------HHHHH
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-------------hhhhh
Confidence                 112345789999999999999999999999999999999999999987543211110             11111


Q ss_pred             hhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          155 DTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       155 ~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ........   ...++..+.+||.+||+.||++|||+.++++.|+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            11111111   12346789999999999999999999999999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.2e-37  Score=254.97  Aligned_cols=169  Identities=27%  Similarity=0.434  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus       103 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--  176 (353)
T 2i0e_A          103 VNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--  176 (353)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc--
Confidence            579999999987665  999999999999999999999765  99999999999999999999999999986332221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+...                ......+...  ..
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~--~~  238 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSIMEH--NV  238 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC--CC
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhC--CC
Confidence            23456799999999999999999999999999999999999999976431                1112222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      .++..++.++.+||.+||..||.+||+     +.++++
T Consensus       239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            456678889999999999999999995     466664

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.1e-37  Score=251.89  Aligned_cols=179  Identities=23%  Similarity=0.346  Sum_probs=138.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++....... .
T Consensus        93 ~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  167 (294)
T 4eqm_A           93 IEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-T  167 (294)
T ss_dssp             CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-c
Confidence            578999999987765  999999999999999999999766  99999999999999999999999999986543321 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC-
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (252)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....                ......+..... 
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------------~~~~~~~~~~~~~  231 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----------------SIAIKHIQDSVPN  231 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----------------HHHHHHHSSCCCC
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHhhccCCC
Confidence            233456899999999999999999999999999999999999999875321                001111111100 


Q ss_pred             --CCCcHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcC
Q 025440          160 --GQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEA  200 (252)
Q Consensus       160 --~~~~~~~~~~~~~li~~~l~~dp~~Rp-t~~~v~~~l~~~~~  200 (252)
                        ......++..+.++|.+||+.||.+|| ++.++.+.|+.+..
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence              012234678899999999999999999 89999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=248.23  Aligned_cols=181  Identities=27%  Similarity=0.400  Sum_probs=140.1

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCC-CCeeeccCCCCceeecCCCc-eEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~-~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++..... ..+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            578999999987654 24789999999999999999999733 46999999999999998886 799999999754322 


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                          .....||..|+|||++.+..++.++||||||+++|+|++|+.||......               ...........
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~~~~~~~~~~  220 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---------------AFRIMWAVHNG  220 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---------------HHHHHHHHHTT
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---------------HHHHHHHHhcC
Confidence                22346899999999999989999999999999999999999999754321               00111112222


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .....+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            33445567788999999999999999999999999999987543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.2e-37  Score=248.58  Aligned_cols=179  Identities=23%  Similarity=0.372  Sum_probs=150.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+.+  |+|+||||+||+++.++.++|+|||++........ .
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~  167 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  167 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-E
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-c
Confidence            46899999998877777999999999999999999999765  99999999999999999999999999987543322 2


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+.....
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----------------~~~~~~~~~~~~  230 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQVYELLEKDYR  230 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGHHHHHHTTCC
T ss_pred             cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhccCC
Confidence            2334456889999999999999999999999999999999 9999976532                 122333344445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            5566778889999999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-37  Score=258.51  Aligned_cols=188  Identities=17%  Similarity=0.156  Sum_probs=141.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec--CCCceEEccccccccCCCCCcc-
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++  .++.+||+|||+++........ 
T Consensus       135 g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~  211 (364)
T 3op5_A          135 GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK  211 (364)
T ss_dssp             EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCC
T ss_pred             CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCccc
Confidence            789999997753 34999999999999999999999875  99999999999998  8899999999999765332111 


Q ss_pred             ----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           80 ----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        80 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                          .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.......  ......  .........+.
T Consensus       212 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~--~~~~~~--~~~~~~~~~~~  287 (364)
T 3op5_A          212 AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--VRDSKI--RYRENIASLMD  287 (364)
T ss_dssp             CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH--HHHHHH--HHHHCHHHHHH
T ss_pred             ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH--HHHHHH--HhhhhHHHHHH
Confidence                1113345999999999999999999999999999999999999999864321110  000000  00011111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...   ....++.++.+++..||+.||.+||++.+|++.|+.+..
T Consensus       288 ~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          288 KCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             HHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             Hhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            111   113456789999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.9e-37  Score=246.92  Aligned_cols=179  Identities=26%  Similarity=0.392  Sum_probs=145.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++....... .
T Consensus        87 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             CTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            578999999966543 4899999999999999999999765  99999999999999999999999999976433211 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+.....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----------------~~~~~~~~~~~~  225 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDISTGFR  225 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----------------HHHHHHHhcCcc
Confidence            1223356778999999999999999999999999999999 9999976432                 112222233334


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            45556678889999999999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.7e-37  Score=248.40  Aligned_cols=178  Identities=24%  Similarity=0.324  Sum_probs=145.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++..........
T Consensus        99 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A           99 AELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             CTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence            468999999987654  999999999999999999999765  9999999999999999999999999998754433221


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+....
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~~~  237 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGE  237 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTC
T ss_pred             cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence             1223346788999999998889999999999999999999 9999976431                 12223333333


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+..++..+.++|.+||+.||.+||++.++++.|+++.
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            44556678889999999999999999999999999998864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-36  Score=249.85  Aligned_cols=186  Identities=23%  Similarity=0.330  Sum_probs=138.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC------CCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      ++||+|.+++...   .+++..++.++.|++.||+|||+.      ..+|+||||||+|||++.++.+||+|||+++...
T Consensus       117 ~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~  193 (337)
T 3mdy_A          117 HENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI  193 (337)
T ss_dssp             CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             cCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeec
Confidence            5789999999765   399999999999999999999976      2259999999999999999999999999997654


Q ss_pred             CCCcce--eeecccccccccCccccccCCCCcc------cceehhHHHHHHHHhC----------CCCCCCcccccchhh
Q 025440           75 TGDRTH--VSTQVMGTHGYAAPEYVATGRLTTK------SDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSL  136 (252)
Q Consensus        75 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Di~slG~il~~lltg----------~~pf~~~~~~~~~~~  136 (252)
                      ......  ......||+.|+|||++.+..++..      +|||||||++|||+||          ..||.......    
T Consensus       194 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~----  269 (337)
T 3mdy_A          194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD----  269 (337)
T ss_dssp             ---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS----
T ss_pred             cccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC----
Confidence            332211  1124578999999999987766655      9999999999999999          44544321110    


Q ss_pred             hhhcchhhhhhhhHHHH-hhhhcCCCCc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          137 VDWAKPYLSDKRKLFRI-MDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       137 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                              ......... .........+     ..++..+.+||.+||+.||.+|||+.++++.|+++...
T Consensus       270 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          270 --------PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             --------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence                    001111111 1122222333     26788999999999999999999999999999987643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-36  Score=246.94  Aligned_cols=178  Identities=25%  Similarity=0.347  Sum_probs=142.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++......... 
T Consensus        94 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  169 (281)
T 3cc6_A           94 YPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-  169 (281)
T ss_dssp             CTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred             CCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCccccccccc-
Confidence            47899999997654 34899999999999999999999765  999999999999999999999999999865433221 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||......                 .....+.....
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----------------~~~~~~~~~~~  232 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----------------DVIGVLEKGDR  232 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----------------GHHHHHHHTCC
T ss_pred             ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----------------HHHHHHhcCCC
Confidence            1233456889999999998999999999999999999998 99999754321                 11222223333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.++|.+||+.||++||++.++++.|+.+.
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            4455667888999999999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-37  Score=256.81  Aligned_cols=181  Identities=27%  Similarity=0.381  Sum_probs=136.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       173 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~  249 (373)
T 3c1x_A          173 MKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  249 (373)
T ss_dssp             CTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             CCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccccccc
Confidence            57899999997654 34899999999999999999999765  999999999999999999999999999865332211 


Q ss_pred             -eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       .......++..|+|||++.+..++.++|||||||++|+|+| |..||.+....                 .....+...
T Consensus       250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----------------~~~~~~~~~  312 (373)
T 3c1x_A          250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----------------DITVYLLQG  312 (373)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----------------CHHHHHHTT
T ss_pred             ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----------------HHHHHHHcC
Confidence             11233457789999999999999999999999999999999 77788664321                 111112222


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .....+..++..+.++|.+||+.||++||++.++++.|+++...
T Consensus       313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            23344566788999999999999999999999999999987543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.9e-37  Score=266.58  Aligned_cols=181  Identities=22%  Similarity=0.233  Sum_probs=142.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ||+|.+++..... .+++..++.++.||+.||+|||+++  ||||||||+||||   +.++.+||+|||+++........
T Consensus        86 g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            8999999976443 4999999999999999999999765  9999999999999   58899999999999875443221


Q ss_pred             -----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           80 -----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        80 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                           .......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........             +..+.
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-------------~~~i~  229 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-------------YEKIS  229 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH-------------HHHHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH-------------HHHHh
Confidence                 112356799999999999999999999999999999999999999987543211111             11111


Q ss_pred             hhhcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          155 DTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       155 ~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ......   .....++.++.+||.+||+.||++||++.+|++.|+.+.
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            111111   111345678999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-36  Score=251.30  Aligned_cols=181  Identities=20%  Similarity=0.221  Sum_probs=140.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc-----eEEccccccccCCCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~   77 (252)
                      ||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.     +||+|||+++......
T Consensus        88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           88 GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            899999998753 34999999999999999999999765  999999999999998887     9999999998653322


Q ss_pred             cce-----eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           78 RTH-----VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        78 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      ...     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........             ....
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-------------~~~~  231 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-------------RYQK  231 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH-------------HHHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH-------------HHHH
Confidence            111     1245679999999999999999999999999999999999999998754221110             0111


Q ss_pred             HhhhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          153 IMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       153 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      +.........   ...++ ++.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            1111110000   11234 89999999999999999999999999987643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.1e-37  Score=253.58  Aligned_cols=199  Identities=19%  Similarity=0.285  Sum_probs=141.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC-------CCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      |+||+|.+++....   +++..++.++.||+.||+|||+.       ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        94 ~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~  170 (336)
T 3g2f_A           94 YPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL  170 (336)
T ss_dssp             CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence            57999999997654   68999999999999999999976       115999999999999999999999999999765


Q ss_pred             CCCCc------ceeeecccccccccCcccccc-------CCCCcccceehhHHHHHHHHhCCCCCCCcccccc-hhhhhh
Q 025440           74 PTGDR------THVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDW  139 (252)
Q Consensus        74 ~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~-~~~~~~  139 (252)
                      .....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||........ ......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  250 (336)
T 3g2f_A          171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT  250 (336)
T ss_dssp             SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred             ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence            43211      111234579999999999976       3566789999999999999999777644322111 100000


Q ss_pred             cchhhhhhhhHHHHh-hhhcCCCCc------HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCC
Q 025440          140 AKPYLSDKRKLFRIM-DTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK  202 (252)
Q Consensus       140 ~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~  202 (252)
                      ............... ........+      ..++..+.+||.+||+.||++|||+.++++.|+++....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            000000111111111 111222222      246778999999999999999999999999999876443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4e-36  Score=258.10  Aligned_cols=171  Identities=24%  Similarity=0.259  Sum_probs=139.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec---CCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++   .++.+||+|||++.......
T Consensus        92 ~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           92 VTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             CBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            578999999988765  999999999999999999999875  99999999999998   46789999999998754432


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+....
T Consensus       168 ~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----------------~~~~~~i~~~~  229 (444)
T 3soa_A          168 Q--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----------------HRLYQQIKAGA  229 (444)
T ss_dssp             C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHHTC
T ss_pred             c--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----------------HHHHHHHHhCC
Confidence            2  13346799999999999988999999999999999999999999976431                11112222222


Q ss_pred             cC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..  ......++.++.+||.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            21  1222467889999999999999999999999987

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-36  Score=249.05  Aligned_cols=166  Identities=27%  Similarity=0.409  Sum_probs=139.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.....    
T Consensus        88 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----  159 (318)
T 1fot_A           88 IEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  159 (318)
T ss_dssp             CCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence            579999999987765  999999999999999999999765  999999999999999999999999999865332    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......++..  ..
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------------~~~~~~i~~~--~~  220 (318)
T 1fot_A          160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------------MKTYEKILNA--EL  220 (318)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHC--CC
T ss_pred             -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhC--CC
Confidence             2345799999999999999999999999999999999999999976431                1112222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      .++..++.++.+||.+||..||.+||     +++++++
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            45567788999999999999999999     8888885

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-36  Score=246.70  Aligned_cols=194  Identities=39%  Similarity=0.633  Sum_probs=147.0

Q ss_pred             CCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++||+|.+++.... ...+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.+||+|||++.........
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            47899999997432 345999999999999999999999765  999999999999999999999999999875544333


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......||..|+|||++.+ .++.++||||||+++|+|++|..||........  ...+..........+...+... .
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~  265 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKK-M  265 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSS-C
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHHHHHhhhhhhhhhhhcccc-c
Confidence            33445578999999998864 588999999999999999999999987543211  1111000000111111222211 1


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            23456778899999999999999999999999999998753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.6e-37  Score=255.08  Aligned_cols=169  Identities=28%  Similarity=0.430  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus       100 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--  173 (345)
T 1xjd_A          100 LNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--  173 (345)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--
Confidence            579999999987655  999999999999999999999865  99999999999999999999999999986432221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+...                ......+..  ...
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~~i~~--~~~  235 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----------------EELFHSIRM--DNP  235 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHH--CCC
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----------------HHHHHHHHh--CCC
Confidence            13456799999999999999999999999999999999999999976432                111111211  123


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH-HHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS-EVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~-~v~~  193 (252)
                      .++..++.++.+||.+||..||.+||++. ++++
T Consensus       236 ~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          236 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence            45566788999999999999999999997 6653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-36  Score=247.13  Aligned_cols=183  Identities=21%  Similarity=0.211  Sum_probs=142.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCCCCcc
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ||+|.+++.... ..+++..++.++.||+.||+|||+++  |+||||||+|||+   +.++.+||+|||++.........
T Consensus        88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            899999997544 34999999999999999999999765  9999999999999   47889999999999865443221


Q ss_pred             -----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           80 -----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        80 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                           .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+........             ....+.
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------------~~~~~~  231 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-------------KYERIS  231 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-------------HHHHHH
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-------------hhhhhc
Confidence                 11234578999999999999999999999999999999999999998754221111             011111


Q ss_pred             hhhcCCC---CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          155 DTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       155 ~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .......   ....++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence            1111111   1134567899999999999999999999999999887543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-36  Score=253.03  Aligned_cols=170  Identities=26%  Similarity=0.332  Sum_probs=137.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----ceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~   76 (252)
                      ++||+|.+++...+.  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++    .+||+|||++......
T Consensus        97 ~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~  172 (361)
T 2yab_A           97 VSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (361)
T ss_dssp             CCSCBHHHHHTTCSC--CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence            579999999977654  999999999999999999999765  99999999999998877    7999999999875443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...
T Consensus       173 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----------------~~~~~i~~~  233 (361)
T 2yab_A          173 VE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------------ETLANITAV  233 (361)
T ss_dssp             CC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHTT
T ss_pred             Cc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhc
Confidence            22   23457999999999999889999999999999999999999999764321                111111111


Q ss_pred             hcCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  .....++..+.+||.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1110  112346778999999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.9e-37  Score=272.38  Aligned_cols=178  Identities=24%  Similarity=0.329  Sum_probs=145.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc-c
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-T   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~   79 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++....... .
T Consensus       451 ~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          451 AELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             CTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             cCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            579999999987654  999999999999999999999865  99999999999999999999999999987544322 1


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+...                 ......+....
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGE  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence            22233456789999999999999999999999999999998 9999987531                 22334444555


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+..++.++.+||.+||+.||++||++.+|++.|+.+.
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            56677788999999999999999999999999999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.1e-37  Score=252.16  Aligned_cols=181  Identities=24%  Similarity=0.371  Sum_probs=144.9

Q ss_pred             CCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRG--------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++||+|.+++....        ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~kl~Dfg~~~~  187 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD  187 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCeEEECcCccccc
Confidence            46899999997532        134799999999999999999999765  99999999999999999999999999976


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ....
T Consensus       188 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------------~~~~  250 (322)
T 1p4o_A          188 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----------------EQVL  250 (322)
T ss_dssp             GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------------HHHH
T ss_pred             cccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----------------HHHH
Confidence            433222222233456889999999999999999999999999999999 8999976431                 1112


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..+........+..++..+.+||.+||+.||.+|||+.++++.|+++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2222222234456778899999999999999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.2e-37  Score=247.27  Aligned_cols=180  Identities=26%  Similarity=0.418  Sum_probs=146.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+||+++.++.+||+|||++........ .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            46899999997654335999999999999999999999765  99999999999999999999999999987543321 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+.....
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------------~~~~~~~~~~~~  228 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------------PEVIQNLERGYR  228 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTCC
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----------------HHHHHHHhcccC
Confidence            1223456788999999988889999999999999999999 9999976431                 112222233334


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            44556778899999999999999999999999999988753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-36  Score=244.38  Aligned_cols=175  Identities=29%  Similarity=0.456  Sum_probs=136.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCC-CeeeccCCCCceeecC--------CCceEEccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES-QVIYRDFKASNILLDA--------EFNAKLSDFGLAK   71 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~ivH~dlkp~Nill~~--------~~~~kl~Dfg~~~   71 (252)
                      ++||+|.+++...   .+++..++.++.|++.||+|||+.+. +|+||||||+|||++.        ++.+||+|||++.
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~  164 (271)
T 3dtc_A           88 ARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR  164 (271)
T ss_dssp             CTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred             CCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence            4689999999543   49999999999999999999997652 2899999999999986        6789999999997


Q ss_pred             cCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           72 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        72 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ......    .....||..|+|||++.+..++.++||||||+++|+|++|..||.+...                .....
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~~~~~  224 (271)
T 3dtc_A          165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----------------LAVAY  224 (271)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----------------HHHHH
T ss_pred             cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHH
Confidence            643322    2234689999999999999999999999999999999999999976431                11122


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...........+..++..+.++|.+||+.||.+|||+.++++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            22333334455667788999999999999999999999999999753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-36  Score=250.15  Aligned_cols=180  Identities=24%  Similarity=0.438  Sum_probs=139.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       128 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  204 (333)
T 1mqb_A          128 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT  204 (333)
T ss_dssp             CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence            46899999997654 34999999999999999999999765  999999999999999999999999999875433211 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+....
T Consensus       205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------------~~~~~~~~~~~  267 (333)
T 1mqb_A          205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------------HEVMKAINDGF  267 (333)
T ss_dssp             ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTC
T ss_pred             cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHHCCC
Confidence            11223346788999999998999999999999999999999 9999976431                 11222223333


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ....+..++..+.++|.+||+.||.+||++.++++.|+++..
T Consensus       268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            344556778899999999999999999999999999988754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-36  Score=246.11  Aligned_cols=180  Identities=26%  Similarity=0.379  Sum_probs=142.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       109 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  185 (298)
T 3f66_A          109 MKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS  185 (298)
T ss_dssp             CTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCB
T ss_pred             CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccccchhc
Confidence            57899999997644 34899999999999999999999765  999999999999999999999999999865433211 


Q ss_pred             -eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....                 .........
T Consensus       186 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----------------~~~~~~~~~  248 (298)
T 3f66_A          186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----------------DITVYLLQG  248 (298)
T ss_dssp             C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----------------THHHHHHTT
T ss_pred             cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----------------HHHHHHhcC
Confidence             12233457889999999999999999999999999999999 56666553321                 111222223


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .....+..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            3334455677889999999999999999999999999988754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-36  Score=245.60  Aligned_cols=180  Identities=25%  Similarity=0.371  Sum_probs=144.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      +.||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       105 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             CTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             ccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            46899999997644 35899999999999999999999765  999999999999999999999999999765332211 


Q ss_pred             -eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCC-CCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       .......++..|+|||.+.+..++.++||||||+++|+|++|..|+ ....                 .......+...
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-----------------~~~~~~~~~~~  244 (298)
T 3pls_A          182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-----------------PFDLTHFLAQG  244 (298)
T ss_dssp             SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----------------GGGHHHHHHTT
T ss_pred             cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-----------------HHHHHHHhhcC
Confidence             1123446788999999999999999999999999999999955554 4322                 11222333333


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .....+..++..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            3445566678899999999999999999999999999988754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-36  Score=246.07  Aligned_cols=186  Identities=24%  Similarity=0.260  Sum_probs=137.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......   .
T Consensus       102 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~  176 (308)
T 3g33_A          102 DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---L  176 (308)
T ss_dssp             CCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---S
T ss_pred             hcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---c
Confidence            579999998877667999999999999999999999876  99999999999999999999999999986543221   3


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhhhhhhHHHHhhhhcCC
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ +.... .+..................
T Consensus       177 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  256 (308)
T 3g33_A          177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPP  256 (308)
T ss_dssp             GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCC
T ss_pred             CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCC
Confidence            44678999999999999999999999999999999999999997754311100 00000 00000000000000000000


Q ss_pred             --C-----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 --Q-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 --~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        .     ....++..+.+||.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          257 RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence              0     01245678999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-36  Score=246.39  Aligned_cols=178  Identities=21%  Similarity=0.329  Sum_probs=144.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++....... .
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            46899999997643 23999999999999999999999765  99999999999999999999999999976433211 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+|..|+|||++.+..++.++||||||+++|+|+| |..||.....                 ......+.....
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  239 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQGLR  239 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHTTCC
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------------hHHHHHHhcccC
Confidence            1222346788999999999999999999999999999998 9999976432                 112222333334


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.++|.+||+.||.+|||+.++++.|+++.
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            4455667788999999999999999999999999998764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=268.93  Aligned_cols=179  Identities=23%  Similarity=0.325  Sum_probs=144.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |+||+|.+++.... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       417 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          417 AGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             CTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             CCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            57999999997653 35999999999999999999999765  999999999999999999999999999875433221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...                 ......+....
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i~~~~  556 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGK  556 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----------------HHHHHHHHTTC
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence            11222345689999999999999999999999999999998 9999987532                 12233334444


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ....+..++.++.+||.+||+.||++||++.++++.|+.+.
T Consensus       557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            55667788999999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-36  Score=246.24  Aligned_cols=180  Identities=23%  Similarity=0.323  Sum_probs=147.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||++......... 
T Consensus        91 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A           91 AGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             CTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            46899999996543 34999999999999999999999765  999999999999999999999999999876433222 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......+|..|+|||++.+..++.++||||||+++|+|++ |..||.+...                 ......+....
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~~~~i~~~~  230 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGK  230 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----------------HHHHHHHHTTC
T ss_pred             eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHHHHHhcCC
Confidence            11223456889999999988889999999999999999998 9999976432                 11222233333


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ....+..++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            445567788999999999999999999999999999988754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.9e-37  Score=253.71  Aligned_cols=196  Identities=25%  Similarity=0.338  Sum_probs=151.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........
T Consensus       108 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  184 (327)
T 3lxl_A          108 LPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY  184 (327)
T ss_dssp             CTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEE
T ss_pred             cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccceecccCCccc
Confidence            469999999976432 3999999999999999999999765  9999999999999999999999999998764433221


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ......+|..|+|||++.+..++.++||||||+++|+|++|..||............  ..............+.....
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  262 (327)
T 3lxl_A          185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLELLEEGQR  262 (327)
T ss_dssp             ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHHHTTCC
T ss_pred             eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHHHHhhcccC
Confidence             223345788899999999989999999999999999999999999764321111000  00011122333444455555


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       263 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          263 LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            666778889999999999999999999999999999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.5e-36  Score=250.89  Aligned_cols=173  Identities=27%  Similarity=0.416  Sum_probs=135.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus        92 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--  165 (345)
T 3a8x_A           92 VNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  165 (345)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCCCC--
Confidence            579999999987654  999999999999999999999865  99999999999999999999999999986322221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........        ...........+. ....
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~~~~i~-~~~~  236 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVIL-EKQI  236 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHH-HCCC
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc--------ccccHHHHHHHHH-cCCC
Confidence            234567999999999999999999999999999999999999999753211000        0001111111111 1223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM  188 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~  188 (252)
                      ..+..++..+.+||.+||+.||.+||++
T Consensus       237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            4566788899999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-36  Score=251.91  Aligned_cols=166  Identities=22%  Similarity=0.308  Sum_probs=139.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.+.+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.....    
T Consensus       123 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----  194 (350)
T 1rdq_E          123 VAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             CTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC----
Confidence            579999999987665  999999999999999999999766  999999999999999999999999999865332    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~~i~~~--~~  255 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------------IQIYEKIVSG--KV  255 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC--CC
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----------------HHHHHHHHcC--CC
Confidence             2345789999999999999999999999999999999999999976431                1111222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      .++..++..+.+||.+||+.||.+||+     ++++++
T Consensus       256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            456677889999999999999999998     888875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-36  Score=255.52  Aligned_cols=168  Identities=26%  Similarity=0.329  Sum_probs=137.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus       121 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~--  194 (373)
T 2r5t_A          121 INGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--  194 (373)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC--
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccccCCC--
Confidence            579999999987655  899999999999999999999765  99999999999999999999999999975322211  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+...                ......++..  ..
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----------------~~~~~~i~~~--~~  256 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----------------AEMYDNILNK--PL  256 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----------------HHHHHHHHHS--CC
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhc--cc
Confidence            23456799999999999999999999999999999999999999976431                1112222222  22


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL  192 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~  192 (252)
                      .++..++..+.+||.+||+.||.+||++.+.+
T Consensus       257 ~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            34556788999999999999999999985433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-36  Score=248.91  Aligned_cols=194  Identities=24%  Similarity=0.331  Sum_probs=150.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus       107 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  183 (302)
T 4e5w_A          107 LPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY  183 (302)
T ss_dssp             CTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEE
T ss_pred             CCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccccccCCCcce
Confidence            468999999965442 3999999999999999999999765  999999999999999999999999999876544322 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......+|..|+|||++.+..++.++||||||+++|+|++|..|+.............  .............+.....
T Consensus       184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  261 (302)
T 4e5w_A          184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP--THGQMTVTRLVNTLKEGKR  261 (302)
T ss_dssp             ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS--CCGGGHHHHHHHHHHTTCC
T ss_pred             eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC--cccccCHHHHHHHHhccCC
Confidence            22334567888999999999999999999999999999999998875432111000000  0011122233344444455


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+++.
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          262 LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            5667788899999999999999999999999999998763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-36  Score=248.47  Aligned_cols=172  Identities=21%  Similarity=0.229  Sum_probs=138.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC--CCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.  ++.+||+|||+++.......
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            57899999997654 34999999999999999999999765  999999999999987  78999999999987644332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+.....
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~~~~~i~~~~~  220 (321)
T 1tki_A          160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQIIENIMNAEY  220 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHTCC
T ss_pred             ---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----------------HHHHHHHHcCCC
Confidence               3345789999999999888899999999999999999999999976432                111112222111


Q ss_pred             CCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 GGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 ~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...  ....++.++.+||.+||..||.+|||+.++++.
T Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111  112467889999999999999999999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.4e-36  Score=252.21  Aligned_cols=171  Identities=25%  Similarity=0.355  Sum_probs=138.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus        97 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--  170 (384)
T 4fr4_A           97 LLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--  170 (384)
T ss_dssp             CTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccCCCc--
Confidence            579999999987655  999999999999999999999765  99999999999999999999999999987543322  


Q ss_pred             eeecccccccccCcccccc---CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       ....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......              ........ ..
T Consensus       171 -~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------------~~~~~~~~-~~  234 (384)
T 4fr4_A          171 -ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--------------SKEIVHTF-ET  234 (384)
T ss_dssp             -BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--------------HHHHHHHH-HH
T ss_pred             -eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--------------HHHHHHHH-hh
Confidence             345679999999999864   458999999999999999999999997543211              11111111 12


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCC-HHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLA  193 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt-~~~v~~  193 (252)
                      ....++..++..+.+||.+||+.||.+||+ ++++++
T Consensus       235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            233556677889999999999999999998 777764

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.4e-37  Score=268.69  Aligned_cols=180  Identities=29%  Similarity=0.425  Sum_probs=148.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++...... ..
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  419 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  419 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence            57899999997654445999999999999999999999765  9999999999999999999999999998654321 11


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...                 ......+....+
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----------------~~~~~~i~~~~~  482 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REVLDQVERGYR  482 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----------------HHHHHHHHTTCC
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1223346788999999999999999999999999999999 9999976431                 122233334445


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            56667888999999999999999999999999999988753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.9e-36  Score=258.80  Aligned_cols=169  Identities=27%  Similarity=0.401  Sum_probs=138.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-CCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+ .+  |+||||||+|||++.++.+||+|||+++....... 
T Consensus       230 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  304 (446)
T 4ejn_A          230 ANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-  304 (446)
T ss_dssp             CSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc-
Confidence            579999999987654  9999999999999999999997 55  99999999999999999999999999976432221 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+..  ..
T Consensus       305 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------------~~~~~~i~~--~~  365 (446)
T 4ejn_A          305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------EKLFELILM--EE  365 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHH--CC
T ss_pred             -ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----------------HHHHHHHHh--CC
Confidence             23456799999999999999999999999999999999999999976431                111111111  12


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..++..++.++.+||.+||+.||.+||     ++.++++
T Consensus       366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            345667788999999999999999999     9999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=9.8e-37  Score=246.76  Aligned_cols=176  Identities=26%  Similarity=0.440  Sum_probs=140.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+...+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++......    
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence            46889999997765445899999999999999999999765  999999999999999999999999998754322    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....                 ......+.....
T Consensus       171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------------~~~~~~~~~~~~  232 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYK  232 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHHHHTTTCC
T ss_pred             -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHhcCCC
Confidence             122356889999999999999999999999999999998 9999976432                 111222223333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.++|.+||+.||.+||++.++++.|+++..
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            45566778899999999999999999999999999988753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-36  Score=248.54  Aligned_cols=193  Identities=29%  Similarity=0.416  Sum_probs=150.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++....   +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......... 
T Consensus       117 ~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  191 (318)
T 3lxp_A          117 VPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY  191 (318)
T ss_dssp             CTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred             ccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence            46899999997654   899999999999999999999766  999999999999999999999999999876544322 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......++..|+|||++.+..++.++||||||+++|+|++|..||......... ...+... ..........+.....
T Consensus       192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~  269 (318)
T 3lxp_A          192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQG-QMTVLRLTELLERGER  269 (318)
T ss_dssp             EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCH-HHHHHHHHHHHHTTCC
T ss_pred             ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhccccc-chhHHHHHHHHhcccC
Confidence            2233456788899999999989999999999999999999999999764321100 0000000 1112233344445555


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            66677888999999999999999999999999999988753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.8e-36  Score=245.91  Aligned_cols=171  Identities=23%  Similarity=0.332  Sum_probs=137.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus       124 ~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  196 (321)
T 2c30_A          124 LQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  196 (321)
T ss_dssp             CCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--
Confidence            5799999998653   3999999999999999999999765  99999999999999999999999999876543321  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc-C
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-G  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  159 (252)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+....                .....+..... .
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~  260 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----------------QAMKRLRDSPPPK  260 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSSCCC
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhcCCCCC
Confidence            133457999999999999989999999999999999999999999764311                11111111111 1


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......++..+.++|.+||+.||++|||+.++++.
T Consensus       261 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          261 LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12334567889999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-36  Score=244.53  Aligned_cols=170  Identities=24%  Similarity=0.338  Sum_probs=134.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++..   ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus       120 ~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  192 (298)
T 2zv2_A          120 VNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--  192 (298)
T ss_dssp             CTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--
T ss_pred             CCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCCEEEecCCCccccccccc--
Confidence            468888887643   24999999999999999999999765  99999999999999999999999999987543322  


Q ss_pred             eeecccccccccCccccccCC---CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.+....                .....+....
T Consensus       193 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~  256 (298)
T 2zv2_A          193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM----------------CLHSKIKSQA  256 (298)
T ss_dssp             EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC
T ss_pred             cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH----------------HHHHHHhccc
Confidence            234457999999999997765   377899999999999999999999764310                0111111222


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+....++..+.+||.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            222223457788999999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.9e-36  Score=250.68  Aligned_cols=171  Identities=23%  Similarity=0.292  Sum_probs=137.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++   .+||+|||++.......
T Consensus       110 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          110 VTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             CCSCBHHHHHTTCSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            578999999977654  999999999999999999999865  99999999999997654   59999999998754332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+....
T Consensus       186 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----------------~~~~~~i~~~~  246 (362)
T 2bdw_A          186 A---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------------HRLYAQIKAGA  246 (362)
T ss_dssp             S---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHTC
T ss_pred             c---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhCC
Confidence            2   2345799999999999988999999999999999999999999976431                11111122222


Q ss_pred             cCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...  .....++.++.+||.+||..||.+||++.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            211  1224568899999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.5e-36  Score=247.08  Aligned_cols=179  Identities=27%  Similarity=0.399  Sum_probs=144.3

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.+++....              ...+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kL~D  185 (327)
T 1fvr_A          108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIAD  185 (327)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCCeEEEcc
Confidence            46899999997654              245999999999999999999999765  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...               
T Consensus       186 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------------  247 (327)
T 1fvr_A          186 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------------  247 (327)
T ss_dssp             TTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------------
T ss_pred             cCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---------------
Confidence            99987432211   1223356889999999988889999999999999999998 9999976532               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                        ......+........+..++..+.+||.+||+.||.+|||+.++++.|+++...
T Consensus       248 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          248 --AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             --HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence              112222233333445667788999999999999999999999999999987544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-36  Score=247.41  Aligned_cols=170  Identities=25%  Similarity=0.334  Sum_probs=136.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----ceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~   76 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++    .+||+|||+++.....
T Consensus        96 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~  171 (326)
T 2y0a_A           96 VAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG  171 (326)
T ss_dssp             CCSCBHHHHHTTSSC--CBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhcCC--cCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC
Confidence            578999999976654  999999999999999999999765  99999999999998887    7999999999875433


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+...
T Consensus       172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~~~~~  232 (326)
T 2y0a_A          172 NE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------------ETLANVSAV  232 (326)
T ss_dssp             SC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHHT
T ss_pred             Cc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----------------HHHHHHHhc
Confidence            22   23456899999999998889999999999999999999999999764321                111111111


Q ss_pred             hcCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  .....++..+.+||.+||..||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1100  111345678999999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.1e-36  Score=269.44  Aligned_cols=169  Identities=27%  Similarity=0.436  Sum_probs=141.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..++.++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+++.......  
T Consensus       424 ~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--  497 (674)
T 3pfq_A          424 VNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--  497 (674)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeeccccCCc--
Confidence            579999999987765  999999999999999999999765  99999999999999999999999999986432221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.                ......++..  ..
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i~~~--~~  559 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----------------DELFQSIMEH--NV  559 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHSS--CC
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhC--CC
Confidence            23456899999999999999999999999999999999999999987431                1122222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~v~~  193 (252)
                      .++..++.++.+||.+||++||.+|+++     ++|++
T Consensus       560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            5567788999999999999999999987     66664

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-36  Score=251.30  Aligned_cols=185  Identities=20%  Similarity=0.160  Sum_probs=142.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC--ceEEccccccccCCCCCcc-
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ||+|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++  .+||+|||+++........ 
T Consensus       141 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~  218 (352)
T 2jii_A          141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV  218 (352)
T ss_dssp             CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCC
T ss_pred             CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccc
Confidence            899999998764445999999999999999999999875  99999999999999998  8999999999765332111 


Q ss_pred             ----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           80 ----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        80 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........            .........
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~------------~~~~~~~~~  286 (352)
T 2jii_A          219 AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED------------IMKQKQKFV  286 (352)
T ss_dssp             CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH------------HHHHHHHHH
T ss_pred             cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH------------HHHHHHhcc
Confidence                0123347899999999999989999999999999999999999999764311100            000000001


Q ss_pred             hhcC-----CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          156 TKLG-----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       156 ~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ....     ......++..+.+||.+||+.||.+||++.++++.|+++...
T Consensus       287 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          287 DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            1100     011124578899999999999999999999999999887543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-35  Score=242.94  Aligned_cols=182  Identities=18%  Similarity=0.247  Sum_probs=142.5

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee----cCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~   75 (252)
                      ++||+|.+++..... ..+++..++.++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+|||+++....
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~  168 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence            568999999976543 34999999999999999999999765  9999999999999    7788899999999987544


Q ss_pred             CCcceeeecccccccccCccccc--------cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVA--------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      ...   .....||..|+|||++.        +..++.++|||||||++|+|++|..||.........            .
T Consensus       169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------------~  233 (319)
T 4euu_A          169 DEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------------K  233 (319)
T ss_dssp             TCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC------------H
T ss_pred             CCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh------------H
Confidence            332   23456899999999986        467899999999999999999999999754321100            0


Q ss_pred             hhHHHHhhh-----------------------hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          148 RKLFRIMDT-----------------------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       148 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .....++..                       .........++..+.+||.+||+.||++|||+.++++......
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            011111111                       0112345678889999999999999999999999999887643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4e-36  Score=257.35  Aligned_cols=174  Identities=22%  Similarity=0.280  Sum_probs=138.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.. ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++....... .
T Consensus       156 ~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~  231 (437)
T 4aw2_A          156 YVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V  231 (437)
T ss_dssp             CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred             CCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-c
Confidence            57999999997743 23999999999999999999999765  99999999999999999999999999976544322 2


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      .....+||+.|+|||++.     +..++.++|||||||++|||++|..||.+...                ......++.
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----------------~~~~~~i~~  295 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----------------VETYGKIMN  295 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHT
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----------------hHHHHhhhh
Confidence            234467999999999987     45689999999999999999999999986432                111222222


Q ss_pred             hhcCCCCc---HHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          156 TKLGGQYP---QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       156 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      ......++   ..++.++.+||.+||..+|++  |++++++++.
T Consensus       296 ~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            22112222   347889999999999998888  9999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.9e-36  Score=241.62  Aligned_cols=179  Identities=26%  Similarity=0.393  Sum_probs=144.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++....... ..
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           85 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             CTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            46899999997754 34899999999999999999999765  9999999999999999999999999997643221 11


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....                 ......+.....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~i~~~~~  223 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDISTGFR  223 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHTTCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----------------HHHHHHHhcCCc
Confidence            1223356788999999998999999999999999999999 8999976431                 111222222333


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...+..++..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34455678889999999999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.7e-36  Score=244.80  Aligned_cols=179  Identities=25%  Similarity=0.377  Sum_probs=131.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        98 ~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  173 (311)
T 3ork_A           98 VDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV  173 (311)
T ss_dssp             CCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC----------
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCccccccccccc
Confidence            468999999987665  999999999999999999999765  999999999999999999999999999765433211 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....                ............
T Consensus       174 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----------------~~~~~~~~~~~~  237 (311)
T 3ork_A          174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----------------SVAYQHVREDPI  237 (311)
T ss_dssp             --------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHHHHCCCC
T ss_pred             ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHhcCCCC
Confidence            1233456899999999999999999999999999999999999999765321                011111111100


Q ss_pred             C--CCcHHHHHHHHHHHHhhccCCCCCCCCHHH-HHHHHHhhc
Q 025440          160 G--QYPQKAAHTAATLALQCLNNEPKLRPRMSE-VLAILERLE  199 (252)
Q Consensus       160 ~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~-v~~~l~~~~  199 (252)
                      .  .....++.++.+||.+||+.||.+||+..+ +...+.++.
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            0  001236778999999999999999996555 555665553

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4e-36  Score=244.46  Aligned_cols=181  Identities=25%  Similarity=0.372  Sum_probs=143.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||+++  ++|+||||+|||++.++.+||+|||++......... 
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  178 (291)
T 1u46_A          102 APLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY  178 (291)
T ss_dssp             CTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE
T ss_pred             ccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccccccccccch
Confidence            46899999997653 23899999999999999999999765  999999999999999999999999999876443322 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+...                ......+.....
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------------~~~~~~~~~~~~  242 (291)
T 1u46_A          179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------------SQILHKIDKEGE  242 (291)
T ss_dssp             EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHHTSCC
T ss_pred             hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----------------HHHHHHHHccCC
Confidence            12233457888999999998889999999999999999999 9999976431                111222222223


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ....+..++..+.++|.+||..||.+|||+.++++.|+++..
T Consensus       243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            334456778899999999999999999999999999988764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.4e-36  Score=242.79  Aligned_cols=174  Identities=27%  Similarity=0.411  Sum_probs=142.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||.|||+.+  |+|+||||+|||++.++.+||+|||++........  
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  177 (284)
T 2a19_B          102 CDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--  177 (284)
T ss_dssp             CCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--
T ss_pred             cCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEEECcchhheecccccc--
Confidence            46899999997765456999999999999999999999765  99999999999999999999999999876544321  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|++.|+|||++.+..++.++||||||+++|+|++|..||....                  ......    ...
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------------------~~~~~~----~~~  234 (284)
T 2a19_B          178 -RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------------------KFFTDL----RDG  234 (284)
T ss_dssp             -CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------------------HHHHHH----HTT
T ss_pred             -ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------------------HHHHHh----hcc
Confidence             233468999999999999899999999999999999999988764311                  001111    112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ..+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            23445677889999999999999999999999999987644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.5e-36  Score=246.87  Aligned_cols=169  Identities=27%  Similarity=0.364  Sum_probs=135.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++......  .
T Consensus       103 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  176 (327)
T 3a62_A          103 LSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--T  176 (327)
T ss_dssp             CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC----------
T ss_pred             CCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--c
Confidence            578999999987665  899999999999999999999765  9999999999999999999999999987533221  1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ......+...  ..
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~~~i~~~--~~  238 (327)
T 3a62_A          177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----------------KKTIDKILKC--KL  238 (327)
T ss_dssp             --CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHHT--CC
T ss_pred             cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhC--CC
Confidence            23445789999999999988999999999999999999999999976431                1111222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++..+.+||.+||..||.+||     ++.++++
T Consensus       239 ~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            45566788999999999999999999     7778876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-36  Score=248.36  Aligned_cols=181  Identities=26%  Similarity=0.373  Sum_probs=143.5

Q ss_pred             CCCCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC---CceEEcccccccc
Q 025440            1 MPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~   72 (252)
                      ++||+|.+++.....     ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+   ..+||+|||++..
T Consensus       115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            468999999987643     34899999999999999999999765  9999999999999844   4599999999875


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............+++.|+|||++.+..++.++||||||+++|+|+| |..||.....                 ....
T Consensus       193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~~  255 (327)
T 2yfx_A          193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----------------QEVL  255 (327)
T ss_dssp             HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HHHH
T ss_pred             cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----------------HHHH
Confidence            433222222334567899999999999999999999999999999998 9999976431                 1122


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..+........+..++..+.++|.+||+.||.+||++.++++.|+.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            2223333344556778899999999999999999999999999987653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.5e-36  Score=240.47  Aligned_cols=174  Identities=24%  Similarity=0.307  Sum_probs=137.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++..........
T Consensus        87 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           87 CSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            468899999976544  999999999999999999999765  9999999999999999999999999997653332222


Q ss_pred             eeecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......|+..|+|||++.+..+ +.++||||||+++|+|++|..||........               ...........
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~  227 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------------EYSDWKEKKTY  227 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---------------HHHHHHTTCTT
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---------------HHHHhhhcccc
Confidence            2344578999999999987765 7789999999999999999999976542110               01111111111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......++..+.+||.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            2223457788999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-35  Score=247.26  Aligned_cols=182  Identities=25%  Similarity=0.300  Sum_probs=134.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC------------------------
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA------------------------   58 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~------------------------   58 (252)
                      ||+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.                        
T Consensus       119 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (360)
T 3llt_A          119 GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT  196 (360)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEE
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhccccccccccccc
Confidence            899999998877667999999999999999999999765  999999999999975                        


Q ss_pred             -CCceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-h
Q 025440           59 -EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-L  136 (252)
Q Consensus        59 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~  136 (252)
                       ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........ +
T Consensus       197 ~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  271 (360)
T 3llt_A          197 KSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM  271 (360)
T ss_dssp             SCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence             788999999999864332     234578999999999999999999999999999999999999998754321110 0


Q ss_pred             hhhcchhhhhhhhHHHHhh-----------------------------hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCC
Q 025440          137 VDWAKPYLSDKRKLFRIMD-----------------------------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR  187 (252)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt  187 (252)
                      .....+....  .......                             ...........+..+.+||.+||+.||.+|||
T Consensus       272 ~~~~~~~p~~--~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  349 (360)
T 3llt_A          272 ESIIQPIPKN--MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS  349 (360)
T ss_dssp             HHHTCCCCHH--HHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHhcCCCCHH--HHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence            0000000000  0000000                             00000001112367889999999999999999


Q ss_pred             HHHHHH
Q 025440          188 MSEVLA  193 (252)
Q Consensus       188 ~~~v~~  193 (252)
                      +.++++
T Consensus       350 a~elL~  355 (360)
T 3llt_A          350 PAELLK  355 (360)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6e-36  Score=254.43  Aligned_cols=172  Identities=24%  Similarity=0.279  Sum_probs=138.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+..   +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++....... .
T Consensus       151 ~~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~  224 (410)
T 3v8s_A          151 MPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V  224 (410)
T ss_dssp             CTTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-E
T ss_pred             CCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-c
Confidence            57999999997643   899999999999999999999866  99999999999999999999999999987544322 1


Q ss_pred             eeecccccccccCccccccCC----CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      .....+||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+...                ......++..
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~~~~i~~~  288 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----------------VGTYSKIMNH  288 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHTH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----------------hhHHHHHHhc
Confidence            234568999999999998765    78999999999999999999999976431                1122223222


Q ss_pred             h--cCCCCcHHHHHHHHHHHHhhccCCCCC--CCCHHHHHHH
Q 025440          157 K--LGGQYPQKAAHTAATLALQCLNNEPKL--RPRMSEVLAI  194 (252)
Q Consensus       157 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~--Rpt~~~v~~~  194 (252)
                      .  ...+....++.++.+||.+||..+|.+  |+++++|++.
T Consensus       289 ~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            2  222223357889999999999999988  9999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=247.51  Aligned_cols=172  Identities=23%  Similarity=0.327  Sum_probs=129.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+++......
T Consensus       130 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          130 VTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            578999999977654  999999999999999999999765  999999999999975   8899999999998653321


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....               ......+....
T Consensus       206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~~~~i~~~~  267 (349)
T 2w4o_A          206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---------------QFMFRRILNCE  267 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---------------HHHHHHHHTTC
T ss_pred             ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---------------HHHHHHHHhCC
Confidence               123457899999999999989999999999999999999999999764321               00111222211


Q ss_pred             cC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..  ......++.++.+||.+||+.||++|||+.++++.
T Consensus       268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11  12234577889999999999999999999999873

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-35  Score=261.05  Aligned_cols=174  Identities=31%  Similarity=0.484  Sum_probs=143.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+...+++..++.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus       266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~--  341 (576)
T 2acx_A          266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--  341 (576)
T ss_dssp             CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecccCcc--
Confidence            57999999998877667999999999999999999999865  99999999999999999999999999987544322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....             ....+...+ .....
T Consensus       342 -~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-------------~~~~i~~~i-~~~~~  406 (576)
T 2acx_A          342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-------------KREEVERLV-KEVPE  406 (576)
T ss_dssp             -EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-------------CHHHHHHHH-HHCCC
T ss_pred             -ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-------------hHHHHHHHh-hcccc
Confidence             234579999999999998899999999999999999999999998753211             011111111 12233


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      .++..++.++.+||.+||..||.+||     ++.++++
T Consensus       407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            45667888999999999999999999     7788875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-35  Score=240.73  Aligned_cols=170  Identities=24%  Similarity=0.399  Sum_probs=135.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+.+.+|+|+||||+|||++ .++.+||+|||++.......  
T Consensus       111 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  186 (290)
T 1t4h_A          111 MTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--  186 (290)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--
T ss_pred             cCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc--
Confidence            578999999987654  8999999999999999999997655599999999999997 78999999999997643332  


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh-c
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  158 (252)
                        .....||+.|+|||++. +.++.++||||||+++|+|++|..||......                ......+... .
T Consensus       187 --~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~~~  247 (290)
T 1t4h_A          187 --AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA----------------AQIYRRVTSGVK  247 (290)
T ss_dssp             --BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----------------HHHHHHHTTTCC
T ss_pred             --cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----------------HHHHHHHhccCC
Confidence              23456899999999886 46899999999999999999999999764321                1111111111 1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+...+..+.+||.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11223345578999999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-35  Score=250.04  Aligned_cols=172  Identities=22%  Similarity=0.286  Sum_probs=137.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC--CCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.  ++.+||+|||+++.......
T Consensus       130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            57999999997654 34999999999999999999999765  999999999999974  57799999999987644322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh-
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-  157 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  157 (252)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....                .....+.... 
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----------------~~~~~i~~~~~  267 (387)
T 1kob_A          207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----------------ETLQNVKRCDW  267 (387)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHHCCC
T ss_pred             ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----------------HHHHHHHhCCC
Confidence               23346899999999999989999999999999999999999999864321                1111111111 


Q ss_pred             -cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 -LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       ........++.++.+||.+||..||.+|||+.++++.
T Consensus       268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence             1122234578899999999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.9e-36  Score=249.95  Aligned_cols=175  Identities=23%  Similarity=0.327  Sum_probs=128.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc--eEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++...+.  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.  +||+|||+++...... 
T Consensus        98 ~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            579999999977665  999999999999999999999766  999999999999987765  9999999987432221 


Q ss_pred             ceeeecccccccccCccccccCCCCcc-cceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                        ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......            .......+....
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------------~~~~~~~~~~~~  238 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD------------YRKTIQRILSVK  238 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC------------HHHHHHHHHTTC
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH------------HHHHHHHHhcCC
Confidence              1234578999999999988887665 8999999999999999999976432110            011111222222


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+....++..+.+||.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            2222233567889999999999999999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-35  Score=255.58  Aligned_cols=168  Identities=28%  Similarity=0.410  Sum_probs=138.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        98 ~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~--  171 (476)
T 2y94_A           98 VSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--  171 (476)
T ss_dssp             CSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC--
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcccccc--
Confidence            579999999987655  999999999999999999999765  99999999999999999999999999987544322  


Q ss_pred             eeecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....                .....+...  .
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~~i~~~--~  232 (476)
T 2y94_A          172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----------------TLFKKICDG--I  232 (476)
T ss_dssp             -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----------------HHHHHHHTT--C
T ss_pred             -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcC--C
Confidence             234579999999999988776 68999999999999999999999864321                111112211  1


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++.++.+||.+||..||.+|||+.++++
T Consensus       233 ~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            2344567788999999999999999999999997

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-35  Score=247.48  Aligned_cols=172  Identities=28%  Similarity=0.297  Sum_probs=135.4

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~   75 (252)
                      |+||+|.+++.+..  ...+++..++.++.||+.||+|||+++  |+||||||+|||++.++.   +||+|||++.....
T Consensus       108 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~  185 (351)
T 3c0i_A          108 MDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE  185 (351)
T ss_dssp             CSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence            57899998886542  234899999999999999999999765  999999999999976654   99999999987544


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                 .....+..
T Consensus       186 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------------~~~~~i~~  246 (351)
T 3c0i_A          186 SGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----------------RLFEGIIK  246 (351)
T ss_dssp             TSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----------------HHHHHHHH
T ss_pred             CCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----------------HHHHHHHc
Confidence            322  13345799999999999998999999999999999999999999976421                 01111111


Q ss_pred             hhcCCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......  ....++..+.+||.+||..||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111  01245778999999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9e-36  Score=253.48  Aligned_cols=173  Identities=21%  Similarity=0.235  Sum_probs=135.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+. .+++..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++....... .
T Consensus       143 ~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~  218 (412)
T 2vd5_A          143 YVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-V  218 (412)
T ss_dssp             CCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-E
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheeccCCCc-c
Confidence            579999999977542 4999999999999999999999765  99999999999999999999999999987544322 1


Q ss_pred             eeecccccccccCccccc-------cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           81 VSTQVMGTHGYAAPEYVA-------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                      .....+||+.|+|||++.       +..++.++|||||||++|||++|+.||.+...                ......+
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i  282 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----------------AETYGKI  282 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHH
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----------------HHHHHHH
Confidence            233467999999999987       35689999999999999999999999976432                1112222


Q ss_pred             hhhhcC---CCCcHHHHHHHHHHHHhhccCCCCCC---CCHHHHHHH
Q 025440          154 MDTKLG---GQYPQKAAHTAATLALQCLNNEPKLR---PRMSEVLAI  194 (252)
Q Consensus       154 ~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R---pt~~~v~~~  194 (252)
                      +.....   ...+..++.++.+||.+||. +|.+|   ++++++++.
T Consensus       283 ~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          283 VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            221111   11234678899999999999 99998   589998763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.1e-36  Score=246.51  Aligned_cols=178  Identities=23%  Similarity=0.324  Sum_probs=118.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++   .+||+|||+++......
T Consensus        88 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           88 LNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             CCSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            578999999988755  999999999999999999999765  99999999999997765   79999999998654332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......         .........+....
T Consensus       164 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------~~~~~~~~~i~~~~  232 (325)
T 3kn6_A          164 Q--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---------TSAVEIMKKIKKGD  232 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---------CCHHHHHHHHTTTC
T ss_pred             C--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---------ccHHHHHHHHHcCC
Confidence            2  133456899999999999999999999999999999999999999764321000         00011111111111


Q ss_pred             cCCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  ....++.++.+||.+||..||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1111  11346789999999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-35  Score=251.40  Aligned_cols=192  Identities=20%  Similarity=0.252  Sum_probs=135.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      |+||+|.+++.......+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~  185 (389)
T 3gni_B          108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ  185 (389)
T ss_dssp             CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred             cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence            57999999998875556999999999999999999999876  99999999999999999999999998865322111  


Q ss_pred             ---ceeeecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhh-hhhcchhhhhh-----
Q 025440           79 ---THVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDK-----  147 (252)
Q Consensus        79 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~-~~~~~~~~~~~-----  147 (252)
                         ........||..|+|||++.+  ..++.++|||||||++|+|++|+.||.+......... .....+.....     
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (389)
T 3gni_B          186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA  265 (389)
T ss_dssp             SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------
T ss_pred             cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccc
Confidence               011223468999999999987  5789999999999999999999999987543211100 00000000000     


Q ss_pred             -------------hhHHHHh---------hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          148 -------------RKLFRIM---------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       148 -------------~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                                   .......         ........+..++..+.+||.+||+.||.+|||+.++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                         0000000         0000112344567889999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=246.18  Aligned_cols=195  Identities=23%  Similarity=0.325  Sum_probs=148.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++..........
T Consensus       126 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~  202 (326)
T 2w1i_A          126 LPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY  202 (326)
T ss_dssp             CTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEE
T ss_pred             CCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhhcccccccc
Confidence            46899999998764 34999999999999999999999765  9999999999999999999999999998765433221


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       ......++..|+|||++.+..++.++||||||+++|+|+||..||................ .......+...+.....
T Consensus       203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  281 (326)
T 2w1i_A          203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-GQMIVFHLIELLKNNGR  281 (326)
T ss_dssp             ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC-THHHHHHHHHHHHTTCC
T ss_pred             ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc-hhhhHHHHHHHhhcCCC
Confidence             1223456788999999998889999999999999999999999986532111000000000 00011122233333444


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++.++.+||.+||+.||++|||+.++++.|+++.
T Consensus       282 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            4556778899999999999999999999999999998874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.9e-36  Score=245.11  Aligned_cols=175  Identities=26%  Similarity=0.354  Sum_probs=136.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc--------eEEcccccccc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~~~   72 (252)
                      ++||+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.        +||+|||++..
T Consensus        94 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~  170 (289)
T 4fvq_A           94 VKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT  170 (289)
T ss_dssp             CTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTT
T ss_pred             CCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeeeccCccccc
Confidence            578999999987643 4899999999999999999999776  999999999999988887        99999999875


Q ss_pred             CCCCCcceeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCC-CCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                      ...      .....+|..|+|||++.+ ..++.++||||||+++|+|++|. .||.....                 ...
T Consensus       171 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------------~~~  227 (289)
T 4fvq_A          171 VLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----------------QRK  227 (289)
T ss_dssp             TSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHH
T ss_pred             ccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----------------HHH
Confidence            422      123457889999999987 67899999999999999999954 44443221                 011


Q ss_pred             HHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCCCC
Q 025440          151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN  203 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~~~  203 (252)
                      .....  .....+...+.++.+||.+||+.||.+|||+.++++.|+++..+..
T Consensus       228 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          228 LQFYE--DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHHHH--TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             HHHhh--ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            11111  1223344456778999999999999999999999999998866543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-35  Score=245.64  Aligned_cols=173  Identities=20%  Similarity=0.298  Sum_probs=136.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+++......
T Consensus       111 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             CTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            57899999997765566999999999999999999999765  999999999999987   7899999999998754322


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh-
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-  156 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  156 (252)
                      .   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....                .....+... 
T Consensus       189 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~  249 (327)
T 3lm5_A          189 E---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----------------ETYLNISQVN  249 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTC
T ss_pred             c---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------------HHHHHHHhcc
Confidence            1   23457899999999999999999999999999999999999999764321                111111111 


Q ss_pred             -hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 -KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       .........++..+.+||.+||+.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             11222334577889999999999999999999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-36  Score=249.18  Aligned_cols=175  Identities=27%  Similarity=0.361  Sum_probs=137.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC----CceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~   76 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+++  |+||||||+|||+..+    +.+||+|||+++.....
T Consensus        98 ~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           98 MKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            579999999987765  999999999999999999999875  9999999999998433    35999999999865433


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......             ......+...
T Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------------~~~~~~i~~~  238 (342)
T 2qr7_A          174 NG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-------------EEILARIGSG  238 (342)
T ss_dssp             TC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-------------HHHHHHHHHC
T ss_pred             CC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-------------HHHHHHHccC
Confidence            22  13345789999999999888899999999999999999999999976422111             1111111111


Q ss_pred             hc--CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 KL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..  ....+..++.++.+||.+||..||++||++.++++.
T Consensus       239 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11  122335678899999999999999999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=244.69  Aligned_cols=165  Identities=25%  Similarity=0.295  Sum_probs=129.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++...+ ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.......   ..
T Consensus       140 ~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~  213 (311)
T 3p1a_A          140 GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AG  213 (311)
T ss_dssp             CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC--------
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CC
Confidence            789999987654 34999999999999999999999865  9999999999999999999999999987654322   13


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCC
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY  162 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (252)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..+|.+...                   ...+.........
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~~~~~~~~~~  273 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQLRQGYLPPEF  273 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHHTTTCCCHHH
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHhccCCCccc
Confidence            34568999999999875 799999999999999999999766654211                   0111111111112


Q ss_pred             cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          163 PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       163 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      +..++.++.+||.+||+.||++|||+.++++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            3346788999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.9e-35  Score=245.77  Aligned_cols=186  Identities=23%  Similarity=0.325  Sum_probs=139.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC------CCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      ++||+|.+++.+.   .+++..++.++.||+.||+|||..      ..+|+||||||+|||++.++.+||+|||++....
T Consensus       122 ~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  198 (342)
T 1b6c_B          122 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  198 (342)
T ss_dssp             CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             cCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecc
Confidence            4689999999764   399999999999999999999931      2349999999999999999999999999997654


Q ss_pred             CCCcce--eeecccccccccCccccccCC------CCcccceehhHHHHHHHHhC----------CCCCCCcccccchhh
Q 025440           75 TGDRTH--VSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSG----------RCAVDKTKVGIEQSL  136 (252)
Q Consensus        75 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~~lltg----------~~pf~~~~~~~~~~~  136 (252)
                      ......  ......||..|+|||++.+..      ++.++|||||||++|+|+||          ..||........   
T Consensus       199 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~---  275 (342)
T 1b6c_B          199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP---  275 (342)
T ss_dssp             TTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC---
T ss_pred             ccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc---
Confidence            332211  123457899999999997652      34689999999999999999          667755321100   


Q ss_pred             hhhcchhhhhhhhHHH-HhhhhcCCCCc-----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          137 VDWAKPYLSDKRKLFR-IMDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       137 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                               ....+.. +.........+     ..++..+.+||.+||+.||++|||+.++++.|+++...
T Consensus       276 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          276 ---------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             ---------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                     0111111 12222223333     25677899999999999999999999999999987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-35  Score=238.85  Aligned_cols=168  Identities=27%  Similarity=0.420  Sum_probs=135.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||++.......   
T Consensus        91 ~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---  163 (279)
T 3fdn_A           91 APLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---  163 (279)
T ss_dssp             CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence            468999999987655  999999999999999999999765  9999999999999999999999999986543322   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++||||||+++|+|++|..||......                .....+  .....
T Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~--~~~~~  224 (279)
T 3fdn_A          164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----------------ETYKRI--SRVEF  224 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHH--HHTCC
T ss_pred             -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----------------HHHHHH--HhCCC
Confidence             23456899999999999989999999999999999999999999764311                011111  11223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++..+.+||.+||+.||.+|||+.++++.
T Consensus       225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            4556678889999999999999999999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.3e-36  Score=249.98  Aligned_cols=167  Identities=23%  Similarity=0.326  Sum_probs=136.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........   .
T Consensus        92 ~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~  164 (336)
T 3h4j_B           92 GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---L  164 (336)
T ss_dssp             CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---T
T ss_pred             CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---c
Confidence            7899999987665  999999999999999999999765  99999999999999999999999999986544322   2


Q ss_pred             ecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           83 TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........                 .+ ......
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----------------~i-~~~~~~  226 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----------------KV-NSCVYV  226 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----------------CC-CSSCCC
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----------------HH-HcCCCC
Confidence            34579999999999988776 689999999999999999999997643211000                 00 001123


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+..++..+.+||.+||..||.+|||+.++++.
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            455677889999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=244.11  Aligned_cols=184  Identities=23%  Similarity=0.297  Sum_probs=140.6

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++...  ....+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  189 (317)
T 2buj_A          112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE  189 (317)
T ss_dssp             CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred             CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence            5689999999763  2345999999999999999999999765  99999999999999999999999999875422110


Q ss_pred             ce-------eeecccccccccCccccccCC---CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           79 TH-------VSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        79 ~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                      ..       ......||..|+|||++.+..   ++.++||||||+++|+|++|..||......               ..
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------~~  254 (317)
T 2buj_A          190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---------------GD  254 (317)
T ss_dssp             SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---------------TS
T ss_pred             cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---------------cc
Confidence            00       012235799999999987654   688999999999999999999999642110               00


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ............+....++..+.++|.+||+.||.+|||+.++++.|+.+..+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          255 SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            11111122222333456778999999999999999999999999999988644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-35  Score=250.52  Aligned_cols=187  Identities=23%  Similarity=0.282  Sum_probs=131.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC-----
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-----   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-----   77 (252)
                      +|+|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......     
T Consensus        94 ~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  168 (388)
T 3oz6_A           94 ETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN  168 (388)
T ss_dssp             SEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred             CcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence            36888888764   3899999999999999999999876  9999999999999999999999999997643211     


Q ss_pred             --------------cceeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hc
Q 025440           78 --------------RTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WA  140 (252)
Q Consensus        78 --------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~  140 (252)
                                    ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ +.. ..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  248 (388)
T 3oz6_A          169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID  248 (388)
T ss_dssp             GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence                          0112344579999999999977 578999999999999999999999998764321110 000 00


Q ss_pred             chhhh--------hhhhHHHHhhhh-------cCC------------CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          141 KPYLS--------DKRKLFRIMDTK-------LGG------------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       141 ~~~~~--------~~~~~~~~~~~~-------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .+...        ........+...       ...            .....++.++.+||.+||..||.+|||+.++++
T Consensus       249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence            00000        000000000000       000            011145678999999999999999999999986


Q ss_pred             H
Q 025440          194 I  194 (252)
Q Consensus       194 ~  194 (252)
                      .
T Consensus       329 H  329 (388)
T 3oz6_A          329 H  329 (388)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-35  Score=242.83  Aligned_cols=174  Identities=24%  Similarity=0.347  Sum_probs=133.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.+|+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++. +.+||+|||++..........
T Consensus       109 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          109 CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             CCSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence            357899999987764  899999999999999999999765  999999999999964 899999999998754433222


Q ss_pred             eeecccccccccCcccccc-----------CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                      ......|++.|+|||++.+           ..++.++||||||+++|+|++|..||.....               ....
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------------~~~~  248 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------QISK  248 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------------HHHH
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH---------------HHHH
Confidence            2334578999999999865           4688899999999999999999999976421               1112


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .............+...+..+.++|.+||+.||.+||++.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            233333344445555667889999999999999999999999974

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6e-35  Score=246.67  Aligned_cols=122  Identities=25%  Similarity=0.267  Sum_probs=107.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec--CCCceEEccccccccCCCCCcce
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +|+|.+++.......+++..+..++.||+.||.|||+++.+|+||||||+|||++  .++.+||+|||+++.....    
T Consensus       139 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~----  214 (382)
T 2vx3_A          139 SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----  214 (382)
T ss_dssp             CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC----
T ss_pred             CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc----
Confidence            5799999988765669999999999999999999997556799999999999994  4778999999999875432    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcc
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK  129 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~  129 (252)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus       215 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          215 -IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             -CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence             234578999999999999999999999999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-35  Score=248.11  Aligned_cols=176  Identities=30%  Similarity=0.378  Sum_probs=138.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       141 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  215 (355)
T 1vzo_A          141 INGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-  215 (355)
T ss_dssp             CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-
Confidence            578999999987654  999999999999999999999765  999999999999999999999999999865332211 


Q ss_pred             eeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||.........             ..+.... ...
T Consensus       216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------------~~~~~~~-~~~  281 (355)
T 1vzo_A          216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AEISRRI-LKS  281 (355)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HHHHHHH-HHC
T ss_pred             cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-------------HHHHHHH-hcc
Confidence            23345799999999999863  4788999999999999999999999754321100             0111111 112


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAIL  195 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~~l  195 (252)
                      ....+..++..+.+||.+||..||.+||     ++.++++..
T Consensus       282 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            3345667788899999999999999999     899988743

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-35  Score=250.98  Aligned_cols=120  Identities=27%  Similarity=0.299  Sum_probs=107.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc--eEEccccccccCCCCCcce
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.  +||+|||+++.....    
T Consensus       182 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~----  255 (429)
T 3kvw_A          182 SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----  255 (429)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC----
T ss_pred             CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccceecCCc----
Confidence            579999998887677999999999999999999999765  999999999999999887  999999999764332    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcc
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK  129 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~  129 (252)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus       256 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          256 -VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             -CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence             234578999999999999999999999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=246.14  Aligned_cols=179  Identities=23%  Similarity=0.297  Sum_probs=123.7

Q ss_pred             CCChhhhhhcC-CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce-
Q 025440            3 KGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-   80 (252)
Q Consensus         3 ggsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-   80 (252)
                      +|+|.+++... ....+++..++.++.||+.||+|||+.+.+|+||||||+|||++.++.+||+|||+++......... 
T Consensus       117 ~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  196 (337)
T 3ll6_A          117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW  196 (337)
T ss_dssp             SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----
T ss_pred             CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccc
Confidence            57899988652 2234999999999999999999999765559999999999999999999999999998754332211 


Q ss_pred             ---------eeecccccccccCcccc---ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           81 ---------VSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        81 ---------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                               ......||+.|+|||++   .+..++.++|||||||++|+|++|..||......                 
T Consensus       197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------------  259 (337)
T 3ll6_A          197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----------------  259 (337)
T ss_dssp             ---------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----------------
Confidence                     11134589999999998   5667899999999999999999999999753210                 


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                         .+.............+..+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       260 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          260 ---RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               11112222223334455688999999999999999999999999987643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.4e-35  Score=241.37  Aligned_cols=179  Identities=23%  Similarity=0.265  Sum_probs=132.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...+.  +++..++.++.||+.||+|||+.+  |+|+||||+|||++.++.+||+|||++........ .
T Consensus       116 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~  190 (309)
T 2h34_A          116 INGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-T  190 (309)
T ss_dssp             CCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-c
Confidence            468999999987654  999999999999999999999765  99999999999999999999999999876543221 1


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC-
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG-  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  159 (252)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|..||.+....                 .....+..... 
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------------~~~~~~~~~~~~  253 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----------------VMGAHINQAIPR  253 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----------------HHHHHHHSCCCC
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----------------HHHHHhccCCCC
Confidence            123456899999999999889999999999999999999999999764321                 11111111111 


Q ss_pred             -CCCcHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhcCC
Q 025440          160 -GQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEAP  201 (252)
Q Consensus       160 -~~~~~~~~~~~~~li~~~l~~dp~~Rp-t~~~v~~~l~~~~~~  201 (252)
                       ...+..++..+.++|.+||+.||++|| +++++++.|++....
T Consensus       254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence             122345677899999999999999999 999999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=247.86  Aligned_cols=175  Identities=15%  Similarity=0.126  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcC---CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-----------CCceEEcc
Q 025440            1 MPKGSLENHLFRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----------EFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-----------~~~~kl~D   66 (252)
                      |+||+|.+++...   ....+++..++.++.||+.||+|||+++  |+||||||+|||++.           ++.+||+|
T Consensus       149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~D  226 (365)
T 3e7e_A          149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID  226 (365)
T ss_dssp             CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------CTTEEECC
T ss_pred             cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccccCCEEEee
Confidence            5799999999742   2345999999999999999999999765  999999999999988           89999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                      ||+++..............+||..|+|||++.+..++.++|||||||++|+|+||+.||......... .          
T Consensus       227 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~----------  295 (365)
T 3e7e_A          227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-P----------  295 (365)
T ss_dssp             CTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-E----------
T ss_pred             CchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-e----------
Confidence            99997543223333455668999999999999999999999999999999999999999654321000 0          


Q ss_pred             hhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhc
Q 025440          147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE  199 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-t~~~v~~~l~~~~  199 (252)
                              .... ...  .....+.+++..||+.+|.+|+ ++.++.+.|+++.
T Consensus       296 --------~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          296 --------EGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             --------CSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             --------chhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                    0000 011  1355678899999999999995 7888888777653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-35  Score=256.88  Aligned_cols=175  Identities=25%  Similarity=0.429  Sum_probs=140.0

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++....  ...+++..++.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......
T Consensus       267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            57999999997654  345999999999999999999999765  99999999999999999999999999987544322


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .  ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+......            .......+..  .
T Consensus       345 ~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~------------~~~~~~~i~~--~  408 (543)
T 3c4z_A          345 K--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE------------NKELKQRVLE--Q  408 (543)
T ss_dssp             C--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC------------HHHHHHHHHH--C
T ss_pred             c--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh------------HHHHHHHHhh--c
Confidence            1  2345799999999999999999999999999999999999999976432100            0111111221  1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCH-----HHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~-----~~v~~  193 (252)
                      ...++..++..+.+||.+||+.||.+||++     .++++
T Consensus       409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            234566788999999999999999999975     56654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.2e-35  Score=247.21  Aligned_cols=183  Identities=22%  Similarity=0.264  Sum_probs=137.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----------------------
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------------------   60 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----------------------   60 (252)
                      +|+|.+++.......+++..++.++.||+.||+|||++ .+|+||||||+|||++.++                      
T Consensus       128 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (397)
T 1wak_A          128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS  206 (397)
T ss_dssp             CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------
T ss_pred             CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCC
Confidence            67888888777656699999999999999999999976 1499999999999998775                      


Q ss_pred             ---------------------------ceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHH
Q 025440           61 ---------------------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV  113 (252)
Q Consensus        61 ---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  113 (252)
                                                 .+||+|||+++.....     .....||..|+|||++.+..++.++|||||||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  281 (397)
T 1wak_A          207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTAC  281 (397)
T ss_dssp             ----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred             CCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHH
Confidence                                       7999999999865332     23346899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCcccccch----h---hhhhcchhh--------------hhh-----------hhHHHHhhhhcCCC
Q 025440          114 VLLELLSGRCAVDKTKVGIEQ----S---LVDWAKPYL--------------SDK-----------RKLFRIMDTKLGGQ  161 (252)
Q Consensus       114 il~~lltg~~pf~~~~~~~~~----~---~~~~~~~~~--------------~~~-----------~~~~~~~~~~~~~~  161 (252)
                      ++|+|++|..||.........    .   +........              ...           ......+.  ....
T Consensus       282 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  359 (397)
T 1wak_A          282 MAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV--EKYE  359 (397)
T ss_dssp             HHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH--HTSC
T ss_pred             HHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh--hhcc
Confidence            999999999999765432110    0   000000000              000           00000010  1123


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .+...+..+.+||.+||+.||.+|||+.++++
T Consensus       360 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          360 WSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            45677889999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.5e-35  Score=241.20  Aligned_cols=183  Identities=21%  Similarity=0.307  Sum_probs=133.3

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++...  ....+++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.+||+|||++........
T Consensus       114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~  191 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  191 (310)
T ss_dssp             CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred             CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence            4688999999652  2345999999999999999999999765  99999999999999999999999999876533221


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|..||.+.....              ......+.....
T Consensus       192 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~  255 (310)
T 2wqm_A          192 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--------------YSLCKKIEQCDY  255 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH--------------HHHHHHHHTTCS
T ss_pred             --cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH--------------HHHHHHhhcccC
Confidence              1234568999999999999899999999999999999999999997643210              000111111111


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .......++.++.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus       256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            2222345778899999999999999999999999999988643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-35  Score=247.73  Aligned_cols=171  Identities=23%  Similarity=0.275  Sum_probs=137.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee--cCCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus       168 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            57899999997654 24899999999999999999999765  9999999999999  5678899999999987544332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...                ...+..+.....
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----------------~~~~~~i~~~~~  305 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----------------AETLNNILACRW  305 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHTCC
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhccC
Confidence               2334689999999999888899999999999999999999999977532                111222222211


Q ss_pred             CC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..  .....++.++.+||.+||+.||.+|||+.++++
T Consensus       306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11  112356789999999999999999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-35  Score=243.46  Aligned_cols=172  Identities=24%  Similarity=0.358  Sum_probs=132.0

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.+++..... ...++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........
T Consensus       143 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~  220 (332)
T 3qd2_B          143 CRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE  220 (332)
T ss_dssp             CCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC---
T ss_pred             cCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhh
Confidence            578999999987654 34677789999999999999999765  999999999999999999999999999875443211


Q ss_pred             ----------eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh
Q 025440           80 ----------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK  149 (252)
Q Consensus        80 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  149 (252)
                                .......||+.|+|||++.+..++.++|||||||++|+|++|..|+...                  .. 
T Consensus       221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------------------~~-  281 (332)
T 3qd2_B          221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------------------VR-  281 (332)
T ss_dssp             -----------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------------------HH-
T ss_pred             ccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------------------HH-
Confidence                      1123456899999999999999999999999999999999987654321                  00 


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .................+..+.+||.+||+.||.+|||+.++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          282 IITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            11111111111112345677899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=242.45  Aligned_cols=181  Identities=18%  Similarity=0.251  Sum_probs=134.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      ++||+|.+++...+ ..+++..++.++.||+.||+|||+.+  |+||||||+|||++ ++.+||+|||+++.......  
T Consensus       111 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          111 CKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             ccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            46899999997654 35999999999999999999999765  99999999999998 68999999999875432111  


Q ss_pred             -ceeeecccccccccCcccccc---------CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhh
Q 025440           79 -THVSTQVMGTHGYAAPEYVAT---------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR  148 (252)
Q Consensus        79 -~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  148 (252)
                       ........|+..|+|||++.+         ..++.++||||||+++|+|++|..||......                .
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~  250 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----------------A  250 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----------------H
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------H
Confidence             111233458999999999864         35788999999999999999999999764321                1


Q ss_pred             hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          149 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      ....+............++.++.++|.+||..||.+|||+.++++.|+++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11111111111122234667899999999999999999999999999887654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.1e-35  Score=240.66  Aligned_cols=170  Identities=26%  Similarity=0.332  Sum_probs=136.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----ceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~   76 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++    .+||+|||++......
T Consensus        97 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~  172 (321)
T 2a2a_A           97 VSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG  172 (321)
T ss_dssp             CCSCBHHHHHHTCSC--EEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceecCcc
Confidence            468999999987654  999999999999999999999765  99999999999999888    7999999999875443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ..   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....                .....+...
T Consensus       173 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~i~~~  233 (321)
T 2a2a_A          173 VE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------------ETLANITSV  233 (321)
T ss_dssp             CC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHHHHHHTT
T ss_pred             cc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhc
Confidence            22   23456899999999999889999999999999999999999999764321                111111111


Q ss_pred             hcCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  .....++..+.+||.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100  011345678999999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.5e-35  Score=242.79  Aligned_cols=161  Identities=21%  Similarity=0.254  Sum_probs=134.0

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......   .
T Consensus       114 g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~  186 (335)
T 3dls_A          114 GLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---F  186 (335)
T ss_dssp             SCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---B
T ss_pred             CccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---e
Confidence            3499999987665  999999999999999999999765  99999999999999999999999999987544332   2


Q ss_pred             ecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           83 TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......                      ..  ....
T Consensus       187 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------------~~--~~~~  242 (335)
T 3dls_A          187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------------VE--AAIH  242 (335)
T ss_dssp             CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------TT--TCCC
T ss_pred             eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------Hh--hccC
Confidence            34568999999999988877 78999999999999999999999763210                      00  0112


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+..++.++.+||.+||+.||.+|||+.++++.
T Consensus       243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            233467789999999999999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.2e-35  Score=237.29  Aligned_cols=167  Identities=25%  Similarity=0.375  Sum_probs=138.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+|+||||+||+++.++.+||+|||++.......   
T Consensus        96 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---  168 (284)
T 2vgo_A           96 APRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---  168 (284)
T ss_dssp             CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence            468899999987654  999999999999999999999765  9999999999999999999999999987643322   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....|+..|+|||++.+..++.++||||||+++|+|++|..||......                .....+..  ...
T Consensus       169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~~~~--~~~  229 (284)
T 2vgo_A          169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----------------ETHRRIVN--VDL  229 (284)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHT--TCC
T ss_pred             -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----------------HHHHHHhc--ccc
Confidence             23456899999999999989999999999999999999999999764311                11111111  122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++..+.++|.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            445667889999999999999999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.1e-35  Score=262.22  Aligned_cols=178  Identities=26%  Similarity=0.352  Sum_probs=143.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...+ ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       472 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-  547 (656)
T 2j0j_A          472 CTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-  547 (656)
T ss_dssp             CTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred             CCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-
Confidence            57899999997654 34899999999999999999999865  999999999999999999999999999875443221 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...                 ......+.....
T Consensus       548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----------------~~~~~~i~~~~~  610 (656)
T 2j0j_A          548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------------NDVIGRIENGER  610 (656)
T ss_dssp             ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHHTCC
T ss_pred             eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            1233456789999999999999999999999999999997 9999976431                 112222223334


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+++.
T Consensus       611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            4566778899999999999999999999999999998763

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-36  Score=253.78  Aligned_cols=173  Identities=14%  Similarity=0.041  Sum_probs=131.0

Q ss_pred             CChhhhhhcCCCCCCCHHHH------HHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC
Q 025440            4 GSLENHLFRRGPQPLSWAVR------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+|.+++...+. .+.+..+      +.++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++..... 
T Consensus       172 ~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-  247 (371)
T 3q60_A          172 VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-  247 (371)
T ss_dssp             EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-
T ss_pred             CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCC-
Confidence            899999976532 2455556      788899999999999766  999999999999999999999999999865321 


Q ss_pred             cceeeecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                          .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.............         ......
T Consensus       248 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---------~~~~~~  314 (371)
T 3q60_A          248 ----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS---------LRVPGT  314 (371)
T ss_dssp             ----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCC---------TTSCCC
T ss_pred             ----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhh---------hhhccc
Confidence                224567799999999987  67999999999999999999999999876432111100000         000000


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..........++..+.+||.+||+.||++|||+.++++
T Consensus       315 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          315 DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111222466889999999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-34  Score=240.34  Aligned_cols=184  Identities=21%  Similarity=0.243  Sum_probs=137.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-------------------CCceE
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------------------EFNAK   63 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-------------------~~~~k   63 (252)
                      +|+|.+++...+..++++..++.++.||+.||+|||+++  |+||||||+|||++.                   ++.+|
T Consensus       100 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~k  177 (339)
T 1z57_A          100 GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK  177 (339)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEE
T ss_pred             CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCCCce
Confidence            789999998887667999999999999999999999765  999999999999987                   66899


Q ss_pred             EccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hhcch
Q 025440           64 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKP  142 (252)
Q Consensus        64 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~~~~  142 (252)
                      |+|||+++.....     .....||..|+|||++.+..++.++|||||||++|+|++|..||............ ....+
T Consensus       178 l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  252 (339)
T 1z57_A          178 VVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGP  252 (339)
T ss_dssp             ECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCS
T ss_pred             EeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999999864332     23456899999999999989999999999999999999999999875432111000 00000


Q ss_pred             hh--------------------hhhhhHHHHhhhh-----cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          143 YL--------------------SDKRKLFRIMDTK-----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       143 ~~--------------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..                    .............     .........+..+.+||.+||+.||.+|||+.++++
T Consensus       253 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          253 LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            00                    0000000000000     011223456788999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.9e-35  Score=244.54  Aligned_cols=170  Identities=28%  Similarity=0.412  Sum_probs=135.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..+..++.||+.||.|||+.+  |+|+||||+|||++.+|.+||+|||++........  
T Consensus       182 ~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~--  255 (365)
T 2y7j_A          182 MRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--  255 (365)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc--
Confidence            578999999987654  999999999999999999999765  99999999999999999999999999986544322  


Q ss_pred             eeecccccccccCccccccC------CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           81 VSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                       .....||+.|+|||++.+.      .++.++|||||||++|+|++|..||.+....                .....+.
T Consensus       256 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----------------~~~~~i~  318 (365)
T 2y7j_A          256 -LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----------------LMLRMIM  318 (365)
T ss_dssp             -BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHH
T ss_pred             -cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHH
Confidence             2345789999999998643      5888999999999999999999999764311                1111111


Q ss_pred             hhhcCCCCc--HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ........+  ..++..+.+||.+||+.||.+|||+.++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111111  245678999999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1e-34  Score=238.72  Aligned_cols=186  Identities=19%  Similarity=0.241  Sum_probs=132.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus       102 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~  176 (311)
T 3niz_A          102 EKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SY  176 (311)
T ss_dssp             SEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred             CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cc
Confidence            357888886654 34999999999999999999999765  99999999999999999999999999987543222  13


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cch---hhhhhhhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKP---YLSDKRKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~~---~~~~~~~~~~~~~~  156 (252)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ +... ..+   ..............
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR  256 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence            34568999999999876 468999999999999999999999998754321110 0000 000   00000000000000


Q ss_pred             hcC---CC----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLG---GQ----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~---~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...   ..    ....++.++.+||.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000   00    01235678899999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-35  Score=246.21  Aligned_cols=178  Identities=22%  Similarity=0.303  Sum_probs=118.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.+.+...+++..++.++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+++......
T Consensus       108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~  185 (336)
T 3fhr_A          108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA  185 (336)
T ss_dssp             CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence            57899999998887667999999999999999999999765  999999999999976   4559999999997643321


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........          ............
T Consensus       186 ----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~  251 (336)
T 3fhr_A          186 ----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRIRLGQYG  251 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------C
T ss_pred             ----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhhhccccc
Confidence                234567999999999988889999999999999999999999997643211000          000000000111


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ........++..+.+||.+||+.||.+|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1112224578889999999999999999999999983

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=242.69  Aligned_cols=173  Identities=24%  Similarity=0.325  Sum_probs=131.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+.+  |+|+||||+|||++.++.+||+|||++........  
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--  184 (326)
T 2x7f_A          109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--  184 (326)
T ss_dssp             CTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTTC---------
T ss_pred             CCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--
Confidence            46889999998765556999999999999999999999765  99999999999999999999999999876533211  


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......|+..|+|||++.     +..++.++|||||||++|+|++|..||.+....                .....+..
T Consensus       185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~  248 (326)
T 2x7f_A          185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------------RALFLIPR  248 (326)
T ss_dssp             ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHH
T ss_pred             ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----------------HHHHHhhc
Confidence            123456899999999986     456889999999999999999999999764311                11111111


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..........++..+.+||.+||..||.+||++.++++
T Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11222223456788999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.5e-35  Score=244.61  Aligned_cols=183  Identities=16%  Similarity=0.249  Sum_probs=135.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC-CCCeeeccCCCCceeec------CCCceEEccccccccCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLD------AEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~~~ivH~dlkp~Nill~------~~~~~kl~Dfg~~~~~~~   75 (252)
                      ||+|.+++.......+++..++.++.||+.||+|||++ +  |+||||||+|||++      ..+.+||+|||+++....
T Consensus       113 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred             CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccCC
Confidence            78999999886666699999999999999999999975 5  99999999999994      444799999999976543


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCccccc----chhhhhh---cchh----h
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI----EQSLVDW---AKPY----L  144 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~----~~~~~~~---~~~~----~  144 (252)
                      .     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....    ...+...   ....    .
T Consensus       191 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  265 (373)
T 1q8y_A          191 H-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL  265 (373)
T ss_dssp             C-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHH
T ss_pred             C-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHH
Confidence            2     233468999999999999999999999999999999999999998654211    0000000   0000    0


Q ss_pred             hhhh---------------------hHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          145 SDKR---------------------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       145 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ....                     .......  .....+..++.++.+||.+||+.||.+|||+.++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          266 RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            0000                     0001111  1224567788999999999999999999999999873

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-34  Score=250.21  Aligned_cols=182  Identities=21%  Similarity=0.267  Sum_probs=126.4

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      |+|.+++..    .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ...
T Consensus       151 ~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~  221 (464)
T 3ttj_A          151 ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMT  221 (464)
T ss_dssp             EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC-
T ss_pred             CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccC
Confidence            456666633    2899999999999999999999876  9999999999999999999999999998654322   234


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcch---hhhhh-hhHHHHhhhh
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKP---YLSDK-RKLFRIMDTK  157 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~---~~~~~-~~~~~~~~~~  157 (252)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...... +.. ...+   ..... ......+...
T Consensus       222 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~  301 (464)
T 3ttj_A          222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR  301 (464)
T ss_dssp             ---CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTS
T ss_pred             CCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcc
Confidence            4678999999999999999999999999999999999999998765321100 000 0000   00000 0001111100


Q ss_pred             cC---CC---------------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LG---GQ---------------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~---~~---------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..   ..               .....+.++.+||.+||..||++|||++++++.
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00   00               011236789999999999999999999999873

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-34  Score=235.20  Aligned_cols=171  Identities=23%  Similarity=0.299  Sum_probs=137.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+||+++.++.   +||+|||++.......
T Consensus        87 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           87 VTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            578999999987755  999999999999999999999765  999999999999976655   9999999997654332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....                .....+....
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----------------~~~~~~~~~~  223 (284)
T 3kk8_A          163 A---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----------------RLYAQIKAGA  223 (284)
T ss_dssp             B---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHTC
T ss_pred             c---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh----------------HHHHHHHhcc
Confidence            2   23456899999999999999999999999999999999999999764321                1111111111


Q ss_pred             cC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..  ......++.++.+||.+||+.||++|||+.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          224 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11  12223567889999999999999999999999873

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.3e-36  Score=241.61  Aligned_cols=177  Identities=24%  Similarity=0.290  Sum_probs=138.6

Q ss_pred             CCCCChhhhhhcCC--CCCCCHHHHHHHHHHHHHHhHHHhcCC---CCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      ++||+|.+++....  ...+++..++.++.||+.||+|||+.+   .+|+|+||||+|||++.++.+||+|||+++....
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~  168 (279)
T 2w5a_A           89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  168 (279)
T ss_dssp             CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC--
T ss_pred             CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecc
Confidence            46889999997542  345999999999999999999999754   2399999999999999999999999999976543


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ....  .....|+..|+|||++.+..++.++||||||+++|+|++|..||.....                 ......+.
T Consensus       169 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~i~  229 (279)
T 2w5a_A          169 DTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------------KELAGKIR  229 (279)
T ss_dssp             -CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred             cccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----------------HHHHHHHh
Confidence            2211  2234689999999999988999999999999999999999999976431                 11112222


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                      .......+..++.++.++|.+||+.||.+||++.++++.+.
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          230 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            22233455677889999999999999999999999998653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-35  Score=253.14  Aligned_cols=189  Identities=22%  Similarity=0.242  Sum_probs=127.3

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--   79 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--   79 (252)
                      .+|+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+++........  
T Consensus       139 ~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  214 (458)
T 3rp9_A          139 ADSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS  214 (458)
T ss_dssp             CSEEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCC
T ss_pred             cccchhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccCcccccc
Confidence            46889999976654  999999999999999999999876  999999999999999999999999999875322110  


Q ss_pred             -----------------------eeeecccccccccCcccc-ccCCCCcccceehhHHHHHHHHh-----------CCCC
Q 025440           80 -----------------------HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLS-----------GRCA  124 (252)
Q Consensus        80 -----------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt-----------g~~p  124 (252)
                                             ......+||+.|+|||++ .+..++.++|||||||++|||++           |..+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~  294 (458)
T 3rp9_A          215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL  294 (458)
T ss_dssp             CCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCS
T ss_pred             ccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccccc
Confidence                                   123445789999999976 45679999999999999999999           5666


Q ss_pred             CCCcccccch----hhhhhcchhhhhhhhHHHH-----------------------hhh---hcCC---CCcHHHHHHHH
Q 025440          125 VDKTKVGIEQ----SLVDWAKPYLSDKRKLFRI-----------------------MDT---KLGG---QYPQKAAHTAA  171 (252)
Q Consensus       125 f~~~~~~~~~----~~~~~~~~~~~~~~~~~~~-----------------------~~~---~~~~---~~~~~~~~~~~  171 (252)
                      |.+.......    ...............+..+                       +..   ....   ......+.++.
T Consensus       295 f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  374 (458)
T 3rp9_A          295 FPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAI  374 (458)
T ss_dssp             CC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHH
T ss_pred             CCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHH
Confidence            6554310000    0000000000000000000                       000   0000   01123477899


Q ss_pred             HHHHhhccCCCCCCCCHHHHHHH
Q 025440          172 TLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       172 ~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      +||.+||..||.+|||++++++.
T Consensus       375 dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          375 HLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhccCccccCCHHHHhcC
Confidence            99999999999999999999974

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.9e-35  Score=242.59  Aligned_cols=170  Identities=27%  Similarity=0.390  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.....  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++........  
T Consensus       123 ~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--  196 (335)
T 2owb_A          123 CRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--  196 (335)
T ss_dssp             CTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--
Confidence            468999999977654  999999999999999999999765  99999999999999999999999999986543221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++||||||+++|+|++|..||......                .....+..  ...
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~~~~--~~~  258 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----------------ETYLRIKK--NEY  258 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHH--TCC
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----------------HHHHHHhc--CCC
Confidence            123456899999999999889999999999999999999999999764311                11111111  122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++..+.+||.+||+.||++||++.++++.
T Consensus       259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            3455677889999999999999999999999973

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-34  Score=233.68  Aligned_cols=167  Identities=22%  Similarity=0.324  Sum_probs=134.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++.....  +++..++.++.|++.||+|||+.+  |+||||||+|||+   +.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            478999999987655  999999999999999999999765  9999999999999   788899999999997654332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......                .....+....
T Consensus       164 ~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~  223 (277)
T 3f3z_A          164 M---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS----------------EVMLKIREGT  223 (277)
T ss_dssp             C---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC
T ss_pred             c---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHhCC
Confidence            2   234568999999999865 4899999999999999999999999764321                1111111111


Q ss_pred             cCCCCcH----HHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYPQ----KAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~~----~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        ...+.    .++..+.+||.+||+.||.+|||+.++++
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 --FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11222    46788999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.9e-35  Score=238.03  Aligned_cols=171  Identities=27%  Similarity=0.383  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++...   .+++..++.++.||+.||.|||+.+  |+|+||||+||+++.++.+||+|||++........  
T Consensus       102 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  174 (303)
T 3a7i_A          102 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  174 (303)
T ss_dssp             CTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence            4688999999653   3999999999999999999999765  99999999999999999999999999976543221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|..||.....                 ......+......
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~~~  237 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----------------MKVLFLIPKNNPP  237 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------------HHHHHHHHHSCCC
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----------------HHHHHHhhcCCCC
Confidence            12345689999999999998999999999999999999999999976431                 1111112222233


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ..+..++..+.+||.+||+.||.+|||+.++++..
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            44556778899999999999999999999998743

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-35  Score=250.67  Aligned_cols=161  Identities=15%  Similarity=0.157  Sum_probs=127.2

Q ss_pred             CCChhhhhhcCCC-----CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC
Q 025440            3 KGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      +|+|.+++...+.     ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....  
T Consensus       183 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--  258 (377)
T 3byv_A          183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--  258 (377)
T ss_dssp             SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC--
T ss_pred             CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC--
Confidence            6899999976533     12345888899999999999999876  99999999999999999999999999986322  


Q ss_pred             cceeeecccccccccCccccccC-----------CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATG-----------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                         ......| ..|+|||++.+.           .++.++|||||||++|+|++|+.||.+........           
T Consensus       259 ---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~-----------  323 (377)
T 3byv_A          259 ---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-----------  323 (377)
T ss_dssp             ---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG-----------
T ss_pred             ---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh-----------
Confidence               2344567 999999999887           79999999999999999999999997643211000           


Q ss_pred             hhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                           .+.      .....++.++.+||.+||+.||.+|||+.++++
T Consensus       324 -----~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          324 -----WIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             -----GGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             -----hhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence                 000      111345678999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-34  Score=246.62  Aligned_cols=170  Identities=25%  Similarity=0.302  Sum_probs=127.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+++  |+||||||+|||++.++   .+||+|||+++......
T Consensus       221 ~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  296 (419)
T 3i6u_A          221 MEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS  296 (419)
T ss_dssp             CTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---
T ss_pred             CCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCCCc
Confidence            579999999977654  999999999999999999999765  99999999999996544   59999999998754322


Q ss_pred             cceeeecccccccccCcccccc---CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                         ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+.....                .....+
T Consensus       297 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----------------~~~~~i  357 (419)
T 3i6u_A          297 ---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----------------SLKDQI  357 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----------------CHHHHH
T ss_pred             ---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----------------HHHHHH
Confidence               2334679999999999854   568889999999999999999999997643211                011111


Q ss_pred             hhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ........   ...++..+.+||.+||+.||.+|||+.++++
T Consensus       358 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11111111   1245778999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-34  Score=233.65  Aligned_cols=171  Identities=20%  Similarity=0.248  Sum_probs=136.3

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      ++|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.............
T Consensus        92 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~  169 (305)
T 2wtk_C           92 CGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR  169 (305)
T ss_dssp             EEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEEC
T ss_pred             CCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccCccccccccc
Confidence            34778887765566999999999999999999999765  9999999999999999999999999998754433333334


Q ss_pred             cccccccccCccccccCC--CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCC
Q 025440           84 QVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ  161 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (252)
                      ...||..|+|||++.+..  ++.++||||||+++|+|++|..||.+...                 ......+.. ....
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~i~~-~~~~  231 (305)
T 2wtk_C          170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----------------YKLFENIGK-GSYA  231 (305)
T ss_dssp             CCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHHHHH-CCCC
T ss_pred             cCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----------------HHHHHHHhc-CCCC
Confidence            557899999999987654  37799999999999999999999976431                 011111111 1223


Q ss_pred             CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       162 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .+..++..+.+||.+||+.||.+|||+.++++.
T Consensus       232 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            455677889999999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-34  Score=239.61  Aligned_cols=184  Identities=21%  Similarity=0.226  Sum_probs=135.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee-------------------cCCCceE
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-------------------DAEFNAK   63 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill-------------------~~~~~~k   63 (252)
                      +|+|.+++.......+++..++.++.||+.||+|||+++  |+||||||+|||+                   +.++.+|
T Consensus       105 ~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~k  182 (355)
T 2eu9_A          105 GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR  182 (355)
T ss_dssp             CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEE
T ss_pred             CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccCCCcEE
Confidence            678888888776667999999999999999999999765  9999999999999                   5678899


Q ss_pred             EccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcch
Q 025440           64 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKP  142 (252)
Q Consensus        64 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~  142 (252)
                      |+|||+++.....     .....||..|+|||++.+..++.++|||||||++|+|++|..||.......... +.....+
T Consensus       183 l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (355)
T 2eu9_A          183 VADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP  257 (355)
T ss_dssp             ECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999999864332     234578999999999999999999999999999999999999998754321100 0000000


Q ss_pred             hhh--------------------hhhhHHHHhhhhc-----CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          143 YLS--------------------DKRKLFRIMDTKL-----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       143 ~~~--------------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...                    .............     ........+..+.+||.+||+.||.+|||+.++++
T Consensus       258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          258 IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000                    0000000000000     01122345678999999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-34  Score=241.07  Aligned_cols=182  Identities=23%  Similarity=0.301  Sum_probs=134.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|.+++...   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....     .
T Consensus       113 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~  182 (367)
T 1cm8_A          113 GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M  182 (367)
T ss_dssp             SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----C
T ss_pred             CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----c
Confidence            78899998763   3899999999999999999999876  999999999999999999999999999875332     2


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhh-cch---hhh--hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKP---YLS--DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~-~~~---~~~--~~~~~~~~~  154 (252)
                      ...++|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... .+... ..+   ...  ........+
T Consensus       183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~  262 (367)
T 1cm8_A          183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM  262 (367)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred             CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Confidence            34578999999999887 67999999999999999999999999875432110 00000 000   000  000000111


Q ss_pred             hhh---cCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DTK---LGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~~---~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...   ...   ......+..+.+||.+||..||.+|||+.++++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            100   000   1123457889999999999999999999999873

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=237.83  Aligned_cols=188  Identities=20%  Similarity=0.215  Sum_probs=130.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.....  +++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++........  
T Consensus        84 ~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           84 CDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             CSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence            467888888876654  999999999999999999999765  99999999999999999999999999987543222  


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hhcchhhhhhhhHHHHhh--h
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKRKLFRIMD--T  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~  156 (252)
                      ......||..|+|||++.+ ..++.++||||||+++|+|++|..||.+.......... ..................  .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            1234568999999999976 56899999999999999999999999875432111110 000000000000000000  0


Q ss_pred             hcCCCC----------cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 KLGGQY----------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......          ...++..+.+||.+||+.||.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000          02456789999999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-34  Score=236.75  Aligned_cols=170  Identities=27%  Similarity=0.390  Sum_probs=139.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++........  
T Consensus        97 ~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--  170 (294)
T 2rku_A           97 CRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--  170 (294)
T ss_dssp             CTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--
Confidence            468999999977654  999999999999999999999765  99999999999999999999999999976543221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||..|+|||++.+..++.++||||||+++|+|++|..||......                .....+..  ...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~--~~~  232 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----------------ETYLRIKK--NEY  232 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHT--TCC
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHhh--ccC
Confidence            123456899999999998888999999999999999999999999764321                11111111  122


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+..++..+.++|.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            3455677889999999999999999999999974

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.2e-35  Score=235.72  Aligned_cols=170  Identities=28%  Similarity=0.378  Sum_probs=116.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++........  
T Consensus        93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  167 (278)
T 3cok_A           93 CHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--  167 (278)
T ss_dssp             CTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence            46899999997653 34999999999999999999999765  99999999999999999999999999986543221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||........                ......  ...
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~--~~~  229 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVVL--ADY  229 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCS--SCC
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHhh--ccc
Confidence            12335689999999999888899999999999999999999999976432110                000000  111


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++.++.+||.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            334556788999999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9e-35  Score=242.65  Aligned_cols=168  Identities=29%  Similarity=0.374  Sum_probs=134.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++......      
T Consensus       137 ~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------  207 (348)
T 1u5q_A          137 LGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------  207 (348)
T ss_dssp             SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------
T ss_pred             CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------
Confidence            367888885433 34999999999999999999999865  999999999999999999999999999765322      


Q ss_pred             ecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           83 TQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ....||+.|+|||++.   +..++.++|||||||++|+|++|..||.+...                ......+......
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----------------~~~~~~~~~~~~~  271 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNESP  271 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHSCCC
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----------------HHHHHHHHhcCCC
Confidence            2356899999999985   46789999999999999999999999976431                1112222222222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL  195 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l  195 (252)
                      ...+..++..+.+||.+||+.||++|||+.++++..
T Consensus       272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            233445678899999999999999999999998744

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.1e-35  Score=245.73  Aligned_cols=186  Identities=25%  Similarity=0.391  Sum_probs=136.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.+|+.||+|||+. .+|+||||||+|||++.++.+||+|||++......    
T Consensus       113 ~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  185 (360)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred             CCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence            578999999987665  99999999999999999999974 13999999999999999999999999998643211    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhh---------------------
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW---------------------  139 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~---------------------  139 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............                     
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            12345789999999999999999999999999999999999999986543211110000                     


Q ss_pred             -----cchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          140 -----AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       140 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                           ..+..........+............++.++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 000000001111111111122222346788999999999999999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-34  Score=241.53  Aligned_cols=159  Identities=25%  Similarity=0.237  Sum_probs=121.5

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC--ceEEccccccccCCCCC--cceeeecccccccccC
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAA   93 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~a   93 (252)
                      +++..++.++.||+.||+|||+.+  |+||||||+|||++.++  .+||+|||+++......  .........||+.|+|
T Consensus       165 ~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a  242 (345)
T 3hko_A          165 QREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA  242 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence            467788999999999999999875  99999999999998776  89999999997542211  1112344578999999


Q ss_pred             cccccc--CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCCCC--cHHHHHH
Q 025440           94 PEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHT  169 (252)
Q Consensus        94 PE~~~~--~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  169 (252)
                      ||++.+  ..++.++|||||||++|+|++|..||.+...                ......+.........  ...++..
T Consensus       243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~  306 (345)
T 3hko_A          243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND----------------ADTISQVLNKKLCFENPNYNVLSPL  306 (345)
T ss_dssp             HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCCCCTTSGGGGGSCHH
T ss_pred             chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh----------------HHHHHHHHhcccccCCcccccCCHH
Confidence            999875  5788999999999999999999999976532                1122222222222222  2246788


Q ss_pred             HHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          170 AATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       170 ~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      +.+||.+||+.||.+||++.++++.
T Consensus       307 ~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          307 ARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcC
Confidence            9999999999999999999999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=235.83  Aligned_cols=174  Identities=25%  Similarity=0.410  Sum_probs=136.8

Q ss_pred             CCCCChhhhhhcCC-CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      ++||+|.+++.... ...+++..+..++.||+.||+|||+.+  |+|+||||+||+++. ++.+||+|||++........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            46899999997663 345789999999999999999999765  999999999999987 89999999999976543221


Q ss_pred             ceeeecccccccccCccccccCC--CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           79 THVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                        ......|+..|+|||++.+..  ++.++||||||+++|+|++|..||......               ..........
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------------~~~~~~~~~~  241 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---------------QAAMFKVGMF  241 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---------------HHHHHHHHHH
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---------------hHHHHhhccc
Confidence              123456899999999997654  789999999999999999999999653211               0111111122


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......+..++.++.+||.+||+.||++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2334556677889999999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1e-34  Score=236.21  Aligned_cols=186  Identities=21%  Similarity=0.292  Sum_probs=129.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        83 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  157 (288)
T 1ob3_A           83 DQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY  157 (288)
T ss_dssp             SEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--cc
Confidence            358888886643 34999999999999999999999765  99999999999999999999999999976432211  12


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cchhhhhhhhHHHH--hhhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPYLSDKRKLFRI--MDTK  157 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~--~~~~  157 (252)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........ .... ..+...........  ....
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            344689999999998764 58999999999999999999999998754211000 0000 00000000000000  0000


Q ss_pred             cC-------CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..       ......++.++.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       0111346778999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.5e-34  Score=246.61  Aligned_cols=121  Identities=26%  Similarity=0.328  Sum_probs=98.3

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--   79 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--   79 (252)
                      -+|+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........  
T Consensus       112 ~~~~L~~~~~~~~~--l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  187 (432)
T 3n9x_A          112 ADSDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI  187 (432)
T ss_dssp             CSEEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC--------
T ss_pred             CCcCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccc
Confidence            35799999977654  999999999999999999999876  999999999999999999999999999875432211  


Q ss_pred             ------------------eeeecccccccccCcccc-ccCCCCcccceehhHHHHHHHHhCCCCCC
Q 025440           80 ------------------HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVD  126 (252)
Q Consensus        80 ------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~lltg~~pf~  126 (252)
                                        ......+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence                              113456899999999986 45569999999999999999998655554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-35  Score=252.46  Aligned_cols=162  Identities=14%  Similarity=0.148  Sum_probs=127.8

Q ss_pred             CCCChhhhhh-----cCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCC
Q 025440            2 PKGSLENHLF-----RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         2 ~ggsL~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~   76 (252)
                      .+|+|.+++.     ......+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus       187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~  264 (413)
T 3dzo_A          187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS  264 (413)
T ss_dssp             CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred             hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecCCeEEEEeccceeecCCc
Confidence            4678888884     222345889999999999999999999766  999999999999999999999999998764322


Q ss_pred             CcceeeecccccccccCcccc----------ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYV----------ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                           ....+| +.|+|||++          .+..++.++|||||||++|+|++|+.||.+.......            
T Consensus       265 -----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~------------  326 (413)
T 3dzo_A          265 -----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------  326 (413)
T ss_dssp             -----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS------------
T ss_pred             -----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH------------
Confidence                 344567 999999999          4556888999999999999999999999764321100            


Q ss_pred             hhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          147 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                          ..++.      ....++..+.+||.+||+.||++||++.++++
T Consensus       327 ----~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          327 ----EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             ----GGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----HHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                00000      01134578999999999999999999888764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-34  Score=248.83  Aligned_cols=170  Identities=27%  Similarity=0.365  Sum_probs=135.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec---CCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++   .++.+||+|||+++......
T Consensus       103 ~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          103 YTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             CCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            578999999977655  999999999999999999999766  99999999999995   45679999999997654332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...                ......+....
T Consensus       179 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~~~~~i~~~~  238 (486)
T 3mwu_A          179 K---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----------------YDILKRVETGK  238 (486)
T ss_dssp             ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHTC
T ss_pred             c---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCC
Confidence            1   334579999999999865 699999999999999999999999977532                11112222222


Q ss_pred             cCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...  +....++.++.+||.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            222  2234578899999999999999999999999974

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-34  Score=236.04  Aligned_cols=170  Identities=23%  Similarity=0.367  Sum_probs=137.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+|+||||+||++   +.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           88 VSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             CCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            468999999977665  999999999999999999999765  9999999999999   778899999999987643321


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                          .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....                .....+....
T Consensus       164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~i~~~~  223 (304)
T 2jam_A          164 ----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----------------KLFEKIKEGY  223 (304)
T ss_dssp             ----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHCC
T ss_pred             ----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHHcCC
Confidence                23346899999999999989999999999999999999999999764311                1111111111


Q ss_pred             c--CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 L--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .  .......++..+.+||.+||..||.+|||+.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1  122335677899999999999999999999999873

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-34  Score=238.16  Aligned_cols=187  Identities=25%  Similarity=0.291  Sum_probs=132.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.   +||+|||++.......
T Consensus        93 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           93 MRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             CCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            578999999987654  999999999999999999999865  999999999999988776   9999999987643221


Q ss_pred             c-----ceeeecccccccccCcccccc-----CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           78 R-----THVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        78 ~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      .     ........||..|+|||++.+     ..++.++|||||||++|+|++|..||.+...........  .......
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~  246 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG--EACPACQ  246 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc--ccchhHH
Confidence            1     111223468999999999875     458899999999999999999999998754321100000  0000001


Q ss_pred             hhHHHHhhhhcCCCCc----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          148 RKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       148 ~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..+...+... ....+    ..++..+.+||.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1111111111 11222    2467789999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-35  Score=247.84  Aligned_cols=184  Identities=18%  Similarity=0.241  Sum_probs=142.4

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee----cCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~   75 (252)
                      |+||+|.+++..... ..+++..++.++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+|||+++....
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            568999999976543 34999999999999999999999765  9999999999999    7778899999999987543


Q ss_pred             CCcceeeecccccccccCcccccc--------CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVAT--------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                      ...   .....||..|+|||++.+        ..++.++|||||||++|+|++|..||.........            .
T Consensus       169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~------------~  233 (396)
T 4eut_A          169 DEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------------K  233 (396)
T ss_dssp             GGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC------------H
T ss_pred             CCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch------------H
Confidence            322   234568999999999865        46788999999999999999999999754321100            0


Q ss_pred             hhHHHHhhh-----------------------hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          148 RKLFRIMDT-----------------------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       148 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      .....++..                       .........++..+.++|.+||+.||++||++.++++.++.+...
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            001111110                       011123467888999999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-34  Score=234.92  Aligned_cols=186  Identities=23%  Similarity=0.232  Sum_probs=130.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.... ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        84 ~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  158 (292)
T 3o0g_A           84 DQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CY  158 (292)
T ss_dssp             SEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CC
T ss_pred             CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cc
Confidence            356666665543 24999999999999999999999875  99999999999999999999999999986543222  23


Q ss_pred             ecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccch--hhhh-hcchhhhhhhhHHHHhh---
Q 025440           83 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD-WAKPYLSDKRKLFRIMD---  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~---  155 (252)
                      ....||..|+|||++.+.. ++.++|||||||++|+|++|..||.........  .+.. ...+.............   
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            3457899999999997766 799999999999999999988886433221100  0000 00000000000000000   


Q ss_pred             ------hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 ------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                            ..........++..+.+||.+||+.||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                  00001122346788999999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-34  Score=238.37  Aligned_cols=183  Identities=22%  Similarity=0.309  Sum_probs=133.2

Q ss_pred             CCChhhhhhcCC----CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc
Q 025440            3 KGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         3 ggsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      .|+|.+++....    ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  163 (317)
T 2pmi_A           86 DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN  163 (317)
T ss_dssp             CCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred             CCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence            368999886542    245999999999999999999999765  99999999999999999999999999986543221


Q ss_pred             ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcc----hhhhhh-----
Q 025440           79 THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK----PYLSDK-----  147 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~----~~~~~~-----  147 (252)
                        ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........ +.....    ..+...     
T Consensus       164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          164 --TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             --CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             --cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence              12345689999999999764 68999999999999999999999998754321110 000000    000000     


Q ss_pred             ----------hhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          148 ----------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       148 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                                ..+...+.    ......++.++.+||.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQ----PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHG----GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhHHHhhc----ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                      00000000    0111235678999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-34  Score=251.54  Aligned_cols=170  Identities=26%  Similarity=0.366  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      +.||+|.+++...+.  +++..++.++.||+.||+|||+++  |+||||||+|||+   +.++.+||+|||+++......
T Consensus       108 ~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          108 YTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            579999999987765  999999999999999999999875  9999999999999   567889999999997654432


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...                ......+....
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~~~~~i~~~~  243 (484)
T 3nyv_A          184 K---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----------------YDILKKVEKGK  243 (484)
T ss_dssp             S---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHCC
T ss_pred             c---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHcCC
Confidence            2   234579999999999865 799999999999999999999999987532                11122222222


Q ss_pred             cCCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ....  ....++..+.+||.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          244 YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            2222  224678899999999999999999999999963

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-34  Score=237.21  Aligned_cols=186  Identities=19%  Similarity=0.259  Sum_probs=129.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++...+. .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        83 ~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~  157 (324)
T 3mtl_A           83 DKDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TY  157 (324)
T ss_dssp             SEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             ccCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--cc
Confidence            4689999877653 4999999999999999999999765  99999999999999999999999999976433221  12


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cc---hhhh---hhhhHHHH
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AK---PYLS---DKRKLFRI  153 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~---~~~~---~~~~~~~~  153 (252)
                      ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+........ +... ..   ..+.   ........
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            34568999999999876 568999999999999999999999998754321110 0000 00   0000   00000000


Q ss_pred             hhhhcCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......    .....++.++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000000    001235678899999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-34  Score=235.60  Aligned_cols=172  Identities=27%  Similarity=0.366  Sum_probs=137.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||.|||+.+  ++|+||||+||+++.++.+||+|||++........  
T Consensus       106 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--  180 (314)
T 3com_A          106 CGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--  180 (314)
T ss_dssp             CTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--
Confidence            46889999996433 34999999999999999999999765  99999999999999999999999999976533221  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh-hcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  159 (252)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|..||......                ......... ...
T Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~~~~  244 (314)
T 3com_A          181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----------------RAIFMIPTNPPPT  244 (314)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHHHHHSCCCC
T ss_pred             ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----------------HHHHHHhcCCCcc
Confidence            123456899999999999889999999999999999999999999764311                011111111 111


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++..+.+||.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            2234566788999999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-34  Score=231.75  Aligned_cols=169  Identities=27%  Similarity=0.417  Sum_probs=129.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...+.  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++........  
T Consensus        93 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  166 (276)
T 2h6d_A           93 VSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--  166 (276)
T ss_dssp             CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             cCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCCCcc--
Confidence            468999999987655  899999999999999999999765  99999999999999999999999999987543321  


Q ss_pred             eeecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||......                 .....+.. ..
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------------~~~~~~~~-~~  227 (276)
T 2h6d_A          167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-----------------TLFKKIRG-GV  227 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------HHHHHHHH-CC
T ss_pred             -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----------------HHHHHhhc-Cc
Confidence             234468999999999987765 68999999999999999999999764310                 11111111 11


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...+..++..+.++|.+||+.||.+|||+.++++.
T Consensus       228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            23455667889999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-34  Score=234.28  Aligned_cols=175  Identities=25%  Similarity=0.355  Sum_probs=135.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----ceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~   76 (252)
                      ++|++|.+++.....  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.++    .+||+|||++......
T Consensus        90 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~  165 (283)
T 3bhy_A           90 VSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG  165 (283)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceeccCC
Confidence            468999999977654  999999999999999999999765  99999999999998877    7999999999865432


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ..   .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+....                .....+...
T Consensus       166 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~  226 (283)
T 3bhy_A          166 NE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----------------ETLTNISAV  226 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHHHHTT
T ss_pred             Cc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----------------HHHHHhHhc
Confidence            21   23456899999999999889999999999999999999999999764321                011111111


Q ss_pred             hcC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhh
Q 025440          157 KLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL  198 (252)
Q Consensus       157 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~--~l~~~  198 (252)
                      ...  ......++..+.+|+.+||..||.+||++.++++  .++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          227 NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            100  0111245678999999999999999999999997  44444

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.1e-34  Score=235.25  Aligned_cols=186  Identities=24%  Similarity=0.282  Sum_probs=137.0

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ..
T Consensus       102 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~  176 (326)
T 1blx_A          102 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---AL  176 (326)
T ss_dssp             SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GG
T ss_pred             CCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---Cc
Confidence            479999998876666999999999999999999999765  9999999999999999999999999997643221   12


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhh-cchhhhhh---hhH-HHHhhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDK---RKL-FRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~-~~~~~~~~---~~~-~~~~~~  156 (252)
                      ....||..|+|||++.+..++.++||||||+++|+|++|..||.+....... .+... ..+.....   ... ......
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 1blx_A          177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS  256 (326)
T ss_dssp             CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCC
T ss_pred             cccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcc
Confidence            3456899999999999989999999999999999999999999875421100 00000 00000000   000 000000


Q ss_pred             ---hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 ---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         .........++..+.+||.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          257 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               0000122346788999999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-34  Score=232.57  Aligned_cols=171  Identities=27%  Similarity=0.340  Sum_probs=128.0

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee---cCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~   75 (252)
                      ++||+|.+++...  ....+++..++.++.||+.||+|||+.+  |+||||||+|||+   +.++.+||+|||++.....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            5789999999643  1245999999999999999999999765  9999999999999   4567899999999976543


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ...   .....||..|+|||++. ..++.++||||||+++|+|++|..||.+......                ......
T Consensus       180 ~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~----------------~~~~~~  239 (285)
T 3is5_A          180 DEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----------------QQKATY  239 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHH
T ss_pred             ccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH----------------Hhhhcc
Confidence            221   33456899999999985 5789999999999999999999999987532110                001110


Q ss_pred             hhcC-CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .... ......++..+.+||.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          240 KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1110 1111235678899999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.2e-34  Score=231.96  Aligned_cols=170  Identities=30%  Similarity=0.369  Sum_probs=136.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++........  
T Consensus       106 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--  179 (298)
T 1phk_A          106 MKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--  179 (298)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--
T ss_pred             cCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc--
Confidence            468999999987654  999999999999999999999765  99999999999999999999999999976543322  


Q ss_pred             eeecccccccccCccccc------cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           81 VSTQVMGTHGYAAPEYVA------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                       .....|+..|+|||++.      ...++.++||||||+++|+|++|..||.....                ......+.
T Consensus       180 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------------~~~~~~~~  242 (298)
T 1phk_A          180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------------MLMLRMIM  242 (298)
T ss_dssp             -BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHH
T ss_pred             -cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----------------HHHHHHHh
Confidence             23456899999999985      44688999999999999999999999976431                11111122


Q ss_pred             hhhcC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....  ......++..+.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            22211  1223467889999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.8e-34  Score=247.79  Aligned_cols=169  Identities=25%  Similarity=0.338  Sum_probs=135.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC---CceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+.+  |+||||||+|||++..   +.+||+|||++.......
T Consensus       118 ~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          118 YKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            579999999987755  999999999999999999999765  9999999999999764   459999999998754332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+...                ......+....
T Consensus       194 ~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------~~~~~~i~~~~  253 (494)
T 3lij_A          194 K---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----------------QEILRKVEKGK  253 (494)
T ss_dssp             C---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHTC
T ss_pred             c---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCC
Confidence            1   33457999999999985 5799999999999999999999999987532                11111222222


Q ss_pred             cCCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  ....++..+.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            2111  12356788999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-34  Score=234.55  Aligned_cols=172  Identities=26%  Similarity=0.345  Sum_probs=125.2

Q ss_pred             CCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            3 KGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         3 ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +|+|.+++...  ....+++..++.++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||++........  
T Consensus        89 ~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  165 (290)
T 3fme_A           89 DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--  165 (290)
T ss_dssp             SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             ccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc--
Confidence            35787777542  224599999999999999999999975 1399999999999999999999999999976533221  


Q ss_pred             eeecccccccccCcccc----ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                       .....||+.|+|||++    .+..++.++||||||+++|+|++|..||.....               ...........
T Consensus       166 -~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------------~~~~~~~~~~~  229 (290)
T 3fme_A          166 -KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---------------PFQQLKQVVEE  229 (290)
T ss_dssp             -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---------------HHHHHHHHHHS
T ss_pred             -ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---------------hHHHHHHHhcc
Confidence             2334689999999996    455789999999999999999999999975321               11122222233


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .........++.++.+||.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            3333334467888999999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-34  Score=238.22  Aligned_cols=185  Identities=21%  Similarity=0.210  Sum_probs=126.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-----CCCceEEccccccccCCCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-----AEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      +|+|.+++.....  +++..++.++.||+.||+|||+.+  |+||||||+|||++     .++.+||+|||+++......
T Consensus       116 ~~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          116 ENDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             SEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             CCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            4689999987765  999999999999999999999865  99999999999994     45569999999997643222


Q ss_pred             cceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcchhhhhhhhHHHH-
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFRI-  153 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~-  153 (252)
                      .  ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+........ ... ...+........... 
T Consensus       192 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          192 R--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            1  13345679999999999875 48999999999999999999999998754211000 000 000000000000000 


Q ss_pred             -hhh---hcCC-----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 -MDT---KLGG-----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 -~~~---~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ...   ....     ..+..++.++.+||.+||+.||.+|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             000   0000     001225678899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.4e-34  Score=232.39  Aligned_cols=165  Identities=16%  Similarity=0.233  Sum_probs=131.4

Q ss_pred             CCCCChhhhhhcCCC--CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-------------------
Q 025440            1 MPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------   59 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-------------------   59 (252)
                      ++||+|.+++.....  ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+                   
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------C
T ss_pred             cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            578999999976522  34999999999999999999999765  9999999999999844                   


Q ss_pred             CceEEccccccccCCCCCcceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhh
Q 025440           60 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD  138 (252)
Q Consensus        60 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~  138 (252)
                      ..+||+|||++.......      ...||..|+|||++.+. .++.++|||||||++|+|++|..++....         
T Consensus       171 ~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------  235 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------  235 (289)
T ss_dssp             CCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred             eEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence            479999999998754322      23589999999999776 56689999999999999999987764421         


Q ss_pred             hcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          139 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                                . ...+........+..++..+.+||.+||+.||++|||+.++++
T Consensus       236 ----------~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ----------Q-WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----------H-HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------H-HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                      0 1111222233455667889999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.1e-34  Score=241.03  Aligned_cols=182  Identities=24%  Similarity=0.297  Sum_probs=120.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|.+++..   ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....     .
T Consensus       117 ~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~  186 (367)
T 2fst_X          117 GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----M  186 (367)
T ss_dssp             CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC----------------
T ss_pred             CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccccccc-----C
Confidence            6788888865   23999999999999999999999765  999999999999999999999999999864322     2


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cchh---hh--hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPY---LS--DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~~~---~~--~~~~~~~~~  154 (252)
                      ...+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ +... ..+.   ..  ........+
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~  266 (367)
T 2fst_X          187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI  266 (367)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHH
T ss_pred             CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHH
Confidence            34578999999999877 678999999999999999999999998754321100 0000 0000   00  000001111


Q ss_pred             hhhcC---CCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DTKLG---GQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~~~~---~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....   ..+   ....+..+.+||.+||..||.+|||+.++++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            11000   000   11346789999999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.6e-34  Score=243.56  Aligned_cols=182  Identities=25%  Similarity=0.284  Sum_probs=129.3

Q ss_pred             CChhhhhhc--CCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-CceEEccccccccCCCCCcce
Q 025440            4 GSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         4 gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|.+++..  .....+++..++.++.||+.||+|||+++  |+||||||+|||++.+ +.+||+|||+++.......  
T Consensus       137 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~--  212 (420)
T 1j1b_A          137 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--  212 (420)
T ss_dssp             EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred             ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC--
Confidence            355555532  12345999999999999999999999765  9999999999999965 5689999999986543322  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhh-hhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  158 (252)
                       ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....  .+......... ....+.. +....
T Consensus       213 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~-~~~~~  288 (420)
T 1j1b_A          213 -NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE-MNPNY  288 (420)
T ss_dssp             -CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHH-HCSCC
T ss_pred             -ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHh-hChhh
Confidence             2345789999999998765 68999999999999999999999998754211  11110000000 0000100 00000


Q ss_pred             C-CC------------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 G-GQ------------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~-~~------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      . ..            ++..++.++.+||.+||..||.+|||+.++++
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0 00            12345788999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-34  Score=237.43  Aligned_cols=187  Identities=24%  Similarity=0.220  Sum_probs=132.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      .|+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        95 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~  169 (346)
T 1ua2_A           95 ETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AY  169 (346)
T ss_dssp             SEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CC
T ss_pred             CCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cC
Confidence            357888886654 34899999999999999999999766  99999999999999999999999999987543322  13


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcchh---hhhhhhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY---LSDKRKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~~---~~~~~~~~~~~~~  156 (252)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........ +.. ...+.   +............
T Consensus       170 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T 1ua2_A          170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  249 (346)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccc
Confidence            345789999999998764 48899999999999999999999997754211000 000 00000   0000000000000


Q ss_pred             hcCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 KLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......     ...++.++.+||.+||..||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          250 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000000     13456789999999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6e-34  Score=235.75  Aligned_cols=180  Identities=18%  Similarity=0.225  Sum_probs=133.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      +.|++|.+++..     +++..+..++.||+.||+|||+.+  |+||||||+|||++.++ .+||+|||+++....... 
T Consensus       115 ~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-  186 (330)
T 3nsz_A          115 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-  186 (330)
T ss_dssp             CCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred             cCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence            468899998843     889999999999999999999766  99999999999999777 899999999986543322 


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh---
Q 025440           80 HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD---  155 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  155 (252)
                        .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .......  ........+.   
T Consensus       187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l-~~~~~~~--~~~~~~~~~~~~~  261 (330)
T 3nsz_A          187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVL--GTEDLYDYIDKYN  261 (330)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHH--CHHHHHHHHHHTT
T ss_pred             --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH-HHHHHhc--CCchhhhHHHHhc
Confidence              234568999999999877 568999999999999999999999996543221110 0000000  0000000000   


Q ss_pred             --------------------hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 --------------------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 --------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                                          .......+..++.++.+||.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                00111223346889999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.1e-34  Score=239.01  Aligned_cols=187  Identities=26%  Similarity=0.299  Sum_probs=133.5

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-ee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~   81 (252)
                      +|+|.+++....   +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++........ ..
T Consensus       113 ~~~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  187 (364)
T 3qyz_A          113 ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF  187 (364)
T ss_dssp             SEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred             CcCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcccc
Confidence            468999886643   999999999999999999999765  999999999999999999999999999865432211 11


Q ss_pred             eecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-chhhhhh-----hhHHHH
Q 025440           82 STQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDK-----RKLFRI  153 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~~~~~~-----~~~~~~  153 (252)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........ +.... .+.....     ......
T Consensus       188 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  267 (364)
T 3qyz_A          188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY  267 (364)
T ss_dssp             TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred             ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence            2345789999999987554 58999999999999999999999998765321111 00000 0000000     000000


Q ss_pred             hhhh-cCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          154 MDTK-LGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       154 ~~~~-~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .... .....     ...++.++.+||.+||+.||.+|||+.++++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000 00011     12456789999999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-33  Score=237.87  Aligned_cols=183  Identities=22%  Similarity=0.282  Sum_probs=124.1

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++..    .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ..
T Consensus       113 ~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~  183 (371)
T 2xrw_A          113 DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MM  183 (371)
T ss_dssp             SEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccccccccc---cc
Confidence            3577787742    3899999999999999999999765  9999999999999999999999999998643321   12


Q ss_pred             ecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcch---hhhhh-hhHHHHhhh
Q 025440           83 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKP---YLSDK-RKLFRIMDT  156 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~---~~~~~-~~~~~~~~~  156 (252)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ +.. ...+   ..... .........
T Consensus       184 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  263 (371)
T 2xrw_A          184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN  263 (371)
T ss_dssp             ------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHS
T ss_pred             CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhh
Confidence            34578999999999999899999999999999999999999998754311100 000 0000   00000 000000000


Q ss_pred             h---------------cCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 K---------------LGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~---------------~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .               ...   ......+..+.+||.+||..||.+|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          264 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            0               000   0012347789999999999999999999999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.7e-34  Score=236.74  Aligned_cols=187  Identities=19%  Similarity=0.236  Sum_probs=135.2

Q ss_pred             CCCCChhhh------hhcCCCCCCCHHHHHHHHHHHHHHhHHHhc-CCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440            1 MPKGSLENH------LFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus         1 ~~ggsL~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      ++||+|.++      +.......+++..++.++.||+.||+|||+ .+  |+|+||||+|||++.++.+||+|||++...
T Consensus       125 ~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  202 (348)
T 2pml_X          125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM  202 (348)
T ss_dssp             CTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcCCCcEEEecccccccc
Confidence            578899999      766445569999999999999999999997 55  999999999999999999999999999865


Q ss_pred             CCCCcceeeecccccccccCccccccC-CCCc-ccceehhHHHHHHHHhCCCCCCCcccccch--hhhhhcchhhhhhhh
Q 025440           74 PTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSDKRK  149 (252)
Q Consensus        74 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~slG~il~~lltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  149 (252)
                      ...    ......|+..|+|||++.+. .++. ++||||||+++|+|++|..||.........  .+.............
T Consensus       203 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~  278 (348)
T 2pml_X          203 VDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNH  278 (348)
T ss_dssp             BTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSS
T ss_pred             ccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhh
Confidence            332    23455789999999999887 6666 999999999999999999999865431000  000000000000000


Q ss_pred             HHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          150 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ................++..+.+||.+||+.||.+|||+.++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          279 FLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             STTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000000000111456788999999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.9e-34  Score=247.64  Aligned_cols=170  Identities=24%  Similarity=0.314  Sum_probs=136.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC---ceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||+|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++   .+||+|||++.......
T Consensus       128 ~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  203 (504)
T 3q5i_A          128 YEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY  203 (504)
T ss_dssp             CTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC
Confidence            579999999987665  999999999999999999999765  99999999999998776   69999999998754432


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....                .....+....
T Consensus       204 ~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~i~~~~  263 (504)
T 3q5i_A          204 K---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----------------DIIKKVEKGK  263 (504)
T ss_dssp             C---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC
T ss_pred             c---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCC
Confidence            2   23457999999999986 56999999999999999999999999875321                1111111111


Q ss_pred             cCCCC--cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....  ...++.++.+||.+||..||.+|||+.++++.
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111  13467889999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.2e-34  Score=236.70  Aligned_cols=159  Identities=25%  Similarity=0.364  Sum_probs=131.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCccee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      +++|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++ .++.+||+|||+++......    
T Consensus       133 ~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----  204 (320)
T 3a99_A          133 VQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----  204 (320)
T ss_dssp             EEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----
T ss_pred             CccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----
Confidence            3899999987654  999999999999999999999765  99999999999998 78999999999998754322    


Q ss_pred             eecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           82 STQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....||..|+|||++.+..+ +.++||||||+++|+|++|..||.....                      ...  ...
T Consensus       205 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------------------~~~--~~~  260 (320)
T 3a99_A          205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------IIR--GQV  260 (320)
T ss_dssp             BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHH--CCC
T ss_pred             ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------------------hhc--ccc
Confidence            234568999999999987776 6789999999999999999999975310                      000  111


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++.++.+||.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            234456778999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-33  Score=235.91  Aligned_cols=189  Identities=19%  Similarity=0.222  Sum_probs=131.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--ce
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--TH   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~   80 (252)
                      +|+|.+++..... .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus       107 ~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  183 (351)
T 3mi9_A          107 EHDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN  183 (351)
T ss_dssp             SEEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCC
T ss_pred             CCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhccccccccccccc
Confidence            3577777765543 4999999999999999999999765  99999999999999999999999999976542221  11


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hh----cchhhhhhh--hHHH
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW----AKPYLSDKR--KLFR  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~----~~~~~~~~~--~~~~  152 (252)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.......... ..    .........  ....
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  263 (351)
T 3mi9_A          184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE  263 (351)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGT
T ss_pred             ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhc
Confidence            22345789999999998764 5799999999999999999999999875432111100 00    000000000  0000


Q ss_pred             Hhhhhc--CCCCcH-----HHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          153 IMDTKL--GGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       153 ~~~~~~--~~~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......  ......     ..+..+.+||.+||+.||.+|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          264 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             SSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            000000  000000     124568899999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-34  Score=237.32  Aligned_cols=187  Identities=23%  Similarity=0.315  Sum_probs=130.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.......  
T Consensus       106 ~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  179 (331)
T 4aaa_A          106 VDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  179 (331)
T ss_dssp             CSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             CCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence            457778887765554  999999999999999999999765  99999999999999999999999999976433221  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhhhhhhHHHHh--hh
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIM--DT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~  156 (252)
                      ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+........ ...................  ..
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            12345689999999999775 68999999999999999999999998754321110 0000000000000000000  00


Q ss_pred             h-----cCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 K-----LGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~-----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .     .....     ...++..+.+||.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0     00000     1245778999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.6e-34  Score=234.89  Aligned_cols=170  Identities=25%  Similarity=0.312  Sum_probs=132.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++.....  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.   +||+|||+++......
T Consensus        96 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  171 (322)
T 2ycf_A           96 MEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS  171 (322)
T ss_dssp             CTTEETHHHHSTTCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH
T ss_pred             CCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc
Confidence            468999999976654  999999999999999999999765  999999999999987664   9999999998754321


Q ss_pred             cceeeecccccccccCccccc---cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                         ......||..|+|||++.   ...++.++|||||||++|+|++|..||........                ....+
T Consensus       172 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------------~~~~~  232 (322)
T 2ycf_A          172 ---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----------------LKDQI  232 (322)
T ss_dssp             ---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----------------HHHHH
T ss_pred             ---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----------------HHHHH
Confidence               123456899999999974   45688999999999999999999999976432110                11111


Q ss_pred             hhhcCCCC---cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ........   ...++..+.+||.+||..||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11111111   1245778999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-34  Score=233.19  Aligned_cols=162  Identities=25%  Similarity=0.428  Sum_probs=134.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      +.|++|.+++...+.  +++..++.++.||+.||+|||+.+  |+||||||+||+++ .++.+||+|||++.......  
T Consensus       121 ~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~--  194 (312)
T 2iwi_A          121 LPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--  194 (312)
T ss_dssp             SSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC--
T ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc--
Confidence            368999999987654  999999999999999999999765  99999999999998 88999999999998754432  


Q ss_pred             eeeecccccccccCccccccCCCC-cccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                        .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.....                      ...  .
T Consensus       195 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------------------~~~--~  248 (312)
T 2iwi_A          195 --YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------------------ILE--A  248 (312)
T ss_dssp             --BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------HHH--T
T ss_pred             --ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------------------Hhh--h
Confidence              2345689999999999877764 589999999999999999999975310                      111  1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ....+..++..+.+||.+||+.||++|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            223445677889999999999999999999999873

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-33  Score=238.06  Aligned_cols=181  Identities=25%  Similarity=0.333  Sum_probs=131.0

Q ss_pred             CChhhhhhc--CCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCcce
Q 025440            4 GSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         4 gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+|.+++..  .....+++..+..++.||+.||+|||+.+  |+||||||+|||++ .++.+||+|||+++.......  
T Consensus       122 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--  197 (383)
T 3eb0_A          122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--  197 (383)
T ss_dssp             EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--
T ss_pred             ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--
Confidence            566666653  12245999999999999999999999765  99999999999997 688999999999986543322  


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhh-cchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~  157 (252)
                       .....||..|+|||++.+. .++.++|||||||++|+|++|+.||.+....... .+... ..+.   ...+.. ....
T Consensus       198 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~---~~~~~~-~~~~  272 (383)
T 3eb0_A          198 -SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT---KEQMIR-MNPH  272 (383)
T ss_dssp             -CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC---HHHHHH-HCTT
T ss_pred             -CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---HHHHHH-hCcc
Confidence             2345689999999998775 4899999999999999999999999875421110 00000 0000   000000 0000


Q ss_pred             c-------------CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 L-------------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .             ....+..++.++.+||.+||..||.+|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0             00123346778999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.5e-34  Score=232.57  Aligned_cols=183  Identities=25%  Similarity=0.345  Sum_probs=131.0

Q ss_pred             CCCCChhhhhhcC------CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRR------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      ++||+|.+++...      ....+++..++.++.||+.||+|||+.+  ++|+||||+||+++.++.+||+|||++....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            4689999999641      2344999999999999999999999765  9999999999999999999999999987654


Q ss_pred             CCCc---ceeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhH
Q 025440           75 TGDR---THVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL  150 (252)
Q Consensus        75 ~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  150 (252)
                      ....   ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.............  ......    
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~----  246 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL--QNDPPS----  246 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH--TSSCCC----
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh--ccCCCc----
Confidence            3221   111234568999999999876 568999999999999999999999997754211100000  000000    


Q ss_pred             HHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          151 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                        .............++..+.+||.+||+.||.+||++.++++
T Consensus       247 --~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 --LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             --TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              00000001122345678999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.4e-33  Score=236.83  Aligned_cols=171  Identities=25%  Similarity=0.307  Sum_probs=125.7

Q ss_pred             CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCcceeeecccccccccCc
Q 025440           16 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP   94 (252)
Q Consensus        16 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP   94 (252)
                      ..+++..+..++.||+.||+|||+.+  |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+||
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aP  210 (394)
T 4e7w_A          136 QTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAP  210 (394)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCH
Confidence            45999999999999999999999765  99999999999998 799999999999987543322   2345789999999


Q ss_pred             cccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhh-hhhhHHHHhhhhc-CC-----------
Q 025440           95 EYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKL-GG-----------  160 (252)
Q Consensus        95 E~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~-----------  160 (252)
                      |++.+. .++.++|||||||++|+|++|+.||.+......  +......... ....+. ...... ..           
T Consensus       211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  287 (394)
T 4e7w_A          211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIK-TMNPNYMEHKFPQIRPHPFS  287 (394)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH-HHCGGGSSSCCCCCCCCCHH
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHH-hhChhhhhhccccccCCcHH
Confidence            998765 589999999999999999999999987542111  1000000000 000000 000000 00           


Q ss_pred             -CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 -QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       .++..++.++.+||.+||+.||.+|||+.++++.
T Consensus       288 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          288 KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             0122366789999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.7e-33  Score=228.67  Aligned_cols=172  Identities=21%  Similarity=0.345  Sum_probs=126.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCc--
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR--   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--   78 (252)
                      ++||+|.+++...+ ..+++..++.++.||+.||+|||+++  |+|+||||+|||++.++.+||+|||++........  
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  173 (303)
T 1zy4_A           97 CENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL  173 (303)
T ss_dssp             CCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----
T ss_pred             CCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchh
Confidence            46899999998654 34889999999999999999999765  99999999999999999999999999976532210  


Q ss_pred             ----------ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhh
Q 025440           79 ----------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK  147 (252)
Q Consensus        79 ----------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  147 (252)
                                ........|+..|+|||++.+. .++.++|||||||++|+|++   ||.....               ..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---------------~~  235 (303)
T 1zy4_A          174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---------------RV  235 (303)
T ss_dssp             --------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---------------HH
T ss_pred             ccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---------------HH
Confidence                      1112345689999999999765 68999999999999999998   5543110               00


Q ss_pred             hhHHHHh--hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          148 RKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       148 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....+.  ........+...+..+.++|.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1111111  111223344566778999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=238.92  Aligned_cols=190  Identities=21%  Similarity=0.243  Sum_probs=123.3

Q ss_pred             CCChhhhhhcC-------CCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceee----cCCCceEEccccccc
Q 025440            3 KGSLENHLFRR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAK   71 (252)
Q Consensus         3 ggsL~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~   71 (252)
                      +|+|.+++...       ....+++..++.++.||+.||+|||+.+  |+||||||+|||+    +.++.+||+|||+++
T Consensus       103 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          103 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            46777777532       1234999999999999999999999876  9999999999999    677899999999998


Q ss_pred             cCCCCCc-ceeeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccch-------hhhhh---
Q 025440           72 AGPTGDR-THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLVDW---  139 (252)
Q Consensus        72 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-------~~~~~---  139 (252)
                      ....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.......       .+...   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~  260 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  260 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence            7543221 1223446789999999999875 4899999999999999999999999765432100       00000   


Q ss_pred             -cch------hhh---hhhhHHHHh-hhhcCCC--------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          140 -AKP------YLS---DKRKLFRIM-DTKLGGQ--------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       140 -~~~------~~~---~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       ..+      ...   ......... .......        .....+..+.+||.+||..||.+|||+.++++.
T Consensus       261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             000      000   000000000 0000000        001125678899999999999999999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.9e-34  Score=232.48  Aligned_cols=172  Identities=24%  Similarity=0.367  Sum_probs=132.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.+++.... ..+++..++.++.||+.||.|||+.+  ++|+||||+|||++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            57899999987643 34999999999999999999999765  999999999999999999999999987532110  01


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......||..|+|||++.     +..++.++||||||+++|+|++|..||.....                .........
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~~~~~~~~  236 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------MRVLLKIAK  236 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----------------HHHHHHHhc
Confidence            123346899999999983     56789999999999999999999999976431                111111111


Q ss_pred             hhc-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ... ....+..++..+.++|.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111 12335567888999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-33  Score=226.73  Aligned_cols=169  Identities=28%  Similarity=0.398  Sum_probs=133.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC---CceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~   77 (252)
                      ++|++|.+++.....  +++..++.++.||+.||+|||+.+  ++|+||||+||+++.+   +.+||+|||++.......
T Consensus       103 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          103 YTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            468999999977654  999999999999999999999765  9999999999999664   469999999997654332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      .   .....++..|+|||++.+ .++.++||||||+++|+|++|..||.+....                .....+....
T Consensus       179 ~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~~~~~  238 (287)
T 2wei_A          179 K---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----------------DILKRVETGK  238 (287)
T ss_dssp             S---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCC
T ss_pred             c---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHcCC
Confidence            1   223458899999999865 5899999999999999999999999764321                1111111222


Q ss_pred             cCCCCc--HHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....+  ..++.++.++|.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            211222  356788999999999999999999999997

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.4e-33  Score=232.20  Aligned_cols=186  Identities=21%  Similarity=0.238  Sum_probs=130.4

Q ss_pred             CChhhhhhc--CCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCcce
Q 025440            4 GSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         4 gsL~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+|.+.+..  .....+++..+..++.||+.||.|||.+..+|+||||||+|||++. ++.+||+|||+++.......  
T Consensus       110 ~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--  187 (360)
T 3e3p_A          110 DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--  187 (360)
T ss_dssp             CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC--
T ss_pred             ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC--
Confidence            455544432  2234489999999999999999999943345999999999999986 89999999999987543322  


Q ss_pred             eeecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh----
Q 025440           81 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD----  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  155 (252)
                       .....||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.......  .................+.    
T Consensus       188 -~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3e3p_A          188 -NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVLGCPSREVLRKLNPSHT  264 (360)
T ss_dssp             -CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTCC
T ss_pred             -cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHcCCCCHHHHHhcccchh
Confidence             23456899999999987654 899999999999999999999999875432110  0000000000000000000    


Q ss_pred             ------------hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 ------------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                                  ...........+.++.+||.+||+.||.+|||+.++++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          265 DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             hccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                        000111122357889999999999999999999999973

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.1e-33  Score=232.20  Aligned_cols=186  Identities=22%  Similarity=0.252  Sum_probs=131.6

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce--
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH--   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--   80 (252)
                      +|+|.+++...   .+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.........  
T Consensus        97 ~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  171 (353)
T 2b9h_A           97 QTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE  171 (353)
T ss_dssp             SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred             CccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccccccccccccC
Confidence            46888888763   3999999999999999999999765  9999999999999999999999999998654322110  


Q ss_pred             ------eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhh-hhh-cchhhh------
Q 025440           81 ------VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW-AKPYLS------  145 (252)
Q Consensus        81 ------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~-~~~-~~~~~~------  145 (252)
                            ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+......... ... ..+...      
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (353)
T 2b9h_A          172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI  251 (353)
T ss_dssp             --------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTC
T ss_pred             ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccccc
Confidence                  1223468999999998765 6789999999999999999999999987643211000 000 000000      


Q ss_pred             hhhhHHHHhhhhcCCC------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          146 DKRKLFRIMDTKLGGQ------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ................      ....++.++.+||.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000111111100000      01246778999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.98  E-value=1.4e-32  Score=231.32  Aligned_cols=181  Identities=21%  Similarity=0.302  Sum_probs=127.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++..    .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....     .
T Consensus       130 ~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~  198 (371)
T 4exu_A          130 QTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----M  198 (371)
T ss_dssp             CEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC------------
T ss_pred             cccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----c
Confidence            3567777632    3899999999999999999999765  999999999999999999999999999764322     2


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc-ch---hhh--hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KP---YLS--DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~-~~---~~~--~~~~~~~~~  154 (252)
                      ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ...... .+   ...  .........
T Consensus       199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  278 (371)
T 4exu_A          199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI  278 (371)
T ss_dssp             -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred             CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence            34578999999999877 67899999999999999999999999875431110 000000 00   000  000000111


Q ss_pred             hhhcCCC------CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DTKLGGQ------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .......      ....++..+.+||.+||+.||.+|||+.++++.
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            1100000      012457789999999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.98  E-value=7.4e-33  Score=232.09  Aligned_cols=186  Identities=22%  Similarity=0.273  Sum_probs=126.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++.... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++......   ..
T Consensus       117 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~  190 (362)
T 3pg1_A          117 RTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NK  190 (362)
T ss_dssp             SEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCTTC-------------
T ss_pred             CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEEEEecCccccccccc---cc
Confidence            468888887554 35999999999999999999999875  9999999999999999999999999997543222   12


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccch-hhhhhc-chhhh-----hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLS-----DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~  154 (252)
                      ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .+.... .+...     .........
T Consensus       191 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (362)
T 3pg1_A          191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL  270 (362)
T ss_dssp             -----CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred             ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHH
Confidence            34568999999999877 67899999999999999999999999875432110 000000 00000     000001111


Q ss_pred             hhhcCC---C----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DTKLGG---Q----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~~~~~---~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ......   .    ....++..+.+||.+||+.||.+|||+.++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            111100   0    012346779999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.98  E-value=1.1e-32  Score=230.29  Aligned_cols=181  Identities=22%  Similarity=0.312  Sum_probs=128.3

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|+|.+++..    .+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....     .
T Consensus       112 ~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~  180 (353)
T 3coi_A          112 QTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----M  180 (353)
T ss_dssp             SEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC----------
T ss_pred             cCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----c
Confidence            3567776632    3899999999999999999999765  999999999999999999999999999764322     2


Q ss_pred             ecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cch---hhh--hhhhHHHHh
Q 025440           83 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKP---YLS--DKRKLFRIM  154 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~~---~~~--~~~~~~~~~  154 (252)
                      ....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .... ..+   +..  .........
T Consensus       181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  260 (353)
T 3coi_A          181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI  260 (353)
T ss_dssp             ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHH
T ss_pred             cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHH
Confidence            34568999999999877 678999999999999999999999998754311000 0000 000   000  000000111


Q ss_pred             hh---hcC---CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          155 DT---KLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       155 ~~---~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..   ...   ......++..+.+||.+||+.||++|||+.++++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00   001   11223567899999999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.98  E-value=4e-33  Score=239.21  Aligned_cols=171  Identities=26%  Similarity=0.363  Sum_probs=122.8

Q ss_pred             CCChhhhhhcCCCCC-----CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC-------------CceEE
Q 025440            3 KGSLENHLFRRGPQP-----LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKL   64 (252)
Q Consensus         3 ggsL~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~-------------~~~kl   64 (252)
                      +|+|.+++.......     .++..++.++.||+.||+|||+.+  |+||||||+|||++.+             +.+||
T Consensus        92 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           92 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            579999997765321     123345789999999999999875  9999999999999654             47999


Q ss_pred             ccccccccCCCCCcce--eeecccccccccCcccccc-------CCCCcccceehhHHHHHHHHh-CCCCCCCcccccch
Q 025440           65 SDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ  134 (252)
Q Consensus        65 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~  134 (252)
                      +|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|+|+| |..||.+.....  
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence            9999998764432211  1234579999999999976       568999999999999999999 999997642110  


Q ss_pred             hhhhhcchhhhhhhhHHHHhhhh-----cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          135 SLVDWAKPYLSDKRKLFRIMDTK-----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                                      ..++...     ........++.++.+||.+||+.||.+|||+.++++
T Consensus       248 ----------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                            0111111     111223467889999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.98  E-value=1.7e-32  Score=225.64  Aligned_cols=186  Identities=22%  Similarity=0.312  Sum_probs=129.9

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCc-ce
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDR-TH   80 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~-~~   80 (252)
                      +|+|.+++...   .+++..++.++.||+.||+|||+.+  |+||||||+|||++ .++.+||+|||+++....... ..
T Consensus       105 ~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  179 (320)
T 2i6l_A          105 ETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG  179 (320)
T ss_dssp             SEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------
T ss_pred             CCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccc
Confidence            36899998543   3899999999999999999999765  99999999999997 567899999999986533211 11


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhh--hhhhhHH----HH
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL--SDKRKLF----RI  153 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~----~~  153 (252)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+..............+..  .......    ..
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (320)
T 2i6l_A          180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY  259 (320)
T ss_dssp             CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHH
T ss_pred             ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccc
Confidence            1234467899999998866 678999999999999999999999998754321110000000000  0000000    00


Q ss_pred             hhhhcC-CC-----CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          154 MDTKLG-GQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       154 ~~~~~~-~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...... ..     ....++.++.+||.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            001110 00     11246788999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.98  E-value=9.9e-33  Score=236.44  Aligned_cols=171  Identities=25%  Similarity=0.334  Sum_probs=122.8

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---C--CceEEccccccccCCCCC
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---E--FNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~~~~   77 (252)
                      +|+|.+++..... .+.+..++.++.||+.||+|||+.+  |+||||||+|||++.   +  ..+||+|||+++......
T Consensus       101 ~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          101 AATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             SEEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            5799999976653 3555567889999999999999876  999999999999943   2  357899999998754332


Q ss_pred             c-ceeeecccccccccCccccc---cCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHH
Q 025440           78 R-THVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR  152 (252)
Q Consensus        78 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (252)
                      . ........||+.|+|||++.   +..++.++|||||||++|+|++ |..||.......                 ...
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-----------------~~~  240 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----------------ANI  240 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-----------------HHH
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-----------------HHH
Confidence            1 12234467999999999997   3567889999999999999999 999996532110                 000


Q ss_pred             Hhhhh-c-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 IMDTK-L-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 ~~~~~-~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..... . ........+..+.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11000 0 01112345667899999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=4.6e-33  Score=230.28  Aligned_cols=171  Identities=27%  Similarity=0.394  Sum_probs=112.2

Q ss_pred             CChhhhhhc---CCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            4 GSLENHLFR---RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         4 gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+|.+++..   .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       105 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  181 (327)
T 3aln_A          105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN-LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA--  181 (327)
T ss_dssp             EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc-CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc--
Confidence            577777653   2234599999999999999999999975 1499999999999999999999999999976533221  


Q ss_pred             eeecccccccccCcccc----ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 VSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                       .....||..|+|||++    .+..++.++||||||+++|+|++|..||.+.......               .......
T Consensus       182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------------~~~~~~~  245 (327)
T 3aln_A          182 -KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------------LTQVVKG  245 (327)
T ss_dssp             -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------------CCCCCS
T ss_pred             -cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------------HHHHhcC
Confidence             2234689999999998    4567899999999999999999999999764321000               0000000


Q ss_pred             ---hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 ---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                         .........++..+.+||.+||+.||.+||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               0111112346778999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1.9e-32  Score=225.40  Aligned_cols=170  Identities=26%  Similarity=0.381  Sum_probs=119.7

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      +.+..++... ...+++..++.++.||+.||+|||+. .+|+|+||||+|||++.++.+||+|||++........   ..
T Consensus       108 ~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~  182 (318)
T 2dyl_A          108 TCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KD  182 (318)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred             CcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---cc
Confidence            3444444332 23499999999999999999999974 1399999999999999999999999999976433221   23


Q ss_pred             cccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           84 QVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ...|+..|+|||++.     +..++.++||||||+++|+|++|..||.....               .............
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------------~~~~~~~~~~~~~  247 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---------------DFEVLTKVLQEEP  247 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---------------HHHHHHHHHHSCC
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---------------cHHHHHHHhccCC
Confidence            446899999999984     45688999999999999999999999976321               1111111111111


Q ss_pred             -CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 -GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       .......++..+.+||.+||+.||.+||++.++++
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             11112346788999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=3.6e-31  Score=235.05  Aligned_cols=190  Identities=21%  Similarity=0.269  Sum_probs=136.7

Q ss_pred             CCCCChhhhhhcCCC-CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc---eEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~   76 (252)
                      |+||+|.+++..... ..+++..++.++.||+.||+|||+.+  |+||||||+|||++.++.   +||+|||++......
T Consensus       100 ~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~  177 (676)
T 3qa8_A          100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG  177 (676)
T ss_dssp             CSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC
T ss_pred             CCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccccccccccc
Confidence            579999999987542 35899999999999999999999765  999999999999987765   999999999875443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhh---HHHH
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK---LFRI  153 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  153 (252)
                      ..   .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.....     .|..........   ....
T Consensus       178 ~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          178 EL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC------CCSCCC
T ss_pred             cc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccchhhhhhhh
Confidence            22   234578999999999999999999999999999999999999997642110     000000000000   0000


Q ss_pred             h------hh--hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHH-----HHHHHHhhcC
Q 025440          154 M------DT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE-----VLAILERLEA  200 (252)
Q Consensus       154 ~------~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~-----v~~~l~~~~~  200 (252)
                      .      ..  .........++..+.+||.+||..||.+|||+.+     +++.++.+..
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0      00  0111234567899999999999999999999988     4455555443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=1e-31  Score=219.54  Aligned_cols=154  Identities=23%  Similarity=0.332  Sum_probs=118.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      ++||+|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||++....   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---  171 (299)
T 3m2w_A           97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---  171 (299)
T ss_dssp             CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence            56899999999877667999999999999999999999866  999999999999988   7889999999986421   


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                                           +..++.++|||||||++|+|++|..||.+..........  ..          .+..  
T Consensus       172 ---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--~~----------~~~~--  216 (299)
T 3m2w_A          172 ---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KT----------RIRM--  216 (299)
T ss_dssp             ---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--CC----------SSCT--
T ss_pred             ---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--HH----------HHhh--
Confidence                                 245678999999999999999999999764321100000  00          0000  


Q ss_pred             cCCCCc----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .....+    ..++.++.+||.+||+.||.+|||+.++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000111    3467789999999999999999999999974

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=6.4e-31  Score=237.17  Aligned_cols=160  Identities=26%  Similarity=0.313  Sum_probs=124.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+|++|.+++..    .+++..++.++.||+.||.|||+++  |+||||||+|||++.+ .+||+|||+++.....    
T Consensus       166 ~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----  234 (681)
T 2pzi_A          166 VGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----  234 (681)
T ss_dssp             CCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCEETTCC----
T ss_pred             CCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccchhcccC----
Confidence            578999988754    4999999999999999999999876  9999999999999875 8999999999875432    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                        ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......           .             ..
T Consensus       235 --~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~-------------~~  287 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------P-------------ED  287 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------C-------------TT
T ss_pred             --CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------c-------------cc
Confidence              345689999999998765 48899999999999999999988875321100           0             00


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhh
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERL  198 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-t~~~v~~~l~~~  198 (252)
                      ......+..+.+||.+||+.||.+|| +++++...|..+
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            01122456788999999999999999 566666666544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=6.2e-29  Score=201.92  Aligned_cols=153  Identities=14%  Similarity=0.115  Sum_probs=114.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++|++|.+++.. +   .....+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+++|            
T Consensus       113 ~~g~~L~~~l~~-~---~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          113 IRGGSLQEVADT-S---PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             CCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             cCCCCHHHHHhc-C---CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc------------
Confidence            578999999954 2   355678899999999999999765  9999999999999999999998543            


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                                |++       .++.++|||||||++|+|+||+.||.+........ ......   ...... .       
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---~~~~~~-~-------  226 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA---GQPIEP-A-------  226 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT---SCBCCH-H-------
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc---cCCCCh-h-------
Confidence                      222       36889999999999999999999998754321000 000000   000000 0       


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                       .....++.++.+||.+||+.||++| |+.++++.|+++...
T Consensus       227 -~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          227 -DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             -HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             -hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence             0113456789999999999999999 999999999987643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=1.3e-29  Score=210.42  Aligned_cols=159  Identities=11%  Similarity=0.044  Sum_probs=120.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHh-cCCCCeeeccCCCCceeecCCC-------------------
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEF-------------------   60 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~ivH~dlkp~Nill~~~~-------------------   60 (252)
                      |+||+|.+.+.+   ..+++..++.++.||+.||+||| +.+  |+||||||+|||++.++                   
T Consensus       144 ~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~  218 (336)
T 2vuw_A          144 EFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG  218 (336)
T ss_dssp             ECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTT
T ss_pred             cCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCC
Confidence            367877777744   23899999999999999999999 776  99999999999999887                   


Q ss_pred             -ceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHH-HHHHHhCCCCCCCcccccchhhhh
Q 025440           61 -NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVV-LLELLSGRCAVDKTKVGIEQSLVD  138 (252)
Q Consensus        61 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i-l~~lltg~~pf~~~~~~~~~~~~~  138 (252)
                       .+||+|||+++.....       ..+||+.|+|||++.+.. +.++|||||+++ .+++++|..||.+...        
T Consensus       219 ~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--------  282 (336)
T 2vuw_A          219 LQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--------  282 (336)
T ss_dssp             EEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--------
T ss_pred             ceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--------
Confidence             8999999999864321       347899999999998766 889999998776 7888899988854110        


Q ss_pred             hcchhhhhhhhHHHHhhhh-c----CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHH
Q 025440          139 WAKPYLSDKRKLFRIMDTK-L----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL  192 (252)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~  192 (252)
                             .......+.... .    ....+..++.++.+||.+||+.|     |+.+++
T Consensus       283 -------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          283 -------LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             -------HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             -------hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence                   000001111110 0    11123468899999999999987     898888

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=1.8e-27  Score=209.94  Aligned_cols=115  Identities=19%  Similarity=0.143  Sum_probs=80.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|.+.++  ++..   .|+.||+.||+|+|++|  ||||||||+||||+.+|.+||+|||+++.......  
T Consensus       324 v~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--  394 (569)
T 4azs_A          324 LPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--  394 (569)
T ss_dssp             CCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--
T ss_pred             CCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--
Confidence            689999999988776  6665   47899999999999876  99999999999999999999999999987544322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV  125 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf  125 (252)
                      .....+||+.|+|||++.+ .+..++|+|++|++++++.++..+|
T Consensus       395 ~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            2345689999999999965 5677899999999998887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.78  E-value=1.4e-20  Score=165.08  Aligned_cols=111  Identities=19%  Similarity=0.242  Sum_probs=91.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+          ++.++.||++||+|||+++  |+||||||+|||++.  .+||+|||+++.........
T Consensus       421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            578999999976          5689999999999999766  999999999999998  99999999998764432111


Q ss_pred             -----eeecccccccccCcccccc--CCCCcccceehhHHHHHHHHhCCCCC
Q 025440           81 -----VSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAV  125 (252)
Q Consensus        81 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~lltg~~pf  125 (252)
                           ......||+.|+|||++.+  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                 1235679999999999977  56888899999998888887766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.58  E-value=2.2e-16  Score=127.60  Aligned_cols=72  Identities=13%  Similarity=0.031  Sum_probs=59.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+ +..        .....++.||+.||.|||+.+  |+||||||+|||++ ++.+||+|||+++.        
T Consensus       182 ~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~DFG~a~~--------  241 (282)
T 1zar_A          182 IDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------  241 (282)
T ss_dssp             CCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECCCTTCEE--------
T ss_pred             cCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEECCCCeE--------
Confidence            57889988 421        124579999999999999766  99999999999999 99999999999863        


Q ss_pred             eeecccccccccCcccccc
Q 025440           81 VSTQVMGTHGYAAPEYVAT   99 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~   99 (252)
                             +..|+|||.+..
T Consensus       242 -------~~~~~a~e~l~r  253 (282)
T 1zar_A          242 -------VGEEGWREILER  253 (282)
T ss_dssp             -------TTSTTHHHHHHH
T ss_pred             -------CCCCCHHHHHHH
Confidence                   345788888743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.23  E-value=8.2e-12  Score=99.40  Aligned_cols=60  Identities=18%  Similarity=0.090  Sum_probs=49.4

Q ss_pred             ChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHh-cCCCCeeeccCCCCceeecCCCceEEccccccccC
Q 025440            5 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG   73 (252)
Q Consensus         5 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~   73 (252)
                      +|.++...     .++..+..++.||+.||.||| +.+  |+||||||+|||++.  .++|+|||++...
T Consensus       159 ~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          159 TLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             BHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             cHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            56665432     234467789999999999999 766  999999999999988  8999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.84  E-value=1.3e-09  Score=91.08  Aligned_cols=48  Identities=19%  Similarity=0.145  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----------ceEEcccccccc
Q 025440           23 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----------NAKLSDFGLAKA   72 (252)
Q Consensus        23 ~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----------~~kl~Dfg~~~~   72 (252)
                      ...++.||+.+|.+||+.+  ||||||||.|||++.+|          .+.|+||+-+..
T Consensus       207 ~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          207 PASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            4568899999999999765  99999999999998776          389999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.38  E-value=1.5e-06  Score=66.06  Aligned_cols=99  Identities=17%  Similarity=0.080  Sum_probs=64.7

Q ss_pred             CChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeee
Q 025440            4 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST   83 (252)
Q Consensus         4 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~   83 (252)
                      -||.+.|...+ .+|+++++|.++.|.+.+|.-+-.... -..+=+.+..|++..+|.|-+.+ +.+.            
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc------------
Confidence            36888887665 479999999999999999887621110 11233456889999999988764 1110            


Q ss_pred             cccccccccCccccccCCCCcccceehhHHHHHHHHh
Q 025440           84 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS  120 (252)
Q Consensus        84 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt  120 (252)
                        .....+.+||... ...+.+.-|||||+++|..+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              0122466888762 345677889999999999885

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.15  E-value=1.6e-07  Score=76.21  Aligned_cols=77  Identities=21%  Similarity=0.259  Sum_probs=47.6

Q ss_pred             CeeeccCCCCceeecC--CCceEEccccccccCCCCCcceeeecccccccc---cCcccccc----C----------CCC
Q 025440           43 QVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY---AAPEYVAT----G----------RLT  103 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~----~----------~~~  103 (252)
                      .++|+|+++.||+++.  .+.+.|+||+.+.........      .....+   ..++....    .          ...
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~  265 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYR  265 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHH
Confidence            4899999999999988  456789999988653211000      000001   12221110    0          112


Q ss_pred             cccceehhHHHHHHHHhCCCCC
Q 025440          104 TKSDVYSFGVVLLELLSGRCAV  125 (252)
Q Consensus       104 ~~~Di~slG~il~~lltg~~pf  125 (252)
                      ...+.|+++.++|.+.+|..+|
T Consensus       266 ~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          266 MKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHcCCHHH
Confidence            2257899999999999998665

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=97.98  E-value=3.3e-06  Score=66.72  Aligned_cols=30  Identities=20%  Similarity=0.177  Sum_probs=25.1

Q ss_pred             CCeeeccCCCCceeecCCCceEEccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            348999999999999876556799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=97.96  E-value=1e-05  Score=67.05  Aligned_cols=55  Identities=15%  Similarity=0.240  Sum_probs=47.1

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcC--------------------------------------------------------C
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDA--------------------------------------------------------E   41 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~--------------------------------------------------------~   41 (252)
                      ++......++.+++..|+.||+.                                                        .
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            67888899999999999999972                                                        2


Q ss_pred             CCeeeccCCCCceeecCCCc--eEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFN--AKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~   72 (252)
                      ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            46999999999999987753  68999998865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=97.71  E-value=2.3e-05  Score=61.50  Aligned_cols=29  Identities=21%  Similarity=0.145  Sum_probs=25.3

Q ss_pred             eeeccCCCCceeecCCCceEEcccccccc
Q 025440           44 VIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        44 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ++|+|++|.|||++.++.+.|+||+.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            99999999999998776677999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.01  E-value=0.00069  Score=55.26  Aligned_cols=32  Identities=16%  Similarity=0.201  Sum_probs=28.0

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            35699999999999998888899999997754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=96.83  E-value=0.0014  Score=52.95  Aligned_cols=31  Identities=23%  Similarity=0.352  Sum_probs=25.5

Q ss_pred             CCeeeccCCCCceeecC---CCc-eEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDA---EFN-AKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~---~~~-~kl~Dfg~~~~   72 (252)
                      ..++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            35799999999999987   455 48999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.13  E-value=0.0046  Score=52.19  Aligned_cols=77  Identities=17%  Similarity=0.207  Sum_probs=45.0

Q ss_pred             CCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccc--cccccCccccccC---CCCcccceehhHHHH
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG--THGYAAPEYVATG---RLTTKSDVYSFGVVL  115 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Di~slG~il  115 (252)
                      ...++|+|+++.|||++.++ ++|+||+.+......  ... .....  ...|++++.....   .-....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45699999999999998876 999999988752211  000 00010  1345666544211   111223445667777


Q ss_pred             HHHHhC
Q 025440          116 LELLSG  121 (252)
Q Consensus       116 ~~lltg  121 (252)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=95.56  E-value=0.0055  Score=48.19  Aligned_cols=30  Identities=23%  Similarity=0.228  Sum_probs=25.8

Q ss_pred             CeeeccCCCCceeecCCCceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       194 ~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          194 VVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            389999999999999877778999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.37  E-value=0.019  Score=46.65  Aligned_cols=32  Identities=34%  Similarity=0.400  Sum_probs=27.5

Q ss_pred             CCCeeeccCCCCceeecCC----CceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3469999999999999874    6799999998865

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=95.30  E-value=0.0094  Score=48.92  Aligned_cols=31  Identities=13%  Similarity=0.252  Sum_probs=26.1

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+++.|||+++++.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644578999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=95.29  E-value=0.0052  Score=49.69  Aligned_cols=31  Identities=26%  Similarity=0.247  Sum_probs=26.2

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3599999999999998876668999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.11  E-value=0.024  Score=45.83  Aligned_cols=30  Identities=23%  Similarity=0.264  Sum_probs=25.6

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+++.|||++ + .+.|+||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            34589999999999998 4 899999987754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=94.42  E-value=0.058  Score=43.08  Aligned_cols=31  Identities=16%  Similarity=0.060  Sum_probs=25.9

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345999999999999 5667789999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.42  E-value=0.041  Score=46.98  Aligned_cols=16  Identities=25%  Similarity=0.179  Sum_probs=14.6

Q ss_pred             CCeeeccCCCCceeec
Q 025440           42 SQVIYRDFKASNILLD   57 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~   57 (252)
                      ..++|+|+.+.|||++
T Consensus       290 ~v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          290 IVLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEEECSCCCGGGEEEC
T ss_pred             eeEEecCCCCCcEEee
Confidence            3599999999999998

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=94.37  E-value=0.049  Score=44.89  Aligned_cols=30  Identities=20%  Similarity=0.256  Sum_probs=24.7

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+++.|||++.++ +.|+||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            4599999999999997655 89999987753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.28  E-value=0.029  Score=45.85  Aligned_cols=31  Identities=19%  Similarity=0.201  Sum_probs=27.2

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=93.96  E-value=0.051  Score=45.24  Aligned_cols=31  Identities=19%  Similarity=0.232  Sum_probs=26.0

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ...++|+|+.+.||+++.+ .++|+||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            3569999999999999875 489999987764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=93.64  E-value=0.045  Score=46.30  Aligned_cols=31  Identities=29%  Similarity=0.285  Sum_probs=24.7

Q ss_pred             CCeeeccCCCCceeecCC----------------------------CceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAE----------------------------FNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~----------------------------~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.|||++.+                            +.+.|+||..+..
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            359999999999999875                            6788999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=92.35  E-value=0.058  Score=44.83  Aligned_cols=31  Identities=29%  Similarity=0.275  Sum_probs=26.7

Q ss_pred             CCeeeccCCCCceeecCC----CceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAE----FNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            359999999999999876    7899999987753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.45  E-value=0.21  Score=37.96  Aligned_cols=81  Identities=12%  Similarity=0.198  Sum_probs=59.1

Q ss_pred             CCCHHHHHHHHHHHHHHhH-HHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcc
Q 025440           17 PLSWAVRMKVAIGAAKGLT-FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE   95 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~-~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE   95 (252)
                      .++...+++++..|+.-.. ++++    -+|--|.|+||+++.++.+++.-.|+-..                   ++|.
T Consensus        81 ~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~  137 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMFNRALEPFFLHVGVKES-------------------LPPD  137 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEECTTCCEEESCCEETTT-------------------BSSC
T ss_pred             hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEEeCCCcEEEEEcCCccc-------------------CCCC
Confidence            3788889999999998888 6663    58889999999999999999998776432                   2232


Q ss_pred             ccccCCCCccccee-hhHHHHHHHHhCCCCCC
Q 025440           96 YVATGRLTTKSDVY-SFGVVLLELLSGRCAVD  126 (252)
Q Consensus        96 ~~~~~~~~~~~Di~-slG~il~~lltg~~pf~  126 (252)
                      -+      ...|.| .+=|++..++.++.-|+
T Consensus       138 e~------~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          138 EW------DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             SC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            11      112222 46778888888887764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=91.22  E-value=0.18  Score=39.87  Aligned_cols=40  Identities=18%  Similarity=0.155  Sum_probs=26.5

Q ss_pred             HHHHHHHHhHHH--hcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440           26 VAIGAAKGLTFL--HDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus        26 i~~~i~~~l~~l--H~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      .+..++..|..+  +.....+||+|+.+.||+++.+|. .+.|
T Consensus       170 ~~e~l~~~L~~~~~~~~~p~LvHGDlw~gNvl~~~~g~-~~iD  211 (288)
T 3f7w_A          170 LVEKVLDALDHLAGDPEPPARIHGDLWNGNVLWQDDGA-VVID  211 (288)
T ss_dssp             HHHHHHHTHHHHTCSCCCCEEECSCCSGGGEEEETTEE-EECS
T ss_pred             HHHHHHHHHHHhcccCCCCeeeecCCCCCcEEEcCCCe-EEEe
Confidence            334444444433  222456999999999999998874 4555

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=90.90  E-value=0.15  Score=41.22  Aligned_cols=27  Identities=4%  Similarity=0.020  Sum_probs=23.7

Q ss_pred             CCCeeeccCCCCceeecCCCceEEcccc
Q 025440           41 ESQVIYRDFKASNILLDAEFNAKLSDFG   68 (252)
Q Consensus        41 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg   68 (252)
                      ...+||+|+.+.|++++.++ +.|.||.
T Consensus       206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          206 KPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            45699999999999999887 8899974

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.51  E-value=0.12  Score=43.17  Aligned_cols=29  Identities=28%  Similarity=0.324  Sum_probs=24.4

Q ss_pred             eeeccCCCCceee------cCCCceEEcccccccc
Q 025440           44 VIYRDFKASNILL------DAEFNAKLSDFGLAKA   72 (252)
Q Consensus        44 ivH~dlkp~Nill------~~~~~~kl~Dfg~~~~   72 (252)
                      ++|+|+.+.|||+      +.++.++++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3456799999988754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.17  E-value=0.27  Score=37.21  Aligned_cols=82  Identities=5%  Similarity=0.061  Sum_probs=60.5

Q ss_pred             CCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCccc
Q 025440           17 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY   96 (252)
Q Consensus        17 ~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~   96 (252)
                      .++...++.++..|+.-..++++    =+|--|.|+||+++.++.+++.-.|+-...                   +|.-
T Consensus        77 ~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~~  133 (215)
T 4ann_A           77 SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------------DPLP  133 (215)
T ss_dssp             GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEECTTSCEEESCCEETTTB-------------------SCCC
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEcCCCCEEEEEccCccCC-------------------CCCC
Confidence            37888999999999999877774    478899999999999999999887764321                   2211


Q ss_pred             cccCCCCcccce-ehhHHHHHHHHhCCCCCCC
Q 025440           97 VATGRLTTKSDV-YSFGVVLLELLSGRCAVDK  127 (252)
Q Consensus        97 ~~~~~~~~~~Di-~slG~il~~lltg~~pf~~  127 (252)
                           .+ ..|. -.+=|++..+++++..|+.
T Consensus       134 -----~~-ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          134 -----VS-EAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             -----CC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             -----CC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence                 11 1122 2467888999999888753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=88.82  E-value=0.17  Score=42.66  Aligned_cols=30  Identities=17%  Similarity=0.326  Sum_probs=26.0

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            35999999999999 7788899999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	252
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-40
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-38
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-35
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-35
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-34
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-30
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-30
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-27
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-27
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-23
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-23
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-23
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-21
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-21
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-19
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-17
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-15
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-14
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-49
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 20/207 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
               SL +HL             + +A   A+G+ +LH     +I+RD K++NI L  + 
Sbjct: 85  CEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDL 141

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLE 117
             K+ DFGLA        +H   Q+ G+  + APE +        + +SDVY+FG+VL E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           L++G+            +  D     +        +                   L  +C
Sbjct: 202 LMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSK------VRSNCPKAMKRLMAEC 249

Query: 178 LNNEPKLRPRMSEVLAILERLEA--PK 202
           L  +   RP   ++LA +E L    PK
Sbjct: 250 LKKKRDERPLFPQILASIELLARSLPK 276

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (364), Expect = 1e-42
 Identities = 50/222 (22%), Positives = 84/222 (37%), Gaps = 44/222 (19%)

Query: 1   MPKGSLENHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLH 38
           M  G L   L                          P PLS A ++ +A   A G+ +L 
Sbjct: 98  MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157

Query: 39  DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 98
             E + ++RD    N L+      K++DFGL++   + D             +  PE + 
Sbjct: 158 --ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215

Query: 99  TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT 156
             R TT+SDV+++GVVL E+ S                    +PY  ++ +  ++ + D 
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGL-----------------QPYYGMAHEEVIYYVRDG 258

Query: 157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            +    P+        L   C +  P  RP    +  IL+R+
Sbjct: 259 NI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (362), Expect = 2e-42
 Identities = 44/198 (22%), Positives = 81/198 (40%), Gaps = 19/198 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G+L ++L     Q +S  V + +A   +  + +L   +   I+RD  A N L+    
Sbjct: 95  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENH 152

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGL++    GD             + APE +A  + + KSDV++FGV+L E+ +
Sbjct: 153 LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
              +                     D  +++ +++     + P+        L   C   
Sbjct: 212 YGMSPYPGI----------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255

Query: 181 EPKLRPRMSEVLAILERL 198
            P  RP  +E+    E +
Sbjct: 256 NPSDRPSFAEIHQAFETM 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 7e-41
 Identities = 46/200 (23%), Positives = 83/200 (41%), Gaps = 25/200 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL ++L  RG   L     +K ++   + + +L    +  ++RD  A N+L+  + 
Sbjct: 83  MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDN 140

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
            AK+SDFGL K     + +           + APE +   + +TKSDV+SFG++L E+ S
Sbjct: 141 VAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                                PY     + +   ++       P         +   C +
Sbjct: 196 FGRV-----------------PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 238

Query: 180 NEPKLRPRMSEVLAILERLE 199
            +  +RP   ++   LE ++
Sbjct: 239 LDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-40
 Identities = 46/217 (21%), Positives = 80/217 (36%), Gaps = 23/217 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH------DAESQVIYRDFKASNI 54
              GSL ++L R     ++    +K+A+  A GL  LH        +  + +RD K+ NI
Sbjct: 83  HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139

Query: 55  LLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT------GRLTTKS 106
           L+       ++D GLA    +   T        +GT  Y APE +             ++
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199

Query: 107 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK- 165
           D+Y+ G+V  E+    C++       +    D      S +     + + KL    P + 
Sbjct: 200 DIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 258

Query: 166 ----AAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
               A    A +  +C       R     +   L +L
Sbjct: 259 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-40
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 19/196 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL + L       L+    + +A   A+G+ F+   E   I+RD +A+NIL+    
Sbjct: 89  MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTL 146

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + K++DFGLA+     +             + APE +  G  T KSDV+SFG++L E+++
Sbjct: 147 SCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
                                       ++ + ++       P         L   C   
Sbjct: 206 HGRIPYPGM----------------TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249

Query: 181 EPKLRPRMSEVLAILE 196
            P+ RP    + ++LE
Sbjct: 250 RPEDRPTFDYLRSVLE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-39
 Identities = 42/193 (21%), Positives = 71/193 (36%), Gaps = 23/193 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE- 59
           M  G+L+ +L R     +   V         KGL FLH     +I+RD K  NI +    
Sbjct: 94  MTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 151

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            + K+ D GLA       R   +  V+GT  + APE     +     DVY+FG+ +LE+ 
Sbjct: 152 GSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMA 206

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +      + +   +                  R+        + + A      +   C+ 
Sbjct: 207 TSEYPYSECQNAAQI---------------YRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251

Query: 180 NEPKLRPRMSEVL 192
                R  + ++L
Sbjct: 252 QNKDERYSIKDLL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-39
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 21/200 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N +      P +    +   +  AKG+ FL     + ++RD  A N +LD +F
Sbjct: 111 MKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKF 167

Query: 61  NAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
             K++DFGLA+       D  H  T       + A E + T + TTKSDV+SFGV+L EL
Sbjct: 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           ++            + +  D     L  +R L            P+        + L+C 
Sbjct: 228 MTRGAPPYP-----DVNTFDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCW 271

Query: 179 NNEPKLRPRMSEVLAILERL 198
           + + ++RP  SE+++ +  +
Sbjct: 272 HPKAEMRPSFSELVSRISAI 291

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-39
 Identities = 45/219 (20%), Positives = 76/219 (34%), Gaps = 42/219 (19%)

Query: 1   MPKGSLENHLFRRGPQ---------------------PLSWAVRMKVAIGAAKGLTFLHD 39
              G L N+L  +  +                      L++   +  A   AKG+ FL  
Sbjct: 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE- 181

Query: 40  AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 99
                ++RD  A N+L+      K+ DFGLA+   +     V         + APE +  
Sbjct: 182 -FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240

Query: 100 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK 157
           G  T KSDV+S+G++L E+ S                     PY  +      ++++   
Sbjct: 241 GIYTIKSDVWSYGILLWEIFSLGV-----------------NPYPGIPVDANFYKLIQNG 283

Query: 158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 196
                P  A      +   C   + + RP    + + L 
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-39
 Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KGSL + L     + L     + +A   A G+ ++       ++RD +A+NIL+    
Sbjct: 93  MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENL 150

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFGLA+     +             + APE    GR T KSDV+SFG++L EL +
Sbjct: 151 VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
                               +        R++   ++       P +   +   L  QC 
Sbjct: 210 KG------------------RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 251

Query: 179 NNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQTG 217
             EP+ RP    + A LE           + +EP  Q G
Sbjct: 252 RKEPEERPTFEYLQAFLEDY--------FTSTEPQYQPG 282

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 4e-39
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 33/219 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+  L + G   +   +  KV+I   KGLT+L + + ++++RD K SNIL+++  
Sbjct: 86  MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRG 142

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFG++          ++   +GT  Y +PE +     + +SD++S G+ L+E+  
Sbjct: 143 EIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198

Query: 121 GR----------------CAVDKTKVGIEQSLVDWAKPYLSD------KRKLFRIMDTKL 158
           GR                C V+              +P  S          +F ++D  +
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258

Query: 159 GGQYPQKAAHT----AATLALQCLNNEPKLRPRMSEVLA 193
               P+  +            +CL   P  R  + +++ 
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-39
 Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 22/199 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L N+L             +++     + + +L     Q ++RD  A N L++ + 
Sbjct: 81  MANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQG 137

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFGL++     D    S        ++ PE +   + ++KSD+++FGV++ E+ S
Sbjct: 138 VVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                                PY      +    +   L    P  A+    T+   C +
Sbjct: 197 LGK-----------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239

Query: 180 NEPKLRPRMSEVLAILERL 198
            +   RP    +L+ +  +
Sbjct: 240 EKADERPTFKILLSNILDV 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 7e-39
 Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 28/199 (14%)

Query: 1   MPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLH---DAESQVIYRDFKASNIL 55
              G L + + +  +  Q L     ++V       L   H   D    V++RD K +N+ 
Sbjct: 87  CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 146

Query: 56  LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
           LD + N KL DFGLA+       T  +   +GT  Y +PE +       KSD++S G +L
Sbjct: 147 LDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 204

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATL 173
            EL +                     P+   S K    +I + K   + P + +     +
Sbjct: 205 YELCALM------------------PPFTAFSQKELAGKIREGKF-RRIPYRYSDELNEI 245

Query: 174 ALQCLNNEPKLRPRMSEVL 192
             + LN +   RP + E+L
Sbjct: 246 ITRMLNLKDYHRPSVEEIL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 8e-39
 Identities = 48/214 (22%), Positives = 77/214 (35%), Gaps = 33/214 (15%)

Query: 1   MPKGSLENHLFRRGPQ----------------PLSWAVRMKVAIGAAKGLTFLHDAESQV 44
              G L N L R+                    L     +  +   AKG+ FL       
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNC 166

Query: 45  IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 104
           I+RD  A NILL      K+ DFGLA+         V         + APE +     T 
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226

Query: 105 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 164
           +SDV+S+G+ L EL S   +                 P +    K ++++        P+
Sbjct: 227 ESDVWSYGIFLWELFSLGSSPY---------------PGMPVDSKFYKMIKEGFRMLSPE 271

Query: 165 KAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
            A      +   C + +P  RP   +++ ++E+ 
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-38
 Identities = 44/210 (20%), Positives = 90/210 (42%), Gaps = 20/210 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
             +    +   R      S    + +  G A G+ +L       ++RD  A NIL+++  
Sbjct: 90  YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNL 147

Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+SDFGL++      + T+ ++       + APE ++  + T+ SDV+SFG+V+ E++
Sbjct: 148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 207

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +                      +     ++ + ++       P         L +QC  
Sbjct: 208 TYG----------------ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQ 251

Query: 180 NEPKLRPRMSEVLAILERL-EAPKNSAKLS 208
            E   RP+ +++++IL++L  AP +   L+
Sbjct: 252 QERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 2e-38
 Identities = 41/199 (20%), Positives = 83/199 (41%), Gaps = 21/199 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           MP G L +++             +   +  AKG+ +L D   ++++RD  A N+L+    
Sbjct: 92  MPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQ 148

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + K++DFGLAK     ++ + +        + A E +     T +SDV+S+GV + EL++
Sbjct: 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
                              +KPY      ++  I++       P         + ++C  
Sbjct: 209 FG-----------------SKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251

Query: 180 NEPKLRPRMSEVLAILERL 198
            +   RP+  E++    ++
Sbjct: 252 IDADSRPKFRELIIEFSKM 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-38
 Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 38/229 (16%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
            P G+L + L +                   LS    +  A   A+G+ +L   + Q I+
Sbjct: 93  APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIH 150

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 106
           RD  A NIL+   + AK++DFGL++      +    T       + A E +     TT S
Sbjct: 151 RDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNS 207

Query: 107 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR-KLFRIMDTKLGGQYPQK 165
           DV+S+GV+L E++S                     PY      +L+  +      + P  
Sbjct: 208 DVWSYGVLLWEIVSL-----------------GGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 166 AAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPKNSAKLSQSEPH 213
                  L  QC   +P  RP  +++L  L R LE  K     +  E  
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 299

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-38
 Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 30/194 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
            P G++   L +                  A  L++ H    +VI+RD K  N+LL +  
Sbjct: 88  APLGTVYRELQKLSK--FDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAG 143

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K++DFG +   P+  RT +     GT  Y  PE +       K D++S GV+  E L 
Sbjct: 144 ELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           G+                   P+ ++  +    RI   +    +P      A  L  + L
Sbjct: 200 GK------------------PPFEANTYQETYKRISRVEF--TFPDFVTEGARDLISRLL 239

Query: 179 NNEPKLRPRMSEVL 192
            + P  RP + EVL
Sbjct: 240 KHNPSQRPMLREVL 253

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (331), Expect = 1e-37
 Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 24/210 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  GSL+    R+     +    + +  G A G+ +L D     ++RD  A NIL+++  
Sbjct: 109 MENGSLD-SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNL 165

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQV---MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
             K+SDFGL++           T          + APE +   + T+ SDV+S+G+V+ E
Sbjct: 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQ 176
           ++S                    +PY     + +   ++       P         L L 
Sbjct: 226 VMSYGE-----------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLD 268

Query: 177 CLNNEPKLRPRMSEVLAILERLEAPKNSAK 206
           C   +   RP+  +++  L+++    NS K
Sbjct: 269 CWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-37
 Identities = 46/198 (23%), Positives = 82/198 (41%), Gaps = 20/198 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L ++  R      +    + + +   +G+ +L   E+ VI+RD  A N L+    
Sbjct: 82  MEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQ 138

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             K+SDFG+ +     D+   ST       +A+PE  +  R ++KSDV+SFGV++ E+ S
Sbjct: 139 VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
                 + +                   ++   + T      P+ A+     +   C   
Sbjct: 198 EGKIPYENR----------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

Query: 181 EPKLRPRMSEVLAILERL 198
            P+ RP  S +L  L  +
Sbjct: 242 RPEDRPAFSRLLRQLAEI 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 5e-37
 Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 23/198 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L  +L +     +     +++    + G+ +L +  S  ++RD  A N+LL  + 
Sbjct: 89  AELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQH 144

Query: 61  NAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL+KA     +     T       + APE +   + ++KSDV+SFGV++ E  
Sbjct: 145 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           S                    KPY   K  ++  +++       P         L   C 
Sbjct: 205 SYG-----------------QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW 247

Query: 179 NNEPKLRPRMSEVLAILE 196
             + + RP  + V   L 
Sbjct: 248 TYDVENRPGFAAVELRLR 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-36
 Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 26/218 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L   L  +  + +  +   ++    + G+ +L +     ++RD  A N+LL    
Sbjct: 90  AGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRH 146

Query: 61  NAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
            AK+SDFGL+KA G         +       + APE +   + +++SDV+S+GV + E L
Sbjct: 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           S                    KPY   K  ++   ++     + P +       L   C 
Sbjct: 207 SYG-----------------QKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249

Query: 179 NNEPKLRPRMSEVLAILERLEAPKNS-AKLSQSEPHRQ 215
             + + RP    V    +R+ A   S A   +   H  
Sbjct: 250 IYKWEDRPDFLTV---EQRMRACYYSLASKVEGHHHHH 284

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-36
 Identities = 50/212 (23%), Positives = 77/212 (36%), Gaps = 31/212 (14%)

Query: 1   MPKGSLENHLFRRGPQ--------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
              G+L  +L  +  +               L+    +  +   AKG+ FL     + I+
Sbjct: 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIH 157

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 106
           RD  A NILL  +   K+ DFGLA+                   + APE +     T +S
Sbjct: 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 217

Query: 107 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKA 166
           DV+SFGV+L E+ S   +                 P +    +  R +      + P   
Sbjct: 218 DVWSFGVLLWEIFSLGASPY---------------PGVKIDEEFCRRLKEGTRMRAPDYT 262

Query: 167 AHTAATLALQCLNNEPKLRPRMSEVLAILERL 198
                   L C + EP  RP  SE++  L  L
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 1e-35
 Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 20/193 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L + +       +      +       G+ +LH     + +RD K  N+LLD   
Sbjct: 85  CSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERD 140

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELL 119
           N K+SDFGLA      +R  +  ++ GT  Y APE +          DV+S G+VL  +L
Sbjct: 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
           +G    D+      Q   DW +                      +K       L  + L 
Sbjct: 201 AGELPWDQPS-DSCQEYSDWKEKKTYLN--------------PWKKIDSAPLALLHKILV 245

Query: 180 NEPKLRPRMSEVL 192
             P  R  + ++ 
Sbjct: 246 ENPSARITIPDIK 258

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-35
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 1   MPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 52
           M +G L+++L    P         P S +  +++A   A G+ +L+   ++ ++RD  A 
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAAR 162

Query: 53  NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 112
           N ++  +F  K+ DFG+ +     D      + +    + +PE +  G  TT SDV+SFG
Sbjct: 163 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 222

Query: 113 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 172
           VVL E+ +                 +     LS+++ L  +M+  L    P         
Sbjct: 223 VVLWEIATLA---------------EQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFE 266

Query: 173 LALQCLNNEPKLRPRMSEVLAILERLEAP 201
           L   C    PK+RP   E+++ ++    P
Sbjct: 267 LMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-35
 Identities = 44/201 (21%), Positives = 80/201 (39%), Gaps = 31/201 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G+++  +     +PL+ +    V       L +LH  ++++I+RD KA NIL   + 
Sbjct: 91  CAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDG 147

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVL 115
           + KL+DFG++       +       +GT  + APE V            K+DV+S G+ L
Sbjct: 148 DIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG-QYPQKAAHTAAT 172
           +E+                       P+  L+  R L +I  ++      P + +     
Sbjct: 206 IEMAEIE------------------PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 173 LALQCLNNEPKLRPRMSEVLA 193
              +CL      R   S++L 
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 5e-35
 Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 23/202 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
            P GSL + L +            + A+  A+G+ +L     + I+RD  A N+LL    
Sbjct: 92  APLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRD 148

Query: 61  NAKLSDFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFGL +A P  D  +V          + APE + T   +  SD + FGV L E+ 
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           +                    +P+  L+  + L +I         P+        + +QC
Sbjct: 209 TYG-----------------QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251

Query: 178 LNNEPKLRPRMSEVLAILERLE 199
             ++P+ RP    +   L   +
Sbjct: 252 WAHKPEDRPTFVALRDFLLEAQ 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-34
 Identities = 51/215 (23%), Positives = 87/215 (40%), Gaps = 34/215 (15%)

Query: 1   MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 46
             KG+L  +L  R P              + LS    +  A   A+G+ +L     + I+
Sbjct: 101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIH 158

Query: 47  RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 106
           RD  A N+L+  +   K++DFGLA+     D    +T       + APE +     T +S
Sbjct: 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218

Query: 107 DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL-SDKRKLFRIMDTKLGGQYPQK 165
           DV+SFGV+L E+ +   +                 PY      +LF+++        P  
Sbjct: 219 DVWSFGVLLWEIFTLGGS-----------------PYPGVPVEELFKLLKEGHRMDKPSN 261

Query: 166 AAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 200
             +    +   C +  P  RP   +++  L+R+ A
Sbjct: 262 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (302), Expect = 3e-33
 Identities = 46/197 (23%), Positives = 69/197 (35%), Gaps = 33/197 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
               + +     + P  L       V  GA +GL +LH     +I+RD KA NILL    
Sbjct: 97  CLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPG 152

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLE 117
             KL DFG A           +   +GT  + APE +     G+   K DV+S G+  +E
Sbjct: 153 LVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           L   +                   P   ++    L+ I   +         +        
Sbjct: 207 LAERK------------------PPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248

Query: 176 QCLNNEPKLRPRMSEVL 192
            CL   P+ RP    +L
Sbjct: 249 SCLQKIPQDRPTSEVLL 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 7e-33
 Identities = 46/198 (23%), Positives = 79/198 (39%), Gaps = 20/198 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L + L  R    L  A  +  A   +  L +L     + ++RD  A N+L+ +  
Sbjct: 89  CTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSND 145

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL DFGL++        + +++      + APE +   R T+ SDV+ FGV + E+L 
Sbjct: 146 CVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
                                  + +   + RI + +     P     T  +L  +C   
Sbjct: 205 HGV---------------KPFQGVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAY 248

Query: 181 EPKLRPRMSEVLAILERL 198
           +P  RPR +E+ A L  +
Sbjct: 249 DPSRRPRFTELKAQLSTI 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 4e-32
 Identities = 39/203 (19%), Positives = 74/203 (36%), Gaps = 26/203 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L  ++ + G                   L +LH     +I+RD K  NILL+ + 
Sbjct: 90  AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDM 145

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + +++DFG AK      +   +   +GT  Y +PE +        SD+++ G ++ +L++
Sbjct: 146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           G                    P+ +        +I+  +    +P+K    A  L  + L
Sbjct: 206 GL------------------PPFRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLL 245

Query: 179 NNEPKLRPRMSEVLAILERLEAP 201
             +   R    E+         P
Sbjct: 246 VLDATKRLGCEEMEGYGPLKAHP 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  112 bits (280), Expect = 2e-30
 Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 35/203 (17%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M KG L ++L  +    LS     K+     + +  LH     +++RD K  NILLD + 
Sbjct: 92  MKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDM 147

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL------TTKSDVYSFGVV 114
           N KL+DFG +     G++     +V GT  Y APE +             + D++S GV+
Sbjct: 148 NIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 204

Query: 115 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK--LFRIM--DTKLGGQYPQKAAHTA 170
           +  LL+G                    P+   K+   L  IM  + + G       + T 
Sbjct: 205 MYTLLAGS------------------PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246

Query: 171 ATLALQCLNNEPKLRPRMSEVLA 193
             L  + L  +P+ R    E LA
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALA 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  112 bits (282), Expect = 5e-30
 Identities = 48/252 (19%), Positives = 79/252 (31%), Gaps = 28/252 (11%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L   +       +S    ++      KGL  +H+     ++ D K  NI+   + 
Sbjct: 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKR 161

Query: 61  N--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           +   KL DFGL                 GT  +AAPE      +   +D++S GV+   L
Sbjct: 162 SNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQ 176
           LSG                       +D   L  +               +        +
Sbjct: 219 LSGLSPFGGE----------------NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262

Query: 177 CLNNEPKLRPRMSEVLA--ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 234
            L  +P  R  + + L    L    AP   +++  S   +    +  +     +   PL 
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLG 322

Query: 235 MTPTASPLPSHR 246
                S L  HR
Sbjct: 323 RISNYSSLRKHR 334

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 8e-30
 Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 28/195 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  GSL + +               V     + L FLH   +QVI+RD K+ NILL  + 
Sbjct: 99  LAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDG 153

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + KL+DFG              + ++GT  + APE V       K D++S G++ +E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211

Query: 121 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQC 177
           G                    PY   +  R L+ I  +     Q P+K +        +C
Sbjct: 212 GE------------------PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 178 LNNEPKLRPRMSEVL 192
           L+ + + R    E+L
Sbjct: 254 LDMDVEKRGSAKELL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 9e-29
 Identities = 47/258 (18%), Positives = 97/258 (37%), Gaps = 36/258 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +    +   +       L+    +       + L FLH     + + D +  NI+     
Sbjct: 83  ISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRR 139

Query: 61  NA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
           ++  K+ +FG A+    GD   +   +     Y APE      ++T +D++S G ++  L
Sbjct: 140 SSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK--LFRIMDTKLG--GQYPQKAAHTAATLA 174
           LSG                    P+L++  +  +  IM+ +     +  ++ +  A    
Sbjct: 197 LSGI------------------NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 175 LQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRS 231
            + L  E K R   SE L    + +++E  + S K+ ++  HR+    T+ K  +    S
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIE--RVSTKVIRTLKHRRYYH-TLIKKDLNMVVS 295

Query: 232 PLNMTPTASPLPSHRQSP 249
              ++   +       S 
Sbjct: 296 AARISCGGAIRSQKGVSV 313

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-28
 Identities = 45/203 (22%), Positives = 73/203 (35%), Gaps = 16/203 (7%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
                L  +L +     +       +     +GL FLH    +V++RD K  NIL+ +  
Sbjct: 96  HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 153

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFGLA+           T V+ T  Y APE +      T  D++S G +  E+  
Sbjct: 154 QIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210

Query: 121 GRCAVDKT----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 170
            +     +           V       DW +   +  R+ F     +   ++        
Sbjct: 211 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV-ALPRQAFHSKSAQPIEKFVTDIDELG 269

Query: 171 ATLALQCLNNEPKLRPRMSEVLA 193
             L L+CL   P  R      L+
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALS 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  106 bits (266), Expect = 4e-28
 Identities = 32/208 (15%), Positives = 57/208 (27%), Gaps = 28/208 (13%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-- 61
           G     L     +  S       A      +  +H  E  ++YRD K  N L+    +  
Sbjct: 84  GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKN 141

Query: 62  ---AKLSDFGLAK-----AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 113
                + DFG+ K                  + GT  Y +         + + D+ + G 
Sbjct: 142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201

Query: 114 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---A 170
           V +  L G                       ++K+K  RI + K      +  A      
Sbjct: 202 VFMYFLRGSL-------------PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF 248

Query: 171 ATLALQCLNNEPKLRPRMSEVLAILERL 198
                   N      P    +  +  ++
Sbjct: 249 YKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 1e-27
 Identities = 51/186 (27%), Positives = 72/186 (38%), Gaps = 24/186 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L  H+       LS A     A     GL FLH     ++YRD K  NILLD + 
Sbjct: 85  LNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLH--SKGIVYRDLKLDNILLDKDG 140

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + K++DFG+ K    GD         GT  Y APE +   +     D +SFGV+L E+L 
Sbjct: 141 HIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 198

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G+                   P+     +            YP+     A  L ++    
Sbjct: 199 GQS------------------PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 181 EPKLRP 186
           EP+ R 
Sbjct: 241 EPEKRL 246

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-27
 Identities = 41/215 (19%), Positives = 78/215 (36%), Gaps = 21/215 (9%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L + +  RG Q  +     ++     + + +LH     + +RD K  N+L  ++ 
Sbjct: 91  LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKR 148

Query: 61  N---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
                KL+DFG AK   + +          T  Y APE +   +     D++S GV++  
Sbjct: 149 PNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 205

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
           LL G                +         +   R+   +       + +     L    
Sbjct: 206 LLCGYPPFYS----------NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255

Query: 178 LNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQ 209
           L  EP  R  ++E +    I++  + P+     S+
Sbjct: 256 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  105 bits (262), Expect = 3e-27
 Identities = 46/250 (18%), Positives = 83/250 (33%), Gaps = 40/250 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L + +       +S A  +     A +GL  +H  E  +++ D K  NI+ + + 
Sbjct: 108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKK 164

Query: 61  NA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
            +  K+ DFGLA      +          T  +AAPE V    +   +D+++ GV+   L
Sbjct: 165 ASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLA 174
           LSG                    P+    D   L  +   D +         +  A    
Sbjct: 222 LSGL------------------SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 175 LQCLNNEPKLRPRMSEVLA----------ILERLEAPKNSAKLSQSEPHRQTGPVTVRKS 224
              L  EP+ R  + + L           +  R+ + + +    + +      P      
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAI 323

Query: 225 PMRQQRSPLN 234
                 S L 
Sbjct: 324 GRIANFSSLR 333

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  103 bits (257), Expect = 4e-27
 Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 28/204 (13%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +   +L + +   GP  ++    ++V   A + L F H  ++ +I+RD K +NI++ A  
Sbjct: 93  VDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATN 148

Query: 61  NAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 119
             K+ DFG+A+    +G+    +  V+GT  Y +PE      +  +SDVYS G VL E+L
Sbjct: 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATLAL 175
           +G                    P+   S     ++ +  D        +  +     + L
Sbjct: 209 TGE------------------PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250

Query: 176 QCLNNEPKLRPR-MSEVLAILERL 198
           + L   P+ R +  +E+ A L R+
Sbjct: 251 KALAKNPENRYQTAAEMRADLVRV 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  101 bits (253), Expect = 8e-26
 Identities = 50/194 (25%), Positives = 74/194 (38%), Gaps = 24/194 (12%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           M  G L  HL + G    +        I    GL  +H     V+YRD K +NILLD   
Sbjct: 89  MNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLEHMH--NRFVVYRDLKPANILLDEHG 144

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELL 119
           + ++SD GLA               +GTHGY APE +  G    + +D +S G +L +LL
Sbjct: 145 HVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200

Query: 120 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN 179
            G                 + +    DK ++ R+  T    + P   +    +L    L 
Sbjct: 201 RGHSP--------------FRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQ 245

Query: 180 NEPKLRPRMSEVLA 193
            +   R       A
Sbjct: 246 RDVNRRLGCLGRGA 259

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (249), Expect = 9e-26
 Identities = 39/203 (19%), Positives = 60/203 (29%), Gaps = 20/203 (9%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL---LDAEF 60
           G     LF    +  S    + +A      + ++H      I+RD K  N L        
Sbjct: 86  GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGN 143

Query: 61  NAKLSDFGLAKA-----GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 115
              + DFGLAK               +  + GT  YA+         + + D+ S G VL
Sbjct: 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203

Query: 116 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 175
           +    G       K           + Y     K        L   YP + A        
Sbjct: 204 MYFNLGSLPWQGLKA------ATKRQKYERISEKKMSTPIEVLCKGYPSEFAT----YLN 253

Query: 176 QCLNNEPKLRPRMSEVLAILERL 198
            C +     +P  S +  +   L
Sbjct: 254 FCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 2e-24
 Identities = 41/204 (20%), Positives = 74/204 (36%), Gaps = 14/204 (6%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
                L+  +       +   +         +GL F H    +V++RD K  N+L++ E 
Sbjct: 82  FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEG 139

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             KL+DFGLA+A     RT+ + +V+     A    +     +T  D++S G +  E+++
Sbjct: 140 AIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

Query: 121 GRC----------AVDKTKVGIEQSLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHT 169
            R                +       V W     + D +  F     +   +        
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED 258

Query: 170 AATLALQCLNNEPKLRPRMSEVLA 193
             +L  Q L+ +P  R      LA
Sbjct: 259 GRSLLSQMLHYDPNKRISAKAALA 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.6 bits (237), Expect = 4e-24
 Identities = 43/199 (21%), Positives = 71/199 (35%), Gaps = 29/199 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE- 59
           +  G L + L  +       A           G+ +LH    Q+ + D K  NI+L    
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRN 150

Query: 60  ---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 116
                 K+ DFGLA     G+       + GT  + APE V    L  ++D++S GV+  
Sbjct: 151 VPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207

Query: 117 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM--DTKLGGQYPQKAAHTAATLA 174
            LLSG                       + +  L  +   + +   +Y    +  A    
Sbjct: 208 ILLSGASPFLGD----------------TKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 175 LQCLNNEPKLRPRMSEVLA 193
            + L  +PK R  + + L 
Sbjct: 252 RRLLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.4 bits (234), Expect = 9e-24
 Identities = 44/211 (20%), Positives = 79/211 (37%), Gaps = 34/211 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE- 59
            P+   +   F      L   +         + +   H     V++RD K  NIL+D   
Sbjct: 90  RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNR 147

Query: 60  FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLEL 118
              KL DFG         +  V T   GT  Y+ PE++   R   +S  V+S G++L ++
Sbjct: 148 GELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           + G                    P+  D+     I+  ++   + Q+ +     L   CL
Sbjct: 204 VCGD------------------IPFEHDE----EIIRGQV--FFRQRVSSECQHLIRWCL 239

Query: 179 NNEPKLRPRMSEVLA--ILERLEAPKNSAKL 207
              P  RP   E+     ++ +  P+ +A++
Sbjct: 240 ALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 94.2 bits (233), Expect = 1e-23
 Identities = 35/196 (17%), Positives = 73/196 (37%), Gaps = 14/196 (7%)

Query: 9   HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 68
            L       L         +    G+ + HD   +V++RD K  N+L++ E   K++DFG
Sbjct: 88  KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFG 145

Query: 69  LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 128
           LA+A     R +   +++     A    + + + +T  D++S G +  E+++G       
Sbjct: 146 LARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

Query: 129 ----------KVGIEQSLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
                     ++    +  +W     L      F + +      + +    +   L  + 
Sbjct: 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264

Query: 178 LNNEPKLRPRMSEVLA 193
           L  +P  R    + L 
Sbjct: 265 LKLDPNQRITAKQALE 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 3e-23
 Identities = 41/196 (20%), Positives = 72/196 (36%), Gaps = 15/196 (7%)

Query: 9   HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 68
            + +     L+ +      +   +GL +LH  +  +++RD K +N+LLD     KL+DFG
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFG 145

Query: 69  LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDK 127
           LAK+  + +R +  T  + T  Y APE +   R+     D+++ G +L ELL     +  
Sbjct: 146 LAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203

Query: 128 T----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 177
                      +     +   W           F+             A      L    
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGL 263

Query: 178 LNNEPKLRPRMSEVLA 193
               P  R   ++ L 
Sbjct: 264 FLFNPCARITATQALK 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 7e-23
 Identities = 54/193 (27%), Positives = 79/193 (40%), Gaps = 17/193 (8%)

Query: 16  QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGP 74
           Q LS            +GL ++H   + V++RD K SN+LL+   + K+ DFGLA+ A P
Sbjct: 104 QHLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161

Query: 75  TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVG 131
             D T   T+ + T  Y APE +   +  TKS D++S G +L E+LS R           
Sbjct: 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 221

Query: 132 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNN 180
           +   L     P   D   +  +         P K           A   A  L  + L  
Sbjct: 222 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281

Query: 181 EPKLRPRMSEVLA 193
            P  R  + + LA
Sbjct: 282 NPHKRIEVEQALA 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.8 bits (230), Expect = 7e-23
 Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 31/195 (15%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L + L +    P   A      +     L +LH     +IYRD K  NILLD   
Sbjct: 86  IEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLHSK--DIIYRDLKPENILLDKNG 141

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + K++DFG AK  P    T       GT  Y APE V+T       D +SFG+++ E+L+
Sbjct: 142 HIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196

Query: 121 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           G                    P+   +  +   +I++ +L  ++P         L  + +
Sbjct: 197 GY------------------TPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI 236

Query: 179 NNEPKLRPRMSEVLA 193
             +   R    +   
Sbjct: 237 TRDLSQRLGNLQNGT 251

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 92.4 bits (229), Expect = 8e-23
 Identities = 42/200 (21%), Positives = 77/200 (38%), Gaps = 32/200 (16%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---D 57
           +  G L + +  +G    +     ++       + +LH  +  +++RD K  N+L    D
Sbjct: 89  VSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLD 144

Query: 58  AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 117
            +    +SDFGL+K     D   V +   GT GY APE +A    +   D +S GV+   
Sbjct: 145 EDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201

Query: 118 LLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIM--DTKLGGQYPQKAAHTAATL 173
           LL G                    P+   +D +   +I+  + +    Y    + +A   
Sbjct: 202 LLCGY------------------PPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 174 ALQCLNNEPKLRPRMSEVLA 193
               +  +P+ R    + L 
Sbjct: 244 IRHLMEKDPEKRFTCEQALQ 263

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 5e-22
 Identities = 40/210 (19%), Positives = 73/210 (34%), Gaps = 21/210 (10%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
                            LS   R  V      GL ++H   +++++RD KA+N+L+  + 
Sbjct: 99  CEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIH--RNKILHRDMKAANVLITRDG 154

Query: 61  NAKLSDFGLAKAGPTGDRTHVS--TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLE 117
             KL+DFGLA+A      +  +  T  + T  Y  PE +   R      D++  G ++ E
Sbjct: 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214

Query: 118 LLSGR-------------CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 164
           + +                          +   +     L +K +L +    K+  +   
Sbjct: 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274

Query: 165 KAAHTAAT-LALQCLNNEPKLRPRMSEVLA 193
                 A  L  + L  +P  R    + L 
Sbjct: 275 YVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 2e-21
 Identities = 48/195 (24%), Positives = 75/195 (38%), Gaps = 28/195 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
              G L  HL R   +  +              L +LH     V+YRD K  N++LD + 
Sbjct: 87  ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDG 142

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
           + K++DFGL K G +   T       GT  Y APE +         D +  GVV+ E++ 
Sbjct: 143 HIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

Query: 121 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 178
           GR                   P+     +R    I+  ++  ++P+  +  A +L    L
Sbjct: 201 GR------------------LPFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLL 240

Query: 179 NNEPKLRPRMSEVLA 193
             +PK R       A
Sbjct: 241 KKDPKQRLGGGPSDA 255

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 3e-21
 Identities = 45/206 (21%), Positives = 72/206 (34%), Gaps = 17/206 (8%)

Query: 1   MPKGSLENHL-FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 59
           +P+        + R  Q L             + L ++H     + +RD K  N+LLD +
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPD 158

Query: 60  -FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 118
               KL DFG AK    G+     + +   +  A          T+  DV+S G VL EL
Sbjct: 159 TAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216

Query: 119 LSGR-----CAVDKTKVGIEQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQKAA 167
           L G+      +     V I + L    +  + +      + K  +I        +  +  
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 276

Query: 168 HTAATLALQCLNNEPKLRPRMSEVLA 193
             A  L  + L   P  R    E  A
Sbjct: 277 PEAIALCSRLLEYTPTARLTPLEACA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.9 bits (209), Expect = 9e-20
 Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 27/186 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G + +HL R G    S       A        +LH     +IYRD K  N+L+D + 
Sbjct: 123 VAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQG 178

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 120
             +++DFG AK       T     + GT    APE + +       D ++ GV++ E+ +
Sbjct: 179 YIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

Query: 121 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 180
           G                    P+ +D+             ++P   +     L    L  
Sbjct: 234 GYP------------------PFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275

Query: 181 EPKLRP 186
           +   R 
Sbjct: 276 DLTKRF 281

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 1e-19
 Identities = 40/186 (21%), Positives = 61/186 (32%), Gaps = 15/186 (8%)

Query: 20  WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 79
             +         KGL F H     V++RD K  N+L++     KL++FGLA+A     R 
Sbjct: 100 PEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

Query: 80  HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----- 134
           + S +V+                +T  D++S G +  EL +    +       +Q     
Sbjct: 158 Y-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216

Query: 135 ------SLVDWAKPY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 187
                 +   W     L D +       T        K   T   L    L   P  R  
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276

Query: 188 MSEVLA 193
             E L 
Sbjct: 277 AEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 8e-19
 Identities = 38/203 (18%), Positives = 75/203 (36%), Gaps = 21/203 (10%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G+    L +     L       +     KGL ++H   + +I+RD K  N+ ++ +   K
Sbjct: 106 GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELK 161

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR- 122
           + DFGLA+       + ++  V+     A    +   R T   D++S G ++ E+++G+ 
Sbjct: 162 ILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 123 ------------CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 170
                         +  T     + +         +  K    ++ K        A+  A
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277

Query: 171 ATLALQCLNNEPKLRPRMSEVLA 193
             L  + L  + + R    E LA
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 77.2 bits (189), Expect = 4e-17
 Identities = 33/215 (15%), Positives = 71/215 (33%), Gaps = 32/215 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +     +        Q L+            K L + H     +++RD K  N+++D E 
Sbjct: 114 VNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEH 166

Query: 61  N-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLEL 118
              +L D+GLA+    G         + +  +  PE +   ++     D++S G +L  +
Sbjct: 167 RKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223

Query: 119 LSGRCAVDKTKVGIEQ-----------SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 167
           +  +          +Q            L D+   Y  +    F  +  +   +  ++  
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283

Query: 168 HT---------AATLALQCLNNEPKLRPRMSEVLA 193
           H+         A     + L  + + R    E + 
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (187), Expect = 7e-17
 Identities = 56/199 (28%), Positives = 76/199 (38%), Gaps = 29/199 (14%)

Query: 1   MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 60
           +  G L  HL +R              I     L  LH     +IYRD K  NILLD+  
Sbjct: 111 INGGELFTHLSQRERFTEHEVQIYVGEI--VLALEHLHKL--GIIYRDIKLENILLDSNG 166

Query: 61  NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLEL 118
           +  L+DFGL+K     D T  +    GT  Y AP+ V  G        D +S GV++ EL
Sbjct: 167 HVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 225

Query: 119 LSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLA 174
           L+G                    P+    +K     I    L  +  YPQ+ +  A  L 
Sbjct: 226 LTGA------------------SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267

Query: 175 LQCLNNEPKLRPRMSEVLA 193
            + L  +PK R       A
Sbjct: 268 QRLLMKDPKKRLGCGPRDA 286

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 70.8 bits (172), Expect = 7e-15
 Identities = 29/216 (13%), Positives = 69/216 (31%), Gaps = 32/216 (14%)

Query: 9   HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDF 67
            + +   + +      +++     GL ++H     +I+ D K  N+L++       L   
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQI 171

Query: 68  GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 127
            +A  G         T  + T  Y +PE +        +D++S   ++ EL++G    + 
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231

Query: 128 TKVGIEQSLVD---------------------WAKPYLSDKRKLFRIMDTKL-------- 158
            +        D                     + + + + +  L  I   K         
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291

Query: 159 -GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
              ++ +  A   +      L  +P+ R     ++ 
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.6 bits (169), Expect = 2e-14
 Identities = 41/212 (19%), Positives = 78/212 (36%), Gaps = 29/212 (13%)

Query: 6   LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 65
           ++ +L +     L       +      G+  LH   + +I+RD K SNI++ ++   K+ 
Sbjct: 104 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL 161

Query: 66  DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC-- 123
           DFGLA+   T       T  + T  Y APE +         D++S G ++ E++  +   
Sbjct: 162 DFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218

Query: 124 --------------AVDKTKVGIEQSLVDWAKPYLSDK--------RKLFRIMDTKLGGQ 161
                          +        + L    + Y+ ++         KLF         +
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278

Query: 162 YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 193
           + +  A  A  L  + L  +P  R  + + L 
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.6 bits (164), Expect = 1e-13
 Identities = 39/203 (19%), Positives = 73/203 (35%), Gaps = 21/203 (10%)

Query: 4   GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 63
           G+  N++ +     L+      +     +GL ++H   + +I+RD K SN+ ++ +   K
Sbjct: 106 GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELK 161

Query: 64  LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 123
           + DFGLA+         ++  V      A    +         D++S G ++ ELL+GR 
Sbjct: 162 ILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

Query: 124 -----AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQK--------AAHTA 170
                        I + +       L            +   Q P+         A   A
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 277

Query: 171 ATLALQCLNNEPKLRPRMSEVLA 193
             L  + L  +   R   ++ LA
Sbjct: 278 VDLLEKMLVLDSDKRITAAQALA 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 40.1 bits (93), Expect = 7e-05
 Identities = 7/52 (13%), Positives = 18/52 (34%), Gaps = 3/52 (5%)

Query: 20  WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 71
                +V     + +   +     +++ D    N+L+  E    + DF  + 
Sbjct: 102 VENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	252
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.51
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.03
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	95.36
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	95.06
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.5
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	88.06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-46  Score=297.20  Aligned_cols=181  Identities=27%  Similarity=0.444  Sum_probs=141.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||||.++|...+. .+++..++.++.||++||+|||+++  ||||||||+||||+.++.+||+|||+++.........
T Consensus        85 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          85 CEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             CCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            679999999976543 4999999999999999999999765  9999999999999999999999999998765443333


Q ss_pred             eeecccccccccCccccccC---CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                      ......||+.|+|||++.+.   .|+.++|||||||++|||+||+.||.+...                .......+...
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----------------~~~~~~~~~~~  225 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----------------RDQIIFMVGRG  225 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------------HHHHHHHHHHT
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----------------HHHHHHHHhcC
Confidence            34556799999999998643   588999999999999999999999987432                11122222222


Q ss_pred             cCC----CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          158 LGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       158 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ...    ..+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            211    2345678899999999999999999999999999998764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=299.41  Aligned_cols=178  Identities=25%  Similarity=0.358  Sum_probs=151.2

Q ss_pred             CCCCChhhhhhcCCC---------------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC
Q 025440            1 MPKGSLENHLFRRGP---------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE   59 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~   59 (252)
                      |+||+|.++|.....                     ..+++..++.++.||++||+|||+++  ||||||||+|||++.+
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~~~  200 (325)
T d1rjba_         123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG  200 (325)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEETT
T ss_pred             CCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchhccccccC
Confidence            689999999976532                     34899999999999999999999865  9999999999999999


Q ss_pred             CceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhh
Q 025440           60 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD  138 (252)
Q Consensus        60 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~  138 (252)
                      +.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |..||.+...        
T Consensus       201 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~--------  272 (325)
T d1rjba_         201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--------  272 (325)
T ss_dssp             TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------
T ss_pred             CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH--------
Confidence            9999999999987655444444455678999999999999999999999999999999998 8999987432        


Q ss_pred             hcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHH
Q 025440          139 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE  196 (252)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~  196 (252)
                              ...+.+++....+...+..++.++.+||.+||+.||++|||+++|++.|.
T Consensus       273 --------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 --------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             --------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --------HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                    22334455555666777888999999999999999999999999999985

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=292.35  Aligned_cols=174  Identities=24%  Similarity=0.307  Sum_probs=141.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|...+.  +++..+..++.||++||+|||+++  |+||||||+|||++.++.+||+|||+++.........
T Consensus        85 ~~gg~L~~~l~~~~~--l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            579999999976654  999999999999999999999876  9999999999999999999999999998765444333


Q ss_pred             eeecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.......               ............
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---------------~~~~~~~~~~~~  225 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------------QEYSDWKEKKTY  225 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---------------HHHHHHHTTCTT
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---------------HHHHHHhcCCCC
Confidence            3456789999999999988876 578999999999999999999997653211               111111122222


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ......++.++.+||.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2334567889999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=293.91  Aligned_cols=181  Identities=28%  Similarity=0.347  Sum_probs=144.7

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      |+||+|.++|....              ...+++..++.++.||++||+|||+++  ||||||||+||||+.++.+||+|
T Consensus       100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~~~~~Kl~D  177 (299)
T d1ywna1         100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICD  177 (299)
T ss_dssp             CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECC
T ss_pred             cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECCCCcEEEcc
Confidence            68999999997542              234899999999999999999999866  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhC-CCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||+|| ..||.+...               
T Consensus       178 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---------------  242 (299)
T d1ywna1         178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------------  242 (299)
T ss_dssp             ------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---------------
T ss_pred             CcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH---------------
Confidence            9999875544433334456799999999999999999999999999999999986 567765432               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                       ...+...+........+..++.++.+||.+||+.||++|||+.++++.|+++.
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 -DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             -SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             12233444455556677788899999999999999999999999999998763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-44  Score=291.57  Aligned_cols=180  Identities=23%  Similarity=0.404  Sum_probs=140.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++..... .+++.+++.++.||++||+|||+++  |+||||||+||||+.++.+||+|||+++.........
T Consensus       109 ~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  185 (299)
T d1jpaa_         109 MENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  185 (299)
T ss_dssp             CTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred             cCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence            689999999976543 4999999999999999999999765  9999999999999999999999999998754432221


Q ss_pred             ---eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           81 ---VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        81 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                         ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+...                 ..+...+..
T Consensus       186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----------------~~~~~~i~~  248 (299)
T d1jpaa_         186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----------------QDVINAIEQ  248 (299)
T ss_dssp             ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHT
T ss_pred             eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHc
Confidence               1222457899999999999999999999999999999998 8999976431                 123333444


Q ss_pred             hcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          157 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       157 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..+.+.+..++..+.+||.+||+.||++|||+.+|++.|+++..
T Consensus       249 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            45556677889999999999999999999999999999988754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=286.40  Aligned_cols=167  Identities=27%  Similarity=0.418  Sum_probs=141.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++......   
T Consensus        88 ~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---  160 (263)
T d2j4za1          88 APLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---  160 (263)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred             cCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence            689999999987665  999999999999999999999866  9999999999999999999999999998654332   


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.                ......+..  ...
T Consensus       161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~~~~i~~--~~~  221 (263)
T d2j4za1         161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----------------QETYKRISR--VEF  221 (263)
T ss_dssp             -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHT--TCC
T ss_pred             -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----------------HHHHHHHHc--CCC
Confidence             2346799999999999999999999999999999999999999976431                111111111  223


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++.++.+||.+||+.||++|||++|+++
T Consensus       222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            456678889999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-44  Score=288.80  Aligned_cols=181  Identities=23%  Similarity=0.341  Sum_probs=152.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |++|+|.+++.+.....+++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++....... .
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~  171 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  171 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-E
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCCc-e
Confidence            67999999998877677999999999999999999999765  99999999999999999999999999987644332 2


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......|++.|+|||++.+..++.++|||||||++|||++|..||....                +.....+.+......
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----------------~~~~~~~~i~~~~~~  235 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRM  235 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----------------CHHHHHHHHHTTCCC
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----------------hHHHHHHHHhcCCCC
Confidence            2334468899999999999999999999999999999999766654321                122344455556666


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..+..++.++.+||.+||+.||++|||+.++++.|+.+..
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            7778889999999999999999999999999999988643

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=288.42  Aligned_cols=177  Identities=24%  Similarity=0.336  Sum_probs=148.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |+||+|.+++.+...  +++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        89 ~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          89 AELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             CTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            689999999987765  999999999999999999999765  999999999999999999999999999876544322 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...                 ......+....
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------------~~~~~~i~~~~  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAMLEKGE  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHHHTTC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence            22344578999999999999999999999999999999998 8999987431                 22333444455


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      +...+..++.++.+||.+||+.||++|||+.+|++.|+..
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            5667788899999999999999999999999999888653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-44  Score=285.00  Aligned_cols=170  Identities=24%  Similarity=0.399  Sum_probs=137.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec-CCCceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |+||+|.+++.+...  +++..+..++.||++||+|||+++.+|+||||||+|||++ .++.+||+|||+++......  
T Consensus        94 ~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~--  169 (270)
T d1t4ha_          94 MTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--  169 (270)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS--
T ss_pred             CCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc--
Confidence            689999999987665  9999999999999999999998766699999999999996 57899999999998643321  


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh-c
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  158 (252)
                        ....+||+.|+|||++.+ +++.++|||||||++|+|++|+.||.+...                ...+...+... .
T Consensus       170 --~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----------------~~~~~~~i~~~~~  230 (270)
T d1t4ha_         170 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----------------AAQIYRRVTSGVK  230 (270)
T ss_dssp             --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----------------HHHHHHHHTTTCC
T ss_pred             --cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----------------HHHHHHHHHcCCC
Confidence              335679999999999865 699999999999999999999999976431                11111222111 1


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            12233446778999999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=286.40  Aligned_cols=170  Identities=26%  Similarity=0.381  Sum_probs=141.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.   .+++.++..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus        99 ~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1          99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             cCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            6899999998764   3999999999999999999999765  99999999999999999999999999987643322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh-hcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT-KLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  159 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|+|+||..||.+...                ......+... ...
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~~~~~~~~~  235 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----------------LRALYLIATNGTPE  235 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHHCSCC
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH----------------HHHHHHHHhCCCCC
Confidence            23456799999999999999999999999999999999999999976431                1112222222 223


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3456778899999999999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=287.41  Aligned_cols=178  Identities=25%  Similarity=0.403  Sum_probs=147.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |++|+|.+++.......+++..++.++.||++||+|||+++  |+||||||+||||+.++.+||+|||+++....... .
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            68999999987666556999999999999999999999765  99999999999999999999999999987654322 2


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCC-CCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+ ....                 .......+.....
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----------------~~~~~~~i~~~~~  228 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----------------NPEVIQNLERGYR  228 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------------HHHHHHHHHTTCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----------------HHHHHHHHHhcCC
Confidence            234457899999999999999999999999999999999965554 3321                 1222333444455


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ...+..++.++.+||.+||+.||++|||+++|++.|+.+
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            566778889999999999999999999999999998865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=288.32  Aligned_cols=174  Identities=25%  Similarity=0.314  Sum_probs=132.3

Q ss_pred             CCCCChhhhhhcC--CCCCCCHHHHHHHHHHHHHHhHHHhcCC---CCeeeccCCCCceeecCCCceEEccccccccCCC
Q 025440            1 MPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT   75 (252)
Q Consensus         1 ~~ggsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~   75 (252)
                      |+||||.+++.+.  ....+++..++.++.||+.||+|||+++   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  166 (269)
T d2java1          87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  166 (269)
T ss_dssp             CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred             CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence            6799999999653  2345999999999999999999999754   3599999999999999999999999999987543


Q ss_pred             CCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           76 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        76 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.                 ..+...+.
T Consensus       167 ~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----------------~~~~~~i~  227 (269)
T d2java1         167 DTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----------------KELAGKIR  227 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHHHH
T ss_pred             CCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----------------HHHHHHHH
Confidence            322  23456799999999999999999999999999999999999999976431                 11122222


Q ss_pred             hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .......+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            22233456678889999999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-44  Score=286.52  Aligned_cols=179  Identities=23%  Similarity=0.329  Sum_probs=149.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |+||+|.+++.... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        90 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          90 AGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             CTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            68999999986543 34999999999999999999999865  999999999999999999999999999876543322 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      .......||+.|+|||++.++.++.++|||||||++|||+| |..||.+...                 ..+...+....
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----------------~~~~~~i~~~~  229 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGK  229 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----------------HHHHHHHHTTC
T ss_pred             ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence            22334568999999999999999999999999999999998 9999986431                 12233334445


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      +...+..++.++.+||.+||+.||++|||+.+|++.|+...
T Consensus       230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            56677889999999999999999999999999999887653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=282.90  Aligned_cols=178  Identities=26%  Similarity=0.393  Sum_probs=137.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |++|+|.+++.... ..+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            68999999997654 34899999999999999999999765  999999999999999999999999999875443322 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhC-CCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||..|+|||++.+..++.++|||||||++|||+|+ ..||....                 .......+.....
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----------------~~~~~~~i~~~~~  220 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------------NSEVVEDISTGFR  220 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----------------HHHHHHHHHHTCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----------------HHHHHHHHHhcCC
Confidence            23345689999999999999999999999999999999995 55554422                 1222333344455


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++.++.+||.+||+.||++|||+++|++.|+++.
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            5667778889999999999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=288.19  Aligned_cols=172  Identities=22%  Similarity=0.332  Sum_probs=139.9

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++...+.  +++..+..++.||+.||+|||+.+  ||||||||+|||++.+|.+||+|||+++.........
T Consensus        90 ~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          90 AKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            579999999987765  999999999999999999999876  9999999999999999999999999998765443333


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.                ......+...  ..
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------~~~~~~i~~~--~~  227 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE----------------YLIFQKIIKL--EY  227 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHTT--CC
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH----------------HHHHHHHHcC--CC
Confidence            34456799999999999999999999999999999999999999986431                1111222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .++..++.++.+||.+||+.||.+|||++|+++.
T Consensus       228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            4566788899999999999999999999997653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-43  Score=286.89  Aligned_cols=179  Identities=22%  Similarity=0.353  Sum_probs=148.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.+|+|.+++.... ..+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~  168 (317)
T d1xkka_          92 MPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY  168 (317)
T ss_dssp             CTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--
T ss_pred             ccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecccccccc
Confidence            57899999987764 34999999999999999999999865  9999999999999999999999999998765544433


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+...                 ..+...+....+
T Consensus       169 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----------------~~~~~~i~~~~~  231 (317)
T d1xkka_         169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISSILEKGER  231 (317)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----------------GGHHHHHHHTCC
T ss_pred             cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            3445578999999999999999999999999999999998 8999976432                 223344445555


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++..+.+||.+||+.||.+|||+.++++.|+++.
T Consensus       232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            6677788999999999999999999999999999998764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=280.13  Aligned_cols=181  Identities=24%  Similarity=0.409  Sum_probs=141.3

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |.+|+|.+++.... ..+++.+++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++........ 
T Consensus        91 ~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~  167 (283)
T d1mqba_          91 MENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT  167 (283)
T ss_dssp             CTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             cccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence            56888998887654 34999999999999999999999865  999999999999999999999999999875443222 


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      .......||+.|+|||++.++.++.++|||||||++|||++|..||....                ....+...+....+
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----------------~~~~~~~~i~~~~~  231 (283)
T d1mqba_         168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKAINDGFR  231 (283)
T ss_dssp             ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----------------CHHHHHHHHHTTCC
T ss_pred             eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC----------------CHHHHHHHHhccCC
Confidence            22334568999999999999999999999999999999999665554321                11233444455566


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      .+.+..++..+.+||.+||+.||++|||+.+|++.|+++..
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            67777888999999999999999999999999999988754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-43  Score=287.34  Aligned_cols=190  Identities=25%  Similarity=0.400  Sum_probs=139.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||++ .+|+||||||+|||++.+|.+||+|||+|+.....    
T Consensus        86 ~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----  158 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  158 (322)
T ss_dssp             CTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred             CCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----
Confidence            689999999987765  99999999999999999999964 24999999999999999999999999999864221    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhh---------------------
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW---------------------  139 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~---------------------  139 (252)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+............                     
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            12346899999999999999999999999999999999999999987543211110000                     


Q ss_pred             -----cchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHh
Q 025440          140 -----AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILER  197 (252)
Q Consensus       140 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~--~l~~  197 (252)
                           ..+........................+.++.+||.+||..||.+|||++|+++  .+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                 000000000011111111111112235778999999999999999999999987  3544

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=280.12  Aligned_cols=181  Identities=28%  Similarity=0.418  Sum_probs=153.6

Q ss_pred             CCCCChhhhhhcCCC--------------CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      |+||+|.++|.....              ..+++..++.++.||+.||+|||+.+  ||||||||+|||++.++.+||+|
T Consensus       101 ~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~~~~~kl~d  178 (299)
T d1fgka_         101 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIAD  178 (299)
T ss_dssp             CTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECS
T ss_pred             cCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecCCCCeEecc
Confidence            579999999976642              45899999999999999999999876  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |..||.+...               
T Consensus       179 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---------------  243 (299)
T d1fgka_         179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---------------  243 (299)
T ss_dssp             TTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------
T ss_pred             chhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---------------
Confidence            999987654443333455678999999999999999999999999999999998 7888876431               


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                        ......+........+..++..+.+||.+||+.||++|||+.+|++.|+++.+
T Consensus       244 --~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 --EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             --HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence              22334445556667777888999999999999999999999999999998743

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-42  Score=282.33  Aligned_cols=180  Identities=26%  Similarity=0.363  Sum_probs=145.9

Q ss_pred             CCCCChhhhhhcCC----------------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC
Q 025440            1 MPKGSLENHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA   58 (252)
Q Consensus         1 ~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~   58 (252)
                      |++|+|.++|....                      ...+++..++.++.||+.||+|||+++  ||||||||+|||++.
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld~  175 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE  175 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccceEECC
Confidence            57899999996542                      234899999999999999999999765  999999999999999


Q ss_pred             CCceEEccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCC-CCCCCcccccchhhh
Q 025440           59 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLV  137 (252)
Q Consensus        59 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~-~pf~~~~~~~~~~~~  137 (252)
                      ++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|||++|. .||.+...       
T Consensus       176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-------  248 (301)
T d1lufa_         176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-------  248 (301)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------
T ss_pred             CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH-------
Confidence            9999999999997654443333344567899999999999999999999999999999999985 56765431       


Q ss_pred             hhcchhhhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          138 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                                ......+........+..++.++.+||.+||+.||++|||+.+|++.|+++.
T Consensus       249 ----------~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 ----------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             ----------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                      1122223333345567788899999999999999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-42  Score=280.61  Aligned_cols=171  Identities=23%  Similarity=0.382  Sum_probs=129.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec---CCCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||||.++|...+.  +++..+..++.||+.||+|||+++  |+||||||+|||+.   .++.+||+|||+++......
T Consensus        89 ~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          89 VSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             cCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            679999999987665  999999999999999999999765  99999999999994   57899999999998654332


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                         .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+...                ......+....
T Consensus       165 ---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------~~~~~~i~~~~  225 (307)
T d1a06a_         165 ---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----------------AKLFEQILKAE  225 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHTTC
T ss_pred             ---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----------------HHHHHHHhccC
Confidence               23346799999999999999999999999999999999999999976432                11122222222


Q ss_pred             cC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 LG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ..  ......++.++.+||.+||+.||++|||+.|+++.
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            22  23345678899999999999999999999999873

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-42  Score=277.03  Aligned_cols=178  Identities=26%  Similarity=0.353  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.... ..+++..++.++.||++||+|||+++  |+||||||+||+++.++.+||+|||+++........ 
T Consensus        89 ~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-  164 (273)
T d1mp8a_          89 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-  164 (273)
T ss_dssp             CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred             ccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheeccCCcce-
Confidence            57999999886654 34999999999999999999999866  999999999999999999999999999875433222 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+...                 ..+...+.....
T Consensus       165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----------------~~~~~~i~~~~~  227 (273)
T d1mp8a_         165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------------NDVIGRIENGER  227 (273)
T ss_dssp             ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------------GGHHHHHHTTCC
T ss_pred             eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence            2344568999999999999999999999999999999998 8999976532                 112222333444


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .+.+..++.++.+||.+||+.||++|||+.+|++.|+++.
T Consensus       228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            5667788999999999999999999999999999998763

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=280.31  Aligned_cols=172  Identities=25%  Similarity=0.369  Sum_probs=138.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+ .++++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++......  .
T Consensus        91 ~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  165 (288)
T ss_dssp             CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence            68999999986543 34999999999999999999999876  9999999999999999999999999987542211  1


Q ss_pred             eeecccccccccCccccc-----cCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhh
Q 025440           81 VSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD  155 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (252)
                      ......||+.|+|||++.     +..|+.++|||||||++|+|+||+.||.+...                ...+..+..
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----------------~~~~~~i~~  229 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----------------MRVLLKIAK  229 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG----------------GGHHHHHHH
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH----------------HHHHHHHHc
Confidence            123467999999999984     44588999999999999999999999977532                111222222


Q ss_pred             hhc-CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 TKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 ~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ... ....+..++.++.+||.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211 22345678899999999999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=272.79  Aligned_cols=176  Identities=22%  Similarity=0.334  Sum_probs=147.2

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +++|+|.+++..... .+++..++.++.||++||+|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          81 MANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             CTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             cCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            578999999766543 4899999999999999999999765  999999999999999999999999999865443322 


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+...                 ..+...+....+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----------------~~~~~~i~~~~~  219 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQGLR  219 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHHHHHHTTCC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----------------HHHHHHHHhCCC
Confidence            2334568999999999999999999999999999999998 8999987532                 122333344455


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHh
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER  197 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~  197 (252)
                      ...|..++.++.+||.+||+.||++|||++++++.|..
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            66777888999999999999999999999999998854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=280.13  Aligned_cols=169  Identities=28%  Similarity=0.410  Sum_probs=142.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.+.+.  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.......  
T Consensus        87 ~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--  160 (337)
T d1o6la_          87 ANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--  160 (337)
T ss_dssp             CTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--
T ss_pred             cCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCCc--
Confidence            689999999988776  999999999999999999999876  99999999999999999999999999986543222  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.                ......+..  ...
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----------------~~~~~~i~~--~~~  222 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------------ERLFELILM--EEI  222 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHH--CCC
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----------------HHHHHHHhc--CCC
Confidence            23456899999999999999999999999999999999999999987542                111112222  224


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      .+|..++.++.+||.+||++||.+|++     +.++++
T Consensus       223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            567778999999999999999999994     788876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-42  Score=276.95  Aligned_cols=180  Identities=28%  Similarity=0.391  Sum_probs=142.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.......+++.+++.++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+++....... .
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            57999999997765456999999999999999999999765  99999999999999999999999999986543322 2


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..||....                ........+......
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----------------~~~~~~~~i~~~~~~  233 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRM  233 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----------------CHHHHHHHHHTTCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC----------------CHHHHHHHHHhcCCC
Confidence            2334568999999999999999999999999999999999665554321                112223333444556


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      +.+..++.++.+||.+||+.||++||++++|++.|+...
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            677888999999999999999999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-42  Score=280.63  Aligned_cols=167  Identities=27%  Similarity=0.362  Sum_probs=137.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|..++...+.  +++.+++.++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++....     
T Consensus        97 ~~~g~l~~~~~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----  167 (309)
T d1u5ra_          97 CLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----  167 (309)
T ss_dssp             CSEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred             cCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence            578889887776654  999999999999999999999766  99999999999999999999999999986433     


Q ss_pred             eeecccccccccCcccccc---CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhh
Q 025440           81 VSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK  157 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (252)
                       .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+...                ...+..+....
T Consensus       168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----------------~~~~~~i~~~~  230 (309)
T d1u5ra_         168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------------MSALYHIAQNE  230 (309)
T ss_dssp             -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------HHHHHHHHHSC
T ss_pred             -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhCC
Confidence             234579999999999864   4589999999999999999999999976431                12222333333


Q ss_pred             cCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          158 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       158 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....+..++.++.+||.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            333344567889999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-42  Score=274.61  Aligned_cols=179  Identities=25%  Similarity=0.371  Sum_probs=146.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |++|+|.+++..... .+++..++.++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~  168 (273)
T d1u46a_          92 APLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY  168 (273)
T ss_dssp             CTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE
T ss_pred             ecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhcccCCCcc
Confidence            578999998876543 4999999999999999999999865  9999999999999999999999999998765443322


Q ss_pred             -eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 -VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+...                ......+.....
T Consensus       169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----------------~~~~~~i~~~~~  232 (273)
T d1u46a_         169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------------SQILHKIDKEGE  232 (273)
T ss_dssp             EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHHTSCC
T ss_pred             eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----------------HHHHHHHHhCCC
Confidence             2334567889999999999999999999999999999998 8999976432                222333344445


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ..+.+..++..+.+||.+||+.||++|||+.+|++.|.+.
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            5566678889999999999999999999999999999865

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-41  Score=279.09  Aligned_cols=172  Identities=22%  Similarity=0.264  Sum_probs=139.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec--CCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++.+... .+++..+..++.||+.||+|||+++  ||||||||+|||++  .++.+||+|||+++.......
T Consensus       105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            689999999965432 3999999999999999999999876  99999999999995  467899999999987644332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.                ...+..+.....
T Consensus       182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------~~~~~~i~~~~~  242 (350)
T d1koaa2         182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----------------DETLRNVKSCDW  242 (350)
T ss_dssp             ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHTCC
T ss_pred             ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCCC
Confidence               3446799999999999999999999999999999999999999986432                111222222222


Q ss_pred             C--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 G--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .  ......++.++.+||.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1  22234678899999999999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-42  Score=282.67  Aligned_cols=176  Identities=22%  Similarity=0.279  Sum_probs=139.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGD   77 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~   77 (252)
                      |+||||.++|.+.+...|++.++..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+|||+++......
T Consensus        91 ~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          91 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             CCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCCC
Confidence            68999999998877677999999999999999999999766  999999999999975   5679999999998754433


Q ss_pred             cceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHH-Hhhh
Q 025440           78 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDT  156 (252)
Q Consensus        78 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  156 (252)
                      .   .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.......             ..+.. +...
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------------~~~~~~i~~~  232 (335)
T d2ozaa1         169 S---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMKTRIRMG  232 (335)
T ss_dssp             C---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------CCCSC
T ss_pred             c---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-------------HHHHHHHhcC
Confidence            2   34467999999999999999999999999999999999999999764321100             00000 0001


Q ss_pred             hcCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          157 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       157 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ....  .....++.++.+||.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1111  1123567889999999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-42  Score=273.45  Aligned_cols=175  Identities=26%  Similarity=0.442  Sum_probs=142.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      ++||+|.++|.+.....+++..++.++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++.....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCC----
Confidence            57999999997765556999999999999999999999765  999999999999999999999999999864332    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....++..|+|||++.+..++.++|||||||++|||+| |+.||.....                 ......+....+
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----------------~~~~~~i~~~~~  218 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDVVPRVEKGYK  218 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGHHHHHTTTCC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----------------HHHHHHHHcCCC
Confidence             223457899999999999999999999999999999998 7888876432                 122333344455


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ...+..++.++.+||.+||+.||.+|||+.++++.|++++
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            6777788899999999999999999999999999998875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-41  Score=280.86  Aligned_cols=170  Identities=30%  Similarity=0.408  Sum_probs=138.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.++|.+...  +++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+++......   
T Consensus        89 ~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~---  161 (364)
T d1omwa3          89 MNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  161 (364)
T ss_dssp             CCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC---
T ss_pred             cCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCCCc---
Confidence            689999999987765  899999999999999999999766  9999999999999999999999999998754432   


Q ss_pred             eeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           81 VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                       .....||+.|+|||++.+ ..|+.++|||||||++|+|+||+.||.+.......              .... ......
T Consensus       162 -~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------------~~~~-~~~~~~  225 (364)
T d1omwa3         162 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EIDR-MTLTMA  225 (364)
T ss_dssp             -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--------------HHHH-HSSSCC
T ss_pred             -ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--------------HHHH-hcccCC
Confidence             234579999999999865 46899999999999999999999999875321110              0111 111122


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ...+..++.++.+||.+||+.||.+|||     ++++++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            3445678889999999999999999998     688875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.5e-41  Score=278.34  Aligned_cols=172  Identities=22%  Similarity=0.284  Sum_probs=141.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeec--CCCceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.+++...+ ..|++.+++.++.||+.||+|||+++  |+||||||+||||+  .++.+||+|||+++.......
T Consensus       108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            68999999886654 34999999999999999999999765  99999999999997  678999999999987654332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                         .....||+.|+|||++.+..++.++|||||||++|+|+||..||.+...                ...+..+.....
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~~~~i~~~~~  245 (352)
T d1koba_         185 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----------------LETLQNVKRCDW  245 (352)
T ss_dssp             ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----------------HHHHHHHHHCCC
T ss_pred             ---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCCC
Confidence               3445789999999999999999999999999999999999999987532                111222222222


Q ss_pred             --CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          159 --GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       159 --~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                        .......++.++.+||.+||+.||.+|||+.|+++.
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              223345678899999999999999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-41  Score=278.42  Aligned_cols=166  Identities=22%  Similarity=0.308  Sum_probs=140.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.||+|.+++.+.+.  +++..+..++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+++.....    
T Consensus       123 ~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----  194 (350)
T d1rdqe_         123 VAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             CTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             ccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence            579999999988765  999999999999999999999876  999999999999999999999999999875432    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       .....||+.|+|||++.+..++.++|||||||++|+|+||..||.+...                ......+...  ..
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~i~~~--~~  255 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----------------IQIYEKIVSG--KV  255 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHHC--CC
T ss_pred             -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----------------HHHHHHHhcC--CC
Confidence             2345799999999999999999999999999999999999999976431                1111222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++.++.+||.+||+.||.+|+     |++++++
T Consensus       256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            45667888999999999999999994     8999886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-41  Score=273.58  Aligned_cols=180  Identities=27%  Similarity=0.395  Sum_probs=152.2

Q ss_pred             CCCCChhhhhhcCC----------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEE
Q 025440            1 MPKGSLENHLFRRG----------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL   64 (252)
Q Consensus         1 ~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl   64 (252)
                      |+||+|.++|....                ...+++..++.++.||+.||+|||+++  +|||||||+|||++.++.+||
T Consensus       109 ~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~~~~~~ki  186 (311)
T d1t46a_         109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKI  186 (311)
T ss_dssp             CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEETTTEEEE
T ss_pred             CCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccccccccCcccc
Confidence            67999999997653                235999999999999999999999876  999999999999999999999


Q ss_pred             ccccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHh-CCCCCCCcccccchhhhhhcchh
Q 025440           65 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY  143 (252)
Q Consensus        65 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  143 (252)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..+|.+..              
T Consensus       187 ~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--------------  252 (311)
T d1t46a_         187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--------------  252 (311)
T ss_dssp             CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------------
T ss_pred             cccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--------------
Confidence            99999998765555445556789999999999999999999999999999999999 555565532              


Q ss_pred             hhhhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          144 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                        ....+.+++....+...+..++..+.+||.+||+.||.+|||+.+|++.|++.
T Consensus       253 --~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         253 --VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             --SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence              12234455566666677777889999999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-40  Score=272.55  Aligned_cols=166  Identities=27%  Similarity=0.409  Sum_probs=140.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|..++.....  +++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+++.....    
T Consensus        86 ~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----  157 (316)
T d1fota_          86 IEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  157 (316)
T ss_dssp             CCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             cCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence            679999999988776  899999999999999999999765  999999999999999999999999999875432    


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                       ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+.                ......+...  ..
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----------------~~~~~~i~~~--~~  218 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------------MKTYEKILNA--EL  218 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHC--CC
T ss_pred             -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----------------HHHHHHHHcC--CC
Confidence             2346799999999999999999999999999999999999999987431                1112222222  23


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCC-----CHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~v~~  193 (252)
                      ..+..++.++.++|.+||.+||.+|+     |++++++
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            45667888999999999999999996     8999886

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.2e-41  Score=270.06  Aligned_cols=179  Identities=26%  Similarity=0.384  Sum_probs=137.6

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCC-cc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~   79 (252)
                      |+||+|.+++...+.  +++.+++.++.||+.||+|||+++  |+||||||+|||++.++.++|+|||++....... ..
T Consensus        93 ~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~  168 (277)
T d1o6ya_          93 VDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV  168 (277)
T ss_dssp             CCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC------
T ss_pred             CCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhccccccc
Confidence            578999999988765  999999999999999999999765  9999999999999999999999999987643322 22


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcC
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG  159 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (252)
                      ......+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+...                .......+.....
T Consensus       169 ~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----------------~~~~~~~~~~~~~  232 (277)
T d1o6ya_         169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----------------VSVAYQHVREDPI  232 (277)
T ss_dssp             ----------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------------HHHHHHHHHCCCC
T ss_pred             cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH----------------HHHHHHHHhcCCC
Confidence            224456799999999999999999999999999999999999999986432                1111122221111


Q ss_pred             --CCCcHHHHHHHHHHHHhhccCCCCCCC-CHHHHHHHHHhhc
Q 025440          160 --GQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE  199 (252)
Q Consensus       160 --~~~~~~~~~~~~~li~~~l~~dp~~Rp-t~~~v~~~l~~~~  199 (252)
                        ......++.++.+||.+||+.||.+|| |++++++.|.++.
T Consensus       233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence              112345778999999999999999999 8999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=269.09  Aligned_cols=170  Identities=25%  Similarity=0.334  Sum_probs=138.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC----ceEEccccccccCCCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPTG   76 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~   76 (252)
                      |+||+|.++|.+.+.  +++..++.++.||+.||+|||+.+  |+||||||+|||++.++    .+||+|||++......
T Consensus        95 ~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~  170 (293)
T d1jksa_          95 VAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG  170 (293)
T ss_dssp             CCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred             CCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence            689999999987765  999999999999999999999776  99999999999998776    4999999999876443


Q ss_pred             CcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhh
Q 025440           77 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT  156 (252)
Q Consensus        77 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (252)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..                .....+...
T Consensus       171 ~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~~~~i~~~  231 (293)
T d1jksa_         171 NE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----------------ETLANVSAV  231 (293)
T ss_dssp             CB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHTT
T ss_pred             cc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhc
Confidence            32   23457899999999999999999999999999999999999999875321                111111111


Q ss_pred             hcCC--CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          157 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       157 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ....  ..+..++..+.+||.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111  112356778999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=272.91  Aligned_cols=169  Identities=28%  Similarity=0.430  Sum_probs=141.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||+|.+++.....  +++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        85 ~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--  158 (320)
T d1xjda_          85 LNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--  158 (320)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred             cCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence            689999999987765  899999999999999999999876  99999999999999999999999999986543322  


Q ss_pred             eeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           81 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.                ......+..  ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----------------~~~~~~i~~--~~~  220 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----------------EELFHSIRM--DNP  220 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHHH--CCC
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----------------HHHHHHHHc--CCC
Confidence            23446799999999999999999999999999999999999999987532                111112221  233


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHH-HHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMS-EVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~-~v~~  193 (252)
                      ..+..++.++.+||.+||+.||.+||++. ++++
T Consensus       221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            55667889999999999999999999995 6754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=269.46  Aligned_cols=182  Identities=26%  Similarity=0.355  Sum_probs=146.5

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      |+||+|.+++..... .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++........ 
T Consensus       111 ~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         111 MKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             CTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             eecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            679999999976553 4889999999999999999999765  999999999999999999999999999875433221 


Q ss_pred             -eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           80 -HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        80 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                       .......||..|+|||.+.+..++.++||||||+++|||+||..||.....                .......+....
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----------------~~~~~~~i~~g~  251 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------------TFDITVYLLQGR  251 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------CHHHHHTTC
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----------------HHHHHHHHHcCC
Confidence             122335689999999999999999999999999999999998888765321                111122222333


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcCC
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP  201 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~~  201 (252)
                      +...+..++.++.+||.+||+.||++||++.||++.|+++...
T Consensus       252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            4556677888999999999999999999999999999998643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-40  Score=264.54  Aligned_cols=170  Identities=30%  Similarity=0.368  Sum_probs=140.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |+||||.++|..++.  +++.++..++.||++||+|||+++  |+||||||+|||++.++.+||+|||+++.......  
T Consensus        92 ~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~--  165 (277)
T d1phka_          92 MKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--  165 (277)
T ss_dssp             CTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--
T ss_pred             CCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchheeEccCCCc--
Confidence            679999999987765  999999999999999999999765  99999999999999999999999999987654332  


Q ss_pred             eeecccccccccCcccccc------CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHh
Q 025440           81 VSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (252)
                       .....||..|+|||.+.+      ..++.++||||+||++|+|++|+.||.+...                ......+.
T Consensus       166 -~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----------------~~~~~~i~  228 (277)
T d1phka_         166 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------------MLMLRMIM  228 (277)
T ss_dssp             -BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------------HHHHHHHH
T ss_pred             -eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----------------HHHHHHHH
Confidence             344679999999999864      3468899999999999999999999987532                11222233


Q ss_pred             hhhcC--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      .....  ......++.++.+||.+||+.||.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            33222  2334578899999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-40  Score=270.00  Aligned_cols=178  Identities=27%  Similarity=0.384  Sum_probs=145.7

Q ss_pred             CCCCChhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcc
Q 025440            1 MPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD   66 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~D   66 (252)
                      ++||+|.++|++..              ...|++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~kl~D  170 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIAD  170 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCceEEcc
Confidence            58999999997652              245999999999999999999999865  99999999999999999999999


Q ss_pred             ccccccCCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCC-CCCCCcccccchhhhhhcchhhh
Q 025440           67 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLS  145 (252)
Q Consensus        67 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~  145 (252)
                      ||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|. .||.+.+                
T Consensus       171 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~----------------  231 (309)
T d1fvra_         171 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----------------  231 (309)
T ss_dssp             TTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------
T ss_pred             cccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC----------------
Confidence            999976433221   23346899999999999999999999999999999999965 5676542                


Q ss_pred             hhhhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          146 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                       ...+...+....+...+..++.++.+||.+||+.||++|||+.+|++.|+++..
T Consensus       232 -~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         232 -CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             -HHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             122233333444556677889999999999999999999999999999998754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-40  Score=267.09  Aligned_cols=195  Identities=23%  Similarity=0.265  Sum_probs=142.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcC------CCCeeeccCCCCceeecCCCceEEccccccccCC
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP   74 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~   74 (252)
                      |++|+|.++|.+..   +++..++.++.|++.||+|||+.      .++||||||||+||||+.++.+||+|||+++...
T Consensus        83 ~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          83 HEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             ccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            57999999997753   99999999999999999999974      3569999999999999999999999999998654


Q ss_pred             CCCcce--eeecccccccccCccccccCC------CCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhh
Q 025440           75 TGDRTH--VSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD  146 (252)
Q Consensus        75 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  146 (252)
                      ......  ......||+.|+|||++.+..      ++.++|||||||++|||+||..||............ ........
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~  238 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSV  238 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSCCH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cccccchH
Confidence            332211  234567999999999987642      577899999999999999999888654332111110 00000011


Q ss_pred             hhhHHHHhhhhcCCCCcH-----HHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          147 KRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      ............+...+.     .....+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111112222233333322     35567999999999999999999999999998875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-40  Score=267.63  Aligned_cols=181  Identities=24%  Similarity=0.367  Sum_probs=148.3

Q ss_pred             CCCCChhhhhhcCC--------CCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEcccccccc
Q 025440            1 MPKGSLENHLFRRG--------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus         1 ~~ggsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      |++|+|.+++....        ...+++..++.++.|+++||.|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~DFGla~~  182 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD  182 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEeeccccee
Confidence            57999999986432        234799999999999999999999765  99999999999999999999999999987


Q ss_pred             CCCCCcceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhC-CCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           73 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        73 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ..............||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+..                 .....
T Consensus       183 ~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----------------~~~~~  245 (308)
T d1p4oa_         183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----------------NEQVL  245 (308)
T ss_dssp             GGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----------------HHHHH
T ss_pred             ccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----------------HHHHH
Confidence            5444433334445789999999999999999999999999999999998 46776542                 11222


Q ss_pred             HHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhcC
Q 025440          152 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA  200 (252)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~~  200 (252)
                      ..+........+..++..+.+||.+||+.||++|||+.+|++.|++...
T Consensus       246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            3333344455667788999999999999999999999999999987644

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-40  Score=262.23  Aligned_cols=159  Identities=25%  Similarity=0.367  Sum_probs=131.7

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-CCceEEccccccccCCCCCccee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      +++|.+++...+.  +++.++..++.||+.||+|||+.+  |+||||||+|||++. ++.+||+|||+++......    
T Consensus        94 ~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----  165 (273)
T d1xwsa_          94 VQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----  165 (273)
T ss_dssp             EEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----
T ss_pred             cchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceeccccc----
Confidence            3678888877665  999999999999999999999765  999999999999985 4789999999998653322    


Q ss_pred             eecccccccccCccccccCCC-CcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhcCC
Q 025440           82 STQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG  160 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (252)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+..                      .+..  ...
T Consensus       166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------------------~i~~--~~~  221 (273)
T d1xwsa_         166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------------EIIR--GQV  221 (273)
T ss_dssp             BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------------HHHH--CCC
T ss_pred             ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------------------HHhh--ccc
Confidence            335679999999999988776 567899999999999999999997531                      0111  112


Q ss_pred             CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          161 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       161 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ..+..++.++.+||.+||+.||++|||++|+++
T Consensus       222 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            344567889999999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-39  Score=262.94  Aligned_cols=171  Identities=21%  Similarity=0.234  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCC--CceEEccccccccCCCCCc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~   78 (252)
                      |+||+|.++|.+.+ ..+++.++..++.||+.||+|||+++  |+||||||+|||++.+  +.+||+|||+++.......
T Consensus        83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            67999999997654 24999999999999999999999765  9999999999999754  4799999999987544332


Q ss_pred             ceeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           79 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        79 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                         .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+...                ......+.....
T Consensus       160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----------------~~~~~~i~~~~~  220 (321)
T d1tkia_         160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----------------QQIIENIMNAEY  220 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----------------HHHHHHHHHTCC
T ss_pred             ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----------------HHHHHHHHhCCC
Confidence               3445789999999999999999999999999999999999999987532                111222222221


Q ss_pred             CCC--CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          159 GGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       159 ~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ...  ....++.++.+||.+||..||.+|||+.|+++
T Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111  11246788999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-39  Score=260.87  Aligned_cols=187  Identities=23%  Similarity=0.175  Sum_probs=131.4

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||++..++....  .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          82 METDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             CSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             hcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            34566665554443  3899999999999999999999866  999999999999999999999999999875443322 


Q ss_pred             eeecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhh-cchh---hhhhhhHHHHh
Q 025440           81 VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPY---LSDKRKLFRIM  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~-~~~~---~~~~~~~~~~~  154 (252)
                       ....+||+.|+|||++.+. .++.++|||||||++|||+||..||.+........ +... ..+.   ...........
T Consensus       157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence             3345799999999998755 57999999999999999999999998754211000 0000 0000   00000000000


Q ss_pred             hhhcCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 DTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 ~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ........     ...++.++.+||.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000     1235678999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-38  Score=258.11  Aligned_cols=187  Identities=22%  Similarity=0.262  Sum_probs=133.7

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCccee
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV   81 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~   81 (252)
                      .||++.... ......+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++......   .
T Consensus        98 ~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~  171 (305)
T d1blxa_          98 DQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---A  171 (305)
T ss_dssp             SCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---G
T ss_pred             cCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhhhhcccc---c
Confidence            455544333 334455999999999999999999999766  9999999999999999999999999987643322   2


Q ss_pred             eecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhc-ch---hhhhhhhH-HHHhh
Q 025440           82 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KP---YLSDKRKL-FRIMD  155 (252)
Q Consensus        82 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~-~~---~~~~~~~~-~~~~~  155 (252)
                      .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...... +.... .+   ........ .....
T Consensus       172 ~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  251 (305)
T d1blxa_         172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH  251 (305)
T ss_dssp             GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC
T ss_pred             CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhc
Confidence            345679999999999999999999999999999999999999998754321100 00000 00   00000000 00000


Q ss_pred             hhc---CCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          156 TKL---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       156 ~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      ...   .......++..+.+||.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000   011223467789999999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-38  Score=257.95  Aligned_cols=181  Identities=21%  Similarity=0.207  Sum_probs=137.2

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC---CCceEEccccccccCCCCCc
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDFGLAKAGPTGDR   78 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~   78 (252)
                      -||+|.+++.... ..+++..++.++.|++.||+|||+++  |+||||||+|||++.   +..++|+|||+++.......
T Consensus        85 ~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          85 LGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             cCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            3678887776554 34999999999999999999999866  999999999999854   45699999999987644322


Q ss_pred             c-----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHH
Q 025440           79 T-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI  153 (252)
Q Consensus        79 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (252)
                      .     .......||+.|+|||++.+..++.++|||||||++|||+||..||...........             ....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-------------~~~~  228 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-------------YERI  228 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------------------HHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-------------HHHh
Confidence            1     123456799999999999999999999999999999999999999976543211110             0011


Q ss_pred             hhhhcCCC---CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhh
Q 025440          154 MDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL  198 (252)
Q Consensus       154 ~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~  198 (252)
                      ........   ....++.++.+||.+||+.||++||++.++.+.|+.+
T Consensus       229 ~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            11111111   1234678899999999999999999999998888765

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.6e-38  Score=253.28  Aligned_cols=182  Identities=18%  Similarity=0.173  Sum_probs=140.7

Q ss_pred             CCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecC-----CCceEEccccccccCCCC
Q 025440            2 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLSDFGLAKAGPTG   76 (252)
Q Consensus         2 ~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~   76 (252)
                      .||+|.+++...+. .++...++.++.|++.||+|||+.+  |+||||||+|||++.     ++.+||+|||+++.....
T Consensus        83 ~~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          83 LGPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CCCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             cCCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            48999999977653 4999999999999999999999765  999999999999964     578999999999875432


Q ss_pred             Ccc-----eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHH
Q 025440           77 DRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF  151 (252)
Q Consensus        77 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (252)
                      ...     ......+||+.|+|||++.+..++.++|||||||++|||+||..||.+........             ...
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-------------~~~  226 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-------------KYE  226 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-------------HHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-------------HHH
Confidence            211     12345679999999999999999999999999999999999999998754321111             011


Q ss_pred             HHhhhhcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHHHHhhc
Q 025440          152 RIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE  199 (252)
Q Consensus       152 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~l~~~~  199 (252)
                      .+.......   ....+++.++.+++..|+..+|++||+++.+.+.|+++.
T Consensus       227 ~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111111100   111245678999999999999999999999988887753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-38  Score=254.59  Aligned_cols=188  Identities=22%  Similarity=0.253  Sum_probs=133.2

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      +|++.+++.......+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++.......  ..
T Consensus        84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~  159 (298)
T d1gz8a_          84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY  159 (298)
T ss_dssp             SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CT
T ss_pred             CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc--cc
Confidence            456667776665566999999999999999999999766  99999999999999999999999999976533221  23


Q ss_pred             ecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcchhhhhhhhHHHHhh--hh
Q 025440           83 TQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFRIMD--TK  157 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~--~~  157 (252)
                      ....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+...... ... ...+.............  ..
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            3457899999999887765 4789999999999999999999998754211000 000 00000000000000000  00


Q ss_pred             ----cCCC---CcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 ----LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 ----~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                          ....   ....++.++.+||.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                0000   012346789999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-37  Score=256.07  Aligned_cols=189  Identities=25%  Similarity=0.267  Sum_probs=135.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc-
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-   79 (252)
                      +.||||.+++....   +++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++........ 
T Consensus        92 ~~~g~L~~~l~~~~---l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~  166 (345)
T d1pmea_          92 LMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT  166 (345)
T ss_dssp             CCCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred             ecCCchhhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence            46899999997653   999999999999999999999765  999999999999999999999999999765332211 


Q ss_pred             eeeecccccccccCcccccc-CCCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhh--cchhhh-----hhhhHH
Q 025440           80 HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW--AKPYLS-----DKRKLF  151 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~--~~~~~~-----~~~~~~  151 (252)
                      ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+............  ..+...     ......
T Consensus       167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T d1pmea_         167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR  246 (345)
T ss_dssp             CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred             eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence            11244578999999999844 4678999999999999999999999987543211111000  000000     000000


Q ss_pred             HHhh-hhcCCCC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          152 RIMD-TKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       152 ~~~~-~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .... .......     ...++.++.+||.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 0000011     12345689999999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=253.02  Aligned_cols=174  Identities=29%  Similarity=0.363  Sum_probs=137.7

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      |.||+|.+++...+.  +.+..+..++.||+.||+|||+.+  |+||||||+|||++.+|.+||+|||+++........ 
T Consensus       111 ~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-  185 (322)
T d1vzoa_         111 INGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-  185 (322)
T ss_dssp             CCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-
T ss_pred             ccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhhhcccccc-
Confidence            579999999988776  789999999999999999999766  999999999999999999999999999865433222 


Q ss_pred             eeecccccccccCccccccC--CCCcccceehhHHHHHHHHhCCCCCCCcccccchhhhhhcchhhhhhhhHHHHhhhhc
Q 025440           81 VSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL  158 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (252)
                      ......|++.|+|||.+.+.  .++.++|||||||++|+|++|..||.+......             ....... ....
T Consensus       186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-------------~~~i~~~-~~~~  251 (322)
T d1vzoa_         186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------------QAEISRR-ILKS  251 (322)
T ss_dssp             GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-------------HHHHHHH-HHHC
T ss_pred             cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHHh-cccC
Confidence            23445789999999999765  467899999999999999999999987542110             0111111 1122


Q ss_pred             CCCCcHHHHHHHHHHHHhhccCCCCCCCC-----HHHHHH
Q 025440          159 GGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA  193 (252)
Q Consensus       159 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt-----~~~v~~  193 (252)
                      ....+..++.++.+||.+||+.||++|||     ++|+++
T Consensus       252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            33456678999999999999999999994     788875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.9e-37  Score=247.84  Aligned_cols=185  Identities=21%  Similarity=0.253  Sum_probs=126.4

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |+.+..+....+  .+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||++........  ..
T Consensus        84 ~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  157 (286)
T d1ob3a_          84 QDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KY  157 (286)
T ss_dssp             EEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             hhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCcc--cc
Confidence            344444444443  4999999999999999999999866  99999999999999999999999999976433221  13


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcch---hhhhhhhHHHHhh-
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAKP---YLSDKRKLFRIMD-  155 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~~---~~~~~~~~~~~~~-  155 (252)
                      ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+........  ......+   ............. 
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            344689999999998765 46899999999999999999999998754211100  0000000   0000000000000 


Q ss_pred             -----hhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          156 -----TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       156 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                           ..........++..+.+||.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00001112345778999999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-36  Score=245.79  Aligned_cols=177  Identities=20%  Similarity=0.248  Sum_probs=123.3

Q ss_pred             CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcc--eeeecccccccccC
Q 025440           16 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAA   93 (252)
Q Consensus        16 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~a   93 (252)
                      ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++........  ......+||+.|+|
T Consensus       112 ~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~a  189 (318)
T d3blha1         112 VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP  189 (318)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCC
T ss_pred             cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhh
Confidence            34899999999999999999999765  999999999999999999999999999765433221  12234579999999


Q ss_pred             ccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchhh-hhhcchh----hhh--hhhHHHHhhhhcCCCC--c
Q 025440           94 PEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPY----LSD--KRKLFRIMDTKLGGQY--P  163 (252)
Q Consensus        94 PE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~-~~~~~~~----~~~--~~~~~~~~~~~~~~~~--~  163 (252)
                      ||++.+. .++.++|||||||++|||++|+.||.+......... .......    ...  ................  .
T Consensus       190 PE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (318)
T d3blha1         190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK  269 (318)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHH
T ss_pred             HHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccch
Confidence            9998765 689999999999999999999999987543211110 0000000    000  0000000000000000  0


Q ss_pred             -----HHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          164 -----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       164 -----~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                           ...+..+.+||.+||+.||++|||++|+++.
T Consensus       270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                 1124577899999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-36  Score=249.59  Aligned_cols=177  Identities=24%  Similarity=0.296  Sum_probs=127.8

Q ss_pred             CCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcceeeecccccccccCc
Q 025440           16 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP   94 (252)
Q Consensus        16 ~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP   94 (252)
                      ..+++.++..++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||+++.......   ....+||..|+||
T Consensus       117 ~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP  191 (350)
T d1q5ka_         117 QTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAP  191 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccCh
Confidence            45999999999999999999999765  99999999999999775 899999999987544322   2345789999999


Q ss_pred             cccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhh-hcchhhhhhhhHHHHhhhhcC------------
Q 025440           95 EYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPYLSDKRKLFRIMDTKLG------------  159 (252)
Q Consensus        95 E~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~------------  159 (252)
                      |.+.+. .++.++|||||||++|||++|+.||.......... +.. ...+..   ..+.........            
T Consensus       192 E~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  268 (350)
T d1q5ka_         192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR---EQIREMNPNYTEFKFPQIKAHPWT  268 (350)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH---HHHHHHCC---CCCCCCCCCCCGG
T ss_pred             HHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH---HhhhhhccchhhccccccccCchh
Confidence            988654 68999999999999999999999997654321100 000 000000   000000000000            


Q ss_pred             CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH--HHHhhcC
Q 025440          160 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEA  200 (252)
Q Consensus       160 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~--~l~~~~~  200 (252)
                      .......+.++.+||.+||..||++|||+.|+++  .++.+..
T Consensus       269 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            0112346778999999999999999999999996  3555543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=249.57  Aligned_cols=182  Identities=22%  Similarity=0.283  Sum_probs=132.0

Q ss_pred             CCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceee
Q 025440            3 KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS   82 (252)
Q Consensus         3 ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~   82 (252)
                      |++|..++...   .|++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....     .
T Consensus       106 ~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~  175 (346)
T d1cm8a_         106 GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M  175 (346)
T ss_dssp             SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----C
T ss_pred             cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceeccCCc-----c
Confidence            45666666443   3999999999999999999999876  999999999999999999999999999875432     2


Q ss_pred             ecccccccccCccccccC-CCCcccceehhHHHHHHHHhCCCCCCCcccccchh-hhhhcc--------hhhh-hhhhHH
Q 025440           83 TQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK--------PYLS-DKRKLF  151 (252)
Q Consensus        83 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~-~~~~~~--------~~~~-~~~~~~  151 (252)
                      +...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+...... ......        .... ......
T Consensus       176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (346)
T d1cm8a_         176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM  255 (346)
T ss_dssp             CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred             ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhh
Confidence            345789999999998765 56899999999999999999999998764321100 000000        0000 000000


Q ss_pred             HHhhhhcCC---CCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          152 RIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       152 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                      .........   .....++..+.+||.+||..||.+|||+.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000000   1123457789999999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.9e-35  Score=242.97  Aligned_cols=183  Identities=17%  Similarity=0.198  Sum_probs=131.8

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCC-ceEEccccccccCCCCCcc
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~   79 (252)
                      |.+|+|..+.     +.+++..+..++.||+.||+|||+++  |+||||||+|||++.++ .+||+|||+++....... 
T Consensus       114 ~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-  185 (328)
T d3bqca1         114 VNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-  185 (328)
T ss_dssp             CCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred             cCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence            4678887664     23999999999999999999999876  99999999999998655 599999999987544332 


Q ss_pred             eeeecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchhhh--hhcc-hhhhhh--------
Q 025440           80 HVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAK-PYLSDK--------  147 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~--~~~~-~~~~~~--------  147 (252)
                        ....++|..|+|||.+.+.. ++.++|||||||++|+|++|..||............  .... +.....        
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence              34457899999999987754 799999999999999999999999765432111100  0000 000000        


Q ss_pred             -hhHHHH--------hhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          148 -RKLFRI--------MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       148 -~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                       ......        ............++.++.+||.+||..||.+|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000        0001111223456788999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=246.09  Aligned_cols=183  Identities=24%  Similarity=0.295  Sum_probs=130.0

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.||+|.+++...   .+++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+|++|||++......    
T Consensus       104 ~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~----  174 (348)
T d2gfsa1         104 LMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----  174 (348)
T ss_dssp             CCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTGG----
T ss_pred             ecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCcc----
Confidence            4689999999553   3999999999999999999999765  999999999999999999999999998764321    


Q ss_pred             eeecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchhhh-hh-cch---hhh--hhhhHHH
Q 025440           81 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AKP---YLS--DKRKLFR  152 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~~~-~~-~~~---~~~--~~~~~~~  152 (252)
                       .....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+........ .. ..+   ...  .......
T Consensus       175 -~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (348)
T d2gfsa1         175 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  253 (348)
T ss_dssp             -GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred             -cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence             23456899999999876654 688999999999999999999999876432111100 00 000   000  0000000


Q ss_pred             HhhhhcCC-CC-----cHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          153 IMDTKLGG-QY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       153 ~~~~~~~~-~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                      ........ ..     ...++.++.+||.+||..||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00000000 00     1245678999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-35  Score=236.05  Aligned_cols=187  Identities=22%  Similarity=0.209  Sum_probs=133.1

Q ss_pred             CCCCChhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcce
Q 025440            1 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH   80 (252)
Q Consensus         1 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~   80 (252)
                      +.|++|..++...+.  +++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||.++........ 
T Consensus        83 ~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-  157 (292)
T d1unla_          83 CDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             CSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred             ccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence            356777777766554  899999999999999999999765  999999999999999999999999999875443322 


Q ss_pred             eeecccccccccCccccccCC-CCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhh-cchhhhhhhhHHHHh--
Q 025440           81 VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDW-AKPYLSDKRKLFRIM--  154 (252)
Q Consensus        81 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~--  154 (252)
                       .....++..|+|||++.+.. ++.++|||||||++|||++|..||.......+..  +... ..+............  
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence             33345788999999987765 6899999999999999999999975433211110  0000 000000000000000  


Q ss_pred             -------hhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          155 -------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       155 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                             ............+..+.+||.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   000111223456778999999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-34  Score=237.39  Aligned_cols=172  Identities=22%  Similarity=0.288  Sum_probs=119.5

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   97 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   97 (252)
                      +++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++++|||+++......   ......+|+.|+|||++
T Consensus       116 ~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l  190 (355)
T d2b1pa1         116 LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI  190 (355)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhh
Confidence            899999999999999999999876  9999999999999999999999999987654332   23445789999999999


Q ss_pred             ccCCCCcccceehhHHHHHHHHhCCCCCCCcccccchh--hhhhcc---hhhhh-hhhHHHHhhhh--------------
Q 025440           98 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWAK---PYLSD-KRKLFRIMDTK--------------  157 (252)
Q Consensus        98 ~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~~~--~~~~~~---~~~~~-~~~~~~~~~~~--------------  157 (252)
                      .+..++.++||||+||++|+|++|+.||.+.+......  ......   ..... ...........              
T Consensus       191 ~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (355)
T d2b1pa1         191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD  270 (355)
T ss_dssp             TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCG
T ss_pred             cCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccc
Confidence            99999999999999999999999999998754321100  000000   00000 00001111110              


Q ss_pred             -c-C--CCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHHH
Q 025440          158 -L-G--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI  194 (252)
Q Consensus       158 -~-~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~~  194 (252)
                       . .  .......+.++.+||.+||..||++|||++|+++.
T Consensus       271 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             GGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             0 0  01123467889999999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=4.1e-33  Score=231.77  Aligned_cols=180  Identities=16%  Similarity=0.219  Sum_probs=127.3

Q ss_pred             hhhhhhcCCCCCCCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCc------eEEccccccccCCCCCcc
Q 025440            6 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN------AKLSDFGLAKAGPTGDRT   79 (252)
Q Consensus         6 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~------~kl~Dfg~~~~~~~~~~~   79 (252)
                      ...+........+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.      ++++|||.+......   
T Consensus       110 ~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---  185 (362)
T d1q8ya_         110 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---  185 (362)
T ss_dssp             HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---
T ss_pred             cccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeeccCcccccceeeEeecccccccccc---
Confidence            33444444555699999999999999999999972 35999999999999976653      999999998764332   


Q ss_pred             eeeecccccccccCccccccCCCCcccceehhHHHHHHHHhCCCCCCCcccccc----hhhhhhcchhhh-------hh-
Q 025440           80 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE----QSLVDWAKPYLS-------DK-  147 (252)
Q Consensus        80 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~lltg~~pf~~~~~~~~----~~~~~~~~~~~~-------~~-  147 (252)
                        ....+||+.|+|||++.+..++.++|||||||++++|++|+.||........    ..+.........       .. 
T Consensus       186 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~  263 (362)
T d1q8ya_         186 --YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK  263 (362)
T ss_dssp             --CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred             --cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccc
Confidence              2345789999999999999999999999999999999999999975432110    000000000000       00 


Q ss_pred             --------------------hhHHHHhhhhcCCCCcHHHHHHHHHHHHhhccCCCCCCCCHHHHHH
Q 025440          148 --------------------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA  193 (252)
Q Consensus       148 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~v~~  193 (252)
                                          .......  ..........+.++.+||.+||..||.+|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         264 YTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             THHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             ccccccccchhhhccccccCCchhhhc--ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                                0000000  0122344567889999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.51  E-value=5e-16  Score=116.50  Aligned_cols=90  Identities=12%  Similarity=0.063  Sum_probs=61.1

Q ss_pred             CCHHHHHHHHHHHHHHhHHHhcCCCCeeeccCCCCceeecCCCceEEccccccccCCCCCcceeeecccccccccCcccc
Q 025440           18 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV   97 (252)
Q Consensus        18 l~~~~~~~i~~~i~~~l~~lH~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~   97 (252)
                      ++...+..++.|++.+|+|||+++  |+||||||+|||++++ .++|+|||++...............+..    -.+.+
T Consensus       100 l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~f  172 (191)
T d1zara2         100 VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IITYF  172 (191)
T ss_dssp             CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHHHH
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHHHH
Confidence            555667789999999999999765  9999999999999865 4899999998764322111000000000    01111


Q ss_pred             ccCCCCcccceehhHHHH
Q 025440           98 ATGRLTTKSDVYSFGVVL  115 (252)
Q Consensus        98 ~~~~~~~~~Di~slG~il  115 (252)
                       ...|+.++|+||+.--+
T Consensus       173 -~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         173 -SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -HHHHCCCCCHHHHHHHH
T ss_pred             -cCCCCCcccHHHHHHHH
Confidence             35678899999975433

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.03  E-value=0.00087  Score=52.32  Aligned_cols=30  Identities=27%  Similarity=0.258  Sum_probs=27.0

Q ss_pred             CCeeeccCCCCceeecCCCceEEccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      .++||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            469999999999999988878899999875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=95.36  E-value=0.0032  Score=47.34  Aligned_cols=30  Identities=20%  Similarity=0.194  Sum_probs=25.5

Q ss_pred             CeeeccCCCCceeecCCCceEEcccccccc
Q 025440           43 QVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .++|+|+.+.|||+++++.+.|+||+.+..
T Consensus       184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEEeeccCcceeecCCceEEEeechhccc
Confidence            489999999999999876677999987753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=95.06  E-value=0.0035  Score=46.89  Aligned_cols=29  Identities=21%  Similarity=0.126  Sum_probs=25.2

Q ss_pred             CeeeccCCCCceeecCCCceEEccccccc
Q 025440           43 QVIYRDFKASNILLDAEFNAKLSDFGLAK   71 (252)
Q Consensus        43 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~   71 (252)
                      .++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            48999999999999987667899998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.71  E-value=0.012  Score=45.93  Aligned_cols=29  Identities=24%  Similarity=0.176  Sum_probs=23.8

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      .++||+|+.+.|||+++ + ..++||+-++.
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            46999999999999974 3 45899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.50  E-value=0.017  Score=46.23  Aligned_cols=30  Identities=20%  Similarity=0.186  Sum_probs=25.8

Q ss_pred             CCeeeccCCCCceeecCCCceEEcccccccc
Q 025440           42 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA   72 (252)
Q Consensus        42 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~   72 (252)
                      ..++|+|+.+.|||++.++ ++|+||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            4599999999999998765 89999988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=88.06  E-value=0.086  Score=41.94  Aligned_cols=15  Identities=33%  Similarity=0.454  Sum_probs=13.3

Q ss_pred             eeeccCCCCceeecC
Q 025440           44 VIYRDFKASNILLDA   58 (252)
Q Consensus        44 ivH~dlkp~Nill~~   58 (252)
                      ++|+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            689999999999854